0001469709-14-000352.txt : 20140815 0001469709-14-000352.hdr.sgml : 20140815 20140815165349 ACCESSION NUMBER: 0001469709-14-000352 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20140630 FILED AS OF DATE: 20140815 DATE AS OF CHANGE: 20140815 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entia Biosciences, Inc. CENTRAL INDEX KEY: 0001408299 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 260561199 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-52864 FILM NUMBER: 141047099 BUSINESS ADDRESS: STREET 1: 13565 SW TUALATIN-SHERWOOD RD. STREET 2: SUITE 800 CITY: SHERWOOD STATE: OR ZIP: 97140 BUSINESS PHONE: 844-559-9910 MAIL ADDRESS: STREET 1: 13565 SW TUALATIN-SHERWOOD RD. STREET 2: SUITE 800 CITY: SHERWOOD STATE: OR ZIP: 97140 FORMER COMPANY: FORMER CONFORMED NAME: Total Nutraceutical Solutions, Inc. DATE OF NAME CHANGE: 20090608 FORMER COMPANY: FORMER CONFORMED NAME: Total Nutraceutical Solutions DATE OF NAME CHANGE: 20081024 FORMER COMPANY: FORMER CONFORMED NAME: Generic Marketing Services, Inc. DATE OF NAME CHANGE: 20070730 10-Q 1 ergo10q_063014apg.htm ERGO 10-Q 06/30/14 ERGO 10-Q 06/30/14

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


[X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

        EXCHANGE ACT OF 1934


For the Quarterly Period ended June 30, 2014


  [   ]

TRANSITION REPORT PURSUANT SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

For the Transition Period from _______ to _______.


Commission File Number:  000-52864


[ergo10q_063014apg001.jpg]


Entia Biosciences, Inc.

 (Exact name of Registrant as specified in its charter)


Nevada

26-0561199

(State or other jurisdiction

(IRS Employer

of incorporation or organization)

Identification No.)

 

13565 SW Tualatin-Sherwood Rd #800, Sherwood, OR 97140

 (Address of principal executive offices)


(503) 334-3575

 (Registrant’s telephone number)


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes [X]  No [   ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive DataFile required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).YES [X]  NO [   ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer [  ]

Accelerated filer [  ] 

Non-accelerated filer [  ] 

Smaller reporting company [X]


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes [   ]  No [X]


On July 18, 2014, 9,359,621 shares of the registrant's common stock, par value $0.001 per share, were outstanding.






TABLE OF CONTENTS

 

 

 

 

 

 

 

PART I - FINANCIAL INFORMATION

 

 

 

 

3

Item 1.

Financial Statements

 

 

 

 

3

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

20

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

23

Item 4.

Controls and Procedures

 

 

 

 

23

PART II - OTHER INFORMATION

 

 

 

 

23

Item 1.

Legal Proceedings

 

 

 

 

23

Item 1A.

Risk Factors

 

 

 

 

23

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

 

 

23

Item 3.

Defaults upon Senior Securities

 

 

 

 

24

Item 4.

Mine Safety Disclosures

 

 

 

 

24

Item 5.

Other Information

 

 

 

 

24

Item 6.

Exhibits

 

 

 

 

24

SIGNATURES

 

 

 

 

26



2



Part 1: FINANCIAL INFORMATION

Item 1. Financial Statements

 ENTIA BIOSCIENCES, INC.

 CONSOLIDATED BALANCE SHEETS

 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30,

2014

 

 

December 31,

2013

 Assets

 

 

 

 

 

 

 

 Current Assets:

 

 

 

 

 

 

 

 Cash

 

 

$

15,484 

 

 $

36,886 

 

 Accounts receivable, net

 

 

30,770 

 

 

11,197 

 

 Inventory, net

 

 

113,066 

 

 

138,941 

 

 Interest income receivable

 

 

 

 

3,965 

 

 Prepaid expenses

 

 

22,973 

 

 

34,462 

 

 Other current assets

 

 

1,300 

 

 

 

 

 Total Current Assets

 

 

183,593 

 

 

225,451 

 

 

 

 

 

 

 

 

 

 

 Property and Equipment, net

 

 

52,787 

 

 

62,145 

 Patents and license, net

 

 

343,141 

 

 

343,498 

 Total Assets

 

$

579,521 

 

 $

631,094 

 

 

 

 

 

 

 

 

 

 

 Liabilities and Stockholders' Equity (Deficit)

 

 

 

 

 

 

 Current Liabilities:

 

 

 

 

 

 

 

 Accounts payable and accrued expenses

 

$

1,303,040 

 

 $

1,157,717 

 

 Short-term convertible notes payable, net of discount related-party

 

 

 

23,427 

 

 Short-term convertible notes payable, net of discount  

 

587,470 

 

 

373,644 

 

 Capital lease payable

 

 

467 

 

 

2,105 

 

 Notes payable

 

 

33,058 

 

 

23,788 

 

 

 Total Current Liabilities

 

 

1,924,035 

 

 

1,580,681 

 

 

 

 

 

 

 

 

 

 

 Total Liabilities

 

 

1,924,035 

 

 

1,580,681 

 

 

 

 

 

 

 

 

 

 

 Stockholders' Equity (Deficit):

 

 

 

 

 

 

 

 Preferred stock, $0.001 par value, 5,000,000 shares authorized,

 

 

 

 

 

 

 

 Series A preferred stock, 350,000 shares designated,

 

 

 

 

 

 

 

 237,807 and 281,969 shares issued and outstanding,

 

 

 

 

 

 

 

 respectively, aggregate liquidation value of $1,189,035

 

 

 

 

 

 

 

 and $1,409,845 respectively

 

 

238 

 

 

282 

 

 Common stock, $0.001 par value, 150,000,000 shares authorized,

 

 

 

 

 

 

 

 9,133,091 and 8,297,645 shares issued and outstanding, respectively.

9,134 

 

 

8,298 

 

 Stock subscription receivable

 

 

 

 

(49,000)

 

 Additional paid-in capital

 

 

8,400,983 

 

 

7,793,760 

 

 Deferred compensation

 

 

(188,367)

 

 

(182,576)

 

 Accumulated deficit  

 

 

(9,566,502)

 

 

(8,520,351)

 

 

 

 

 

 

 

 

 

 

 

 

 Total Stockholders' Equity (Deficit)

 

 

(1,344,514)

 

 

(949,587)

 

 

 

 

 

 

 

 

 

 

 Total Liabilities and Stockholders' Equity (Deficit)

 

$

579,521 

 

 $

631,094 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the consolidated financial statements.



3







ENTIA BIOSCIENCES, INC.

 CONSOLIDATED STATEMENTS OF OPERATIONS

 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months

 

Three Months

 

Six Months

 

Six Months

 

 

 

 

Ended

 

Ended

 

Ended

 

Ended

 

 

 

 

June 30, 2014

 

June 30, 2013

 

June 30, 2014

 

June 30, 2013

 

 

 

 

 

 

 

 

 

 

 

 REVENUES

 

$

104,693 

 

$

73,887 

 

$

267,261 

 

$

170,143 

 

 

 

 

 

 

 

 

 

 

 

 COST OF GOODS SOLD  

 

36,202 

 

29,408 

 

96,024 

 

57,987 

 

 

 

 

 

 

 

 

 

 

 

 GROSS PROFIT

 

68,491 

 

44,479 

 

171,237 

 

112,156 

 

 

 

 

 

 

 

 

 

 

 

 OPERATING EXPENSES

 

 

 

 

 

 

 

 

 

 Advertising and promotion

 

13,136 

 

81,878 

 

35,086 

 

128,273 

 

 Professional fees

 

38,454 

 

30,302 

 

87,216 

 

77,239 

 

 Consulting fees  

 

191,063 

 

441,401 

 

293,592 

 

528,739 

 

 General and administrative

 

342,938 

 

493,896 

 

717,148 

 

805,814 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Total Operating Expenses

 

585,591 

 

1,047,477 

 

1,133,042 

 

1,540,065 

 

 

 

 

 

 

 

 

 

 

 

 LOSS FROM OPERATIONS

 

(517,100)

 

(1,002,998)

 

(961,805)

 

(1,427,909)

 

 

 

 

 

 

 

 

 

 

 

 OTHER INCOME (EXPENSES)

 

 

 

 

 

 

 

 

 

 Interest income

 

 

2,450 

 

 

4,898 

 

 Interest expense

 

(96,684)

 

(37,790)

 

(174,402)

 

(67,601)

 

 Other income (expense)

 

 

 

(12,965)

 

 

 Gain on settlement of accounts payable

103,021 

 

 

103,021 

 

 

 

 

 

 

 

 

 

 

 

 

 NET LOSS

 

$

(510,763)

 

$

(1,038,338)

 

$

(1,046,151)

 

$

(1,490,612)

 

 

 

 

 

 

 

 

 

 

 

 NET LOSS PER COMMON SHARE

 

 

 

 

 

 

 

 

 

  - BASIC AND DILUTED:

 

$

(0.06)

 

$

(0.14)

 

$

(0.12)

 

$

(0.20)

 

 

 

 

 

 

 

 

 

 

 

 

 Weighted common shares outstanding

 

 

 

 

 

 

 

 

 

 

  - basic and diluted

 

8,532,935 

 

7,456,281 

 

8,429,958 

 

7,308,930 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the consolidated financial statements.





4







ENTIA BIOSCIENCES, INC.

 CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

 FOR THE PERIOD ENDED DECEMBER 31, 2013 and

 FOR THE INTERIM PERIOD ENDED JUNE 30, 2014

 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

Stock

 

 

 

 

Total

 

 

 

 

 

Preferred Stock

 

Common Stock

 

 

Paid

 

 

Deferred

 

 

Subscriptions

 

 

Accumulated

 

Stockholders'

 

 

 

 

 

Shares

 

Amount

 

Shares

 

 

Amount

 

 

In Capital

 

 

Compensation

 

 

Receivable

 

 

Deficit

 

Equity (Deficit)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance - December 31, 2012

 

 

109,900 

 

$

110 

 

7,444,591

 

 

$

7,444

 

 

$

5,115,587 

 

 

$

(394,510)

 

 

$

(49,000)

 

 

$

(5,327,924)

 

(648,293)

 Issuance of preferred stock for cash

 

140,175 

 

140 

 

-

 

 

-

 

 

700,735 

 

 

 

 

 

 

 

700,875 

 Issuance of preferred stock for  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 cancellation of debt

 

 

3,162 

 

 

-

 

 

-

 

 

15,747 

 

 

 

 

 

 

 

15,750 

 Issuance of warrants in connection with

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 convertible notes payable

 

 

-

 

 

-

 

 

16,400 

 

 

 

 

 

 

 

16,400 

 Beneficial conversion feature in connection

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

with convertible note payable

 

 

-

 

 

-

 

 

64,956 

 

 

 

 

 

 

 

64,956 

 Issuance of preferred stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of convertible notes payable

23,332 

 

23 

 

-

 

 

-

 

 

116,629 

 

 

 

 

 

 

 

116,652 

 Issuance of preferred stock for

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 conversion of accounts payable

 

30,400 

 

31 

 

-

 

 

-

 

 

151,970 

 

 

 

 

 

 

 

152,001 

 Deemed dividend related to beneficial

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

conversion feature of convertible preferred stock

 

 

-

 

 

-

 

 

87,600 

 

 

 

 

 

 

(87,600)

 

 Issuance of common stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of preferred stock

 

 

(25,000)

 

(25)

 

250,000

 

 

250

 

 

(225)

 

 

 

 

 

 

 

 Issuance of common stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of accrued compensation

 

 

 

 

273,158

 

 

274

 

 

129,727 

 

 

 

 

 

 

 

130,001 

 Stock compensation

 

 

 

 

-

 

 

-

 

 

413,921 

 

 

 

 

 

 

 

413,921 

 Issuance of common stock for services

 

 

 

129,896

 

 

130

 

 

83,270 

 

 

 

 

 

 

 

83,400 

 Issuance of common stock & warrants for  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 license agreement

 

 

 

 

200,000

 

 

200

 

 

215,329 

 

 

 

 

 

 

 

215,529 

 Issuance of warrants for services

 

 

 

 

-

 

 

-

 

 

584,108 

 

 

(584,108)

 

 

 

 

 

 Issuance of warrants for extension on debt

 

 

 

-

 

 

-

 

 

98,006 

 

 

 

 

 

 

 

98,006 

 Amortization of deferred compensation

 

 

 

-

 

 

-

 

 

 

 

796,042 

 

 

 

 

 

796,042 

 Net loss

 

 

 

 

-

 

 

-

 

 

 

 

 

 

 

 

(3,104,827)

 

(3,104,827)

(Continued on next page)






5







Continued from previous page)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance - December 31, 2013

 

 

281,969 

 

$

282 

 

8,297,645

 

 

$

8,298

 

 

$

7,793,760 

 

 

$

(182,576)

 

 

$

(49,000)

 

 

$

(8,520,351)

 

$

(949,587)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Issuance of warrants in connection with

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 convertible notes payable

 

 

 

 

-

 

 

-

 

 

52,780 

 

 

 

 

 

 

 

52,780 

 Beneficial conversion feature in connection

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

with convertible notes payable

 

 

 

-

 

 

-

 

 

77,482 

 

 

 

 

 

 

 

77,482 

 Issuance of common stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of preferred stock

 

 

(44,162)

 

(44)

 

441,620

 

 

442

 

 

(398)

 

 

 

 

 

 

 

 Issuance of common stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of convertible debt

 

 

 

 

151,126

 

 

151

 

 

32,369 

 

 

 

 

 

 

 

32,520 

 Issuance of common stock for conversion

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 of accounts payable

 

 

 

 

86,717

 

 

87

 

 

50,814 

 

 

 

 

 

 

 

50,901 

 Stock compensation

 

 

 

 

-

 

 

-

 

 

108,739 

 

 

 

 

 

 

 

108,739 

 Issuance of common stock for future services

 

 

68,283

 

 

68

 

 

44,182 

 

 

(44,250)

 

 

 

 

 

 Issuance of common stock for services

 

 

 

87,700

 

 

88

 

 

52,581 

 

 

 

 

 

 

 

52,669 

 Receipt of stock subscription receivable, less

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

write-  off  of $9,000

 

 

 

 

-

 

 

-

 

 

 

 

 

 

49,000 

 

 

 

49,000 

 Issuance of warrants for services

 

 

 

 

 

 

 

 

 

 

 

 

188,674 

 

 

(188,674)

 

 

 

 

 

 Amortization of deferred compensation

 

 

 

-

 

 

-

 

 

 

 

227,133 

 

 

 

 

 

227,133 

 Net loss

 

 

 

 

-

 

 

-

 

 

 

 

 

 

 

 

(1,046,151)

 

(1,046,151)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Balance - June 30, 2014

 

 

237,807 

 

$

238 

 

9,133,091

 

 

$

9,134

 

 

$

8,400,983 

 

 

$

(188,367)

 

 

$

 

 

$

(9,566,502)

 

$

(1,344,514)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the consolidated financial statements.



6






ENTIA BIOSCIENCES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Six Months

 

 

Six Months

 

 

 

 

 

 

 

 

 

 

 

 

 

Ended

 

 

Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

June 30, 2014

 

 

June 30, 2013

 

 CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 Net loss

 

 

 

 

 

 

 

 

$

(1,046,151)

 

$

(1,490,612)

 

 Adjustments to reconcile net loss to net cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 used in operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Depreciation/amortization

 

 

 

 

 

 

 

 

 

19,710 

 

 

14,410 

 

 

 Gain on settlement of accounts payable

 

 

 

 

 

 

 

 

 

(103,021)

 

 

 

 

 Amortization of discount on convertible notes

 

254,202 

 

 

51,591 

 

 

 Stock-based compensation

 

 

 

 

 

 

 

 

 

388,541 

 

 

725,434 

 

 

 Loss on sale of stock subscription receivable

 

12,965 

 

 

 

 

 Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Accounts receivable

 

 

 

 

 

 

 

 

 

(19,573)

 

 

(18,944)

 

 

 

 Inventory

 

 

 

 

 

 

 

 

 

25,875 

 

 

24,675 

 

 

 

 Prepaid expenses

 

 

 

 

 

 

 

 

 

15,090 

 

 

14,397 

 

 

 

 Other current assets

 

 

 

 

 

 

 

 

 

(1,300)

 

 

(919)

 

 

 

 Accounts payable and accrued expenses

 

196,224 

 

 

365,541 

 

 NET CASH USED IN OPERATING ACTIVITIES

 

(257,438)

 

 

(314,427)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 Purchase of property and equipment

 

 

 

 

 

 

 

 

 

(2,654)

 

 

(38,105)

 

 

 Acquisition of patents and patents pending  (net)

 

(7,341)

 

 

(5,117)

 

 NET CASH USED IN INVESTING ACTIVITIES

 

(9,995)

 

 

(43,222)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 Proceeds from issuance of common stock, preferred stock and warrants

 

 

372,000 

 

 

 Proceeds from convertible notes payable and notes payable

267,000 

 

 

 

 

 Payment on notes payable

 

 

 

 

 

 

 

 

 

(20,969)

 

 

(14,271)

 

 

 Payment on convertible note payable - related party

(40,000)

 

 

 

 

 Proceeds from sale of stock subscription receivable

40,000 

 

 

 

 NET CASH PROVIDED BY FINANCING ACTIVITIES

246,031 

 

 

357,729 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 NET CHANGE IN CASH

 

 

 

 

 

 

 

 

 

(21,402)

 

 

80 

 

 Cash at beginning of period

 

 

 

 

 

 

 

 

 

36,886 

 

 

13,081 

 

 Cash at end of period

 

 

 

 

 

 

 

 

$

15,484 

 

$

13,161 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:

 

 

 

 

 

 

 Interest paid

 

 

 

 

 

 

 

 

$

840 

 

$

770 

 

 SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING

 

 

 

 

 

 

 AND INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Stock issued for accounts payable

 

 

 

 

 

 

 

 

$

50,901 

 

$

 

 

 Conversion of accounts payable, accrued compensation, notes

 

 

 

 

 

 

 

 

 payable and accrued interest to preferred and common stock

$

32,520 

 

$

348,614 

 

 

 Debt issued for license

 

 

 

 

 

 

 

 

$

 

$

140,000 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 See accompanying notes to the consolidated financial statements.




7



NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 – ORGANIZATION AND OPERATIONS

Generic Marketing Services, Inc. was incorporated on July 19, 2007 under the laws of the State of Nevada as a subsidiary of Basic Services, Inc., also a Nevada corporation.   On December 31, 2007, Basic Services spun off Generic Marketing Services.  On October 8, 2008, Generic Marketing Services changed its name to Total Nutraceutical Solutions, Inc. (TNS, the Company, us, we, or our).  We engage in the distribution of organic dietary supplement nutraceutical products in the United States of America.  We are also engaged in the discovery, scientific evaluation and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics and other products developed and sold by Entia and by third parties.


On January 9, 2012, the amendment to our Articles of Incorporation involving the name change from Total Nutraceutical Solutions, Inc. to Entia Biosciences, Inc. (“Entia”) became effective with the Secretary of State of Nevada.  We also filed articles of incorporation for a wholly owned subsidiary of Entia, with such subsidiary to be named Total Nutraceutical Solutions, Inc. in January 2012.


We have a history of incurring net losses and net operating cash flow deficits.  We are also developing new technologies related to our organic nutraceutical products.  At June 30, 2014, we had cash and cash equivalents of $15,484.  These conditions raise substantial doubt about our ability to continue as a going concern.  As a result, we anticipate that our cash and cash equivalent balances, anticipated cash flows from operations and anticipated operating cash flows will be sufficient to meet our cash requirements through September 2014.


In order for us to continue as a going concern beyond this point and ultimately to achieve profitability, we may be required to obtain capital from external sources, increase revenues and reduce operating costs.  The issuance of equity securities will also cause dilution to our shareholders.  If external financing sources of financing are not available or are inadequate to fund our operations, we will be required to reduce operating costs including personnel costs, which could jeopardize our future strategic initiatives and business plans.  The accompanying consolidated financial statements have been prepared assuming that the Company continues as a going concern.  


The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the matters discussed herein.



NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Basis of presentation and principles of consolidation


The accompanying consolidated unaudited interim financial statements and related notes have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information, and with the rules and regulations of the United states Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements.  The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented.  Unaudited interim results are not necessarily indicative of the results for the full year.  These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the SEC.  


All intercompany accounts have been eliminated for the purpose of the consolidated financial statement presentation.

 

Use of estimates


The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of



8



contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.


Cash


We consider all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.


Accounts receivable


Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts.  The allowance for doubtful accounts is our best estimate of the amount of probable credit losses based on specific identification of accounts in our existing accounts receivable.  Outstanding account balances are reviewed individually for collectibility.  We determine the allowance based on historical write-off experience, customer specific facts and economic conditions.  Bad debt expense is included in general and administrative expenses, if any.  We consider all accounts greater than 30 days old to be past due.  Account balances are charged off against allowance after all means of collection have been exhausted and the potential for recovery is considered remote.  The allowance for doubtful accounts was $2,526 at both June 30, 2014 and December 31, 2013.


Inventory


Inventory, which consists primarily of raw materials to be used in the production of our dietary supplement products, is stated at the lower of cost or market using the first-in, first-out method. We regularly review our inventory on hand and, when necessary, record a provision for excess or obsolete inventory.   


Property and equipment


Property and equipment are recorded at cost. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred.  Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations.  Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets:


Office equipment

 

3 years

Production equipment

 

5 to 7 years

Equipment under capital lease

 

5 to 7 years

Leasehold improvements

 

Lesser of lease term or useful life of improvement


Patents


Patents, once issued or purchased, are amortized using the straight-line method over their economic remaining useful lives. All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs.  Patent application costs, generally legal costs, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally 15 to 20 years for domestic patents and 5 to 20 years for foreign patents, or expensed if the patent application is rejected.  The costs of defending and maintaining patents are expensed as incurred.  Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.


Impairment of long-lived assets


Our long-lived assets, which include property and equipment, patents and licenses of patents, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.


We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful



9



lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets.  Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.  If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.  

 

Discount on convertible notes payable


We allocate the proceeds received from convertible notes between convertible notes payable and warrants, if applicable. The resulting discount for warrants is amortized using the effective interest method over the life of the debt instrument. After allocating a portion of the proceeds to the warrants, the effective conversion price of the convertible note payable can be determined. If the effective conversion price is lower than the market price at the date of issuance, a beneficial conversion feature is recorded as an additional discount to the convertible note payable. The beneficial conversion feature discount is amortized using the effective interest method over the life of the debt instrument.  The amortization is recorded as interest expense on the consolidated statements of operations.


Fair value of financial instruments


The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable and accounts payable, approximate their fair values (determined based on level 1 inputs in the fair value hierarchy) because of the short maturity of these instruments.  Due to conversion features and other terms, it is not practical to estimate the fair value of notes payable and convertible notes.


Fair value measurements


We measure fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:


Level 1

 

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

 

 

 

Level 2

 

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

 

 

 

Level 3

 

Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.


We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at June 30, 2014 or December 31, 2013, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended June 30, 2014 and June 30, 2013.


Revenue recognition


We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.


Revenues from the sale of products, including shipping and handling fees but excluding statutory taxes collected from customers, as applicable, are recognized when shipment has occurred. We sell our products directly to customers. Persuasive evidence of an arrangement is demonstrated via order and invoice, product delivery is evidenced by a bill of lading from the third party carrier and title transfers upon shipment, the sales price to the customer is fixed upon acceptance of the order and there is no separate sales rebate, discount, or volume incentive.





10




Shipping and handling costs


Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred.  


Advertising and promotion costs


Costs associated with the advertising and promotions of our products are expensed as incurred.


Equity instruments issued to parties other than employees for acquiring goods or services


We account for all transactions in which goods or services are the consideration received for the issuance of equity instruments based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable.  The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur.  Currently such transactions are primarily awards of warrants to purchase common stock.


The fair value of each warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.  


The assumptions used to determine the fair value of our warrants are as follows:


-

The expected life of warrants issued represents the period of time the warrants are expected to be outstanding.

 

 

-

The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant.

 

 

-

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant.

 

 

-

The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.


Income taxes


We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns.  Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized.  Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in our consolidated statements of income in the period that includes the enactment date.


We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position.  The tax benefits recognized in our consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.  Should they occur, our policy is to classify interest and penalties related to tax positions as income tax expense.


We did not record an income tax provision for the three months and six months ended June 30, 2014 and 2013 as we had a net taxable loss in the periods.




11




Net loss per common share


Basic and diluted net loss per share has been computed by dividing our net loss by the weighted average number of common shares issued and outstanding. Convertible preferred stock, options and warrants to purchase our common stock as well as debt which are convertible into common stock are anti-dilutive and therefore are not included in the determination of the diluted net loss per share for three months ended June 30, 2014 and 2013 and the six months ended June 30, 2014 and 2013.   The following table presents a reconciliation of basic loss per share and excluded dilutive securities:



 

 

 

For the Three

Months Ended

June 30,

 

For the Six

Months Ended

June 30,

 

 

 

2014

 

2013

 

2014

 

2013

 Numerator:

 

 

 

 

 

 

 

 

 Net loss  

 

$

(510,763)

 

$

(1,038,338)

 

$

(1,046,151)

 

$

(1,490,612)

 

 

 

 

 

 

 

 

 

 

 Denominator:

 

 

 

 

 

 

 

 Weighted-average common

shares outstanding

8,532,935 

 

7,456,281 

 

8,429,958 

 

7,308,930 

 

 

 

 

 

 

 

 

 

 

 Basic and diluted

 net loss per share

$

(0.06)

 

$

(0.14)

 

$

(0.12)

 

$

(0.20)

 

 

 

 

 

 

 

 

 

 

 Common stock warrants

4,520,308 

 

3,495,902 

 

4,520,308 

 

3,495,902 

 Series A convertible

 preferred stock

2,378,070 

 

2,411,940 

 

2,378,070 

 

2,411,940 

 Stock options

2,572,099 

 

1,450,172 

 

2,572,099 

 

1,450,172 

 Convertible debt

 including interest

900,321 

 

816,516 

 

900,321 

 

816,516 

 Excluded dilutive

 securities

10,370,798 

 

8,174,530 

 

10,370,798 

 

8,174,530 



Reclassifications 


Certain reclassifications have been made to prior period financial statements and footnotes in order to conform to the current period's presentation.


Segments


We have determined that we operate in one segment for financial reporting purposes.


Recently issued accounting pronouncements


In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for Entia beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our financial statements.




12



NOTE 3 – INVENTORY


Inventory consists of the following:


 

 

 

June 30,

2014

 

December 31,

2013

 Raw materials

 

 

$

218,980 

 

$

240,750 

 Finished goods

 

 

45,150 

 

49,255 

 

 

 

264,130 

 

290,005 

 Less:  reserve for excess and obsolete inventory

(151,064)

 

(151,064)

 

 

 

$

113,066 

 

$

138,941 



NOTE 4 – PROPERTY AND EQUIPMENT


Property and equipment, stated at cost, consists of the following:


 

 

 

June 30,

2014

 

December 31,

2013

 Office equipment

 

$

27,507 

 

$

26,284 

 Production equipment

85,046 

 

83,615 

 Leasehold improvements

16,328 

 

16,328 

 

 

 

128,881 

 

126,227 

 Less:  accumulated depreciation

(76,094)

 

(64,082)

 

 

 

$

52,787 

 

$

62,145 



NOTE 5 - PATENTS AND LICENSES, NET


Our identifiable long-lived intangible assets are patents and prepaid licenses.  Patent and license amortization is $3,849 and $790 for the three months ended June 30, 2014 and 2013, respectively and $7,699 and $3,247 for the six months ended June 30, 2014 and 2013, respectively.  


The licenses are being amortized over an economic useful life of 17 years. The gross carrying amounts and accumulated amortization related to these intangible assets consist of the following at:


 

 

 

June 30,

2014

 

December 31,

2013

 Licenses and amortizable patents

 

$

234,324 

 

$

234,324 

 Unamortized patents

 

132,643 

 

125,301 

 Accumulated amortization

 

(23,826)

 

(16,127)

 Patents and Licenses, net

 

$

343,141 

 

$

343,498 


NOTE 6 – ACCRUED EXPENSES


Accrued expenses (included with accounts payable) consists of the following at:


 

June 30,

2014

 

December 31,

2013

Executive compensation

$

710,928

 

$

476,368

Other accruals

108,199

 

60,671

 

$

819,127

 

$

537,039



13








NOTE 7 – NOTES PAYABLE


Notes payable consists of the following:


 

 

 

June 30,

2014

 

December 31,

2013

Notes payable - current

 

 

 

7.85% unsecured, $781 due monthly

$

-

 

$

1,964

7.85% unsecured, $373 due monthly

2,545

 

-

4.15% unsecured, $2,678 due monthly

5,513

 

21,824

10.00% unsecured, interest only, due December 30, 2014

25,000

 

-

 

 

 

$

33,058

 

$

23,788



Convertible notes payable, net

 

 

 

8%, unsecured due June 2014  (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share.

$

312,500

 

$

263,496

8% secured due August 2014 (net of discount related to beneficial conversion feature of $2,050 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share.

47,950

 

37,700

6% unsecured, convertible into common stock at $2.00 per share, due on demand

50,000

 

50,000

8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $5,310 in 2014 and $40,552 in 2013), convertible into common stock at an average price of $0.205 per share

27,690

 

22,448

8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $13,517 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.

28,483

 

-

8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.

15,503

 

-

8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.

10,273

 

-

 

 

 

 

 

 

10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined

17,913

 

-

10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined

70,600

 

-

10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined

6,558

 

-

 

 

 

 

 

 

 

 

 

$

587,470

 

$

373,644



Convertible notes payable, net related party

 

 

 

 

 

 

 

 

 

0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share.  This note was paid off on March 31, 2014.

$

-

 

$

23,427

 

 

 

 

 

 

 

 

 

$

-

 

$

23,427






14




$312,500 in notes payable was due on June 30, 2014.  We are currently in negotiations with the note holder to extend this note and we are not in default.  


During 2014, we entered into the following debenture agreements that accrue interest at 10%, mature in 1 year and grant the investor on a one warrant per dollar basis that are exercisable for 3 years at $1 per share and vest immediately:


o

On April 15, 2014, we entered into an agreement for $10,000.  We calculated the fair value of the warrants at $4,130,

o

On April 27, 2014, we entered into an agreement for $100,000.  We calculated the fair value of the warrants at $39,200, and

o

On March 28, 2014, we entered into an agreement for $25,000.  We calculated the fair value of the warrants at $9,450.


We posted the fair value of the warrants as a discount on the notes and amortize them over the life of the debenture.  Total value of the discounts is $52,780.


In addition to the debentures, during 2014, we entered into the following convertible promissory notes with an interest rate of 8% per annum, compounded annually.  If the note remains unpaid after one hundred eighty (180) days from the Issue date, the holder has the option to convert the principal and accrued interest into shares of our Company stock at a conversion price equal to 58% of the “trading price” as described in the note.  We have calculated a discount for the beneficial conversion feature in the amount of $77,482 and will be amortized over the life of the loan.  The amount amortized for 2014 is $14,603:


o

On February 3, 2014, $42,000 due on November 3, 2014,

o

On April 17, 2014, $32,500 due on January 17, 205, and

o

On June 13, 2014, $32,500 due on March 13, 2015.  


On March 25, 2014, we entered into a line of credit arrangement.  The line of credit is $60,000 with an interest rate of prime plus 3.00%.  There are no loan covenants applicable to this line of credit and the amount outstanding as of June 30, 2014 is $11,750.  The line of credit is reported on the balance sheet with accounts payable and accrued expenses.



NOTE 8 – RELATED PARTY TRANSACTIONS


Debt agreements from board member


In December 2013, we entered into a promissory note due on March 31, 2014 at 0% in the principal amount of $40,000.  The note was paid off on March 31, 2014.



NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT)


Preferred Stock


On May 26, 2011, our board of directors designated 350,000 shares of preferred stock as Series A preferred stock, $0.001 par value.  The Series A preferred stock is entitled to a liquidation preference in the amount of $5 per share, votes on an as converted basis with the common stock on all matters as to which holders of common stock shall be entitled to vote, and is currently convertible into common stock on a one-for-ten basis.  


During second quarter 2014, two investors converted 44,162 shares of Series A Preferred stock for 441,620 shares of common stock.




15



Common stock


During second quarter 2014, we issued shares of common stock for the following:


o

151,126 shares of common stock with a value of $32,520 upon conversion of $30,000 of convertible notes payable along with accrued interest of $2,520,

o

23,000 shares of common stock for a value of $13,113 for services rendered,

o

441,620 shares of common stock in exchange for 44,162 shares of Series A Preferred stock, and

o

80,000 shares of common stock with a value of $46,400 for the settlement of accounts payable in the amount of $149,421.  We posted a gain on settlement in the amount of $103,021.


During first quarter 2014, we issued shares of common stock for the following:


o

64,700 shares of common stock for a value of $39,556 for services rendered,

o

68,283 shares of common stock for a value of $44,250 for services to be performed in the future, and

o

6,717 shares of common stock with a value of $4,501 for the settlement of accounts payable.


Stock incentive plan


On September 17, 2010, our Board of Directors adopted the 2010 Stock Incentive Plan (“Plan”). The Plan provides for the grant of options to purchase shares of our common stock, and stock awards consisting of shares of our common stock, to eligible participants, including directors, executive officers, employees and consultants of the Company.  We have reserved 4,650,000 shares of common stock for issuance under the Plan with an annual increase in shares of 50,000 as of January 1 of each year; commencing January 1, 2012.  Stock options are granted at or below the closing price of our stock on the date of grant for terms ranging from four to fifteen years and generally vest over a five year period.  The fair value of option grants were calculated at the date of the grants using the Black-Scholes option pricing model with the following assumptions:


 

 

June 30,

2014

 

December 31,

2013

 Expected dividend yield

 

                          -   

 

                          -   

 Expected stock price volatility

 

210.51%-216.96%

 

216.96% - 236.55%

 Risk-free interest rate

 

0.28% - 1.84%

 

0.95% - 2.47%

 Expected term (in years)

 

3 - 7 years

 

5 - 10 years

 Weighted-average granted date fair value

 

$0.62

 

$0.45



A summary of option activity under the stock option plan as of June 30, 2014 and changes during the quarter then ended is presented below:



16





 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

Weighted

 

Remaining

 

 

 

 

Number 

 

 

 

Average

 

Contractual

 

Aggregate

 

 

of

 

Exercise Price

 

Exercise  

 

Term

 

Intrinsic

 

 

Shares

 

Range

 

Price

 

(Years)

 

Value

Outstanding, December 31, 2012

 

1,202,099

 

 $0.40 - $1.00

 

$

0.56

 

7.74

 

-

 

 

 

 

 

 

 

 

 

 

 

Exercisable, December 31, 2012

 

830,504

 

 $0.40 - $1.00

 

$

0.57

 

8.19

 

-

 

 

 

 

 

 

 

 

 

 

 

Granted

 

1,150,000

 

 $0.38 - $0.81

 

$

0.47

 

8.07

 

-

Exercised

 

-

 

                    -   

 

$

-

 

-

 

-

Expired

 

-

 

                    -   

 

$

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

Outstanding, December 31, 2013

 

2,352,099

 

 $0.38 - $1.00

 

$

0.51

 

7.90

 

199,505

 

 

 

 

 

 

 

 

 

 

 

Exercisable, December 31, 2013

 

1,810,344

 

 $0.38 - $1.00

 

$

0.52

 

7.88

 

138,707

 

 

 

 

 

 

 

 

 

 

 

Granted

 

220,000

 

 $0.60-$0.75

 

$

0.62

 

5.27

 

 

Exercised

 

-

 

                    -   

 

$

-

 

-

 

 

Expired

 

-

 

                    -   

 

$

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding, June 30, 2014

 

2,572,099

 

 $0.38 - $1.00

 

$

0.52

 

7.68

 

143,063

 

 

 

 

 

 

 

 

 

 

 

Exercisable, June 30, 2014

 

2,044,836

 

 $0.38 - $1.00

 

$

0.52

 

7.89

 

125,127



The range of exercise prices for options outstanding under the 2010 Stock Incentive Plan at June 30, 2014 are as follows:


Number of

 

Exercise

shares

 

Price

55,000

 

$

0.38

135,000

 

$

0.40

20,000

 

$

0.44

540,000

 

$

0.45

247,242

 

$

0.47

247,857

 

$

0.49

844,000

 

$

0.50

15,000

 

$

0.62

40,000

 

$

0.65

20,000

 

$

0.75

160,000

 

$

0.60

10,000

 

$

0.81

200,000

 

$

0.85

38,000

 

$

1.00

2,572,099

 

 




17



At June 30, 2014, the Company had 2,077,901 unissued shares available under the Plan.  Also, at June 30, 2014, the Company had $263,507 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 7 years.


Warrants – Consulting Agreements


Outstanding warrants to purchase common stock are as follows:


Date of Issue

 

June 30, 2014

 

Exercise Price

 

Expiration

June-14

 

15,000

 

$0.50

 

06/2019

April-14

 

113,333

 

$0.65 - 1.00

 

04/2017 - 03/2021

January-14

 

62,277

 

$0.65 - $1.00

 

01/2019 - 01/2021

As of December
2013

 

4,349,698

 

$0.36 - $10.00

 

10/2013 - 10/2021

Total

 

4,540,308

 

 

 

 

Less:

 

 

 

 

 

 

Expired

 

20,000

 

 

 

 

Exercised

 

-

 

 

 

 

Total

 

4,520,308

 

 

 

 



We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant.  In determining the fair value of warrants, we employed the following key assumptions:


 

 

June 30, 2014

 

December 31, 2013

Risk-Free interest rate

0.28% - 1.91%

 

0.95% - 3.32%

Expected dividend yield

0%

 

0%

Volatility

 

210.51%-222.30%

 

216.48%-239.20%

Expected life

 

3 - 7 years

 

3-10 years

 

 

$0.75

 

$0.45



At June 30, 2014 and 2013, the weighted-average Black-Scholes value of warrants granted was $0.75 and $0.45, respectively.


NOTE 10 - COMMITMENTS AND CONTINGENCIES


Leases


On April 4, 2012, the Company entered into a Commercial Lease agreement with Lanz Properties, LLC for 13,081 square feet of office and warehouse space located at 13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, OR 97140.  The new lease commenced on June 1, 2012 and will terminate on July 31, 2015.  No rent was payable until October 2012.  The base monthly rental rate started at $3,160, increasing to $3,260 in October 2013, and then $3,343 in June 2014.  The Company has straight-lined the full value of the lease agreement over the life of the lease and has recorded this amount monthly.  The amount of rent expense that is above the actual rent amount is recorded as deferred rent and is shown on the balance sheet in current liabilities as part of accounts payable and accrued expenses. The amount recorded for as of June 30, 2014 and 2013 is $4,160 and $15,585, respectively.




18




NOTE 11 – SUBSEQUENT EVENTS


On July 14, 2014, we were notified by the Michael J Fox Foundation that we had been awarded a grant to conduct a pre-clinical study of our ErgoD2® medical food formulation as a potential therapy for Parkinson’s Disease.


On July 14, 2014, we entered into a debt agreement with an investor for $42,500.  The note is convertible after 180 days and is due in April 2015.  The conversion price is not set for 180 days.  Interest accrues at 8%.  We have calculated a discount related to the beneficial conversion in the amount of $30,776 and will amortize over the life of the loan.


In July 2014, an investor converted the remaining $33,000 from a note due in August 2014 for 226,530 shares of common stock.  


On July 1, 2014, we entered into a promissory note with Dr. Sobol, (a board member) for $15,000.  The note matures on October 31, 2014 and does not accrue interest.  In conjunction with the note, we granted Dr. Sobol a five year warrant to purchase 15,000 shares of common stock at $0.50 per share and fully vests upon receipt of monies.  We calculated a discount on the granting of the warrants in the amount of $5,445 and will expense this in July.  The note also contained a conversion feature where the member can convert the note into common stock at $0.50 per share.  We calculated and posted a discount related to this beneficial conversion of $7,545 and will amortize this over the life of the loan.




19




Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations


Overview of Current Operations


Entia Biosciences, Inc. (Entia) is an emerging biotechnology company engaged in the discovery, formulation, production and marketing of functional ingredients that can be used in branded medical foods, nutraceuticals, cosmetics and other products developed and sold by Entia and third parties.  Our current portfolio of formulations contains ERGO D2, vitamin D2, L-Ergothioneine and curcumin.  


Through our wholly owned subsidiary Total Nutraceutical Solutions, Inc. (TNS), we currently market nutraceutical products under the GROH® and SANO brands direct to consumers online and through leading hair salons and other resellers in North America.  TNS currently offers  three natural organic nutraceutical mushroom dietary supplement products, ImmuSANO®, GlucoSANO®, and GROH®, which has been designed to nutritionally support hair follicles and nail beds.  ImmuSANOTM is designed to nutritionally address the needs of the immune system by balancing cellular function and promoting a stronger immune system.  GlucoSANOTM is designed to assist in maintaining more normal cellular metabolism and stabilizing blood sugar levels.  


Our formulations, which contain highly potent antioxidants, have the nutritional potential to provide multiple health benefits, including balancing iron homeostasis, reducing inflammation, supporting the immune system, promoting healthy joints, increasing stamina, and reducing stress and anxiety.  These naturally occurring dietary substances and products have not been chemically altered, and we believe these products have both health benefits and mass appeal to people wanting natural and non-toxic nutritional-based healthcare.  We utilize novel clinical models, biomarkers, and analytical tools to validate the nutritional and clinical efficacy of our formulations and the products that incorporate them.  Research and development of new formulations and nutraceutical products are also performed under contract with outside laboratories, such as the Department of Food Science, Pennsylvania State University.


Material Changes in Results of Operations for the Three and Six Months ended June 30, 2014 and 2013.


Revenues and Cost of Goods Sold:


 

 

For the Three Months Ended June 30,
December 31,

 

Change

 

 

2014

 

2013

 

$

 

%

Revenues

 

$

104,693

 

$

73,887

 

$

30,806

 

41.7%

Cost of Goods Sold

36,202

 

29,408

 

6,794

 

23.1%

 

 

 

 

 

 

 

 

 

 

 

For the Six Months
Ended June 30,

 

Change

 

 

2014

 

2013

 

$

 

%

Revenues

 

$

267,261

 

$

170,143

 

$

97,118

 

57.1%

Cost of Goods Sold

96,024

 

57,987

 

38,037

 

65.6%



Revenues.  Revenues are generated primarily from the sale of our ERGO D2® ingredients and our GROH® ERGO Boost line of beauty and wellness products as well as our mushroom-based nutraceutical dietary supplement products.  The increase in revenues for the three and six months ending June 30, 2014 from 2013 was due to increased product sales from the expansion of the Groh® product line.


Cost of Goods Sold.   Cost of goods sold includes raw materials such as nutraceutical mushrooms, as well as production costs for manufacturing our supplement products.  Cost of goods sold for the three and six months ended June 30, 2014 increased from 2013 due to increased product sales and the result of changes in our product mix.  




20



The following is a summary of certain consolidated statement of operations data for the periods:


Operating Expenses:


 

 

 

 

 

For the Three Months Ended June 30,
December 31,

 

Change

 

 

 

 

 

2014

 

2013

 

$

 

%

Advertising & promotion expenses

 

$

13,136

 

$

81,878

 

$

(68,742)

 

-84.0%

Professional fees

 

 

38,454

 

30,302

 

8,152 

 

6.6%

Consulting fees

 

 

191,063

 

441,401

 

(250,338)

 

-56.7%

General and Administrative expenses

 

342,938

 

493,896

 

(150,958)

 

-30.6%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Six Months
Ended June 30,

 

Change

 

 

 

 

 

2014

 

2013

 

$

 

%

Advertising & promotion expenses

 

$

35,086

 

$

128,273

 

$

(93,187)

 

-72.6%

Professional fees

 

 

87,216

 

77,239

 

9,977 

 

12.9%

Consulting fees

 

 

293,592

 

528,739

 

(235,147)

 

-44.5%

General and Administrative expenses

 

717,148

 

805,814

 

(88,666)

 

-11.0%



Advertising and promotional expenses.  These costs include costs for promotional products, production fees for marketing materials, costs associated with fulfillment, fees for advertising programs such as ad placement fees, and postage fees for mailing marketing materials.  The decrease in these expenses is attributed to the re-branding campaign we went through in 2013.  So far in 2014, we have not incurred any of these expenses.


Professional fees.  These expenses primarily include accounting/auditing fees, legal fees and stock transfer fees.  The increase in professional fees from 2013 is due primarily to increased accounting fees during 2014.


Consulting fees.  These expenses are comprised of fees incurred by third-party consultants for the provision of administrative, information technology and marketing management services.  The decrease in these expenses from 2013 is due to decreased consultants fees for their services during 2014 and the decrease in warrants granted.  


General and administrative expenses.  These expenses primarily include compensation, costs related to travel, rent and utilities, insurance, depreciation, product development, payroll and bad debt.  The decrease from 2013 is attributable to a decrease in stock based compensation and travel during 2014.


Material Changes in Financial Condition


At June 30, 2014, cash totaled $15,484, compared to $36,186 at December 31, 2013.  The primary reasons for the net decrease in 2014 are described below.  Working capital deficit was $(1,740,442) at June 30, 2014, compared to $(1,355,230) at December 31, 2013.  The change in working capital was due primarily to the accrual of the increase in compensation for executive officers and issuance of short-term debt.  The net change in cash and cash equivalents for the periods presented was comprised of the following:


 

 

 

For the Six Months
Ended June 30,

 

Change

 

 

 

2014

 

2013

 

$

 

%

Net cash provided by (used in)

 

 

 

 

 

 

 

 

Operating activities

$

(257)

 

$

(314)

 

$

57 

 

-18.2%

 

Investing activities

(10)

 

(43)

 

33 

 

-76.7%

 

Financing activities

246 

 

357 

 

(111)

 

-31.1%




21



Operating Activities.  The decrease in net cash flows used from operating activities was due primarily to a larger amortization of debt discount and a reduction in accounts payable.


Investing Activities.  The increase in net cash flows used from investing activities was due primarily to lack of acquisitions of patents and patents pending.


Financing Activities.  The decrease in net cash flows from financing activities was due primarily to the lack of proceeds from the issuance of Series A Preferred Stock.  


Future Liquidity.  We have a history of incurring net losses and negative operating cash flows.  We are also deploying new technologies and continue to develop commercial products and services.  Based on our cash on hand, income from operations and the degree to which our burn rate can be reduced while continuing operations, management believes it has sufficient funds to remain operational through September 2014.


We expect our revenues to increase in the third quarter of 2014.  Notwithstanding that expected increase in revenues, we anticipate that we will continue to generate losses in 2014 and therefore we may be unable to continue operations in the future.   In order for us to continue as a going concern and ultimately to achieve profitability, we may be required to obtain capital from external sources, increase revenues or reduce operating costs or take all of these actions.  We will require additional capital of at least approximately $412,500 to repay debt principal and accrued interest maturing on September 30, 2014 and we intend to raise the monies by undertaking one or more equity private placements.  We may also pursue re-negotiation and re-structuring of the debt.  However, there can be no assurances that our operations will become profitable or that external sources of financing, including the issuance of debt and/or equity securities, will be available at times and at terms acceptable to us, or at all.  The issuance of additional equity or convertible debt securities will also cause dilution to our shareholders.  If external financing sources are not available or are inadequate to fund our operations, we will be required to reduce our operating costs, which could jeopardize our future strategic initiatives and business plans.  For example, a reduction in operating costs could jeopardize our ability to launch, market, and sell new nutraceutical supplement products necessary to grow and sustain our operations.  


Subsequent Events


On July 14, 2014, we were notified by the Michael J Fox Foundation that we had been awarded a grant to conduct a pre-clinical study of our ErgoD2® medical food formulation as a potential therapy for Parkinson’s Disease.


On July 14, 2014, we entered into a debt agreement with an investor for $42,500.  The note is convertible after 180 days and is due in April 2015.  The conversion price is not set for 180 days.  Interest accrues at 8%.  We have calculated a discount related to the beneficial conversion in the amount of $30,776 and will amortize over the life of the loan.


In July 2014, an investor converted the remaining $33,000 from a note due in August 2014 for 226,530 shares of common stock.  


On July 1, 2014, we entered into a promissory note with Dr. Sobol (a board member) for $15,000.  The note matures on October 31, 2014 and does not accrue interest.  In conjunction with the note, we granted Dr. Sobol a five year warrant to purchase 15,000 shares of common stock at $0.50 per share and fully vests upon receipt of monies.  We calculated a discount on the granting of the warrants in the amount of $5,445 and will expense this in July.  The note also contained a conversion feature where the member can convert the note into common stock at $0.50 per share.  We calculated and posted a discount related to this beneficial conversion of $7,545 and will amortize this over the life of the loan.


Off-Balance Sheet Arrangements


We have no off-balance sheet arrangements.


Critical Accounting Policies and Estimates




22



Revenue Recognition:  We recognize revenue from product sales once all of the following criteria for revenue recognition have been met: pervasive evidence that an agreement exists; the services have been rendered; the fee is fixed and determinable and not subject to refund or adjustment; and collection of the amount due is reasonable assured.


Item 3. Quantitative and Qualitative Disclosures about Market Risk.


Not applicable.


Item 4.  Controls and Procedures


Evaluation of Disclosure Controls and Procedures


In connection with the preparation of this Quarterly Report on Form 10-Q, an evaluation was carried out by our management, with the participation of our Chief Executive Officer who is also our principal financial and accounting officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of June 30, 2014.  Based on that evaluation, our principal executive officer and principal financial officer concluded that the material weaknesses identified in our management report on internal controls and procedures contained in our Form 10-K for the fiscal year ended December 31, 2013, Item 9A filed on March 31, 2014 still exist, and therefore our disclosure controls and procedures were not effective as of June 30, 2014.


Changes in Internal Control Over Financial Reporting


As of June 30, 2014, there have been no changes in internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) during the quarter ended June 30, 2014, that materially affected, or are reasonably likely to materially affect, our company’s internal control over financial reporting.


Part II. OTHER INFORMATION


Item 1.  Legal Proceedings


From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business.  However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.


We are not presently a party to any material litigation, nor to the knowledge of management is any litigation threatened against us, which may materially affect us.


Item 1A.  Risk Factors


See Risk Factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2013, and the discussion above in Part I, Item 2, under " Liquidity and Capital Resources.”


Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds 


During second quarter 2014, we issued common stock to the following:


o

151,126 shares of common stock in exchange for the conversion of short-term note payable in the amount of $30,000 and accrued interest in the amount of $2,520 to Asher Enterprises on June 26, 2014,

o

11,250 shares of common stock for services rendered with a value of $5,625 to Oregon Rain Soap,

o

3,750 shares of common stock for services rendered with a value of $2,288 to Woody Michleb on June 30, 2014,

o

8,000 shares of common stock for services rendered with a value of $5,200 to Julia Perederiy on June 30, 2014, and

o

80,000 shares of common stock in exchange for settlement of accounts payable with Penn State Research Foundation with a value of $46,400 on June 30, 2014.



23




The issuance of these shares was exempt from registration pursuant to Section 4(2) of the Securities Act of 1933.


Item 3.  Defaults Upon Senior Securities


None.


Item 4.  Mine Safety Disclosures


Not Applicable.


Item 5.  Other Information


None.


Item 6.  Exhibits 

Exhibit Number

Description of Exhibit

Filed Herewith

Form

Exhibit

Filing Date

 

 

 

 

 

 

3.1

Amended and Restated Articles of Incorporation of Registrant

 

8-K

3.1

10/29/2010

3.2

Amended and Restated Bylaws of Registrant

 

8-K

3.2

09/22/2010

3.3

Amended Articles of Merger Incorporation as currently in effect

 

8-K

3.3

10/13/2008

10.1

Exclusive Option Agreement dated May 1, 2006, between The Penn State Research Foundation and Northwest Medical Research Inc.

 

8-K

10.1

09/04/2008

10.2

Assignment Agreement to the Option Agreement, dated July 31, 2008, among The Penn State Research Foundation, Northwest Medical Research Inc. and Generic Marketing Services, Inc.

 

8-K

10.2

09/04/2008

10.3

Assignment and Assumption Agreement, dated July 31, 2008, between Northwest Medical Research Inc. and Generic Marketing Services, Inc.

 

8-K

10.3

09/04/2008

10.4

Form of Common Stock and Warrant Purchase Agreement

 

8-K

10.1

06/12/2009

10.5

Form of Securities Purchase Agreement

 

8-K

10.1

09/21/2009

10.6

$50,000 Promissory Note between TNS and Marvin S. Hausman, M.D. and Philip Sobol dated December 30, 2009

 

8-K

10.1

12/31/2010

10.7

$100,000 Promissory Note between TNS and Larry A. Johnson dated January 12, 2010

 

8-K

10.1

2/24/2010

10.8

$100,000 Promissory Note between TNS and Mark C. Wolf dated February 18, 2010

 

8-K

10.2

2/24/2010

10.9

$50,000 Promissory Note between TNS and Mark C. Wolf dated February 18, 2010

 

10-K

10.9

4/15/2010

10.10

Profit Sharing Agreement between TNS, American Charter & Marketing LLC, and Delta Group Investments, Limited dated March 26, 2010

 

10-K

10.10

4/15/2010

10.11

Form of Common Stock and Warrant Agreement 2010

 

8-K

10.1

12/20/2010



24






10.12

$312,500 Promissory Note between TNS and Delta Group Investments Limited dated January 26, 2011

 

8-K

10.2

2/22/2010

10.13

Termination of Profit Sharing Agreement dated February 21, 2011

 

8-K

10.1

2/22/2011

10.14

Lease Agreement between TNS and Sherwood Venture LLC dated March 15, 2011

 

8-K

10.1

4/6/2011

10.15

Form of Warrant A Agreement 2010

 

8-K

10.2

12/22/2010

10.16

Form of Warrant B Agreement 2010

 

8-K

10.3

12/22/2010

10.15

Form of Warrant A Agreement 2010

 

8-K

10.2

12/22/2010

10.16

Form of Warrant B Agreement 2010

 

8-K

10.3

12/22/2010

10.17

Asset Purchase Agreement between TNS, FunGuys, LLC and Mark C. Wolf dated May 27, 2011

 

8-K

10.1

3/3/2011

10.18

Certificate of Designation of Preferences, Rights and Limitations of the Series A Preferred Stock of Total Nutraceutical Solutions, Inc. dated May 26, 2011.

 

8-K

10.3

3/3/2011

10.19

Employment Agreement between Marvin S. Hausman, M.D. and Total Nutraceutical Solutions, Inc. dated October 28, 2011.

 

8-K

10.1

11/2/2011

10.20

Employment Agreement between Devin Andres and Total Nutraceutical Solutions, Inc. dated October 28, 2011.

 

8-K

10.2

11/2/2011

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer).

X

 

 

 

32.2

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Financial Officer).

X

 

 

 




25



SIGNATURES


In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


 

Entia Biosciences, Inc.

 

 

August 15, 2014

By:  

/s/ Marvin Hausman, M.D. 

 

Marvin Hausman, M.D.

Chief Executive Officer

(Principal Executive Officer and Acting Principal Financial and Accounting Officer)





26


GRAPHIC 2 ergo10q_063014apg001.jpg GRAPHIC begin 644 ergo10q_063014apg001.jpg M_]C_X``02D9)1@`!`@$`2`!(``#_X0RH17AI9@``34T`*@````@`!P$2``,` M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q M``(````<````<@$R``(````4````CH=I``0````!````I````-``"OR````G M$``*_(```"<0061O8F4@4&AO=&]S:&]P($-3,B!7:6YD;W=S`#(P,3(Z,#,Z M,#4@,3`Z-3,Z,S8``````Z`!``,````!``$``*`"``0````!```#TZ`#``0` M```!````MP`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0`` M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```MR```` M`````$@````!````2`````'_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\, M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`'@"@`P$B``(1`0,1`?_=``0` M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$` M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$% M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B M$P4R@9$4H;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=7 M9W>'EZ>WQ__:``P#`0`"$0,1`#\`UO\`&!]<F],>]U5#L! MMF18R"X5LMRG.V;O;OL]M37?X/U/4].Q!ZS_`(O>D6]$ZM?C])OZ+?TMCKL7 M)LO]<95=;7/L]2GU+?0<]M3O9^CV>I39_I*$E.?_`..9TO\`T/5O_<@__P`B ME_XYG2_]#U;_`-R#_P#R*M6?5[_%]TCI7U=ZAU?#R+;.K8]0?758_8ZRQE-E MN5=^D8]GI.M_FZ'_`.$_FEH=#^KO0_JS_C+^P5U6VNRL?[3TM^Z1C@C(9E57 M>YOK;FU/90[])_+_`$GZ=)35Z/\`6NWKF99@]+P>K9&54PV65GJ7I[6MK`C0@]0?\`^16GT/$Z%U;_`!E]5IPJ\K#;3CY' MVMS,BVI]F4W+:W(N;;C7-L^SVLL_F=VS_@USOU(Z#@]1Z=??;]7 M>H/(;ZCA7OVQ[MNY>A_\VJ?_`"PZC_[%V_\`DEY=U?ZL8/U:_P`971<;IY=] MER'OTR:WMI;EYM&&67VX/ZOD7;*6?H?\`"?X-:63EX9P>@]`^K&6[ M'P>MOM%>;4]]EC,:EC\G+KQ[LAUEM.4]WZO6ZW^A_I/T7J5>Q*=K_FU3_P"6 M'4?_`&+M_P#))?\`-JG_`,L.H_\`L7;_`.20:/JET+I3LCJ&!395E.KLW6G( MO>7;FG=ZC;K[&6?]<7(VNQ[L7ZCT]1^TW8E^%D'(JQSD.L>6TXSZO9T_]:?L M?_KZ:2GM/^;5/_EAU'_V+M_\DE_S:I_\L.H_^Q=O_DES'7\+#;T;I.)T*S,Z M6W+ZQ6QMMPR!:VUU-XKL]/J1]=U'JUTO]/\`FG_\8KC^N7]4QN@67-.+GT=8 M;B=3QFD@,OKHR_7JT<_?0_V75?I+?T3ZTE.W_P`VJ?\`RPZC_P"Q=O\`Y)+_ M`)M4_P#EAU'_`-B[?_)+'Z=TC&^M[,KJG7'6Y.*_)MIP,)MME5-=./8_&98^ MC'?7ZF9=8RVRZVY]O^#KJ]-C%7^LG3^DX?5/J]TNZO*?TMM6=^@H?EW6$M^S M65R<1]F;8VMSG;?=Z=7_`!:2GH/^;5/_`)8=1_\`8NW_`,DK.!T>O!O-SX..1N>US?4;[?M.[_`*VO2?V93_Y%]??JQTSZY9/7^G]/R:\;,Q7UY%1(-CLF MV]N5=D>^ZUC*W,9M].M__6U3Z5]=>A?\T6_5OKO3[\JO$M-V(,>TUBPE]E_I M9;]S7L9OM>S?6R[]'_@O7I98O4/V93_YJ M](I^PLQ.K9678_+=9:^UE&8YV\-PQ136[)KJ?_W-]+U%EUFKU)&S M;1B;MWYNR*MVY7OV9UG_`,N;?^V*/_222FB/JDPY]C'N#^E6='KZ1M+B;R&. MMW/<[9L_F;?YS=_._P"#0\?I_P!=\7I;>CU9&$\5@44]6>ZWUFT@"OU7]/\` M2?5;FUL^A^O^B]_\ZM+]F=9_\N;?^V*/_227[,ZS_P"7-O\`VQ1_Z224@JZ? MUCHN/A].Z#3B7=-Q:/2+,JRRF[U`=+O5QZ,BE_J>]]S?L]?Z59M'U*S*NFLN M;F,IZ^W.MZL,AC2<=M]_MR<)M;SZ_P"SK:?T#_TGK?X?_@%L_LSK/_ES;_VQ M1_Z22_9G6?\`RYM_[8H_]))*1X__`#KNBGJ%&!52ZI[;K*+KK'.L+8K-5=N- M2VJK?]/?;@XUU%[+K+6,>ZVJJ@.I?71:_:WTWN]] M=:W/V9UG_P`N;?\`MBC_`-))?LSK/_ES;_VQ1_Z224T,[I/U@ZM5TQV<,.B_ MI_5*LQ[:++'L-%;'L(:ZRFM_VGU+?H;/2V?X51ZM]4[+7>M2+KPQU.S]'Z63]GW5Y'K_3WXMM?I*/U?Z+G8>=U/J_4GU?;NK65FRG' M+C377CM-&,QEEK:[;K75']8M```````$`````#A"24T$&@`````#/P`` M``8``````````````+<```/3````!0!E`&X`=`!I`&$````!```````````` M``````````````$``````````````],```"W``````````````````````$` M````````````````````````$`````$```````!N=6QL`````@````9B;W5N M9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!, M969T;&]N9P``````````0G1O;6QO;F<```"W`````%)G:'1L;VYG```#TP`` M``9S;&EC97-6;$QS`````4]B:F,````!```````%7!E96YU M;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$````` M``!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<````````` M`$)T;VUL;VYG````MP````!29VAT;&]N9P```],````#=7)L5$585`````$` M``````!N=6QL5$585`````$```````!-'1415A4`````0``````"6AOD%L M:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T M06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E M0D=#;VQO```!X``` M.$````MR`!@``?_8_^``$$I&248``0(``$@`2```_^T`#$%D;V)E7T--``'_ M[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5 M$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT. M#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`S_P``1"``>`*`#`2(``A$!`Q$!_]T`!``*_\0!/P`` M`04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````! M``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&! M,@84D:&Q0B,D%5+!8C,T)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>' MEZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12A ML4(CP5+1\#,D8N%R@I)#4Q5C+R MLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?' M_]H`#`,!``(1`Q$`/P#6_P`8'UQP^A]7Q\+(KS7.=CBX.Q,HX[8>^RN'UM'O M>WT/IKF?_',Z7_H>K?\`N0?_`.16M]>?JZ/K)_C)Z;TQ[W54.P&V9%C(+A6R MW*<[9N]N^SVU-=_@_4]3T[$'K/\`B]Z1;T3JU^/TF_HM_2V.NQD MZW^;H?\`X3^:6AT/ZN]#^K/^,O[!75;:[*Q_M/2W[I&.",AF55=[F^MN;4]E M#OTG\O\`2?ITE-7H_P!:[>N9EF#TO!ZMD953#996>I>GM:US:WDNO]-OM?8W MVK//^,OI@)!IZL"-"#U!_P#Y%:?0\3H75O\`&7U6G"KRL-M./D?:W,R+:GV9 M3 M_;'NV[EZ'_S:I_\`+#J/_L7;_P"27EW5_JQ@_5K_`!E=%QNGEWV7)R,;(KK> M=QKF\UNJ#S[GL;Z7LW^]:V59@5T]8SPJY./B]2:[(KQJ0J9P.]V)T%ES*S/IFT7Y.PNK#OHN?M_.W^FC4_4?%R<&O+R\K* M/U@MJW/ZLV^T6,M>"]WH55658U>-6^STZL:NKTO0]G_")*=/_FU3_P"6'4?_ M`&+M_P#))?\`-JG_`,L.H_\`L7;_`.27)NZG=]8.C="ZKUG'R_3)K>VEN7FT899?;@_J^1=LI9^A_P`)_@UI9.7AG!Z#T#ZL9;L?!ZV^T5YM M3WV6,QJ6/RI5[$IVO^;5/_`)8=1_\`8NW_ M`,DE_P`VJ?\`RPZC_P"Q=O\`Y)!H^J70NE.R.H8%-E64ZNS=:T_ MYM4_^6'4?_8NW_R27_-JG_RPZC_[%V_^27,=?PL-O1NDXG0K,SI;K72_T_P":?_QBN/ZY?U3&Z!9K1S]]#_9=5^DM_1/K24[?_`#:I_P#+#J/_`+%V_P#DDO\`FU3_`.6' M4?\`V+M_\DL?IW2,;ZWLRNJ=<=;DXK\FVG`PFVV54UTX]C\9ECZ,=]?J9EUC M+;+K;GV_X.NKTV,5?ZR=/Z3A]4^KW2[J\I_2VU9WZ"A^7=82W[-97)Q'V9MC M:W.=M]WIU?\`%I*>@_YM4_\`EAU'_P!B[?\`R2LX'1Z\&\W-RLN\EI9LR+WV MLU+7;@RP[=_M^FN:ZIA55=!Q6='Q.H/Z0W-=0Z M[T?6HI_GJ_YO_"K:^J;/JVWICO\`FXZ<(VO#V%]KBRT>VVM]68XW8SM/YG95 M_I?\(DI__]!O\8GU@R/J[_C#Z;U7'8+33@,;92XEH?6^W+997N;]%VT_HW_F M6_X.SZ"P>N_6KZFYV#ENP>GYU'4N]7PZ[\ECW9]>&0R/3?70\D2??NRF/L_P"^*C^S*?\`RYI_[8P__222GR;Z MP?7'"ZKTGZO8-5%M=G1:V,NQF^U M[-];+OT?^"]>EEB]0_9E/_ES3_VQA_\`I)+]F4_^7-/_`&QA_P#I))3YOF_6 MO$^M/U\^KN=CT/QC3;BTV5V$$;A?ZGZ-S?I,_2KOC]7_`*SC!ZKTBG["S$ZM ME9=C\MUEK[649CG;PW#%%-;LFNI___9G6?\`RYM_[8H_]))*:(^J3#GV,>X/Z59T>OI&TN)O(8ZW<]SMFS^9 MM_G-W\[_`(-#Q^G_`%WQ>EMZ/5D83Q6!13U9[K?6;2`*_5?T_P!)]5N;6SZ' MZ_Z+W_SJTOV9UG_RYM_[8H_]))?LSK/_`)M_A_^`6S^S.L_^7-O_;%'_I)+]F=9 M_P#+FW_MBC_TDDI'C_\`.NZ*>H48%5+JGMNLHNNL[WUUK<_9G6?_ M`"YM_P"V*/\`TDE^S.L_^7-O_;%'_I))30SND_6#JU73'9PPZ+^G]4JS'MHL ML>PT5L>PAKK*:W_:?4M^AL]+9_A5'JWU3MR?K+@=;PK64M9=7;U*AVGJFAEU M6)>QS&.=]HJKR;J?>_8^GT_]"M']F=9_\N;?^V*/_227[,ZS_P"7-O\`VQ1_ MZ224Y^/T?ZP]%S\MW1G8N7TS-M?E'$RWV4OINLVNM^S7TU9;'8]C_4L]'T*_ M3_S_`%&S^F_6J_,Z1U6MF`<[!9ELR:76W-I/V@U-I]"QN/9:_971^E]2NM:/ M[,ZS_P"7-O\`VQ1_Z22_9G6?_+FW_MBC_P!))*1>I]<114\T=--XM=ZU(NO# M'4[/T?I9/V?=7D>O]/?BVU^DH_5_HN=AYW4^K]2?5]NZM96;*<.TT8 MS&66MKMNM=4?UBUS*_?_`#=3$?\`9G6?_+FW_MBC_P!)*QA8>?1:Y^3GOS&% ML"MU=3`#/T]U+&.24__9.$))300A``````!5`````0$````/`$$`9`!O`&(` M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T M`&\`&UL;G,Z>#TB M861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](C,N,2XQ+3$Q,2(^"B`@(#QR9&8Z M4D1&('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z>&%P/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@ M("`@("`@/'AA<#I#&%P.DUO9&EF>41A=&4^,C`Q,BTP,RTP-50Q,#HU,SHS M-BTP.#HP,#PO>&%P.DUO9&EF>41A=&4^"B`@("`@("`@(#QX87`Z365T861A M=&%$871E/C(P,3(M,#,M,#54,3`Z-3,Z,S8M,#@Z,#`\+WAA<#I-971A9&%T M841A=&4^"B`@("`@(#PO&UL;G,Z&%P+S$N,"]S M5'EP92]297-O=7)C95)E9B,B/@H@("`@("`@("`\>&%P34TZ1&]C=6UE;G1) M1#YU=6ED.CDU1CE!-#@S1C0V-D4Q,3%!,$5&13A&1$4X-C(T03@V/"]X87!- M33I$;V-U;65N=$E$/@H@("`@("`@("`\>&%P34TZ26YS=&%N8V5)1#YU=6ED M.CDV1CE!-#@S1C0V-D4Q,3%!,$5&13A&1$4X-C(T03@V/"]X87!-33I);G-T M86YC94E$/@H@("`@("`@("`\>&%P34TZ1&5R:79E9$9R;VT@&UL;G,Z=&EF9CTB:'1T<#HO+VYS M+F%D;V)E+F-O;2]T:69F+S$N,"\B/@H@("`@("`@("`\=&EF9CI/&UP;65T83X*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`* M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@ M("`@("`*/#]X<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10`!`0`` M#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C%```8VEA96B`````````D MH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`L@"W M`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(! M.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J(" MK`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B M`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V!,0$ MTP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G M!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&09!ZP' MOP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)9`EY M"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+ M@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI M#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0 M)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$)%ZX7TA?W&!L80!AE&(H8KQC5 M&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL;8QN*&[(;VAP"'"H< M4AQ['*,0!YJ'I0>OA[I'Q,?/A]I'Y0?OQ_J M(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B--@U$S5--8Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$25^!8+UA]6,M9&EEI6;A:!UI66J9: M]5M%6Y5;Y5PU7(9O5\/7V%?LV`%8%=@JF#\84]AHF'U M8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-I MFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z M<95Q\')+%V/G:;=OAW5G>S>!%X;GC,>2IY MB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'- M@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2* MRHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.V ME""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>= M9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;] MIVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:QK_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;& MP\=!Q[_(/%$XIZ#+HO.E& MZ=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#U MWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!9&]B M90!D0`````'_VP"$``("`@("`@("`@(#`@("`P0#`@(#!`4$!`0$!`4&!04% M!04%!@8'!P@'!P8)"0H*"0D,#`P,#`P,#`P,#`P,#`P!`P,#!00%"08&"0T* M"0H-#PX.#@X/#PP,#`P,#P\,#`P,#`P/#`P,#`P,#`P,#`P,#`P,#`P,#`P, M#`P,#`P,#/_``!$(`+<#TP,!$0`"$0$#$0'_W0`$`'O_Q`&B````!P$!`0$! M```````````$!0,"!@$`!P@)"@L!``("`P$!`0$!``````````$``@,$!08' M"`D*"Q```@$#`P($`@8'`P0"!@)S`0(#$00`!2$2,4%1!A-A(G&!%#*1H0<5 ML4(CP5+1X3,68O`D' MEZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK* MVNKZ$0`"`@$"`P4%!`4&!`@#`VT!``(1`P0A$C%!!5$382(&<8&1,J&Q\!3! MT>$C0A528G+Q,R0T0X(6DE,EHF.RP@=STC7B1(,75),("0H8&28V11HG9'15 M-_*CL\,H*=/C\X24I+3$U.3T976%E:6UQ=7E]4969G:&EJ:VQM;F]D=79W>' MEZ>WQ]?G]SA(6&AXB)BHN,C8Z/@Y25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK: MZOK_V@`,`P$``A$#$0`_`/OYBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK_`/_0^_F*NQ5\5?\`.>?EK_G(SS7^ M2-EIG_.+][K%C^9"^:+">YGT35(M(N?T6D%T+@&XEF@4J9&BJO+?8TVQ5^-W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J3_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W M_*D_^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI+_G\ MK_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_`-Y/%7?\J2_Y_*_]3+^8 MO_A=6/\`WD\5=_RI+_G\K_U,OYB_^%U8_P#>3Q5W_*DO^?RO_4R_F+_X75C_ M`-Y/%7?\J2_Y_*_]3+^8O_A=6/\`WD\5=_RI/_G\K_U,OYB_^%U8_P#>3Q5^ M[G_.)FC_`)M^7_\`G'G\MM'_`#VN=0N_S8LK6]7SA<:I>IJ-VTK:A\U^6-"N_*7Y?QVFLZO96-U)%I^H!Q'<3I$Y4G4"`: M,:5!Q5_3'BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B MKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BK_`/_3^_F*NQ5_,3_S^M_]:=_+O_S5 M^G_]UK6<5?CSBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL M5=BKL5=BKL5=BKZ6_P"<9O\`G%#\W/\`G*SS9<^6_P`M-,@BT_2!')YG\X:F MSPZ7ID M-)9Y=-OO2W>+DZH\4R@@M'(H--UY+OBKY5Q5V*NQ5V*NQ5V*NQ5V*NQ5V*LU M_+7_`,F-Y`_\"32O^HR+%7]X^*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_U/OYBKL5?S$_ M\_K?_6G?R[_\U?I__=:UG%7X\XJ[%78J[%78J[%78J[%78J[%78J[%78J[%7 M8J[%78J[%78J[%78J],_+W\F/S:_-B\2Q_+7\M_,7G>=FX,^D:=<7,*'OZDR M(8XP*[EV`&*L3\U^5M?\C^9M?\F^:M-?1_,WE>_N-+U_2I&1WMKNUD,4T3-& MS(2CJ02I(]\58_BKL5?UV_\`/K3R5H/E/_G#'\M-2TBWC2_\\3:IKWF.\4#G M/=M?SVB\R!4^G#;1QCPXXJ_0_%7PI_S\H\F:'YR_YPS_`#C_`$U!&\WE6QM_ M,6A73@^L;F,HT9/0O&[Q>X3?RE\Y:IJ6D>7MH?G/^3QTH:Z/S7\G'1"GJC6/T[I_U7ATY>MZ_"E>]<5?AC_S\X_Y M^#>0/S#\D7G_`#CS^1NN1^;--UJYMY?S$\]61)L'@M9%GBL+*6@]?G*B/)(O MP47@I;DW%5^#>*NQ5V*NQ5V*NQ5V*NQ5V*NQ5FOY:_\`DQO('_@2:5_U&18J M_O'Q5\W_`/.37_.4?Y;_`/.*/DO2_._YE6^LWNGZWJ0TC2;+0[6.YN);HPR3 MA2)9H$5>$3;L^*OS)US_`)_??EM!)*OEO\B_,NJ1BOHRZEJEG8D^%4BCNZ?? MBKS>Z_Y_D:H2XLO^<;K55#G@\_FIV)3M55TH4/TXJGNC?\_QM.>6GF'_`)QT MN+6"OV].\RI.U/'C+IT(_'%7UU^4O_/V7_G$_P#,JZM=+\P:MJ_Y3:M M:K5%L"YIM]?M))XD7_*F],8J_2O3M1T_5[&TU32;^WU33+^)9['4;25)X)XG M%5DCEC+*RD;@@T.*HS%78J_)G_G(;_GZWY._YQ]_./SM^3^I_D]K/F.^\EW% MO!/K=MJEO!%<&XM8;H,D;PNRT$W'<]L5?1G_`#AE_P`YJ:%_SF/I_G[4-#\A MZAY(3R'<:?;W"7UY%=FY-^D[J4,41]'7](:Q(K"JEK:,TA##HT[1J>QQ5^5/GW M_G]\1<30?EA^1(DM140:KYHU7B[;[%K.RB(&W;ZP<5>2+_S^U_/?D"WY2^0B ME=U'Z4!I\_KA_5BKW7\NO^?W>@7-S!:_FO\`DC>Z1;LZK-K/E?4DO>*G[3?4 M[R.W.W@)SBK]9/R,_P"C'%7T!BKL5=BK1(`))H!N2<5?F]_SD%_S]'_YQI_(W4+[R MWI6HW?YM^D>5C$]E;S*2#'<:E(P@!!%"(O593LP!Q5^K7][J,U.Q+P?4E^CCBJ6:5_S^W_.J&6(ZU^3ODK4; M=0/6CLY]1LY&\:/)-9+&WU/0]4A MY>G://R>9? M-MD62?R;Y60:I?1R**F.=D9;>!J[<995;VQ5^:?G?_G^!)ZTD/Y6O\`G]_Y^@GC'G#\B/+^J6Q8>JVC:M=6#A>Y47$5X"?I&*OT$_YQ MV_Y^C_\`./OY_>:=`_+]M.\P_E_Y]\RW*66BZ/JEJ+NTNKF2O&*&\LS)0FG6 M6.,>^*OTIQ5^;O\`SE[_`,_&O+'_`#B/^9.D_EQK7Y8:KYSN=6T"WUZ/5;+4 M(+6-$GN+BW$122)V)!MR:UIOBJK_`,X?_P#/Q7RQ_P`Y=_F)KGY>Z)^6.J>3 M+G1-`FUZ34[W4(+N-TBN;>W]()'%&029P:UIMBK]'<5>#?\`.3'Y[:?_`,XV M?DUYI_.+5/+MSYJL?*\EA'-H=I.EM++]>O(;,%99%91P,W([;@8J_*O_`*+@ M^0/_`"P?F#_N-6G_`&3XJ[_HN#Y`_P#+!^8/^XU:?]D^*N_Z+@^0/_+!^8/^ MXU:?]D^*N_Z+@^0/_+!^8/\`N-6G_9/BK-ORU_Y_&>2/S)_,3R+^7MI^2&NZ M9=>>-?T[0;?4I=7M9$MWU"YCMUE9!`I8(7Y$`U-,5?LOBKYD_P"GY9>4?S4\CW?UGR_YML5NHHF(,UK. M"4N+2<+4"6"56C<>(VVH<5>GXJ[%78J^9O\`G+#_`)R7T7_G%'\K8OS1U[RO M?>;K"76[31/T5I\T4$H>[CFD60O*"O%?1((Z[XJ^*/R3_P"?MOY?_G7^:_D3 M\J=,_*#S#HE_Y[U6+2[75KG4+22&W>0$\W1%#$"G08J_7#%78J[%4'J&H:?I M-C=:GJM];Z9IMC$TU]J%W*D,$,2"K/)(Y"JH&Y)-,5?FQ^:M9>9M"LDO]<\JZU8M;W-O;NZQ>H)HS+;NO M-@OPREO\G%7UWBK\:_S/_P"?Q/DC\LOS(\__`)N=3B MU>UCCN7TRZDM6F1#`Q57,?(`FH!Q5@W_`$7!\@?^6#\P?]QJT_[)\5=_T7!\ M@?\`E@_,'_<:M/\`LGQ5W_1<'R!_Y8/S!_W&K3_LGQ5W_1<'R!_Y8/S!_P!Q MJT_[)\5?J=_SC%^?>G?\Y,?DYY<_.'2O+ESY4L?,5Q?P1:)=SI_.S_`)_#?\X^_E[>WFB_EEH>J_G-JMH7C?4[-UTS1N:[ M42\G22645_:2`J1NK'%7Q!JW_/[?\ZIYY3H?Y/>2M-M6/[B*]GU&\D45_:DC MFME;_@!BJ9:%_P`_O/S4@N5;S-^2'E35;.HY0Z9J%]I\M.]'F^N#_A<5?=OY M&?\`/V[_`)QU_-C6-+\K>;=,UO\`*;S+K%Q%9Z=^DXQJ&F37$[!(XEO+0%T+ M,0`9847?[6*OU1Q5V*NQ5V*O_];[^8J[%7\Q/_/ZW_UIW\N__-7Z?_W6M9Q5 M^/.*NQ5V*LE\J^3/-_GK5H=!\E>5]6\W:W<$"'2=&LY[ZX:O<10([4]Z8J^S M/*__`#[-_P"Z68?2F*I]KO_/J_P#Y MS9T2![B/\K;37$C%633-3&ELNLV,UK'-M7]S*ZB.44[HQQ5YOBKL5;`)(`%2=@!BKVZ/_G&; M_G)"6-)8O^L M?]DN*O(-8T;5_+VJZAH6OZ5>:'K>DSO:ZIH^H026UU;3QFCQ30RJKHZG8JP! M&*LR_+K\H_S/_-S56T7\L?(.N^>M2CIZ\&CV4MTL(/1II$4I$/=V`Q5]F:3_ M`,^KO^26U_KVDQS'IMP6Z?B37HU,5>2_F5_S@I_SEG^4 MUE=:KYP_)/71H]DI>ZU?2/0UFWC0=7D?39;C@HZDN!3OBKY*(*DJP((-"#U! MQ5K%62>5/)OF_P`]ZLN@^2/*NL>8O.7Y0>=O*7E^TT[74N]E:O8^6M4N;6YMYM0F>.:&:*V9)$=2"K*2".F*OG'4?^<<_P#G M(/1]/O\`5]7_`"*_,+2]*TNWEN]3U.[\L:K!;VUO`ADEFFEDME5$15+,S$`` M5.*O&L5>H^6/R._.KSMH]OYB\F?E!YU\W>7[MI$M=L?]DN*I'YD_(G\[_)NC7?F+S?\` MDYYX\J^7[#A]>UW5_+VI6-G#ZCB-/4N+BW2->3L%%3N2!BKRK%78JC=.TS4M M8O(-.TG3[G5-0N6XVUC:1//-(W@D<89F/R&*OJ_R7_S@3_SF#Y]A@N=!_(3S M-!:W*\X;G68HM%1E/0_[DY+8_ABKW6R_Y](_\YH748>;REY=TYB`?2N-?LRP M]OW+2BOTXJQ3S/\`\^N?^/RX\_\`Y9:N^@?F)Y+UOR1K*5IIVMV,]E*P4T+()D7FO^4M1[XJPO%7 M8J[%6:_EK_Y,;R!_X$FE?]1D6*O[Q\5?C'_S^R_\D!^5?_@?I_W2[W%7\_\` M^0/Y4_\`*\?SE_+S\I?TW_AP>>]6CTQM<]#ZS]6#*SEQ#SCYFBT`Y#YXJ_=; M3O\`GR!^6T2*-6_/;S+>R4/)K32K.U!/:@DEN*??BK$_-O\`SX^T\VDTGD3\ M_KA+Y16WL]>T1&B8[[-/:W*LOS$1^6*OR._YR1_YQ(_.O_G%C6[73/S1\O(F MD:M(\?E[SEICFZTB_*"K+%/Q0I(!N8Y51Z;\:;XJ]]_YP-_YSO\`.7_.,'G/ M2?*GFC5;K7/R*U^]2'S)Y=F9IOT09V"MJ.G!B3&8R>4L:_#(M=N?%@J_K>M+ MNUO[6VOK*XCN[.]B2>TNH6#QRQ2*&1T85!5@001U&*HC%7\=7_/RK_UMO\]? M^VAIG_=(LL5?II_SXZ_Y1G_G(C_MI^7?^3-_BK]X<5=BK\._^?B?_/RV^_+O M4]9_(C_G'K5(T\Y67.S\_P#YCPTD_14O1['3CNIN5Z2RFOI'X5_>5,:K^?\` M\M>5_P`P?S@\[6V@^6=+U?S_`.?/-=TS1VT/J7M]=SR'E)++(Y9CW9Y':@%6 M8@;XJ_8S\GO^?*GGW7-/M-5_.O\`-"Q\BRW"AY/*GE^V&K7D0)'P37;R16Z/ M2M?3$J_Y1Q5]'W?_`#Y(_)![-DL?S@\\6]_Q(6YGCTV:$-V)B6WB8@>'J?3B MKX6_YR#_`.?0_P">WY5Z9?\`F?\`+#6+3\ZO+NGH\UUIMC;M8Z]'$NY9;!GE M2>@[0RLY[1G%7Y=^6_,WFW\O/,]AYC\K:SJ7E#S=YMM?U/_`)Q@ M_*76Y=)LM.A5/S<\R6,A2>XFG0.-(AE0U2-$8&X*FK,?2-`KAE7X\?D/_P`X M^?FG_P`Y(^=X?(7Y5>7FUG51']9U34)F]"PTZU!"FXO;D@B-*F@V+,?A16;; M%7[4^1?^?(.B+I\$OYF?GG?3ZHZ@W-AY8TR**WC;:H2YO7D:0>YA3Y8JF_F; M_GR!Y&GMY3Y._/C7=,NPK>BNLZ3;7T9/[(8V\UH0/&@.*OBWS#_SZ0_YR0\H M_F1Y'T*:#3O/'Y>^8_,-AINL^=_+LS$Z=8SSJL]S=VEPLFZ+I5LEGIFCVL-EIUHFRQ06Z".)%]E50!BJ88JDOF/S'H7 ME#0=7\T>:-6M=!\NZ!:2WVM:S>R+%;VUO"I>221VH`%`Q5_,7_SFQ_S]!\^_ MG3?ZQ^7OY(:C??E_^4<3R6MQK=NS6^L^8(Q52\LHH]M;N/LQ(0S#^]._IJJ_ M-;\L_P`IOS*_.?S-#Y1_*_R9JGG;S#..;V6G0F01(33U;B8TCACKU>1E7WQ5 M^LOY9?\`/E3\X->MK:^_-/\`,[R_^7PF`:71M+@EUR\C!ZK(X>UMPP_R)''O MBKZ0M?\`GR%^6"6I2]_//S1<7M-KB#3+*&*M.OI,\K4K_EXJ\U\Y?\^/M2C@ MEE_+[\_;:\N0&,-AYAT5[:,G]D-7?_`'4] M/Q5_3KBK\]?^?IO_`*Q!^;G_`#$>7_\`NMV6*OY%K.V:]N[6S1@CW'R M/_R*U+_LGQ5W_1$C\[?_`"\'D?\`Y%:E_P!D^*O1OR?_`.?/GYQ?EO\`FO\` MEI^8.H_FKY-O]/\`)'F?2M=OK&WBU`330Z?=QW$D?^?3__`#EQ_P`JA_,IOR+\[:GZ/Y=_ MFM>QKY?N;AZ1:7YB<+%":G98[T!87_RQ$=AR.*OZ@\5=BKL5?E-_S^-_]9$M M?_`\T7_J'OL5?@M_S@3_`.MC?\X\_P#@76W_`!"3%7]H6*NQ5X?_`,Y!_P#. M0?Y<_P#.-7Y<:G^9'YD:F;:PM3]7T?1X.+7VJ7S@F*TM(B1R=J5)/PHH+,0H M.*OY/O\`G*S_`)SA_.;_`)RKURZ7S'JLOEG\NH9BV@_EGIDSK80HK$QR7;#B M;N>G6204!^PJ#;%6"?D+_P`XE_GW_P`Y)WKQ?E5Y$NM4TBWE]+4?-UZ19:/; M-W62\FHC,.I2/F_^3BK]4_(W_/D'S%<6T,_YD_GMI^DW3*#-IOES29;Y5-=U M%U=S6M=N_H_?BKUF?_GR%^5S6H2V_/+S3#>TWN)=-LI(JT._I*R-U_R\5>`_ MF)_SY+_,W2K>YN_RP_.#0?.#Q`M#I6N64^C324'V5EB>]C+'MRXCWQ5]T?\` M/K+_`)Q2\]?\XX>2OS5U+\UO+?\`AOS_`.;/,,>G)9-+%G^8=8\NW M6ISW&JZ8LJVTBWU]-=(%$RH]560`U'7%7U$S*BL[L%502S$T``ZDG%7\G7_/ MQ7_G.7S%_P`Y&>?M8_+KR3K$UA^1GDR_>UTRSM7*)K]W;,4?4KKC3U(^0/U= M#LJT>G-C15X#_P`XM?\`.%GYS_\`.66K72>0M/M](\H:1,(?,/Y@:P7BTVUD M(#>A'P5I)YN)!].-304+E`0<5?KUY;_Y\A?EW!91#S?^>?F/4]1*#UVT?3+2 MQA#TWXBX>[8BOB1MBK&O.7_/C_3&M99?R]_/JZBOE7]Q9>8M'22)VH=FN+2= M&4$]Q$U/?%7D?_.+O_/M#\]/RQ_YR_\`RTN?S9\LV=_^7?DVXF\T?XTTF<7F MEW5QI@YV,%66.6.1KHQ-PEC6JJU.0!Q5_27BKL5=BKL5?__7^_F*NQ5_,3_S M^M_]:=_+O_S5^G_]UK6<5?CSBKL5?JC_`,X&_P#/MWS!_P`Y+):_F;^9\][Y M/_):&>FGK`/2U'S$T34D2S9U(BMU(*O.0:FJQBH9D5?TP_E?^3WY8_DMY2=*\EZ)`H#P:?`J2SL/]V7,YK+.Y[O(S-[XJ]*Q5V*L=\U>4?*WGK0= M0\K^<_+NG>:O+FJQF+4=$U6VCN[692*?%%*K*2*[&E1VQ5_-]_S\,_Y]JI^2 M]CJ?YV?D/9W-Y^5\+&;SGY+9VN+CR^'8#ZS;.U7ELZFC!B7BZDM'4HJ_&;%6 MU8JRL.JD$?1BK^]+R->#4/)7D^_#B47VB:?<"4"@;U;:-J@>]<593BK\&=8_ MY]SZA_SD1_SG=^?OG7S_`!W>@?D9I'F&SNYI8"8;GS!>7>FVEU+:6"?&2T:K]M/(?Y>^1_RO\`+5AY/_+SRKIOD_RSIB\;31]+@6"('N[\ M15W;JSN2S'S6 M5A&L%KYF$:\G@N(UXHMTP'[N8`%F^&2H(9%7\LUQ;SVL\UK=0R6US;2-%<6\ MJE)(Y$/%D=6H0010@],5?J'_`,^?_P#UL2Q_\`[7/U08J_JTQ5V*NQ5V*O#O M^__P#.+'DS\O?S%_YR%_*; MR'^:DEY'Y&\X:]#I&KFPG6VF:2[5HK1/696X*]RT:N1OQ)XD&AQ5_9#^57Y" M_DW^2.EII/Y5?ESHGDN!4"37=C;+]J0+,@)%`\3'XHG'[+H58=01BK^7/ M_GX-_P`X`W__`#BSJT/G[\OVN]<_)'S)=_5[6:X)FN]"O9*LEG=R`?'$X!]& M4[FG!_CXM(J_,?%78JS7\M?_`"8WD#_P)-*_ZC(L5?WCXJ_&/_G]E_Y(#\J_ M_`_3_NEWN*OQ?_YP#_\`6R?^<>__``*H?^3,N*O[/,5=BKY^_P"[N--A))Z_N[9<5?8V* MOXZO^?E7_K;?YZ_]M#3/^Z198J_33_GQU_RC/_.1'_;3\N_\F;_%7[PXJ^!? M^?BW_.40G4_O+5F3E>:B!_RZQ'X3_OUXZ[ M5Q5_(GING:SYHURQTK3;:YUOS!YAOHK6PM(^4MQ=WEW($C1:U+/)(P'B2<5? MV!?\X,_\X:>5?^<3_P`M;-+FRMM1_-[S3:13?F)YL`$CK(P#_HZTD_9MX":? M#3U&'J-^R%5?2+ M]M/\R^3]0BOK&0$\)54TEMY@*5AQGMI"-N<$JO&WNIQ5GFK:A'I.EZEJDPK%IMK-=2B MM*K"A<[GV&*OX.?.GFG4_/'G#S5YSUJX>ZU?S9J][J^IW$AJSSWL[SR$_P"R M8?S5N;W7_,NI`*9)!%=36=G"7%3PBA MA!"UV9W-*L<5?I1BKL5=BKL5=BK^;S_G[I_SEW>^:O.#_P#.,7D?4S%Y2\FR M17'YFW-NQ`U#6*"6*Q9@=XK-2&9>\QH16(8J_.'_`)Q-_P"<8O.'_.5GYLZ9 M^7?EMFTS1K91?^=_-;1^I%I6F(P5Y2*@/+(3PB2OQ,=Z*&8*OZ_OR/\`R%_+ M#_G'?R19>0_RM\MP:'I4"HVHWY"O?:E<*M#GXJ_IUQ5^>G_/T[_UB#\W/^8CR_P#]UNRQ5_)'H7_';T;_`)CK?_DZN*O[ MX+7_`'FM_P#C$G_$1BJOBKL5=BKL5?E7_P`_BO\`UD*/_P`#G1/^3-YBK^?_ M`/YPL\A>7?S5_P":[<3Z!^8-MKFA7KT4O`USHUZ(+F/E^W!,$E3H M>2C?%7B7YC^0?,_Y1_F'YL_+OS3`^G>:/(^K3Z;J`6J_O;=Z)-$VQ*2+QDC8 M=5((ZXJ_JQ_Y]P?\Y:I_SDU^2T&F>9]1$WYM?EE'!I7G99&'K7\!4K9ZJ!W] M=4*RGM*K'8,M57Z(8J[%7Y3?\_C?_61+7_P/-%_ZA[[%7X+?\X$_^MC?\X\_ M^!=;?\0DQ5_:%BJ#U'4+'2-/OM5U.[BL--TRWEN]0OIV"10P0H9))'8[!54$ MDGH,5?QM?\YQ?\Y6:W_SE9^<^J^9$N9X/RZ\LR3:7^66@O55AL%>C7N/S*_,NWN+7\E/*-X+=K1"T4G MF#48PKM9QR*0RP1`@S.IJ:B-"&+,BK^IGR]Y=T#RCHFF>6O*^C67E[R]HL"6 MNDZ+I\*6]M;0H**D44855`]ABJ73F@)::=W.6-U)#*ZD$$&A&*NU#3['5K"^TO4[2'4--U*WEM=0L+A!)%/!,I M22*1&!#*ZD@@[$8J_B]_YS7_`.AVMSJTMK(/M1W# MVDH_DC_SD]^17_.15K>W'Y0_F%8>:KG3(UEU71>,MIJ-J MCF@>6SNDBF"$[\5=BK^2W_GZM^2EE^4?_`#E1K.M:)9K9>7?S M;T^+S;:PQK2..^FD>#4D6@I5IXC,1V]7%7GG_/O'\]?R[_YQV_YR*MOS&_,_ M4+O3?*\7EW5-.:YL[22\D^L70B])?2B!:AXFI[8J_HY_)C_GX1_SC/\`GW^8 M.D?EC^7'F/6-1\VZY%=3:?:W6CW=K$R6<#W$I::10JT2,D5ZG;%7VYBKL5?G MUYZ_Y^<_\XE_ESYT\U^0?-'FG7+7S)Y+U:\T37K>+0[R6-+NQF:"94D5.+J' M0T8;$;C%7@WYW?\`/T3_`)Q$\\?DQ^;GDKR_YKUV?7O-_DO7M%T2"70[R)'N M[_3I[>!6D90%!DD`).PZXJ_F!Q5_6Y_SZ>_]8E_+K_MK>8O^ZM4Q1*@_%BK\[?/_P#S^]TV*XEM_P`K?R+N+ZV! M80ZMYHU1;9C0_"39V44W7O\`O\5>1V7_`#^Y_.6.[C?4OR:\EW=@&K+;6USJ M-O,5\%E>690??@?EBK]7?^<._P#G/O\`*[_G+L:EH.F:;=>1?S)T2U^NZEY' MU"9+CUK4,J/D:K#_)0/_``)-*_ZC(L5?WCXJ_&/_ M`)_9?^2`_*O_`,#]/^Z7>XJ_%_\`YP#_`/6R?^<>_P#P*H?^3,N*O[/,5=BK MY?\`^&TBC3J MW!CZKTZ1HQ[8J_BML;&\U.]L]-TZUEOM0U">.VL;*!2\LTTK!(XT45+,S$`` M=3BK^W?_`)Q<_*NY_)+_`)QZ_*/\KK\(NJ^4_+UM#KBQT*#4;CE=7P4BM1]8 MF>A[]<5>]XJ_CJ_Y^5?^MM_GK_VT-,_[I%EBK]-/^?'7_*,_\Y$?]M/R[_R9 MO\5?O#BK^4K_`)^X_FW-^8/_`#E3>^3+:Z,NA?E!I%KH5K"#6/Z_=HM]?2`5 M^U66.)O^,0Q5-O\`GT)^2UK^8_\`SDG=_F!K%F+O1?R9TDZM;!Q5/TQ?,UM8 M5'BBB:5?!HU.*OZG\5=BKL5=BJ$O["RU2QO=,U*UBOM.U&"2UO[*90\5==G30FD^T^F706Z MT]B>Y-M-'4^-<5?NM_SY5_-.?7_RB_,S\IK^Z]63\O-=@U;186K5+'7(WYQI MVXK<6TC_`#D]\5?L_J=C%JFG:AIDYI!J-M+;3$?RS(4;\#BK^$#\P?)NK?EW MY[\X^0M=MWM=8\G:S?:-J,$@((ELIWA8[@5!XU![C?%7]%G_`#Z%_P"W'D^RG=8SJND7' M_GK+Q0?/%7\-6OZ[JOFC7=:\RZ[>2:CK?F&^N-2U>_E-7GNKJ1III&/BSL2< M5?U@_P#/K7\A;+\G?^<8/+GFB[L!#YR_.0)YIU^[=:2BRE!&E6]>O!;:?_P!U'4<51?\`SY6_ M]:4\_P#_`)KR[_[J>GXJ_IUQ5^>O_/TW_P!8@_-S_F(\O_\`=;LL5?R1:%_Q MV]&_YCK?_DZN*O[X+7_>:W_XQ)_Q$8JKXJ[%78J[%7Y5_P#/XK_UD*/_`,#G M1/\`DS>8J_![_GWU/]7_`.G\I/U:0GL8?`XJ_(/_G%/ M_G(GS%_SC!^=/E?\T-$,MSIMM)]0\YZ#&W%=2T:X9?K5N:[<@%$D9/21$/0' M%7]I/DWS?Y=\_P#E3R[YV\I:G%K/EGS5I]OJ>AZG":I-;7*"1&\0:&A!W!J# MN,59+BK\IO\`G\;_`.LB6O\`X'FB_P#4/?8J_!;_`)P)_P#6QO\`G'G_`,"Z MV_XA)BK^T+%7YF_\_7_SEN/RL_YQ5U?R[I5V;77OS>U&'RK;LAI(M@Z-<:BP MH?LM#%Z+>TN*OY6/)_E;5O/'FSRQY+T&#ZSKGFW5;/1](@W^.YOID@B!I4TY M.*XJ_N,_)K\K/+GY)_E=Y(_*SRK`L6C>2]*AL(I0H5KB91RN+J2G[<\S/*Y_ MF8XJ]-Q5V*NQ5V*NQ5V*OX@_^2M'@:Z MU?5/*MY/I5F@)>:YL.-[#$H'5G>`*/5?^<>O,OYI7-J%UC\U/,,T=M=%1R.EZ+6UA4'K3ZRUR3X[>&*OV!Q5^2O M_/W?S/\`F2?R1\I?E7^7'EK7M?;\R=9DE\W/H=A=WI73-(6.803&VC<()KB6 M)OB^T(R-Q7%7\WW_`"H[\ZO_`"T'G;_PG]2_ZH8J[_E1_P"=7_EH/.W_`(3^ MI?\`5#%7]5O_`#[+U?SQ??\`.(WD;1?S`T?5=$UWR1>ZCY=M[;6;6>TN6L;: M;U;,^G<*K%$BF6)32E$IVQ5]_8J_`O\`Y_?>0+V:G;HI6X/7OBK^??%7]V?Y-?\`DH/RI_\``.T+_NGP8J])Q5^;W_/T M'_G(WS%_SC]_SCN;;R3>RZ7YU_-+4O\`#>E:U`Q2:PM#"\U]2 MVVH>5=2BGN[>-BJWEBS!;NSE`(Y)/"60@^-1N`<5?W(Z7J-KK&F:=J]B_JV6 MJVL-Y9R?S13H)$/TJPQ5'XJ_!'_G^)H$+:5_SCSYH6'_`$B*[\PZ5-/M]B1+ M&>-3WZHYQ5_/CBK]&_\`GU'_`.MM?EM_VS/,'_=)N<5?UPXJ[%7\2O\`SF/_ M`.M8_P#.2/\`YLGS+_W4I\5?-N*NQ5_6Y_SZ>_\`6)?RZ_[:WF+_`+JUSBK] M(,5?`'_/T+_UB'\Y/^W'_P!UJRQ5_(%BKL57QI)-(D42-++(P2.-069F.P`` MW)/08J^S/RI_Y]]?\Y;_`)OV]KJ/ES\HM1T71+Q!)!KWF9X]%MVC/1T6\:.: M1338QQM7%7VGY8_Y\G?GG?PQR^;/S6\E^6W<`M;6*7^IR)XAN4-HE1[,<5?9 M7_.*W_/JWS#_`,XW?G9Y,_.(_GM#KI\K?6EO/+]KH;VHO8KRTFM9(6G>]DXK M^]Y5X'=1MBK]D,5=BK^,W_GX/H,/ES_G,W_G(#3X%"Q7'F,:G04IRU.T@OGZ M?Y4YQ5\:XJS7\M?_`"8WD#_P)-*_ZC(L5?WCXJ_&/_G]E_Y(#\J__`_3_NEW MN*OP._YQL_-/2_R2_/7\LOS7UO3+K6=*\C:PFI7VF6)1;B9%1TXQF0JE:MW. M*OW?_P"BW'Y+?^6<\Z_\C]._ZK8JP#SS_P`_OM(6PFB_+7\BKR74W6EO?^9M M4CC@C:AW>VLXW:0`TV$RU\1BK\G?S*_-S_G);_G.C\SM.AU6+5/S#\T2"1/* MWD/R]:/]2T^#8R?5;2+D(U&QDED)8BG-Z`45?M;_`,X`_P#/L:7\FM;T?\ZO MS\^J:C^8NG4N/)_D2W9+FTT2<_9N[J9:I-=)^P$JD1^(,[\2BK]HL5=BK^.K M_GY5_P"MM_GK_P!M#3/^Z198J_33_GQU_P`HS_SD1_VT_+O_`"9O\5?O#BK^ M&K_G(WS1-YT_/_\`.KS5/*9FUWSOKUU$Y[1-?S")1[*@4#Y8J_?3_GR=Y5CL M/R+_`#5\XM%QN?,OG5=-$G=H-+L('3Z`]Y)BK]H<5=BKL5=BKL5?RD?\_?K) MK7_G,74KAH1$NI>4="N$D`IZ@5)H.1\2#%Q^0Q5Z+_SY7\PO8?\`.1_Y@>7: MGT?,'D&YG(K0>I8ZC9%=NYXS-^.*OZ>?[>'S1,M3Y'UL?H[5P12HC@E/&>E=S`\@'CBKZP MQ5V*OS/_`.?MGFFX\N?\X:>:=/MI6B;SEY@T31)F4T)B^L&^=?DPM*'V.*OY M2-!TJ;7MQ@/7X[B58EZ>[8J_O/\O:+9^6]`T/R[IT8BT_0- M/MM-L(AL%AM8EAC4?)5&*IQBKL5=BKL5=BKL5?R__P#/Z/\`]:?\F?\`FO-/ M_P"ZCJ.*HO\`Y\K?^M*>?_\`S7EW_P!U/3\5?TZXJ_/7_GZ;_P"L0?FY_P`Q M'E__`+K=EBK^1G3KE;+4+&\=2Z6EQ%,Z+U(C<,0*_+%7]'\7_/[7\EHXXX_^ M5.>=O@4+_?Z=V%/]_8JO_P"BW'Y+?^6<\Z_\C]._ZK8J[_HMQ^2W_EG/.O\` MR/T[_JMBKZ3_`.<5O^?D/Y=?\Y6_F=-^5_E;\O?,?EC4X-$N];;4M5EM'@,5 MI)#&T8$$CMR)G%-J;8J_1O%7Y5_\_BO_`%D*/_P.=$_Y,WF*OP-_YP.N#:_\ MYB?\X\2!.?+SC9Q4)I_?!XR?HY5Q5_9#YR\H>7O/_E/S'Y(\V:='JWEKS7IU MQI6N:=*/AEMKJ,QR+7L:&H(W!H1N,5?Q6?\`.47_`#C]YC_YQF_.CS;^56OB M2XM=-F^M^5=:=>*ZEH]R6:SNEIM4J"D@&RR*Z]L5?JY_SZ!_YRX_1.IS_P#. M+'GK4Z:;K,L^I?E)>W#T6&\(,MYI8)Z+,`TT0_G$@W,BC%7]#F*ORF_Y_&_^ MLB6O_@>:+_U#WV*OP6_YP)_];&_YQY_\"ZV_XA)BK^T+%7\ZO_/[_P`U2S^> MOR)\D+-^XTK0=5UR6W_R]0NHK9&/T6;`8J^)/^?9/E*#S=_SFI^3L-U'ZMMH M$VI:\XI4!].T^XF@8^%)@A'O3%7]@N*NQ5V*NQ5V*NQ5V*OX@_\`G+#_`-:A M_P": MXFHZ5+:)`(;FWM85C(GD1N0,!)[;C%7VE_T6X_);_P`LYYU_Y'Z=_P!5L5=_ MT6X_);_RSGG7_D?IW_5;%7?]%N/R6_\`+.>=?^1^G?\`5;%7[-:)JD>N:+I& MM0Q-!#K%E;WL4+T+(MQ&L@5J;5`:AIBJ:8J_F"_Y^1_\^_?,'Y1^:O,/YX_E M)H4NJ_E!YCN)-1\RZ18QEY/+-Y,W*;E$@K]2D3_-6E$FRUG393%*%;[4;C=9$:E&1P58;,#BK]NOR` M_P"?TE]:0V.@_P#.2'D,ZIPXQR>?_*2I',PK3GZ*DA@U.U!`_WHL)PD\=":5*<3V)Q5[C MBKL5=BKL5=BK_]+[^8J[%7\Q/_/ZW_UIW\N__-7Z?_W6M9Q5^/.*O[0/^<"- M'CT+_G#G_G'NRCC](3^4[>_=:`5;4))+MCMXF:N*OKS%78J[%78J[%78J_(3 M_G]%;02_\XO^3;B2,--:_F'I_H2'JO/3M1#4^8Q5_+]BK^[/\FO_`"4'Y4_^ M`=H7_=/@Q5Z3BK\,?^?X/_*`?D'_`.!!K7_4+;XJ_G1Q5V*O[I/R$=Y/R+_) M>21VDD?R)Y<9W8DDDZ9;DDD]2<5>L8J_#C_G]_\`^2W_`"(_\"75O^H.+%7\ MY6*OT;_Y]1_^MM?EM_VS/,'_`'2;G%7]<.*NQ5_$K_SF/_ZUC_SDC_YLGS+_ M`-U*?%7S;BKL5?UN?\^GO_6)?RZ_[:WF+_NK7.*OT@Q5\`?\_0O_`%B'\Y/^ MW'_W6K+%7\@6*O6/R2_);SY_SD#^8^@?E?\`ESIGZ1\PZZY+S2$I;65K'0SW MEU(`?3BB7=C2I-%4%F52J_JY_P"<4_\`GW]^1_\`SC!I>FZC!H]OY[_-%(U; M4_S'UBW22:.8[L--@?FMG&#L.'[PC[;MBK[KQ5V*NQ5V*NQ5_'=_S\O_`/6W MOSU_YC=)_P"Z+88J^%,59K^6O_DQO('_`($FE?\`49%BK^\?%7XQ_P#/[+_R M0'Y5_P#@?I_W2[W%7X`?\X__`)4K^>/YS?EY^4K:V?+B^>]633#K@@^M&VY( M[\_1YQ\_LTIR&*OVC_Z(<6__`+$=)_X3`_[R6*O-O-O_`#Y&_-33[.:;R3^= M7EGS/>1J6CLM5TZ[T@.0-E$D4E^`2=MP!BK\S?SC_P"<=?\`G(#_`)Q8\QV< M?YB^5=5\DW4DI_0/FVPF+V-RZ?%6TU&U8H7`'+AR#KW48J^[/^<0/^?JWYH? ME1JVE^3_`,^M3OOS0_+&XDCMY/,%TQN-?T=#1?62=OCO(UZM'*2]/L/MP95_ M3?Y>\PZ)YLT+1_,_EK5+?6_+_F"SAU#1=7M'$D%S;7""2*6-AU#*0<53C%7\ M=7_/RK_UMO\`/7_MH:9_W2++%7Z:?\^.O^49_P"&Y'\KOAH.=]IR** M^)+8J_J5Q5V*O@/_`)R>_P"?8[C39/RY_,F[J\GGOR['&C M74IZ-J%F:0W/NWP2G_?E,5?A=^>?_/JC_G*'\HDOM6\LZ1:_G'Y6M.3_`*1\ MKECJ*Q*">4NERTGK0;B$RT\<5?F]-#J>B:B\,\5UI&KZ7/22*17M[FWGB;H0 M>+HZ,/8@XJ_9G_G!W_GZ?YN\BZMHOY8?\Y)ZU/YL_+V[:.RTK\Q[LM-JNBDG MBAO9/B>[MAL&9JRH-^3J.&*OZ3;6ZM;^UMKZQN8KRRO(DGL[N!UDBEBD4,CH MZDAE92""#0C%7Y0?\_ET9O\`G$_0V"DJGY@:278#85LM0`KBK^:?\JYH;;\T M/RWN+@*T$'FG1Y)U8T4HM["6!/84&*O[O\5=BKL5=BKL5=BKL5?R_P#_`#^C M_P#6G_)G_FO-/_[J.HXJB_\`GRM_ZTIY_P#_`#7EW_W4]/Q5_3KBK\]/^?IW M_K$'YN?\Q'E__NMV6*OY%K.V>\N[6SC8+)=S)"C-T!D8*":=M\5?LC'_`,^3 M_P#G("1$D'YJ?E\`ZA@#)JO<5_Y8,57?]$3/^<@?_+J_E[_R,U7_`+(,5;_Z M(F?\Y`_^75_+W_D9JO\`V08J^T/^<$/^?0WVDZE;L8Y[:ZMG$D4L;#<,CJ"/?%7]F7_.%?_.36F?\` M.4_Y&^7_`#YSAM_.6ETT?\QM'BHOU?5[=%,DB(.D5PI$T?@&X5JAQ5\O_P#/ MXM&?_G$.!E%1%YZT5G/@/0O5_61BK\$_^<"?_6QO^<>?_`NM?^(28J_M"Q5_ M,G_S^NCF7_G(W\M97),,GY=6PAZT!75M1Y#P[@XJ\H_Y]%W5M;_\YF>7(I^/ MJWOEG7H;.M*^H+82GC7OPC;IV]L5?UAXJ[%78J[%78J[%78J_B#_`.2_._E7R[I-CK=QHT6YD2:XTC3+2RGECKP9[>%(V9:@&A*[5&*IYBJG+%%/%)!/ M&DT$R&.:&0!E=6%&5E.Q!&Q!Q5^4G_.2G_/I?\C_`,X+G4?-'Y77;?DMYTO6 M>:>VL(!<:!=3-N2^G\D-N6/>!U4=?3)Q5^(WY[_\^[/^!42Z@6FY:2(*/YL5?&_EOS-YC\G:WI_F7RGKM_Y M:\PZ3*)M,UO3+B2UNH)!^U'+$RLI^1Q5_1+_`,^_O^?GEU^9VLZ%^1__`#D- M=6\/G?4BEEY*_,A52"'5KCI'9ZA&H5([F3I'(@"R-\)57(+JOV[Q5V*NQ5V* MO__3^_F*NQ5_,3_S^M_]:=_+O_S5^G_]UK6<5?CSBK^S/_GWSKL'F'_G#/\` M("]@E686GEL:9*5/+C)IMS-9LIZ[@P],5?9.*ODS_G*O_G,+\OO^<1=,\G:O M^87EOS)KFG^=+J[L["X\OP6TPAFM$CD*S_6;FWIS62JTK7BWABKXO_Z+3_\` M.,O_`%(?YB_](.E_]Y+%7?\`1:?_`)QE_P"I#_,7_I!TO_O)8J[_`*+3_P#. M,O\`U(?YB_\`2#I?_>2Q5W_1:?\`YQE_ZD/\Q?\`I!TO_O)8J_/_`/Y^&_\` M/P/\KO\`G+'\L?)?D/\`+GR[YHT2?0_,PUS5Y]>@M(8GCCLY[>-(S;W5P2W* MM8J_#C_G]_\`^2W_ M`"(_\"75O^H.+%7\Y6*OT;_Y]1_^MM?EM_VS/,'_`'2;G%7]<.*NQ5_$O_SF M2K)_SEC_`,Y(!U*$_F1YD8!A0T;49B#OV(-1BKYKQ5V*OZW/^?3W_K$OY=?] MM;S%_P!U:YQ5^D&*O@#_`)^A?^L0_G)_VX_^ZU98J_D"Q5_3W_SYU_(S3?)G MY#ZG^=-]8K_BK\VM0N(+"^D7]Y%HFES-;Q1(3NHEN4ED:FS`1_RC%7[`XJ\+ M_P"V>BB.WTK1+=@D^HZA0ZAJ][ M?F%H5OYB\J^8 M[=K?4-/G454D?!-"_6.6-OB1UHRL`1BK^*3_`)R'_*"__(3\Z_S&_*/4+AKU MO)6KR6MCJ#@*US92JL]E.P&P,MO)&Y`Z$TQ5^\__`#Y?_.S4_-7Y9_F#^2FM MWCW9_+.]M]5\IF4EC'INKF7UK="3]F*YB9QX>KX4Q5^U^*OXZO\`GY5_ZVW^ M>O\`VT-,_P"Z198J_33_`)\=?\HS_P`Y$?\`;3\N_P#)F_Q5^\.*OXD?^*ZA-E=.HK6B-;P@[?M#%7[QXJ[%78J[% M78J_D9_Y^I^;],\V?\YG_F%%I;B6/RG8:3H%W.""K75K:)).!3^1YC&?=3BK M[$_Y\A>2;F?S?^>?YC20E;/3-(TSRY:3D"CRWL[W0M?O&OM6_)C55T>PGD; ME)^AKV,SZ>CD[_NF6:)/!$4=L5>D_P#/U'R7/YP_YPP_,2>UB,UUY-OM)\Q1 MH.T=M>)!<-_L8+B1OHQ5_(Y!/+;3PW,#F*>WD66&130JZ&JD'Q!&*O[K?R;\ M_67YI_E/^7'YC:?*LUMYU\N:;J]4-0LES;H\L9]TD+*1V(Q5Z5BKL5=BKL5= MBKL5?R__`//Z/_UI_P`F?^:\T_\`[J.HXJB_^?*W_K2GG_\`\UY=_P#=3T_% M7].N*OSU_P"?IO\`ZQ!^;G_,1Y?_`.ZW98J_DBT+_CMZ-_S'6_\`R=7%7]\% MK_O-;_\`&)/^(C%5?%78J[%78J_*O_G\5_ZR%'_X'.B?\F;S%7X"?\X,?^M? M_P#..W_@;:;_`,G,5?VGXJ[%7\KW_/U'_G$@_D?^:_\`RMOR;IGH?EA^;EW+ M<30P(!#I>OL#+=VM%V1+C>>(=/[Q1L@Q5X[_`,^[/^;=;W_G#;4KJ M.4&.S\V:#-[>[MU+?Y0>4@>QQ5^8O_`#@E M^8EM^5W_`#EM^1_FJ_N1::8_F%-&U2Y8T6.WUJ*337=S_*GU@,?88J_M&Q5V M*NQ5V*NQ5V*NQ5_$'_SEA_ZU#_SD7_YLOS5_W5KG%7]!_P#SYE_]93\Q?^;" MU7_J!T[%7ZVXJ[%78J[%78J[%78J[%7Y"?\`/P7_`)]R^2?S4\H^9OS>_)GR M[;>5_P`WM`MIM4U31-,B6"S\R0PJ9)HVMT`1+PJ"8Y%`]1O@DJ6#HJ_F$@GN M+2XAN;::2UNK619;>XB8I)'(AJK*PH5*D5!'3%7]IW_.%/YSWWY^?\XR?E7^ M8VLS_6?,EYIK:9YJN.ADU+2Y7LKB9AV,QB]7_98J^J,5=BKL5?_4^_F*NQ5_ M,3_S^M_]:=_+O_S5^G_]UK6<5?CSBK^E#_GR[^OR0O[I1K7Y?ZL MVNZ%;,WQ/I.K4$O!:[B&Z1BQ'3U5\<5?M9BKYO\`^=*ADO=%NXQ]F1+N)2L98;\)0CCNN*OF'% M52*&6>1(8(GFFD/&.*-2S,3V`&YQ5[KY5_YQ>_YR&\Z:#K'FKR[^3OFFZ\LZ M#I]QJNJ>89["6SLDM+2%YYI$N+H1)(0B$A4+,>@!)`Q5X-BKL5?W9_DU_P"2 M@_*G_P``[0O^Z?!BKTG%7X8_\_P?^4`_(/\`\"#6O^H6WQ5_.CBKL5?W1?D# M_P"2)_)7_P``/RW_`-TNWQ5ZUBK\./\`G]__`.2W_(C_`,"75O\`J#BQ5_.5 MBK[\_P"?8.N1:'_SFU^3AGH(]6;6-,#MV>YTF["?26``^>*O[`,5=BK^9_\` MY^9_\X/?G#!^>GFG\Z_RR\C:MY^\B_F,8=2U9-!M9+^[TO4UB2&ZCGM8%:;T MY602K(%*_$RL05%57Y>7OY"_GAIFDZMKVJ?D[YUTG0M!MFO-:UJ^T'4+6TM8 M$(!DFGF@1$&XZG%7DV*OZW/^?3W_`*Q+^77_`&UO,7_=6N<5?I!BKX`_Y^A? M^L0_G)_VX_\`NM66*OY`L5?V;?\`/OOZI_T)E_SC[]2),/\`AD/BK\8 M_P#G]E_Y(#\J_P#P/T_[I=[BK\7_`/G`/_ULG_G'O_P*H?\`DS+BK^SS%78J M[%7\AW_/TS6M,UG_`)S9_-8Z84<:7;Z)IU_,E"&NK?2K42@T)W0G@?=<5?5? M_/D6PNY/S>_.K4T0FPL_)]G:W,F]!-0?GU^5A4F@Y.:#L,5?UM?\^T?R-N/R M0_YQ5\G1:Q9&R\U_F-(_G'S'"Z<98_T@B"RA>NX*6D<55/1BV*OO_%78J[%7 M8J[%7\@7_/T&VTJU_P"2M6 MNM)U-*$*SV\A42I7JDBT=#W4@XJ_?C_GSM_SE'I^L>4=0_YQ@\V:BL'F'RQ) MGUS39V,][91\CN]M*S3!1N4=J"D9Q5^YF*NQ5V*NQ5V*NQ5_+_\` M\_H__6G_`"9_YKS3_P#NHZCBJ+_Y\K?^M*>?_P#S7EW_`-U/3\5?TZXJ_/7_ M`)^F_P#K$'YN?\Q'E_\`[K=EBK^2+0O^.WHW_,=;_P#)U<5?WP6O^\UO_P`8 MD_XB,55\5=BKL5=BK\J_^?Q7_K(4?_@._GY^2OE3_G(3\IO.'Y3^<(@--\SV92SU%4#RV%]'\=I M>PU_;AE`:E?B%5.S'%7\4WYJ_EEYK_)O\Q/-WY8^=K$V'F7R;J$MAJ,8KPD" M_%%/$33E'-&5DC;NK`XJ_6V;_G(>?_G(+_GU+^9ODW7[MKW\P?R$O?*VGZJ[ ML6FNM&.K6L6F7C=2>,?*!R>\?)C5\5?!?_.!/_K8W_.//_@76W_$),5?VA8J M^#?^?D7Y&W/YZ?\`.*WG;3M'LS>>:_(31^E5Q5_9A^ M2WYT_E]^?OY?:)^97Y;:W'K'E_68QZL50MS97*@>M9W<528IHB:,IZ[,I92K M%5ZMBJUT21'CD021R`JZ,*A@=B"#U!Q5Y[>_E!^4VIW#W>H_E?Y1U"[D_O+J MYT2PED;ON[PDG%4VT;R!Y#\N,C^7O).@Z$R?8;3M-M;4CY&*-:8JG^JZ;:ZS MI>I:1?)ZMEJMK-9WD9_:BG0QN/I5CBK^#KSQY9N?)?G7S?Y.O5*WGE/6]0T: MZ4]1)8W,EN_7W3%6+XJ_NS_)K_R4'Y4_^`=H7_=/@Q5Z3BK\,?\`G^#_`,H! M^07_`($&M?\`4+;XJ_G1Q5V*O[HOR!_\D3^2O_@!^6_^Z7;XJ]:Q5^''_/[_ M`/\`);_D1_X$NK?]0<6*OYRL5>B_E%^8-[^5'YI?E[^9>G1F:[\B^8=/UM+< M&GK+9W"2R15/:1%*GYXJ_N5\H^:]!\]>5O+WG/RMJ$>J^7/-.GV^J:)J,)!2 M:VNHQ)&VU:&C;CL=CBK(L5=BKY/_`.-,5?Q9XJ_K<_Y]/?^L2_EU_VUO,7_`'5KG%7Z08J^`/\`GZ%_ZQ#^_YQ&U37I?,M]_SC[Y.EU:>8W$S+8".W>0GD6:TC*P&IW-8]\5?3&DZ1I'E M[3+/1]"TRST/1M,B$.GZ5801VUK;Q+T2*&)51%'@`!BJ9`UW&X/0XJ[%7\?_ M`/S]`LVL_P#G.#\Z:Q-&EVVA7$1)KR#Z'858>W('%7P'BK-?RU_\F-Y`_P#` MDTK_`*C(L5?WCXJ_&/\`Y_9?^2`_*O\`\#]/^Z7>XJ_%_P#YP#_];)_YQ[_\ M"J'_`),RXJ_L\Q5V*O@C_G+K_GX!^3O_`#C)YO\`VT-,_P"Z198J_33_`)\=?\HS_P`Y$?\`;3\N_P#)F_Q5^\.*O!O^ M=OR6\_>8_RU_,+1Y-$\T^6+IK:^MFJ8Y5ZQ7%O)0"2&9*/&XV92 M,5?KK_S[P_Y^7Z?^5FC:/^17_.0-]/\`X&L66U\B?F&5:=M'A8@+8WZ*"[6J M'^[D4$Q#X2#&`8U7]%?E_P`Q>7_-FCV/F#ROK=AYBT+4XQ-IVLZ;<1W5K.AZ M-'-$S(P^1Q5.<5>8?FQ^<_Y8?D=Y6N_./YI^0]DC4G%7\JO_.>/_.<_F#_G+GS9::5HEK<^6?R=\HSN_E3RU.P^L7EP M04.I7X0E?59251`2(E)`)9F8JLI_Y]M?\X9WO_.2GYGP>>/-NG_\@8_+2_BG M\QR2CX-7U*(+-!I,?\RD%9)_".B[&13BK^L]55%554*J@!5`H`!T`&*J<\\- MK!-(/)?FQ M;F:WA\L>:7CT^6Z$;E4DM)WZ\T26SOY6_+ZTF1M5U2XI^[58A M4Q1%J8?.VK7.K:F4J(T>X< ML(H@:D)&M$0=E`&*OZB_^?4GY$:E^3W_`#C-;>9/,=F]AYF_.&__`,3S6DJ\ M)8=,])8=-1P17XX@TXKT$H'6N*OTWQ5^(O\`S]=_YPEU+\P[$_\`.2GY5Z,^ MH>;O+MDL'YG>7K1"T^H:9;+2+488UJ7EM4'"10*M$`1_=T95_.UY8\S^8/)? MF'1?-GE36+K0/,GEV\BO]$UJRK(RU^I2-U8./2[AU^P%7Z_: M+KFB>9--MM8\NZQ8Z]I%XO*TU33KB.ZMI5\4EB9D8?(XJFN*K7=(U9W8(B`L M[L:``;DDG%7F6@_G5^4OFGSS??EIY8_,30?,?GK2].?5=3\MZ7>1W<]O:1RQ MPM),82ZH0\J#BS!MZTIBKT_%7\O_`/S^C_\`6GO)?_FO+#_NHZCBJ+_Y\K_^ MM*>?_P#S7EW_`-U/3\5?TZXJ_/3_`)^G?^L0?FY_S$>7_P#NMV6*OY(]"_X[ M>C?\QUO_`,G5Q5_>];.GU:W^-?[I.X\!BJOS3^=?O&*NYI_.OWC%7=/RVL_0\]VENG[S4/+Z,6 M^LD#=GL68L3_`+Y+U/[M1BK^=GR=^8.O>2M/\\Z1I4H;2OS#T"3R]YET^0GT MYK8W$%W$]`:.1#V(IW.*OH'_G`G_P!;&_YQY_\``NMO^(28J_M"Q5Q% M=CN#U&*OY2_^?E?_`#A)JG_./GYA:A^:7D31WE_)/S_?/<0FV0F/0-3N&+RZ M?,!4)#(Q+6[;"E8NJ`LJ^+/^<>/^1K]6US0[G MD]AJMBS!I+2[B!')2156!#(U&4@C%7]0G_.-/_/R'_G';_G(33].L+[S';?E M;^8LRJE[Y(\RW,=NLDU-Q87S\(;E21\(JLGC&,5?H"CI*B21NLD5SJ-]/';P1KXO+*RJH^9Q5A_Y= M_FO^6_YMV&LZM^6?G32O/&E:!JDNC:MJ>D3KVMN5$UP8P!%!%S*KSED98UJ0*D8J\G_`")_ MYS)_YQX_YR*L+27\N_S#L/T]<(IN/)&KNFGZU`YZH;29@9:';E"73P;%7U#B MKL5?FS_SGE_SGOY"_P"<<_(WF'R;Y-\P6?F+\\]>M)K#1=#L)DG_`$&TR%#? MZ@R$B(PUY1Q-\;OQ^'AR8*OY.;"PU/7M5LM,TVUGU36-9NH[6PLX5,D]SO$Q.`/VSBK]`O*W_.7G_.+OG2%)_+WY^^1KH.H;T+C M6K6RG`/3E!=O#(I]BM<59J?SY_(U06;\YO(JJHJS'S%I@`'_`$D8JP'S-_SF M1_SBIY021M=_YR!\C0M$I9H+76+:^FH.O&*S>9V^07%7QS^9_P#S^"_YQ9\F M0W,/D:/S#^:^JQU6W73;)M-L&8=.=UJ`BD`/BD+XJ_FN_.O\R$_.#\V?S!_- M%/+\/E7_`![K=UK4GE^"8W$=L]T_-U$K)&7JQ+$\1N>@Q5Y?BK^M;\LO^?CG M_.&&@?EM^7NA:M^==K::KHOEK2;'4[4Z3K#&*XM[.**5"R6)4\64BH)'ABK- M_P#HIE_SA#_Y?.T_[@^M?]D&*OR>_P"?K'_.4_Y"_P#.0_D_\G],_)WS_#YS MOO+6LZI7/SN\MZ==3IR?1?,%TFB7L9INK0Z@8>1'_P#. M.GYT?E_H_P"=7ESS)YP\V>5]0TC0M%T*=M4:6[GC*(C26:RQ1BO4NZ@8J_E% MQ5_1C_S[Q_YS;_YQ?_)7_G%CR5^7WYF_FG;^5_.&EZCK4U_HTFG:G<-''=:C M//"WJ6UI+&>2.#LWSQ5]N?\`13+_`)PA_P#+YVG_`'!]:_[(,5?'G_.>_P#S MG+_SBQ^GJ/UQ5^BFE?GE^2NNVB7VC?F]Y+U2S=5=;BUU[ M3Y5HPJ*E9S2H\<5>8_F%_P`YI_\`.*WY8V,U[YJ_//RH7AC,BZ;I%\FL7LE. MBI:Z=]8E))VW4#Q(Q5^&O_.:/_/UGS!^")(F9;2"0;-1VD=?A)0%E95^H'Y5_\_,?^<11^67Y=KYR_..#2 MO-Z>6M*3S3IDNE:M(\&HI:1K=1L\5G(C<90VZL0?'%6>?]%,O^<(?_+YVG_< M'UK_`+(,5?SS_P#/R'\T/RO_`#E_YR9U3\Q?RE\UP^6D36TD3)=PPN2$C1JA:;]<5?!6*LU_+7_R8WD#_P`"32O^HR+%7]X^*OQC M_P"?V?\`Y(#\JO?S^G_=+O<5?S<^7/,GF#RAKFF>9O*NM7OEWS%HLZW.D:YI MT[VUU;3+TDBFC*LC"O4'%7TC#_SG+_SE]!$D*?\`.17GADC%%,FJ2R-]+OR8 M_2<58=YM_P"0#%7[J? M\X7_`//I>+R)K>D?F=_SDQ-I_F#7=*=+O0/RMLG%UI]M6([?S''_AK\P- M%A9/*7YBV,2M=VPJ6%O/UBV+&IC8@J22C*2:JOYB_^?G1^;? MY2W#W/Y9_F3YC\BO*W*>/1M1N+6*4[?WL,;B-^G[2G%7O-Y_S\#_`. MQF_YR#\SI#(O%GMVMK>:G3:>&%)`?<-7%7S=K&O_`)A_FKYDCNM>UCS!^8OF MW4G$4$M[/=:K?S,S;1IS,LC5)V48J_37_G%K_GTY^_+ MLLLTNGW*K_B*_CZ^G#:-7ZJ&Z%[@!AU$;8J_I2_*[\K/(?Y,>2-%_+O\MO+U MOY9\J:#&4LM/@!+.[;R3SR-5Y99&^)W7?S!\W_D3^ M:WE/\JVM%\_>9_+=[I/EUKV?ZM$)+V,P2GUN+<'$3OP)%.?&I`W"K^,7\T_R M)_.'\D]4DTC\U/RZUSR7@:I_SFM_SEKK%I)8W M_P#SD1YZ:VF!$J0ZQ<6Y8$4(+0,C4WZ5Q5X/:6?G3\QO,BV]E:ZUYZ\W:W+\ M,,*7&IZC=R'V422R'[\5?MO_`,X0?\^HO,=QKFB?FG_SE#I2:1HFF21WNA_E M'*RR75[*A#1/J_`E8H5-"8*EW/PR<%JK*OZ&HXTB1(HD6..-0L<:@!54"@`` MV``Q5?BKL5?C-_SF1_SZ=\K_`)K:AJ_YD?\`./MW8>0//5^TEWK/D>Y4Q:'J M<[59I+=HP392N>H"F)CVC^)BJ_`'\VO^<>OSK_(S4Y=+_-7\MM;\H,CF.'4K MFV9]/N#4BMO?1<[>4&A^Q(<58;Y1_,?\P?(%P;KR+YYU_P`FW!8,TNB:E=6! M8CH6^KR)7Z<5>U1_\YI_\Y;16S6J?\Y&_F#Z3%34Z[>,XX[`"0R%P/$`[]\5 M>:>;OSP_.?S\DD7G?\V/-_FR"8<9;;5M:OKN)A6M#'+,R]?;%7W;_P`^J_+O MYMZ9_P`Y3^1_.OEOR#K^I^1)[?4='\Z^98;.5=.M[*\MGXM+=.JQ?!<)$_$- MR--@<5?U>XJ_E^_Y_1LI_P"X!U+4:?JQ5%_\`/E7A"]R!J>G5_7BK^G;%7YZ?\`/T\@?\X0?FY4@5N/+X%?$ZW94Q5_ M(=BJ-_2>I?\`5PN?^1K_`-<5=^D]2_ZN%S_R-?\`KBKOTGJ7_5PN?^1K_P!< M5=^D]2_ZN%S_`,C7_KBK^YC\AFY_D;^3#\N?/R+Y=;F36M=,MS6O>N*O@'_G M\60/^<0H@30GSUHH'O\`N;PXJ_`7_G!D@?\`.7__`#CL2:#_`!OI@W]Y*#%7 M]I^*NQ5V*J%S;6U[;7%G>6\=W:7<;PW5K,H>.2.0%71T8$,K`D$'8C%7\>G_ M`#\"_P"<4KG_`)Q:_._4-/T:SD7\K_/9FUG\N+PU9(H"X^L:JV0)+%+*ZF98[J->BK(RR`;5E.^*OQG\X>1?. MOY>ZQ/Y?\]^4M8\G:Y;$B;2=9LI[&<4)%?3G1"1ML1L<599Y._/?\[/R\B2# MR+^;?G#RC;1"D=II.M7MK"HZ[112JGX8J]$N?^O(V()J>3)(&8^[$G%7BWFCS_`/F!Y]N%E\Y>=-?\Y73.3&VL:C=:@_)C M^SZ\DE"3X8J_H%_Y\P^7_P`V?*.@?F]IOF_R%KWEWR'YCDTO6?*>O:I9RV=O M<7B++;W2P"<(9.$%U-"A-2D;LHKXT!Q54_2>I?]7"Y_Y&O_7%7?I/4O\` MJX7/_(U_ZXJ[])ZE_P!7"Y_Y&O\`UQ5_0=_SX_NI[G0O^=(L8MHK"/ M7+U[=12E!#)*Z``=-L51OF;_`)R\_P"O5K33+:2Y8%CO)/(!Q MC7N7D8*.I.*OZ-?^<`/^?9T?Y$:GIOYR?G@;/6?S6MD+^5_*=NRW-CY?9Q3U MY)A59[L*2`5^"+1="D4AEEL?+VFP M."*;\D@!KMXXJ];AAAMHHX+>)(((@%BAC4*B@=`%%`!BJKBKL5=BK$]1\A>1 M=7O)]1U;R7H6IZA:0@!07DDC9C0`#6O+GEQ;A/+WE_ M3=!2[*M=+IUI#:B0I7B7$2KRI4TKBJ=XJ[%78JTRJZLK*&5@0RD5!!Z@C%7S MSYV_YQ)_YQE_,2YDO?./Y%^3-6U";>;4UTJ"VNG_`-:XMEBD;Z6Q5YS;?\^] M/^<+[29)XO\`G'[RZSH:JLSWLR;;[I+<,I^D8J^A_(OY0?E3^6,7H_EU^6_E MGR.O$JSZ)I=K9.P/7G)#&K-7O4G%7HV*NQ5V*NQ5!:CING:O9SZ=JVGVVJ:? M&1?!XY`RL/F,5?-/FC_G";_G$OSC<27>N_\X_>3'NIF+S7%CIR M::[L:DEFL?0))KWQ5C%G_P`^]O\`G#"QG2XA_P"N*LZ MQ5V*NQ5V*NQ5"7UA8ZG:3V&I6<&H6-RO"YL[F-98I%/9T<%2/F,5?-?FK_G" MO_G$[SG<2W>O_P#./_DN6[G8O/=6>F1:?(['J6>R]!B3[G%6&)_S[M_YPL1@ MX_(#025-0&GU!A](-T0<5>H>4_\`G$__`)QF\C31W/E;\A_(^E7D0I%?C1;2 M:X7Y3S1R2?\`#8J]]@@AMH8[>VA2W@A4)#!&H1$4;`*HH`![8JJXJQO5_)OE M#S!:_Y5T?7+R.,11W6H6-ON)+O0/*V MD:'=RQF*6ZT^QM[:1HR02A>)%)%0#2N*LCQ5`:GI6EZU9RZ=K&FVNK:?/Q,] MA>0I/"_$AEY1R!E-"`14=<58K_RK#\M?_+>>6?\`N$V?_5+%7?\`*L/RU_\` M+>>6?^X39_\`5+%7?\JP_+7_`,MYY9_[A-G_`-4L5=_RK#\M?_+>>6?^X39_ M]4L5=_RK#\M?_+>>6?\`N$V?_5+%6:000VT,-M;0I;V]NBQ001*$1$045544 M```H`,50.K:+HVOVGU#7=)LM:L>8D^IW\$=S%S6O%N$JLM14T-,52.R_+WR# MIMW;W^G>1_+]A?6CB2UO;;3+6*6)QT9'2,,I'B#BK+\5=BKL5=BJ3:SY<\O> M8XX(O,.@Z=KL5LQ>VBU&UANEC9A0E!*K!21UIBJ4V/Y?>0M,NX+_`$WR1H&G MWUJXDM;VVTVUBFC<=&1TC#*?<'%67XJ[%78J[%6.^9?*'E/SG8'2O.'EC2?- M6F-6NG:Q907T'Q"A_=SHZ[CVQ5\S:S_S@3_SASKUPUU?_P#./?E.*5S5A86\ MFGI7_C'9R0I^&*I?:_\`/O7_`)POLYEGB_YQ^\NNZD$+.]Y.FWBDMPZGZ1BK MW#R9^0?Y'_ETT:7HME;SAAT;UDB$A/N6Q5ZWBKL58;= M?EU^7U]^1/+UY>7;K!M+\U^7-+\SZ8U>6G:M:0WL!KL? MW6_*?E7R;IR: M1Y0\M:5Y6TF.G#3-(LX+*W%!04B@1%Z>V*L@Q5V*NQ5V*NQ5_]#[^8J[%7\Q M/_/ZW_UIW\N__-7Z?_W6M9Q5^/.*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ M5FOY:_\`DQO('_@2:5_U&18J_O'Q5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V M*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5__1^_F*NQ5^ M'_\`S\Q_YPB_YR$_YR6_/#R?YW_*7RSI^M>7M'\C6>AWUS=ZI9V+K>PZGJ5R MZ".XD1B!'0%-Z=L5?G3_T2:_YS6_ZD+1?_"ATS_JMBKO^B37_`#FM_P!2 M%HO_`(4.F?\`5;%7?]$FO^LW_D71H['2=9L+V\D'F#36*Q07"2.0JS M$FBJ=@,5?U88J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[% M78J[%78J[%78J[%78J[%78J[%78J[%78J__2^_F*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\`_]/[^8J[%7YN M_P#.>/YX?\Y@?E%K/Y;VW_.,'Y6WGYB:=KEEJ4OF^>U\LZAY@%K-!);K;*SV M1`BYJ[FC?:IMTQ5\!?\`0Z7_`#]G_P#89=6_\]QKW_->*N_Z'2_Y^S_^PRZM M_P">XU[_`)KQ5W_0Z7_/V?\`]AEU;_SW&O?\UXJ[_H=+_G[/_P"PRZM_Y[C7 MO^:\5=_T.E_S]G_]AEU;_P`]QKW_`#7BKO\`H=+_`)^S_P#L,NK?^>XU[_FO M%7?]#I?\_9__`&&75O\`SW&O?\UXJ[_H=+_G[/\`^PRZM_Y[C7O^:\5=_P!# MI?\`/V?_`-AEU;_SW&O?\UXJ[_H=+_G[/_[#+JW_`)[C7O\`FO%7?]#I?\_9 M_P#V&75O_/<:]_S7BKO^ATO^?L__`+#+JW_GN->_YKQ5W_0Z7_/V?_V&75O_ M`#W&O?\`->*N_P"ATO\`G[/_`.PRZM_Y[C7O^:\5=_T.E_S]G_\`89=6_P#/ M<:]_S7BKO^ATO^?L_P#[#+JW_GN->_YKQ5W_`$.E_P`_9_\`V&75O_/<:]_S M7BKO^ATO^?L__L,NK?\`GN->_P":\5=_T.E_S]G_`/89=6_\]QKW_->*N_Z' M2_Y^S_\`L,NK?^>XU[_FO%7?]#I?\_9__89=6_\`/<:]_P`UXJ[_`*'2_P"? ML_\`[#+JW_GN->_YKQ5W_0Z7_/V?_P!AEU;_`,]QKW_->*N_Z'2_Y^S_`/L, MNK?^>XU[_FO%7?\`0Z7_`#]G_P#89=6_\]QKW_->*N_Z'2_Y^S_^PRZM_P"> MXU[_`)KQ5W_0Z7_/V?\`]AEU;_SW&O?\UXJ[_H=+_G[/_P"PRZM_Y[C7O^:\ M5=_T.E_S]G_]AEU;_P`]QKW_`#7BKO\`H=+_`)^S_P#L,NK?^>XU[_FO%7?] M#I?\_9__`&&75O\`SW&O?\UXJ[_H=+_G[/\`^PRZM_Y[C7O^:\5=_P!#I?\` M/V?_`-AEU;_SW&O?\UXJ[_H=+_G[/_[#+JW_`)[C7O\`FO%7?]#I?\_9_P#V M&75O_/<:]_S7BKO^ATO^?L__`+#+JW_GN->_YKQ5W_0Z7_/V?_V&75O_`#W& MO?\`->*N_P"ATO\`G[/_`.PRZM_Y[C7O^:\5=_T.E_S]G_\`89=6_P#/<:]_ MS7BKO^ATO^?L_P#[#+JW_GN->_YKQ5W_`$.E_P`_9_\`V&75O_/<:]_S7BKO M^ATO^?L__L,NK?\`GN->_P":\5=_T.E_S]G_`/89=6_\]QKW_->*N_Z'2_Y^ MS_\`L,NK?^>XU[_FO%7?]#I?\_9__89=6_\`/<:]_P`UXJ[_`*'2_P"?L_\` M[#+JW_GN->_YKQ5W_0Z7_/V?_P!AEU;_`,]QKW_->*N_Z'2_Y^S_`/L,NK?^ M>XU[_FO%7?\`0Z7_`#]G_P#89=6_\]QKW_->*N_Z'2_Y^S_^PRZM_P">XU[_ M`)KQ5W_0Z7_/V?\`]AEU;_SW&O?\UXJ[_H=+_G[/_P"PRZM_Y[C7O^:\5=_T M.E_S]G_]AEU;_P`]QKW_`#7BKO\`H=+_`)^S_P#L,NK?^>XU[_FO%7?]#I?\ M_9__`&&75O\`SW&O?\UXJ[_H=+_G[/\`^PRZM_Y[C7O^:\5=_P!#I?\`/V?_ M`-AEU;_SW&O?\UXJ[_H=+_G[/_[#+JW_`)[C7O\`FO%7?]#I?\_9_P#V&75O M_/<:]_S7BKO^ATO^?L__`+#+JW_GN->_YKQ5W_0Z7_/V?_V&75O_`#W&O?\` M->*N_P"ATO\`G[/_`.PRZM_Y[C7O^:\5=_T.E_S]G_\`89=6_P#/<:]_S7BK MO^ATO^?L_P#[#+JW_GN->_YKQ5W_`$.E_P`_9_\`V&75O_/<:]_S7BKO^ATO M^?L__L,NK?\`GN->_P":\5=_T.E_S]G_`/89=6_\]QKW_->*N_Z'2_Y^S_\` ML,NK?^>XU[_FO%7?]#I?\_9__89=6_\`/<:]_P`UXJ[_`*'2_P"?L_\`[#+J MW_GN->_YKQ5W_0Z7_/V?_P!AEU;_`,]QKW_->*N_Z'2_Y^S_`/L,NK?^>XU[ M_FO%7?\`0Z7_`#]G_P#89=6_\]QKW_->*N_Z'2_Y^S_^PRZM_P">XU[_`)KQ M5W_0Z7_/V?\`]AEU;_SW&O?\UXJ[_H=+_G[/_P"PRZM_Y[C7O^:\5=_T.E_S M]G_]AEU;_P`]QKW_`#7BKO\`H=+_`)^S_P#L,NK?^>XU[_FO%7?]#I?\_9__ M`&&75O\`SW&O?\UXJ[_H=+_G[/\`^PRZM_Y[C7O^:\5=_P!#I?\`/V?_`-AE MU;_SW&O?\UXJ[_H=+_G[/_[#+JW_`)[C7O\`FO%7?]#I?\_9_P#V&75O_/<: M]_S7BKO^ATO^?L__`+#+JW_GN->_YKQ5W_0Z7_/V?_V&75O_`#W&O?\`->*N M_P"ATO\`G[/_`.PRZM_Y[C7O^:\5=_T.E_S]G_\`89=6_P#/<:]_S7BKO^AT MO^?L_P#[#+JW_GN->_YKQ5W_`$.E_P`_9_\`V&75O_/<:]_S7BKO^ATO^?L_ M_L,NK?\`GN->_P":\5=_T.E_S]G_`/89=6_\]QKW_->*N_Z'2_Y^S_\`L,NK M?^>XU[_FO%7?]#I?\_9__89=6_\`/<:]_P`UXJ[_`*'2_P"?L_\`[#+JW_GN M->_YKQ5W_0Z7_/V?_P!AEU;_`,]QKW_->*N_Z'2_Y^S_`/L,NK?^>XU[_FO% M7?\`0Z7_`#]G_P#89=6_\]QKW_->*N_Z'2_Y^S_^PRZM_P">XU[_`)KQ5W_0 MZ7_/V?\`]AEU;_SW&O?\UXJ[_H=+_G[/_P"PRZM_Y[C7O^:\5=_T.E_S]G_] MAEU;_P`]QKW_`#7BKO\`H=+_`)^S_P#L,NK?^>XU[_FO%7?]#I?\_9__`&&7 M5O\`SW&O?\UXJ[_H=+_G[/\`^PRZM_Y[C7O^:\5=_P!#I?\`/V?_`-AEU;_S MW&O?\UXJ[_H=+_G[/_[#+JW_`)[C7O\`FO%7?]#I?\_9_P#V&75O_/<:]_S7 MBKO^ATO^?L__`+#+JW_GN->_YKQ5W_0Z7_/V?_V&75O_`#W&O?\`->*N_P"A MTO\`G[/_`.PRZM_Y[C7O^:\5=_T.E_S]G_\`89=6_P#/<:]_S7BKO^ATO^?L M_P#[#+JW_GN->_YKQ5W_`$.E_P`_9_\`V&75O_/<:]_S7BKO^ATO^?L__L,N MK?\`GN->_P":\5=_T.E_S]G_`/89=6_\]QKW_->*N_Z'2_Y^S_\`L,NK?^>X MU[_FO%7?]#H_\_9__89=6'O_`,JXU[_FO%7]`_EZYU"]T#0[S5H#;:I=Z?;3 M:E;%#&8[B2)6E0HVZT8D4.XQ5.,5=BK_`/_4^_F*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V* MNQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O\`_]7[^8J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J M[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J[%78J $_P#_V3\_ ` end EX-31.1 3 ex31_1apg.htm EXHIBIT 31.1 Exhibit 31.1 Certification EX-31.2 4 ex31_2apg.htm EXHIBIT 31.2 Exhibit 31.2 Certification


Exhibit 31.2


CERTIFICATION


I, Marvin S. Hausman, M.D., Acting Chief Financial Officer of Entia Biosciences, Inc., certify that:


1.

I have reviewed this Quarterly Report on Form 10-Q of Entia Biosciences, Inc;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Dated:  August 15, 2014

By:  /s/ Marvin S. Hausman, M.D.

 

Marvin S. Hausman, M.D.

 

President and Chief Executive Officer

Acting Chief Financial Officer




EX-32.1 5 ex32_1apg.htm EXHIBIT 32.1 Exhibit 32.1 Certification


Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Entia Biosciences, Inc. (the “Company”) for the quarter ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Marvin S. Hausman, M.D., Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:  August 15, 2014

By:  /s/ Marvin S. Hausman, M.D.

 

       Marvin S. Hausman, M.D.

 

       President and Chief Executive Officer

     Acting Chief Financial Officer


This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.


A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



EX-32.2 6 ex32_2apg.htm EXHIBIT 32.2 Exhibit 32.2 Certification


Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-Q of Entia Biosciences, Inc. (the “Company”) for the quarter ended June 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Marvin S. Hausman, M.D., Acting Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:


(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



Dated:  August 15, 2014

By:  /s/ Marvin S. Hausman, M.D.

 

       Marvin S. Hausman, M.D.

 

       President and Chief Executive Officer

     Acting Chief Financial Officer


This certification accompanies each Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of §18 of the Securities Exchange Act of 1934, as amended.


A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.





EX-101.INS 7 ergo-20140630.xml XBRL INSTANCE FILE 0001408299 us-gaap:PreferredStockMember 2012-12-31 0001408299 us-gaap:CommonStockMember 2012-12-31 0001408299 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0001408299 us-gaap:DeferredCompensationShareBasedPaymentsMember 2012-12-31 0001408299 us-gaap:RetainedEarningsMember 2012-12-31 0001408299 ERGO:NotesPayableCurrent7.85PercentUnsecuredDueMonthlyMember 2013-12-31 0001408299 ERGO:NotesPayableCurrent7.85PercentUnsecuredDueMonthlyMember 2014-06-30 0001408299 ERGO:ConvertibleNotesPayableCurrent6PercentUnsecuredConvertibleMember 2014-06-30 0001408299 ERGO:ConvertibleNotesPayableCurrent6PercentUnsecuredConvertibleMember 2013-12-31 0001408299 ERGO:ConvertibleNotes5PercentUnsecuredConvertibleToCommonSharesMember 2013-12-31 0001408299 ERGO:ConvertibleNotes5PercentUnsecuredConvertibleToCommonSharesMember 2014-06-30 0001408299 ERGO:ConvertibleNotesRelatedParty6PercentUnsecuredConvertibleToCommonSharesMember 2013-12-31 0001408299 ERGO:ConvertibleNotesRelatedParty6PercentUnsecuredConvertibleToCommonSharesMember 2014-06-30 0001408299 ERGO:NotesPayableCurrentTotalMember 2013-12-31 0001408299 ERGO:NotesPayableCurrentTotalMember 2014-06-30 0001408299 2011-05-26 0001408299 2012-10-01 2013-09-30 0001408299 2013-10-01 2014-05-31 0001408299 2014-06-01 2015-07-31 0001408299 2012-06-01 0001408299 2012-01-01 2012-12-31 0001408299 2014-08-14 0001408299 ERGO:StockSubscriptionsMember 2012-12-31 0001408299 us-gaap:WarrantMember 2012-01-01 2012-12-31 0001408299 ERGO:NotesPayableCurrent4.15PercentUnsecuredDueMonthlyMember 2013-12-31 0001408299 ERGO:NotesPayableCurrent4.15PercentUnsecuredDueMonthlyMember 2014-06-30 0001408299 us-gaap:OptionMember 2014-01-01 2014-06-30 0001408299 us-gaap:WarrantMember 2014-01-01 2014-06-30 0001408299 2013-01-01 2013-12-31 0001408299 us-gaap:OptionMember 2012-01-01 2012-12-31 0001408299 ERGO:OustandingMember 2013-12-31 0001408299 ERGO:OustandingMember 2014-06-30 0001408299 ERGO:OustandingMember 2012-12-31 0001408299 ERGO:GrantedMember 2013-01-01 2013-12-31 0001408299 ERGO:GrantedMember 2014-01-01 2014-06-30 0001408299 ERGO:ExercisedMember 2013-01-01 2013-12-31 0001408299 ERGO:ExercisedMember 2014-01-01 2014-06-30 0001408299 ERGO:ExpiredMember 2013-01-01 2013-12-31 0001408299 ERGO:ExpiredMember 2014-01-01 2014-06-30 0001408299 ERGO:ExercisableMember 2012-12-31 0001408299 ERGO:Options0.40Member 2014-06-30 0001408299 ERGO:Options0.44Member 2014-06-30 0001408299 ERGO:Options0.45Member 2014-06-30 0001408299 ERGO:Options0.47Member 2014-06-30 0001408299 ERGO:Options0.49Member 2014-06-30 0001408299 ERGO:Options0.50Member 2014-06-30 0001408299 ERGO:Options0.85Member 2014-06-30 0001408299 ERGO:Options1.00Member 2014-06-30 0001408299 ERGO:IssuedWarrantsMember 2014-04-02 2014-04-30 0001408299 ERGO:IssuedWarrantsMember 2014-01-02 2014-01-28 0001408299 ERGO:IssuedWarrantsMember 2014-06-02 2014-06-30 0001408299 2013-12-31 0001408299 us-gaap:PreferredStockMember 2013-01-01 2013-12-31 0001408299 us-gaap:PreferredStockMember 2013-12-31 0001408299 us-gaap:CommonStockMember 2013-01-01 2013-12-31 0001408299 us-gaap:CommonStockMember 2013-12-31 0001408299 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-12-31 0001408299 us-gaap:AdditionalPaidInCapitalMember 2013-12-31 0001408299 us-gaap:DeferredCompensationShareBasedPaymentsMember 2013-01-01 2013-12-31 0001408299 us-gaap:DeferredCompensationShareBasedPaymentsMember 2013-12-31 0001408299 ERGO:StockSubscriptionsMember 2013-12-31 0001408299 us-gaap:RetainedEarningsMember 2013-01-01 2013-12-31 0001408299 us-gaap:RetainedEarningsMember 2013-12-31 0001408299 ERGO:ExercisableMember 2013-12-31 0001408299 ERGO:Options0.38Member 2014-06-30 0001408299 ERGO:NotesPayableCurrent0.00PercentUnsecuredDueMonthlyMember 2013-12-31 0001408299 ERGO:NotesPayableCurrent0.00PercentUnsecuredDueMonthlyMember 2014-06-30 0001408299 2013-01-01 2013-06-30 0001408299 ERGO:ConvertibleNotes8PercentSecuredConvertibleToCommonSharesMember 2013-12-31 0001408299 ERGO:ConvertibleNotes8PercentSecuredConvertibleToCommonSharesMember 2014-06-30 0001408299 2013-04-01 2013-06-30 0001408299 ERGO:ConvertibleNotesPayableCurrentTotalMember 2013-12-31 0001408299 ERGO:ConvertibleNotesPayableCurrentTotalMember 2014-06-30 0001408299 ERGO:RelatedPartyLongTermConvertibleNotesPayableCurrentTotalMember 2013-12-31 0001408299 ERGO:RelatedPartyLongTermConvertibleNotesPayableCurrentTotalMember 2014-06-30 0001408299 ERGO:ConvertibleLongTermRelatedPartyNotes6PercentUnsecuredDueDecember2013ToCommonSharesMember 2013-12-31 0001408299 ERGO:ConvertibleLongTermRelatedPartyNotes6PercentUnsecuredDueDecember2013ToCommonSharesMember 2014-06-30 0001408299 ERGO:Options0.62Member 2014-06-30 0001408299 2014-02-03 0001408299 2013-06-30 0001408299 2014-01-01 2014-06-30 0001408299 2014-06-30 0001408299 2013-03-31 0001408299 ERGO:NotesPayableCurrent10PercentUnsecuredInterestOnlyMember 2014-06-30 0001408299 ERGO:NotesPayableCurrent10PercentUnsecuredInterestOnlyMember 2013-12-31 0001408299 ERGO:NotesPayableCurrentNovember20148PercentUnsecuredConvertibleMember 2014-06-30 0001408299 ERGO:NotesPayableCurrentNovember20148PercentUnsecuredConvertibleMember 2013-12-31 0001408299 ERGO:NotesPayableCurrent7.85PercentUnsecured373DueMonthlyMember 2014-03-31 0001408299 ERGO:NotesPayableCurrent7.85PercentUnsecured373DueMonthlyMember 2013-12-31 0001408299 2014-03-25 0001408299 2013-12-01 2013-12-31 0001408299 ERGO:ExercisableMember 2014-06-30 0001408299 ERGO:Options0.60Member 2014-06-30 0001408299 ERGO:Options0.65Member 2014-06-30 0001408299 2014-04-01 2014-04-30 0001408299 2014-04-01 2014-06-30 0001408299 2012-12-31 0001408299 us-gaap:PreferredStockMember 2014-01-01 2014-06-30 0001408299 us-gaap:PreferredStockMember 2014-06-30 0001408299 us-gaap:CommonStockMember 2014-01-01 2014-06-30 0001408299 us-gaap:CommonStockMember 2014-06-30 0001408299 us-gaap:AdditionalPaidInCapitalMember 2014-01-01 2014-06-30 0001408299 us-gaap:AdditionalPaidInCapitalMember 2014-06-30 0001408299 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-01-01 2014-06-30 0001408299 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-06-30 0001408299 ERGO:StockSubscriptionsMember 2014-01-01 2014-06-30 0001408299 ERGO:StockSubscriptionsMember 2014-06-30 0001408299 us-gaap:RetainedEarningsMember 2014-01-01 2014-06-30 0001408299 us-gaap:RetainedEarningsMember 2014-06-30 0001408299 ERGO:ConvertibleNotes8PercentUnsecuredConvertibleToCommonSharesJanuary2015Member 2014-06-30 0001408299 ERGO:ConvertibleNotes8PercentUnsecuredConvertibleToCommonSharesJanuary2015Member 2013-12-31 0001408299 ERGO:ConvertibleNotes8PercentUnsecuredConvertibleToCommonSharesMarch2015Member 2014-06-30 0001408299 ERGO:ConvertibleNotes8PercentUnsecuredConvertibleToCommonSharesMarch2015Member 2013-12-31 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesMarch2015Member 2014-06-30 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesMarch2015Member 2013-12-31 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesApril2015Member 2014-06-30 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesApril2015Member 2013-12-31 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesApril2015BMember 2014-06-30 0001408299 ERGO:ConvertibleNotes10PercentUnsecuredConvertibleToCommonSharesApril2015BMember 2013-12-31 0001408299 2014-07-14 0001408299 2014-07-01 0001408299 2014-07-02 2014-07-31 0001408299 2014-04-15 0001408299 2014-04-27 0001408299 2014-04-17 0001408299 2014-06-13 0001408299 ERGO:Options0.75Member 2014-06-30 0001408299 ERGO:Options0.81Member 2014-06-30 0001408299 2014-01-01 2014-03-31 0001408299 ERGO:ExercisableMember 2014-01-01 2014-06-30 0001408299 ERGO:ExercisableMember 2013-01-01 2013-12-31 0001408299 ERGO:OustandingMember 2014-01-01 2014-06-30 0001408299 ERGO:OustandingMember 2013-01-01 2013-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:M utr:Y utr:sqft ERGO:Units iso4217:USD ERGO:Unit 11197 30770 138941 113066 34462 22973 225451 183593 62145 52787 343498 343141 631094 579521 1157717 1303040 373644 42000 587470 42500 15000 32500 32500 23788 33058 1580681 1924035 1580681 1924035 282 238 8298 9134 7793760 8400983 -182576 -188367 -8520351 -9566502 631094 579521 2105 467 0.001 0.001 5000000 5000000 350000 350000 281969 237807 1409845 1189035 0.001 0.001 150000000 150000000 8297645 9133091 240750 218980 49255 45150 290005 264130 -151064 -151064 26284 27507 83615 85046 16328 16328 64082 76094 126227 128881 234324 234324 16127 23826 1964 0 50000 50000 263496 312500 22448 27690 23788 33058 0 2545 21824 5513 37700 47950 373644 587470 23427 0 23427 0 25000 0 28483 0 15503 0 10273 0 17913 0 70600 0 6558 0 350000 0.001 5 4650000 .0095 0.0028 0.0028 0.0095 .0332 0.0184 0.0191 0.0247 216.48 2.1051 210.51 2.1696 239.20 2.1696 2.2230 2.3655 P10Y P7Y P7Y P10Y P5Y P3Y P3Y P5Y 3160 3260 3343 8437345 49000 0 0.00 0.00 0.00 0.00 23427 0 3965 0 2.00 2.00 .45 .45 0.65 0.65 5.00 5.00 49004 0 40552 25345 12300 8200 16573 0 23655 0 16997 0 22227 0 7087 0 29400 0 3442 0 30776 7545 781 781 2678 2678 373 373 476368 710928 60671 108199 537039 819127 <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected dividend yield </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected stock price volatility </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">210.51%-216.96%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">216.96% - 236.55%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Risk-free interest rate </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.28% - 1.84%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.95% - 2.47%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected term (in years) </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3 - 7 years</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">5 - 10 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Weighted-average granted date fair value </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.62 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.45 </font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June 30, 2014</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">December 31, 2013</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Risk-Free interest rate</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.28% - 1.91%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.95% - 3.32%</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="2" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expected dividend yield</font></td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Volatility</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">210.51%-222.30%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">216.48%-239.20%</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expected life</font></td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3 - 7 years</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3-10 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.75 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.45 </font></td></tr> </table> 50000 6555 15585 4160 2352099 2572099 1202099 830504 1810344 2044836 .51 0.52 .56 .57 .52 .52 199505 143063 0 0 138707 125127 .38 0.38 .40 0.40 .38 .38 1.00 1.00 1.00 1.00 1.00 1.00 1150000 220000 0 0 0 0 0.38 .60 0 0 0 0 .81 0.75 0 0 0 0 0.47 0.62 0 0 0 0 P8Y1M P5Y4M P0Y P0Y P0Y P0Y P7Y10M P7Y10M P7Y8M P7Y10M 0 0 0 0 0 0 135000 20000 540000 247242 247857 844000 200000 38000 55000 15000 160000 40000 20000 10000 .45 0.62 0.75 .45 8174530 8174530 10370798 10370798 816516 816516 900321 900321 1450172 1450172 2572099 2572099 2411940 2411940 2378070 2378070 3495902 3495902 4520308 4520308 .36 10.00 4349698 4520308 0.0785 0.0785 0.08 0.08 0.08 0.08 0.0415 0.0415 .08 .08 0.10 0.10 0.08 0.08 0.0785 0.0785 .08 .08 0.08 0.08 .10 .10 0.10 0.10 0.10 0.10 44162 441620 125301 132643 20000 13081 Entia Biosciences, Inc. 0001408299 10-Q 2014-06-30 false --12-31 No No Yes Smaller Reporting Company Q2 2014 36886 13161 15484 33409 13081 0 1300 110 7444 5115587 -394510 -5327924 -49000 -949587 282 8298 7793760 -182576 -49000 -8520351 -1344514 -648293 238 9134 8400983 -188367 0 -9566502 -3104827 -3104827 -1490612 -1038338 -1046151 -510763 -1046151 68 44182 -44250 44250 130 83270 13113 88 52581 39556 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Use of estimates</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Cash</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We consider all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Accounts receivable</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses based on specific identification of accounts in our existing accounts receivable. Outstanding account balances are reviewed individually for collectibility. We determine the allowance based on historical write-off experience, customer specific facts and economic conditions. Bad debt expense is included in general and administrative expenses, if any. We consider all accounts greater than 30 days old to be past due. Account balances are charged off against allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $2,526 at both June 30, 2014 and 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Inventory</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory, which consists primarily of raw materials to be used in the production of our dietary supplement products, is stated at the lower of cost or market using the first-in, first-out method. We regularly review our inventory on hand and, when necessary, record a provision for excess or obsolete inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Property and equipment</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment are recorded at cost. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Office equipment</font></td> <td nowrap="nowrap" style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">3 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Production equipment</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Equipment under capital lease</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Leasehold improvements</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Lesser of lease term or useful life of improvement</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Patents</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Patents, once issued or purchased, are amortized using the straight-line method over their economic remaining useful lives. All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs. Patent application costs, generally legal costs, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally 15 to 20 years for domestic patents and 5 to 20 years for foreign patents, or expensed if the patent application is rejected. The costs of defending and maintaining patents are expensed as incurred. Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Impairment of long-lived assets</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our long-lived assets, which include property and equipment, patents, and licenses of patents are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset&#146;s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Discount on convertible notes payable</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We allocate the proceeds received from convertible notes between convertible notes payable and warrants, if applicable. The resulting discount for warrants is amortized using the effective interest method over the life of the debt instrument. After allocating a portion of the proceeds to the warrants, the effective conversion price of the convertible note payable can be determined. If the effective conversion price is lower than the market price at the date of issuance, a beneficial conversion feature is recorded as an additional discount to the convertible note payable. The beneficial conversion feature discount is amortized using the effective interest method over the life of the debt instrument. The amortization is recorded as interest expense on the consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Fair value of financial instruments</u></i></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable and accounts payable, approximate their fair values (determined based on level 1 inputs in the fair value hierarchy) because of the short maturity of these instruments. Due to conversion features and other terms, it is not practical to estimate the fair value of notes payable and convertible notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Fair value measurements</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We measure fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; font: 10pt Arial Unicode MS"> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top; width: 7%"><font style="font-family: Times New Roman, Times, Serif">Level 1</font></td> <td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 92%"><font style="font-family: Times New Roman, Times, Serif">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</font></td></tr> <tr> <td style="vertical-align: top">&#160;</td> <td>&#160;</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Level 2</font></td> <td>&#160;</td> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</font></td></tr> <tr> <td style="vertical-align: top">&#160;</td> <td>&#160;</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Level 3</font></td> <td>&#160;</td> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at June 30, 2014 or 2013, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended June 30, 2014 and June 30, 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Revenue recognition</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues from the sale of products, including shipping and handling fees but excluding statutory taxes collected from customers, as applicable, are recognized when shipment has occurred. We sell our products directly to customers. Persuasive evidence of an arrangement is demonstrated via order and invoice, product delivery is evidenced by a bill of lading from the third party carrier and title transfers upon shipment, the sales price to the customer is fixed upon acceptance of the order and there is no separate sales rebate, discount, or volume incentive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred. In 2012 and 2011, we incurred $26,059 and $32,784, respectively, in shipping costs included in cost of goods sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Shipping and handling costs</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred. In 2013 and 2012, we incurred $31,996 and $26,059, respectively, in shipping costs included in cost of goods sold.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Advertising and promotion costs</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Costs associated with the advertising and promotions of our products are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><u>Equity instruments issued to parties other than employees for acquiring goods or services</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We account for all transactions in which goods or services are the consideration received for the issuance of equity instruments based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. Currently such transactions are primarily awards of warrants to purchase common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of each warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 32pt">&#160;&#160;The assumptions used to determine the fair value of our warrants are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table align="center" cellspacing="0" cellpadding="0" style="width: 6.5in; font-family: Times New Roman, Times, Serif"> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="width: 7%; font-weight: bold; text-align: center"><font style="font-size: 10pt">-</font></td> <td style="width: 93%"><font style="font-size: 10pt">The expected life of warrants issued represents the period of time the warrants are expected to be outstanding.</font></td></tr> <tr> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">-</font></td> <td><font style="font-size: 10pt">The expected volatility is generally based on the historical volatility of comparable companies&#146; stock over the contractual life of the warrant.</font></td></tr> <tr> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">-</font></td> <td><font style="font-size: 10pt">The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant.</font></td></tr> <tr> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">&#160;</font></td> <td><font style="font-size: 10pt">&#160;</font></td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="font-weight: bold; text-align: center"><font style="font-size: 10pt">-</font></td> <td><font style="font-size: 10pt">The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.</font></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Income taxes</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in our consolidated statements of income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Should they occur, our policy is to classify interest and penalties related to tax positions as income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We did not record an income tax provision for the three months and six months ended June 30, 2014 and 2013 as we had a net taxable loss in the periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><u>Reclassifications</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Certain reclassifications have been made to prior period financial statements and footnotes in order to conform to the current period's presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Segments</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have determined that we operate in one segment for financial reporting purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Basis of presentation and principles of consolidation</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated unaudited interim financial statements and related notes have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information, and with the rules and regulations of the United states Securities and Exchange Commission (&#147;SEC&#148;) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2013 and notes thereto contained in the Company&#146;s Annual Report on Form 10-K filed with the SEC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All intercompany accounts have been eliminated for the purpose of the consolidated financial statement presentation.</p> <p style="font: 10pt Arial Unicode MS; margin: 0; text-align: justify">&#160;</p> -1490612 -1038338 -1046151 -510763 2526 2526 P30D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 3 &#150; INVENTORY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Raw materials </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;218,980&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;240,750&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Finished goods </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;45,150&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;49,255&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">264,130&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;290,005&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Less:&#160;&#160;reserve for excess and obsolete inventory </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(151,064)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(151,064)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;113,066&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;138,941&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 4 &#150; PROPERTY AND EQUIPMENT</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Property and equipment, stated at cost, consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 26%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Office equipment</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;27,507&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;26,284&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Production equipment </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;85,046&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;83,615&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Leasehold improvements </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;16,328&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;16,328&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;128,881&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;126,227&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Less:&#160;&#160;accumulated depreciation </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(76,094)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(64,082)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;52,787&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;62,145&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 5 - PATENTS AND LICENSES, NET</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our identifiable long-lived intangible assets are patents and prepaid licenses. Patent and license amortization is $3,849 and $790 for the three months ended June 30, 2014 and 2013, respectively and $7,699 and $3,247 for the six months ended June 30, 2014 and 2013, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The licenses are being amortized over an economic useful life of 17 years. The gross carrying amounts and accumulated amortization related to these intangible assets consist of the following at:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 22%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Licenses and amortizable patents </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;234,324&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;234,324&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Unamortized patents </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;346,231&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;125,301&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Accumulated amortization </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(23,826)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(16,127)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Patents and Licenses, net </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;343,141&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;343,498&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> P17Y 3247 7699 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 6 &#150; ACCRUED EXPENSES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Accrued expenses (included with accounts payable) consists of the following at:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 47%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="width: 27%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 24%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Executive compensation</font></td> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$ </font>710,928</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;476,368</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Other accruals</font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;</font>108,199</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;60,671</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;819,127</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;537,039</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> 0.03 60000 40000 0.00 2404099 23000 64700 68283 80000 6717 2077901 263507 <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="width: 37%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Office equipment</font></td> <td nowrap="nowrap" style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">3 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Production equipment</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Equipment under capital lease</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Leasehold improvements</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt; color: black">Lesser of lease term or useful life of improvement</font></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0">&#160;</p> P3Y P3Y P5Y 1.00 1.00 .50 110000 110000 15000 P4M 77482 91908 140000 3108 51200 80000 109900 7444591 281969 8297645 237807 9133091 140175 700875 140 700735 3162 15750 3 15747 -87600 87600 16400 16400 52780 52780 200000 215529 200 215329 4607050 413921 413921 108739 108739 584108 -584108 188674 -188674 98006 98006 796042 796042 227133 227133 23332 116652 23 116629 30400 152001 31 151970 64956 64956 77482 77482 -25000 250000 -44162 441620 -25 250 -225 0 -44 442 -398 0 0 0 273158 130001 274 129727 129896 87700 68283 49000 49000 9000 -0.20 -0.14 -0.12 -0.06 0 0 -12965 0 -67601 -37790 -174402 -96684 4898 2450 0 0 -1427909 -1002998 -961805 -517100 1540065 1047477 1133042 585591 805814 493896 717148 342938 528739 441401 293592 191063 77239 30302 87216 38454 128273 81878 35086 13136 112156 44479 171237 68491 57987 29408 96024 36202 170143 73887 267261 104693 7308930 7456281 8429958 8532935 0 0 103021 103021 151126 32520 151 32369 0 0 0 86717 50901 87 50814 0 0 0 80 -21402 357729 246031 0 40000 0 -40000 -14271 -20969 0 267000 372000 0 -43222 -9995 -5117 -7341 -38105 -2654 -314427 -257438 365541 196224 -919 -1300 14397 15090 24675 25875 -18944 -19573 0 12965 725434 388541 51591 254202 14410 19710 770 840 46400 4501 348614 32520 140000 0 <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><b>NOTE 1 &#150; ORGANIZATION AND OPERATIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Generic Marketing Services, Inc. was incorporated on July 19, 2007 under the laws of the State of Nevada as a subsidiary of Basic Services, Inc., also a Nevada corporation. On December 31, 2007, Basic Services spun off Generic Marketing Services. On October 8, 2008, Generic Marketing Services changed its name to Total Nutraceutical Solutions, Inc. (TNS, the Company, us, we, or our). We engage in the distribution of organic dietary supplement nutraceutical products in the United States of America. We are also engaged in the discovery, scientific evaluation and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics and other products developed and sold by Entia and by third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On January 9, 2012, the amendment to our Articles of Incorporation involving the name change from Total Nutraceutical Solutions, Inc. to Entia Biosciences, Inc. (&#147;Entia&#148;) became effective with the Secretary of State of Nevada. We also filed articles of incorporation for a wholly owned subsidiary of Entia, with such subsidiary to be named Total Nutraceutical Solutions, Inc. in January 2012.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have a history of incurring net losses and net operating cash flow deficits. We are also developing new technologies related to our organic nutraceutical products. At June 30, 2014, we had cash and cash equivalents of $15,484. These conditions raise substantial doubt about our ability to continue as a going concern. As a result, we anticipate that our cash and cash equivalent balances, anticipated cash flows from operations and anticipated operating cash flows will be sufficient to meet our cash requirements through September 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In order for us to continue as a going concern beyond this point and ultimately to achieve profitability, we may be required to obtain capital from external sources, increase revenues and reduce operating costs. The issuance of equity securities will also cause dilution to our shareholders. If external financing sources of financing are not available or are inadequate to fund our operations, we will be required to reduce operating costs including personnel costs, which could jeopardize our future strategic initiatives and business plans. The accompanying consolidated financial statements have been prepared assuming that the Company continues as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the matters discussed herein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Three</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Six</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 16%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Numerator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Net loss&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(510,763)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(1,038,338)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,046,151)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,490,612)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Denominator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Weighted-average common shares outstanding</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,532,935&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,456,281&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,429,958&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,308,930&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Basic and diluted</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">net loss per share</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.06)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.14)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.12)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.20)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Common stock warrants </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Series A convertible</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">preferred stock</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Stock options </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Convertible debt</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">including interest</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Excluded dilutive</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">securities</p></td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Net loss per common share</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic and diluted net loss per share has been computed by dividing our net loss by the weighted average number of common shares issued and outstanding. Convertible preferred stock, options and warrants to purchase our common stock as well as debt which are convertible into common stock are anti-dilutive and therefore are not included in the determination of the diluted net loss per share for three months ended June 30, 2014 and 2013 and the six months ended June 30, 2014 and 2013. The following table presents a reconciliation of basic loss per share and excluded dilutive securities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Three</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Six</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 16%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Numerator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Net loss&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(510,763)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(1,038,338)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,046,151)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,490,612)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Denominator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Weighted-average common shares outstanding</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,532,935&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,456,281&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,429,958&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,308,930&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Basic and diluted</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">net loss per share</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.06)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.14)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.12)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.20)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Common stock warrants </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Series A convertible</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">preferred stock</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Stock options </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Convertible debt</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">including interest</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Excluded dilutive</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">securities</p></td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Recently issued accounting pronouncements</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for Entia beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Basis of presentation and principles of consolidation</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The accompanying consolidated unaudited interim financial statements and related notes have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information, and with the rules and regulations of the United states Securities and Exchange Commission (&#147;SEC&#148;) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2013 and notes thereto contained in the Company&#146;s Annual Report on Form 10-K filed with the SEC.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">All intercompany accounts have been eliminated for the purpose of the consolidated financial statement presentation.</p> <p style="font: 10pt Arial Unicode MS; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Use of estimates</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Cash</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We consider all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Accounts receivable</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses based on specific identification of accounts in our existing accounts receivable. Outstanding account balances are reviewed individually for collectibility. We determine the allowance based on historical write-off experience, customer specific facts and economic conditions. Bad debt expense is included in general and administrative expenses, if any. We consider all accounts greater than 30 days old to be past due. Account balances are charged off against allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $2,526 at both June 30, 2014 and December 31, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Inventory</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Inventory, which consists primarily of raw materials to be used in the production of our dietary supplement products, is stated at the lower of cost or market using the first-in, first-out method. We regularly review our inventory on hand and, when necessary, record a provision for excess or obsolete inventory.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Property and equipment</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Property and equipment are recorded at cost. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Office equipment</font></td> <td nowrap="nowrap" style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 59%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">3 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Production equipment</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Equipment under capital lease</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">5 to 7 years</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Leasehold improvements</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Lesser of lease term or useful life of improvement</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><u>Patents</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Patents, once issued or purchased, are amortized using the straight-line method over their economic remaining useful lives. All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs. Patent application costs, generally legal costs, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally 15 to 20 years for domestic patents and 5 to 20 years for foreign patents, or expensed if the patent application is rejected. The costs of defending and maintaining patents are expensed as incurred. Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Impairment of long-lived assets</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Our long-lived assets, which include property and equipment, patents and licenses of patents, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset&#146;s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.</p> <p style="font: 10pt Arial Unicode MS; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Discount on convertible notes payable</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We allocate the proceeds received from convertible notes between convertible notes payable and warrants, if applicable. The resulting discount for warrants is amortized using the effective interest method over the life of the debt instrument. After allocating a portion of the proceeds to the warrants, the effective conversion price of the convertible note payable can be determined. If the effective conversion price is lower than the market price at the date of issuance, a beneficial conversion feature is recorded as an additional discount to the convertible note payable. The beneficial conversion feature discount is amortized using the effective interest method over the life of the debt instrument. The amortization is recorded as interest expense on the consolidated statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Fair value of financial instruments</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable and accounts payable, approximate their fair values (determined based on level 1 inputs in the fair value hierarchy) because of the short maturity of these instruments. Due to conversion features and other terms, it is not practical to estimate the fair value of notes payable and convertible notes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Fair value measurements</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We measure fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; font: 10pt Arial Unicode MS"> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top; width: 7%"><font style="font-family: Times New Roman, Times, Serif">Level 1</font></td> <td style="width: 1%">&#160;</td> <td style="vertical-align: top; width: 92%"><font style="font-family: Times New Roman, Times, Serif">Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.</font></td></tr> <tr> <td style="vertical-align: top">&#160;</td> <td>&#160;</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Level 2</font></td> <td>&#160;</td> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.</font></td></tr> <tr> <td style="vertical-align: top">&#160;</td> <td>&#160;</td> <td style="vertical-align: top">&#160;</td></tr> <tr style="background-color: #CCFFCC"> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Level 3</font></td> <td>&#160;</td> <td style="vertical-align: top"><font style="font-family: Times New Roman, Times, Serif">Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at June 30, 2014 or December 31, 2013, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended June 30, 2014 and June 30, 2013.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Revenue recognition</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Revenues from the sale of products, including shipping and handling fees but excluding statutory taxes collected from customers, as applicable, are recognized when shipment has occurred. We sell our products directly to customers. Persuasive evidence of an arrangement is demonstrated via order and invoice, product delivery is evidenced by a bill of lading from the third party carrier and title transfers upon shipment, the sales price to the customer is fixed upon acceptance of the order and there is no separate sales rebate, discount, or volume incentive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Shipping and handling costs</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Advertising and promotion costs</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Costs associated with the advertising and promotions of our products are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Equity instruments issued to parties other than employees for acquiring goods or services</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We account for all transactions in which goods or services are the consideration received for the issuance of equity instruments based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. Currently such transactions are primarily awards of warrants to purchase common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The fair value of each warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The assumptions used to determine the fair value of our warrants are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; font: 10pt Arial Unicode MS"> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="width: 7%; text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>-</b></font></td> <td style="width: 93%"><font style="font-family: Times New Roman, Times, Serif">The expected life of warrants issued represents the period of time the warrants are expected to be outstanding.</font></td></tr> <tr> <td style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>-</b></font></td> <td><font style="font-family: Times New Roman, Times, Serif">The expected volatility is generally based on the historical volatility of comparable companies&#146; stock over the contractual life of the warrant.</font></td></tr> <tr> <td style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>-</b></font></td> <td><font style="font-family: Times New Roman, Times, Serif">The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant.</font></td></tr> <tr> <td style="text-align: center">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: top; background-color: #CCFFCC"> <td style="text-align: center"><font style="font-family: Times New Roman, Times, Serif"><b>-</b></font></td> <td><font style="font-family: Times New Roman, Times, Serif">The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i><u>Income taxes</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in our consolidated statements of income in the period that includes the enactment date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Should they occur, our policy is to classify interest and penalties related to tax positions as income tax expense.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We did not record an income tax provision for the three months and six months ended June 30, 2014 and 2013 as we had a net taxable loss in the periods.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Net loss per common share</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Basic and diluted net loss per share has been computed by dividing our net loss by the weighted average number of common shares issued and outstanding. Convertible preferred stock, options and warrants to purchase our common stock as well as debt which are convertible into common stock are anti-dilutive and therefore are not included in the determination of the diluted net loss per share for three months ended June 30, 2014 and 2013 and the six months ended June 30, 2014 and 2013. The following table presents a reconciliation of basic loss per share and excluded dilutive securities:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; border-collapse: collapse; font-size: 10pt"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Three</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">For the Six</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Months Ended</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 15%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2014</font></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 16%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: center"><font style="font-size: 10pt">2013</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Numerator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Net loss&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(510,763)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(1,038,338)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,046,151)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;$&#9;(1,490,612)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Denominator: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Weighted-average common shares outstanding</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,532,935&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,456,281&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,429,958&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;7,308,930&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Basic and diluted</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">net loss per share</p></td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.06)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.14)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.12)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">$&#9;(0.20)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Common stock warrants </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;4,520,308&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;3,495,902&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Series A convertible</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">preferred stock</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,378,070&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,411,940&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;Stock options </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;2,572,099&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;1,450,172&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Convertible debt</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">including interest</p></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;900,321&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;816,516&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Excluded dilutive</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">securities</p></td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;10,370,798&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-family: Times New Roman, Times, Serif; text-align: right"><font style="font-size: 10pt">&#9;8,174,530&#160;</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Reclassifications&#160;</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Certain reclassifications have been made to prior period financial statements and footnotes in order to conform to the current period's presentation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Segments</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We have determined that we operate in one segment for financial reporting purposes.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Recently issued accounting pronouncements</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for Entia beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Raw materials </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;218,980&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;240,750&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Finished goods </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;45,150&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;49,255&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">264,130&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;290,005&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Less:&#160;&#160;reserve for excess and obsolete inventory </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(151,064)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(151,064)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;113,066&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;138,941&#160;</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 26%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Office equipment</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;27,507&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;26,284&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Production equipment </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;85,046&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;83,615&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Leasehold improvements </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;16,328&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;16,328&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;128,881&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;126,227&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Less:&#160;&#160;accumulated depreciation </font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(76,094)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(64,082)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;52,787&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;62,145&#160;</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 36%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 22%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Licenses and amortizable patents </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;234,324&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;234,324&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Unamortized patents </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;346,231&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;125,301&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Accumulated amortization </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(23,826)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;(16,127)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Patents and Licenses, net </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;343,141&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;343,498&#160;</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 47%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td nowrap="nowrap" style="width: 27%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 24%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Executive compensation</font></td> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$ </font>710,928</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;476,368</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Other accruals</font></td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;</font>108,199</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;60,671</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;819,127</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;537,039</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>NOTE 7 &#150; NOTES PAYABLE</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Notes payable consists of the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 22%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline"><font style="font-size: 10pt"><b><u>Notes payable - current</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">7.85% unsecured, $781 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;1,964</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">7.85% unsecured, $373 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;2,545</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">4.15% unsecured, $2,678 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;5,513</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;21,824</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">10.00% unsecured, interest only, due December 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;25,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;33,058</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;23,788</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; border-collapse: collapse; font-family: Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-decoration: underline"><font style="font-size: 9pt"><b><u>Convertible notes payable, net</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8%, unsecured due June 2014&#160;&#160;(net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;312,500</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;263,496</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% secured due August 2014 (net of discount related to beneficial conversion feature of $2,050 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;47,950</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;37,700</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">6% unsecured, convertible into common stock at $2.00 per share, due on demand</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;50,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;50,000</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $5,310 in 2014 and $40,552 in 2013), convertible into common stock at an average price of $0.205 per share</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;27,690</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;22,448</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $13,517 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;28,483</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;15,503</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;10,273</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;17,913</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;70,600</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;6,558</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;587,470</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;373,644</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="width: 6.5in; border-collapse: collapse; font-family: Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-decoration: underline"><font style="font-size: 10pt"><b><u>Convertible notes payable, net related party</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-decoration: underline"><font style="font-size: 10pt"><b><u></u></b></font></td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share.&#160;&#160;This note was paid off on March 31, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;23,427</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;23,427</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">$312,500 in notes payable was due on June 30, 2014. We are currently in negotiations with the note holder to extend this note and we are not in default.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During 2014, we entered into the following debenture agreements that accrue interest at 10%, mature in 1 year and grant the investor on a one warrant per dollar basis that are exercisable for 3 years at $1 per share and vest immediately:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On April 15, 2014, we entered into an agreement for $10,000. We calculated the fair value of the warrants at $4,130,</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On April 27, 2014, we entered into an agreement for $100,000. We calculated the fair value of the warrants at $39,200, and</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On March 28, 2014, we entered into an agreement for $25,000. We calculated the fair value of the warrants at $9,450.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We posted the fair value of the warrants as a discount on the notes and amortize them over the life of the debenture. Total value of the discounts is $52,780.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In addition to the debentures, during 2014, we entered into the following convertible promissory notes with an interest rate of 8% per annum, compounded annually. If the note remains unpaid after one hundred eighty (180) days from the Issue date, the holder has the option to convert the principal and accrued interest into shares of our Company stock at a conversion price equal to 58% of the &#147;trading price&#148; as described in the note. We have calculated a discount for the beneficial conversion feature in the amount of $77,482 and will be amortized over the life of the loan. The amount amortized for 2014 is $14,603:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On February 3, 2014, $42,000 due on November 3, 2014,</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On April 17, 2014, $32,500 due on January 17, 205, and</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 58.5pt"></td><td style="width: 13.8pt"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On June 13, 2014, $32,500 due on March 13, 2015. </font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On March 25, 2014, we entered into a line of credit arrangement. The line of credit is $60,000 with an interest rate of prime plus 3.00%. There are no loan covenants applicable to this line of credit and the amount outstanding as of June 30, 2014 is $11,750. The line of credit is reported on the balance sheet with accounts payable and accrued expenses.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 22%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 20%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-decoration: underline"><font style="font-size: 10pt"><b><u>Notes payable - current</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">7.85% unsecured, $781 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;1,964</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">7.85% unsecured, $373 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;2,545</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">4.15% unsecured, $2,678 due monthly</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;5,513</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;21,824</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">10.00% unsecured, interest only, due December 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;25,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;33,058</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;$&#9;23,788</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="width: 9in; border-collapse: collapse; font-family: Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-decoration: underline"><font style="font-size: 9pt"><b><u>Convertible notes payable, net</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8%, unsecured due June 2014&#160;&#160;(net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;312,500</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;263,496</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% secured due August 2014 (net of discount related to beneficial conversion feature of $2,050 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;47,950</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;37,700</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">6% unsecured, convertible into common stock at $2.00 per share, due on demand</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;50,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;50,000</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $5,310 in 2014 and $40,552 in 2013), convertible into common stock at an average price of $0.205 per share</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;27,690</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;22,448</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $13,517 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;28,483</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;15,503</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;10,273</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;17,913</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;70,600</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt"><font style="font-size: 9pt">10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;6,558</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;587,470</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 9pt; text-align: right"><font style="font-size: 9pt">&#9;$&#9;373,644</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="width: 6.5in; border-collapse: collapse; font-family: Times New Roman, Times, Serif"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-decoration: underline"><font style="font-size: 10pt"><b><u>Convertible notes payable, net related party</u></b></font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-decoration: underline"><font style="font-size: 10pt"><b><u></u></b></font></td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 39%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td colspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share.&#160;&#160;This note was paid off on March 31, 2014.</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;23,427</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-size: 10pt">&#9;$&#9;23,427</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 8 &#150; RELATED PARTY TRANSACTIONS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Debt agreements from board member</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In December 2013, we entered into a promissory note due on March 31, 2014 at 0% in the principal amount of $40,000. The note was paid off on March 31, 2014.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 9 &#150; STOCKHOLDERS&#146; EQUITY (DEFICIT)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Preferred Stock</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 26, 2011, our board of directors designated 350,000 shares of preferred stock as Series A preferred stock, $0.001 par value. The Series A preferred stock is entitled to a liquidation preference in the amount of $5 per share, votes on an as converted basis with the common stock on all matters as to which holders of common stock shall be entitled to vote, and is currently convertible into common stock on a one-for-ten basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During second quarter 2014, two investors converted 44,162 shares of Series A Preferred stock for 441,620 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Common stock</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During second quarter 2014, we issued shares of common stock for the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">151,126 shares of common stock with a value of $32,520 upon conversion of $30,000 of convertible notes payable along with accrued interest of $2,520,</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">23,000 shares of common stock for a value of $13,113 for services rendered,</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">441,620 shares of common stock in exchange for 44,162 shares of Series A Preferred stock, and</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">80,000 shares of common stock with a value of $46,400 for the settlement of accounts payable in the amount of $149,421. We posted a gain on settlement in the amount of $103,021.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">During first quarter 2014, we issued shares of common stock for the following:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">64,700 shares of common stock for a value of $39,556 for services rendered,</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">68,283 shares of common stock for a value of $44,250 for services to be performed in the future, and</font></td></tr></table> <table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Arial Unicode MS; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top"> <td style="width: 0.75in"></td><td style="width: 0.25in"><font style="font-family: Courier New, Courier, Monospace">o</font></td><td style="text-align: justify"><font style="font-family: Times New Roman, Times, Serif">6,717 shares of common stock with a value of $4,501 for the settlement of accounts payable.</font></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Stock incentive plan</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September 17, 2010, our Board of Directors adopted the 2010 Stock Incentive Plan (&#147;Plan&#148;). The Plan provides for the grant of options to purchase shares of our common stock, and stock awards consisting of shares of our common stock, to eligible participants, including directors, executive officers, employees and consultants of the Company. We have reserved 4,650,000 shares of common stock for issuance under the Plan with an annual increase in shares of 50,000 as of January 1 of each year; commencing January 1, 2012. Stock options are granted at or below the closing price of our stock on the date of grant for terms ranging from four to fifteen years and generally vest over a five year period. The fair value of option grants were calculated at the date of the grants using the Black-Scholes option pricing model with the following assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 48%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">June 30,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2014</p></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">December 31,</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">2013</p></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected dividend yield </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected stock price volatility </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">210.51%-216.96%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">216.96% - 236.55%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Risk-free interest rate </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.28% - 1.84%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.95% - 2.47%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Expected term (in years) </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3 - 7 years</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">5 - 10 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#160;Weighted-average granted date fair value </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.62 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.45 </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">A summary of option activity under the stock option plan as of June 30, 2014 and changes during the quarter then ended is presented below:</p> <p style="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"></p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Weighted </font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Average</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Number&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Average</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Aggregate</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">of</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise Price</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Term</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Intrinsic</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Shares</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Range</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Price</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">(Years)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Value</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2012</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,202,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.40 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.56</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.74</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, December 31, 2012</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">830,504</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.40 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.57</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;8.19</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Granted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $0.81 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.47</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;8.07</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expired</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2013</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,352,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.51</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.90</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;199,505</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, December 31, 2013</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,810,344</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.88</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;138,707</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Granted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">220,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.60-$0.75 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.62</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;5.27</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expired</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, June 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,572,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.68</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;143,063</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, June 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,044,836</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.89</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;125,127</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The range of exercise prices for options outstanding under the 2010 Stock Incentive Plan at June 30, 2014 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Number of</font></td> <td nowrap="nowrap" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise </font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">shares</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Price</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">55,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.38</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">135,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.40</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.44</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">540,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.45</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">247,242</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.47</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">247,857</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.49</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">844,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.50</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">15,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.62</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">40,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.65</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.75</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">160,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.60</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.81</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">200,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.85</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">38,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;1.00</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,572,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At June 30, 2014, the Company had 2,077,901 unissued shares available under the Plan. Also, at June 30, 2014, the Company had $263,507 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 7 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Warrants &#150; Consulting Agreements</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Outstanding warrants to purchase common stock are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 34%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Date of Issue</font></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June 30, 2014</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise Price</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Expiration</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;15,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.50 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">06/2019</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">April-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;113,333</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.65 - 1.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">04/2017 - 03/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">January-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;62,277</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.65 - $1.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">01/2019 - 01/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">As of December</font><br /> <font style="font-size: 10pt">2013</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,349,698</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.36 - $10.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">10/2013 - 10/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Total</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,540,308</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Less: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">Expired </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Total</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,520,308</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 7%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June 30, 2014</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 29%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">December 31, 2013</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" colspan="2" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Risk-Free interest rate</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.28% - 1.91%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0.95% - 3.32%</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" colspan="2" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expected dividend yield</font></td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">0%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Volatility</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">210.51%-222.30%</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">216.48%-239.20%</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expected life</font></td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3 - 7 years</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="background-color: white; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">3-10 years</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.75 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.45 </font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">At June 30, 2014 and 2013, the weighted-average Black-Scholes value of warrants granted was $0.75 and $0.45, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 10 - COMMITMENTS AND CONTINGENCIES</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Leases</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On April 4, 2012, the Company entered into a Commercial Lease agreement with Lanz Properties, LLC for 13,081 square feet of office and warehouse space located at 13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, OR 97140. The new lease commenced on June 1, 2012 and will terminate on July 31, 2015. No rent was payable until October 2012. The base monthly rental rate started at $3,160, increasing to $3,260 in October 2013, and then $3,343 in June 2014. The Company has straight-lined the full value of the lease agreement over the life of the lease and has recorded this amount monthly. The amount of rent expense that is above the actual rent amount is recorded as deferred rent and is shown on the balance sheet in current liabilities as part of accounts payable and accrued expenses. The amount recorded for as of June 30, 2014 and 2013 is $4,160 and $15,585, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 11 &#150; SUBSEQUENT EVENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 14, 2014, we were notified by the Michael J Fox Foundation that we had been awarded a grant to conduct a pre-clinical study of our ErgoD2&#174; medical food formulation as a potential therapy for Parkinson&#146;s Disease.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 14, 2014, we entered into a debt agreement with an investor for $42,500. The note is convertible after 180 days and is due in April 2015. The conversion price is not set for 180 days. Interest accrues at 8%. We have calculated a discount related to the beneficial conversion in the amount of $30,776 and will amortize over the life of the loan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In July 2014, an investor converted the remaining $33,000 from a note due in August 2014 for 226,530 shares of common stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On July 1, 2014, we entered into a promissory note with Dr. Sobol, (a board member) for $15,000. The note matures on October 31, 2014 and does not accrue interest. In conjunction with the note, we granted Dr. Sobol a five year warrant to purchase 15,000 shares of common stock at $0.50 per share and fully vests upon receipt of monies. We calculated a discount on the granting of the warrants in the amount of $5,445 and will expense this in July. The note also contained a conversion feature where the member can convert the note into common stock at $0.50 per share. We calculated and posted a discount related to this beneficial conversion of $7,545 and will amortize this over the life of the loan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> 0.08 .08 0.08 0.08 2015-04-01 P180D 33000 226530 .50 5445 312500 9450 4130 39200 52780 10000 100000 25000 0.10 0.10 0.10 P12M 0.58 0.58 0.58 14603 11750 2014-03-31 <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 35%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Weighted </font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 9%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Average</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Weighted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Remaining</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Number&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Average</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Contractual</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Aggregate</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">of</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise Price</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Term</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Intrinsic</font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Shares</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Range</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Price</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">(Years)</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Value</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2012</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,202,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.40 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.56</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.74</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, December 31, 2012</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">830,504</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.40 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.57</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;8.19</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Granted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,150,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $0.81 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.47</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;8.07</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expired</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, December 31, 2013</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,352,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.51</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.90</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;199,505</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, December 31, 2013</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">1,810,344</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.88</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;138,707</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Granted</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">220,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.60-$0.75 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.62</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;5.27</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Expired</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;-&#160;&#160;&#160;</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Outstanding, June 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,572,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.68</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;143,063</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Exercisable, June 30, 2014</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,044,836</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#160;$0.38 - $1.00 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;$&#9;0.52</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;7.89</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">&#9;125,127</font></td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 6.5in; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Number of</font></td> <td nowrap="nowrap" style="width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise </font></td></tr> <tr style="vertical-align: bottom"> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">shares</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Price</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">55,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.38</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">135,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.40</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.44</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">540,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.45</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">247,242</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.47</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">247,857</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.49</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">844,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.50</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">15,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.62</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">40,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.65</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.75</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">160,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.60</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">10,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.81</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">200,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;0.85</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">38,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">&#9;$&#9;1.00</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="border-top: Black 1pt solid; border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">2,572,099</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td></tr> </table> <table cellspacing="0" cellpadding="0" align="center" style="font: 10pt Times New Roman, Times, Serif; width: 9in; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 34%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Date of Issue</font></td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 23%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June 30, 2014</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 17%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Exercise Price</font></td> <td nowrap="nowrap" style="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="width: 21%; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">Expiration</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">June-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;15,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.50 </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">06/2019</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">April-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;113,333</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.65 - 1.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">04/2017 - 03/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">January-14</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;62,277</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.65 - $1.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">01/2019 - 01/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">As of December</font><br /> <font style="font-size: 10pt">2013</font></td> <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,349,698</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">$0.36 - $10.00</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 10pt">10/2013 - 10/2021</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Total</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,540,308</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Less: </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">Expired </font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;20,000</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCFFCC"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">Exercised</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;-</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 10pt">Total</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="border-bottom: Black 2.25pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><font style="font-size: 10pt">&#9;4,520,308</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> </table> 0.65 0.65 .50 1.00 1.00 .50 2013-10 2017-04 2019-01 2019-06 2021-10 2012-03 2021-01 2019-06 113333 62277 15000 151126 32520 30000 2520 103021 149421 1:10 P15Y P20Y P5Y P20Y 0 -103021 P6M P3Y P5Y P7Y P5Y P7Y P3Y EX-101.SCH 8 ergo-20140630.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - NOTE 1 - ORGANIZATION AND OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - NOTE 3 - INVENTORY link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - NOTE 6 - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTE 7 - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - NOTE 8 - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - NOTE 11 - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - NOTE 3 - INVENTORY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - NOTE 6 - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - NOTE 7 - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - NOTE 1 - ORGANIZATION AND OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - NOTE 2 - ESTIMATED USEFUL LIVES OF THE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER COMMON SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - NOTE 3 - INVENTORY (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - NOTE 3 - INVENTORY (Details Narrative) (USD $) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT - PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT (Details Narrative) (USD $) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET - PATENTS AND LICENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - NOTE 6 - ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - NOTE 7 - NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - NOTE 7 - NOTES PAYABLE (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - NOTE 7 - NOTES PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - NOTE 8 - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) - BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - NOTE 9 - OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - NOTE 9 - RANGE OF OPTIONS EXERCISE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - NOTE 9 - OUTSTANDING WARRANTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - NOTE 11 - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 ergo-20140630_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 ergo-20140630_def.xml XBRL DEFINITION FILE EX-101.LAB 11 ergo-20140630_lab.xml XBRL LABEL FILE Preferred Stock Equity Components [Axis] Common Stock Additional Paid In Capital Deferred Compensation Accumulated Deficit Notes payable - current, 7.85% unsecured, $781 due monthly DebtInstrument [Axis] Notes payable - current, 4.85% unsecured, due monthly 6% unsecured, convertible into common stock at $2.00 per share, due March 31, 2014 Convertible Notes payable, net - 5% unsecured due June 2013, convertible into preferred stock at $5.00 per share Convertible Notes payable, net - 8%, unsecured note due June 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share Convertible Notes payable, net - 5% unsecured due June 2013, convertible into preferred stock at $5.00 per share Convertible Notes Payable Net Less: Current Portion Convertible Notes payable related party, net - 8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $25,345 in 2014 and $40,552 in 2013), convertible into common stock at a price to be determined after June 5, 2014 Notes Payable Current Total Convertible Notes Payable Net Total Convertible Notes - 6% unsecured due June 2013 (net of discount related to beneficial conversion feature of $0 in 2013 and $4,277 in 2012), convertible into preferred stock at $5.00 per share Issued Warrants Oustanding Warrants [Axis] Stock Subscriptions Warrant Member Black Sholes Pricing Model [Axis] Notes payable - current, 4.15% unsecured, $2,678 due monthly Option Member Outstanding Option Activity [Axis] Granted Exercised Expired Exercisable Options $0.40 Exercise Price [Axis] Options $0.44 Options $0.45 Options $0.47 Options $0.49 Options $0.50 Options $0.85 Options $1.00 Options $0.38 Notes payable - current, 4.15% unsecured, $2,771 due monthly 8% secured due August 2014 (net of discount related to beneficial conversion feature of $8,200 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share Convertible Notes Payable Current Total Related Party Long Term Convertible Notes Payable Current Total 0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share. This note was paid off on March 31, 2014. 10% unsecured long term due March 2015 (net of discount related to discount of $9,450 in 2014 and $0 in 2013) convertible price not yet determined 10% unsecured long term due March 2015 (net of discount related to discount of $9,450 in 2014 and $0 in 2013) convertible price not yet determined Options $0.62 Notes payable - current, 10.00% unsecured, interest only, due December 30, 2014 Notes payable - current, 8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $23,655 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014. Notes payable - current, 7.85% unsecured, $737 due monthly Options $0.60 Options $0.65 8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014. 8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014. 10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined 10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined 10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined Options $0.75 Options $0.81 Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] Assets Current Assets: Cash Accounts receivable, net Inventory, net Interest income receivable Prepaid expenses Other current assets Total Current Assets Property and Equipment, net Patents and license, net Total Assets Liabilities and Stockholders' Equity (Deficit) Current Liabilities: Accounts payable and accrued expenses Short-term convertible notes payable, net of discount related-party Short-term convertible notes payable, net of discount Capital lease payable Notes payable Total Current Liabilities Long Term Liabilities: Capital lease payable Total Long Term Liabilities Total Liabilities Stockholders' Equity (Deficit): Preferred stock, $.001 par value, 5,000,000 shares authorized, Series A preferred stock, 350,000 shares designated, 237,807 and 281,969 shares issued and outstanding, resepecively, aggregate liquidation value of $1,409,845 and $1,409,845 respectively Common stock, $.001 par value, 150,000,000 shares authorized, 9,133,091 and 8,297,645 shares issued and outstanding Stock subscription receivable Additional paid-in capital Deferred compensation Accumulated deficit Total Stockholders' Equity (Deficit) Total Liabilities and Stockholders' Equity (Deficit) Preferred stock, par value Preferred stock, authorized Preferred stock Series A, designated Preferred stock, issued Preferred stock, aggregate liquidation value Common Stock, par value Common stock, authorized Common stock, Issued Income Statement [Abstract] REVENUES COST OF GOODS SOLD GROSS PROFIT OPERATING EXPENSES Advertising and promotion Professional fees Consulting fees General and administrative Total Operating Expenses LOSS FROM OPERATIONS OTHER INCOME (EXPENSES) Interest income Interest expense Other income (expense) Gain on settlement of accounts payable NET LOSS NET LOSS PER COMMON SHARE - BASIC AND DILUTED: Weighted common shares outstanding - basic and diluted Statement [Table] Statement [Line Items] Beginning Balance, Shares Beginning Balance, Amount Conversion of note payable into preferred stock, Shares Conversion of note payable into preferred stock, Amount Issuance of preferred stock for cash, Shares Issuance of preferred stock for cash, Amount Issuance of preferred stock for cancellation of debt, Shares Issuance of preferred stock for cancellation of debt, Amount Issuance of preferred stock for services, Shares Issuance of preferred stock for services, Amount Deemed dividend related to beneficial conversion feature of convertible preferred stock, Shares Issuance of preferred stock for conversion of convertible notes payable, Shares Issuance of preferred stock for conversion of convertible notes payable, Amount Issuance of preferred stock for conversion of accounts payable, Shares Issuance of preferred stock for conversion of accounts payable, Amount Issuance of warrants in connection with convertible notes payable Beneficial conversion feature in connection with convertible notes payable Issuance of common stock for license agreement, Shares Issuance of common stock for license agreement, Amount Issuance of common stock for conversion of preferred stock, Shares Issuance of common stock for conversion of preferred stock, Amount Issuance of common stock for conversion of convertible debt, Shares Issuance of common stock for conversion of convertible debt, Amount Issuance of common stock for conversion of accounts payable, Shares Issuance of common stock for conversion of accounts payable, Amount Issuance of common stock for conversion of accrued compensation, Shares Issuance of common stock for conversion of accrued compensation, Amount Issuance of common stock for future services, Shares Issuance of common stock for future services, Amount Issuance of common stock for services, Shares Issuance of common stock for services, Amount Issuance of common stock and warrants for cash, Shares Issuance of common stock and warrants for cash, Amount Issuance of common stock for note receivable, Shares Issuance of common stock for note receivable, Amount Stock compensation, Amount Receipt of stock subcription receivable, less write-off of $9,000 Issuance of warrants for services Issuance of warrants for extension on debt Amortization of deferred compensation Net loss Ending Balance, shares Ending Balance, amount Statement of Stockholders' Equity [Abstract] Write off amount on stock subscription receivable Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation/amortization Gain on settlement of accounts payable Amortization of discount on convertible notes Stock-based compensation Loss on sale of stock subscription receivable Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses Other current assets Accounts payable and accrued expenses NET CASH USED IN OPERATING ACTIVITIES CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Acquisition of patents and patents pending (net) NET CASH USED IN INVESTING ACTIVITIES CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of common stock, preferred stock and warrants Proceeds from convertible notes payable short-term Payment on notes payable Payment on convertible note payable - related party Proceeds from sale of stock subscription receivable NET CASH PROVIDED BY FINANCING ACTIVITIES NET CHANGE IN CASH Cash at beginning of period Cash at end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION: Interest paid SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES: Stock issued for accounts payable Conversion of accounts payable, accrued compensation, notes payable and accrued interest to preferred and common stock Debt issued for license Common stock issued for future services Accounting Policies [Abstract] NOTE 1 - ORGANIZATION AND OPERATIONS NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Inventory Disclosure [Abstract] NOTE 3 - INVENTORY Property, Plant and Equipment [Abstract] NOTE 4 - PROPERTY AND EQUIPMENT Notes to Financial Statements NOTE 5 - PATENTS AND LICENSES, NET NOTE 6 - ACCRUED EXPENSES Debt Disclosure [Abstract] NOTE 7 - NOTES PAYABLE Related Party Transactions [Abstract] NOTE 8 - RELATED PARTY TRANSACTIONS Equity [Abstract] NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) Commitments and Contingencies Disclosure [Abstract] NOTE 10 - COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] NOTE 11 - SUBSEQUENT EVENTS Basis of presentation and principles of consolidation Use of estimates Cash Accounts receivable Inventory Property and equipment Patents Impairment of long-lived assets Discount on convertible notes payable Fair value of financial instruments Fair value measurements Revenue recognition Shipping and handling costs Advertising and promotion costs Research and development Equity instruments issued to parties other than employees for acquiring goods or services Income taxes Net loss per common share Reclassifications Segments Recently issued accounting pronouncements Estimated Useful Lives of the Assets Net Loss Per Common Share Inventory Property and Equipment Patents and Licenses Accrued Expenses Notes Payable Short Term Convertible Notes Payable, Net Convertible notes payable, net related party BlackSholesPricingModelAxis [Axis] Black-Scholes Option-Pricing Model Assumptions Option Activity Range of Options Exercise Price Outstanding Warrants Cash and cash equivalents Estimated useful life of office equipment Minimum estimated useful life of production equipment Maximum estimated useful life of production equipment Minimum estimated useful life of equipment under capital lease Maximum estimated useful life of equipment under capital lease Reconciliation Of Basic Loss Per Share And Excluded Dilutive Securities Numerator: Net loss applicable to common shareholders Denominator: Weighted-average common shares outstanding Basic and diluted net loss per share Common stock warrants Series A convertible preferred stock Stock options Convertible debt including interest Excluded dilutive securities Allowance for doubtful accounts Accounts receivable past due period Domestic patent life minimum (in years) Domestic patent life maximum (in years) Foreign patent life minimum (in years) Foreign patent life maximum (in years) Shipping costs included in costs of goods sold Research and development expense Impairment of intangible asset Inventory Raw materials Finished goods Inventory gross Less: reserve for excess and obsolete inventory Inventory net Reserve adjustment for excess inventory Property and Equipment Office equipment Production equipment Leasehold improvements Property and Equipment Gross Less: accumulated depreciation Property and Equipment Net Depreciation expense Long-Lived Intangible Assets Licenses and amortizable patents Unamortized patents Accumulated amortization Patents and Licenses, net Patent and license amortization Amortization of licenses over economic useful life, minimum Amortization of licenses over economic useful life, maximum PSRF license fee PSRF license payment due Impairment of intangible asset License acquired for stock, fair value Annual aggregate license amortization expense Patent amount capitalized and amortized Executive compensation Royalties Other accruals Total accrued expenses Debt Instrument [Axis] Notes payable Monthly due on note payable Discount related to beneficial conversion feature Convertible to preferred stock, price per share Convertible to common stock, price per share Interest percent of note payable Due November 2013 on note payable Due May 2014 on note payable Promissory note amount, instant Promissory note term in months, duration Interest rate of promissory note, instant Line of credit arrangement amount Interest rate of line of credit on top of prime Line of credit amount oustanding Mature convertible notes payable in aggregate Number of convertible notes payable outstanding Amount of June 30, 2013 note payable Amount payable at August 31, 2014 Amount payable in November 2014 Amount payable in March 2015 Interest rate on June 30, 2013 extended note Amount of February 18, 2012, notes payable due March 31, 2014 Amount of February 18, 2012, notes payable due June 5, 2014 Interest rate on February 18, 2010 note payable Debt converted to Series A preferred stock, June 30, 2013 maturity Debt converted to Series A preferred stock, December 31, 2013 maturity Price per share of debt converted to Series A preferred stock Accrued interest converted to Series A preferred stock, June 30, 2013 maturity Accrued interest converted to Series A preferred stock, December 31, 2013 maturity Price per share of accrued interest converted to Series A preferred stock Amount of August 13, 2013, notes payable due August 13, 2014 Interest rate on August 13, 2013 note Convertible to Series A Preferred stock for August 13, 2013 lender, per share price Warrants issued to August 13, 2013 lender Exercise price of August 13, 2013 lender warrants per share Discount on August 13, 2013 lender August 13, 2013 lender agreement classified as reduction in debt August 13, 2013 lender note secured by property, value Mature note payable due on demand Mature note payable with extended maturity date as short term month to month Warrants issued in consideration of extending maturity date Value of warrants Gain on extinguishment of note License fee owed to PSRF on exclusive license agreement Upfront payment on $150,000 license fee to PSRF Due fourth quarter of 2013 on $150,000 license fee payable to PSRF Due second quarter of 2014 on $150,000 license fee payable to PSRF Interest rate of license fee payable to PSRF Amount of note payable due on June 30, 2014 Amount of accrued interest on note payable that was due June 30, 2014 Interest rate of June 30, 2013 extended note Warrant granted to note holder to extend note, amount Warrant exercise price per share Fair value of warrants granted to note holder Convertible price, per share Discount for the beneficial conversion feature of the convertible promisorry note Loss on cash sale of note Convertible promissory note amount, instant Convertible promissory note amount, duration Convertible promissory note term in months, duration Due date of convertible promissory note Interest rate of convertible promissory note, instant Interest rate of convertible promissory note, duration Convertible price, per share, instant Convertible price, per share, duration Convertible price, percent of market trading price Period until Convertible note is convertible Discount for the beneficial conversion feature of the convertible promisorry note, instant Discount for the beneficial conversion feature of the convertible promisorry note, duration Warrants granted for promissory note issuance Warrant term, in years Warrant exercise price per share Discount on granting warrants Beneficial conversion feature amortized in 2014 Debt converted to common stock, value Debt converted to common stock, shares Expense for consulting by affiliate Amount of accrued compensation owed to CEO converted to common stock Common stock issued to CEO for conversion of accured compensation Share price of common stock issued to CEO for conversion of accrued compensation Discount on shares issued to CEO for conversion of accrued compensation, posted as period expense Promissory note due to affiliate, amount, duration Promissory note due to affiliate, interest percent, duration Promissory note due to affiliate, amount, instant Promissory note due to affiliate, interest percent, instant Promissory note due to affiliate, interest accrued Promissory note due to affiliate, converted to Series A Preferred stock, per share Promissory note due to affiliate, paid in full date Promissory note of $40,000 from a board member, maturation date Promissory note of $40,000 from a board member, vesting date Warrant granted to $40,000 note holder to purchase shares, amount Affiliate purchase of Series A Preferred Stock, shares Affiliate purchase of Series A Preferred Stock, total price Affiliate purchase of Series A Preferred Stock, price per share Risk-Free interest rate, minimum Risk-Free interest rate, maximum Expected dividend yield Expected stock price volatility, minimum Expected stock price volatility, maximum Expected term (in years), minimum Expected term (in years), maximum Weighted-average granted date fair value OptionActivityAxis [Axis] Number of Shares, instant Number of Shares, duration Exercise Price Range, instant, minimum Exercise Price Range, instant, maximum Exercise Price Range, duration, minimum Exercise Price Range, duration, maximum Weighted Average Exercise Price, instant Weighted Average Exercise Price, duration Weighted Average Remaining Contractual Life (in years), duration Aggregate Intrinsic Value, instant Aggregate Intrinsic Value, duration OptionExercisePriceRangeAxis [Axis] Number of Shares underlying options Total number of option shares outstanding OustandingWarrantsAxis [Axis] Warrants issued, shares Exercise price, per share, minimum Exercise price, per share, maximum Exercise price, per share, minimum, instant Exercise price, per share, maximum, instant Expiration date, earliest Expiration date, latest Warrants outstanding Warrants issued Expired warrants Exercised warrants Preferred Stock Shares of preferred stock designated as Series A preferred stock Series A preferred stock par value Liquidation preference per Series A preferred share Basis that Series A Preferred stock is convertible into common stock Series A preferred stock issued for cash Cash proceeds from issuance of Series A preferred stock Note converted to Series A preferred stock Note interest converted to Series A preferred stock Total Series A preferred stock shares issued for conversion of note and related interest Series A preferred shares converted to common stock Common stock issued for conversion of Series A preferred shares Non-cash deemed dividend on the Series A preferred stock Series A preferred stock issued in exchange for conversion of note payable Series A preferred stock issued in exchange for cancellation of note payable, instant Note payable amount cancelled in exchange for Series A preferred shares Note payable amount cancelled in exchange for Series A preferred shares, instant Accrued interest amount of note payable cancelled in exchange for Series A preferred shares Interest rate of note payable coverted into Series A preferrred shares Maturity date of note payable coverted into Series A preferrred shares Series A preferred stock issued in exchange for conversion of accounts payable Accounts payable amount cancelled in exchange for Series A preferred shares Series A preferred stock issued for consulting services Value of Series A preferred shares issued in exchange for consulting services Series A preferred stock issued Value of Series A preferred stock issued Number of investors that bought Series A preferred stock for cash Common stock issued for consulting agreement Common stock issued for consulting agreement, instant Warrants issued for a common share per share of Series A preferred stock owned related to anti-dilution feature of the Series A Preferred Stock Warrants issued for anti-dilution feature of Series A Preferred Stock Warrant term Common stock issued to affiliate in exchange for accured payroll Common stock issued to affiliate in exchange for accrued payroll, value Common Stock Common stock issued Fair market value of common stock issued Common stock issued upon conversion of convertible notes payable, shares Common stock issued upon conversion of convertible notes payable, value Convertible notes payable converted to common stock Common stock issued upon conversion of convertible notes payable, interest accrued Common stock issued in exchange for license agreement Value of common stock issued in exchange for license agreement Common stock issued for employee agreement Value of stock issued for employee agreement Common stock issued for vendor consulting agreement in 2013 Common stock issued for vendor consulting agreement in 2013, value Number of common shares rescinded from employee and stock options granted instead Value of common shares rescinded from employee related to stock options granted instead Common stock issued for employee bonus Value of stock issued for employee bonus Value of stock issued for consulting agreement Stock issued for services, value Stock issued for services, shares Common stock issued for future services, value Common stock issued for future services, shares Stock issued for accounts payable, value Stock issued for accounts payable, shares Stock issued for accounts payable, amound owed Gain on settlement of shares issued for accounts payable Stock incentive plan Common stock issued to employees as performace bonus Value of performance bonus Common stock issued to employees as compensation Number of employees who received common stock as compensation Fair market value of common stock issued to employees as compensation Common shares reserved for the 2010 Stock Incentive Plan 2010 Stock Incentive Plan increase in shares reserved Annual increase in reserved shares of the 2010 Stock Incentive Plan Minimum expected volatility assumption for Black-Scholes option pricing Maximum expected volatility assumption for Black-Scholes option pricing Minimum risk free rate assumption for Black-Scholes option pricing Maximum risk free rate assumption for Black-Scholes option pricing Minimum expected life assumption for Black-Scholes option pricing model Maximum expected life assumption for Black-Scholes option pricing model Authorized shares underlying options available for granting under the 2010 Stock Incentive Plan Shares available for purchase from exercisable options The weighted average fair value of stock options granted Weighted average exercise price of stock options granted and exercisable Aggregate fair value of options vested Unvested options Options forfeited Value of options forfeited Number of options exercised Number of options expired Aggregate intrinsic value of outstanding stock options Aggregate intrinsic value of exercisable stock options Unissued option shares available under the Plan Total unrecognized compensation cost related to unvested stock options Weighted average period to recognize compensation cost related to unvested stock options (in years) Warrants - Consulting Agreements Number of common shares underlying the warrants issued for consulting service agreement Number of common shares underlying the warrants issued under debt agreements to raise capital Minimum warrant exercise price Maximum warrant exercise price Average term of warrants (in years) Exercise price of warrants Term of warrants (in years) Special conversion price for options and warrants if holder commits to exercising by July 31, 2012 Warrants exercised at special price Proceeds from warrants exercised at special price Cash received from exercise of warrants at special price Warrants exercised at special price in exchange for short term notes with interest Term of promissory notes Minimum interest rate of short term notes issued for warrant exercise at special price Maximum interest rate of short term notes issued for warrant exercise at special price Weighted-average Black-Scholes value of warrants granted Common stock granted quarterly to CEO per employment agreement, shares Common stock granted quarterly to CEO per employment agreement, fair value Common stock granted quarterly to CFO per employment agreement, shares Common stock granted quarterly to CFO per employment agreement, fair value Common stock issued to CEO for settlement of accrued compensation and accrued expenses, shares Common stock issued to CEO for settlement of accrued compensation and accrued expenses, fair value Value of the common stock issued to CEO in excess of the carrying amount of the liability Common stock issued to cancel accounts payable for services, shares Common stock issued to cancel accounts payable for services, fair value Value of the common stock issued to cancel accounts payable for services in excess of the carrying amount of the liability Units available for sale in private placement Shares sold in private placement Cash in from private placement Price per unit Shares per unit "A" warrants per unit Exercise price of share related to "A" warrant "B" warrants per unit Exercise price of share related to "B" warrant Common stock granted to third party in consideration for an Assignment and Assumption Agreement Value of common stock granted to third party in consideration for an Assignment and Assumption Agreement Square feet of leased office and warehouse space Monthly rental rate of office space Period of office lease Deferred rent accrual Future lease payments Rent expense Cash proceeds from issuance of Series A preferred shares License fee incurred Outstanding royalties owed on license fee Common stock issued in exchange for license fee debt Common stock issued in exchange for license fee debt, value Gain on extinguishment of accounts payable Due date of convertible promissory note Discount on granting warrants ConvertibleNotes5PercentUnsecuredConvertibleToPreferredSharesMember ConvertibleLongTermRelatedPartyNotes0PercentUnsecuredDueMarch2015ToCommonSharesMember Assets, Current Assets [Default Label] Liabilities, Current Capital Lease Obligations, Noncurrent Liabilities, Noncurrent Liabilities Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Shares, Issued IncreaseDecreaseGainOnSettlementOfAccountsPayable Increase (Decrease) in Prepaid Expense Increase (Decrease) in Other Current Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, Policy [Policy Text Block] AccountsReceivablePolicyTextBlock Inventory, Policy [Policy Text Block] Schedule of Inventory, Current [Table Text Block] Inventory, Net [Abstract] Inventory, Gross Property, Plant and Equipment, Gross Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Accumulated Amortization Impairment of Intangible Assets (Excluding Goodwill) Notes Payable [Default Label] WarrantExercisePricePerShare PreferredStockAbstract CommonStockAbstract ConvertiblePromissoryNoteDueDate DiscountOnGrantingWarrants EX-101.PRE 12 ergo-20140630_pre.xml XBRL PRESENTATION FILE XML 13 R39.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 8 - RELATED PARTY TRANSACTIONS (Details Narrative) (USD $)
1 Months Ended
Dec. 31, 2013
Notes to Financial Statements  
Promissory note due to affiliate, amount, duration $ 40,000
Promissory note due to affiliate, interest percent, duration 0.00%
Promissory note due to affiliate, paid in full date Mar. 31, 2014
EXCEL 14 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0!(8>].!`(``)T<```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F=UJVS`8AL\'NP>CTQ$K MDKRN&W%ZL)_#K;#N`E3K2VQB2T)2N^3N)SMM&25+"0WL/8E)+'WO$X&?`[^+ MJ^W0%_<48N=LS40Y9P79QIG.KFOVZ^;;[)(5,6EK=.\LU6Q'D5TMW[Y9W.P\ MQ2+OMK%F;4K^$^>Q:6G0L72>;+ZSLFFGO^Z[1*9/R>VN>I

$LJ\DK,5=SI@<^J+QK+/D/F0#:?RL7E'P`` M`/__`P!02P,$%``&``@````A`+55,"/U````3`(```L`"`)?]=J>*V?5@^@8B)G:13'&HX<85?=WFQ?>*24FV+7^ZBRBXL:NI3\(V(T M'4\4"_'L)MI<3_3_ MMCAQ(DN)T$C@\SS?BG-`Z^N!+I]HJ?B]SCSBIX3A363X8<'%#U1?````__\# M`%!+`P04``8`"````"$`)NK?!#("``#0&P``&@`(`7AL+U]R96QS+W=O7 M3Q_N3!%3U375ON]":8XAFL?U^WF]*,SXU34[P&@&(3=H`0V M*,\VQ1Z:8C8-A&$GSI0W]NI_N/5/````__\#`%!+`P04``8`"````"$`_"Y. M?#@$``"8#@``#P```'AL+W=O*][?( M'TE,Q6P1'!-J%3P8S>;>3+$Z1FH1+"!G\NVO9ZBP;1RNUE?8(`\]3_^Z!VZ_ MONUS[5]>U5E9C'7SRT#7>+$N-UGQ,M:7=/K7M:[535ILTKPL^%A_Y[7^]>[/ M/VZ/9?7S1UG^U$"@J,?ZKFD.-X91KW=\G]9?R@,OX,JVK/9I`V'U8M2'BJ>; M>L=YL\\-:S!PC7V:%7JK<%/]CD:YW69K/BG7KWM>-*U(Q?.T@?3K77:H];O; M;9;S5;LB+3T;_ENI:G=4,V6<,W8WT(87GD)R>JU\/]:Y;#U9$]L'7C MKEODHM(V?)N^Y@V%Y7VH@U^68UFN^*>P8I7Q8_WK)A%J;T]9L2F/XJ]@[7L7 MV9#`45YZRC;-#JX/!H/NW"//7G;-QTF0-Y"^=!">(X]:(9?WX0B#2C%2-%GS MSH*B=3\KH83"]0!69NI:=9/!CRK8F")QK.)'81+-@HE'R83=>S,O]`E+'@FA M"9*PD(1U@01;I$C%1BK2Z]Y$$@KYS$E($Q9-6;0@2,5!*L[_YM*I")&$1CY2 M`=\[4X:7J8"?G;X54KCXG$T:4,)-%\8,7!O]X-(A"YH43 MX4KL492+@V6NE3(62Y;SN1<_2T>"AS"8!KX74H9EH/T[:T9*&9L%X0JJ$\7/ M^,81NM$<*.]TV"(6B=-GN0;R]S)8B#HCF2$T3?=\\PQ8:<>0+0`0@8=P8A;X M)$Q(PD+,R?"$^S-JI8[+/-^/EX`^^;Z0&C@13+UY!JP4N&+BD$`ZS][][.3Q MF';S#%1Y]S6+R4QVWL(3EM#8"Q//IP'.`O-NGJ$J=4:2[F^/T6Q"XH0)5T%M M0J98!Q-OGK$J=F]JSCYG,QM)8:VE[XL34NAM=2PWM.OV)A&&-+C?&G)E"(8(:M"QD^616&N-V% M\X;E5C(P@A"H"JXQ4A"@[GLSV5"ILL93)H5-#NJNX4)A$"MTS-TP=J. M0.N$P`M1!GL[(1N3"($J(XSRA#=IEF.6;_& MM(.1AD"M`[OO`VE?.(4@;*3?2>SCS=C!1$.@UHF6%%X]PTD0/K`G+P99>%&9 M<%PQ/'X<-="]!F&@'0PT!*J$>G=U7#(7U]Y1$VTJMG585Y.BE3F810@@(4/. M)OAZ6:?Y&CZKQ$%\E\AR&A\?E7?_`0``__\#`%!+`P04``8`"````"$`M+UB MC^8%``"%%P``&````'AL+W=O]FZE/>ETNH?7E)`$;0@1T.WNM[\Q)L$S;!/:%VV# M?Q[\]XQG)G[\\+T^6M_*MJN:T\9F*]>VRE/1;*O3?F/_\_>GA]"VNCX_;?-C MQ#WY_7CM,5A[+.NU5S+D\PLFO: M.N_A8[MWNG-;YMMA4GUTN.L&3IU7)UM;6+=+;#2[7564:5.\U.6IUT;:\ICW ML/[N4)V[B[6Z6&*NSMNO+^>'HJG/8.*Y.E;]C\&H;=7%^O/^U+3Y\Q%T?V:(R=RP-+3X[8"!6K;K;;<;>R/;)UQSW:> M'H<-^K*EZYOZ/PVQT90VPDBQ-1B\"-*OOTI\2R%(4T8^*BL; M6]H6++X#MWQ[DNZC\PUVLAB1^"<(PTAR0=2^*;/IY<%DEDS)+H1R&BBZRH(- M,67]W#^7U2M8K?[RWE@_`-M7.9PL=4Y(@J1SA!#9G#",(#G>>^0H&`++6+WT M\/)CC0@#\3&1W"72NT1VBT#R8"'+O:7@C0U[=W6.%'CQL4;"(1"9*X*(Z$], M0'IA*+&!U!SG@>0!C3L38-)E8GH#4@9':KDR!1-EQ"VQ1H)!F1=PEX148H[S M2+@A$6:.1X'+R%FQ1K2L(!01V>[$'!="R`C/ M3\UQ)AGWB$,S!##._&D%2!BDL.7^4C`Y:.2]L48@6J[!2CR:W"72NT1VBT#R M5!]B9/O;:5'!Q&\DG&*-:+\QCWG3K@X)/#''0Q9*,C\UQSW?#(IULAXS$+ADV.2H''7H\W-U!^2Q<4C,[I.P/)(S"6($#`>$>^DB)"03P2QD2$B=/V031&" M/:AJ_'*!NB-``LG>QJK7NWK0#WU_EBP1`>5/"DG24HH1YGFN(._),.(+^*(Q MI2ZL4=7YY1IU5X`TDAB,F6:T$Q]\\(!+`CG!"(SS*")>2C$3!0P\A0M'AA$F MN(SH.`81<,W\XQRFPCVI6H`EHO4[0+R M)=GA6'T]@G@50\LR\Z+9;W#AD_'TUN1L'!PS56BX'TM2M7^Y)-TI($DD/\3, M["8>H@`Z%AQ6"28\"5&%B1033`I!BTB&D4`&1B;&"E7]7ZY0=PM((JS-Z9C1:KP&XK4UU(/2M?MAH7I=@$I(SDA M'AF]/J9*-ZD@R4C\-N].S-Z9C>:K^&_+NR-+=`I(UY:@QE6A&?^6!C.G* M>6%'"$@//5H;4T88$3"?[$]&&!&Y`9N*!]+)W]6_##3NI^FQB4?F5LJ\CZ3W MD>PF@D6^JX?A\QZ&%O!X9$R1M,5*1B8:TNJ#NX(^#?T0KZ4S?G*9/I84F,:Q M6@C#Y:'+%4U<2HO]R)AJ20U)[B/I?22[B6"1[^IHX,)1B33/9T0*0CPR.NV$ MOJ?:9EP1$H1(X0><-KQVP-=W;SYRGL$N`0]Y_OR MC[S=5Z?..I8[>)6[DE#_6WV-JC_TS7FXDWQN>KC^'/X]P'5W";>![@K@7=/T MEP_JSN]Z@?[T/P```/__`P!02P,$%``&``@````A`+0E9;!]!0``;QH``!D` M``!X;"]W;W)K&ULG%E=CZ,V%'VOU/^`>-\`-H8D M2K+:9#3M2JU45=WM,T-(@B9`!,QDYM_W^F,27\,8Z,LD#.?>'!]?WV/#ZNM; M<79>L[K)JW+M!C/?=;(RK?9Y>5R[/_YY_#)WG:9-RGURKLIL[;YGC?MU\^LO MJVM5/S>G+&L=R%`V:_?4MI>EYS7I*2N29E9=LA+N'*JZ2%JXK(]>9H]5.E+D96M3%)GYZ0%_LTIOS0?V8IT3+HB MJ9]?+E_2JKA`BJ?\G+?O(JGK%.GR^[&LZN3I#.-^"\(D_<@M+CKIBSRMJZ8Z MM#-(YTFBW3$OO(4'F3:K?0XCX+([=798N]^"Y8[&KK=9"8%^YMFUT;X[S:FZ M_E;G^S_R,@.U89[X##Q5U3.'?M_S?T&PUXE^%#/P5^WLLT/R&J!(\B8^K_F^/:U=&LU8 M[-,`X,Y3UK2/.4_I.NE+TU;%OQ(4J%0R"5%)X%,E">#KR&"J@N'S%CPC)$(!W\$BNH\*,8)AZ8S&32T/ MPLP88P8UB;&I9D,@CK!V=(YVU3@8<^NH)B&14(VPT&"^D[=#0U3$*,*,QJG& M@S`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`7;X>`QDA7]<_:'C?**GJLYF#ZGTV")9ODG^0$?ZA M,%*^V(\Z'JP`5OGX0Q]]4?#>-RR?B#(7KWE\4R!;]5DA2#XZR3H$&O/K]#Z% MD?)%GB(@XC" M2/78/`YC<_>"$#2FD=;=,3D8@%F"P_9+>12>8A89SWVV"M2OD%S!5@CF.JA0?]XNL)7NQD\&3_OMY.4L_3,>U[&M55C.*+)G7O7VPKN]5>;EH?2O)DNL9 MUX-QMJ]F5?YENO)_K__^\_)I.]_=DVEZ$BA M(7*TG8OAP:GSGG5OCFD<[H4NYVQ.40K9BV%=9:Y0<=)HV,>CM3<;]O[C8EX] M+N*89\.#^KLGZ^8^U"[[-'(7P_G^[(_VXYU&%A7$WH;QLD?@3?;_NZCW8-_"0IG MA=*M^PA,'.E@'HV/LS>S/SNF]7[R8+AU:)'?L,KA5\-T]]"C()/)Z;[2WCY# M!>`H72Q_:D"/&#_O_S^M@W>JREHAHQ<5305<>C-=KV7YDK*T_W`]^[+FD!I( M<9%<(*)![8.XFLGG]&+I3U3R#Y7?,NGKDN7MNG=3P_",UQ?'_I1@[D'-W9OA MSV2UHH'RHX-X)+]@<,S3Y@:G%, M*^6B1%,D-"6*M$0$1C7*M$4&RW1$!-6E*Q)8I"R9S2#3BMDL!T^-^'S_R%Y^,3][^?G?3V@EG$,5ITO)8IF%4<@\9]G8+9B(R61_79IF!V<0SR M!6-IH,"#88=I>=0R%O@R&8KQJI8O1/N:Q9A5A&+B\9W+7BVCNU3@#:\7?3+2E=9)H<*)T7\;!&C5:OID8;86C6A'- MH'9BM!..Y@I%M#;L)H=[/)S0\CY)#$AB2!(CDAB3Q(0DIB0Q(XDY22Q(8DD2 M*Y)8D\2&)+8DL2,)QFB$]A>C#<8"AR7,51;8+`D)O):$!(:+1R*9")!()O*_ M!VKDPLDOA3,2\GR-,SR;:$JQB#)O/1POZCC%-W@8CE\EM"9)M$BB31(=DNB2 M1(\D^B0QX`3O3K00&H9C^;*BH`?O*!POP9NH:&8?A\-J3L/Q"8_#\:NAF)+$ M+'R/G"X\T>?A>%[1=?1\6X3C.:V`U[C+3RD+#!/['1B@6\" MZ^;S:"Q8X!I<.))7X"W97^05OQ3.*V@RUS@#7??5;*R31(,DFB31(HDV271( MHDL2/9+HD\2`)(8D,>($GQ1HO3Y.B$U(Y2E)S$AB3A(+DEB2Q(HDUB2Q(8DM M2>Q(@C$:H9W&:*LQVFN,-ANCW<82[1;)386_RDU^*9R;T#RO<28I-Y%$@R2: M)-$BB39)=$BB2Q(]DNB3Q(`3Y?NW4B6#UXG#Y/"(U!^3Q(03/+.A9^$T(38C ME>7O@S(EO?D-S?YF"J:5@H%? M@OTV)=ZK$V7R&557PG\YH7;=/R[1BY90,N@=6)^(#W!<0>^RAA0PHH`Q!4PX MD##V4Y*843>94\""`I84L.)`0CO6)+&A;K*E@!T%,$82@1L?LUN85:R.)="T M8\B+H@(RH@@@%XH`LF`8X+F*;[7@>P@NIO-NULWSV97V]H>_C4*#)/&\^GN+ M1\[_:0U=KZD5>,SSP*P(^-FO)M#PWFWKJYT-H]P*R53A+6K MP_=T\!//OMUW-+S9'NS%N'\\P=X;$W[24S(`'VW;>YSX-WCNYGG]'P``__\# M`%!+`P04``8`"````"$`]N$R??P(``"F/@``&0```'AL+W=O)3D:X_M%6JW.V7TFX"1H M`"-,)C/?_E2[FTN7/?T/S,,D,3\7IJNZL0O\^.?/[:;SHSA4ZW+WU+5[5K=3 M[);E:KU[>^K^_5?PQ[3;J8Z+W6JQ*7?%4_=7477_?/[WOQX_R\/WZKTHCAV* ML*N>NN_'X_ZAWZ^6[\5V4?7*?;&C1U[+PW9QI#\/;_UJ?R@6JWJG[:;O6-:X MOUVL=UT9X>'PE1CEZ^MZ67CE\F-;[(XRR*'8+(YT_-7[>E^=HFV77PFW71R^ M?^S_6);;/85X66_6QU]UT&YGNWR(WW;E8?&RH=?]TQXNEJ?8]1^-\-OU\E!6 MY>NQ1^'Z\D";KWG6G_4ITO/C:DVO0`Q[YU"\/G6_V0^Y,^OVGQ_K`?K?NOBL MKG[O5._E9WA8K[+UKJ#1ICR)#+R4Y7=!XY781#OW&WL'=0;^<^BLBM?%Q^;X MW_(S*M9O[T=*]XA>D7AA#ZM?7E$M:40I3,\9B4C+Z.)-;")=UZ*ZABL13R6/_!\V:I3)NFYGJ9GXR8I*(P)[<0/^?`T]L?1__1$[[!'Q#R#=$ M?$/,-R1\0\HW9'Q#?K6A3Z-['F+*G#;$[C6NW$#!SR,PFLST M(9BWF*FE&Z]I'%WX33$:LP0%;88=3=ABIBQI49MAQQ.WF8%^S$F;&>HF;3,C MW61M9JR;O&D&ET'64DX3Z8:4"TUK_E6&!_8E<#T/7&EH2;U4@7YT%"/W6IG"[)G/+54AI3PJ'PH/"A"*`( MH8BDF-;O"\[(LEAQQS!"A`+G6AOXPY%%Z+F+(%VF\Q^O,$4(101%#$4"10I%!D4.0F MH:6>3D;O2+W8BZ5^QJ:`*XTI]5!X4/A0!%"$4$12V`.[GO!6C[WWQS!"`B*D MX/$,/D-N$EK*Z9Q62[EYE@O-4\U>OBN-*=50>%#X4`10A%!$4,10)%"D4HSK M-K9V:PKC2GM4'A0^%`$4(101%#$4"10 MI%)9RSOYFDN-,\W.SA7&E.^H?"@\*$(H`BAB*"(H4B@ M2*60T]RV)R/V'IG!"+E):.FVZ7SMCGE>[\83SRXW785,F M'P<),`DQB3"),4DP23'),,F-1*\"T;*Y?;47+;W&]&<-!5)C$B@R4Z?AK$)#'"'"),8DP23%),,D-Q(] M]:*S_CD_T+J99M(G_RLM>:*SWW9Y*!_`-O6> M5"%`XN$HOB)7_1+VOA3@("$,$N$@,0R2X"`I)AE\GMP81"\!T2JZ+@%P)B@[ M2WKJ+^\W\D-;V]1^4JF'Q,-1?$P"17Y[,0"/(\)/$F.28))BDF&2&XF>>M$V MND[]US[1LV6W22\!MO"Z"AG.G^:8>)CXF`28A(I^[F&]FW[M,+;8@+H*71?,V&*7F/,6Q`K/P\3'),`D MQ"3"),8DP23%),,D-Q*]$-H:B+B-X#0;B&.+O5F["ET7`LOQ'!,/$U^1W[<1 M--#21L#/$6$28Y)@DF*289(;B5X!M/PWWCN^4`%B-[X4\&M)1R)C!4#BJ2@R MO9/)<,HO'_#3!)B$F$28Q)@DF*289)CD1J(7@>BCW7X"X.+ M?PK)]+6T<.8ZJ+\`C1V6@F8 M+Q\/@3I;FD;VKQ;Y."V(2:>(NJC`V?";P;P<8P` MDQ"3"),8DP23%),,D]Q(].3?US)T6EJ&-EO3784,4W..B:>(.G,8COG7IWP< M(\`DQ"3"),8DP23%),,D-Q*]"$37[(X3/]ELTT_\V,KJ.A+)E7TP:'S>-5?` M4"4>)CXF`28A)A$F,28))BDF&2:YD>A%<%_[D.Y(;9X"-KI!$LDY[#CC$?_& MS%R%,5:!#&(@/HX28!)B$F$28Y)@DF*282)N&Q9):A\Z607RMF!Y4^6V.+P5 M\V*SJ3K+\D/<\NO0EV_.6\^W(W]SQ/U];+MK/]#]C[2]?WZ`[A+>+]Z*?'%X M6^^JSJ9XI9!6;T+G90=YG['\XUCNZULY7\HCW1]<__I.]X,7=`>EU2/\6I;' MTQ_B":81C%&HN6ZD&V5XU\_ES>W&%G'VH(UNA4Y?A$6W\\_?ICMM%G;6@B'@*&U M.:Z=ZZ:$6%X+Q6RD.]'"EU(;Q1P,345L9P0K^DFJ(4D^E),5)\^E2U MVK!5`[F?Z8CQ`W<_.*-7DAMM=>DBH"/!Z'GF.W)'@&D^*R0D\&5'1I0Y7M#I MPQB3^:ROSV\I=O;D&=E:[SX;67R5K8!BPS+Y!5AIO?;0I\*_@LGD;/:R7X#O M!A6B9)O&_="[+T)6M8/5SB"0SS4M7AZ%Y5!0H(F2S#-QW8`!N"(E?6=`0=AS M?]_)PM4Y3L=1-HE3"G"T$M8MI:?$B&^LT^I/`-$]52!)]B1PWY/0+!HEV>3V M"A82'/4!'YEC\YG1.P1-`YJV8[X%Z128#\F"CR'K6U$AHR=9>)8<3S""%!:6 M9SL?T\F,;*&F?(]Y"!BX#ABP/F`(^!E,@9%34Y?+?-#V8*_MR^[-/(07IT)I M?%DG?8^.!\/"G?A/Z9$W2`?,Z`23758&R&E"7_84VO+?2?VD'$.\H8)C>JQ@ M[WGX>UPL"R2_FP8/L#&[E@EOC%3 MR=:B1I0P-8XFD-R$HR$,G.[Z[;72#K9T_UC#"2Z@1>,(P*76[C#PA\_PGS#_ M"P``__\#`%!+`P04``8`"````"$`*L"$X8L"``!S!@``&0```'AL+W=OQJ;7G%:^2+9QFB1%+*GH<'"8ZVL\5%T+QA\4VTG> MV6"B>4LM\)M&].;-3;)K["353[O^ABG9@\5&M,*^>E.,))M_V79*TTT+?;^0 M6\K>O/W@PEX*II51M8W`+@Z@ESW/XED,3LM%):`#%SO2O"[Q/9FOU'9IL19 M$>63)",@1QMN[*-PEABQG;%*_@DBXJ`&D_1@`L^#"8'7*XNS0S$\A^(HG>8D M+_Z/$(=V?#H/U-+E0JL]@AT'P*:G;O^2.3B[6#((]]^Q0"NNYMX5^5)0&UC* MYV6>DT7\#/FS@V9UJ4G'BO6E(DL&20Q\`R2$=`KY/IP30Q,8#7`9.?KZ!E9! M9O6+]GF+$!A-=S^;$)0;O(UMZ-O,J:*8^U@E)9NGT#.U4<#LILN(H M&)%!>]>3.?$Y63&>>!4TA2&T^]<&+G<.QR.)0%PK9=\&[EX:_BZ6?P$``/__`P!02P,$%``& M``@````A`*K*F.SN`@``*`@``!D```!X;"]W;W)K&ULC%5=;YLP%'V?M/]@^;T0($`2A51-4+=*FS1-^WAVP(!5P,AVFO;?[QH' M`J1+\\*'?>ZYYYYK+NO[UZI$+U1(QNL(.]8,(UHG/&5U'N'?OQ[O%AA)1>J4 ME+RF$7ZC$M]O/G]:'[EXE@6E"@%#+2-<*-6L;%LF!:V(M'A#:]C)N*B(@E>1 MV[(1E*1M4%7:[FP6V!5A-38,*W$+!\\REM"8)X>*ULJ0"%H2!?IEP1K9L57) M+705$<^'YB[A50,4>U8R]=:28E0EJZ>\YH+L2ZC[U9F3I.-N7R[H*Y8(+GFF M+*"SC=#+FI?VT@:FS3IE4(&V'0F:1?C!6<4!MC?KUI\_C![EX!G)@A^_")9^ M8S4%LZ%-N@%[SI\U]"G52Q!L7T0_M@WX(5!*,W(HU4]^_$I97BCHM@\%Z;I6 MZ5M,90*&`HWE^IHIX24(@"NJF#X98`AY;>]'EJHBPEY@^>',E&X/GIV"X=\&!-7?]<'&#!-N4T[H3$T4V M:\&/"$X<")8-T>?760%S9XLIHC?J?SZ!09KD0;-$.,0(+)#0VY>-/_?7]@LT M)#EAMI<89XS8=0CMOJ:-S0)<>5MU6X.!_IV-ZC,;_1\B MXFN(D7I(<[MZ#8XP6'-6-@_'VK8&LVC/31@LE^/MW7#;M'10=-]2]Z?N.^P8P4S*=%O(,9L\37$*,Z@G$=U_5K\$2_ M/ST]!C/2/]:V^Q`!HUOG,3UT'=]WSP88\68RF]E349'3'2U+B1)^T%/7A>;W MJ_T/X<'5G^AD?>NL8%+`NMUOP*!N2$Z_$Y&S6J*29D`YLT*P5)A1;UX4;]J) MM^<*1G3[6,`?F<*LF5D`SCA7W8M.T/_C-_\```#__P,`4$L#!!0`!@`(```` M(0"-IE!5GP(```X'```9````>&PO=V]R:W-H965TW[V(%CTSI;GL2AP'$4:LH[+BW:;$/[X_WDPPTH9T%6EEQTK\ MRC2^6[Q_-]])]:0;Q@P"A4Z7N#&FGX6AI@T31`>R9QW\4TLEB(&IVH2Z5XQ4 M+DBT81)%12@([[!7F*EK-&1=<\H>)-T*UADOHEA+#/C7#>_U04W0:^0$44_; M_H9*T8/$FK?HS[Q@4&]ID M&["6\LFBGRK["H+#B^A'UX"O"E6L)MO6?).[CXQO&@/=SB$AF]>L>GU@FD)! M029(!<2\2P^.5P>D^&,9C<)!,\C@O_FTA].FXZCP00Q9S)7<(=AP8 MUCVQ^S>>@;(M2_;7LD`];,R]#7*A0&MHY?,B3Z?S\!GJ3_?,\I))AL3JDDBC M(Q*"OZ-)*-*YR3_W[&#.PM`=C$[FLI.N2V#IF>R<.:[LB-5;Q,`;+'2]-PN7 M&+3/O,7#E9>>F;BR)FF6)MD06+T!#)Q!>M<[L_#8V:AA2\\4SEF<)D66CIP- M@"1/HU-N`V>PP:YW9N&QL]'"2\]X9S=).DF*D;,!$!=Q&PO=V]R:W-H965TV04]42,:[#/N.AQ'M"EZR;IOA7S\?;E*,I")= M21K>T0R_4(EO5Q\_+/=-PT)[EG;*F`C:$`7\LF:]/+JU MQ35V+1&/N_ZFX&T/%AO6,/4RF&+4%HLOVXX+LFD@[V<_(L71>WBXL&]9(;CD ME7+`SC6@ESG/W;D+3JMER2`#778D:)7A.W^1I]A=+8?Z_&9T+\_ND:SY_I-@ MY5?642@VM$DW8,/YHY9^*?5?$.Q>1#\,#?@N4$DKLFO4#[[_3-FV5M#M&!+2 M>2W*EWLJ"R@HV#A!K)T*W@``_**6ZS:7&&P7MD\^=3-J-)A[(&L]B;V>RYM9X$:32N6UR0W/5<6CSE"D=? M4S.C20:N-/:BQ%[/K?4P\4\5M;A@N*[GTN(IU^2]:Z,Q7'X2!NF$Z_5UBRMY M#Y<6VUQQ..4RF@-7D*;3(&ULC)5=;YLP%(;O)^T_6+XO MWY`0A51-JFZ5-FF:]G'M@`E6`2/;:=I_OV,[36JR9=P$"(]?WO/Z<%C>OG0M M>J9",MX7./0"C&A?\HKUNP+__/%P,\=(*M)7I.4]+?`KE?AV]?'#\L#%DVPH M50@4>EG@1JEAX?NR;&A'I,<'VL.=FHN.*+@4.U\.@I+*+.I:/PJ"S.\(Z[%5 M6(@I&KRN64GO>;GO:*^LB*`M4>!?-FR0;VI=.46N(^)I/]R4O!M`8LM:IEZ- M*$9=N7C<]5R0;0MUOX0)*=^TS<6%?,=*P26OE0=ROC5Z67/NYSXHK985@PIT M[$C0NL!WX6(SP_YJ:?+YQ>A!OCM'LN&'3X)57UA/(6S8)KT!6\Z?-/I8Z;]@ ML7^Q^L%LP#>!*EJ3?:N^\\-GRG:-@MU.H2!=UZ)ZO:>RA$!!QHM2K53R%@S` M+^J8[@P(A+R8XX%5JBEPG'GI+(A#P-&62O7`M"1&Y5XJWOVV4'B4LB+1402. M1Y$03B M!^2@V3L-FR50J80M?%ZE4;[TGR'W\LBL+YG()3:71!R<$!]\G\)]-] M:7CL:]1(:\M87U&6A.-(-PZ0!T'P#V>9ZTS/AA@FS/6702\:.XS=;EI;QCJ\ M@78,LL0E-M<()[V9Z_&Z-PV/O8V>O+:,[;<0LLNRD34'B.=Y&ULE)9;;YLP&(;O)^T_6+XOQY"30JHF M5;=)FS1-.UP[8,`J8&0[3?OO]QD'#PCMTAN.KU\>OY\/;&Z?JQ(]42$9KV/L M.QY&M$YXRNH\QK]^/MPL,9**U"DI>4UC_$(EOMU^_+`Y/,M8 M0N]Y#PV-PFO&K`XL)*IE]84HRI9?\EK M+LBAA'X_^S.2=-[MS85]Q1+!)<^4`W:N`;WL\\I=N>"TW:0,>J!C1X)F,;[S MU_L5=K>;-I_?C)YD[QK)@I\^"99^936%L*%,N@`'SA^U]$NJ'T%C]Z+U0UN` M[P*E-"/'4OW@I\^4Y86":D?0(=VO=?IR3V4"@8*-$T3:*>$E`,`154R/#`B$ M/+?G$TM5$>-P[D0++_1!C@Y4J@>F+3%*CE+QZH\1^6!\-O$C9Q9$ MB^5[7,*S"YP[E\`)EI$?S?_/XII^M3'=$T6V&\%/"(8>D,N&Z('LK\%9YQ-" MRJ8W-K'7`H.DM,F==HGQ`B-H+J'(3]O(7VW<)ZA,)81N0]%BC:)KJ=EVYD'_N\'HNY>*T+.2`0DD=#V)%D.:O0Z'_C]? M`V38MC#!VWQ8B",9O1+-MR!E$P'X&]^GI`!;/D M>BHM'E.-!LG.:.#C/?)Q02$RWL+XF0Z,9 MT'GC#"H]=%H\IEM:7T-G-`.ZBRDRH;$NALYL7&9%KJC(Z9Z6I40) M/^I-R8>Y9Y_:_?(N:+<\^P+VJX;D]!L1.:LE*FD&33UG`;-`F!W/W"C>M.O] M@2O8J=K+`GY,*"R2G@/BC'/5W>@EV/[J;/\"``#__P,`4$L#!!0`!@`(```` M(0!UIOW?7@0``)<0```9````>&PO=V]R:W-H965TN#"CDYGIR;>R]Q^?A>Y,8;J5E&RY6)+,'N6DP'I=I MG-.2K,P/PLS']1]?EB=:O[(#(=P`AI*MS`/GU<*V67(@19E5-XK295.0V=IS`+N*L-"7#HI["07>[+"'/-#D6I.22I"9YS$$_.V05 MZ]B*9`I=$=>OQ^HAH44%%-LLS_A'0VH:1;+XMB]I'6]S6/<[\N*DXVXN1O1% MEM24T1VW@,Z60L=K#NW0!J;U,LU@!<)VHR:[E?F$%A%V3'N];`SZF9$3&WPW MV(&>_JRS].^L).`VQ$E$8$OIJX!^2\4MF&R/9K\T$?BW-E*RBX\Y_X^>_B+9 M_L`AW#ZL2"QLD7X\$Y:`HT!C85\P)30'`?!N%)G8&N!(_-Y\GK*4'U:F&UC^ MS'$1P(TM8?PE$Y2FD1P9I\4O"4(ME23!+0E\MB3(MSSLS^;WL+@M"WQV+,%D M%ENNJ['I.>;Q>EG3DP%[#Y2S*A8[&2V`6?CCPF M`=,91/EM'6"TM-\@,DF+V4@,O/<8#1&-$;X7]"PV*.YE@Y5#V9?#V:D38*%. MA%?(W<@;0RFX_YD&$8T17CCO,8H4<&VZ%`%>F<#>F^"%;L\KU4F,-\#X*B*Z MA5"T`-1M=&%4V0 MX@:_LSMX#Q>-057S;6P'6E9Z=D`DN,9`G?1'P'=W0 M2YASC!1]"`(^M/2VP`:M*YSU*Y<*6Y`J45M&=`$4X"M%$HG:?G?8FUFZUE#7 M*MM&V%0DQPIT)UN2;MP[[QO515'R!PH_<5$V"+60GYE;%R5(<5$5'Z%;$%7? M77T&C1O-N)BWH'/**+59IHR&N:.<(]$(IALJT'JH]8+>4,*32MM^D!4Z2F\) MA[6[U2]YNRFNY>(A2+7XK@XD'B,UQ>,2WX*ZG]=K_-5A59?6>:95>31N0>,R MWX(Z?1@YEC]Z+%,[$4;PV'DMS?]7/T*7&M(HF?06@S%6@J]GEH9W0^M<&51[ MM9;T2>9?ZD5::=P@"5(R?U3B+X*NU?B[FA"ZU(5&-?Y2B]$6$K5,PX5$_^B>M]5C(C)SN8ZE@S*`.U/%C*"TZKYEBU MI1P.A,W7`_P!0.#@`76>P8``'4?```9````>&PO=V]R:W-H965T"L8W&&`O(9.;OMYIJ M+EW@IC-Y2&+7Z>+4I>L`_?CQ>W&QOF55G9?7OW\KJ:WW.LL8"#]=Z;Y^;YO:P7M?I.2N2 M>E7>LBM8CF55)`U\K$[K^E9ER:%=5%S6KN.$ZR+)KS9Z>*A,?)3'8YYFO$Q? MB^S:H),JNR0-\*_/^:WNO!6IB;LBJ;Z^WCZD97$#%R_Y)6]^M$YMJT@?/I^N M996\7"#N[\Q/TLYW^V'BOLC3JJS+8[,"=VLD.HUYM]ZMP=/3XR&'"$3:K2H[ M[NUG]L"]C;U^>FP3]&^>O=6C_ZWZ7+[]5N6'/_)K!MF&.HD*O)3E5P']?!!? MP>+U9/6GM@)_5M8A.R:OE^:O\NWW+#^=&RAW`!&)P!X./WA6IY!1<+-R`^$I M+2]``'Y;12Y:`S*2?&__ON6'YKRWO7`5;!R/`=QZR>KF4RY19>]O;&MB`7-53YVU/H.8_K;U"9 M5&(BQ,#O'L-41#Q%!'ZH8GB'$46'$/HX(,?C..;KV]$58$%7U%OPC_"+,3=7 MO6X\1=``^13B[[:]&X4M=((Y6P'>V^"]3USHD=1%B($"]IB@OW(;8KR(X#J$ MPAXN8\Y>@"E[DMP(,6';.*[C^UN/E#T>(]B6.9[OJ_'Q,6+K.8$S`!3RL&W- MR0LP)>^I%XX0LVO).RMOJ#CF76_FJOD.YU#E+#:I!Z-0W^1B$>4^^,>^1\RV MY4Y:*M;8^+Q-R3,,@W&>S3B+190S:>0(,5V^`])+L=[,B3G<*3_#M918Q-T` M&9++^1>+:"RDK2/$0.OVVS;T-FI_Q088/L74XHAQ9"0)E39S[I](@A2([-8.,Z.Q)EK$*\8`KA"H2YC@)10Q`"9QX"RJ$: M`IV=#$'=9IX,SP4[)_9AO*G$A;*-B)O-(H9ZJ`8P7`$'J`3-3U"=D=\QJL2% MJ+V?.$JA2IPT=\00U&5^,D:IG:@#I_;047Z&RZD!";E[?T`HDFI`=)2*NWJ8 M5N,-'?K#/)%;>@9$!RZ?\70O'*&#HW`6-C6JIAH&G:<,0;BIF>\Y(=DSL8K8 M[0)G8-=&R27"QUN2?O"IE1!":$X=97-,W6=DD$<,0>,*$&;Q,H1K(6H(0O7, M0T"-'(<0^J2K(X8@.5+A6=V9=-`8P5@PA7#I9#X/:@1"^T81&`XF5$PUDHDX M(*C;WV2WQ$PUT\'+I=T@!I=HLUD,[2JBT3[I]$B"NA@VM)N(?4NJR:7=)`BB MSH9!S*@T?2Z)7`1U082D4#&Q^V17<6DW"0(ZXOW=Y(I5I!+T\2N2H#&)T)^4 M`SVI(-)X?,;3X$?9'"Y1;?UP;=$D#)K+2(+H8$1MT!EY;QSNU._1AOC'55B@ M+=`J;9^1N[C(1=`XL+I\$30F$3HD_N^6'K2 M@O@,:!@$2C.)UQ/F4ZA%JU,HG`Q/"9H?GCHC[XV+6]@C.JR?/"U:I>V[Y"8@ MDJ!Q8H>&%$&;4=S(\O4Y8YX:GSLA[XW+FB=J:;5]OYAEY M,CPE:'[[ZHQ<&N=KIV8=,.-^-Z0O5JD--!V>'H+NT-<8N5P)D/[UWM!Z*GVB MN(;TYY27#D\/07?H:XQ-83HC1[+ M%K8P2B3LT;[*,\-3([(Q'("*-IPMD3@=Q3NGP3VEC:>?>*Q79-4IB[/+I;;2 M\E6<;#)X#=!_VY^Z/KOMN6EO@$//6W+*OB35*;_6UB4[PE)GM8$&J?#8%#\T MY:T]-'PI&SCN;/\]P_%V!J=HS@K`Q[)LN@_BC*X_,'_Z'P``__\#`%!+`P04 M``8`"````"$`?#V'/N8#``"F$0``&0```'AL+W=O:^TXR5KMCZ9A;Y'FYP597/<^O_^ M\_1UZ7M<9$V15:RA6_^='ZB=<9G MK*4-_.?`NCH3<-L=`]YV-"O4HKH*HC!,@SHK&U]'6'4O-6V$ M#M+1*A.0/S^5+?^(5NJL>WYIO^:L;B'$OJQ*\:Z"^EZ=KW\<&]9E^PIT MOY$XRS]BJYM)^+K,.\;90!:L`(NTV10D*9-F]CAZV_G>R?IB' M?K#;J`+]5](S'UQ[_,3.OW=E\6?94*@V]$EV8,_8LX3^*.1'L#B8K'Y2'?C9 M>04]9"^5^)N=_Z#E\22@W0DHDL+6Q?LCY3E4%,+,HD1&RED%"<"K5Y=R-*`B MV9MZ/Y>%.&W]>3I+%N&<`-S;4RZ>2AG2]_(7+EC]2X.(":6#1"8(O)L@!"[O M+PYT(DK78R:RW:9C9P^&!:AXF\G1(VN((@5!`6\(`B5RS7>Y2"T%-(+4)7J%RN<$\3#'1!1$`^24#8'7/0"[:^O#:9Y"$E_@JRP>-255^41S&X:K/ M<93!?)S!]69^:)=@S$P0L\;$@^R2"V+$#)"A]OO,$HR9^YIJS1JC-2=)&/8U M&?'"L-GS2C#FG5_T:%Z-L5"XW68(Q,Y:L,6:PH<;"!_;V"**>\3H.TV<;$RAL?`% M%FYM9`2*X]!QB<;DO2P];2KDUC=C'B^629_>6+B3F\G']81[B85;^QEQ,C2% M_E3XT-*6L9SU2WICX4Z>1JZ96O]$-$6W=C7B9&L*_:GPH;&1VU9.G)Q-H1%U MVE?4Z+;VMLC)VQ0:D2=XT@U(3_H=:XN M6=MM2X^K1F0C6XG8XNT9WVB>VAL<&2' MO^N.'CDYFT*C84OQILV`+(3+X/<0"L?2<`;@`V/BXT:> MY"^_L.S^!P``__\#`%!+`P04``8`"````"$`1KU/=E4%```L%0``&````'AL M+W=O0V\L4>RK"U%F MKC17&HUF>288VRC&6$"VOY_3G`Z]X#CV2VRGJP]%]>DJZ+MO;\W>>ZFZOFX/ M2Y\L0M^K#F6[K@_;I?_/WP\WB>_U0W%8%_OV4"W]]ZKWOZU^_>7NM>V>^EU5 M#1Y4./1+?S<,Q]L@Z,M=U13]HCU6!QC9M%U3#/"SVP;]L:N*]3BIV0J#CQ5NNTMJM)M-75;W;?G<5(U\/[6-3WFO+VQ_;0=L7C'N[[C?"B_*@]_IB5;^JR:_MV,RR@7(!$ MY_>V_9)0G^LY;]@@B>*J5MQ941N(5NJ%5 MFZ;J7CH;*TZZQ:F@>LD4.:RBA&,D3+75V.2N,GR"=@U_)\?G>F-AORD,..B$ MT:NFV&&9TQ";GC1B8W]>&.=HWY:&3M=G!#&H$%@M"]T>R&T($7%,=(/:-)T@ MN)#F/!&X7B:E)F)?T7/BX$)Z\UPP]I^B9YJ_2&(^2U)B(EC, M(N,6;0VO2@@RCPCN1H3"H'8\TN(H]E5@ MC&C'E=W`4!BU:4_2LR%GZ5T5&A0?[TWK$VYH*,QI7T/USD)L]:2%.]8'3?K5 MJPQ%YS>]SPAT7&6%P8U!F=,$N3V<:(.W^4D3=_A%7[YI4;1^BYZ^@**'&%SE ME##'$W-5`\<3^EGN4B<[SC\4C&B[_82;&0ISVHS5(+*ZX6EH//S9PDG7-H3[ M@A=ZO"68(T@F7Y>GYZB$AV&:.-1S"Q+'*8LCW;TV/25X(-R\41ET<]@,\HCLMD-N8E*<0QM.+@"V@$QJ7/0S`49;[IN'&5J8P M^+(O3CV66HCHU&,IGG?ABW/@B#V&TQ;5RLL^RD:K"QI3FY9_M"05FB1GM18@']>T8Z_ MJ#7Y%+D&]_P(KFP9?%\2W@.&049;Q9)I9S58`!^G8;*TH",X"=U/-!"5&LWC+UH$80( M<&='N+BC4M)U\@_FXB=*5 M_PCISX](-D9F)K$=$V$P(#[8&SQ"CLX]7O8F85B#ZPS>XI.LLI]I9'Z&1,.# M%;&]1!C6X#G3K4EX[8+VR1HR'YQI)%4Y19^N0O/V]M7;ABE8V713$K9,63N5 M:236&QVH/\O7)<*P!KTRW9J$+6M60C*-:&MA)*U9SBX`AK'X/<8D;!F;F\_- M-**-S<)%$BQ,8&L`"4KC4P<9QA:FL6D-*H,L@U:)9QI)=*6A)`U"B]@:Q#Q( MD_F),"S*&7GV#KGN7 M[I'1%E,4AD%JO?SD_)59R>[WJ"=7A/ON-^3UONU*2$8@F\!?1[ MKZ>[OA"L4Y-JQP1,975:P5<8@3$6>`"7C(F7"_G],'S7;?X!``#__P,`4$L# M!!0`!@`(````(0!R`[(.XD0``&7M```4````>&POOB,A,1B8E5;N-@;>]2\R,TXIU^-CZ>3;5YVM]JLDFPRFP]'D]MM7'Z[>;NZ_2O)%.AFFX^DD M^_;58Y:_^OV;__I?OLGS14+;2?[MJ[O%8O:[K[_.!W?9?9IO36?9A"W7^6R>I]V]5V^^R4=OOEF\.9X.EO?99)$PC^1DLA@M'I/3B1N`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`Z:#P7R) MM*ZC1_\.$=N$NO<8$/8`>5/3R70!8_N.;+;)]"89HDYD4J#_F$4--V?$S'2S9_IX4AT7^3W&F0 M=+E@'T9_RX8H%LRWO[G=:![L' MH>^1]/30GDQ+1=5B#_-LE@U&'[,Q0I?>WLZS6SI+QB"'T3!=@`;EE8-S%EO;9<1X:.6\\Z0ART.KU>JWW0L2'W6]V#O=8N M$_`T:UY7/`7;NR1?7N>#^6AFBRHU4?SRX7"(:$TG\)V4R.9HD@P<'\9OLOEN MBU%'4C1&KO@E!')YOS1)28:.6^)7'),^S6#-;2K\:O3YO#Z>M`P76#5`7[88 M`1Z^6F-9EH]S)P4%_S_[9BD-S[Q:R$H+^@9A>*9-*W&,\^QK3TA$ MW+:*"IYZUBJ5P)K7/*W64V!5I`R#U6#YRN;VK[#^[T_.,/GG;Y/SBY/+PZM3 M<,&Z;>V]&/'7X`'06L998"TSP/H_#J^%S@>+_QDO]_+DAY.S#R?]^/>C\_Z5 MYOG]^?EQ/P&\',=O?']YWN\G%Y?G;T^OXF=^=6??)R?_<7%RUJ_W?S@T$Y<+ M5,IRS^;3^ZE$/NX*^WZ3Y7+E4`8W61U('$TG^7)LZ+3I\??9)),OH4'2X?UH M8GZ*U&0\DE,!YZ`)E`C3.EF#7-YIW6\OS]]7-C'NZ_SJ#R>7R>G9T?G[D^1U M($(-Y)U.5N!4W$OQV(.&^+G#4!Z*O?8OU0;Y'J\TP88`%1=CQP\8$O"($$2! M+>*^STZN$JUTW>\)#)RPO/?G9R#9P\N3^,5-@&[_]"@Y/#M.CD_??0#ZUBST M1O*ZO=7>K4WYQVQT>X<]!0H9S/>6IF(VZZ-=I_EH8-L\'(V7-(Y?:99&,7G_ MZOSH3W^`QT\N^^"*/W\XO?H)7''R]O3H]&JMWJT8J0LAW=,)[HV!I7CDPDBA M--8:*5/>2;]B(/.XGZH=\Z@G?L68./[Q.[SSR40\_5TZ3G&_6\GAO>''=)$< M5QR-FM_3T-+[6L^UE$;44`(M$8!*B')@S_.[X+C%\WU96[>$SV_+I,9@`<$J M0>GL&F_!+>JWZ:MY7L<9HC<$N7\<#8DC@/H<'EE,DVM4E"`L6LI!?VD[=!VN M]MSH5W4((EK^ZJF;CV$#083J`),JEO^W=]],K&<98&7VL2K[;29=[_7YN3ZD M<\7`H\8!V0N5I4/ M_;Q4O*27Y\E6ZZ4B!G7U\:OF]4R/__(%_@XDV=_LK9IMG\X^$ M//)?-:>R\6>.+-!5R,1S6M\9P%4"/C_>2O=AHK%(51E_I4'VB9"0TX(3,P5Q M2R9`).9O%7/Q`G_S+%LDXVE>L]]$EE>,<-IHA'OQ'.)F'@U%%KC6K+KH9R2L MJO]?:A`_N\OG]_*9+NL:^5*MDR2=S2NM9\LEFOQZ" MORP44GJ\$,CT21PM7.\)_RAB02A<(R>6OCO_ M<:VW7WFCZEKB01\>79W^<'IU>M*ON4^'P[\L\X5L=9Z`(XFG32<#LCF*ZYL" MTJ_ZM\!VLLS!GW(%"P^7@`!PM#&&?9P!-(&DPB]?0Y!""<8,!)\6SPQ/A]`T MY*NJE8E@9=S8MF@3S\VY>H7EC-][AS(U%S9E<57>?TDP\>@NG=P2R%U=NB4< MS%TE*FQH? M7"SG@SN%YPTL5?(A66]M\.LBR89[<$"&RD&'P*JO6@H#>:I#>=C:8^G@BQ)0J M?=:X-&0Y"'"'G$RMA_31`FLP^:3J+SWQ7CQ,,&?S@\^_Y$_*O]B]\XDF8!B5P7(0;QH"72U[T* M7QG/-;[4_W!Q\<["I(?O"!OUCXA!?;@\492FPCZG9V_/+]];_+0F#$703)F# M>`Y/=']V?E89H4(=XE=-W%T;^.@9I[09RT^J[..BE-Z5&(7@($J\Y&Y!ZBKG MQRL\)I[A(^M5MRY^[>S\ZB3I))O)^>7WAV>G_]UH:;&Z,C(=MSET(4-!V(LI M[J*R8^OMJ1_AGW__7Y\SAH5KB>.]3^<_D_=@J'[AN:AB!'="FGPPG5.2@*:" ME2;)'Y?CQZ1SH%PYJ;2\XFB9]G]->.Y5'U[KQ5UD^2SI0)- M-\GZI5E/YX/%5!WMVS+XW_7O)VA[3!K6',,_H=Y&=MZ%K\^6BO-G2TL9)7V* M/&3!*^OSOHM(\>1JZYH@0I:R0,!04)RT^7\JRU*3))L9C*8HB+) MYL5\=&T=B4P4/Z43MF@XRJQ^)%_.9CZN/%D9G9C^<#EPT1!U]&$"PAJZM(3M M"Q4U3ZT>IT8"UFQ!^+N]&,P`0C*7,[ M*P&Z`99"J\I:2B'66A0<2),'X#JB3'D3+PMVE\)I4X%5%4K+EP/]3_&85;"M M(L#P16(`8P?:4ZW3K>T-(G"7?H0?DSMXGUH8T9[Y4JPB:@=TS9YHJ_5GB:D- M:M^,IP\ATYROLK=G'-?/0[+(!G>3Z7AZ*V4:<(#?^2!H*XQ9L.!62JSL*#X317:Z=X=,1/XBN M%$=2KS=.AM,EUB2])O%BO.AJ7F#MJ=JAGI<028KT=JH%\=L@FZ,8#_4;!0GD MY6Q2ZFXP$K)T@BB^7C?)Y-KE*)#`LIE?BNCJD:"GN&1;FU!]M6$S\(5'X[&X M)%_>*-8.-;2*>ZHW;64VF[E(-;?@IS3&?+J\O8._9V11I9E5V57CE5.4^UP& M1QR\-#_L"=(P@T<(+MU`Y@VB05W^5/Z2PE(*0#2I='`W0KUHIV^HO;$Z(]0? MFWN?/FH-?IYT@XJX7BB_Y\LCG.0KJC57OC2'T!;T@WFI5F5WYW3,KCFB41JS M'.`U%`XA*H_J5G'&"M(66:BTR3,DP-Q%1TVSC(,4OQ);X`R-S8C-S55.XWWO MK>3TAK(G/Z6;T00`+V[QDY-LE3_*#`")DO1C.AI;\904`S_2;,@\C(50)QAY MV[>2#8Q`89>K%&I>I>1YO#0/A^7G"M8K_<+ZZ>ANA((A/XI6_TLV184/*0FR M\4*]!6?N': MJI"LSYWNN' M%U^9OJO/9E26L$M_$_Z7P39&6(H.;HJW!2YC\_700T,3@ER0(B@:O7_RR<,: M>/Y^9+4@AD[Z)T>&3="";\%ZB8J[;0`/F9)]Z9;++(R6]#?_`]MDBV=-JK9C M[$>LW"J_8RC\M"JKL8Y!B@M'V$+!`/0<^2"*T42B/LZP=$VR[73K"[?S9CFG M6N6.C2"V8?+&]JR(XFOQ%!!%.\24)SJ>,.;M@%38Z/D2-?V55VGH$LJN'*R? MSE!=("_:W:<3\+X"&JHPQ6#D@J60-4UNTA':/.BF0!`+C&'6&2$G^;2!H__$E`2="SF"ZVM:[!":V!Z( M^4Q?.\FM*H!L/,*".*OCMVVVQ(O&>GM2EPJ*\1H($;;5%%QM#A]<1Q2'&Y2I MQ7JOH"Y\@3TKU/YS`X8\.@2_%P"I*"M)FY?!O,*_8MK[]&<,Y*PXF!VHX>V1E$_5W.AO611R>V5EAH1/:')=&VY?2F>G M)<6-D`MV6)W;"H(+U>3)$(5I\"`TTE].'*7R%F*N($H.V`Q'T`#8JK`J1<_L M7D&SVM[B$)FF$@6<8U]F-KDO)6JGFPPQ"CD`3)G8]T6R%TF M!1XVNBBF9T'3!S.&$FQS>5`R9B0Q?@'"/?T2<-G@X36++^@8]MLQEOX"T5\; MJ`6-8\\M1X-1=`D0A%X5W!;?4(V013H*64&5NWH]-)?/[]P.@X7@3T@->6-R*TIZPPM/DC8V7N0AZ(.?Q1RC+1"6",G!(="+OJ'\QTTX,UHGB\V M1Y,65DS_4OB"4-[=%#R"*IL;(IPS6W0I4F#R),5EYYYD?&$'AIL,M5!44H&) M=%A#2@5@Q`0_DD'C9=$\^R34I,E,K_&N!/^*#FMTO*@>69)O;4>6OHE.?#:_ M5=-LBI(X"*@P8/1RNPYXEHYOC%C"UQ>VM/BGJ6"5YP=+]3&7&XA$^@;5.KT0=R)>3!T1,@GSV1EQA8X@"*F69N/\YTK8@61UW%*S_!P M#7#!0(I5BT77-MV1?.XUMS\)X_F,2@@QV4FPF%O?*;JD@$]29;[Z6ZS09-<= M)Y-9T=84Q'!,6.DB[N$"Q<+FKOF9-(;8$Q]1)ZWHN``3.*/P*998Q0H\*Y7% MZLXY-5%L'G7]`FMJPD)9,2PB(PD+-"(73>+&8F(2%*PL*00'`>G@D1+`F7GXYEJVTB M6XFCX*O**L:<02OB82)=11>`*S'4T`$LC/]05!%H526<:%B3BPBH M-P6984JVDK$R0@1P1;DY!:YP/2K`IH-@VGD$!AZY596MCMN5$^X8*W?;CI=- M*0]!',C;P#=U&J'^&OJ;XP8`3\=:E@HK%!H0PC:K<7_FV5]`2E)U5RS=;3.B MS!$S3R!M@)A&(5H1S`_QG,Z\AN^!+7'+P5DX*':6CU?$`("^<)C0TC%'KBI M>XPJ"XM."+.332:,C6C*9)O5=0$BYR^.YI@+U#B:0#]80$'(U;L!`VJT'[49 MD&H)0['6PN@IE#@A)'$MNOFXY3BK40H,(9I@3L0;Q9LZ#VP(2)BF1AJE!,T] M+QPU](/C'RE87S8%N8N"+9?M8*2I#!Y/BAA`,)'Q(%)YMZ0M9EI5_+`T2&BU M4IFM,4FI![2LT%X/ATM1!"OT0P&6C!,@MZ&V%2D.`,F)4]1'H6Y=N,GC$[TJ MM]2QWU;R5J$H]PS=6$I^X9U4M;HULLB*1%E"2L[`RC0KE#;7TE$9PGD8:2/8 M0G2_AS!M&$">FR4SZI05NX;7&,HI[H(Q=-2>_+EQRR1[J'3)N\_OA/2E/&PX MWAR5X%)+=08\X52#6.=Z.OW9D$ MK0ZB9%CC:@WY1*>0P7E>QH-ZV0N,&]-KUQ#G$@23!L;DHTV?.M]$OQ(4%ZF1 MC2;"[<(`&/UB1SP)UBW)6>"G!RKZ^C=MZ!4D63&_TZ' M"6_%_X@EIJ(-V>XR6ENR6`TD:X*1YG6C8*[*#IRZ->Q8B7T2Y%/1!>A22I-= M#>$H)Z#5:RYO"Z9L`R#C3'L8ZK31A,\ M+#/JHE/9C/@CP1\0[J,K3`&/!YXW10EG6JS1C#%->5PA"ZX<90LP5$5N_&$[ M!Q%=J8]\DQR%@?-,D16@8*8#U!;CHFU0O+:#E9FQ%[P+\*BJGYAKZ]5`E=TD M6J3HLI1$;0=1D_YQE1I*_.+C?6*J)HN*4J#:E8N47A'M/-8Q$/10)D*\;F4] M.6(4H!:RN#C4C"B9513%7A%M8.B@CX-NL(H?*C]8 M#"J/4`Y<1%AFQ92G7I/X0O`*`9B[@A?D<4,$D@P.CJ9SNI43KP;U&\9,W&+% M(,Q9U#%-&X(`+ITB3F63^G`H&=9 M!L03GOC=TIB5);-?+B)0OSKFG>/\6-C_O(2G0IF;VV3V_&,HD=!V0'Z29HX$ M+C'G8L@J-%`_B'S%HP/?^$YSNW^HL]=02\FZX<)T;K0 MF5\&S@530&;X7Q@/2,^A>4UAHLR2BE)%I#3,U^>@3,A*,DKR<`40'^]^6Z6F M;NUB*P+3UNB,=`]=*MI5GZGNPB)"&C[PJ7;.2PB>V:+*5XB?JJY"\I=&*;.> M;)8_65QJB]H1KC[RWC<+4?D.;@FDA<958Q$$8@5KIIUDBY3#U8Z M*]E<3@#XDO:AA0A7AQT[3&:-2B>$.:YF!('?Z,V[C+@78ZK_D@D,"HEB^CED MQEVZ>)4DZK3Z2Z_&&9?R=#%:[.3T5@5']0(2F,<_17WY'*&++KT>?:7AP6.Y M5`0A[Z&2,B(:LFHGEEWR7R;$ZI]>CV@R)&$,V'Z$*2`-(5B[28GE2&)TE+22 MPZ![%DKY92NA+8V=O4''L`LWHT]2V(3YO1(OP,+KT<>OV-)JOLEF98XYBD/[ MKTON:&"B@%DMBQ(M:K_QN-)LY&T!-$)0G7HMRYEX1 M\]!P4WU1F.+`2ZO]7*2?>.JGR4J<)[)T"2T0`N3Q<3M<"OYDR<5.X+,K@:!1 M+;!2I:49'+.[BA>$R2*+M);:@_="V@S;>?&B'313259504U9C(_C-IKQR?6#G1)!9*E&KR)*A?!#CO5C$+FXBR5 M$[@M%[=<\P=W$'D7U$)YU$CC<8D%I)4_ULU;OY$E+)H7&XQ#SYDA\U?=(G,: M"_8JME/L4+5W*^E[IS#0-6R5"Q_J]4HT%S6EWR45MZI2IVA2JD9&U0ED31S6 M7JSC!HA7=*2*1^GT6HPI77=#C\&&%9;5I(N(Z5.34TH!NU@!XVR\Q>JA)%NI M2OFD`B0R2JFFCQ).LSPZM&;1,T>+BBZ*EX4V]!Z*:PDO5U"J81)7Y%GKR>17 M^R)3@Z;TU2K(I(]#>(4>'%QM#;8T7E:!4M55Q9IZ=E[3N>^[_GYM!$\W#T,P M#V`D@`&A;*1`6`$%XF""M*USCZO`VHR3H50H'Q2SX9Z&V:X;74-J?60;QM(# M?G'6-V#$45@O>/M@`DT;A4$M1^K7N]K`>5P(D"N5,&M>[YA1HQTZ MVH/):S%JD469'2=![(9BY(67\100T2KZ,V++ZC'.9R. M(=@NW:0K?ACI=!)=%"V"LK"8+%MP#1(IJU4:UUL,CRZ'-A9FA]QE"'A%VBK% M*)7WF8N+ODL>W#\G:!M"Q&[3RZ@=L@D?N9*IL-[*"AIG.!_E/V_>J*2IB/*8 M76*6*W.S4M$KH9HER.IQ)."((@>6H>E=\"T`2:,GJ MJ0R@%14$M&84>J3V@5)>0-P'?S014KM$L^Y+?'ZV$ID5-G*U>VZ&(>*R9A(. MG#$)=6#K64,2IYTH\'""J6F#2\Q4>L8,1+.Z5QBPU._5^<3R+<`SSS%!W%A6 MWQ=6!JA?#E!B!CM+]5<6-:$DW%Y9`K@L5M9.":YKDA8E,O,W'OULYV@4B)C@ MT]J^J;U?MYD//4#Q!`=PS>0BIM'*"M=[';D*CF+6<@L,Q\,$IG9@&EW,Z(57 M=*Q`$9?MXJP1+J_JKY\BJLW=$I00#BYS=_OY1+3?+LS92Y@+%9-6O&+C5[?Q M+C"/ORD7F3F;4D`XZK4RQE>KB_,FP*CO9<6#!7&8.4.RCC5MNB+*VC9-R`7V M"7;("V%?E\CFW,X]Z6E9@S"!W&3L7\(-*PW#L:$<=X14O6BJ@&IJ!=,6UF0; MW5S,=W2W!`NMDM@+\4A[0X%TRZ,K>QJA7Q)0(QO4)#.6)C*G60.^TOB#8A1*,[7`ZMX)J3,[>% ML#C7+AQ9\ZSGC;P`0NR:D)0S)24I MA^`0Y9#;EM17-E=."DU,?O2[Y`P]W<0_(9HE+URU>CHI6[3#3%7J]FS/%.D- MI3V$&S8YYSK78>_)TLXXLMO5V;`.YY]I`E68IA@B+5TJ=K9Z]P:;[L/R:E4` M/S:T@-M.E920V]%2*0C%^BG[=;9%:T/)%P/!,DK;5-OQALY^;AIU%-_2F*R0 M*P[VRFX'K`R])BE#6I1\2C?9FO[73 MZ[8.>CNUB;S9:VWO[+:X[+W^:+^UW3UH'>SLUQ_MM7KM?3ILUQ_51#Z>3"', M4AZF`:(WUA'GJ"HZA6!&C=]L4RG>UO3J4^NUM@]V6@?M;OU1'TT'#0^K`AOW M'"F*^'&WU=O;;[7W&FC2;6UWN$U_N_YHW5K[=G=7T$3UH7;VNMQI?U!?"#?L MUT]FM3^?$0M(5@8Z[ M+.4[?M)AK+UV:^^@82?W62$;W<1_EUF(0+H3NGE]4D<>?J&85@[S5I,"]^G0 MXKQ$-E`S'@\VPAGIK?)HI9"FG:@W76_G2[:L`%S=\>]K\+1ICBK!#65$^W^CP$'6$> M"(MH%;H#KI8IDG7!X51C544.B8,10L#6L@XB4=A(_AV<_?(L:]$[4-BN*UAP M8G1@YK4X2FA-R/F\79GM#4V34-W#"M3%I0![CC^Q$HM]:3W% M'KE$BCCECKLU0G^L2[;1^2AN.#"?Q?WW^?I,0X/N@;[!4V^Q M;E[O*-?^G7"D>%0!5TD",J4J;FF5^KFM&A[=2#H=OH.SVV"D>=2#A-L-AMWX M:AN^XO(]OIG`EP7T101]9.!"7P.)"73A3T:UD@LN$''.\4EQ$N<9;MLV;ON\ M@9Q&#R-0Y[_5]Y\GPM#;M2?K M]A,ZU4XWU79LGP\\;3=LUWZOM=OY'-YI.MQ4&PT$U^LV0*U.=[^UW^0>=+3F M;IT:Z]9<\#"ZKOE$7,Q-&\E.M[6W7Q\"R=[MMCK;=2*\,8;=$>7CAE2! MN*&A<*[@G#PRW&G_%\SV%28*>_\B9^ M:JO98]GZ!]^M.OSI\+MWM8\6'2OV^')TMV?V]LD>SU:JP=:=/C.4WMEHB%"0JI%-S%IRB6R7?,IXZ-*+'A2):P)2+S4_2^XWC10 MQ@:PL*6N\1,0U,764ERA6@P=/T;VS(U^^B0)C3;:\LG4E3,KX-=V>]O_UOO* M8--38>L%/6SQ#<4B@E,(RV&2\:T%H*'. MZM;^=O1!W7<"+<+NMEL[.]VGZ!,"R19T5+B!,`#K56;%RN#%:.QXMUW9\CJ_ M1FLZP\87-T\F_]JNX[GL``E6F#:LLG'':ROR"W&1B2(N`WZP@VR5:S+MF\7U MFS)K6Q;B#DC1SK^ZNMW6P<&_<77AJ[V_=AG"`X5Z<`*#?N)J?5N9%@F:[T'U>WDO!^/\X,7(MVT'G_#;S>MI\%O9/A;@UW+"&!WK> M4O^+\AL([M>I7`@0)-BCE4T`-\0Y8#.FNQ7-NB7[[J+>H`12T#J/QQD7W=2$ M27'LZS^N7E=4&SWLX8[C";@0UR0/PIAZ))?LH9JX1@)N4LHM:@CA>&G%T`(A M=HH')YFTMX+%]*NABA@B78!H[/A[\7DWA:1EJ`RZJXTOQEAPCR;`R8Y06B*D M8U=JV+Q<+:*ZUNU&(`%J?G7H2+D2+U0&"(:!N1"6IPS#X\=FG;#X8Y>;T M*_KF[ZTQ+,%GN:&'JV80!=0[X5Y=T0XF&S_6\/$TU@;GD\2)/_=;VZ;4:2*C M'+YN9^[Z!ADR/HIDX68.R@UT+:D`H&A7'E%$>^F70FL(^UA4LK5V#H2Y/F,. MOW82/8*FY!.U-0TS\4K:OB?0Q"%U:N#I_CIJH$)WVC7^1";(CKV$H$H5%#`< MCA*Y)0PK00&K(^:Z(.R$O5"MS2WXFVC'5)^KM^/%(2P1NE8U"[!5$;'Z;$]A M#G_P7'*I*12]4N8U?+FPK=HR98YR)0W<@IP_K)(D+W!6)PR+`8\D`BD7@=[+ M?:`,<&EWB^H7W2Q4'-)71RAK72S#.9N):38'PB2'=[22%K`"G\?D=6>_S6$N M76Q7G.$Y54V/%:>['*/71CJ5JPHHM*5'AMIA_5[0^/``R3<[=F10@$M^75U0SJ?. MKDW!V8Q$!Q-=R^96Y+?"3"Y9IG+E)^\@<"Q'N&;I;H39V-OCDORN+344!Y8Q MI$86'$]3;KZ_@GZ^F_)]34):VM@/4=QM]VKZ#/7U-KOFMEXXI1>4Q\8VSAJ& MR-N M^X2\+D_>$%97U^5X^/S,0-=^A#(A2!@W-ZXZFAGPM7!6%"!$!)*Y#'+F6L:MO`]*MX M3W@#-`M`TS96U%HI_>0\S1!*FJ5E/A=!&N4/H/S37Q:/EZ@\'V1_)LEW8)2N M]JQ#+/%7R^.^3?PH+-DUW4*J7QK:T1MYV^["MZAGY0R`]O` M0]BW('YXECLE=FPE'PTVT$3P1D?-S*^D3P=&39RT[ROA#;U.$0R8%Z.,$L`. M3GUMAK.-9M-6FD`46EP;"Q:3UN"F4K4:7U)#F405$)B=7.E)@PM!;V(F-LET MN9G6T)1'^\0$]0$1S*9=".7`_^)A6B#RZIJW@:F[W58L*8VYZ:+&+KJZ*:!RH2:87[4C.6G9U.B^3IFIEZG5EB M0+-4+,S.%KO-<-_\A7EP8,7CLCF5$(2$OG3[4EV@56ABRW04\(V&=K5NN^8, M=*D56)&>*C5MD6EEBB@TJ@OL9]4GV`'[N7*26,):UT_OE$1DI5KHQ6S0!`?> M[,=:8&4=SCY5%D(>3?&4`+S%7\*N^CN6)YDZ[->[V;FN/,/$:R:QO-MBR\\*] MKNV+J]#%JY#>)[FG+^;$>W<^P<*$#S#YZ"L>KXS7=P868*ICNS%!QLOJQV0_ M4/!HQC9E"/J\_6DQA&IJ[-LA^H<^'N*,DOU-3-FRXYYYW.%YO=SN[6P>X7]MC=VMZ+'ZX;N-@),:DJ+!PK?E7SM%7$NN9.;Y5U MH1:-AZ,)KQNV=F8FR)M)3X6OH_[>''+9V_V]XAF2/3L1AOU'T\O'*76'ETCW M?";][)7#DE!`D5XP56;USXK`%U?H!AB,2(!Y+%P&\L9;T,DI@7YI@Y>Q>EAG MC9R'+H\;+R^\'_]^&:X)CQ]PTHFO"-8*'-\<38O[!N(FA[>$JV_14O&#Z4W\ M"S4R"JYG^E+7H/9^>"J!BUM>P4[Q;Z=,B>CB:!`_Z-M)J?C72T5IXA\;)_+Z M)QUZKGU/_`=NO:AU<%Z&5EJE[^_3-O%U=.O85V46;;A^HZ/R@GB.GBY*23P_ MQ)OO,0QP5=3)$R/W%'UA!I3D1(U4TV3[%??&J;>7_:=9>=+O##A4Z_5)6L87 MXSV[HL^GY6<,L=O>A&1[.S62K:QA)D MD-_R1UDK9P,KRFL]R`2-K`QL\48TFS/&]9L?G79`549K:=Z+P#TU&CFD%?7Q MYC":C`O[>QS(Z>%A0IR9D/Z MNQ2?\&5N[,#"LC.Z>B^YG&+"FN6><*J MN[""HH5:GV"%8P]++4T3CV3RW5C_B-"0`Q?@:+?C5NWMKV%5E3^V>_RKVXE? M"(U-3<8/VQVU5CS3_E5O?6AP/H1GX^;TW5/!*=G6AJEUVNIN\60"L M%#[F_N97O4:,7W[S8Z;+DPQJ-Z'IXD:FAK-H0N`5Y`,K%"S)WNXA!N M<]^!6-_>1;6=!^?\V!*]_\RM"D\@^#>&3-_JC'H1G5)R,=Z.$I@>=+ZH/W3` MM+?5Z]8>0DEWE?ZJ+Q#W\4.!R>,G!23O=K=Z[5K_0NK;^R#VW@&5E!9CF9G)T_O[]Z97._[CC%4?G]HW9D[.F#\RBI_G\H1VFL+D+,**. MY"$3I'Q1M;)]GJ>NM4+)!/4C$,1_@3Z8!2%HD(2825\"U2P$6=)Q8KV5R1L7 M&7V73OX&^-0)6GTDNIRGESGTR)EFRKRJ(\*25 MG%\F!WN=;9]QT_E3][DA*6'E$"S59M;9'7FLY'F=C)H"5L*3X+W'FV0TSW2\ MECBF*R>R[QA@+?$^DU`>*"(Z?Y]L0U&";:T@FV7Z.5[EONA($0DA7[*7$-@B M);(P4)I?N[M6#U7I%5X5I%X,P&#%]47N':;`"QS??;!8L/I8S95"DG". MN7I=,CTIE":+7XL_BZJAEL%/-5]91S$?@4%ZHI,(U]&#M(GFIK(@]L[T`65( M.YP_8T'/:H0.&J'_X;L^.3PT0G*B\Z?]6,'UBT\F)2?N1K)G\H2=CDL4/M;9YH"LNMV3E"^60Q,Y/#!/9^[#E1?`:5NIB>)5.E>]P.M1W(R0AK0Q(=EP+.1:4#CU7!E-!U"8V MC=4PS,ODLLR#$W[9V]LU?K8J&,343I^MT12J@(G9]M1SE^,LHCL%%3VQX!*- M6GX&9Z/G$F?NLB^7?P]DJQR"T"9T26=SA<6:=$5M+L7>5Q@]VGJ2`"L5!!9$ M/>9CT_WI]73,]=8']7XP^&N%"M!@.:;K5T.N3R&$R0_LT?9\2::..V/[$.QE&-F,F`+,8&A MHCB9B1U$J]^::PP]`23\?OJM<5%),?%:V>H4WBC8,KVRQ)I\*EO'=#HX_ZV: MG53U^/1L?#(^'F`;P:&]V5+,RFH^P_G=\:BN'LU)Q8;!RR)P@W!$3\;9WZ^` M#HS['^8)F^4YQ*':14U\NT7YVRW*B(I@YC,3B!7V/[]%F99@ON_`M,GN8(LQ M+'=2%E:1N$YP\:%>`(MU-P:`JQ]]"V2B7-7_,JN M2KSX/]QIPG'_=HU)PS7*U\%`M@R8R4@B\>)T;KWW".P*=Q)G[I>_/H&1.8R= MBP#@#P0$B`D*=_4B=(W3LH'F@0<'X!ZE'AV]]W6S&;VFO2*LQ(R.+_`]]#.>X5)L`7LC23@N7.N^W/-7K<3 M$VO!M%-N8(UP5Q#<`DS[I2/JF``H(O$$FE4#X2G/ZH?[-R%QQQS;*P-P,*QK M9F"S%T%J@/-4"7E5]:C0#C$;RWQ$Q7(^M.?VI\A(9#:$68AYB3RF7(';Z&3. M!>(+4[Q%7E&4"KM6`)L,'I-FQ)28\4(4Q9W!:8@OX88:8%X1G'222@ M408$.N_NS$9TX\6+K9HY],3`HRNT>$G/TPES[]U6,7UHYNC39-:O/A6F1?H: MIR94OQE!=Z_V615]P2FOM>!\#_>@:=&^RLJ6+=.7`;/9^>G@;/S[@.<8A**( M[%KR']RWU1F;3W#A]]6C93VLOLO\'IP->!QBO,]T4Y#1B@\UX.#E M,2["E,DJUPC38D-PE:::EA(=M5&]&$_E),:R'ITL)V!5>@.G#'[;XO6H&M3U M:+%N>];2M0)!J#QE^O&A]&@SZOI[_J"E_GV*$-S5_55R;8D2#),TX]C20GK[ M)IKHY72%.S\?++P`8^IL>>P+GZOWM]>[B+?^A,ZF;B4MCG:]W-@M!RO-:%%- M9G5=81)+=@B3NGX].!_%N5RF6&Y(_)J&[=IBR,0?$5,RTI0*P$Z[A M/EJ,^R`Z1L)JC3VTDP(9L*J$)CQ$GK3@>!["!9!,.O.LC&"*;QPN1#],];Z$ MD9TQ2,478GRZ2!P4^38.BO"^V(/"?7[;F,_FRG"`.[@_"K:7UOC%S?W;.RH: M!"F%ODFWW(H9O5\A-LUPK8-9Z"(]'Q_0OP_A!,!`^L-[M2[ZQ6PY=<@:ZZB+ M]<#T8($97]KRO$YJD8=3(J:\$[#*XES4ELTS2W4V0C2(,N;\&):50,KPJ7NI MRH7Q\DSVA$KV-P9"+@YJOI%\F>(=:/%M4+ MI(SZ@1\C:%J8D01=2#2$&TUZ6;8N);UF>T-=^F(A.#S,^09OGUF!X1QU23\3 M+RFPID3RNA^JG&JN@ZZN*.D3..BVDG5XV$JC5Y2U&Z([)]Z[F>&60T=M\;,Z M\Y]:'(U6N=1,']GAE`;OFEDO[L\1/+);ZIX'$^'I[\,ABL_#@X?#=4"$(T:' M`-=ST0;?[8('3[?_(&&JVX06T*+!:QY@US449T#,21+^`HY%&LV<#W"*/D^7 MDBH5J7*0";E;.;QX$?F_/-.<3%P`:SALNBO.2HHG^^C(I2&C M_S!N/9ST/=A7GQUFUI?AULNGP$:Z8T]/!3_1`$K;0;>$+@B+ZZ&D7OX>"RHP M!\';F-'KO$%K0>.I(TK7KG)EWVW=%H%%@DW]USMX-*O+HM$.5,/C*L"N]%26 MAWL.H)C-\S1JE3TL+@)C]WUV*)L!_'@B^'0;Q(H"!I+[!3S]:W:]W]7UJX2A M"GM.@H.P(1`>H*$%I%,8*_]]DZ"`=Y;S&&<$J704#Z$%9T)UE(4)[3!5D,[# MR+3RVKZU8_PWB#H^:3509>@#7DA_**!CB$GZ%:H?0C=B1B$3:2E'*1F8R71) M>>@/6&YNI5EM_1]7F('I*G"(HAN*2K@\^"GM3S.*QCV4%+4^BD07P7`F<. MRP7'!$OSFFK`!?QTO>DBED6'=0LG24*$^MVH,>CK,`?6JB[X+7SICR2QXD;K MY@-"%VR3KJ#9F*VF6EO1C:?=\\*L&T*;`C@K1\[RSXE<@<%>=DL;A%: MG-'-+X:J349NRT)!A5X!D`N+L\'EIC]J+F?D/8P^;0,'5$%J==E>`-?J!SN? M6<4.^`PUE;18R,3%E"3DUSEU^C!WD#&\UST%NL(*AO2+6 M,V@,W817)AXRH#6A^@59+*`):_,:$I/M)[930\TM7@XVZ#J["HE>RN*!LKVW M\Z;%"-T&>[W>MFA,08NN<`"&%WIBH85]KS3TW1+^5A9,>3/LEB5\DI@B1`"+ MGM*]*OVS0;:Z7[V:#(Y_Z=?'KV<3YCGGS-7VY^?`HIZ=5M/9<#1AUG,YE0=) MZK.4K"V<<$.\S64*=$O+[]OQ.8($Y/ISFV*B6$]WN8[Z9$]9IR6Z*\H+V#7T M2J?BLF1 MRNZZT$.5)X!0J(E8K?Z8K%QDA"`J!+NA M._WG*XDF*?.%Y!0O;%/H=8E0RVWI';+ZLGKDNT@);^+]99R#/& MY062SM,1H2%NG=6XIF=T?CRN1[A'#G=QK9>;;HR+[(-$&&0C7%$N4>U,\-8D MN\/IR)G69T=:JAYTAZNX_%=.=]BI\$3>\^Q`>OHPG#P[:'+UH> M[K_G[B_[>@?7[ M87\O6RO^_6SZP"1I-H2GD\QF/'U2:,;3_EZ&B$-U>'\OJRX.?`N*1YH$V[WD M(<1YFW+;]C)FVZCZ-K"]G3E!-:CBB2G/+DV/0ND]1$4]RZTN,;%9 M;!D5L819X%ZBG_PU"K'(O!D>59XRS"=X&*F#I)O5>_)3/O>B]*07V*!XL#5W MO+36V!=+5:TB3B#Q=7[A0*"N$;@(%*WEA20U/ZWT8ZRY[K[+XZ^H,_NZQIJP:\E8W/K^69!GFS1<+6\;VMWJW,Y!QSK*+*Y MCMZV4-W&I>W*L]:B%P2\%A(7A6HW*/?)%8I_?U'=?,RQ**-H$4;Z[`_-U MH,EU-?E-5+`@^BOTH(9><\O5H[4R89JI8SR,D[HS#?*A^(W5CD M,A!*W3B4NA=3XI72+7+V[$,9H[14V6NZJ5BVV6N.*DF7%4!'@!BT/0;);>F-N&JD4OW6,%PQ2,D$G>(VC$O]DALXDS%CF\$*@"O0T6"S M%-:0"UU5XB17'V[^78$$##L+5S%7;(".08(N&!9CJFBQS!N_@<``/__`P!02P,$ M%``&``@````A`+P8T/.\#@``TI$```T```!X;"]S='EL97,N>&ULW%W[;^/& M$?Z]0/\'0M<6#5!;+\JV',O!67=L`URN0>Z"%FB*@I8HFSD^5)*ZV"GZOW=F M^9HE17)77&E]K=&<)8LSWWSSV-DA1=Y\\^1[QF'2/CF_'Y^'6">`OFS#R[01>1@_#>!LY]CK&@WQO.!F-+H:^[0:#5,*U MOQ(1XMO1I]WV;!7Z6SMQ[UW/39Z9K('AKZZ_?0C"R+[W`.K3V+17N6SVHB;> M=U=1&(>;Y!S$#_2?U[]Z=6KT;^^^OH?/SCK?_[TQ_K??OIJ,,S5 M$)G@@W:9YZ-6L?#G5/(PL^#V9A,&I2'3"="$;%U_"L)?`@O_!L$`YN'';F_B M7XW/M@?OC!'>*O3"R$C`RV`?>R>P?2?]Q-+VW/O(Q8]M;-_UGM.W)_@&"XSL M<[X+;L(WAZF&T^JY1S2Y35<(@[-IBN]0FWPPR<8WVVVR?]YC$Z=KUJVK#W^< M+F9%NUW*=-7CHL9A'UV%KXB>Z.%^,;`LJ"'CT0AII0X[DK+Y<@3Z3J;L8G8R MRZ;6U+I4:AD7BW6_H<*II9+*#H76Z\LW)Z-3O;(FZ[(R?*H,P(13RZ(+J=N2 MWY<6_IPB3DZ\H!W'8TPJ5_19ZI6U\:/K.['QWOG%^"'T[0")I8L:^S2W)G.! MIUX\Y_[CB-_1"%.OH@C>3M&OH8OPC!\#%_IKQ_CN0Y5\UB5QY(O+[M=XH9./ M3%-5Q1RM5QJI.5G'D]S=_TJG5PYZW!D]RW`7N4Z$N5L-'-9L=09.T3'52_C! ML.O-<]]Z0PN"2NF,GABJG>MYQ0YN.L,]#KQS>P.;R<2)`@M>&-GO'Y^WL,,) M8-^+A`_3SW5\^B&RG\<3UN>+'1"'GKM&%`]+MJ_*O+2\>&LMWS*]!)DHB@:A MEK6\/(+0MW?SI7JDRSE+Y*%"\R<6_"A&^GJ&/XJ%6O"_I3).L\[&5`6RD&7\_G\:GQQ=74U-Z=CTV0DWV<1[09KY\G!T8@RFNH(9H!@/KV:7TP` MR,B\8JI.BF`*`"YGLZO9>#XQX?^L$!X?@6I.9P/=7B4(-'F5(-#D5;855U'Z MLDR!J:3F7"4(-'F5(-#DU4O%%?A2NU<)`DU>)0@T>95UJ0IS%:;]FG.5(-#D M58)`DU>5-9]9!9YK]RI!H,FK!,&IO9IOJY9Y8UWOS)3UQYDN;.(M-KJ4T<5V MC;!/O0^C-9R6S<\UCDW8(Z;OW=YXSB:!'6GD/CSBOTFXA?_>ATD")S%O;]:N M_1`&M@>_#O,C\G];CH33O'!&=S%('MW5)U#&S692;E(5Q])05#T3=Q/FI3FZ M-&>3BW3#IDBU[ZS=G5^WKM"]-RZ!1N2VVW#"85`HR<*AG&0/T0N9^P2/8*YF MGA8\`&(B#PG!(U386)[5$;61'"%F(SE`T$9RA*B-D#K[DBMGR)F/PAR3)W/SD/V,-IYC*RM4%]JN7$WP1_6'>^QM..( MNIT=!^RQLN,(41OYN,F]RPDO1A=8GO<@J?#-??PP&*`H/3#'4RF"67W"J7!Z M:D^XW/'FUO143%&E1]B,;G9U0@*Z]JW4V9(-'<#*\;P/N";_?5.T`3!9N[UY MVI!K@^""+;QX!B\]PE]A?)W]FB[YZ0O0U7007/K3<)!A;[?>\_N=?^]$%KN* MBZE@[UJ@IWQUQWJ5\O5KSWT(?(?-!@>IF.^C,'%6";O*C)WJ:,(S;<`SS@2) MX.FCWVS0#SP)\]%'/\R>]OH#>-&J'X)+6+_*>,#KZ;*@!A?0H&[#HQ(!3!AR M!.`$'0CP^K^,`PA/'0A@YY8C@``M$0"JEL*K&Z2@QQ.V1:20&\:*'` M@E57S9(W;JKYV@@A11Q#2%!@*=(-`>!H M@4`<,=:T_HXI!DTK,(T&34LPA<"MP2?,">H);H74A`'P:,F*LD\8%I)[052(I!ETUDKA"5XDD$(`1+162 M>D)7B:08=-7(TA5372620-!5(8DG\+N&QXS((1V;ID-4,C\=3_$\:M/L$3R4 M[_^KSGK:=$Y2QTV[)I"5'YYNG]*M(SB#;:;(7AJ_G!Q8! M3W<0T6DYV]5W3N8KD<%/MSLCI!,$3G=T8T"N,PS*0T!1BF#FZJ8)5DGM&*BK M8,7L*H92U:PS5JER)".;>,/;W'K1NY3^O(L3=_,L6;RD$;6<;ZI4J[WU)<5TEYWTDEH5,Q]+8>RH_"T0&]L8 M2AN[C(]=`EACC;3G+:P!`3QK^S=3_/K(^_<@+EN`XWH$O.#H8();L:SI.W8$ MG@A12X?+6:LO<)KX/P11B[4R0:DI_)HA2A6;OIE,'-(;T4$.46_MJ4IIU5Q< MT;+:PE'9'MOR-;&ORX5PPITUOICBW4YP6W[WI9)D3^\"6PTG(ELBG$YD;3.B M$_1*8JLI!Y%OYR!@^,:DC;4CMB`M$&OIIPDB%]8R-J233,N7YS M0*D]T(L;_-&`!"[Z;^_I?N+_911)QC$OA"/AL.6+B-#J=YC75".222OETVL9 MYLN?@5E.];1.PL]FW=>F`*+]W.54S MQ;F[OI?AZ^#)1DZT./!#XY?I?IY%J.E\UZS?_4UQRP%7@%MHI11K7[D8X/,+ M&@N>X%.&:=-(]Z51*82SGO'Z8[4).!<#7TJLUG"VA6IC]G2NYDWY_=(X$_(M M?EV'SV_]00E^S!?^"9":;W[YQ4G0V2W[ZN:B)RB[XVQ?9R!1.]%9+^N\3U]$ M+ M_QQ0CTL\*2]*L-`EMSBS(0M0Z`**FN/DPU*HI3U@\JR4X;QJL:F(M;> MF\AH5!2-3=[A@*KMXR20MZ0Z_<8PE^L\\EY>39$>5*3::CG[8N^^!8>#K@!Y M[R:%W4WJRT`JM"%Y"9P"AN[%M0:TK?;*N+G[)@1B%:&V.,C7KH/RJJ4B?*G$ M`N'W[&M)V;V(#U^%U%16O3S"2EK_)AA>JO1%E"'"W81<7\4WH(+)7>TIFF2W MKQK["T>+;/KM25#9$IJ\:+55B!B+]P+*3PHJ!U0,&F0&EU.H?B\`$6Y)\[00 MYFA_G6YT7BO#(+%QL,+-6<(./T+]+W\QNB]0F MJ[A0`J_UI[*@#,G*`@GI8H=G=:DLV#[)R@+UJ2Q,3B(+'@(@+0O.OV2R\+YX M)5\FQ+V>O\ZK+!PRN,R(PEK:WVGDV/H$E%X0366(0WK1# M2-*CL_ID+.'I-(4@/A]P&141]/9IZ]F!G831LX%W,"S$\4Z?"8K[RU&SP8P$NVB',$X9!+1DR1"SP].(&2$0-'IVCX^,,)H8P8.#H5 MPQ=5[)]$Q'P;;'>%A_A:BDNWB(AW;O#)6?.1PU<)/.DM(NF]LTLBNX@_/J4F M@L2\QV<:%3+X$L$>453M&=_#(XQR$K'3)KF#^Q81X'_=)81&/(H(P6^2B0CY MZ";P]+G,FWP.(RPA$2'<5;004:DH@C+^9D>ZPC!E'WJ>_=SF#`1BT'Y M^SM\8"9D,8P*H-R\B^$AC/"OL8O`_;^\NYV_>6I.SJ]'=U9DY=69G\]G= MF[.9N;Q[\\::CR:CY7^!,M\+XNNGL;D8/";)]GHXC%>/CF_'Y[Z[BL(XW"3G M*W@.9[C9N"MG&&\C*"KQH^,DOC>"#D.O;@4U%F;`;^0_G> M8D!>I/#9+7(`-@R5:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L M*]`"NW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5Q MVZM=KGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6 MF[CMA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@ M>WLRH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT M)`^4AQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU M)9E;G4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P] M?O/R\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B0 M1D2B6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q M*`->G]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[ MBV/'M;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@> M11U,2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ M=?L>FT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[ M^`''*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]= MV684ZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A M5^7RQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[* MGC8;^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*= MF5O-B&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F M%N.%BW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D M,Z7M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$- MD*"P'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%N MJDE:!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8 M[*IVO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@ MWA`E<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[: M8-*DK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4 MX-F3*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:&PO=V]R M:W-H965T]W2?7]GXVQYU&[?=.1WQ;(JZW+= M#$AN*#K:O>?9<#8DI9?G54%WP,/>J_+UO/^%/:7VI#]\>6X#]%^1?]07?_?J M3?D15<7JCV*?4[3))^[`:UE^Y6BRXI>H\;#3.FP=^*OJK?)U]KYM_BX_XKQX MVS1D]X3NB-_8T^J'G]=+BBC)#$0WEN66.D"_>[N"#PV*2/:]??TH5LUFWA\Y M@XEKC1CAO=>\;L*"2_9[R_>Z*7?_"XCQ3IU$;"E"KU*$L<'8GKC3>U1&4H5> MCRKV@(TMYXZ>C*4&O1XU)O?WA.Z\#8IS5GG@?ERI0J_'OE"`;@PIY6?;!7H] M-;XW&#.IP?BHDK[9`WLZ89,;8CH4(Z4=>'[69"_/5?G1HVRFL5`?,CXWL"VGH??:+`O);/H,C2F5,8[ M,GQ`FWH]WA9EJL?2[C*VJ!%UBXFC1#J\Q6F^B*\Q4"T$0U/-V1FU=QXD?$@$ MD`@A$4$BAD0"B=1$*%90R!0K^`PRHIG$G!F\U;Q/AI_"[&X(Q.0()'Q(! M)$)(1)"((9%`(A6$R/,1L\Y+#\4/7KGJRT_\\."M=#^T]<9","8_(.%#(H!$ M"(D($C$D$DBD@A!^3'^=(%1F/&`(;Z4;,CYE8#NO+P1C,@02/B0"2(20B"`1 M0R*!1"H(8B$ADR<8\24B[F3&9A>Y+I[H M6"/$2(21&",)1E(CHGK#J\3[IR\FBLO+Q>]D=IX@1;I(R.B-T#$@OE21HVSJ MCMWS,)/F"!%!T#;/Q3AL@5"18/2YIA`IP*BK$",@48`QI8+V%:D"C-R1,S[/ M+JHCO(1\P!%1>:J.:)7P@@GH,MR.WE/O"J1EG8^1`",A1B*,Q!A),)(:$=4? M7E8^X(^H1B_]<2Q]3:8BTC^;X..(^=)4SYC3!5LBWA2QV":CY$`(Z%$9M(R;61$6"'& M2(*1U(BHCO"B\]*1VXI))FI5=2[3;G5OLRQ+J2-!_^*CH8$ M&`DQ$F$DQDB"D=2(J/[PTE7W9TQ3%Y@!1<6K^M-996 MZVHC)50`=S+6[(WP=\0823"2&A'5&%["/F",J'Q58SJ+;5A`>PPBOD1$U%UW M/-5V[0*L$6(DPDB,D00CJ1%1O+$?VS9HFVD+.:958PL)B:A>J0@]%6#*;E,[ MY?F0""1A>`*&&(DP$F,DP4AJ1%1G]$T#\S1F=S<+'*:7/A)2@F5IJSWO*J0E MA'\+%%R#U&=:B)$((S%&$HRD1D3UAB8E948#WG!QCQ,1)@ M))2(F#\GX\ZC'DO$&$DPDAH1U1(:94IBW%;KV+R9GB#:RF8A(9$!HU%G]\^3 M@&&@^Q@),!)B),)(C)$$(ZD14;W1=P9N].;*#@'35J4+?EJ/#!1#U;:=R<6! M'%&\2,)HCA`Q(`%6"3$2823&2((1?@B4A^7Z'0ESQ"%/<=9NEU=ON9=OMW5O M6;[S`YPV;7.6A/^+V6#9WV;/_G`[660."UV79'-_P+SB=%W[Y M"0``__\#`%!+`P04``8`"````"$`HK^@)R,$``#A#P``&0```'AL+W=OSL MG(]KQ*ID@!**X\R_/ZM4&"@>ZMR(K#Y]Z7K[O?K^GF?*&ZYH2HJUBC1#57"1 MD&-:G-?JWW_YWQ:J0NNX.,89*?!:_J[-.RPK'QZ92GNFF848NCZO7:_DM(7D)$H;^C69RTVLW+2#Y/DXI0KQI]_4GRCO?\*O9!;4*7''VF!P6SH)M8!!T)>&1H=60@JZZ/: M?M,!ORKEB$_Q-:M_DUN(T_.EAMZV(2&6EWO\\#!-P%"0T4R;*24D@P;`KY*G M;&2`(?%[\[REQ_JR5JVY9CN&A0!7#IC6?LHD526YTIKD_W((W:6XB'D7@>== M!-G:S+2=Q5=4K+O*[%/%U,R%C>SY%]H"K6X2@F?;EOG7VS*_J\"S58'DGK3# MN5>&9U?YZXG`!&T26?949$W0>>\V@\6+ZWBSJLA-@0D(_4?+F$UGY()@.TIX MGW;CYO^P7)O+"5-8JI`4C@L)0?]LXQG*EO\'X3.[,EC/P^\D@8\CLQCKV M;#YDO)9A0Y9]?/](&`TK^2W35@K$0"@&HEY`![,ZQZ"[^XX]GD^M,0QFQK3? MW?(`LJS&I1EREJ(';96^3^8P'6_,S):+(;,?,PZRAHP_9H0O!6/"$AH'F#VMH[O1,83`WLQX(N!0`R$8B#B@6&& M]N,,81E[/D,&P]+;<\X29\V6,_#;N?OYY6:*[*2$)R7V4L*7$H&4"*5$-$4, M1A(L]'V?V=)FP38Z/6%9I;4*X[7STD'""K3E#+2C8T2_I80G)?92PI<2@90( MI43$B7FS7B'+6'PNK0.W84/LNSWM,H-%EYUNMC1C=LN91?-=RYP+J\YN4(S$ M8H\73_31?B!@S<2E42H02(E02D13Q,!>V%N?MY?!HKW"]K#ES(1!.RGA/2`, M8>G?/V"&'>U+B4!*A%(BFB(&3K/[3^]$-#V0&2PZ+1Y\.#/EM)3PI,1>2OB< MX!-J-IHQ0;]X;MO"DA;VBY%M+X1RN,HP)QYGR?WE5Q5^^LQQ=<8[G&542=.%L`7&]2P!N6&5\QC_CZIP65,GP"5(W-`<6V8K? MT?A+3&ULG)I=CZ,V%(;O*_4_(.XWP7PFT616RX?;2JU45?VX9@A)T(80`;.S M^^][S'$8?)BQD]F+D(3'+_CUL7DGWH?/W^N3]:ULNZHY;VVV<&RK/!?-KCH? MMO8_?_-/*]OJ^OR\RT_-N=S:/\K._OSX\T\/+TW[M3N696^!PKG;VL>^OVR6 MRZXXEG7>+9I+>88S^Z:M\QX^MH=E=VG+?#Z+S/Z^5Z"4J/#[L* M>B!LM]IRO[6_L`UW(WOY^#`8]&]5OG23]U9W;%Y^::O=[]6Y!+=AG,0(/#7- M5X'^MA-?0>/EK#4?1N#/UMJ5^_SYU/_5O/Q:5H=C#\,=0(]$QS:['VG9%>`H MR"S<0"@5S0EN`%ZMNA*E`8[DWX?C2[7KCUO;"Q=!Y'@,<.NI['I>"4G;*IZ[ MOJG_0XA)*11QI0@+]**%7@>%4!\UP,/(RY$O@B5K1W9%HQI!]7Z[3%^P[%-.T[V_7]K6+`A9=O-Y;C%],[\U5 MKYO,"9@!*I/.&:*2S0E_O5)5N&0\=_#>=\+5>B24+L-LN+W+`H:).W$_)+#D4B-1&8D.!*KP8;7 M@5`\@/7Z?@]$(^K!ZV*#I8",S@,CD4#$R.!]]GX5D>4_PO,:KU$AD1H+K",6']4=\$(VH#Z2?,3(3 M'\A@)@CHC#`2F9'@.D(Q@L%385H1^@5RH,FSDCXA)*/I86)&4C.2F1&N150? M1'JZ>V8PS%S*(W/]NA3C,B$AK`D6,.82RQ)):"Q+S4AF1K@64?T06>M^/S"A MJ7[XXZ-)^H$0KMF>&[ATBH@_?V"B:>TP(IE9A6L1U0Z1O.ZW`_.::@=9NV.& MD(PR2I(9_$HDH+5#%PP'E* M`\_#ZWL!+)42&B0S(UR+J&Z(+#8I#H,+F-S4HJ`I4_P(`5;)-<-CC"PJB0)X MZR`@/J82T)J`%]$@7*NBFB"2V.TF8&Y33:`9DR$D2\&;9GPY,Z9`Z$>3/P(& M()4*FAYF9H1K$=4$$<0F)MR6MQG&-]4,&C8EI.E*(A'TRX??;\C"FIHU,C/" MM8AJA\AC]]N!*6YJQVQD8Z:+>K(Z$$$[PI6[(G,H-6MD9H1K$=4.D4UZ9&>%:1/'");GSMIDRM%*?()%#([B$ MT(O5&P]4!0@C1A;?5)[7>6%&N!91O?A0]G3GV1-^>"992T+H!?/7ODL&/I&$ MIK.I&THK5!LZ>$I!^.Y\S]0!FM'T8DD]?1J'`MHOI! MPJ<^7[B8!>%U#$C>:C9'C($QD3J:+J1F)#,C7(NH1L#-?*`P1"M:%NPA= M%U#U%T5\GDA$:XA1)3.K<"VB&D*2YXVKZ#R!1@[)C['8;`'7-+U-S$AJ1C*) MH/-O^,ZU&JH=)(/>:,<\BT8.>2;$[C1JNDX4K>DC-)&(QK'4K)*95;@640WY M4!Z%'=?YA*'A7$+X5[P;PF_PQ+)$$EH_\$KOBV1F$;%!_'ZEHAVX`8P[@G79 M'LJD/)TZJVB>Q>:NV$X:OQTWGK^X8A.,?!^S#6S?B1VV\03L!U_R0_E'WAZJ M=RCU(.HL(YD^+.\KXH6\NPS[D4]/#3O#P]@@[_R5L`#H+@/=-TU\_B`N, M_Y?@\7\```#__P,`4$L#!!0`!@`(````(0"E?>L=)00``!H0```9````>&PO M=V]R:W-H965T\^WW/PR@,R!8+U2&'P_S//.^_?*>9\H;KFA*"EJ5GC&L%%`KJ MJN>Z+C>:1N,SSB.Z("4NX,Z15'E4PV5UTFA9X2AI'LHSS=1UI.516JA<85,] MHT&.QS3&/HDO.2YJ+E+A+*JA_O2KV4GV.2ER!Q2+.T_FA$ M526/-U]/!:FB0P:^WXUE%'?:S<5`/D_CBE!RK!<@I_&*#CVOM;4&2KMMDH(# M%KM2X:.KOAB;T#!5;;=M`OJ5XBN]^Z_0,[G^7:7)M[3`D#:T$VN!`R&O#/V: ML")X6!L\'38M\*-2$GR,+EG]+[G^@]/3N8;FML$1,[9)/GQ,8T@49!:FS91B MDD$%X%O)4]8U()'HO?F]IDE]=E4++6Q'MPS`E0.F=9@R256)+[0F^6\.&:T4 M%S%;$?AM10Q[L31M9_4G*E:K`K^="OISE66K@FXJS]=%X^DT8?M1'>VV%;DJ MT(/!/RTC-AZ,#2AW*?-,^MP?Q0YY,Y$7IN*JCJI`HA3ZRML.(;35WJ!]XY;Q M.`/?/6.(Q'Y(V$M)Q1^^"1I#U`DZAG4*5KWPKD`#W[UY:-9[\^-=J_/(8.:Q M4_6Z@ILA4ZS(?DA8NHCX'($*]JE((L&0L%>22CAD$+JE(GB&3OB\9P8+GN6" MO5S@\X)[0P@YHNG@"2:<9@1+,#*>M\1@5X7`^L`16HOU\S@#WSUCB\1^EO`Y M@9K!8-BZ+C59(-PW+/B(KPCO`62:SBU$P3Q,9L^;9[!DWI$JYG$&WO[0_"SA M!=)M\.'MP7?,%D][YO!LF]I]O$X,^5[EO`Y\<@WO[OB74)J M[?%[@F.87N\=LZG:@F5U>M9B#\G.I1G&X\R4S1#A%""&LQ1"F^P"#9?-+L?]Y MG)DR/R20(PU=?XR1.DLPQMSF-KY@CS$/UC,#AL!]?YB.HJ'E+.3IOX6FPAA! MD+PJ^V.0(\#X+OH<0@Y%$"!QXVE'@0 M<""45_5]"TQX].>18!YA1R]6D_$7\1CXT8KO]G-9QE58G)AQZ8E+$-] M:7^D>['8_E8J]]E1;Z3<,S?>&+\W-[`O!!VM%X*361F=\/>H.J4%53)\A"KH M"P?6^HJ?[?A%3DO@,``)H-```8````>&PO=V]R:W-H965T M&ULE)?;CN(X$(;O5]IWB'P_!(=C(\*HDU;/C+0CK78.>VT2 M`U8G<=8V3??;3SD.P79@-MP`2?[\];GLLHOUQ[>R"%ZID(Q7,<*C,0IHE?&< M5?L8_?C^_&&)`JE(E9."5S1&[U2BCYL__UB?N'B1!TI5``Z5C-%!J7H5AC([ MT)+($:]I!4]V7)1$P:78A[(6E.3-2V411N/Q/"P)JY!Q6(DA'GRW8QE]XMFQ MI)4R)H(61`&_/+!:GMW*;(A=2<3+L?Z0\;(&BRTKF'IO3%%09JLO^XH+LBU@ MW&]X2K*S=W/1LR]9)KCD.S4"N]"`]L?\$#Z$X+19YPQ&H-,>"+J+T2->I7B. MPLVZ2=!/1D_2^AW(`S]]$BS_BU44L@WSI,CV&RUHIF@.,X<"/2-;SE_TJU_@ MUAB"R$:@@\C_SF$>(QTE[,+8O\\AGYMI^UL$.=V18Z'^X:?/E.T/"B+-(`TZ M&ZO\_8G*#*8!8HVBF7;->`$6\!F43*\G2"-Y,W0L5X<83>:CV6(\P2`/ME2J M9Z8M49`=I>+EOT:$6RMC$K4F\'TRSZ/[32:M"7RW)C@:3:/98CD`)33#:C+V M1!39K`4_!;!>`5S61*]^O`+GZVF!?&CMHQ;':`$3%R,)<_.Z&:_#5\A^UBH2 MHX#/3H%=17I6Z`D$A@X$0:;%+AOT%;B0V&O97>%]R@PT*:7C6 MM-AC\Y9X8B2SIC"G>!EY[*EY;K/?`-,GYN!-08L]L$MEF1HP$CLP]LHD[4MN ML#W_68M)K?\QD?6W.+3V_6P_G,UF[S^4L_ MP49CQX[\NKVBN<6GM^SA?&:#=_C\TL7]0R#RJBB]HKG%!^.T^0:N0_V6NPXC MKTP3;#1V'B\,34&EK63>;$/+Z60QF5XD;KG<=6SHKLW'NQB;8FXU-E[D5_,5 MS<7&Y;OK\(#6M\?7*^/^V1#URKBO\?E,YVOZN)**/4UI4<@@XT?=R6+(?'>W M:\W;GKE[`$UN3?;T*Q%[5LF@H#MX=3Q:0):%:9/-A>)UTR5NN8+VMOEY@/]` M%+JN\0C$.\[5^4+W=-V_JLTO````__\#`%!+`P04``8`"````"$`QIQ[O?D# M```]#0``&0```'AL+W=O]7 MVG>(-44/E]W6$?N. M%>MA4E,[+B&ATQ15:RN%:?>(!M]LJI)EO#PTK.V52,?JHH?]BUVU%Z-:4SXB MUQ3=ZV'_5/)F#Q*KJJ[ZCT'4MIIR^G7;\JY8U>#[G?I%.6H/%U?R355V7/!- M/P$Y1VWTVG/B)`XH+6;K"AS(L%L=V\SM9SK-*;6=Q6P(T#\5.PKMNR5V_/BY MJ]9_52V#:$.>9`96G+]*].M:#L%DYVKVRY"!;YVU9IOB4/??^?$+J[:['M(= M@"-I;+K^R)@H(:(@,W$#J53R&C8`GU93R=*`B!3OP_]CM>YW<]L+)T%$/`JX MM6*B?ZFDI&V5!]'SYE\%#8[.(NY)!&:<1"@,W9_LJ(T,OK*B+Q:SCA\M*!98 M2NP+67IT"H+2D`=A4*:=,4WW;ML=\RDES&X)YSE9`49VDBHF'VGR",$2AAWP:!"5>['FQB60(\4,: MH'5R$_$3$M)+U@VK\+3]OE4Y"5N]Z`\/3:J8<+`:!YZ;>('I8ZD3D1^$;HQL M9#H1^VZ2!"@6N4Y$'HD3[U):AL_0]'F_9"6,_:%$I8I)5"K)A(3(';I/?6+\ M8:L81^',T?W+;<,EG'UZ-N^[E#!VZ9LN4L6H+/J!2R#$)K'4"<]/@H1<]J:. M3YVXJ9'K!-8P_,D.1GM/W/P/U6"J&.7/]:*81)?Z&7:_-`B?TL1'1&80 MMS1R@T`:AK_D=_Q)&/M#59@JYN0OB%R2H!?B4B>H'Q"J'?XJ?SKAWM+(=0)K M&/XHO-0?3^!`8X>167_I"5(6$T(\%SU:2X.(:1A0%*7,(&YIY`:!-$R'LA5X MN$2A2[S.(7K"TA.D',(K(2)1@IBEP<04CE/M(%1I-)#;,K)KE?M12V$9Y5-U MI:I[:UBW94M6U\(J^4%VG!ZZ<)T#S MNB^V[.^BVU:ML&JV@:7()(+3OU/MK[KH^7[H)5>\A[9U^+J#GRD,FC@R`7C# M>3]>R`7./WP6_P$``/__`P!02P,$%``&``@````A`+O$4Z>C`@``-P<``!D` M``!X;"]W;W)K&ULE)5=;]HP%(;O)^T_6+YO/L@' M`1&JMI2M4B=-TSZN3>(0JW$N1//BUU.6(U;PEQ> MPA!%P3*Z$MF.TUJW$$DKHF'_JF2-.M!X=@F.$_FT:ZXRP1M`;%C%]*N%8L2S M^<.V%I)L*LC[Q0])=F#;R0C/62:%$H5V`.>V&QWG/'-G+I"6BYQ!!L9V)&F1 MXAM_O@ZPNUQ8?WXSNE='STB58O]%LOR1U13,AC*9`FR$>#+2A]S\!<'N*'IM M"_!=HIP69%?I'V+_E;)MJ:':$21D\IKGKRNJ,C`4,,XD,J1,5+`!^$6,.,7`[K,+ M9[-A?K>M)K%]XD=A$@[7[X[7@SA)3CII=;SN!W[L#^/OC]>#(/1.W@^WH]EC M]_[`2][BV[S;NZ\]%0W9TF]$;EFM4$4+R,ISIG`>9'OSM1,M&MO]&Z'AQK*/ M)7R@*!P-SP%Q(80^3,S=VG_REG\!``#__P,`4$L#!!0`!@`(````(0#6,Z$C M5`4``$`4```9````>&PO=V]R:W-H965TBEQ[I56=L7*GDX6I:[1,V3$KSSO]SV_1PT;7ZB8ICTG.2KK3 MO]-:_[+_^:?MC57/]8721@.&LM[IEZ:Y>H91IQ=:)/6"76D)=TZL*I(&+JNS M45\KFAQ;IR(W+--TC"+)2ETP>-4]'.QTRE(:L/2EH&4C2"J:)PW$7U^R:]VS M%>D]=$52/;]<'U)67('B*(OLC2 MBM7LU"R`SA"!8LVNX1K`M-\>,U#`TZY5]+33'XD7D[5N[+=M@O[*Z*V6_M?J M"[O%57;\-2LI9!OJQ"OPQ-@S-_UZY!`X&\@[:BOP>Z4=Z2EYR9L_V.T7FITO M#91[!8JX,._X/:!U"AD%FH6UXDPIRR$`^*L5&6\-R$CRUO[>LF-SV>FVLUBM M39N`N?9$ZR;*.*6NI2]UPXJ_A1'IJ`0)6+8D\-N1K!=+:[7>?(9DW9'`;T=" MR((L3>??`S&$J#9'0=(D^VW%;AHT'H1=7Q/>QL0#WCXY0LJ0KO>R!6GB)(^< M9:>#/R2BAA*_[BW7VAJO4):TLSE@&Z):^+T%KP&G#:9`.`6B*1!+@`$2!YW6 M_Z*3LW"=?82''I"$3T3U%KU+,`7"*1!-@5@"%%$V%F7#^ICO[+Y6W`EZ6*F5 MK09]$#8K2.90T)5JX@\F@S"$A`B)$!++B")NB<7Q9?O)SN0LT-OPE$$);DUA M]*'2%^7$-NW*KJHSD(Q)$K9KG+2P&M8/AL(.XN>?Q+56 MN:(^B#%#\;SC9G!4)?.C^'[)XN"&TZ>/_$`$!(64PW2'I[4=X(]6O6.`H;"' M8%\8)-OFV)DM5]1966(@Y7-5/.\XCF.J9'Y"2Y)_K*7%,:]D0D!*\6US,C7Z M_.2&KE&*CZ"PLW)@FY"LV_WL8>V8TRDGZDR(7&;5RUF:F['1U!SP2>$_YT",&TH. M!*24'D$!Z2"Y]`*RX4=J;;2O(:ZXXYHXOK>O\=GB`]G?V/6]3&A*+H% MY(R;MP\O^VT)1RC`4(BA"$/\P\'()0HI/@2(E]R"5F?JTSROM92]\)=\Z(K] M=H#%%XC#VH/9"KINBF\\F&!F<`(.\.2Y.[87"/E3+K*".^WWAO$QA_''I/3/@SN./!'#V#N]X!1@9\ MPW<]?_9&X$(NYCPBU^,#":8Z$`(NL^D@%MQI$V(,F87O-]?D3']+JG-6UEI. M3U!ZLQW#*O$%2%PT75L_L0:^W+0=?H$O=10.27,!>\:)L::_@*",X=O?_A\` M``#__P,`4$L#!!0`!@`(````(0!R`Q'D>@4``*X4```9````>&PO=V]R:W-H M965T7'S.#_S.#Q[#Z\EJ>K6=:U06[K&TR MF=H6O>1L7UR.:_NO[\G=PK;J)KOLLS.[T+7]1FO[R^;77U8OK'JL3Y0V%D2X MU&O[U#37T''J_$3+K)ZP*[W`E0.KRJR!G]71J:\5S?:M4WEVW.DT<,JLN-@B M0EC=$H,=#D5.(Y8_E?32B"`5/6<-K+\^%==:1BOS6\*56?7X=+W+67F%$`_% MN6C>VJ"V5>;AU^.%5=G#&72_DEF6R]CM#Q2^+/**U>S03""<(Q:*-2^=I0.1 M-JM]`0IXVJV*'M;V/0E3,K>=S:I-T-\%?:FU_UOUB;VD5;'_5EPH9!OJQ"OP MP-@C-_VZYPB<'>2=M!7XH[+V])`]G9L_V&BBW#XJXL'#_%M$ZAXQ" MF(GK\T@Y.\,"X%^K+'AK0$:RU_;O2[%O3FO;FTT6OC\+%G,(\T#K)BEX3-O* MG^J&E?\(*]+%$E'<+LH,EB^NN\'$GT\]`C?]R!&NMK>'O])Q-B&S:?`#OZ#S M@[_2[[8;SCM'^-LY>NYDYOKSQ3M+=43"VOQ'69-M5A5[L:"I(2/U->./"`DA MFDR\R)(JQ7N5@!+P(/<\RMH&?\AQ#>WSO/&FRY7S#"7/.YLMMB&FQ4Y:\/KR ML-$0Q$.0#$&J`0Y`E+20+M$0Q$.0#$&J`4.4 M]RFB>!1X8/3BD:FI8BML?,BNJK!OFNR4B5**2(Q(@DBJ$T,M/):?4$(>!9H= M[J*4X%X51A_*529*+B(Q(@DBJ4X,N;"9Z'+'MT+Y`'+C5I5$>J(Q411")$4D0275BZ.-')FW#_[BMN+$I0A`0 M(=>W0R1")$8D0235B;'BY<^LF!N;*Q9DD/;A+JV,I*P(D1B1!)%4)X8(`F>B MV_/>6ILR.J1G'J,(HQBC!*/40.;*^4B]N6.(&,"PO\I,;COD+13:811)U#_K M<8=%`^. M.MT!2(QH0[9`AFR$(M(A7;9`[K(]2+E3,C,G;8)]T@[U/I[R,<7RZ:J)'1$% M9U:E2LQB0Y5`,VAG51./]'=KT['CXQ4>0["271!U*'`5BCODF;&0VFX1?8;2 M'SF:DOF$O5VRF,=P![GR+1$("JE+'AY_>BOI&'4(^E>B6%K!]JRE+U#%:M.7 M2$?Q>L*/PNFXXUPYFI+Y/-8D_[>6%D/=R(1`@^(OU"*ZXBLK*3OB[W+0#T;Q M.[1HN_S.]18N2H,P(7KE32\2$/>]'/`)_[]S((X)1@X$&G3#X&5G1Y15GP.! MC&X0*("IT7>#V^]373=TCGHWC#KV9PFS&_A9X(-,?&?7]S8X?2\0)PHC%?HA MHZL]0A%\-^"UUP97C%&"$?_@T#L*1>(#@GB!+6EUI#MZ/M=6SI[XQP&70"\I M++Y<;. MC_`@A$/T""0SSM\94L\B#8F$39LN-)J M<506X6O1-3O2W[/J6%QJZTP/T##3=LI7XGN3^-%T#\,#:^`S4?M,K?`@Z,-?('+,I17QHW_P(``/__`P!02P,$%``&``@````A`)9E3LN!!``` M+`\``!D```!X;"]W;W)K&ULK%??CZ,V$'ZOU/\! M\7X!\SLHR2D$MCWI*E75M7TFQ$G0`HXPV>S^]QUC##;.[:7MOBS+EYG/\\V, M&7OU^;6NC!?_H4F0;M\N:05Z3!:_,-4_/S MYN>?5C?2/M,SQIT!#`U=F^>NN\2618LSKG.Z(!?' MWJFN+,>V`ZO.R\;D#''["`/T-5Y M^WR]?"I(?0&*?5F5W5M/:AIU$7\Y-:3-]Q7H?D5>7@CN_D6CK\NB)903[7A"%0+/' MM'LJ&:=I%%?:D?IO;H4&+L[B#"SP%"S!PHE\Y`>PZGN>[N`)S\$3V0L_M%WT M`T=O<(2G<'06R+-_M""$TPN&I_#S),&Z2(MGK"]`FG?Y9M62FP%=#2FAEYSM M$10#F\@\9QAK\;U20`T8R9:QK,W0-"#)%/KG9>,ZSLIZ@9H7@TVBVR#58BE?*:#)*T9!,1A0IL`-D*?>_/Z+IF7$?L5@IX4@@9]IU9N78C4;"+=603$:4 M`(-_$R`S5@/D"`0HUMYI2*HAF8PHT<"&?SQ=S%B-AB/^4BFY-VO-T4B$G&I( M)B-*@.R`('W=WJ\G,U8#Y`@$*-;>:4BJ(9F,*-&`T,>C8<9J-!QQHRD:CCBP MX+AG',]6$Y@.;I.([)Y;-+DI,2,8YG+0?$`LV%CMSF7QG!!8&AK^3FI=&`3# M>&`DJIB>%[YI,MCD>+@3$+.>Q3M`D+LQ MUZXS_XX.CJ'=2PB1O72B63D$]R0\4[V\,'"#R4N5P::)).._58./)/C4BK9. M$(<<$"FI"]30=X-5X/7JD!VAY5(U2051?][KBY^I7H$=A-/<5\6Q"?._Q?$Q MI8@;H*EM=FS,0(%#U"L!'<@)YTH&+[E.BI?OP@%OTJ]*81/F'2G?R.5[NP9. MC..VX7-*T<(A^0L.!W.F18)2'6+']\F*Q\J/X_PT6./VA'>XJJA1D"L[:L.J MF]4(\WM`$L;PK86NF>-1#%^].SCRQ,5A[K&,$]B[NDNZC-D^UW^`.\C6N8,G M[&YR#W=B.'OI/(D;PU%&Q[=>O.5WG'FHH*&_^\QQ/X8YK1,E00P3$W!K=("[ MRB4_X=_R]E0VU*CP$1)L]Q_1EM]V^$LWM,6>='!)Z3OD#+=2#&=AN$^8QI&0 M3KRP!<9[[N8?````__\#`%!+`P04``8`"````"$`!<'*L6@,``!(/```&0`` M`'AL+W=OLT3\^;M:=Z-??M]WNB(OL MNY?5$?0_/&]>#W:U[?J2Y;:K_;?OK[^M^^TK+/%U\[(Y_M*+CD?;]>*/IUV_ M7WU]`;M_)OEJ;=?6O[#EMYOUOC_TC\<;6&Z"BG*;JTDU@97N;Q\V8(%R^VC? M/=Z-OR2+=C8=3^YOM8/^L^G>#M[_1X?G_JW=;Q[^OMEUX&V(DXK`U[[_ID3_ M>%`()D_8[$9'X)_[T4/WN/K^ MK;\?COWVORB5F+5PE=2L`C_-*DGIK7)B9F9FPD\S,S]Y)1C5^L)/(Y_-;HIR MFEVC+ABF%X&?5MWB,G5G9B;\M#,O-+0T,^&GF9DF)Z\YP4CIP(O5<75_N^_? M1K";(!2'UY7:F\D"5K,11R"D#LU2)?U"IW8Y@/P3U`WOZXS]+R=O(# M#-J15+E"G`NX-0047J062PE!') M2,-(ZQ-B+>S23[!6K0+)#E<9+.&YBD(GS1U$!G,9D8PTC+0^(>;">>*;&S^# M[094PMHJJ\T2R$0NUQC)4PU1E)4?GIET\#M@Y`U2S`B&6D8:7U"C%`-F7>J MG\X=)4R-0`)&6/UJ1@0CDI&&D=8G1&-PV.4:*V&J,9)L[C1F1#`BD:2@U'`6 MI'D0K,9,<\YH8]/F;AJQ*X$FS#<,"^Q-"3OF^+Q9?UOV<&G8I)$095!(37E5 MBU"#];IP:GL6=E:R:6J0YW4LU M;BT6:6(MHAQ2U=/074UK6*NZ"S$'*6:8HT4>]!J-$4C\0.(R$$AW M_=1K0JFUJNI>;BW6:&(MHI+&(U"S3@8I9RU#TDKEVMJB2%A8<0X)JUD&YZ3) M/'6>II:JTNQ9^K'S!^L[<0"B(-RSX5PPX1ZDG`,8DNH6$Y)B"/=TZ@Y3D]@H M0>*-Z,)XJW+_?WL!>P;B!41>9.J$(<&1-`C*@+Y9RJ9%T'$W?%)+)Z59.7>3 M:-!58W#"W#_[U_>*#MRG#U4'VPMB+R*_,T@8$AQ)CAJ.6H*H1:IQ\"R*E$M? M"._:G)3SPC#1(FFDYJJ-_'&?EU41GJI6(O><@.N825E9>IZC/E"M MAN>#TQLRQ<:$F(J(!CQLOFLS$:2L78(C:=`<3U.(MJ9#.\WG82ED)/P]P'3CMW)Y[ MMW%4C[$_PP^FG_'N%O3*<(!#1-S6SP/]:R?E_(!KP42+I)$RN9`4Q318I[$2 M?B[@.G,XS@<%WO>#ZG(^(1^P62+Y@"C(!]?=FD(P2%FC14:6(YNZ&J.9(<"0M<@^C&XM\8\SR6HKN:-7J!!%4 MN^/:4HX=$XD@HB"3PWLC]=1%-2PN;05'TB";R67%;HZLA)_)N/2%F:R:G4_P M`_9,Q`^F_R(M3>YZ"I/)@Y3+9(8D/*Y1WC*97$YGO,(9"3_XB"[+9'4C]0E^ MT,O0ULZ@(!_"!M9)#7[@2!ID\F%6L-LF*^"E@T6PK\\?;)EJ@()T2(HKG]?I M10(GF,;*V^=&RMOZ@B-ID=>R6^2%VB(M1?9Y%C1J'WH`H!<)#,+^;>[N&VHC MY2'!D32HFNJ^M)B7>1EV*G:6'T33+N*LK,QFN:L)UTYR(X&4WOQEV1OY^ M-LB_A>1(<"0Y:CAJ":(6J0[%L^ATD!FPC M2!@052ZM:W7;".>ZIY/@2'+4<-021#4/NA1U!J@_;EY9ZS/>OAA40:7QXA/> ML#HIZWG!D;3+D[6RL&,S4OY=C%T+[^32+'_OL:]Z%.]'\&-G(787)+"(2M?+ MU/I2\*J`0X(C:9#7?C8A5:T`SRCK^:(\&1Y*CAJ"6(!#$/6H[3 MAZ26#C3'WH)HSI`P$STIR5'#44L0U3SH+=]@D$%C+@]$#Y\JYW4<"9R)#EJ.&H)HG9>U3KDO'4P M"(RQ:M8<"8XD1PU'+4%4#8A"#$\_;;JYMH#I'.H#+=.95/T=$=#92YW2V M8E3G=VYH!2_>!L$5;";5'`F.)$<-1RU!5'-5 M.J.;Z,Q!@"67[!E$_HE5&*DS)]8@1D^L=_["5:@"^1&5L;`2E1$1E8W4.96M M&%79W4]3+T<*,!Y59[S,ZV^!B*ALI,ZI;,6(RC/W2(^JK"J?Y^4SBIHZZ?)W M62`B*J9<,[,&$^\_O*6GXU76E89*S8F MF4Q-@Q8IVV?%<6/^]3UZ<$VCJI-BGYQ903?F.ZW,+]M??UE?6?EJ)Y4DW8A1;PY,#*/*GA:WFTJDM)DWWCE)\M>SI=6'F2%:9@ M\,I[.-CAD*4T8.E+3HM:D)3TG-00?W7*+E7+EJ?WT.5)^?QR>4A9?@&*I^R< MU>\-J6GDJ??U6+`R>3J#[C8+=PDT3[2JHXQSFD;Z4M4L M_T=8$,^DY[SW)A,RG"XCVUHKPM(D;/N6*[L1V'>(T MCG>&O90D\-F&W2]^F\,2>6S*$B1ULEV7[&I`KT.BJDO"=P[Q@+>MATA!5Z&/ M"@25X22/G&5C@C^DOH*N>MW:R\7:>H5.2*6-CVV(;K%K+7C9.6TP!,(A$`V! M6`$LD-CIA%)_@D[.PG6V$?HMH`@?B&HM6I=@"(1#(!H"L0)HHJ`;/T$49]F8 M\%% MT4VYG4DG%R$A0B*$Q"JBR857A2IW_`W9;D!NW*AJH_$%XD#K*#K=0?&>L0" M@8C5M*\&:>^,NK0C)$1(A)!81301?%Q2WNJW>X<;ZR($HJ8=(0%"0H1$"(E5 M1(MX]2,1B0%C2N9#Q9*F]XDE3>\SZWQTL?R( M5<2.B(()KU,E#F1-E82@7?J:N&C"Z:S:=`1$0`N[RU`HH1DTF,)E=Y$WJ8VD M%5'5"JZ!XT>2^4&K2/ZY^HK36LN$@&PHAA+]H%8[?@##'@:K/A,2ZO=#**T6 M\$3A&DP>$>:*QQW[D50O/C^#E4S\1_'%B0TKM)'[1$)]*788"B2D55HX#@HV M&+XBS!5+:.#8'^^Z/GX\*_I^KM+BC-=D"PAVLEJ=X6''?]Y!I97]'F`HE-!B MWFSN!^*0Z6+0,Y&T47HFONVF9X$?^?\["V)NT+(@(;7X"`J(@+3B2PCRTS?W MJG\;RVV.N.*62W?LWS6Z;#XDW)#]G5T^>HVK;SPQ:FBZU>FCB74'-P>\U,HQ M'&`HQ%"$(7X+T7,)1>)60?Q\S6EYI#MZ/E=&RE[XC0$X;-<=+*XS?+)L[S.& M3^8>C-ZP@X>XX\$T.X(O/)@91W!8H/D]..1Q/1AV1NQ7'HP4(SB9>OQHQ$]V M\&0W^@1F`X\?E-@'#G\O&GWB$P=\QA3"U<]CH$3RPNA7@:N>2'.GO27G,BLHXTP,45ODT$AX``#BR```8````>&PO=V]R:W-H965T&ULK)U; M;]S&ED;?!YC_8/@]5K-;K1ML'\1JWF>`P>#,S+,BMVTAMF5(RDGR[^>KKB*K M=JV*)`HY#_+)JEV\+!;)C^QN\NT__OCV]=6_]G?W-[??W[VNWJQ>O]I_O[[] M>//]\[O7__//YJ>SUZ_N'ZZ^?[SZ>OM]_^[UG_O[U_]X_^__]O;WV[M?[[_L M]P^O-(7O]^]>?WEX^'%Q='1__67_[>K^S>V/_7>U?+J]^W;UH/^\^WQT_^-N M?_7QT.G;UZ/U:G5R].WJYOMK/X6+N^=,X_;3IYOK_>[V^K=O^^\/?B)W^Z]7 M#UK^^R\W/^ZGJ7V[?L[DOEW=_?K;CY^N;[_]T"1^N?EZ\_#G8:*O7WV[ON@_ M?[^]N_KEJ];[C^KXZGJ:]N$_,/EO-]=WM_>WGQ[>:')'?D&YSN='YT>:TONW M'V^T!D[[J[O]IW>O?ZXNQNKXY/71^[<'0_][L__]/OG_K^Z_W/[>WMU\_(^; M[WOIUH9RF^"7V]M?76G_T2%U/D+OYK`)_NONU^M5LFMV<7'/W?[^VLIU63>K+=N2M>W7[4`^OOJVXT;&U)R]?=Z<_)F>[K:5"I_]KZM_N'VV__YXNJ,"D_D768B/X-$UF? MOSG;;H]/SDXUE4=Z;D+/X[GG"V:O61S6X62>2%6]69]MJ^V)6XE'9G\:>NK? ML.#5^DUUO'JJGW:?PQSU[]3OF7,\#SWU[]3S67.L-#+\AG)#)&R$9\ZSFC>R M_L_4][&Y'OE!!Y_?S7\ M-.[<5'YVDWGW6M(ULNZUT_SK?76V>GOT+XWSZU#SH5!C*RZG"C>HW61W.:AS MT.2@S4&7@SX'0P[&!!S)TRQ+>\/?(G&JOC@:[;:1O-8V]J2R[EDU@52 M@S0@+4@'TH,,(&-*C#8=)/\.;6XRVH$UFUD)=S]?]*BWN63V!E*#-"`M2`?2 M@PP@8TJ,-YT#C+?RN7$Z.+GJ@YYIM3YXLM5H_FMAEW/1U&T'4H,T("U(!]*# M#"!C2HP-G247V'#5UH8GV\U\0+H$V8'4(`U("]*!]"`#R)@2L^HZXRQ8=5=M M5]V3K09:,A"J['`R%\T#`:0&:4!:D`ZD!QE`QI08&^X:(#V9/[Y;N&IKPY-T M((#L0&J0!J0%Z4!ZD`%D3(E9=:4OL^HNQYQLWL2P^NPHXZ9DM7@B+>D@R<_0 M<]$\2$!JD`:D!>E`>I`!9$R),>5RIU'U^"@YE%L?`:7CA&A'5!,U1"U11]03 M#42C05:#"WG/WUE<-LZ&14#9N,CBRF6LF@<&44W4$+5$'5%/-!"-!EDS+N2E M9OPUP6%?*HR5C>)^N`CPZ5`Y9%K5#Y5'6W^AZC+])=&.J"9JB%JBCJ@G&HA& M@ZP0E]]2(04+NBR=-?BX9S1XE)UGCK/SC`MP&F.JFOSMB&JBAJ@EZHAZHH%H M-,B:<0EM@1D?Z#2]:04_5"'C171)M".JB1JBEJ@CZHD&(MWU\9OGL*A6@XMF MJ0:WQZRW;X277D?[D&<,A=RGP9%DE/R2Q]TAMP1U40-44O4$?5$`]%H MD)7F0ETJ[8F]RF=`8R:-A8=#T&4%M".JB1JBEJ@CZHD&HM$@J\&EN04:?/@S M&N8\&`?()H\GU5PT[7H[HIJH(6J).J*>:"`:#;)B7-9;(,9'0R,F38MA?`#M M*J":J"%JB3JBGF@@&@VR&ER06Z#!YSZC88Z"<7Q49R?YR6>NB@,$J*Z`&J*6 MJ"/JB0:BT2!C9KTLR![*;9`-*#EH7A+MB&JBAJ@EZHAZHH%H-,AJ6!9DUPRR M`=ETLLUNWU[&JGF`$-5$#5%+U!'U1`/1:)`UDP?9Q\\P:\;7@,P`"8DV.=&R MJB9JB%JBCJ@G&HA&@ZP&%RO3(XA+)^X^X,)LLO;Q-#VT!)1=`IUFAY98%4=. MB+K18LVJAJ@EZHAZHH%H-,@J6Y9KU\RU`9F1D^9'__D&JVJBAJ@EZHAZHH%H M-,AJ<*$R'3E/[$`,K^[3.G])DYQ[MOD-ME@5!\C<<4(UJQJBEJ@CZHD&HM$@ M:V99>%TSO`9D!@C#*ZMJHH:H)>J(>J*!:#3(:LC#ZXLO?-;,M0%E!Y>S_.`2 M@FT\DNQBQSAV4-6PJB7JB'JB@6@TR$IS@7/!7N7SJ3GLALAZ^!:"#[9KH!U1 M3=00M40=44\T$(T&60TN2B[0X).GT1#"J(ZKR97Q>3Y`YJII-.S60#510]02 M=40]T4`T&F3,;)8%VT.Y#;8!I0<7HAU13=00M40=44\T$(T&60UYL'4'E\V9 M^];+TNBR8>@-R!Y=SO/0&ZOFP4-4$S5$+5%'U!,-1*-!UMJRT+MAZ`UH&[^@ M<$FT(ZJ)&J*6J"/JB0:BT2"K(0^]CT>7#;/MA'2LB$>7\SRZQ*HX0,*T;,=X M0\8NY[*DN6'2#,A=!B7+F7\,$:OB]CQJJXG&%:MN-?+>>R8+9A,`LHTY+?+HE5<3G]M+*.\6+(^LR3TQ/CD_%H M$R)-NIL"[5A5$S5$+5%'U!,-1*-!5L.R++1A%@IHJY9D^.J(>J*!:#3(FM%P7[+#N?(L!'BT/9]7\'(#M".JB1JBEJ@CZHD& MHM$@H^$XST(OO'EQF([U$U"6`/+X&*OFD4-4$S5$+5%'U!,-1*-!5EF>FQX_ MM!PS&P64QD>B'5%-U!"U1!U13S00C099#$6-5'"!^6HFLFE4-44O4$?5$`]%HD#6S+.P=,^P% ME*S@)=&.J"9JB%JBCJ@G&HA&@ZR&/$N^]-S#D*D?D(2/ZV-J6:_B-8*_J1.K MXLB9.TZH9E5#U!)U1#W10#0:9)7EL=8IJ[9/?W?HF`$WH/2[0T0[HIJH(6J) M.J*>:"`:#;)"E@7<8P;<@+*S4'Y]%ZNF<;$CJHD:HI:H(^J)!J+1(&MF6<`] M9L`-R!QD0L!-[@:SJB9JB%JBCJ@G&HA&@XR&[=\4<`_3L0$WH.ST%"^<_4$F M5LTCAZ@F:HA:HHZH)QJ(1H.LLF4!UWW4F5T:!92.'*(=44W4$+5$'5%/-!"- M!ED-RP*N^[5#KF'.J>E9*+\E$SHF:79'5!,U1"U11]03#42C0=;,LH#K=I#< M#-+L9:A*QLR.J"9JB%JBCJ@G&HA&@ZR&/."ZD_&+OI;H3CZYH3G"IF,GOTT6 M.FH9X\%E[CBAFE4-44O4$?5$`]%HD)6V+/LJG<",1\DZ7X:J!.V(:J*&J"7J MB'JB@6@TR&K(L^_C-Q&VC+@!.=/SC;GU*MX.#6>?D&>3[SS'CG&`H*IA54O4 M$?5$`]%HD#631]PGS##8ZI,5-V:2T7!)M".JB1JBEJ@CZHD&HM$@JR$/MB\_ MN##SNKNYWE`Z=O*;NK%J&B@[HIJH(6J).J*>:"`:#;+2EF5>W;K%P04!]S)4 M)<-I1U03-40M44?4$PU$HT%&PTDI\X9/=@M[4_R%R:&C#;D!N:^_)8>9_"[N M5)6Z]H3A,R!][6H:MI<3BC^3V4WH4&67Q:6V]*,X MMRPN)CZNSF>]]!.Y$X^LNBJ_?355I>J*'>/="[NX>1A[MCK&LA./C+J`4G5I ME5T6ESUR=<\:>#ZT&'L>9?;RZ_*34)7:*W:,EV5VB9?%D1/&D8"2P\,ET8ZH M)FJ(6J*.J"<:B$:#K(8\CKA!]++O@IPPJ@0D1J(>J*!:#3(FEF61TZ81P(R1Q=$ ME!VK:J*&J"7JB'JB@6@TR&@XS?/(XP/D4&Y32$#9$22_V(E5\P`AJHD:HI:H M(^J)!J+1(&LFSSU/F&':.?4H'2!$.Z*:J"%JB3JBGF@@&@VR&DJ1ZV6GGU/F ML("RP9-?[<2J.'C\M!*W-:L:HI:H(^J)!J+1(&O-Y;`T;3TQ>'QL2S/6J4?I MZ8=H1U03-40M44?4$PU$HT%6@\M["S3X>&@T>)2=?O)KG-.Y*@X0H)I5#5%+ MU!'U1`/1:)`ULRS0=;Q6M;?:XM5<8#,'2=4LZHA:HDZHIYH(!H-LF:6!=A3!MB`S`#Q M50G:L:HF:HA:HHZH)QJ(1H.LAF4!]I0!-B![!%GGE_JQ:AH-.Z*:J"%JB3JB MGF@@&@VR9I8%V%,&V("2T7!)M".JB1JBEJ@CZHD&HM$@H^%L68`]E-L`&U!V M!(FW=/P1)%;-`X2H)FJ(6J*.J"<:B$:#K)EE`?:,`3:@=(`0[8AJHH:H)>J( M>J*!:#3(:L@#[..GF#.&U("R(TA^NRM6Q0$20FJ\W5FSJB%JB3JBGF@@&@VR M9I:%U#.&U(#,``FY-;GKQZJ:J"%JB3JBGF@@&@VR&EQ23$/JRV^PG?G0F0;8 M@+*C2[SE&8XN(:VFUH#J.*UIB#5$+5%'U!,-1*-!UMJR`'O&`!N0&3R^*D$[ M5M5$#5%+U!'U1`/1:)#5L"S`GC'`!I0-D/P.;*R:-OV.J"9JB%JBCJ@G&HA& M@ZR990'VC`$VH&0T7!+MB&JBAJ@EZHAZHH%H-,AJ6!9@SQA@`\H&2'X'-E;% M`>*GE?BK6=40M40=44\T$(T&63/+`NP9`VQ`R0I>$NV(:J*&J"7JB'JB@6@T MR&@XSP-LMHL&Y![;$'\2'B=WXR=JA1/DJIXU\TN7QXCG_LAYCD# M94!Z0,`T2"\G=/@0T\XX#VYNQG_Q86_R&<8Y`UQ`3UGQ'>VGFNMXJ\DN7)Z= MGFV%*>K<(V,EH(*54EIYAA4FDW./GK(2JLQ8V<3[*]9*'@J>;87QX-PC8R6@ M@I7\-/S,L<+3\;E'3UD)5=9*O*E@K2P[$Y[S3!B0OE82]QM?E:`=JVJBAJ@E MZHAZHH%H-,AJ6'8F/.>9,"#W):-XW,+S_F+5)&M'5!,U1"U11]03#42C0=;, MLC/A.<^$`26CX9)H1U03-40M44?4$PU$HT%&0[4JG0K=L6WAX[K\A.R9<6(V M1FWRJ_BD;!X]!:;G.;ME-=]DU`.=P?1$9S`]TAE,SW0&TT.=P?14YY1E^O(S M]>/QH5KQ!#VQ-%(5F)YP[?LF=5(")B5@4@(F)6!2`B8E8%*2LDR).Z?_/=?V MU4L+L5:T\RP9. M?M6?E"4#9^XZ,5D"DR4P60*3)3!9`I,E,%E*668ISX)/66($K%:>V8$#IH$# M)B5@4@(F)6!2`B8E8%(")B4IRY3D*?4I)8RGUS-ZD]\-2,JF02)+<]>) MR1*8+(')$I@L@F!TX(3$G]U@+=5*".BD!DQ(P M*0&3$C`I`9.2E&5*\NCL+F]>]B6<:L54GEYB603`9 M!)-!,!D$DT$P&023P91E!I=%[&K%C#VQ-&07F)3XODF=E(!)"9B4@$D)F)2` M20F8E*3,*CF\("3-1D\F#M\6"1+<]DT"UD"DR4P69I9,HOC>.?B,`N)F\NF64A<# MIQ7GF14')G%@$A>8%1?OW4WBYK)IK20.3.+`)&YFB;A--@N)F\NF64A=CJ17GF14')G%@$A>8$7<<;^]-XN:R::TD#DSBP"1N9HFX?!82-Y=- MLY"XE&7B7/),Q26W&A^^W%S_^N%6NY!&;.&H%G]5584WFVA&TUP_3$S/;YV8 M]F`?=!,FGV#R&=CYX4V@>B).=BVHG1>]I#+OE=V6D%CTDMB\5S8O.44O.$`[SK];,W55V61<=GU7O01A8K+K MF1Z<.C'Y!)-/,!G$]&00=7(&)FN$X]'G8RO/,/2@OD19'L@X,`\R28FFZ%H/7>43=M1E\9GFTUV4I+? M4!7W)/G->QZ?5/DCT&4<\Y3QK.?Q^>JDBN,FVP8N.3^V#?YY^^.OC@5F!/L$ M;C>"9XE)&0>3<3`9]TR/:IVV@@2#23"8=`9F=*).\L`D+V69*A>14U5/[=0^ M4ELEGF4[=7;PD:6Y;%I[60*3)<_TF-:I3I;`9`E,E@*+/X'4H$.=+(')4LHR M2RXUIY9>N%.[R62WH<-+7;*=&C=^8MDD1?+\Y)+SO.0%IMTE.49DMP/D,Y3% MD2B?Q:[919\4AS(S$(M=LT."K&.NLE[L&F.4W1"'=[\\MB&>N6>'=\B881R8 MV;/)](8^?[V0U.D5?9Z9/9M,+^E#G=[2%U@J=&)Q^^@]?>BK%_6E+%/ETGFJ MZHD]6^N#P1F8W;/Q.IPJEL7!229+?A9Z4*5[+?I/JS3U5]=1^[?.]5>*9/>ELX\@.23*\#B8JO:$LSE5ZBUWC7#/C+NTO,>ZO#JQQS[)=&*=YI4^W M]]M=&$S&`],_B?'L7*V].I1%;3)>[)J=JV4\E)D=O=@UFZN,8ZXR7NP:YYH9 M=VE_B7%_=6"->Y89STXX.A+,9=-XUA@'D_'`8K*4WL",7M3)96#&)>HD#M.3 MN+0NL^1B_1)+_C+`6@J7!LJ^R4"*\6LZ$LQEB24P60I,_\3)G>#VT506]TF- MRV+7["0GEZ$L.M=1M=@UFZOTAK(X5^DM=HUSS8R[2X0EQOTEA37NF1V7)SSV MSF6)<3`9#TS[5V(\'LH.&U!#-91%;3)>[)H=DV0\E)G16^R:S57&,5<9+W:- M<\V,N\N#U/@+4Y6_RK`;PK-L0V3G#QT@YK)D0X!I0P06GP\BZX$9ZZB3XL", M8M3))Z8GGVF=E7=XH5`J[XFH$%Y`9"P%9J/""0ZCL2Q:(M,;N_T%BWM*<#)< MXWD@#->I+-[LTVN\BUVS0Y5>[>W+],S4:4GT;N]BUVRN>M]W*(MSU0N_BUWC M7#/C[FHA-?ZRX1K>:60WA+\0R39$=O*]K$)7D]G(M"'"=4V\J:UWIP<6UU_6 M42?%GEG%J)-/3$\^T[I,GKL^>$S>,R\"PJN0K#U_[:$GG4VC0JK`]))Y,*D" MDRHPJ0*3*C"-1C"I`I.JE&6JW/5!JNJI/=M?3U@EGNFYAHD2,"D!DQ(P*0&3 M$C`I`9,2,"D!DY*494I)9_4:Y2`20F8E(!)"9B4@$D)F)2` M20F8E*0L4^)"]Q(E/J1;)9[9[Q>=9ME*EN:R:3#)$I@L@I$2,"D!DQ(P*0&3$C`I`9,2,"D!DY*494I< M*EZBQ*=HJ\0S^QVBTYBLPY7%]$*L&)%D:>XZ#299`I,E,%D"DR4P60*3)3!9 M2EEFR279)99\\K66/$L?ZU.Y4[S[*GE,DE(")B5@4@(F)6!2`B8E8%(")B4I MRY2X,+I$B0^O5HEGV1$'%TC3B[)B9I:EN6LR<,!D"4R6P&0)3);`9`E,EE)F M+;E+CB66#O79YT:!F2,.V4ZWROU@BOM776!-@;4%UA587V!#@8V694I<+%PP M<,++KLS`B2_`2JXM3G%!%\NF02)+/I4F-F4)3);`9`E,EL!D"4R6P&0I99DE MEPB76/()TEKR+%G5RVIZ058<)%*".BD!DQ(P*0&3$C`I`9,2,"E)6:;$)<(E M2GR"M$I"JE22BA>EI]G=#%F:RY*!`R9+8+($)DM@L@0F2V"R!"9+*&M6=95B)O:(LF(BC>Y0O@Q+]PZ,.F;NTZC3/K`I`],^L"D#TSZP*0/3/I2 MENESZ3'5]T=U?'5]\?'/W?[^>O]=:[URKZ>>GB1;A1=E64L^@>KYWM.J:D2! M20F8E(!)"9B4@$D)F)2`20F8E*3,*SFZ_[+?/^RN'J[>O_VVO_N\O]Q__7K_ MZOKV-Z>ATI.Z$_[J;O_IW>L/FL[%86):\[G/W+9R;8=;%6RK7-O!&-O6KNUP M>YMM&]=VV'?9=NS:#D&*;5O7=OC4`VT;UT_7GZ5UV+A^NNHJMKEUU^5'L>W4 MM1WN27!^9Z[M<,>*;>>N[7#G"FTK-TW]G*(TOY6;IGXH4&QST]0WYDMME=M& M^NIXJ6WCMH/NWA3;W';0;8Q2V\IM6_UZL=CFIJG?Y17;W#3U`[5BF]M&^EE6 MLK)%H>5VGU")!>MI-J47K MJ@?`%%I.U4>/>"RUJ(^>>EAJD1\]]:_4(C]Z$%ZAY4QZ]""X4HN&F)Z-5F@Y M51\]_;C4HCYZ('"I1:[UT-M2BUSK.;"E%KG6JE%KO6(\%*+ED!/S2ZT;+6F/DSGR[;5FNHJ MMM1'2ZT7#I5:M-3^PA]3TU+[>[5HT5+K&0B%J1VKCSYJ*;6HCUY(6&K1FNH= M?866K4:(O^>/)=`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`:RMM=TW3[4?ELXD6P[65EE.;H'+; MH=2F35"Y[5!JTX\AG+/B646_.SD<&PO=V]R:W-H965T&ULE%;;;MLP#'T?L'\0]-XX=BYNC#A%NJ+;@`T8AEV>%5N.A=J6 M(2E-^_QR9I7 M\$LF5 M=]Z)SN7^LQ+I-U%QR#;4"2NPD?()7;^F:(+#WMGI1UN!'XJD/&.[POR4^R]< M;',#Y9Z!(A06I:\/7">048`9!3:,1!80`#Q)*;`U("/L):8!$(O4Y#&=S$>S M<#SQP9ULN#:/`B$I27;:R/*O<_)M4`[+AO;`#%LME=P3J#=XZYIA]_@1`!]B M<@AME->"A.@09(TH,0TI`7X-F7U>^6&P])XA&TGC<^]\X'GT:3T\B*8-"<+H MAG0Y/0=F=$9F2+P-Y=X9NC3'0'HTD_^A06?(=S?X<-*&[YB=S[3C,VL]>LS@ M,EP@.D-Q^M1'28[:.0V@AD;I4F.Y@SFVVY4N/*09S]DHVCPW%K@%QWJ&T\N" MYQ=8)[;+WZ'%@WW:QM*MKQ]>R3/T8U?LVXV$SGVJQN+N3[=!<2"?WIG@=D`6 M\6"?H['TYX4W_8JFD[F!FL)P0-OY[0PYLC2FOJ;%%4UXUX=K.I\5N.5.-+DMZ591 MR=66?^)%H4DB=[@!`]@AK;7=SNL`TW1JGT9KM[6]]A?8FC7;\N],;46E2<$S MP!R/0@A#N;WK/HRLH7M@=TH#^]*^YO#_B,-*&V.K9%*:PP

^T_KM4_```` M__\#`%!+`P04``8`"````"$`!88N$2<&``#P&0``&````'AL+W=OX6/IL%OE?M MRG99[]8+_Y^_/S\DOMVNY;OZFJP0,+NW[A M;X9A_SB?]^6F:HI^UNZK'5Q9M5U3#/"Q6\_[?5<5RW%1LYWS((CF35'O?+3P MV%UCHUVMZK+ZU):O3;4;T$A7;8L!^/M-O>\/UIKR&G--T7U[W3^4;;,'$R_U MMAY^CD9]KRD?OZQW;5>\;&'?/Y@LRH/M\<.)^:8NN[9O5\,,S,T1]'3/Z3R= M@Z7GIV4-.U!N][IJM?`_LL=<1/[\^6ETT+]U]=9;?WO]IGW[K:N7?]2["KP- M<5(1>&G;;TKZ9:F^@L7SD]6?QPC\V7G+:E6\;H>_VK??JWJ]&2#<(>Q(;>QQ M^?-3U9?@43`SXZ&R5+9;`("?7E.KU`"/%#_&WV_U2]4/ MGVMETO?*UWYHF_]0Q+0I-,*U$0'T^CI\-;UXCB#COCX50_'\U+5O'B0+W*K? M%RKUV",8/&P(;W_%B@#@'1EA=S;C>6[$]>"4@G@PHHS3'E1B MQX/2N7.&F@@+(XU90-ES5+$GK[#"6(!P$6`7?CBPHY M;L#`$S@UXIQ&6`R:RSPW!:$+$P-/`%,*>!T5)78 M!7/K`C4()I(DE.;&"&8+8D`7)F<)&8,6%)KEQ>&C1H3;2,'8Z M=^XHDE2^%V75P:^GPWY/Z9P$RQB*#K61Q"?1)0(960+J.=7`KV?#=F^S";=J M&6ITXH5!ZG@VIP(I4E->%,V9&!>"BDV>H!G#.J:H.<14!"=HATFA'F0>4F:2 MEI(Y<^*Z6<9.!\;)TX#6:.>E$>#UE^G/HL="HTTZ+)'H-VSDLHYTUCA)V9 M(Z$3RTR+#GZ,7$%.!2)A@:ES`L?O&B3C*F>0A.8.6#1:I"%C<3+LJ"!DS)0= M9;QKF'!\-[#KFH5NS]$BS9BFJ;.)G`JDX-SD-(6$&]G]\+K2YFJ5,_%"XP;M M2!2=3S4L;FWGO(1RJOYN]>TK.7$J4&B"!EX%-L,FA(5[A8HX$WC1;VENV"1V;H&(_.%!VGDH.?: MC$Y4>%6.S62G='>-&'XZ8EAD[J`I4:09)'C/V4>NS4R[[Z[QPL^,E\B4H@9$ M$0*>Y4/!--]=8X7C."`%$KEC18MT_LD(#G'HPVU.%"*,8VX2@8;YIJ'"SPR5 MR!TJ6J3#RYD\>6W2"G1?8H)/R-0KG%V_TT]?H]JI6_>-(],B)!-1DCAM/"<" M)H+$^)6R.9/D`MN9"1(YM\X$BI"-A3)QW)I3@;#+BK*I+G]S8Q8X&Z"YFL>9 MR!T@6@2][2ARY]RDA'*J1FYQ7O`AMGU:%^[@$"C2>25-8F%3)I?CV%RF7*IU M6UQJL$GHJQ?XL.%3_YF:P[XB#E-APG]3$LKIC`_%&5T^$3PS1BQ/:$Y[C`@> M*7'#BF>EAS2<-AR(\%#P!LR]"Y[%'"X+A`3L>1#=5 MMZ[R:KOMO;)]58?G',Z9CM\>#_8_#H^/UZ`\_9]L:Z^%MVZ MWO7>MEJ!R6`6@[/_:I[_!P``__\#`%!+`P04``8`"````"$`9XZU$F0"``!>!0``&````'AL M+W=OK;*N\V`:?.7/.S,#LY:@JL@=CI:Y3FD0Q M)5`+GP]&7^\9.%94CJB!,,MMF<_3_J3 M&=MC3<49LPP8?%XQ'8*AFDX2RKB5]'Z1+YD]V&?V1?=2EF'C-DWO_33]MVDN MSO^?S@=AA6Y-#.*./R@(F,$-9M@AWAA%R*W1QQ3XH)2BRVL9!TG''Q0$S+AM MQ"2.KP)#^C#G80P4F`(^0559(O3.SW""8=UN=[P6O?:$=#]PO!M>P#=N"EE; M4D&.H7$TPGDVX8"$A=--.V0;[7"PV\\2[S'`5L41@G.MW67ACV!W,\[_`@`` M__\#`%!+`P04``8`"````"$`QG']RCT+``#H1```&````'AL+W=OM]^B2!^J)+/LW,2=YL<2]:M(UB\K>OCMU_I]\K/=[E;=YG$J M[H+II-TLN^?5YO5Q^I]_RUD^G>SVB\WSXKW;M(_3O]K=]+>GO__MX;/;?M^] MM>U^`A$VN\?IVW[_<3^?[Y9O[7JQN^L^V@VTO'3;]6(/OVY?Y[N/;;MX[CNM MW^=A$*3S]6*UF=H(]]MK8G0O+ZME6W?+'^MVL[=!MNW[8@_CW[VM/G:':.OE M->'6B^WW'Q^S9;?^@!#?5N^K_5]]T.EDO;S_XW73;1??WN&\?XEXL3S$[G\9 MA%^OEMMNU[WL[R#,[%O)A#I*>'YQ6<@9%]LFU?'J>_BWL=%]/YTT,O MT']7[>?N[-^3W5OWJ;:KYS]7FQ;4ANMDKL"WKOMNT#^>S7]!Y_F@M^ROP#^W MD^?V9?'C??^O[E.WJ]>W/5SN!,[(G-C]\U]UNUN"HA#F+DQ,I&7W#@.`GY/U MRJ0&*++XU7]^KI[W;X_3*+U+LB`2@$^^M;N]7)F0T\GRQV[?K?]G(>%"V2"A M"P*?+HB([_(DB=,\NSY*Y*+`YRE*F"+$D9WF0B*Z(:AP*![ M5>#S$"2\.4CJ@L#GX7SRNYO/)W-1X/,0I;@3<7"+)C#9^].!ST,,<>U%GMN$ MZ?.O7NP73P_;[G,"DQI28O>Q,$N$N(?`)O%BT&L\\2#C3)_?3:>^*]`[F"T_ MGXKD8?X3$GSID'*(I`%&JA$DQ4@]1`J"-"-(AJ/($23'B!I!"HSH(2*"TRG- M0<^CJ#"#J*@1K`E^44VGQRG\/(HJ`H''4%HF[R47XG3T_K)4YZU9',>X MG`B1)#D1JCDG9E$1)_00$A%Q$9PIT(]!(2")PJP(R3@T0M(X#XOH.%(D(RPA MM\MH.E$9PV/\?I"E95(K8U#`:6"@.@>,DDE!KD1M"5B>CE>+S("&)21+*);0 M/@*)"4.]74S3B8IYNEA63,LX,>-`9$2(R@+P\Y)4-4LT+"%90K&$]A%(3%@A M;Q?3=*)BDKE16B:VF1G3M#RT7E;2$O9B9$&01>1B-&P(R1**)309!M0/QPF& M=(1-]78=32>JXRF^34K+6!TBD9(%H++-<+DOIB1+-"PA64*QA/812$JH+&Z7 MTG2B4I(-MK2,34DR]ZM#VV4=+>%6AR2+Z9;#1I`LH5A"DU$DIXF%-#1VZN9B MR'2B&I*S+"WCR;>*)6I+6"7S+*5[5L-&D"RA6$*?CV*&AX&D++XBI>E$I225 M6FD9*T,811&=VK;=(W7-$@U+2)90+*%]!-)20.UX>U[VO:B:I*@M'61G=TBG M]['U\OQVB)O@(DU#4&UM.4\F2>\_6YL`8`JM?CIC$H MP4L'63FB(*:SM'*`+S]YI.$1R2.*1[07P:*:LIZ(>H63M&8`BTIJ[5)8R&U! MI+4ZMIZN"ZD&:H>X)$U$D9TV@+Y>:/@@DD<4CV@R%+C/=CH?K*>I[(F>5R2I M]0-8S],TL,61\)F&'JEXI':($S4=I'K#QY`\HGA$>T:")8591R6](D5-+[*. M"K)2EL)"GFE=\4CM$"MI&A<)J<4:/H;D$<4CVC,2+*FI]&_/4NL/<)92*V3N M?X+N7DG/?09,I<'MB)H/TO"(Y!'%(]J+8%5-U7^[JM8K8%7)4E@*GZ%P<_^` MF!M[H.K1NO7-M8M@DS04<(]GL.,?`EQ5&]<$`\B>43QB/8B6%3C!6X7U3H(+"KU M2^)@1$P*@J@X!2O4#(KBYAHUST+:O3FV>_+S,("+B.*C:"^"M31F@&AYQ=9D M+036DAHFX?,9;L9;Q$WI+!()"5+S01H>D3RB>$1[$:1J^"7CU/>B&SY9XTH' M>>9C=43Z=30C^UOMFEW]%!992&9!T7@H$2QA%XK2\$O.J>]% M!`W)I"T=Y!74.K"C8CG],JCF@S0\(GE$\8CV(CA-80+3R<^7^J'I154]7;=^ M9I<.\JIJX[A[SA&Y+K6+8$7/X0L=`C3\(22/*![17@0+^B7O%(YXIY!Z)P=Y M!67M5T0>X'C-,B"LPT5RPIG?9ZGS/>9AJ;Y27U3:"&OG"Q2 MNRCN%$14A&0>-/QQ)(\H'M&^H6`QB7-BQ!QQ3/2+U=(\7\$X)AZI'6+%3/)8 M!*08:!`Q&T,D?QS%(]J+8#6-Y2#UTQ5+J#4JJ'ZBU6(9LFZFXI':(5;5(H?' MJW#1VO`Q)(\H'M&>D6!)O^29PA'/%))S+1WDG?6L):KY*(U#K.I9D08Q6<\E M'T3QB/8=!XM*/!,SZT>\$JT2RY"U*A6/U#S2\(CD$>40>TEFD0C@`1!2^&H_ M@P4=,4Y73/P1XQ229:X,#\:IK]]SDCF5:[8G`@^QD.XU:L\R>'*-/@'5(&0F M\C#)R%21&!E]XN;U%L)I?\DO1V#=-)/U*!WD$ MJ7BD=HB]-DF8Y;2ZYV-('E$\HCTCP9*.F"7^3DDT8I8&-_$=Y)7T8)8N6O+: M1;&29ADL;V2GYP\C>43QB/:,!$OZ);L4C=@E09:OTD%6C%D<#Q_%040/D!2L M'>&Y+`V/2!Y1/**]"!85QGN^D)HG:\W"P2RHIA=94`79'LO(0M:Q@Z@XORK4 M'-.*IT;-\)0GV;<:U$ZNA?0U*E^COM"(-2.>Z$K-1KP1O8U11KPW:#-#PB>43QB/8B6-41;W3%BCGBC2)25Y01[XV.B*FB0%6JIN/`L'A?43QB/8B6%3B@J[[JX-HQ`U%](:2@[RB'@R329JS.MA^O>D" M6,F3(!=D>6V.1QC).>EK5+Y&38Y;7+H%'WW)\/2]R+X2D3,K'>35[MQLI'F8 M$_UK/D;#(Y)'%(]H+X(2,B:NY[J-I^]%127&I7203]0C8C(J)?MQ[5IM0D*! M-*@G$0#EP.`+47D\P,6J5?&(]B)8SB_9GGC$]IPMR_8+#0=YY;1QW**9P6/P MQZ7=3G$^1L,CDD<4CV@O@D4=,3Y\01F/&!]Z=[QTD%?4@_'I%\U!CMI6MVB& M24ZV^88_@N01Q2/:BV`]B>OQ%^;QB-NAS\N6#O+J:.-XD-I%L6+"W?T;[C8%&).6)2 M=,04T5O_96PA[VQGD9J/TO"(Y!'E$'M)9O!E1CJPN-K/8$&),6($'3-$]&91 M;"'[-\-A1';N"C47@GJ"&K7G\)!W04O^!B%FMDZ8:,S!,^-ODTZJ#-20&B='0&AJH7TY_U4%%*N'5#V;==!,O@KODY`0K1(", M43#XBV&'>#*[X1')(XI'S+LL+F\$5DW[K@K[KH"/Q6O[C\7V=;793=[;%U`J MN#/O8=C:-U787_;=1_].@&_='MXPT?_S#=XHTL(+`X([@%^Z;G_XQ;P+X_B. MDJ?_`P``__\#`%!+`P04``8`"````"$`D=6S`+$"``!K!P``&0```'AL+W=O M)/S6C>0T2>P]&+U\<-RJ\V]K0`<08;&9K1RKETP M9D4%BMM(M]#@FT(;Q1W>FI+9U@#/NR)5LU$<3YGBLJ&!86'>PJ&+0@JXUF*C MH'&!Q$#-'>JWE6SMGDV)M]`I;NXW[9G0JD6*M:RE>^I(*5%B<5LVVO!UC;X? MDPD7>^[NY@6]DL)HJPL7(1T+0E]Z/F?G#)E6RURB`Q\[,5!D]#)97,TI6RV[ M?'Y)V-J#:V(KO?UL9/Y5-H!AXS;Y#5AK?>^AM[E_A,7L1?5-MP'?#,FAX)O: M?=?;+R#+RN%NIVC(^UKD3]=@!0:*--$H]4Q"UR@`CT1)WQD8"'_LSEN9NRJC MXVF4SN)Q@G"R!NMNI*>D1&RLT^IW`"4[JD`RVI'@>4>2I-%DE,[F;V!A05%G M\)H[OEH:O278-+BF;;EOP62!S'MG04?O]36KZ-&37'J6C,XH01<6M^=AE<;Q MDCU@IF*'N0H8//:8I$/V@(F&,-K^3@_Q*#;_#?_>"+AAKF`PT!F$F*#`E?(*Z MMD3HC1]H"7[,_=-^UEZ.NG'9O\!9U_(2[K@I96-)#066QM$,>\&$:1ENG&Z[ MB;/6#J=<=UGA3PWPNXTC!!=:N_V-G\?];W+U!P``__\#`%!+`P04``8`"``` M`"$`)IW\-+4"``!O!P``&0```'AL+W=OY$ M01^$I9?K]^]6>VUN;2.$(\#0V8(VSO5Y&%K>",5LH'O1P9M*&\4?<:UZH-C*5KJ'@902Q?,O=:<-V[;@^SY>,'[D'AZ>T"O)C;:Z<@'0A3[1 MIYXOPHL0F-:K4H(#+#LQHBKH)LZOXHB&Z]50H-]2[.WDGMA&[S\967Z5G8!J M0Y^P`UNM;Q'ZI<00'`Z?G+X9.O#=D%)4;->Z'WK_6$[ MZ[3ZXT'QD)3G&E*[9HZM5T;O"?0;T+9G.#UQ#L3/YP))(':#X(*>4P(R%@IX MMTZS9!7>@6E^P%QY#%Q'3#PB0A`=E4'M=&4$HS)6!5.Y\H&IS&,B,YGT+3(( MAK).DD^S=$S?*WO,8H)9CHB9,D!.-XA@Z,%<^M&2E_:@$Z1A'J;2.&E)AE/U M2H/QW)#%6.=#9*J99HOG#6=SU9=G"<%SJ4/$S^MT4F#@IFY>YD7PG/<0`2?C M2*;9?WJ&N_;DSP'!O-@3/S24.D>GDIUGV?$-@ MF[W!SH">BQU#$T-^O?D=HH2IQ4?1MI9POS6GQCII:=):VH@#,:ZF3\PO0/3O>0*"P][6#1#;<-_-@$;(8H@*)6 M6KOC`RB'XZ]R_1<``/__`P!02P,$%``&``@````A`!WI!$["`@``D`<``!D` M``!X;"]W;W)K&ULE%5;;YLP%'Z?M/]@^;T8"+FA MD"I=U:W2)DW3+L\.&+`*&-E.T_[[G8,3!$V69B]1./G\7!3MEYU#?HMQ=X,OA-3JOUG+;.OLA'0;9@33F"KU!-"'S,LP6%V6KU=: M[0G,&]"FY7A[@AB(CYX<0^_R7R;!'9)LD"6AWSEPF&B`F?:(45"`7!\4P3"DL?3;'CO0%=)P88;2&#Z MZUST_3Y4AIK#V8\"S\:JEUN-X+'4H>(N]/#&P,4;IKG,B^`Q[Z$"2?JK&4V7 MYV>&RWCPOER60O!8ZE`YC;`<\[J!++QW!X+GQA*'RO`-B&;^^32P[OXC3H<> MBQU+@T!N_[DE4PM=B$^BJ@Q)U0YW6PC;H:_V>W<3X@O\MA[%&[>/6?\+[,.6 M%^(;UX5L#*E$#IR^-X<^:;=1W8-5+1B%K:@L;,+N:PG_?`(VA(]-S96RQP=0 M9OU_Z?HO````__\#`%!+`P04``8`"````"$`JL*7#I,1``!/5@``&0```'AL M+W=O87M" MK)-D;<3&Q,SNLRS1-J,ET2'2[>YO/\A*(`$D2@<]W0_C\8]`'DADXI]5-#_\ M_8_'AXO?=\_'_>'IXV5R-;F\V#W='>[W3U\_7O[KG\W?YI<7Q]/MT_WMP^%I M]_'RS]WQ\N^?_ON_/OP\//]V_+;;G2Z@A:?CQ\MOI]/WY?7U\>[;[O'V>'7X MOGN"3[XGQX3J=3*;7C[?[ITO?PO+Y/6TYI[O'W^[/=\OUUZ?#\^WG!YCW'TE^>T=M#W\QS3_N[YX/Q\.7TQ4T=^T' M:N>\N%Y<0TN?/MSO808N[!?/NR\?+V^293\K+J\_?1@"]'_[W<^C^/\7QV^' MG^WS_K[?/^T@VK!.;@4^'PZ_.=/UO4/@?&V\FV$%_O?YXG[WY?;'P^D?AY_= M;O_UVPF6NX`9N8DM[_^L=L<[B"@T7<\-7O7Y.7%W8_CZ?#X_]XH<8,*C:38"/Q)C>17 MZ;Q(BND9K>38"OR)K22_T,H46X$_J97B*LDGYXP$-L<0%/B3VH!!O3,8":RA M#ZE;3!^NQ=6\*/+I'#+AC6:N_?H,RUW=GFX_?7@^_+R`/00K@&L(7(@>!.ROB)YKQD6/YKTBP.%, MHU"1!;E4,:ACT,2@C4$7@W4,-C'8QJ`70(4J^VM"Y9J!7(4_.-,6$QV43DZ4AE1(X(]P].23/(QG4"%U,*)Y M-(%(MZC$M,&(W+I`I-M4][8.1N2V"42ZQ>=C,"*W/A#IQJNK8KV(8NUEX)43 MEJ=O^[O?5@>(#]33D37(0.YY$>@:T4N`1"2Y(162"1SG8@VB35V3%9^W#2'E MF$2;NB4K=NP(:<=H6ZW)BATWA+1CG/=DQ8X](>WX0MX[I7]&X@_F.NR$H%L. M:1*E=UL2:'12B[&T;NVC&[FD7SW+(!]=LSX@&G*6\IM3<2I_[??Q`-YM%Z^/N# M/(K02J#*HIK0/$RWL:BUJ"/$A]_:HHU%6XMZA71DG-@_(S+^;@#BG19BY:Z< M[LS0F1H=B25;D6.%"#-UGDT*^#SAZCWTU[(5.78TA)"I>33(-5G(U`SC]JDY MB7RVUJ=GQ"-\.37=)>2,U,0[BSPI/((\Y.[R>`N5[AEEG*T>9:`]PYZ7X_0: MCQPY6QM&[)BGT=JU;,5+$`;!CEG&U7[H<4V.G/D;1NQHAKIE*^JQ9S3NJ#># MN]3(M?@EL9?@U4@N$2*U1])(5Y7DR.E7(9J"_VM+Y)M7NP1[G$C/D34RGAV- M8B+38F21L`,>[&;4)G=9DLLTHKWA,3B)[P3O5G(]/!)'=XE6 M`E46U83D9L"V&+76JB/$.;VV:&/1UJ)>(1T9=[.1D?FU!/;W(R@:M(U6"2*= MP)&^+]F*'"M"$R^22`MFQ`'?6$8&,/"9O-9T+.Z/"?=[.#](L3$Y%,3(LJBVI"(C$M M:BWJ"(G$M&ACT=:B7B$=&7=7D4?LZ\4GQ:N-.$L)J<1,(EU9LA6M7X4($S.% M%_]&+Y.)S$L_`C@B95[R0>7ULG7L:`1!+T]-7N+D9%X&Y%*LN!*/#H:.MM0J M^_0*Z6"["\\9P?;W(UFXTG!E$K,WXIBM.-C>\0UQ3(XR6;%'*!CBW(G%L77L M"$D=;W476]%0-XRX1RN[V(H<>X5TX-VUYXS`XRU)9GFX./&@ M6=N:(SE,AE9_$YQ(VTZ-5C!.?7!"<9MGDREK&;TP\74L7ICWB=O47M,003&F MR90651;5A#AO&XM:BSI"W./:HHU%6XMZA73$W&5"IO(;&@+O'C)GPW5$YJS1 M$,&*XE>E'I&&F.3Y/(M2O28;*2+038L(3@@4$<&*^NNPK=?$K1GDAIP6>!F+ MOS"U90/JJ"=$XC8M$J$]=/C==46&WR/NW5_M2ET[PZ5#+,(BNFVNT.K5 M[]RP# M"K,0+L'$8F0LN_10X^M-?&2]ZZUN9F\]A/0[VRS*B3*8\9:N`@.=$61(GK"K MGH'3V3*'WP@VRG+N;Y5Y-,N'35:XI^_ZX7N)%N+XK1`E\(C;Z?O)5<:U1(_/ MJ>`SQN=%L]0QF4=T#<_&!HA>HB:C5S+Q=6MRQ3=W/3ZGYLX8'XH_&3^/,'XC ME[$R\Q8J?MA.B)]XLJ#'YP34&>/S>DO%SR.,7P%?ZK$+C%XR?H@X?GQ3U`-T MFN&,`:+$D`'TB`*8S](\4C-EYDU4!+$ACB!7/3W`6):\L4.L_'!W/SC?J5;F MLWG!?0T5KT03N#KP280-<03Y_-(#=(7OC`ABG901]`@C.,_=&L=[V)NH"&)# M(8(OK7!<)M\(8*B&%(I5YA%MX;$=C$XR?HA"_,1C!Q6__+QZ,YCK>H,(XS>V M0]!"AH_:">&;OA"_/"XRK\=O,(_&YPL,)>#(#B8G$3]"(7ZSE\9W7@G);0E! MA/%+AF^H1/F')BJ`V!`',/CH]3VOA.2VA""B_!N+GZT@U$Z(W_R%$IR[L_S] M^WVQ0TXR+W5E M>2FH[GC_S\>,14*.F>J&_T)5.G99+W-OI**-:+A*ZOR,"TP_-0>(3L M6T25<(56K]XBV(9.X,JBVJ+&HM:BSJ*U11N+MA;U"NFHNNKTGR<`UCB9`%@) MH;RPO,YXZ_B"GJ,5/SFH$"7PDMII7OBN2?Q5A]IZ-814=^+]H+\QDQ5WUQ%2 MCN*.KJ/EBJ6,UALUQIE'9Q`B>*F,LXN_+E;FW@1NV)Q7'M');RM[34[\)*5! MQ)>'*/@M^7!'7?#Q[X_S;"K>E*A0%.?)@<%/>$HT40\S:L( MX3=#$WAR''G5U#"?A@UY02T4V1C)RY:M*/(=(^GXPBW,'1=GI,=@'L4$[[@A M/:9%-+L2O61Z(,+TF,(S\6AF-3F)]"`$.U"$A,6SWS%LQ2'Q8W1/@-@QYTJJ MT^0\U5-8U4/(O4X5_7%!\R=),./':%5@_@ULGN6+:?S/"FHT`IU),VR"'Y1^ MT654)%IA1JZ=8-*5%U%'YSS-55C-10BBXS91.DFX*PP,.L%K/QIE%;SXP*Z1 MJ3B0:QYCGP(U&`]WA0BT`\8".?"I6Z`@/ M\R@Z-;=%J+&HM:A32$_<2;KW%\T"E:-<:X_4R^$\C\I9B8Y@14.O$.'!./+0 MJ$8+(4$;BUJ+.H7T?-\2JN]+^:!3:3:KPB/W[)77V;Q<9RMRK!"]\;5&M!(/ M5QJ+6HLZA70HG+R32_]KN]^+1/FTK?#HK=T?K#@4V%;8_>G8[C=^#7=(3;46 M=0KI2#@%]UHDWKG[41O*#%A$)_ZJ\$:N=(<\,9LEV-!\*G8C5%O46-1:U%FT MMFACT=:B7B$5U&FL07UZG?UF:6AG$&(+TJ(*D1*2J1"2OA23(]>M M9M1Q_H("==_$4K/YI3-H:$5K=41JDEZ^"E2A%;S'0WT6I55-SX M7JCSY./4RD="P(L>&T;BCGF"L'M_( M1"L3IQZI0I'-HU?P)5O1."M"4`K$!.-[%5N18\-(.K+`U!.,1>$;$[3B;QID MG>PNNL:5;$7CK!#I%8Q_P:)F*W)L&(D>Q7MX/<'SQ)^3*-$3$T1Z!>,'=B5; MT3@K0FH%XV)9LQ4Y-HSD!'E3Z`G&:N^-%;2R;HI([<%%M)5*MJ)Q5H3"HW/Q MZ@;/3M^TVG_86W`2.EI/S(D@605^M;BBF!+[*(]GMX)GVV[=7Z^MP88C8%#- M+9%58U%K46?1VJ*-15N+>H5T5)WN^BNBZO4;%%W.T1')XJU>#VNPH8!54X-J MBQJ+6HLZB]86;2S:6M0KI,(Z&U>"9_YNP-"*+O*(X/2AZ)065>3XRC-K\F)) MU!BO:<;GMI[>>8IL9A49(O7];H*(L#(]GC"^H3GJKH MH^R--;/B;&AA^"?=LCLNM+AF0<+Q!!')Q6;5DN%O04G4\?];RKZ']E[W#U_W96[ MAX?CQ=WAA_N]1/C&\:HMA/X)7LTKW''/FD@-;@(8']Y&8Z6=Z` M2K*?P&4>1CT\]XQFNIHFRY4/=/0)7&&7Y>@G-7SB[G$C_I"S=2P/[ M";P^6;I7!_83>(NR;$8_@1P?K`ZY.E>YL`GUR'Z,//>7Z__;K[G]OG MK_NGX\7#[@ND[V0H[<_^!T']7T[XCSH_'T[P0YY0QN%').&'6W?P@TOPKU(O M+[X<#B?ZB^L@_!3LIW\+````__\#`%!+`P04``8`"````"$`^4HMOLL(``!B M)0``&0```'AL+W=OR2R28H7V`XL7K0!LL!BD4V>:8FVB9%$@:3',W^_U5W=[$MQ/++CETQ\NJK8 MIZJZ>$CQYM=OI^/B:],/;7>^7?HK;[EHSOONT)Z?;I?_^Z/Z)5DNAK$^'^IC M=VYNE]^;8?GKW3__=YF?:K;\Q(C9/TU,;K'QW;?%-W^Y=2<1PS2 M-\=ZA/T/S^UE4-%.^VO"G>K^R\OEEWUWND"(A_;8CM]%T.7BM,]^>SIW??UP M!-[?_+#>J]CB#Q+^U.[[;N@>QQ6$6^-&*>=TG:XATMW-H04&/.V+OGF\7=[[ MV2X(ENN[&Y&@/]OF=3#^?S$\=Z^[OCW\WIX;R#;4B5?@H>N^<-/?#AP"YS7Q MKD0%_M,O#LUC_7(<_]N]_JMIGYY'*'<$C#BQ[/"]:(8]9!3"K%C$(^V[(VP` M_KLXM;PU("/U-_'O:WL8GV^7P685Q5[@@_GBH1G&JN4AEXO]RS!VI[_0R)>A M,`B304+8/:XS?Y5$4;A)8HCRAB>LBLO#O](3&O/*J\;2%_Z5OKZ_\D-O\_.= MKS$+(JE%/=9W-WWWNH!.!9[#I>9][V<05V43&4SY_5%Z(:\\R#V/>4+%/X,FC M<)YJAUL%:.+,(:4LE$OA`J4+5"ZP,P"+5/`II'@4.`5&\0*6V"RV:!-!=J<* M1[9)/IE,3`E2$J0BR,Y$++9PV#ZAA#P*-#M<96(2)K'-98M&;]*=3":Z!"D) M4A%D9R(679@0)MWY^:8.(#<6K-1NMH@$R=2K.4$*@I2(,)A)4W98Z-G9J:1; M.H7>S;DEVLWBM;%YX<19\;$Y/K?[+]L.K@Q]-L,W@,F"\X;'L.DB8M(E2$&0 M$A&6BI'%/#]TF$H/@ZGK$4P>%DD8A=<7CQO;;!")X6)3&8+`'9>3D:IY09`2 MD4#<4D7J*D1\@Y)I8Y'@DLFX-\Q4!&X\JB3C MB25!2D0V"?9B%#KSM<)ULW"(0''UI1G3H\QBZ8/5]<44UC9/"<5V%9Q-YMIJ M8DJA4D&AX!I%OEM,:6!6T_9A?L)TDFVF7`(8;?NA`>.CCH#;A.*QE9!3:4?E MY-I*.184*B4T%=OS]+#$=I869KDE=&6]N6;XVUE`X6%E`2&C,KE/H()"I81@ MSG-Y&`1>Y&B,BCKM;"<6Q(EVLHO.5<,;=/_H+M#.LW<58X9Q58#'6Y^HT+BD M*,U66KVI#K2-;@-3V(A();6J*+2S()LU%P\&Z[*H%&3<;!0DK&PR7$089/BY9;#E]SZ*H!:Q6"*40I\: M+'4G29:3E69)H)(_:D*+)#ZV,3PTTJ,K3=B4YYWMQ39!F.K!86>!"XQ/R`+J M%"L+"*6F\@V"=-(O,@N3E` M*Q(C!S]I:]0O%E6$[(*[,C;W)RM-E4"EM$IP;D&UC5V+E%7*PJPWQIEULJER MD6)0Y4T?0)[>V_2H=:P<(&27.W0UI#]9Z1P0J)16LMPLWJ2DW.B4F.66$/8( M8V&H3YR=`ZYC/B$'4B"9XPTAIP]<"0KW6'ZDP4KG@$"EM)(E94F8$-&"3HF. MLY-.,!/UY/FA1&..1/M@+X@PMG:3D-,+SOYS;37E@4*EA&0O^%'D.7$J96'T M@H*@LZ<)_.,\S`BX#YP)D"BN5I>0TP]:1^((U%8Z#QC+:)%26LE^\#T6DSR@ MD]D/TNG*?N"ZRC@7;X]!ABK,'`$22O337TZA@D*E@O2+KDI!1G,K2%A9)YK- MJ+$/W,I%&*>3440YG>P^A4A'L-(5G!P55$HKU!#G4"!DG7,"%=+1L"H59$AV!9GG7,:BDIUQF?.W":%6LJHJY9-^;LC% MI4!W:ZB@4"FAU,,7"TDK M6$)]-PP,=20.[U9:O?F8J6W4:2XH5%*HHM#.@FS67-@8K']R(T(99-53RBE3 M!A'".;R&%:=4=V-!H5)"<"=5E"L*[2S((L-?GUQ/1EC;ITU"J6Z@7$+&G@H* ME12J*+2S('OG<[HHX;]ROO=Q(:#22$(IU&!2:/"4ZCP=:BN5_()"I0IOQ0I< M>22MS$<&%0N?M5@0_NAM9N!((WY#>?L M*+2S(+NV,XKI_810FY@G#WZ)%Z-&C\V<0@6%2@FE,/MU/]`:2C6DSP+_[5^< MXEB,X+D:XD_[^"OTJ>F?FKPY'H?%OGOA/]M#CNYN)EA]4Q!D]S"XH>F<%7@9 ME_$79'3EGB79/6R&KL!DS?BTFUL),ZZ0YE8B6!'?$[@[8"FLB/RZ*X&?\>-! MH\$W$O?B!NMZP+<3<_9;!AN>B;,%\G,,[\/L'EZ=T@MOPPQ^<)S!_3@KX#W& MW$H"*[/)\H$XOI]V:3`/4B*>.L@*I`3')%D)8&6.S!8N,YM>'ZX"OPK,[1FN M`F_+YU:@P/`*96-K"RF5N)LNTH/2,5Z^CKJ[O\```#__P,`4$L#!!0`!@`(```` M(0"N2(^?O0,``&L+```9````>&PO=V]R:W-H965T7^7[>G6=F=IC-IZ>FUAY13S%IM[IM6+J&VH*4N#UO]>_?[CY&ND99WI9Y M35JTU9\1U3_M_OBPN9+^@58(,0T86KK5*\:ZQ#1I4:$FIP;I4`N_G$C?Y`Q> M^[-)NQ[EI7!J:M.QK,!L0]?D_<.E^UB0I@.*>UQC]BQ(=:TIDL_GEO3Y?0VZGVPO+T9N\;*B;W#1 M$TI.S``Z4P:ZUAR;L0E,NTV)00%/N]:CTU;?V\DQULW=1N3G7XRN=/:_1BMR M_;/'Y1?<(D@VE(D7X)Z0!V[ZN>00.)LK[SM1@']ZK42G_%*SK^3Z%\+GBD&U M?1#$=27E%8#HWW"8,B,BP5G.\MVF)U<-FA8DTR[G5\!.@&7,K$S#E.M? MI1IRS$GVG&6KA[H&2:30'H\[+_(VYB/4M!ALTK6-K5H<1@M>0$Z;+8'C##!! MP*0"2O(.*C@+5S&>GX[`39:S"'FT&%VR)7"<`4K(T`#O$#)G@6Z>)=X.737& M5-KXD+NI.KYJNRCA+-"$<,H4I1;Z,3<^-1<3C2:E$W&CJH(-$'+CCDRK'L]3L9X.;&*"B\8\O MN44W-R7F0(U9WF"#CR16X>(A)7`RU/X%+2[<5'E_.8 MW.]L\)BI6'K<&E,1`&/C]4GGQFJD`Q+/4NPZB\8Y2*/0$L'SF>U$BR(,-+?: M'14?+PS.8GT-MK'':> MO?,"GL(N)!:'!4_J)/`Q6/.D;@*S=8WOO60OLK3D\1(88&!O3C_`KM/E9_1W MWI]Q2[4:G4"B)3JPE]N2?&&D@V+`KD`8+#GBWPJ66@3?6LN`@7$BA(TO_(!I M3=[]!```__\#`%!+`P04``8`"````"$`V9L2$ML9``#GB@``&0```'AL+W=O M'C>7*Q.C\[/MR>/M\]?/UX_C]_K_ZV/S][>KYY^'SS_?1P M_'C^K^/3^7]\^O=_^_#S]/C'T[?C\?F,2GAX^GC^[?GYQ]7EY=/MM^/]S=/% MZWSS3?SY^O7SZ\7B\^3PZW7^_7*]6V\O[F[N'-[RCA] M^7)W>RQ.MW_>'Q^>?2&/Q^\WSU3_IV]W/YZXM/O;]Q1W?_/XQY\__G9[NO]! M1?Q^]_WN^5]CH>=G][=7[=>'T^/-[]^IW?],LIM;+GO\#RC^_N[V\?1T^O)\ M0<5=^HIBFP^7ATLJZ=.'SW?4`B?[V>/QR\?SWY*K(5FOSB\_?1@5^M^[X\\G M]?_/GKZ=?M:/=Y^'NXSSX?O]S\ M^?WYOT\_F^/=UV_/U-\;:I)KV=7G?Q7'IUN2E(JY6&]<2;>G[U0!^O?L_L[% M!DER\\_Q[\^[S\_?/IZGVXO-;I4F9'[V^_'IN;IS19Z?W?[Y]'RZ_S]OE(2B M?"'K4`C]G2GD%<.ODV^-'?X+=.+[+U9K;3Q\>3S_/:.*@@IY^ MW+AI*+E*J#`.;M_@*=Q?BG8*D.07R$XW1?WQ*M[L/E_^@874; M;*[1)K$6.5NX,>2*+6)0QJ"*01V#)@9M#+H8]#$8%+@DX2;U2+"_0CU7C%./ MVWW-0.1<1U*Q!;L4,2AC4,6@CD$3@S8&70SZ&`P*&*EH_ODKI'+%T`1J`FUO MM;GV-AOJM"D:-]8DGTPF_8"40"H@-9`&2`ND`](#&30Q0M)\_%<(Z8JA04^G MF43"(>N-7E5R,IF4!%("J8#40!H@+9`.2`]DT,0H28N247)^0>D!S)H8O2AQ7>!/L[:ZN/))IWF MM1Q(`:0$4@&I@31`6B`=D![(H(D1@]:V!6(X:RN&)QL*QBE8MJLH5B:;*5:` ME$`J(#60!D@+I`/2`QDT,?*XW8[.(UX?2\[:RN/)9BNQ`J0`4@*I@-1`&B`M MD`Y(#V30Q(A!J:`1PR55Z\T%#;2%:94KR.KD"8TI":-T%\?19#3%$9`22`6D M!M(`:8%T0'H@@R9&.I<5&^U>#Z31W"H4D)YV$!6(2D05HAI1@ZA%U"'J$0T& M665<$OK^(>:V"%'L!!0%#R3AWE'I5X@C!U2)J$)4(VH0M8@Z1#VBP2`KEDM# M%XCELU;*AKB!UVXS1/HI&7)$!:(2486H1M0@:A%UB'I$=$%$U=XJXQ++!H1#09995S6N$`9GV0:94+>27$R943I M+HU2(G>AS0[#`E&)J$)4(VH0M8@Z1#VBP2`KELLJ%XCEDU`CELY+QVLC>0*H M0%0BJA#5B!I$+:(.48]H,,@JXQ)*K8Q+E=Q^\XUEW^>A1B&/UC+?Y$FP6E%. M(2&VB6:J8C*CTXK9+ILBT=;897UQC7UR]T:=?;IHZNR1J7.P>JO.;&;K+)T3-5-ICTRE@]5;E68S6^GMO-!T21\KO4TO=F]6>O2T M26%`NM)L]4:E)S-;:;FX:91>DY51^O68&,VCFKH2;-X1K%0J4B`J$56(:D0- MHA91AZA'-!ADE5F6D:TQ(PLH2E^CBW^Y6/$:7"`J$56(:D0-HA91AZA'-!AD MQ7+)DQZP;X21S[7T*%V']$OE'8@*1"6B"E&-J$'4(NH0]8@&@ZPR<48F>^LW M-,+L+KVN.Y=AY+2"[NN_C[:!8<3`5B$I$%:(:48.H M1=0AZA$-!ED52;`%\94Z\T@LCW1\!2N%"D0EH@I1C:A!U"+J$/6(!H.L,LN2 MQ!23Q(#2_70))D=4!.2F@&G'M\YD)1QWV"4['J:RJEG'EY;0-,[BW!*:;,8= MS/.WN]L_KD\.S.[!4GJ(PC]:,982=;]/[DPC`17!D4:S>QYCO4ID1QO:%WQT M^SP2'QF`MJ-<`O3^*3(-^9*:(AG1'#AU0;J/JIB+E8QW7]:6^EXYRLXWM&VR M8LN;I9,7U+!CIX$SWLN$,#0R. M$NC5O*-LD&P#76:UH($A$=,-#,CVH.3`H8&3E330(]L1!QA]DQ4[5NF$E*2' M%Y+!=%DR.)I'P\PG@[8'#W'*$QS)BNM9,#(]>)"A%'HP%*][<$*Z@3(H;`^Z MQ&I!#SKSJ($!F1X\1$,IIVEF=)1IHF"T6H]SR^IB&ZE2!@OJ8U:E`J=,SF0; MYO*B!0USYE'#/-J.#W:&.`14I(!*1!6B&E&#J$74(>H1#0899;(X_WH]C1_- MK3(!;:0SD2#0589EQ&]/V8RGT#IC75`-@$]Q/.U M6'%<%XA*1!6B&E&#J$74(>H1#099L9:E61FF68QD>.>("D0EH@I1C:A!U"+J M&*THCY%5]Q`MGCV;2?4'@ZQ:+B=:$%H^A3*A%9"<+L\`%8RH[AQ;Y0RK9E@] MPYH9ULZP3C&MF>0-XP3:*S.NWF"956U9AIAAALA(JQ:L!!5L950+9HI5,W;U M#&L4TVI$:4VKS%B-3C%QS5918M,K,W8=++-"ND1O0?CYO-"$7T"B6IX!*AB9 MH9.M)+OR68LRX]I7,ZR>88UB(E!ZB"*M569\BDXQ<DJM?9M(-0TL:7(W*QXL@K`MKNQVT&_=0=?INF M`S58*50@*AE)5%:(:D0-(Q6HB#I$/:+!(!NHRS9@[BO09!+TG-)?MZ=Q%@;@#/*(XE--E\1#*@Z.)5N_HKA%.4XP> M0J$+0O$Z@"R+IWO1W,8:K1I&.I*#HZ`.K7I$@T%6,;]U$"U(L!GVA@1`/;.25T*U>E,U9^&G9+Y'?F4<+L MD0E,0`7=_7&.RJID)%%8(:H1-8PD"EM$':(>T6"048;NY"U19C2WRC"BID]K M>I9$>64N5MQ_14`A,-?T]AW(E]E$Q:4@=;JU3%0^7Q8K/ET3D.SLXENK+5NH MN!3D0HQ>(A*UJQ<#/M%@D!7;[;K>/PMLG7DDMD<48*KUD!P'1Q6&14!O),?L MJ()5D#HC),=BQ3(TC'15,>\2*W;L!,D9,>T2*W8<#++"+]L6NDDO%G[:.$FE M,DAYV5$BJ`C(/;0V#0]H31FLZ`^WIA(DCICQBA4[-@$E>D#."#\UB!V[.4>H M:B]6[#@89(5W6ZL%$>]W8CI5VX;-F4R#.:("4.JUVC5,)(SMH@Z M1#VBP2"KC-LV:&5^*;?=ALV'2A08Z>[/UO&5-K%B*0I&G-MN=C.Y;3"B'F>_ M:O*S9XQ3!?1LV%-RVR@%;]E"!E3':,IMMW&NP!;B-#"BG^^.N4*6KK920=LQ M\78L[ICW);=;W*8%I*;E'%&!J&2D0SGLM@35:-4PTJ&,VS2TZA$-!EG%W&9" MA_+KR:W;_<>SZ[0=T7-=M-;F["C]6@3$.<0JR_9I%.HEV^B0]>=S\]8T*6>0 MW*)CPU5X.;EE"ZED)R@DM_%N3`QX4`V,.+E=;Q*5>UCYX]W8&_+CKFOK$24N M?/X<48&H1%0AJA$UB%I$':(>T6"05<;M3A8$9MABZ372.V1[ML3((V M[@Z5O4&5!R>5HA1<#KVRPBU?JXM4!KFM7YS1OE$_3%VI8FZ:H6EK3-+2N0H& M+YF0B^"53,],R]4M6[\XL7NC?IC`N5_(4_V"?C,7+/)@8?0+Y4SZJ:MOMG[+ MTJ@=IE$!!?TV](0<=O"4:3(R" MH2!14#)#6T&W#B\8(7[9-B/$HZ#@.MOM-W*N\=)2O@M>.@(#$@5E_K(57+;L M[G#9#2@HN,]<'\=CV'L9!4-!DX(O]/!^V4HWFMN5+B`>PC,CF)V4?HPF_=2E M.:/??MEZ,YI']?-+4-!O;H0$)RT?ES/)MWU)OWB1>7V*V>-J$A`'X,P(9B>M M7RAGTF_W4OV6+2%[7$(""OHEXU-<4?P%$R-@*$@$G'QL_RY;0O:XA`3$\3>G M'ZX@7,ZDW_Z%)7B_;`D9S:/XPR4D'K_!R^@7KR'[ESHX7D-^*.TPTXZ+NW*\I*H\;+R:W7&U6;/ZX9_Z)!>W#>B&IX'5`>H>`J$!4(JH0U8@:1"VB#E&/:##(*K9LQ=OCBA<0 M;30Y8\D1%8A*1!6B&E&#J$74(>H1#08990[Q6NMBZ==>9NI*LM/,6/CXLB.U ML4CC7$NL6-H"48FH0E0C:A"UB#I$/:+!(*OCLIS@@'O0@'2$(2H0E8@J1#6B M!E&+J$/4(QH,LLHLRT8.F(T$Y)YGDOUI_(!;+E821KXLE+./X#"5N+8,#*.ZFZ552M.BE_?21XP M^V5$;^$,K8M_.)$'$Z.)+XCW=[A_+]E)[BE6TZGX$F$D?LT^6HU0X\1?[,O2 MK7IFR$H1)]UO2(')]2$@>B3"2['+Y.9O"`]OHNYK%\&+MY()/4,1>955[LMDY^JC1>SDIC*]^3[DX?22Q3',TNRPC7^#2R_#]U;TQ@5N M)[T-GSU-HA5?&Z57Y(L=.]-+\@7J.DMO1C(MRY>3%2;,$R.97$OI%4AR-E8H MN-&[.+FJI!!#6>]($`^M(&PH"22U'B&UWL"HJ7$"'&_7WW7/Q]U8B$I`IX4I@`(U&`D2::19+$:6XL MR?NN8-!#Q#.:!$:C5HV=.,V;7&72I,#PKO24'`<+*3`5QXP4`$8*`",%-(L4 M6);.)NZ^7C1W,C-/4V;JK3O<^]Z5S+@%U%+/P@PZ%=W?,N4]#`0X>D23BK!`UI M`HPT`4:::!9I\I)(DP$@28"2) M9I$D<>89A\E[9PA,29.59_I!HQE&@P3L*`*`47.!47.!47.!T8=D@-&79(#1 MIV2`T;=D-(ODE()K`CF8"13,!()F`D$S"2 M"1C)!(QD`D8R:1;)Y%*[)3+Y5%#?JTW/C'*!Z6L,"3+Z/)%/+94= M?9\(&'V@"!A]H0@8?:((&'VC"!A]I`@8?:4(&'VF2+-()I<7:IGB:>Q]JUWX M$I)5SZ><:GW.DV"G&*GG[9)7KB^PC=ICD9JQWS:5S5+42I?IZ5:^O@],PN>+ M;'-\MNA>`3>MP%G\8W)JX60FPR@P^QQM!KFLF+$K-=(7%[F^V$Z7SRUI9\C_ M9)]QG5"CQR2%)B5IYP92=C'CRE)/AN+&'R_2,U`VS:G1(\:R"R\\F3R MB7K0)6Q+6N83/"J=JT')H$5PI.UBCHO= MU,XE:HS+::66NIS8-3GP$@F8"03,)()&,D$C&0"1C(! M(YF`D4R:13*YI&:)3#X)LC)-B9&>`B#G!T;<7@=''%X'1UQ>!T><7@='W%X'1!Q@U\S)=/GT['I^+F^>;3Q_NCX]? MC_GQ^_>GL]O3GP^T'M(LH_#9X_'+QW-:,W=7XYBF^)A>;8GHJD)WGFCE"!]"3+S)$#%4?/9LP=2>C(>!<@UNFPIB/C"@M' M4CHR!F-\9$TUH#M\,^=)J0;^NF'LDU(-Z),(N9(1J7Y*]%Q:1F5 M1F_^G?%)MB3I^('EV&=-/CX-@2.D@;\T#D=(`[J#,'.>-84#?8EF[@CUG-]" MQ*6-W3W;/PG5C78:,Z4E5#>?`4%I5#<_'<,1BF]*".=*H_BFM&KF"+G,>I## MK#W)/*LRR3*KB@OGN?-2Y\_U/>WV5U?TSYPFM.M?7=$_<\=H][^ZHG_FCM$\ ML[X:]TXS[:_)5>_S8X0UVES;7+A-,>IPV;+SZY^>V&F2M=7U_2% M"ZPO?>_C*I\]0A_TN"IGC]#5EQ6U<58;NGZUNJ)_YMI#5V-65_3/W+'K+74X M_>@/:WB]I2ZG^[5S1ZC3Z1=>,T=V-.+I%TYTY'(*ZJ=/'W[ZKNY+@_^,YO.?F]]/S\^F>[B6>GWT[WGP^/CH#,OYR M.CWS?[@3_#P]_C&N59_^7P````#__P,`4$L#!!0`!@`(````(0`Y7MBX2`0` M`$\.```9````>&PO=V]R:W-H965TD:KG-R*NK+3O_KS^3)US7:9O4I*TF-=_H[IOJ7 M_<\_;1^D>:%7C%L-&&JZTZ]M>PM,D^977&74(#=?#U4I,F>RY!]QMRL[SGYCF!L3F/;;4P$*6-BU!I]W^@$%*;)T<[_E`?J[P`\Z^J_1*WFD37'Z MM:@Q1!ORQ#+P3,@+,_UZ8A`XFS/OA&?@]T8[X7-V+]L_R.,77%RN+:3;`T5, M6'!ZCS'-(:)`8]@>8\I)"1N`7ZTJ6&E`1+(W?GT4I_:ZTYV5X:TM!X&Y]HQI MFQ2,4M?R.VU)]8\P0AV5(+$[$@=VWSUWC#6R-LX:2+[C"$_YZG#M''W#]CWD MK?['ZNN.!*[]ZLA`KO4!#E-$@P13((Y*-%4IC-`0E_0_W!2I;,`:G2`+ M>8,CKD\<,U:E"@02-Y8Z[2W22$H5"!1JCQP[&]CZ*&:K24([-W&JLS,F771; M2S=%ZD:5^D.ERSC4"`ADDFQ?[D`D6QKU>F.!C)/=(3ZOYB?;\>VI?&$QSK3J M@U;(_H9VF.V4//^0>$ZBJN^@20%L)O('*ZF_@\8ET$$K$#74@#WT(1[*I'<< M%<&RXS"?B"H0LZD8GRK<7'"$RY)J.;FSN1.Y$'<)BZ$XW`01?ZVF.+*""!8% M,9,G,$8?^/L[P4,V7B_8AW8`X\&<)W0".$GG^,$-#HL+AVX`9]'<(?2"<+6` M1UX0+>&Q%T"CG?,D7@#M=(Z'ZP`ZV0+N!Q%_NTT9"1CG;]D%_Y8UEZ*F6HG/ M$':+'QV-^"`0-RVY03I@J"&ULK%?;CJ,X$'T?:?X!\=[A$B`$)1D%",Q(N])JM9=G MFC@):L`1=CK=?S]E#`9L)NI=]4L23JH./G6*PMY\>ZM*[14UI,#U5K<6IJZA M.L?'HCYO];__2IY\72,TJX]9B6NTU=\1T;_MOG[9W''S0BX(40T8:K+5+Y1> M`\,@^055&5G@*ZKAGQ-NJHS"97,VR+5!V;%-JDK#-DW/J+*BUCE#T'R$`Y]. M18YBG-\J5%-.TJ`RH[!^K\H_055GSA^LYPL[[G;"X6^*O(&$WRB"Z`S^$)5S6MC;0#3;G,L0`$KN]:@ MTU;?6T%J6;JQV[0%^J=`=S+ZK9$+OJ=-W&DEZUN^PO?=1W/7P'-,R(T*1BGKN4W0G'U+X]J)0D6NV.! M[X[%\D8L#S*77:8S9%H+RS$]6.VC.\*_[;KAN[NCO[!]UW+;Q`\N>]61P'>_ M[.'FCSD,7L?6ECBCV6[3X+L&O0Z%(M>,/3E6`+R]'[P$PJ%?&03.,)(]8]GJ MD`^E)]!5KSMGM=X8K]`)>1<3JC'6-"+J(YCMC#:6@8,,)#*0C@`#)`J=8/4G MZ&0L3&>_PK`'!N&V)*J/Z%-B&3C(0"(#Z0B8B()N_`11C&6KPZ%U M*ZIC.^;4Z41)2^?2_"%MHLN;ZN(39\&F-[T4^4N(X<[09S-ZES!9^+QA'%.Y M'!G+59"X0T9R.6*OVY%EFY8C*54R4CEC*3(F(F$4?MP\%CQ5TR'KL0V^U*21 M".H]CSGBV8.?'%G">WKPTY=&5*(0I;-IOY#*MF;*&^0_^LDXIA7@B#T>.+8O MV1.)(%&!#AFZ_L`1;_R\PXM7N-;V4Z(0I;-IGDB;F`TVC2LPT[FP.^A;EP5/ MI7;(T):1@L0<&3O+$CVI),!7<0/*SCKI3V M"]$0)=Q5H4,'>4[["#_!*#<]J4V2+@::J6=*'Z=-W(7M\"=4@9%(5>B@D>_M MK2!J@.(.&CO?0VQB]MLM>SU,6][2*A?;V+-%>-/$8:QPV7SOSC>)%6K.*$)E M2;0N4$TA\=N`#-:Y4G<()G#0\L, M8G!2S8!CS+Z=@O**V/%F)CZT`]ADJ3SA,H#]B(KOG6`/E8`_#'$'.*9&PO M=V]R:W-H965T9WGW6A;DA2LM9!53 MSYE0PJM$IJ+:QO3/[\>;6TJT857*"EGQF+YQ3>]6GS\M]U(]ZYQS0X"ATC'- MC:D7KJN3G)=,.[+F%?R2254R`Z]JZ^I:<98VB\K"]2>3T"V9J*AE6*@Q'#++ M1,(?9+(K>64LB>(%,Y"_SD6M#VQE,H:N9.IY5]\DLJR!8B,*8=X:4DK*9/&T MK:1BFP)\OWH!2P["ZB[6C8%^BOX7O>^$YW+_5@2,TMDC?'KA.H*)`X_@S9$ID`0G`DY0"MP94 MA+TVGWN1FCRF_MP)_%ETZP&>;+@VCP(Y*4EVVLCRGT5Y+9=E\5L6^&Q9IJ$S MBR;3$22NS:@Q^,`,6RV5W!/8-2"I:X9[T%L`\65'8`6Q:P3'-*($XN!9X9G99&2#C#2(8>C"4/E;.2EO0"&G85..E$=Q(=\5M(WVA M()Q>=AE^1`K!0ZDVTNST0=]@E_4MX)&+(CQ>5_8HKAM*M)'^7@G"X+(;G-BC MCP."AU)MY-S-?,C;#)")[T17[>#"H48;&=IY9PMZ,.K&^VG00[%#Z-R1!PGT MJ='2%'*[,D%PU8E$&QH:"B_WQ_O0U&C0)VKMX+A@"`]VK_=HR/ M>FI#0T_1.Y[P6/>$KU30#@$0[8XK7'U-`CU/]BJSD[[D:LN_\*+0))$[O*9\ MF-U=M+M"USY2GL:#Q=I>K6[W"UQM-=OR'TQM1:5)P3/@G#2;6=G+T;X864/Q MX7Z3!NZTYFL.?V(XS.\)EC63TAQ>0-GM_A:M_@,``/__`P!02P,$%``&``@` M```A`%V"_&WX(@``&L\``!D```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`QHZ/^[S#C%J/Y*AM&S?F)5;'Q-:?: M1\M8.[4EVZ5DT072@G0@/<@`,H),('-.C#9-DG^'-K<8'G)\N$M`79@;0@'4@/,H", M(!/(G!.SZ3KCF$UWIZ^SD[E`>I`!9`290.:%RI]'A(]_^F*D,BA.E MN9#Q7$=K9K^L]T>G_CK$1;8MT8ZH)>J(>J*!:"2:B&:#K!`7]_)#X[49V,?& MXC2\MMEDXT*V+#Y['DXURV`B:HDZHIYH(!J))J+9(.O0!8B7R[MA:/*)T1C)H3&)&OK M[B658P>H955'U!,-1"/11#0;9#6X^)=K>.T$[6.D&Z3+,#DI`MVF"5GSN>O+ M5)-&TM(MHI95'5%/-!"-1!.1[DOZ7;N_EV<5NER8*WQA)/D8:4922);Y-5,I M;]LL1='"CJ@EZHAZHH%H))J(9H.L&)<:#Q#C0Z81D^?.?5+:-D`[HI:H(^J) M!J*1:"*:#;(:7%P\0(-/ET;#$CC3P=5X@.#`BKQB1`Y*,-#VOSR[M<;=-57&8[(A:HHZH)QJ(1J*):#;( M*G/1]8"1XY.N&3D(OUOW'F,1D8E:HHZH)QJ(1J*):#;(:G#)+]?PRHB\\@E2 M?M(P:4[+MQ)"U?/3050W)`V5R\)=H1M40=44\T$(U$ M$]%LD-7@DFIYD+WJ'L;*9UXS#2TQ.#OR+HKWT+>A8^9Q1]02=40]T4`T$DU$ MLT%&VLEA^7E?;O-S0-DV;XEV1"U11]03#40CT40T&V0U_$WY^:26GR^*\_@F M5#T[0:>:91HB:HDZHIYH(!J))J+9(.OPL/Q\POPFYR]23WPRSJ>?@,Q!YJLRM&-52]01]40#T4@T$]-V30\+JB<,JA&YR)>M:?F>=BC3'8VX MC;L?]$SOT]DU/2PXGC`X1E28*=_;B66YT["PHN>/UK3,=B_L?0:XDX`*I^4= MT%!FG-9[GB\7Y\;I^K!`M2^W@2J@;#[:$NV(6J*.J"<:B$:BB6@VR&KXFP+5 MNA:H+HOJ5-R372\Q*047?2%I.C?L[BYM0]?ST[)>D MFC24@-JTI%C5$?5$`]%(-!'-!EF'A^6\-7->0&9ZAKUMJHK;O"-JB3JBGF@@ M&HDFHMD@:^:P7+EFK@S('&2^*D,[5K5$'5%/-!"-1!/1;)#5<%AH73.T!F1F MX?5Y<7AM4U4:('Y9F:R651U13S00C403T6R0,7-Z6$C>E]N0'%"V@5NB'5%+ MU!'U1`/12#01S099#;60_(KSM^NB-\3R:_Z`S,A9':=O-S[\R,G/W\6-ADVHDG$^3(JI=W,:DO&ST_-2$P?)+G6+ MJ"7JB'JB@6@DFHAF@ZS#P]+S*=-S0&Z>RPZRPMXV544-.Z*6J"/JB0:BD6@B MF@TR9LX.2\_[3=*I)AZ;.Z*6 MJ"/JB0:BD6@BF@VR#EV5J0,547=C;IJIDADF:51U13S00 MC403T6R0-7-8DM8/%V'Z89(.5=EQMR-JB3JBGF@@&HDFHMD@JZ&6I%\W03-+ MGRV1.#_-%V\1;E-5&CM+QXA:5G5$/=%`-!)-1+-!5MIA6?J,63J@;*!LB79$ M+5%'U!,-1"/11#0;9#74LG3XU%!EGDE?B#];PG/JD@U<;CLB%JBCJ@G&HA&HHEH-L@Z/"S#G#/#!&2O#$I[VU25S/AEJ6-$ M+:LZHIYH(!J))J+9(&NFC#4OS-4,,^<>F;D::,>JEJ@CZHD&HI%H(IH-LAK* MK/2"!B:DJ(>J*!:"2:B&:#C)F+,KD];V9?;D-' M0/D`(=H1M40=44\T$(U$$]%LD-502X2O^]+`!3-B0,7@*:\=4]4R>(A:HHZH M)QJ(1J*):#;(6BNSZPN#AXGUPB,S>(!VK&J).J*>:"`:B2:BV2"KH0S$+@F^ MZK[#!;-R0&;LK,_3A8T/0*DJC1V_K$QMRZJ.J"<:B$:BB6@VR$HKX_,+8X<1 M^0))=TNT(VJ).J*>:"`:B2:BV2"KHRX(VJ).J*>:"`:B2:BV2!KYK!@?,%@')#>BX_;O"7:$;5$'5%/-!"-1!/1 M;)#54*;@UT_0#,@72QI.8V==_F#U-E5%CSNBEJ@CZHD&HI%H(IH-LM(.R\P7 MS,P!96>@+=&.J"7JB'JB@6@DFHAF@XR&RS(@OW*"WB]GGYS3,%FMBALZFU#U M[`2=:I:A1-02=40]T4`T$DU$LT'689FNGY^@+YF@`[+7YZ6];:I*9ORR\NMS M5G5$/=%`-!)-1+-!ULQA"?J2"3J@_"`CVA&U1!U13S00C403T6R0U5`FZ!<& M"&/RY9)V\\.KC,FI*@V0I6-$+:LZHIYH(!J))J+9(&OFL)A\R9@J*! M:"2:B&:#K,/#8O(E8W)`[M-T*2:7]K:I*FK8$;5$'5%/-!"-1!/1;)`UL(` MF!XQ`*9G#(#I(0-@>LI`S@I+AT7AYIA9.+)L<.B!"R'G9N\$5YB4H$Y*P*0$ M3$K`I`1,2L"D)&>%DL,R<'/,$!R9&3CK\W)RR,7E]F4)3!9`I,E,%D" MDR4P60*3I9P5EEQ.S3\G\M+AY7-M_O''YCADW>PL56%Z5`?JI`1,2L"D!$Q* MP*0$3$K`I"1GA9(R&[M+\Q]_=";[3$ISS)PC.G M6,LZ+"[,OO3837W/LV8M2 M0IF5DFX_%RMX6-YJCAFX%F:EA,*:E%JX^1DI3#+-L6HV,FE\!>DA++K)1T'\R.E/W#9O(5 M?&$(AX?3V!4+IY[T[L6V,0^QV2?/787IZ3KHJ\?K@.GY.F!ZP`Z8GK`#ID?L M@.D9.SDKE,B<.1&\\H9D$QY7(U?91%8^S4&/*G*OY^>/9;Y#(DM%<8:2SZ5C M9/())I]@\@DFGV#R"2:?8/*9L\*G.\$<,L3\"PV9E/B^)I&1 M20GJI`1,2L"D!$Q*P*0D9X62\M0>)\\#/[G7A(?>R'X<%CKJ_.G=!-K527&C M2B-J*8M=I0],(PI,^L"D#TSZP*0/3/K`I"]GA;XRI;PTHBKI)#[K)IF3$E^7 MC1XI`9,2,"D!DQ(P*0&3$C`I`9.2G!5*RESD1M3K;L`TX6DW=E#Y>%0,*EPE MQ0?E)*LRN'2-`TT&P6003`;!9!!,!L%D$$P&2X.JDN[,`W+B-.7K M[*`"DQ(P*0&3$C`I`9,2,"D!DY*<%4H.S)7A*3AVX/@(60POT ML$(P/:T03(\K!-/S"L'TP$(P/;$03(\LS%FAQ&707,EK@V9X&(YFH_&AZ MDYZ9D\HPQ%)1&F)D\ID'Z+UC^0233S#Y!)-/,/D$D\^<%3Y=!LU]OC`WA2?E MV"$6D$)B5@.A#!I`1,2L"D!$Q*P*0$3$K`I"1GA1*707,E_Q^Q(#Q$Q^I: M,FX^J'#CRSQ_9W](R>#2-0XT&02303`9!)-!,!D$DT$P&> MCZW64HBR^Q*0$=5(")B5@4@(F)6!2`B8E8%*2LT*)BZ&'*/&QU2H) M439MOHXS,"D!DQ(P*0&3$C`I`9,2,"D!DY*<%4I$!( M"9B4@$E)8$HIV>2>[BS'T]A2%E]"EL!D"4R6%I:]Q#K=?=N_A,0M9?$E)"YG MA3B7/@\1Y].J%>>9%0Y01W%+6=PJB0.3.#") M6]@S+R%Q2UE\"8G+F16W?\9.+LYGT_TWN)^^W'W\?7.O#5(6JTSTZ;O[37A4 MC_$9F/9:7)-MK,N8'K7MDW/&]*SMP"[U[>=_?E@=-\6UM1Z]C5YZ]G;9J[C- MHT=QHY>>Q5WV*EY+C^9&+SV;N^R57JLP[()L;KAB4J>7^"WO)CRQQZKT8=C] M?G\VO,H/Y<6N*HO&9==WU15;9++KF38A,OD$DT\P&<3R9!!U<@8F9SDK++D@ MFUMZY3CT>=C*\\P]U"*3EW;7_MC4T%S*HA3)\TS7(I%)7JAK]D/S'Z=Z`^VL M6)ALAJ+5TE$V;4>](7MQ3CRPM97'K90E,ECS3GU@G2V"R M!"9+@:4?VM"@0YTL@5Y5AS4N,L1'E"4G=,E;^D: M14E>8,JTV1Q1W`Z0SU"61J)\5KL6%WU2',K,0*QV+:8$6<>KRGJU:XI1Q8YP M6?VY'?&S1[;/_'9/>&:/;#!I!Y-VS^R1#2;'8!(:F!&*.MD#D[V<%:I<.L]5 MO71D^S1OE7AFCVP\6+H)3W^RI^NE:S8X`PMGG..WQQR8H23)D+2R6[,^-O\K MKE:D-/1(4XBF`2PEG3["14XL22\NPV6WU*OP[4)][ON5_)H3`TJ;+.^ID-C!C%G4:K%B>5.9UA3P7[)^3][/' MM;]`L/8\L\.ZWU] M\:F@P-P.26>)TS2R0Y),96E`D;4Z'+5*>E]2ATJV.&3)6);&7?^#KD5V&):R MW&5RS+A? MG+I&)N.!Z>29+:XX5W=+6=(FX]6NQ;E:QD-9?J!']NRKRGCHFEY5QE]XU<*X M2_N'&/=7!]:X9X7QXH2S;<+#OC*[NPJ3\;"XE"RE-["TH=*+.KD,S+A$G<1A M>1*7UQ667*P_Q)*_#+"6PJ6!G0E2_(HSP5(6QZ`L@F#&.NJD.#"C M&'7RB>7)9UY7R'-7![F\?S7KFX]7G_Z]NWW\>/M=9XYC]Q#DY8Y=>.:8M12N M,,P$<<9I="G++(')DF?N&5[IQ'56G'TD+I2EFWT:KM6NQ50EE[Y,3S^*:Z() MHMJU>%7IQ:M*;[5K>M7"N+;+&'_E<'6+*3.;9S:SG16G?`W7I2QNOF9J,.T( MS_04L5@GZX$9ZZB38L^L8M3))Y8GGWE=(<]='^3#M93WDQ=':`D/![-*`DL_])N0[:K ML+;"N@KK*VRHL+'"I@J;+2N4N-"=*_$'U,&_)*I[]/NC1Z[2K+T^3^?L?8?(+))YA\@LDGF'SFK/#ILGCN\X6C+CQ' MS0XQG^?--^:A?E8@2'U2MDA!> M[3&(&P[Q`6QF!E^Z9@,'3);`9`E,EL!D"4R6P&0I9];2_EEI!UB*SU9+F[II M`C,#AVQ7J6LKK*NPOL*&"ALK;*JPV;)"B8N3N9+7SN#AB6K%#%[<"J*PTD^EXZ1R2>8?(+))YA\@LDGF'R"R6?."I\N>.8^7YC!PQ/8S($8 MG\IF9_!"Y;9)9=&(+(7.9*W('H@LZA M7\X-3UVS(VI)M>FH6Y47R-*WE&4C"DSZP*0/3/K`I`],^L"D#TSZ=#K;7DF8[NN/E2`J81!28E8%(")B5@4@(F)6!2`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`[?"K]=25I.Y M<7--IMG'"]-&9VNNI[=RU MU62Z#\A=[3^<1='N4W%7^P]ILM3:O8N/6LM6D5 M&[>>M3;WQ2GUTP<&.5[<5Z34K]KFOBJE_5YMT[=5SK7?JVWNNU+:[]4V.3MV M7JK'L;YYJ;;ZJ5G?#W1M]?V@UU-;;>QNM!JNK;;M^E;/N?9#M4U?A#K7?JBV MN=_/D+/JR=C]CH:VO7IR=S\5X=IJZ^)^#<&UU4\CRC_Z5E=]G"D!J:VVWW6? MY_Q*_]26Z7YZ1/VJ;>XG2.2LVN9^BD1CJ;I][M@&[.?[^^?XG]HD+_[Z_[A]_W-V0__)0````#__P,`4$L# M!!0`!@`(````(0`GG<&&D00``-P/```9````>&PO=V]R:W-H965T=_N?MROST5N+X!Q7-9E?W[0*IK=1%^OC2XS9\K MT/UFN7DQ<0\/"GU=%BWN\+E?`9U!!ZIJ#HS``*;]]E2"`E)VK47GG7ZPPLRR M=6._'0KT5XD>'?=;ZZ[XD;7EZ4O9(*@V^$0<>,;XA81^/A$(D@TE.QT<^*W5 M3NBZ"("`M/[S'J"J@HT*QLCS`5N((!P*=6EZ0UH"+Y MV_#]*$_]=:<[_LI;FXX%X=HSZOJT))2Z5MR['M=_TR!KI*(D$#F0P/=(LEZY MMK?>?`_)>B2![Y'$LE:6:_K?'HA!10TUBO,^WV];_-"@\6#8W2TG;6R%P#L5 MATIAY?JW:D&9",F!L.QTR(="=&#QZ][=F%OC%6PIQIA(C;'$B.,403P@M+$, M)#*0RD#&`09(9#KM_T4G82$ZIQ%&$S`+MR514\24$LM`(@.I#&0<((AR5%$. MS(_ESIZ\(DG0PYQ7=N"(@XYHC`?%9(9Z8LB1A3!A"I(H2*H@&8\(XEQ5')FV MW]F9A`5Z&]["E+@;J?$B&O15N2R$R5601$%2!+D*$H\()Y#WD04QJ0J2C`@,G4EU3+EU:9!- M]V*RI62+:?-Z($@-1*D_U+J$0ZP`102S'5/>-5@0JX"")!3QH46Y"LP-.I0R MI4&\V=]($RI@02=]W.TA6A0[0IP#1Q6*)VA>O9(1H MCQP7N&[^(8LM>N:`/68R*QHAR61Y1L]14V*L0LD(^>MAU7I:^V:@E&$<`3>E MI2S?-3=SCXDU(*>+_UP#>D01:D`AP7H%BN'D3R8(;$%3#9(1Q*9&W MGG))B?(Z1B\*]!!=A?C(#N&0I_)$3@@')!4_N.$!"J#^$;DA'#$6<"^,_`7\ MZ(7')3SV0M@_59[4"V&75/%H'<)VM(!OPGBPUF"5@+O5+;^@7_/V4C:=5J$S ME-T<3@0MO9W1AQ[?P`ZX8>$>;E7#SRO&PO=V]R:W-H M965TY\K"J2/T]%2==_?-]M!]^:PW'3 M[F^&P<5X.&CVZ_9ALW^Z&?[]5_;E:C@XGE;[A]6VW3GYOF-(`(^^/-\/ET>HE&H^/ZN=FMCA?M2[.'DL?VL%N=X,_#T^CXOKR]?UNWN!4+<;[:;TX\NZ'"P6T?ET[X]K.ZWT._OP72UQMC= M'R+\;K,^M,?V\70!X4:ZH;+/B]%B!)%NKQ\VT`,E^^#0/-X,[X*HGH3#T>UU M)]!_-\W;T?KWX/C?8.)MC8VL;0)N,42+=2L4F$3%Z0NR%R0NZ!P M0>F"R@6U!4:@4R\63,??(98*H\3";L8(2+W0408MT"5Q0>J"S`6Y"PH7E"ZH M7%!;@"DS^3W*J#"P85C3*+B<<"EB;3.#,>KGVHR;+'N37BY!4D$R07)!"D%* M02I!:ILPV6!O^AT32H6!!0S5])),+R^Y*+$V>E>WWJ3739!4D$R07)!"D%*0 M2I#:)DPWV'N9;O[#"3D$*04I!*DM@GK>@!9)NO[9[,(%:=3Q=[(KOJ9VR4%<5?; MS?#=G8QL4,U$HE2B3*)RB[4=>_TO%E_C5M8([#X/&?0!"X^YCJD,Q>H!JN,`XU">W4*E$BK%-&B MNU:%XX`.R:ZR#`TH_E,GF7+I]$43@C:HZ:4>752+-6#"IB"8(6Z)P8%-+E2@R9DE4F42U3( M6*6TJB2J&>+*J&S-5N9S\\WD?+9@&L%JM`6C\3&"]58DF$96'I0&QBKHIN"7 M63"^G#N1,K3I'DUUP7-$QBT83ZXF[K%2H!$UO434^TWGP4R<%Z9-5%_M^DT7 MXWE`4X3KKA+0]W3_JWWYV3JW9ZK)8ZGU<:"1I=]2HD2BU"#]<,\L;1W+0KFT M*A!1(TI$I$XE4EOK8\OUBP)E.F%L2!1LZ"=?:4)5G1_.L=$:7&:C+M MEW4F42Y1@4@_J%2WHQ(1Q:HDJAGBRJ@LV%;F'Y/^Q0YOBT%ZQ[DR(K M5">1*$4$:\3:+9T+3X96-$ER1-R1;CS=M"S0BH:[1,0=G1RR0BNJL4;$'2GA M8>*'_HL&G"I/_O/.0<*=*#U M7"*B&'0(=!.X0@NJN$;4.Y$/U]B]>GQJ_8?R1F*0([W3W259D?0ZEI7TI&A% M$RE#1%W.$9%5@C.:OMV4 M7Y(5BI5(E"*"O(,.CIF;ZZ$5]3E'Q!V=X[Y`*UL_W:$)=W1JK-"1:JP1<4>J MD:M\W@5$O69TCF>#G.7I'L]D12J+.TF*5E!BJ>R4T6]'\ M$RA5#\(A/%]S<^>4S]"*UER."/QIXLZ=,ZI`*U*F1,0=G1HKM*(::T3KA6^AV=&BNTHAIK1#^KD:OL7GX^E9A/ MY)W(($=\Y^Q?"7P+=Q==U8XL6+X1LYG'X<1?,$B:X@G4(&'WTVCNTY* M-_XT@F\3/'$6$;PDE?P.>GWG[4$97D4E[!S2![;I2&TSL@1V:^B&KR0&I1)8 M--(GG@10XM,$]H-(34OIDT&)FIVR!+:"2$U260++/U)S59;`+A"5_I)P!AIT MVZ:C,R2DH(&O!/)2T,!7$H>740)9@VQ!#+HE<-+Y2A90XE,4#O$H]9;`P1VI M(T5&@_,[4B>++($S.U('C"R)H3\)Y-J^DCF4^'H*UPAHFZ\$K@[0-E\)W""@ M;;X2N#5`VWPE\$P&?'SK!AZ^@(^O!)[!P)CZ2N#9"XRIKP0>P<"8^DKB<`H: M>%=<`&,*#VL]N@4PIO!PT5,"]23ZH8$SW^(PA!)?"^!A%FCM*\F@1#U#<,)5VT43\,\"'QR^JI^??J M\+39'P?;YA'.D7'W>/>@/T76?YS,RYG[]@2?$$.N!!^NPB?C#3S@'U]`$OO8 MMB?\`QHUZC]"O_T_````__\#`%!+`P04``8`"````"$`^CF)QC(!``!``@`` M$0`(`61O8U!R;W!S+V-O&UL(*($`2B@``$````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````G)%!3\,@&(;O)OZ'AGL+[=RRD)8E:G9RB8DS+MX0 MOG7$0@F@W?Z]K.OJC)X\DO?EX?D^RL5>-\DG.*]:4Z$\(R@!(UJI3%VAY_4R MG:/$!VXD;UH#%3J`1PMV?54*2T7KX-&U%EQ0X)-(,IX*6Z%=")9B[,4.-/=9 M;)@8;ENG>8A'5V/+Q3NO`1>$S+"&P"4/'!^!J1V):$!*,2+MAVMZ@!08&M!@ M@L=YEN/O;@"G_9\7^N2BJ54XV#C3H'O)EN(4CNV]5V.QZ[JLF_0:T3_'F]7# M4S]JJLQQ5P(0.^ZGX3ZLXBJW"N3M@>W?7)-XOROQ[ZR4HK>CP@$/()/X'CW9 MG9.7R=W]>HE80?*;E,S3?+HN")W.:$%>2WQN#??9"-2#P+^)9P#KO7_^.?L" M``#__P,`4$L#!!0`!@`(````(0`@_ZG68`,``.0+```0``@!9&]C4')O<',O M87!P+GAM;""B!`$HH``!```````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M`)Q6T7*;.A!][\S]!P_O#;;CFR893$N*_.MN.?R!(XK M.-G4S3U7\-GR7DI`G#L;W@IA><^;W@W@NNDI;QHI._MU>5>Y*IN!K+X#](V=@8_N12: MSM39\Z;@E0):VJS[:-?E3JK&_U8WO^16""4]%PRZS7;9M^VOBXD_.6LM8/72 M4GOHF,#!2XZT4*60R2;EC3I`>7+6Y]RRZ!AWA)ZJR$`;#%<*\L6BJJMV4?>9 M_XDA2&*2S*,041RR*S1'<8`9N<&8DK?:LY0?AQ`*-RUP3`E+9BQ)\1L@&D%H M$KP#,GH#IF46H,/QQPG%;,22[!K%T0]$HR1F*`YU)!FB!V]I(6-&EHL%RF[; M(*+K.)I%`8HI,T-.612O(%-)=FLVFK`TTW?3VY8&_KJ,4IU>,^)?ED()=`$T M[WD4X)A@PN+#E6C)GS$4!-D2%(*_IZVYV?TGIB$$+KE%5W.+TW.6X7DKNQ1I M^C1#,4$!C(REMB-Y;>HD8CQA+\`;ET\9AC?RV7H_$;`"Q]\QW,TB&,KE>V&@+:[:7G=,`!<,VN@U[AY7C84V^1UG@;6K)DL*[W(<1O$U^X8R\`"O M0RC,.3,&8RF_L1-;DC8ZT(J!F.)]:B_&J5<#U+RH?LGECM8A5^)I0GRYZ9$M M;\0:9J>G\^<-[P:&PZ;43H(MK^[$^LGF[P,]SZZZH=T?34Z&IT,857M[GOL\ MGOO_`P``__\#`%!+`0(M`!0`!@`(````(0!(8>].!`(``)T<```3```````` M``````````````!;0V]N=&5N=%]4>7!E&UL4$L!`BT`%``&``@````A M`+55,"/U````3`(```L`````````````````/00``%]R96QS+RYR96QS4$L! M`BT`%``&``@````A`";JWP0R`@``T!L``!H`````````````````8P<``'AL M+U]R96QS+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/;A M,GW\"```ICX``!D`````````````````E"$``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`*K*F.SN`@``*`@``!D` M````````````````4#```'AL+W=O&PO M=V]R:W-H965T&UL4$L!`BT`%``&``@````A`-\#W4S``@``J`<``!D````````````````` M8CD``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``& M``@````A`&]3)Y9[!@``=1\``!D`````````````````*T0``'AL+W=O&PO=V]R:W-H965T&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`'(#L@[B1```9>T``!0````````````````` MX5<``'AL+W-H87)E9%-T&UL4$L!`BT`%``&``@````A`+P8T/.\ M#@``TI$```T`````````````````]9P``'AL+W-T>6QE&PO=&AE M;64O=&AE;64Q+GAM;%!+`0(M`!0`!@`(````(0#$K:L#5@<``'0L```9```` M`````````````*&R``!X;"]W;W)K&UL4$L!`BT` M%``&``@````A`**_H"&UL4$L!`BT`%``&``@` M```A`+O$4Z>C`@``-P<``!D`````````````````F=$``'AL+W=O@4``*X4```9`````````````````/[9``!X;"]W M;W)K&UL4$L!`BT`%``&``@````A`)9E3LN!!``` M+`\``!D`````````````````K]\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!Y6^302'@``.+(``!@````````` M````````D_8``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`&>.M1)D`@``7@4``!@`````````````````DQX!`'AL+W=O M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`!WI!$["`@``D`<``!D````````````` M````=#(!`'AL+W=O&PO=V]R:W-H965T M&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`">=P8:1!```W`\``!D` M````````````````QYT!`'AL+W=O&PO M=V]R:W-H965T&UL4$L%!@`````W`#<`\PX``">T`0`````` ` end XML 15 R46.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 11 - SUBSEQUENT EVENTS (Details Narrative) (USD $)
1 Months Ended 3 Months Ended
Jul. 31, 2014
Apr. 30, 2014
Jun. 30, 2014
Jul. 14, 2014
Jul. 01, 2014
Jun. 13, 2014
Apr. 17, 2014
Feb. 03, 2014
Dec. 31, 2013
Subsequent Events [Abstract]                  
Series A preferred shares converted to common stock     44,162            
Common stock issued for conversion of Series A preferred shares     441,620            
License fee incurred                 $ 140,000
Outstanding royalties owed on license fee                 3,108
Common stock issued in exchange for license fee debt                 80,000
Common stock issued in exchange for license fee debt, value                 51,200
Gain on extinguishment of accounts payable     91,908            
Convertible promissory note amount, instant     587,470 42,500 15,000 32,500 32,500 42,000 373,644
Convertible promissory note term in months, duration 4 months                
Due date of convertible promissory note 2015-04-01                
Interest rate of convertible promissory note, instant       8.00%   8.00% 8.00% 8.00%  
Convertible price, per share, instant         $ 0.50        
Convertible price, percent of market trading price           58.00% 58.00% 58.00%  
Period until Convertible note is convertible 180 days                
Discount for the beneficial conversion feature of the convertible promisorry note, instant       30,776 7,545        
Discount for the beneficial conversion feature of the convertible promisorry note, duration     77,482            
Warrants granted for promissory note issuance 15,000 110,000 110,000            
Warrant term, in years 5 years 3 years 3 years            
Warrant exercise price per share $ 0.50 $ 1.00 $ 1.00            
Discount on granting warrants         5,445        
Debt converted to common stock, value $ 33,000                
Debt converted to common stock, shares 226,530                

XML 16 R33.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 5 - PATENTS AND LICENSES, NET - PATENTS AND LICENSES (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Long-Lived Intangible Assets    
Licenses and amortizable patents $ 234,324 $ 234,324
Unamortized patents 132,643 125,301
Accumulated amortization (23,826) (16,127)
Patents and Licenses, net $ 343,141 $ 343,498
XML 17 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 18 R25.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 7 - NOTES PAYABLE (Tables)
6 Months Ended
Jun. 30, 2014
Debt Disclosure [Abstract]  
Notes Payable
     

June 30,

2014

 

December 31,

2013

Notes payable - current      
7.85% unsecured, $781 due monthly $ -   $ 1,964
7.85% unsecured, $373 due monthly 2,545   -
4.15% unsecured, $2,678 due monthly 5,513   21,824
10.00% unsecured, interest only, due December 30, 2014 25,000   -
      $ 33,058   $ 23,788
Short Term Convertible Notes Payable, Net
Convertible notes payable, net      
8%, unsecured due June 2014  (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share. $ 312,500   $ 263,496
8% secured due August 2014 (net of discount related to beneficial conversion feature of $2,050 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share. 47,950   37,700
6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000   50,000
8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $5,310 in 2014 and $40,552 in 2013), convertible into common stock at an average price of $0.205 per share 27,690   22,448
8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $13,517 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014. 28,483   -
8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014. 15,503   -
8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014. 10,273   -
           
10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined 17,913   -
10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined 70,600   -
10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined 6,558   -
           
      $ 587,470   $ 373,644
Convertible notes payable, net related party
Convertible notes payable, net related party      
         
0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share.  This note was paid off on March 31, 2014. $ -   $ 23,427
           
      $ -   $ 23,427
XML 19 R42.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 9 - RANGE OF OPTIONS EXERCISE PRICE (Details)
Jun. 30, 2014
Total number of option shares outstanding 2,404,099
Options $0.38
 
Number of Shares underlying options 55,000
Options $0.40
 
Number of Shares underlying options 135,000
Options $0.44
 
Number of Shares underlying options 20,000
Options $0.45
 
Number of Shares underlying options 540,000
Options $0.47
 
Number of Shares underlying options 247,242
Options $0.49
 
Number of Shares underlying options 247,857
Options $0.50
 
Number of Shares underlying options 844,000
Options $0.62
 
Number of Shares underlying options 15,000
Options $0.65
 
Number of Shares underlying options 40,000
Options $0.75
 
Number of Shares underlying options 20,000
Options $0.60
 
Number of Shares underlying options 160,000
Options $0.81
 
Number of Shares underlying options 10,000
Options $0.85
 
Number of Shares underlying options 200,000
Options $1.00
 
Number of Shares underlying options 38,000
XML 20 R37.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 7 - NOTES PAYABLE (Details) (Parenthetical) (USD $)
Jul. 14, 2014
Jul. 01, 2014
Jun. 30, 2014
Notes payable - current, 7.85% unsecured, $781 due monthly
Dec. 31, 2013
Notes payable - current, 7.85% unsecured, $781 due monthly
Mar. 31, 2014
Notes payable - current, 7.85% unsecured, $737 due monthly
Dec. 31, 2013
Notes payable - current, 7.85% unsecured, $737 due monthly
Jun. 30, 2014
Notes payable - current, 4.15% unsecured, $2,678 due monthly
Dec. 31, 2013
Notes payable - current, 4.15% unsecured, $2,678 due monthly
Jun. 30, 2014
Notes payable - current, 10.00% unsecured, interest only, due December 30, 2014
Dec. 31, 2013
Notes payable - current, 10.00% unsecured, interest only, due December 30, 2014
Jun. 30, 2014
Convertible Notes payable, net - 8%, unsecured note due June 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share
Dec. 31, 2013
Convertible Notes payable, net - 8%, unsecured note due June 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share
Jun. 30, 2014
8% secured due August 2014 (net of discount related to beneficial conversion feature of $8,200 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share
Dec. 31, 2013
8% secured due August 2014 (net of discount related to beneficial conversion feature of $8,200 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share
Jun. 30, 2014
6% unsecured, convertible into common stock at $2.00 per share, due March 31, 2014
Dec. 31, 2013
6% unsecured, convertible into common stock at $2.00 per share, due March 31, 2014
Jun. 30, 2014
Convertible Notes payable related party, net - 8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $25,345 in 2014 and $40,552 in 2013), convertible into common stock at a price to be determined after June 5, 2014
Dec. 31, 2013
Convertible Notes payable related party, net - 8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $25,345 in 2014 and $40,552 in 2013), convertible into common stock at a price to be determined after June 5, 2014
Jun. 30, 2014
Notes payable - current, 8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $23,655 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.
Dec. 31, 2013
Notes payable - current, 8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $23,655 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.
Jun. 30, 2014
0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share. This note was paid off on March 31, 2014.
Dec. 31, 2013
0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share. This note was paid off on March 31, 2014.
Jun. 30, 2014
8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.
Dec. 31, 2013
8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.
Jun. 30, 2014
8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.
Dec. 31, 2013
8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.
Jun. 30, 2014
10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined
Dec. 31, 2013
10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined
Jun. 30, 2014
10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined
Dec. 31, 2013
10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined
Jun. 30, 2014
10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined
Dec. 31, 2013
10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined
Monthly due on note payable     $ 781 $ 781 $ 373 $ 373 $ 2,678 $ 2,678                                                
Discount related to beneficial conversion feature $ 30,776 $ 7,545                 $ 0 $ 49,004 $ 8,200 $ 12,300     $ 25,345 $ 40,552 $ 23,655 $ 0 $ 0 $ 16,573 $ 16,997 $ 0 $ 22,227 $ 0 $ 7,087 $ 0 $ 29,400 $ 0 $ 3,442 $ 0
Convertible to preferred stock, price per share                         $ 5.00 $ 5.00                                    
Convertible to common stock, price per share                     $ 0.45 $ 0.45     $ 2.00 $ 2.00         $ 0.65 $ 0.65                    
Interest percent of note payable     7.85% 7.85% 7.85% 7.85% 4.15% 4.15% 10.00% 10.00% 8.00% 8.00% 8.00% 8.00%     8.00% 8.00% 8.00% 8.00%     8.00% 8.00% 8.00% 8.00% 10.00% 10.00% 10.00% 10.00% 10.00% 10.00%
XML 21 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation and principles of consolidation

 

The accompanying consolidated unaudited interim financial statements and related notes have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information, and with the rules and regulations of the United states Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the SEC.

 

All intercompany accounts have been eliminated for the purpose of the consolidated financial statement presentation.

 

Use of estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Cash

 

We consider all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.

 

Accounts receivable

 

Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses based on specific identification of accounts in our existing accounts receivable. Outstanding account balances are reviewed individually for collectibility. We determine the allowance based on historical write-off experience, customer specific facts and economic conditions. Bad debt expense is included in general and administrative expenses, if any. We consider all accounts greater than 30 days old to be past due. Account balances are charged off against allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $2,526 at both June 30, 2014 and December 31, 2013.

 

Inventory

 

Inventory, which consists primarily of raw materials to be used in the production of our dietary supplement products, is stated at the lower of cost or market using the first-in, first-out method. We regularly review our inventory on hand and, when necessary, record a provision for excess or obsolete inventory.

 

Property and equipment

 

Property and equipment are recorded at cost. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets:

 

Office equipment   3 years
Production equipment   5 to 7 years
Equipment under capital lease   5 to 7 years
Leasehold improvements   Lesser of lease term or useful life of improvement

 

Patents

 

Patents, once issued or purchased, are amortized using the straight-line method over their economic remaining useful lives. All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs. Patent application costs, generally legal costs, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally 15 to 20 years for domestic patents and 5 to 20 years for foreign patents, or expensed if the patent application is rejected. The costs of defending and maintaining patents are expensed as incurred. Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

 

Impairment of long-lived assets

 

Our long-lived assets, which include property and equipment, patents and licenses of patents, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

 

Discount on convertible notes payable

 

We allocate the proceeds received from convertible notes between convertible notes payable and warrants, if applicable. The resulting discount for warrants is amortized using the effective interest method over the life of the debt instrument. After allocating a portion of the proceeds to the warrants, the effective conversion price of the convertible note payable can be determined. If the effective conversion price is lower than the market price at the date of issuance, a beneficial conversion feature is recorded as an additional discount to the convertible note payable. The beneficial conversion feature discount is amortized using the effective interest method over the life of the debt instrument. The amortization is recorded as interest expense on the consolidated statements of operations.

 

Fair value of financial instruments

 

The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable and accounts payable, approximate their fair values (determined based on level 1 inputs in the fair value hierarchy) because of the short maturity of these instruments. Due to conversion features and other terms, it is not practical to estimate the fair value of notes payable and convertible notes.

 

Fair value measurements

 

We measure fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

Level 1   Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
     
Level 2   Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
     
Level 3   Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.

 

We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at June 30, 2014 or December 31, 2013, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended June 30, 2014 and June 30, 2013.

 

Revenue recognition

 

We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.

 

Revenues from the sale of products, including shipping and handling fees but excluding statutory taxes collected from customers, as applicable, are recognized when shipment has occurred. We sell our products directly to customers. Persuasive evidence of an arrangement is demonstrated via order and invoice, product delivery is evidenced by a bill of lading from the third party carrier and title transfers upon shipment, the sales price to the customer is fixed upon acceptance of the order and there is no separate sales rebate, discount, or volume incentive.

 

Shipping and handling costs

 

Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred.

 

Advertising and promotion costs

 

Costs associated with the advertising and promotions of our products are expensed as incurred.

 

Equity instruments issued to parties other than employees for acquiring goods or services

 

We account for all transactions in which goods or services are the consideration received for the issuance of equity instruments based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. Currently such transactions are primarily awards of warrants to purchase common stock.

 

The fair value of each warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.

 

The assumptions used to determine the fair value of our warrants are as follows:

 

- The expected life of warrants issued represents the period of time the warrants are expected to be outstanding.
   
- The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant.
   
- The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant.
   
- The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.

 

Income taxes

 

We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in our consolidated statements of income in the period that includes the enactment date.

 

We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Should they occur, our policy is to classify interest and penalties related to tax positions as income tax expense.

 

We did not record an income tax provision for the three months and six months ended June 30, 2014 and 2013 as we had a net taxable loss in the periods.

 

Net loss per common share

 

Basic and diluted net loss per share has been computed by dividing our net loss by the weighted average number of common shares issued and outstanding. Convertible preferred stock, options and warrants to purchase our common stock as well as debt which are convertible into common stock are anti-dilutive and therefore are not included in the determination of the diluted net loss per share for three months ended June 30, 2014 and 2013 and the six months ended June 30, 2014 and 2013. The following table presents a reconciliation of basic loss per share and excluded dilutive securities:

 

 

     

For the Three

Months Ended

June 30,

 

For the Six

Months Ended

June 30,

      2014   2013   2014   2013
 Numerator:                
 Net loss     $ (510,763)   $ (1,038,338)   $ (1,046,151)   $ (1,490,612)
                   
 Denominator:              

Weighted-average common shares outstanding

8,532,935    7,456,281    8,429,958    7,308,930 
                   

Basic and diluted

net loss per share

$ (0.06)   $ (0.14)   $ (0.12)   $ (0.20)
                   
 Common stock warrants 4,520,308    3,495,902    4,520,308    3,495,902 

Series A convertible

preferred stock

2,378,070    2,411,940    2,378,070    2,411,940 
 Stock options 2,572,099    1,450,172    2,572,099    1,450,172 

Convertible debt

including interest

900,321    816,516    900,321    816,516 

Excluded dilutive

securities

10,370,798    8,174,530    10,370,798    8,174,530 

 

 

 

Reclassifications 

 

Certain reclassifications have been made to prior period financial statements and footnotes in order to conform to the current period's presentation.

 

Segments

 

We have determined that we operate in one segment for financial reporting purposes.

 

Recently issued accounting pronouncements

 

In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for Entia beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our financial statements.

 

EXCEL 22 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X M8CEE,S-D,&$B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3E-/3$E$051%1%]35$%414U%3E137T]&7T-! M4SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?,E]354U-05)97T]&7U-)1TY)1DE# M04Y47SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/ M5$5?,U])3E9%3E1/4ED\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?-5]0051%3E13 M7T%.1%],24-%3E-%4U].13PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?-E]!0T-2545$7T584$5.4T53/"]X.DYA;64^#0H@ M("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I7;W)K#I7 M;W)K#I7;W)K#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/DY/5$5?,E]354U-05)97T]&7U-)1TY) M1DE#04Y47S(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DY/5$5?-%]04D]015)465]!3D1?15%525!- M14Y47SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/ M5$5?-5]0051%3E137T%.1%],24-%3E-%4U].13$\+W@Z3F%M93X-"B`@("`\ M>#I7;W)K#I7;W)K#I7;W)K#I%>&-E M;%=O#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/DY/5$5?,E]%4U1)34%4141? M55-%1E5,7TQ)5D537SPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?,E]354U-05)97T]&7U-)1TY)1DE#04Y47S,\+W@Z3F%M M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?-5]0051%3E137T%.1%],24-%3E-%4U].13(\+W@Z M3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?-U].3U1%4U]005E!0DQ%7T1E=&%I;'-? M4#PO>#I.86UE/@T*("`@(#QX.E=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/DY/5$5?.%]214Q!5$5$7U!!4E197U1204Y3 M04-423$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DY/5$5?,3!?0T]-34E4 M345.5%-?04Y$7T-/3E1)3C$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I3='EL97-H965T($A2968] M,T0B5V]R:W-H965T&-E;"!84"!O3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X M8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED M-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!);F9O2!);F9O'0^)SQS<&%N/CPO2!296=I2!#96YT3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)S`P,#$T,#@R.3D\'0^2G5N(#,P+`T*"0DR,#$T/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3QS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)U$R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N M/CPO6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA3PO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQAF5D+"!397)I97,@ M02!P2P@86=G3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P M7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M)SQS<&%N/CPOF5D/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ-3`L M,#`P+#`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`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`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`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X M93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F M93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPOF%T:6]N/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ.2PW,3`\'0^)SQS<&%N/CPO3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@6UE;G0@;VX@;F]T97,@<&%Y86)L93PO=&0^#0H@("`@("`@(#QT M9"!C;&%S6UE;G0@;VX@8V]N M=F5R=&EB;&4@;F]T92!P87EA8FQE("T@3PO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%B;&4@86YD(&%C8W)U960@:6YT97)E'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA2!S=7!P;&5M96YT(&YU=')A8V5U=&EC86P@ M<')O9'5C=',@:6X@=&AE(%5N:71E9"!3=&%T97,@;V8@06UE2!T:&ER9"!P87)T:65S M+CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY/;B!*86YU87)Y M(#DL(#(P,3(L('1H90T*86UE;F1M96YT('1O(&]U2!O9B!3=&%T92!O9B!.979A M9&$N(%=E(&%L6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA M;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@:&%V92!A(&AI6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY);B!O2!T;R!A8VAI979E('!R;V9I=&%B:6QI='DL('=E(&UA>2!B92!R M97%U:7)E9"!T;R!O8G1A:6X@8V%P:71A;"!F2!S96-U2!C;VYT:6YU97,@87,@ M82!G;VEN9R!C;VYC97)N+CPO<#X-"@T*/'`@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY4:&4@8V]N2!R M97-U;'0@9G)O;2!T:&4@;6%T=&5R3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P M7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&D^/'4^0F%S:7,@;V8@<')E6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5&AE(&%C8V]M<&%N>6EN9R!C;VYS;VQI9&%T960-"G5N M875D:71E9"!I;G1E2P@=&AE>2!D;R!N M;W0@:6YC;'5D92!A;&P@;V8@=&AE(&EN9F]R;6%T:6]N#0IA;F0@9F]O=&YO M=&5S(')E<75I0T*9F]R('1H92!Y96%R(&5N9&5D($1E8V5M M8F5R(#,Q+"`R,#$S(&%N9"!N;W1E28C,30V.W,@06YN=6%L(%)E<&]R="!O;B!&;W)M(#$P+4L@ M9FEL960@=VET:"!T:&4-"E-%0RX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^06QL(&EN=&5R8V]M<&%N>2!A8V-O=6YT2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY4:&4@<')E<&%R871I;VX@;V8@8V]N6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY792!C;VYS:61E'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^06-C;W5N=',@2X@5V4@9&5T97)M:6YE('1H92!A;&QO=V%N8V4@8F%S960@;VX@:&ES M=&]R:6-A;"!W'0M86QI9VXZ(&IU6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SY);G9E;G1O2P@&-E2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&D^)B,Q-C`[/"]I/CPO<#X-"@T*/'`@2!A;F0@97%U M:7!M96YT/"]U/CPO:3X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^4')O<&5R='D@86YD(&5Q=6EP;65N=`T*87)E(')E8V]R9&5D(&%T(&-O M6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C4@=&\@ M-R!Y96%R6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY0871E;G1S+"!O;F-E(&ESF5D('5S:6YG('1H92!S=')A:6=H="UL M:6YE(&UE=&AO9"!O=F5R('1H96ER(&5C;VYO;6EC(')E;6%I;FEN9R!U'!E;G-E9"!I9B!T M:&4@<&%T96YT(&%P<&QI8V%T:6]N(&ES(')E:F5C=&5D+B!4:&4@8V]S=',@ M;V8@9&5F96YD:6YG(&%N9"!M86EN=&%I;FEN9R!P871E;G1S#0IAF5D+"!T:&4@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3W5R(&QO M;F2!A;F0@ M97%U:7!M96YT+"!P871E;G1S(&%N9"!L:6-E;G-E2!N;W0@8F4@'0M86QI9VXZ M(&IU&-E'!E8W1E9"!F=71U2!D971E2!D971E M2!E6QE/3-$)V9O;G0Z M(#$P<'0@07)I86P@56YI8V]D92!-4SL@;6%R9VEN.B`P.R!T97AT+6%L:6=N M.B!J=7-T:69Y.R!T97AT+6EN9&5N=#H@,"XU:6XG/B8C,38P.SPO<#X-"@T* M/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@86QL;V-A M=&4@=&AE('!R;V-E961S#0IR96-E:79E9"!F6%B;&4@ M8V%N(&)E(&1E=&5R;6EN960N($EF('1H92!E9F9E8W1I=F4@8V]N=F5R6%B;&4N(%1H92!B96YE9FEC M:6%L(&-O;G9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&D^/'4^1F%I6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@ M8V%R6%B;&4L(&%P<')O>&EM871E('1H96ER(&9A M:7(@=F%L=65S("AD971E6%B;&4@86YD(&-O;G9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&D^/'4^1F%I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!M96%S=7)E(&9A:7(@ M=F%L=64@87,-"F%N(&5X:70@<')I8V4L(')E<')E'0M86QI9VXZ(&IU M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V)A8VMG3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE2!O6QE/3-$)W9E6QE/3-$)W9E M6QE/3-$)W9E6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN M)SY792!D;R!N;W0@:&%V92!A;GD@87-S971S#0IO2!G86EN'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&D^/'4^4F5V96YU92!R96-O9VYI=&EO;CPO=3X\+VD^/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU2!H87,@;V-C=7)R960@ M;W(@&5D(&]R(&1E=&5R;6EN86)L92!A;F0@*&EV*2!C;VQL96-T M:6)I;&ET>2!O9B!A;6]U;G1S(&ES(')E87-O;F%B;'D@87-S=7)E9"X\+W`^ M#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^4F5V96YU97,@9G)O;2!T M:&4@2!T87AEF5D#0IW:&5N('-H:7!M96YT(&AA2!A(&)I;&P@;V8@;&%D:6YG(&9R;VT@=&AE('1H:7)D M('!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^)B,Q-C`[/"]I/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY!;6]U;G1S(&-H87)G960@=&\@8W5S=&]M97)S M#0IF;W(@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^0V]S=',@87-S;V-I M871E9"!W:71H('1H90T*861V97)T:7-I;F<@86YD('!R;VUO=&EO;G,@;V8@ M;W5R('!R;V1U8W1S(&%R92!E>'!E;G-E9"!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M2!I;G-T'0M86QI9VXZ(&IU2!I;G-T2!I;G-T6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^5&AE M(&%S'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE'!E8W1E9"!T;R!B92!O=71S M=&%N9&EN9RX\+V9O;G0^/"]T9#X\+W1R/@T*/'1R/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D M/B8C,38P.SPO=&0^/"]T3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O M;G0M9F%M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'!E8W1E9"!D:79I9&5N9"!Y:65L9"!I6EE;&0@9F]R('!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE&5S/"]U/CPO:3X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@`T*87-S971S(&%N9"!L:6%B:6QI=&EE65A M"!A M"!R871E'!E8W1E9"!T;R!A<'!L>0T*=&\@=&%X86)L92!I M;F-O;64@:6X@=&AE('EE87)S(&EN('=H:6-H('1H;W-E('1E;7!O2!D M:69F97)E;F-E"!R871EF5D(&EN(&]U'0M86QI9VXZ M(&IU"!P;W-I=&EO;B!O;FQY(&EF(&ET(&ES(&UO"!P;W-I=&EO;B!W:6QL(&)E('-U&%M:6YA=&EO;B!B>2!T:&4-"G1A>&EN9R!A=71H;W)I=&EE"!P;W-I=&EO;G,@87,@ M:6YC;VUE('1A>`T*97AP96YS92X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT M.B`P+C5I;B<^5V4@9&ED(&YO="!R96-O&%B;&4@;&]S6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H- M"@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY"87-I8R!A;F0@9&EL=71E M9"!N970@;&]S2!T:&4@=V5I9VAT960@879E"!M;VYT:',@96YD960@ M2G5N92`S,"P@,C`Q-"!A;F0@,C`Q,RX@5&AE(&9O;&QO=VEN9R!T86)L92!P M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E M6QE/3-$)W=I9'1H.B`R M,24[('!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUR:6=H M=#H@-2XT<'0[('!A9&1I;F3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E M;G1E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#$P<'0G/C(P,3,\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H.B`S M)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)W!A9&1I;F3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0F(SD[*#4Q,"PW-C,I/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG M;CH@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y.R@Q+#`T-BPQ-3$I/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG M;CH@6QE M/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX+#4S,BPY,S4F(S$V,#L\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/B8C.3LW+#0U-BPR.#$F(S$V,#L\+V9O;G0^/"]T9#X- M"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE/3-$)W!A9&1I;F'0M:6YD96YT.B`P+C5I M;B<^;F5T(&QO'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0F(SD[*#`N,C`I/"]F;VYT/CPO M=&0^/"]T6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M:6YD96YT M.B`P+C5I;B<^<')E9F5R6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LR+#,W."PP-S`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C M.3LR+#0Q,2PY-#`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LR+#4W,BPP.3DF(S$V,#L\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B8C.3LQ+#0U,"PQ-S(F(S$V,#L\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^:6YC;'5D:6YG(&EN M=&5R97-T/"]P/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M=#L@9F]N="UF86UI;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M:6YD96YT.B`P M+C5I;B<^17AC;'5D960@9&EL=71I=F4\+W`^#0H@("`@("`@(#QP('-T>6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LQ,"PS-S`L-SDX)B,Q-C`[/"]F;VYT M/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D M:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA M;&EG;CH@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX+#$W M-"PU,S`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$ M)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX M+#$W-"PU,S`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^4F5C;&%S M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY#97)T86EN(')E8VQA6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^)B,Q-C`[/"]I M/CPO<#X-"@T*/'`@'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^4F5C96YT;'D@:7-S=65D M(&%C8V]U;G1I;F<@<')O;F]U;F-E;65N=',\+W4^/"]I/CPO<#X-"@T*/'`@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY);B!-87D@,C`Q-"P@=&AE($9!4T(@ M:7-S=65D#0IN97<@86-C;W5N=&EN9R!G=6ED86YC92!R96QA=&5D('1O(')E M=F5N=64@F5D+B!4:&4@8V]R92!P2!E M>'!E8W1S('1O(&)E(&5N=&ET;&5D(&EN(&5X8VAA;F=E(&9O<@T*=&AO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E M;G0Z(#`N-6EN)SY);G9E;G1O'0M86QI9VXZ(&IU M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I M;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R M,24[(&)O'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F'0M86QI M9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LT-2PQ-3`F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M&-E2`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(&IU'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I M;B<^4')O<&5R='D@86YD(&5Q=6EP;65N="P@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`R,"4[('!A9&1I;F6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.U!R;V1U8W1I;VX@97%U:7!M96YT(#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LX-2PP-#8F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX,RPV,34F(S$V,#L\+V9O M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)V)O'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C M.3LQ-BPS,C@F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LQ,C8L,C(W)B,Q-C`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`P+C5I;B<^3W5R(&ED96YT M:69I86)L92!L;VYG+6QI=F5D#0II;G1A;F=I8FQE(&%S2!A;F0@)#2X\+W`^#0H-"@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^/"]P/@T*#0H\<"!S='EL M93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IUF%T:6]N(')E;&%T960@=&\@=&AE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[ M/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$ M,"!A;&EG;CTS1&-E;G1E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Y)3L@<&%D9&EN M9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE M/3-$)W=I9'1H.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R,B4[ M(&)O'0M86QI9VXZ(')I M9VAT)SX-"B`@("`@("`@/'`@6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.TQI M8V5N'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I M;F6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$ M)V9O;G0MF%T M:6]N(#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LH,38L,3(W*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y.S,T,RPT.3@F(S$V M,#L\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/CQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6%B;&4I#0IC;VYS:7-T6QE/3-$)W=I9'1H.B`V+C5I;CL@8F]R9&5R+6-O;&QA<'-E.B!C M;VQL87!S92<^#0H\='(@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E&5C=71I=F4@8V]M<&5N6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3L\+V9O;G0^ M,3`X+#$Y.3PO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LV,"PV-S$\ M+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6%B;&4@8V]N6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`Y)3L@<&%D M9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ M(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`@6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/C0N,34E('5N6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/C$P+C`P)2!U;G-E8W5R M960L(&EN=&5R97-T(&]N;'DL(&1U92!$96-E;6)E'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LR-2PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`Y:6X[(&)O'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@ M6QE/3-$)V9O;G0MF4Z(#EP="<^."4@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#EP="<^)B,Y.S0W+#DU,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.S,W+#

6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y M.S(W+#8Y,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.S(R+#0T.#PO9F]N=#X\ M+W1D/CPO='(^#0H\='(@6QE/3-$)V9O M;G0M6QE/3-$)W!A M9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X M="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP="<^ M/&9O;G0@2`R,#$U("AN970@;V8@9&ES8V]U;G0@6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`W)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A M9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE M/3-$)W!A9&1I;FF4Z(#EP="<^/&9O;G0@65T(&1E=&5R M;6EN960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z M(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP="<^,3`E('5N'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.RT\+V9O M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE M/3-$)W!A9&1I;FF4Z(#EP="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@ M=6YD97)L:6YE)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB M/CQU/D-O;G9E6%B;&4L(&YE="!R96QA=&5D('!A M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U M+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,'!T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$ M)W9E6QE/3-$)W=I9'1H M.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I M;F6QE/3-$)W=I9'1H.B`S.24[ M('!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=W:61T:#H@,C(E.R!P861D:6YG+7)I9VAT.B`U M+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,'!T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W9EF4Z(#$P<'0G/C`E('5NF4Z(#$P<'0G/B8C.3LD M)B,Y.RT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL M969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,'!T)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@F4Z M(#$P<'0G/B8C.3LD)B,Y.RT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LD M)B,Y.S(S+#0R-SPO9F]N=#X\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6%B M;&4-"G=A2!I;B!N96=O=&EA=&EO;G,@=VET:"!T:&4@;F]T92!H;VQD97(@=&\@97AT M96YD('1H:7,@;F]T92!A;F0@=V4@87)E(&YO="!I;B!D969A=6QT+CPO<#X- M"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY$=7)I;F<@,C`Q-"P@=V4@ M96YT97)E9`T*:6YT;R!T:&4@9F]L;&]W:6YG(&1E8F5N='5R92!A9W)E96UE M;G1S('1H870@86-C65A65A6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R M:6%L(%5N:6-O9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$ M)W=I9'1H.B`U."XU<'0G/CPO=&0^/'1D('-T>6QE/3-$)W=I9'1H.B`Q,RXX M<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M9F%M:6QY.B!#;W5R:65R($YE=RP@ M0V]U6QE/3-$ M)W1E>'0M86QI9VXZ(&IU6QE/3-$)V9O;G0M9F%M M:6QY.B!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^5V4@<&]S=&5D('1H92!F86ER M('9A;'5E#0IO9B!T:&4@=V%R'0M86QI9VXZ M(&IU2X-"DEF('1H92!N;W1E(')E;6%I;G,@ M=6YP86ED(&%F=&5R(&]N92!H=6YD2`H,3@P*2!D87ES(&9R M;VT@=&AE($ES6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS M<&%C:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!! M2<^/&9O;G0@6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L M(%5N:6-O9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU7!E.B!T97AT+VAT;6P[(&-H M87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U% M5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O M:'1M;#L@8VAA6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^1&5B="!A9W)E96UE M;G1S(&9R;VT@8F]A6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^)B,Q-C`[/"]I M/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^/&D^)B,Q-C`[/"]I/CPO<#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA M'0^)SQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]4 M12`Y("8C,34P.R!35$]#2TA/3$1%4E,F(S$T-CL@15%52519#0HH1$5&24-) M5"D\+V(^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^ M3VX@36%Y(#(V+"`R,#$Q+"!O=7(@8F]A2!C;VYV97)T:6)L92!I;G1O(&-O;6UO M;B!S=&]C:R!O;@T*82!O;F4M9F]R+71E;B!B87-I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P M/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^1'5R:6YG('-E8V]N9"!Q=6%R=&5R(#(P M,30L#0IT=V\@:6YV97-T;W)S(&-O;G9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^0V]M M;6]N('-T;V-K/"]U/CPO:3X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^1'5R:6YG('-E8V]N9"!Q=6%R=&5R(#(P,30L#0IW92!I6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C M:6YG/3-$,"!S='EL93TS1"=W:61T:#H@,3`P)3L@9F]N=#H@,3!P="!!2<^/&9O;G0@6%B;&4@86QO;F<@=VET:"!A8V-R=65D(&EN=&5R97-T M(&]F("0R+#4R,"P\+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^#0H-"CQT86)L M92!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P('-T>6QE/3-$)W=I M9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H M.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE&-H86YG90T*9F]R(#0T+#$V,B!S:&%R97,@;V8@4V5R:65S M($$@4')E9F5R6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O M9&4@35,[(&UA3H@0V]U3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^1'5R M:6YG(&9I6QE/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O9&4@ M35,[(&UA3H@0V]U3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W=I9'1H.B`Q,#`E.R!F;VYT.B`Q,'!T($%R:6%L(%5N:6-O9&4@35,[ M(&UA3H@0V]U3H@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&9O;G0@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&D^ M/'4^4W1O8VL@:6YC96YT:79E('!L86X\+W4^/"]I/CPO<#X-"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE3L@ M=&5X="UI;F1E;G0Z(#`N-6EN)SY/;B!397!T96UB97(@,32X@5V4@:&%V92!R97-E2`Q(&]F(&5A8V@@>65A'0M86QI9VXZ(&IU6QE/3-$)W=I9'1H M.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/B8C,38P.T5X<&5C=&5D(&1I=FED96YD('EI96QD(#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/B8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.RTF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.RTF(S$V,#LF M(S$V,#LF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.T5X<&5C=&5D('-T;V-K('!R M:6-E('9O;&%T:6QI='D@/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN M9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E M;G1E'0M86QI9VXZ(&-E;G1E'!E8W1E9"!T97)M("AI;B!Y96%R6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C4@+2`Q M,"!Y96%RF4Z(#$P<'0G/B0P+C8R(#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E2!O9B!O<'1I;VX@86-T:79I M='D-"G5N9&5R('1H92!S=&]C:R!O<'1I;VX@<&QA;B!A6QE M/3-$)V9O;G0Z(#$P<'0O,3$U)2!4:6UE6QE/3-$)W=I9'1H.B`S-24[('!A9&1I;F6QE/3-$ M)W=I9'1H.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E M6QE/3-$ M)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E M6QE M/3-$)W!A9&1I;F'0M M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E M6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F'0M86QI M9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E=E:6=H=&5D M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@ M=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F'0M86QI M9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/D%G M9W)E9V%T93PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I M;FF4Z(#$P<'0G/D5X97)C:7-E(%!R:6-E/"]F;VYT/CPO=&0^ M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I M9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@ M8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#$P<'0G/E)A;F=E/"]F;VYT/CPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/E!R:6-E/"]F M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P M861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X M="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@F4Z(#$P<'0G/BA996%R6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.R0P+C0P("T@)#$N M,#`@/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M=#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E M6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z M(#$P<'0G/B8C.3LD)B,Y.S`N-3<\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G M/D=R86YT960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/C$L,34P+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/B8C.3LX+C`W/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^/"]T&5R8VES M960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.RTF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LM M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO M=&0^/"]T6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/D5X<&ER960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.R0P+C,X("T@)#$N M,#`@/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M=#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z M(#$P<'0G/B8C,38P.R0P+C,X("T@)#$N,#`@/"]F;VYT/CPO=&0^#0H@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U M+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@8V5N=&5R M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M6QE M/3-$)W9E6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/D5X97)C:7-E9#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E M6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LD)B,Y.RT\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G M/D5X<&ER960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.RTF(S$V,#LF(S$V,#LF(S$V,#L\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G M/B8C.3LM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S M='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U M+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-3'0M86QI9VXZ(&-E M;G1E6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F&5R8VES86)L92P@2G5N92`S,"P@,C`Q-#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/B8C.3LD)B,Y.S`N-3(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^5&AE(')A;F=E(&]F(&5X97)C:7-E('!R:6-E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)W9E'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q,"4[('!A9&1I;FF4Z(#$P<'0G/D5X97)C:7-E(#PO9F]N=#X\+W1D/CPO='(^#0H\ M='(@6QE/3-$ M)V9O;G0MF4Z(#$P<'0G/E!R:6-E/"]F M;VYT/CPO=&0^/"]T6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z M(#$P<'0G/B8C.3LD)B,Y.S`N-#`\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(T-RPR-#(\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C@T-"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/C$V,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0MF4Z(#$P<'0G/B8C M.3LD)B,Y.S`N.#4\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C,X M+#`P,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/B8C.3LD)B,Y.S$N,#`\+V9O;G0^/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(L-36QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF M(S$V,#L\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY!="!*=6YE(#,P+"`R,#$T M+"!T:&4@0V]M<&%N>0T*:&%D(#(L,#2!H860@)#(V,RPU,#<@;V8@=&]T86P@=6YR96-O M9VYI>F5D#0IC;VUP96YS871I;VX@8V]S="!R96QA=&5D('1O('5N=F5S=&5D M('-T;V-K(&]P=&EO;G,L('=H:6-H(&ES(&5X<&5C=&5D('1O(&)E(')E8V]G M;FEZ960@;W9E65A M'0M86QI9VXZ(&IU M6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^3W5T6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0MF4Z M(#$P<'0G/DIU;F4@,S`L(#(P,30\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H M=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H.B`Q-R4[(&)O'0M86QI9VXZ(&-E;G1EF4Z(#$P<'0G/D5X<&ER871I;VX\+V9O;G0^/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C`T+S(P M,3<@+2`P,R\R,#(Q/"]F;VYT/CPO=&0^/"]TF4Z(#$P<'0G/DIA M;G5A6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C`Q M+S(P,3D@+2`P,2\R,#(Q/"]F;VYT/CPO=&0^/"]T'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B8C.3LT+#,T.2PV.3@\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E1O=&%L/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A M<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D M9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/D5X<&ER M960@/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE M/3-$)V)O'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LM M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z M(#$P<'0G/E1O=&%L/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL M969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY792!U2!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`S,R4[('!A9&1I;F6QE/3-$)W=I M9'1H.B`R.24[(&)O'0M M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)V9O;G0M6EE;&0\+V9O M;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)V)A M8VMGF4Z(#$P<'0G/C`E/"]F;VYT/CPO=&0^#0H@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT M.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)V)A8VMGF4Z(#$P<'0G/C`E/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/E9O;&%T:6QI='D\+V9O M;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A M9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C(Q M-BXT."4M,C,Y+C(P)3PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1E6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/B0P+C0U(#PO9F]N=#X\+W1D M/CPO='(^#0H\+W1A8FQE/@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY!="!*=6YE(#,P+"`R M,#$T(&%N9"`R,#$S+`T*=&AE('=E:6=H=&5D+6%V97)A9V4@0FQA8VLM4V-H M;VQE2X\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/CQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQP M('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^/&(^3D]4 M12`Q,"`M($-/34U)5$U%3E13($%.1"!#3TY424Y'14Y#2453/"]B/CPO<#X- M"@T*/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^/&D^/'4^3&5A6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@07!R:6P@-"P@,C`Q,BP@=&AE($-O;7!A M;GD-"F5N=&5R960@:6YT;R!A($-O;6UEB!02`S M,2P@,C`Q-2X@3F\@6%B;&4@86YD(&%C8W)U960@97AP M96YS97,N(%1H90T*86UO=6YT(')E8V]R9&5D(&9O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^)B,Q M-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2 M;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU M'0M:6YD96YT.B`P+C5I;B<^3VX@2G5L>2`Q-"P@,C`Q-"P@ M=V4@=V5R90T*;F]T:69I960@8GD@=&AE($UI8VAA96P@2B!&;W@@1F]U;F1A M=&EO;B!T:&%T('=E(&AA9"!B965N(&%W87)D960@82!G'0M86QI9VXZ(&IUF4@;W9E6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^26X@2G5L>2`R,#$T+"!A;B!I;G9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;B<^3VX@2G5L>2`Q+"`R,#$T M+"!W92!E;G1E2!N;W1E('=I=&@@1'(N M(%-O8F]L+"`H82!B;V%R9"!M96UB97(I(&9O'0M86QI9VXZ(&IU'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^)SQS<&%N/CPO'0M86QI9VXZ M(&IU'0M86QI9VXZ(&IU&-H86YG M90T*0V]M;6ES2!5+E,N($=!05`@9F]R(&-O;7!L M971E(&9I;F%N8VEA;"!S=&%T96UE;G1S+B!4:&4@=6YA=61I=&5D(&EN=&5R M:6T@9FEN86YC:6%L('-T871E;65N=',@9G5R;FES:&5D(')E9FQE8W0-"F%L M;"!A9&IU2!T;R!A(&9A:7(@65A'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY4:&4@<')E<&%R871I;VX@;V8@8V]N M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I M;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@8V]N0T*;&EQ=6ED+"!S:&]R="UT97)M(&EN=F5S=&UE;G1S M('=I=&@@;W)I9VEN86P@;6%T=7)I=&EE'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY!8V-O=6YT'!E2X@5V4-"F-O;G-I9&5R(&%L;"!A8V-O M=6YT2!I M6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0M86QI9VXZ(&IU3PO=3X\+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q M,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2P@=VAI8V@-"F-O;G-I2!O M9B!R87<@;6%T97)I86QS('1O(&)E('5S960@:6X@=&AE('!R;V1U8W1I;VX@ M;V8@;W5R(&1I971A&-E'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY02!A;F0@97%U M:7!M96YT#0IA'!E;G-E9"!A6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&-O;&]R.B!B M;&%C:R<^-2!T;R`W('EE87)S/"]F;VYT/CPO=&0^/"]T6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0[(&-O;&]R.B!B;&%C:R<^ M17%U:7!M96YT('5N9&5R(&-A<&ET86P@;&5A6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M65A6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z M(#$P<'0[(&-O;&]R.B!B;&%C:R<^3&5A'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY0871E M;G1S+"!O;F-E(&ESF5D M('5S:6YG('1H92!S=')A:6=H="UL:6YE(&UE=&AO9"!O=F5R('1H96ER(&5C M;VYO;6EC(')E;6%I;FEN9R!U'!E;G-E9"!I9B!T:&4@<&%T96YT(&%P<&QI8V%T:6]N(&ES M(')E:F5C=&5D+B!4:&4@8V]S=',@;V8@9&5F96YD:6YG(&%N9"!M86EN=&%I M;FEN9R!P871E;G1S#0IAF5D+"!T:&4@'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P M/CQS<&%N/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY792!A6EN M9R!A;6]U;G1S+B!);7!A:7)M96YT+"!I9@T*86YY+"!I6EN9R!A;6]U;G0@;W9E'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^)B,Q-C`[/"]P/CQS<&%N/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE2<^ M/&D^/'4^1&ES8V]U;G0@;VX@8V]N=F5R=&EB;&4@;F]T97,@<&%Y86)L93PO M=3X\+VD^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU6%B;&4@86YD M('=AF5D('5S:6YG('1H92!E9F9E M8W1I=F4@:6YT97)EF5D('5S:6YG('1H92!E9F9E8W1I=F4@:6YT97)E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^/&D^/'4^1F%I'0M86QI9VXZ M(&IU6EN9R!A;6]U;G1S(&]F#0IO=7(@9FEN86YC:6%L(&%S2D@8F5C875S92!O9B!T:&4@ M'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU M2!T2X@5V4@=71I;&EZ92!A('1H MF5S('1H92!I;G!U=',-"G5S960@:6X@;65A6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,"!A;&EG;CTS1&-E;G1E6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE M/3-$)W9E6QE/3-$)V9O;G0M9F%M:6QY.B!4:6UE6QE/3-$)W9E6QE M/3-$)V9O;G0M9F%M:6QY.B!4:6UE3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)A8VMG3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI M9VXZ(&IU'0M:6YD96YT.B`P+C5I;B<^5V4@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY2979E;G5E2!T;R!C=7-T;VUE&5D('5P;VX@86-C97!T86YC92!O9B!T:&4@;W)D97(@86YD('1H97)E(&ES M(&YO('-E<&%R871E('-A;&5S(')E8F%T92P@9&ES8V]U;G0L(&]R('9O;'5M M90T*:6YC96YT:79E+CPO<#X-"@T*/'`@2P@:6X@'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY!;6]U;G1S(&-H M87)G960@=&\@8W5S=&]M97)S#0IF;W(@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/CQS M<&%N/CPO'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE2<^/&D^/'4^061V97)T:7-I;F<@86YD('!R;VUO=&EO M;@T*8V]S=',\+W4^/"]I/CPO<#X-"@T*/'`@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY#;W-T'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(&IU'0M M:6YD96YT.B`P+C5I;B<^5V4@86-C;W5N="!F;W(@86QL('1R86YS86-T:6]N M2!M96%S=7)A8FQE+B!4:&4@;65A2!I M;G-T'0M86QI M9VXZ(&IU'0M86QI9VXZ(&IU3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W9E6QE/3-$)V9O;G0MF4Z(#$P<'0G/E1H92!E>'!E8W1E9"!L:69E(&]F('=A M6QE/3-$)W9EF4Z(#$P<'0G/BT\+V9O;G0^ M/"]T9#X-"B`@("`\=&0^/&9O;G0@2!I2!O9B!C;VUP87)A8FQE(&-O M;7!A;FEE'0M86QI M9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0^/&9O;G0@6QE/3-$)V9O M;G0M=V5I9VAT.B!B;VQD.R!T97AT+6%L:6=N.B!C96YT97(G/CQF;VYT('-T M>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'`@6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY792!R96-O9VYI>F4@9&5F97)R960@=&%X#0IA"!C;VYS97%U M96YC97,@;V8@979E;G1S('1H870@:&%V92!B965N(&EN8VQU9&5D(&EN('1H M92!F:6YA;F-I86P@"!R871E"!A'1E;G0@;6%N86=E;65N="!C;VYC;'5D97,@:70@:7,@;6]R92!L:6ME;'D@ M=&AA;B!N;W0-"G1H870@=&AE(&%S65A'!E8W1E9"!T;R!B M92!R96-O=F5R960@;W(@6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S M='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E M'0M86QI9VXZ(&IU'0M:6YD M96YT.B`P+C5I;B<^5V4@2!O8V-U2!I2!I;G1E'!E;G-E+CPO<#X-"@T* M/'`@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SX\+W`^#0H-"CQP('-T>6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N M-6EN)SY792!D:60@;F]T(')E8V]R9"!A;@T*:6YC;VUE('1A>"!P"!M;VYT:',@96YD960@ M2G5N92`S,"P@,C`Q-"!A;F0@,C`Q,R!A'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;B<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`Q,'!T(%1I;65S($YE M=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ M(&IU'0M86QI9VXZ(&IU6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI M;F1E;G0Z(#`N-6EN)SY"87-I8R!A;F0@9&EL=71E9"!N970@;&]S2!T:&4@=V5I9VAT960@879E"!M;VYT:',@96YD960@2G5N92`S,"P@,C`Q-"!A M;F0@,C`Q,RX@5&AE(&9O;&QO=VEN9R!T86)L92!P6QE/3-$)V9O M;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM M97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W=I9'1H.B`R,24[('!A9&1I;F3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E M;G1E6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(&-E;G1E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`Q-24[(&)OF4Z(#$P<'0G/C(P,3,\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUR:6=H M=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE M/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/B0F(SD[*#4Q,"PW-C,I/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@ M<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@6QE/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LD)B,Y.R@Q+#`T-BPQ-3$I/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@ M<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@6QE/3-$)W!A9&1I;F3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B8C.3LX+#4S,BPY,S4F(S$V,#L\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE M/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C M.3LW+#0U-BPR.#$F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R M87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE M/3-$)W!A9&1I;F'0M:6YD96YT.B`P+C5I;B<^;F5T(&QO'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B0F(SD[*#`N,C`I/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W9E M6QE M/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`@6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F'0M:6YD96YT.B`P+C5I;B<^<')E9F5R M6QE/3-$)W!A9&1I;F3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LR+#,W."PP-S`F M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LR+#0Q,2PY-#`F(S$V M,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LR+#4W,BPP.3DF(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LQ+#0U,"PQ-S(F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M:6YD96YT.B`P+C5I;B<^:6YC;'5D:6YG(&EN=&5R97-T/"]P/CPO=&0^ M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I M9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="UF86UI;'DZ M(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M:6YD96YT.B`P+C5I;B<^17AC;'5D960@ M9&EL=71I=F4\+W`^#0H@("`@("`@(#QP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LQ,"PS-S`L-SDX)B,Q-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P M=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX+#$W-"PU,S`F(S$V,#L\+V9O M;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX+#$W-"PU,S`F(S$V,#L\ M+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X-"CQP('-T>6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P M<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SY# M97)T86EN(')E8VQA6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0^ M)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M2<^/&D^ M/'4^4V5G;65N=',\+W4^/"]I/CPO<#X-"@T*/'`@6QE M/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z M(#`N-6EN)SY792!H879E(&1E=&5R;6EN960@=&AA=`T*=V4@;W!E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE3L@=&5X="UI;F1E;G0Z(#`N-6EN)SXF(S$V,#L\+W`^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!I'0^)SQP('-T>6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M3L@=&5X M="UI;F1E;G0Z(#`N-6EN)SY);B!-87D@,C`Q-"P@=&AE($9!4T(@:7-S=65D M#0IN97<@86-C;W5N=&EN9R!G=6ED86YC92!R96QA=&5D('1O(')E=F5N=64@ MF5D+B!4:&4@8V]R92!P2!E>'!E8W1S M('1O(&)E(&5N=&ET;&5D(&EN(&5X8VAA;F=E(&9O<@T*=&AO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQT86)L92!C96QL6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`U)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A M9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P M<'0[(&-O;&]R.B!B;&%C:R<^4')O9'5C=&EO;B!E<75I<&UE;G0\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M65A6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0[(&-O;&]R.B!B;&%C:R<^3&5S'0^ M)SQT86)L92!C96QL6QE/3-$)W=I9'1H.B`Y:6X[(&)O6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX-"B`@("`@("`@/'`@'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`V)3L@<&%D9&EN M9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)V9O M;G0M3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E3H@5&EM97,@3F5W M(%)O;6%N+"!4:6UE'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I M9'1H.B`Q-24[(&)OF4Z(#$P<'0G M/C(P,30\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H.B`S)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I M;F6QE/3-$)V9O;G0MF4Z(#$P<'0G/B8C,38P.TYU;65R871O6QE/3-$)W!A9&1I;F3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A M9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`@6QE/3-$)W9E6QE/3-$)W!A9&1I M;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F3H@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@F4Z(#$P<'0G/B8C,38P.T1E;F]M:6YA=&]R.B`\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@'0M:6YD96YT.B`P+C5I M;B<^5V5I9VAT960M879E6QE/3-$)V)O3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LX+#0R.2PY-3@F(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V)O M3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LW+#,P M."PY,S`F(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R M87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT M)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UE6QE/3-$)V9O;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B0F(SD[*#`N,30I/"]F;VYT/CPO=&0^#0H@("`@ M/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U M+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@;F]W6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B0F(SD[*#`N,3(I/"]F;VYT/CPO=&0^ M#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I M9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@ M6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/B8C.3LT+#4R,"PS,#@F(S$V,#L\+V9O;G0^/"]T9#X- M"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/B8C.3LS+#0Y-2PY,#(F(S$V,#L\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V9O;G0MF4Z(#$P<'0G/B8C,38P.U-T;V-K(&]P=&EO;G,@/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="UF86UI M;'DZ(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#$P<'0G/B8C.3LR+#4W,BPP.3DF(S$V,#L\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#$P<'0G/B8C.3LQ+#0U,"PQ-S(F(S$V,#L\+V9O;G0^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M:6YD96YT.B`P+C5I;B<^0V]N=F5R=&EB;&4@9&5B M=#PO<#X-"B`@("`@("`@/'`@6QE/3-$)V9O;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F3H@5&EM97,@3F5W(%)O M;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LX,38L-3$V)B,Q-C`[/"]F M;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P M861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)V)O M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V9O M;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M:6YD96YT M.B`P+C5I;B<^'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LQ,"PS-S`L-SDX)B,Q M-C`[/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M=#L@=&5X="UA;&EG;CH@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE M,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-? M-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!$:7-C;&]S M=7)E(%M!8G-T3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQT86)L92!C96QL6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`Q)3L@<&%D M9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R,24[(&)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)V9O;G0M6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M&-E2`\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)V)O'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LH,34Q M+#`V-"D\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1E6QE/3-$)V)O6QE/3-$)V)O3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P M9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA M2P@4&QA;G0@86YD($5Q=6EP;65N="!;06)S=')A8W1= M/"]S=')O;F<^/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$2!A;F0@17%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$=&5X=#XG/'1A8FQE(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS M1#`@86QI9VX],T1C96YT97(@6QE/3-$)W=I9'1H M.B`Q,24[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R M.24[(&)O'0M86QI9VXZ M(')I9VAT)SX-"B`@("`@("`@/'`@6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P M.T]F9FEC92!E<75I<&UE;G0\+V9O;G0^/"]T9#X-"B`@("`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`@/&AE860^#0H@("`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`Q)B,Q-C`[/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.T%C M8W5M=6QA=&5D(&%M;W)T:7IA=&EO;B`\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.U!A=&5N=',@86YD($QI8V5N6QE/3-$)V9O;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R M,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1? M.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA6QE/3-$)W9E6QE/3-$)W=I9'1H.B`T-R4[('!A M9&1I;F6QE/3-$)W=I9'1H.B`R)3L@ M<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R-"4[(&)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LD(#PO9F]N=#XW,3`L.3(X/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y.S0W-BPS-C@\+V9O;G0^/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4 M:6UEF4Z(#$P<'0G/D]T M:&5R(&%C8W)U86QS/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!";&%C:R`Q<'0@6QE/3-$)V9O;G0Z M(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y.S@Q.2PQ,C<\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y M.S4S-RPP,SD\+V9O;G0^/"]T9#X\+W1R/@T*/"]T86)L93X\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA6QE/3-$)W=I9'1H.B`S.24[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q)3L@<&%D M9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R,"4[(&)O6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0M M86QI9VXZ(&-E;G1E6QE/3-$ M)W9E'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/CQU/DYO=&5S('!A>6%B;&4@+2!C M=7)R96YT/"]U/CPO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I M9VAT)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F3PO9F]N M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LU+#4Q,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R M87`@6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/B8C.3LD)B,Y M.S(S+#3H@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$ M)W9E6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UD96-O6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP="<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE M/3-$)W!A9&1I;FF4Z(#EP="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.R0F(SD[,S$R+#4P,#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W!A9&1I;FF4Z(#EP="<^/&9O;G0@6QE/3-$)W!A M9&1I;F6QE/3-$)W9EF4Z(#EP M="<^-B4@=6YS96-U6QE/3-$)W!A9&1I;FF4Z M(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0MF4Z(#EP="<^."4@=6YS96-U6QE/3-$)W!A9&1I;F6QE M/3-$)W9EF4Z(#EP="<^."4@=6YS M96-U'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y M.S(X+#0X,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@ M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.RT\+V9O;G0^/"]T9#X\ M+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#EP="<^)B,Y.S$U+#4P,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N M;W=R87`],T1N;W=R87`@'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y M.RT\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.S$P+#(W,SPO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#EP="<^)B,Y.RT\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9EF4Z(#EP="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI M9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R M87`@6QE/3-$)W=I9'1H.B`Q-24[('!A9&1I;F6QE/3-$)W9E6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#EP="<^)B,Y.S$W+#DQ,SPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#EP="<^)B,Y.RT\+V9O M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9EF4Z(#EP="<^,3`E('5N65T(&1E=&5R;6EN960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#EP="<^/&9O;G0@65T M(&1E=&5R;6EN960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;FF4Z(#EP="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#EP M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)W!A9&1I;FF4Z(#EP="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#EP="<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@;F]W6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)OF4Z(#EP=#L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQT86)L92!C96QL6QE/3-$)W=I9'1H.B`V+C5I;CL@ M8F]R9&5R+6-O;&QA<'-E.B!C;VQL87!S93L@9F]N="UF86UI;'DZ(%1I;65S M($YE=R!2;VUA;BP@5&EM97,L(%-E3PO=3X\+V(^ M/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS M1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@ M9F]N="US:7IE.B`Q,'!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/B8C,38P.SPO=&0^/"]TF4Z(#$P<'0[('1E>'0M9&5C;W)A=&EO;CH@=6YD97)L:6YE)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/CQB/CQU/CPO=3X\+V(^/"]F;VYT M/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T M:#H@.24[('!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&YO M=W)A<#TS1&YO=W)A<"!S='EL93TS1"=W:61T:#H@,SDE.R!P861D:6YG+7)I M9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q M,'!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)W=I9'1H.B`Q)3L@ M<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F6QE/3-$)W=I9'1H.B`R,"4[('!A9&1I;FF4Z(#$P<'0G/B8C M,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I M;FF4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.SPO=&0^#0H@ M("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT M.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="US:7IE.B`Q,'!T M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@6QE/3-$)V)O6QE/3-$)V)O'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[ M('!A9&1I;F6QE/3-$)W=I M9'1H.B`Q-24[('!A9&1I;F6QE/3-$)W=I9'1H.B`Q,"4[('!A9&1I;F6QE/3-$)W=I9'1H M.B`Q,B4[('!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)W9E6QE/3-$)W!A9&1I M;F'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E M;G1E6QE/3-$)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/D%V97)A M9V4\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/D-O;G1R86-T=6%L/"]F;VYT M/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D M:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@=&5X="UA M;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N M;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/F]F/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN M9RUL969T.B`U+C1P=#L@=&5X="UA;&EG;CH@8V5N=&5R)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E1E6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/DEN=')I;G-I8SPO9F]N=#X\+W1D/CPO M='(^#0H\='(@6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/E-H87)E'0M86QI9VXZ(&-E;G1E M6QE M/3-$)V)O'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V)OF4Z M(#$P<'0G/E9A;'5E/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I M;F6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;FF4Z(#$P<'0G/B8C.3LD)B,Y.S`N-38\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)V9O M;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;FF4Z(#$P<'0G/B8C.3LX+C$Y/"]F;VYT/CPO M=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^/"]T6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)V9O;G0MF4Z(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P M=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)V)O6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/D]U M='-T86YD:6YG+"!$96-E;6)E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V)OF4Z(#$P<'0G/B8C.3LD)B,Y.S`N-3$\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A M9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;FF4Z(#$P M<'0G/D5X97)C:7-A8FQE+"!$96-E;6)E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LD)B,Y.S`N-3(\+V9O;G0^/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)W9E6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E M6QE M/3-$)W!A9&1I;F6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/D=R86YT960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL M93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(R,"PP,#`\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@;F]W6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C,38P.R0P+C8P+20P+C'0M86QI9VXZ(&-E;G1E M6QE M/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LD)B,Y.S`N M-C(\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F&5R8VES960\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#$P<'0G/BT\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G M/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.RTF(S$V,#LF(S$V,#LF M(S$V,#L\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z M(#$P<'0G/B8C.3LM/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO M=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL M969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/D]U='-T86YD:6YG+"!*=6YE(#,P+"`R M,#$T/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS1&YO=W)A<"!S='EL M93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P M="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE M/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#$P<'0G/C(L,#0T+#@S-CPO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R M87`],T1N;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I M;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B8C.3LQ,C4L,3(W/"]F;VYT/CPO=&0^/"]T M6QE/3-$)W=I9'1H.B`T-"4[('!A9&1I M;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W9EF4Z(#$P<'0G/G-H87)E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O M'0M86QI9VXZ(&-E;G1E M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C4U+#`P,#PO9F]N=#X\+W1D/@T* M("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/B8C.3LD)B,Y M.S`N,S@\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C$S-2PP,#`\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$ M)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE/3-$)V9O M;G0MF4Z(#$P<'0G/B8C.3LD)B,Y.S`N-#4\+V9O M;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V9O;G0MF4Z M(#$P<'0G/B8C.3LD)B,Y.S`N-#D\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C0P+#`P,#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/B8C.3LD M)B,Y.S`N-C4\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(P+#`P M,#PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z M(#$P<'0G/B8C.3LD)B,Y.S`N-S4\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T M>6QE/3-$)W9E6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M6QE/3-$ M)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G/C(P,"PP,#`\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1EF4Z(#$P<'0G/D1A=&4@;V8@27-S=64\+V9O;G0^/"]T M9#X-"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H.B`Q M)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R,R4[(&)O6QE/3-$)V9O;G0M6QE/3-$ M)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)W=I9'1H.B`R,24[(&)O M'0M86QI9VXZ(&-E;G1E MF4Z(#$P<'0G/DIU;F4M,30\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;F6QE/3-$ M)V9O;G0MF4Z(#$P<'0G/B0P+C4P(#PO9F]N M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0MF4Z(#$P<'0G/D%P'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P M<'0G/B8C.3LQ,3,L,S,S/"]F;VYT/CPO=&0^#0H@("`@/'1D(&YO=W)A<#TS M1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P=#L@<&%D9&EN M9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#$P<'0G/B8C.3LV,BPR-S<\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#$P<'0G/C(P,3,\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/DQE6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W!A9&1I;F'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#$P<'0G M/B8C.3LR,"PP,#`\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I M;F6QE/3-$)W=I M9'1H.B`Y)3L@<&%D9&EN9RUR:6=H=#H@-2XT<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0Z(#$P<'0@ M5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W!A9&1I;FF4Z M(#$P<'0G/B8C,38P.T5X<&5C=&5D(&1I=FED96YD('EI96QD(#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G/B8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.RTF(S$V,#LF(S$V,#LF(S$V,#L\+V9O;G0^ M/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W!A9&1I M;FF4Z(#$P<'0G/B8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.RTF(S$V M,#LF(S$V,#LF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE/3-$)W!A9&1I M;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F'0M86QI9VXZ M(&-E;G1E'0M86QI9VXZ(&-E;G1E M6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/C4@ M+2`Q,"!Y96%RF4Z(#$P<'0G/B0P+C8R(#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@'0M86QI M9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0M'0^)SQS<&%N/CPO'0^ M)SQT86)L92!C96QL6QE/3-$)V9O;G0Z(#$P<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UEF4Z(#$P<'0G M/DIU;F4@,S`L(#(P,30\+V9O;G0^/"]T9#X-"B`@("`\=&0@;F]W6QE/3-$)W=I9'1H.B`R)3L@<&%D9&EN9RUR:6=H=#H@-2XT M<'0[('!A9&1I;F'0M86QI9VXZ(&-E;G1E6QE/3-$ M)W=I9'1H.B`R.24[(&)O'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E6QE/3-$)V)A8VMG6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE M/3-$)W9E6QE/3-$)V9O;G0M3PO9F]N M=#X\+W1D/@T*("`@(#QT9"!N;W=R87`],T1N;W=R87`@F4Z(#$P<'0G M/C(Q,"XU,24M,C(R+C,P)3PO9F]N=#X\+W1D/@T*("`@(#QT9"!N;W=R87`] M,T1N;W=R87`@'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)A8VMG'0M M86QI9VXZ(&-E;G1E'0M86QI M9VXZ(&-E;G1E6QE/3-$)W!A9&1I;FF4Z(#$P<'0G/B0P+C'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D M,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X M9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N/CPO3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!? M.&0P9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O M0SHO,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@ M8VAA'0^)S,@>65A'0^)S4@>65A&EM=6T@97-T:6UA=&5D('5S M969U;"!L:69E(&]F(&5Q=6EP;65N="!U;F1E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&-L=61E9"!$:6QU=&EV92!396-U'0^)SQS<&%N/CPO&-L M=61E9"!D:6QU=&EV92!S96-U7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)S$U('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^)SQS<&%N/CPO65A65A'0^)S4@>65A M&EM=6T@*&EN('EE87)S*3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S(P('EE87)S/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0O:F%V87-C M3X-"B`@("`\=&%B;&4@ M8VQA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQAF%B;&4@<&%T M96YTF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@R M,RPX,C8I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO MF%T:6]N(&]F(&QI8V5N&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\ M=&0@8VQA6%B;&4@0W5R'0^)SQS<&%N M/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&4@ M+2!C=7)R96YT+"`X)2!U;G-E8W5R960@9'5E($YO=F5M8F5R(#(P,30@*&YE M="!O9B!D:7-C;W5N="!R96QA=&5D('1O(&)E;F5F:6-I86P@8V]N=F5R'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D M/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T M-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3QB6%B;&4@+2!C=7)R96YT+"`W+C@U)2!U;G-E8W5R960L("0W.#$@ M9'5E(&UO;G1H;'D\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^ M36%R+B`S,2P@,C`Q-#QB3QB6%B;&4@+2!C=7)R96YT+"`T+C$U)2!U;G-E M8W5R960L("0R+#8W."!D=64@;6]N=&AL>3QB6%B;&4@ M+2!C=7)R96YT+"`T+C$U)2!U;G-E8W5R960L("0R+#8W."!D=64@;6]N=&AL M>3QB6%B;&4@+2!C=7)R96YT+"`Q,"XP,"4@=6YS96-U M2P@9'5E($1E8V5M8F5R(#,P+"`R,#$T/&)R/CPO=&@^ M#0H@("`@("`@(#QT:"!C;&%S6%B;&4L(&YE="`M(#@E+"!U;G-E8W5R960@;F]T92!D=64@2G5N M92`R,#$T("AN970@;V8@9&ES8V]U;G0@6%B;&4@2P@;F5T("T@."4@=6YS96-U6%B;&4@+2!C=7)R96YT+"`X)2!U;G-E8W5R960@ M9'5E($YO=F5M8F5R(#(P,30@*&YE="!O9B!D:7-C;W5N="!R96QA=&5D('1O M(&)E;F5F:6-I86P@8V]N=F5R65T(&1E=&5R;6EN M960\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@ M,C`Q,SQB65T(&1E=&5R;6EN960\8G(^/"]T:#X-"B`@("`@("`@/'1H(&-L87-S M/3-$=&@^1&5C+B`S,2P@,C`Q,SQB65T(&1E=&5R;6EN960\8G(^/"]T:#X-"B`@ M("`@("`@/'1H(&-L87-S/3-$=&@^1&5C+B`S,2P@,C`Q,SQB6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P M9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E+"!I;G-T86YT/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@9'5E(&]N($IU;F4@,S`L(#(P,30\+W1D/@T*("`@ M("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO2!N;W1E(&%M;W5N="P@:6YS=&%N=#PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E('1E'0^)S0@;6]N=&AS/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E+"!I;G-T86YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M=&5X=#XG/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)S$X,"!D M87ES/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E(&ES'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S4@>65A'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPOF5D(&EN(#(P,30\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E.60T M,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C871I M;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R.&(Y M93,S9#!A+U=O'0O:'1M;#L@8VAA'0^36%R(#,Q+`T*"0DR,#$T M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\R,V9E M.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P7SAD,&1?.&4R M.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA&EM=6T\+W1D/@T*("`@("`@("`\ M=&0@8VQA'!E8W1E9"!S=&]C:R!P2P@;6%X:6UU;3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)S,@>65A65A'0^)SQS<&%N/CPO6EE;&0\+W1D/@T*("`@("`@("`\ M=&0@8VQA2P@;6%X:6UU;3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S65A'!E8W1E9"!T97)M("AI;B!Y96%R M&EM=6T\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)S$P('EE87)S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO&EM=6T\+W1D/@T*("`@("`@ M("`\=&0@8VQA&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!0'0^ M)S<@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!0'0^)S@@>65A'0^)SQS<&%N/CPO&5R8VES92!0'0^)SQS<&%N/CPO&5R8VES92!0'0^)S`@>65A'!I'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^)S`@>65A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\R,V9E.60T,U\T93AD7S0W-3!?.&0P9%\X93(X8CEE,S-D,&$-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,C-F93ED-#-?-&4X9%\T-S4P M7SAD,&1?.&4R.&(Y93,S9#!A+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO6EN M9R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XR,"PP M,#`\6EN9R!O<'1I;VYS/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU-#`L,#`P/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^)SQS<&%N/CPO6EN M9R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX-#0L M,#`P/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6EN9R!O<'1I;VYS/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$ M;G5M<#XS."PP,#`\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS M<&%N/CPO'0^)S(P,3'0^)S(P,3(M,#,\'0^)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2`R-BP@,C`Q,3QB'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)S$Z,3`\'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6%B;&4L('-H87)E'0^)SQS<&%N/CPO6%B;&4L('9A M;'5E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XD(#,R+#4R,#QS M<&%N/CPO'0^ M)SQS<&%N/CPO6%B;&4@8V]N=F5R=&5D('1O(&-O M;6UO;B!S=&]C:SPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4L('-H87)E'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2`S,2P@,C`Q-#QB'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%L=&EE'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M&-H86YG92!F;W(@;&EC96YS92!F M964@9&5B="P@=F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M,C`Q-2TP-"TP,3QS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO2!N;W1E+"!D=7)A=&EO;CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M65A'0^)S,@>65A'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO&5R8VES92!P'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\ M>&UL('AM;&YS.F\],T0B=7)N.G-C:&5M87,M;6EC XML 23 R43.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 9 - OUTSTANDING WARRANTS (Details) (USD $)
6 Months Ended 12 Months Ended 1 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2014
Issued Warrants
Apr. 30, 2014
Issued Warrants
Jan. 28, 2014
Issued Warrants
Warrants issued, shares     15,000 113,333 62,277
Exercise price, per share, minimum     $ 0.50 $ 0.65 $ 0.65
Exercise price, per share, maximum     $ 0.50 $ 1.00 $ 1.00
Exercise price, per share, minimum, instant   $ 0.36      
Exercise price, per share, maximum, instant   $ 10.00      
Expiration date, earliest   2013-10 2019-06 2017-04 2019-01
Expiration date, latest   2021-10 2019-06 2012-03 2021-01
Warrants outstanding 4,520,308 4,349,698      
Expired warrants 20,000        

XML 24 R29.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER COMMON SHARE (Details) (USD $)
3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Reconciliation Of Basic Loss Per Share And Excluded Dilutive Securities        
Numerator: Net loss applicable to common shareholders $ (510,763) $ (1,038,338) $ (1,046,151) $ (1,490,612)
Denominator: Weighted-average common shares outstanding 8,532,935 7,456,281 8,429,958 7,308,930
Basic and diluted net loss per share $ (0.06) $ (0.14) $ (0.12) $ (0.20)
Common stock warrants 4,520,308 3,495,902 4,520,308 3,495,902
Series A convertible preferred stock 2,378,070 2,411,940 2,378,070 2,411,940
Stock options 2,572,099 1,450,172 2,572,099 1,450,172
Convertible debt including interest 900,321 816,516 900,321 816,516
Excluded dilutive securities 10,370,798 8,174,530 10,370,798 8,174,530
XML 25 R28.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 2 - ESTIMATED USEFUL LIVES OF THE ASSETS (Details)
6 Months Ended
Jun. 30, 2014
Notes to Financial Statements  
Estimated useful life of office equipment 3 years
Minimum estimated useful life of production equipment 5 years
Maximum estimated useful life of production equipment 7 years
Minimum estimated useful life of equipment under capital lease 5 years
Maximum estimated useful life of equipment under capital lease 7 years
XML 26 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) (USD $)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2014
Dec. 31, 2012
May 26, 2011
Preferred Stock          
Shares of preferred stock designated as Series A preferred stock         350,000
Series A preferred stock par value         $ 0.001
Liquidation preference per Series A preferred share         $ 5
Basis that Series A Preferred stock is convertible into common stock     1:10    
Series A preferred shares converted to common stock 44,162        
Common stock issued for conversion of Series A preferred shares 441,620        
Common Stock          
Common stock issued upon conversion of convertible notes payable, shares 151,126        
Common stock issued upon conversion of convertible notes payable, value $ 32,520        
Convertible notes payable converted to common stock 30,000        
Common stock issued upon conversion of convertible notes payable, interest accrued 2,520        
Stock issued for services, value 13,113 39,556      
Stock issued for services, shares 23,000 64,700      
Common stock issued for future services, value   44,250      
Common stock issued for future services, shares   68,283      
Stock issued for accounts payable, value 46,400 4,501      
Stock issued for accounts payable, shares 80,000 6,717      
Stock issued for accounts payable, amound owed 149,421        
Gain on settlement of shares issued for accounts payable 103,021        
Stock incentive plan          
Common shares reserved for the 2010 Stock Incentive Plan 4,650,000   4,650,000    
Annual increase in reserved shares of the 2010 Stock Incentive Plan       50,000  
Unissued option shares available under the Plan 2,077,901   2,077,901    
Total unrecognized compensation cost related to unvested stock options $ 263,507   $ 263,507    
XML 27 R30.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) (USD $)
6 Months Ended
Jun. 30, 2014
Dec. 31, 2013
Notes to Financial Statements    
Allowance for doubtful accounts $ 2,526 $ 2,526
Accounts receivable past due period 30 days  
Domestic patent life minimum (in years) 15 years  
Domestic patent life maximum (in years) 20 years  
Foreign patent life minimum (in years) 5 years  
Foreign patent life maximum (in years) 20 years  
XML 28 R31.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 3 - INVENTORY (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Inventory    
Raw materials $ 218,980 $ 240,750
Finished goods 45,150 49,255
Inventory gross 264,130 290,005
Less: reserve for excess and obsolete inventory (151,064) (151,064)
Inventory net $ 113,066 $ 138,941
XML 29 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 1 - ORGANIZATION AND OPERATIONS
6 Months Ended
Jun. 30, 2014
Accounting Policies [Abstract]  
NOTE 1 - ORGANIZATION AND OPERATIONS

NOTE 1 – ORGANIZATION AND OPERATIONS

Generic Marketing Services, Inc. was incorporated on July 19, 2007 under the laws of the State of Nevada as a subsidiary of Basic Services, Inc., also a Nevada corporation. On December 31, 2007, Basic Services spun off Generic Marketing Services. On October 8, 2008, Generic Marketing Services changed its name to Total Nutraceutical Solutions, Inc. (TNS, the Company, us, we, or our). We engage in the distribution of organic dietary supplement nutraceutical products in the United States of America. We are also engaged in the discovery, scientific evaluation and marketing of natural formulations that can be used in medical foods, nutraceuticals, cosmetics and other products developed and sold by Entia and by third parties.

 

On January 9, 2012, the amendment to our Articles of Incorporation involving the name change from Total Nutraceutical Solutions, Inc. to Entia Biosciences, Inc. (“Entia”) became effective with the Secretary of State of Nevada. We also filed articles of incorporation for a wholly owned subsidiary of Entia, with such subsidiary to be named Total Nutraceutical Solutions, Inc. in January 2012.

 

We have a history of incurring net losses and net operating cash flow deficits. We are also developing new technologies related to our organic nutraceutical products. At June 30, 2014, we had cash and cash equivalents of $15,484. These conditions raise substantial doubt about our ability to continue as a going concern. As a result, we anticipate that our cash and cash equivalent balances, anticipated cash flows from operations and anticipated operating cash flows will be sufficient to meet our cash requirements through September 2014.

 

In order for us to continue as a going concern beyond this point and ultimately to achieve profitability, we may be required to obtain capital from external sources, increase revenues and reduce operating costs. The issuance of equity securities will also cause dilution to our shareholders. If external financing sources of financing are not available or are inadequate to fund our operations, we will be required to reduce operating costs including personnel costs, which could jeopardize our future strategic initiatives and business plans. The accompanying consolidated financial statements have been prepared assuming that the Company continues as a going concern.

 

The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the matters discussed herein.

 

XML 30 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 4 - PROPERTY AND EQUIPMENT - PROPERTY AND EQUIPMENT (Details) (USD $)
Jun. 30, 2014
Dec. 31, 2013
Property and Equipment    
Office equipment $ 27,507 $ 26,284
Production equipment 85,046 83,615
Leasehold improvements 16,328 16,328
Property and Equipment Gross 128,881 126,227
Less: accumulated depreciation (76,094) (64,082)
Property and Equipment Net $ 52,787 $ 62,145
XML 31 R40.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) - BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) (USD $)
6 Months Ended 12 Months Ended
Jun. 30, 2014
Dec. 31, 2012
Option Member
   
Risk-Free interest rate, minimum 0.28% 0.95%
Risk-Free interest rate, maximum 1.84% 2.47%
Expected dividend yield 0.00% 0.00%
Expected stock price volatility, minimum 210.51% 216.96%
Expected stock price volatility, maximum 216.96% 236.55%
Expected term (in years), minimum 3 years 5 years
Expected term (in years), maximum 7 years 10 years
Weighted-average granted date fair value $ 0.62 $ 0.45
Warrant Member
   
Risk-Free interest rate, minimum 0.28% 0.95%
Risk-Free interest rate, maximum 1.91% 3.32%
Expected dividend yield 0.00% 0.00%
Expected stock price volatility, minimum 21051.00% 21648.00%
Expected stock price volatility, maximum 222.30% 23920.00%
Expected term (in years), minimum 3 years 5 years
Expected term (in years), maximum 7 years 10 years
Weighted-average granted date fair value $ 0.75 $ 0.45
XML 32 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED BALANCE SHEETS (USD $)
Jun. 30, 2014
Dec. 31, 2013
Current Assets:    
Cash $ 15,484 $ 36,886
Accounts receivable, net 30,770 11,197
Inventory, net 113,066 138,941
Interest income receivable 0 3,965
Prepaid expenses 22,973 34,462
Other current assets 1,300 0
Total Current Assets 183,593 225,451
Property and Equipment, net 52,787 62,145
Patents and license, net 343,141 343,498
Total Assets 579,521 631,094
Current Liabilities:    
Accounts payable and accrued expenses 1,303,040 1,157,717
Short-term convertible notes payable, net of discount related-party 0 23,427
Short-term convertible notes payable, net of discount 587,470 373,644
Capital lease payable 467 2,105
Notes payable 33,058 23,788
Total Current Liabilities 1,924,035 1,580,681
Total Liabilities 1,924,035 1,580,681
Stockholders' Equity (Deficit):    
Preferred stock, $.001 par value, 5,000,000 shares authorized, Series A preferred stock, 350,000 shares designated, 237,807 and 281,969 shares issued and outstanding, resepecively, aggregate liquidation value of $1,409,845 and $1,409,845 respectively 238 282
Common stock, $.001 par value, 150,000,000 shares authorized, 9,133,091 and 8,297,645 shares issued and outstanding 9,134 8,298
Stock subscription receivable 0 (49,000)
Additional paid-in capital 8,400,983 7,793,760
Deferred compensation (188,367) (182,576)
Accumulated deficit (9,566,502) (8,520,351)
Total Stockholders' Equity (Deficit) (1,344,514) (949,587)
Total Liabilities and Stockholders' Equity (Deficit) $ 579,521 $ 631,094
XML 33 R45.htm IDEA: XBRL DOCUMENT v2.4.0.8
NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details Narrative) (USD $)
8 Months Ended 12 Months Ended 14 Months Ended
May 31, 2014
Sep. 30, 2013
Dec. 31, 2012
Jul. 31, 2015
Jun. 30, 2014
Dec. 31, 2013
Jun. 30, 2013
Jun. 01, 2012
sqft
Notes to Financial Statements                
Square feet of leased office and warehouse space               13,081
Monthly rental rate of office space $ 3,260 $ 3,160   $ 3,343        
Period of office lease     3 years          
Deferred rent accrual         $ 4,160 $ 6,555 $ 15,585  
XML 34 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) (USD $)
6 Months Ended
Jun. 30, 2014
Statement of Stockholders' Equity [Abstract]  
Write off amount on stock subscription receivable $ 9,000
ZIP 35 0001469709-14-000352-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001469709-14-000352-xbrl.zip M4$L#!!0````(`,&&#T6AM9K\-ZD``'5M"0`1`!P`97)G;RTR,#$T,#8S,"YX M;6Q55`D``VIS[E-J<^Y3=7@+``$$)0X```0Y`0``[%UK<^,VEOV^5?L?N)Y) M:K[E:(`_A!YN:SCAQRC]PDPE#L;\CR["=W^ZNM\4^>=[J M[/3TQX\?4\M^UG_8SE_N=&:S%7=OKYT9VI;U\>[7FY^$2QY\_P9D"'A17\VG M+X]8ADO=P\\%_!-^#E3RDO15`&=0.`,R8UV>[JW=;5W@106B"/#_-I^_?7EP M%N89^7\.F\%RSUY<\]U)2+P?<&H[\U,!`/[T_SY_NI\]H:4^,2W7TZT9.@F^ M6IC67TG?\9JFG=*GP:M[;Y+*@SK@*7G\H+N[D@G`C/?WD."GAK?](/RR=+IY M&'G53'Q5WKQJ!J\:*/:>BV;3N?U\BA^<$@--`#^!?/"Z@QY3(IF,R?"<4^]UA4[Q2Q/\%G+,V?:[PQ]%/\`8R,_)Z.B3!'2D;6T_ M(/]!WR'-["1H/(1P9RZE]1UZY"A7SYZH!9$SMR?!!],7USCQ'Y/JWIVX)O$I M)]QI4-2F,T?$!. M`&3[/;(\TWO=_KK]W33(DT<3>S,*%T7T%Q#RXOI_3][C]HU!JX*FO3V-?[Q? ML(OF2_PT],!_9&`P+ZN%.3.]#5;.,/&;&T?M\^B,>!A$OO_X?8UQ$T=K6_@_ MW?,7TSUY'[R6)/K;T\1:P@A/DR$&O\=TY0NTPKRQC00-4E_AO=]99*L>_TF\ M_$A)P8^^@9FMCE6RM*WC,_F>W$=B[W/#,#VL,'UQJYO&M76AKTQ/7QR5[3-U M<"0\N/0]'M$15J-.]''_I#OH`Q[?&+?Z*Q'-/2I:Y%')D;#D#GFZ:2'CH^Y8 M>,IS7'Q(%G[@EH>^Y6=KU[.7W[[8'G(Q]?6'!;I8X]9A>V]8PL8@9.HUB'-=)H>#1JH@L[ M0*,]9QUZX:OM+R:0N<)`ALC,-,JKF('3Z$"G-M*H_S3J0*=VAQ9X!FO;)7TP`;QGTW8)M,DN^*,G"L-*<3P2#/9^)\Z6 MM]MG>Y\ARP@^\N7>56]$/JE$SS"D9Y'8%?)]UC,LHF=?[EKU3!V+KV=I`I2> MZ]D7)Y^>?;GKT?-V@Y8"ZYEN(WN9$Z38Z'"("-!)204/.[M]9\\^V@1;1F)J(N$V;O1_> M]/#JB3CEQV"*G/HX^O66D32](DVM*S2[R1H?FA13`@7]T@WMG_M-"_9N*2QM MJ[V26*17BG&EKHE]*E?&,B=^'(;!.I0N*+ M3IN('C`5P6"L'(P7R/HSNM.M.0HO4<0%'O@"5*J]Q6.SMWC<]I:.S=[2<=M; M.39[*\=M;^W8[*T=M;VE8QNO2<<]7E./K?]6C[G_YJ?@N-KW3N"AVGNW#(?_ M$8)E.#%D^VO772/##U3L^0&C6#A`(%3(\$G2MKTP1RR3>V%.;":*=TL9?B*H M(V6Z0AF^"&6(">NFC!RBC#QZF0Y11BY"F=J7__L9\=U4R&;&+FMPH&*\BJ75 MJU@ZO@L;B^L>2=,)TG3(?8QW^HR.(X?C&.DRNHSQ6JB.70O53U M=!I"Z^M9M$05(_7&(E'2+CI3?1K>CU>;%5?+]!YH M*JP]JJJ]VZ8OU^@2S:A:2(G'.O&H5&''Y;=&VHVT:S,E@2STFR^Y=]0"@8=O M;V$"8,]6.Z)*(@+4/`3HXY)0I,-JY:ZRGBFL'ZD[^ZG;Q@?M`/;\@#,5H.6- M<7YO&_@:EX+'0MZ-=8P;XRSZ&/B`X7`(SDB:7I&F&R$X7^SG8-HEJG%]A>9R MQT>??)HY>N\S$JGW1&K((\%L(BE3=>_Z::C`8XX+9%1)NSZH]F'S81\T4J>' MU&G,ZPA2?Z>EO@`U!V/1JWJ'X//"TNQ2.AR0XF9Q6%M;Q72QC2UG4E3VR^7,Q*G,\3I@!L9 MT]1V)DUMO]S(2)S.$*?=;?ZT[%Y)\;W14\W_UJVU[KSB(GL>(%`X`UH!'0V< M7(Q)&4=R#8U<'4CUQ:ZXS[HS>QJIQ:ZAT6N-Q!H:L3K@L?;/=X[,JDQ%Q^VS M1FH-DUK]\EKG*\=NJU/HS<8M71Z+=&<@V17`UY+F7" MB_T]N.(+4+^20(]/]_@"U+U%C.L0@BUBI7_'H>*[J$2\/U.-4P$:'+^LSW-KO1\AIS[^+[2 M_GRWS70-*G]D]@X$'JJ]D\/_>IBDN)((.5C;V.YPM/:8Z&@,I4R[Z#>R/C02 MI06B%+RIN,9T:8<]RLV:]!2&:E/1IH;5'#P/*(%!H7> MXFH.F&R%_RQL,)I@-YT4:\\Y^URX\#^1[F27_6=Q-G]?8XM<(>2=.TC/K,3] M_N@59S3^(UT&ZM3H*Z6:#"EA,`UFJY,&6LLV-<)L9J\MS[U#,V0^D]'J%^3Y MV:4YW^W>H\SRO*6]/6:HH"R?(&9@% M!P)%`<7@7%O/^%?;><6O%-8&5#61W]4?+C-O?2SB\CP$LLQ6WZV#5KII?'PA MQ]!12;-#492%7;V)91<&P"*Y(&@*S`G@W'61YY:47!`D40J9.%)H[AJ9C*Q" M28.,-=XZ-AY5>:^W"]WRSBV#'/Q;D3%A"5;+`B]*85VG5U$6#HL^)$%1E6)P MKDQ<+/ID/M,;A'1K3F(N-OHLH1\H0E%3=XBR:RF/BZ)\F#8/"O,% M\D`3XX1EKX.)!(HF"7O-,*V+\6]2P.S`OSAK9'PR]0=S87HF*NL/>%Y2%#ZA M"V2HLV*X3,X$`@C$A"ZR`-QX9%/TOHK"K4F!LAAB3W8MY3$%][=F81(%`$"C MD`XW`%41E68QT>"L;#5)#:N)AD)E\EUJVG(TC"&3X(UKB08-U`:IPK8O0$4- M=:355<[494(@Y:N\PEY$4H&LAOJSP]ZWPCY!$T0`I8*5UR%RSNK*"IDP4PDE M-/Y=7ZQ184:KT6E2O-R"53--D:":J^I00M92(JM">#`<+[5(K2S2:CP4V6M- MR1)95&1%T:`BAT=5R>67@,&B`U4$0%-A;AA).>J"YO%:TK-->%60E-`:!4ME M50%D41H&J$)9*041L>A)##?*?("BO=VM[MPX-!6603N#6^30[3=F506[ M=2%\UU^N3MZ#*0!\6A^;5FMU6!.5V"!6_Y#2VGNR'?-O9+#I,P4?F:=%IFK9 M=95'MJ^]:I'1'9[HJY?(-><6T7(I54%I@R>SAL(PF/62"T:6[JY==UU2)8+* M:[*6;:)-->4`,2N'S&2!4AX0;8XW:R^(""D\VQ+QR#"ZBI]537E0;-M7JA:9 MD^4#%1KD-^7B&:JL"&49YUX.9:5NG?>])TA$=\BKYT3%W#HK1E6!`\.39D4. MM\^42DI@8=8.GDI#H"7S*0O+=O?Y3O_Q&3/.,7&9A<>C(E"DD'T2"R^,@&G] M!'LGM3`"LN'F/B'C5]LV"BM!U`1)2D`0*;PX!*91N,0GFH$-PJ^.[1:G@(9; M:)+XM-3\=3(9719YF"1OI$XZY+E#+G*>T97M?'R9(9=,WFX>7'N!/+3]JOBJ MB<0#6?0'5RPU50*-;;VD%+2;QT=SAK:;](6Y(0MJ@"%69-[JF&B!?9'"4-VM M8QOK&3VS559"%)ZN7+L9YILVBW5 MZGD9"J'UX_0*RD%A&I\6A1)9]%HYN$RZ7('_Q@V#!'U;QOG2=CSS;_I[:@A+ MX:4O$L`>V>.O!$Z38K+81Y&C<28UB9GZ8CF>8Q#]$[S"-B_M9/DR__!77`YUQ M9U.0JX0>WNO/T&=P#"DA-$"9JE(\K]/E&M&3`XM7_[12]OZT'.).N(:\8&-' MZ^H`"VI!FAUV(F>DS6*`+$6G^V5@'TB"UE/8>XRX2$M+Q@!;D*&HR8VPI%+< MD(]&0M6H[SM$W=*MCOO7+)+DU[T@BBEQ3!6KOCX1%%FKQPH)+?2KO;LCM6!P M6O4NFA541M!:]9H2IWP7^XTZD))3'DVIE:S>EP/+JT)C@X?2:"6)AXUXV.`V MAOL*^@5%J:I;8+R]I0+0HJ));0QYF'U7+-*_L:$D*\!XC'V%&@QWG9]L:_X5 M.5Z%2Z\-<.TL#N&$1:&E[PQ;LRB[1C$(F)>8?NM2F_E;$::S' MWD^+C.?R"(/T;BS&'KNNF5(=:!O3ZQ>R4+VQOIAU/1&+AE51K:?GKA=WLQUW MD3O]LL])2*#9\5+5$G1-__&+?C*U#P2E:]K/@[\9W9>X92E3^8K6T%2A)@$Z MI_WX;3&9NVM`;F@IK"8!NJO]#PSH9:FFA9VF!#B@_LT5]K38F\>T\.%S]QXY MY&!$](4D*?D)D":"G#-NN2"`J!!);^`Q>>IYMGVHAV,[#]<4P?3)_+XV#7^? MF[R-K!D-_HR70"LM#3((5,E7;01QF&=^5)%Q93M4Q/,?NL,:PI:"4)3#9C]< M603;E6YN='SNNNOE)N'RG>G^=>4@%`S\[S!=/IN6N5PO(T#]K(9"**NAX#=( MOWE\^T-W'-WR]MH4S6L6%P3300O4G1-7U3(E)?0,9-ID-V03B5"]P#TP.:W<5)\D\/)4S/)UF="J%ZRJ]B1,>2!E4:]#W_+@3P:XH0JK`LG<-M[?*AV$&-=C6Q@/,K9V$URO`I-(.+,LO')?FWP&;'4HHP M%RX#F6R>D#V='4*/9--/.A8M0@204D:VN0\?#[]W] M9IGT'+?_HS\!W:9*+WYH.?-@?1X(=8O#F2,*A:(2Z'/CB,,Q[F5.$`H*-OM'];:*@3)Z&P* M`MPE+/`7#K>>IVP^;DV.Y&!(*;X4CIQ^^"`(JL-+].!=6Z[GK,F)U9!&-W^Z M=(\2=^E\R*TW?DHM;4-5V#6H(G+4HHA:S[T-2!'E3J2E*6(J2EW30ZTG\WJD MAU;BSM/C1>3.*:B52/9.*>AP_%*-AYE2HW8*^-:,.*@*E5'C(:FFE&&Z]&(5 MG]A?[0_(HOF/]<6NE"ND>^O,+(6-G'HF,_8@:B`/[DH%;O*8-VA;V+;.AHM` MDH2VA6_M5+D$=V.'CEJ^PN.?O`!!ZT1O[K2K*K0O;1<.(/*RI,"V%=&1HXN= M4D+-A_-"V_1=X7_MQ_HZ9=\TWU;Y@4!9TY2V96_O*.%`;)[G&)D@",)P+)[S M`%VG[5W3N4$%J%VW=WTG)H=B\#Q'%05-[/+HM>93FH.S.,OQ2"B*K<_$VSL9 MVKK)#UYF"X&BR)T`>N"*6T4JOZKAQSOA*=>-14U_;AF?;-UJ.2FJH@9G%`X! M+"U-`UE3&Y2F@5Q^@JRHW3%.W\2!^5L.5&`NB:`"NT.W%@7R[[/_^()K]'/_]B6[-R@3*B(D,YX%#>2BM'S)0_GP>:4!9Q)-VY7\C^!=*5:%@& MLA+*3I^CQHK!,N72!RJO:96@K5>K$E0`#`%M&B/3K22\%LE6GP\CY?>'A3[[ MRYT]V0OD;D(;\9!U9EKSS[:!%J%@Q:_$@WS%(#\LXKO3N4]8_+SPWG@;KXD6 M"W>EDPJ)1/2_5[IA!/^M+\RY]>Z$.$CB!EWO=8'>G3SBRL\X'JP\[JNY1"[W M!?W@[NRE;OVR^>$7CJ36>'S#_3`-[^F,DZ>2:;WA'FS'0,YD9B\6^LI%9USP MU\G/<^_-S__@X1L*S0DJHJ/ZF;Z84!QGN``/>W)<$%;:W,%C2H,49CMGW(\G MTPL50Q1,BS(XR_[AZ*MW)YM_;V7PD8GJ3V\X7^*)8\Z?L%QYNU\7Z#'X M<5.!OER]^01^ MRQL+J6W'^;%O>*=,?]G[%%134&,3N4C6[&]G106Q+Q/>"`NH;90_V! M2*'(F.A8!'V.N#DYK4_FXZ2?>M1-AWNF&9S'!A;1X#_!5!8:4TJ/VQ96E"BE M*RJA59W2O0+RD[\I5W#3HHV-CUC>IG'G8[L:#&$;FQ!**SL?6I4+WZ5:7["7 MP6TW%XI[JT"ZSNPO=$?-X1T#;KN$WY%1!/X$>Q[L7(0:1Q1TIGNU-]-MOX/, M-?W4^''ZR3[]A%,H5#K]+$KGE%XJM^MGD#UEOZHD:\H+4,Z@C;&^-,.[JZDA MS0]W:8Q[0XR&MP`$80J;:S8][BPVMR)@C=$<[LUW%RUV$0OSL>P`J"K8_?6X M+:QD]EYED^$L9C;AWWKB2?\)IDK&2MK8Y71LR?'(Y(RK4/K[M7;O57\A.UVL?O M:SPPWZ5F<\F?>N;1A^!,TLTZR)&^=](H+?,HE`1`3G#4@[EYC<1.T170B*0, M2R/;5->Y5<$+8)BJ\,GQ\04Y,]/5DU+QI%U5`(&T32,X`(W`TAKA51Y`<4`J MB7F0`BH1@"BJ4&Y$)<$&__EF?]]'BVCJSDHZCJPLQ=O;]1A05(&:W;EGIL;= M9H=L"#:#!\[4LMP.7(8&D`E;:19V#E>6";MA61771)E+E\11RE"(,,F4+*YAI34,HT@8^-E&PCS M-?BXB:&J`*4%(N:$*4B\4``F7038K&Q$/$#277"5#@E@D&KA`(*R:"L:"C0% MM^000`3-PBS7&8'&\%;4Y[=$VF[`3;BDM$J/P.^N'#@`H2S<2EQ"(F>7_VWO7YL:-9$'T^T;L?T#TL<_: M$9",%U_=8T?(:K6WY[1;FI;Z>'V_G(#(HH0Q"'#PD)KSZV]F5A4>?`(D2`(D M=N?,2&H`E965[\S*_(W?0R@<9=*SZ8_JH#X@,I;5E6^'#,-H.B[6$(8DV<+8 M:#0BUA#%>2%B+45,G>!,T+"6'FJ%AA5*YGT3_M[3-K:2Q>L.I':GT:1M;"$'Z[>)+:38L3:QQ"[?BYBZ3/HB%P2I MJFU4*Z6P1NTX^SB:F#K8<31I&T<24P<\BX-N8EW23KYW"%/**I*SE0!5LH.J MQ5.W2!ZTTAWL2S#5X0B:L8']"*-ZX/]PX-/W'C<[BH_SCB*7=>%M',E`]MS: M7]C$!MO,>[J&S0?V,(IM%\+RDJT3HO*':@RJT!:1.Y`DRTBJV3N3'[SE[O>G[K6ZIV=]$Z+ MSXKHF`ZV!';.B?M@.P%9:K=C\;3P5PHVU5G1M[O@G:O.\DS: M2J`JVTGAT:L[YL2/NY,MSB13?73PK2PCK_*'L2-5W7P;NO&(C=X[+LVOOL
+._-]_?:)65I/>LCBF9=_6"N\%EU1&N)=1:1-29/:TWZ.\9,.M`@%W[ M'O4'?'39>_88??3P+9#6'SW1]KLZ.NMV=-G98M.J58"X#WVM M=T@8MZ#`[6&\]B<3WZ._"^.V.K/,M`:=@68D8G1AI2TA*4]H>X%D*W*R.H9F M:OW*(2E/-.4@R=5BWH[E,^+^RN:.-T7;1'03TZ_`>H4@Y*7K54&H:^FE]4(K MSK=VO7;M,$P>O@V^H$N5R0D7@W#5F0*A=]%\+KI:%="5I[AMH>/FE[S<*>VO M+W;$[B/XK]$=G`?\`\X,W-QDX;,?L?#.GF$5RG4,TM&+>I?]COC&5R]$9P-\ MCYC]#M]Z=F<+/O,=_/L2?U_KY9O]%H6YVMW.!<1.?+=S9YO1?;3QA7UF'GCP MA>PCHBV\[?[Q-SUWQ.>QZ0TG_86Y]`T[B&;=DT3`AE,_?01LEN/6I5Z%9+/T M&DBVS7+\E':[@;O[XNW[2LBY%M2\@9U/?\=+*%K7YNE9KG'K%:=H73O^7C?+ MJM/9Z^9S_>R_T'[PX?X:W71:VN@4=PUG;9;WI>2(.QNEON*!>VFQ:_MWV M8CN8P2<7ZT;JJZ0*&B*GNOW*3O]W.Q@^%]]\/:1;98??R-UO./M%@Z6J[=?" MBMEP]B>^^^K._FH:.&X9TJ_#]JL[_$9N?P^G_VN3]K^'XS_0_C.)WS392Y`( M$-DH`;#2U+-EZ4FI9HGU5V4Y><7$!S_@KX6.[]V.EWZWVAUHBVG0XJ#D-O/5 MLR<^D,2_,08;L?F,;8EYE;K1,359A+3XV2U6+3(P4C>-KF466U5F/,7MMNIJ M+C*EV'-KY`G^7V!:LP^,19]PFNCH=CQVANS*&\%+[-F/0W8_M8=+6=U`6+1< M2C7YV%7`["77W;2T'6*Q=26L(^:\O?$B)YI]84\.L#7LY[,]847Q]0N^;"N_ M.GXX=)@W9*&J?/2&EW_[:=67%U>^9GBEV/WHC=BW_V*SPDO#0>B6UC>POFGE MU[++O?>')+4>9M/B&]2UBW_P[V=?7_99$'V./[KQ1N^!'@M_/_TYOTKN:]GE MKN!?1_C$!]=^*KS,&,B%\15R'\A^640+/CCAT';_9'90=B\77'3P959];9$` M_F"N^U^>_^K=`\GZ'AN1?`L*+_O9SQ+`BJ\M+OO?OAN#I@IF'QP7A.B6R\U] M90EYP"LX=.%@6Y5J=OO];J;^I,A:%0)81/OJ7?U8 M`!8R#SI6WSHB!LV-1VQ:VN!8`"X.1E]VQ&1([`3@;?3,@JLP9%$H9-6V')'Q M.A8_NMVRQ:Q,K=3*9)$_^^X(I#]O\K\&_?^3KW#PVP=% MP+(&FK8'3!61/!<#:[`7@I)1''EIL[0T,/K&_J$J)Q7``>OO'Z;MI4.O-S![ MW?U14@)B=5)"[QN=7G=_$(L@8AWY,L'F-I*LCU7<';UZX(K8#1>Z:8%PWY\< M7;]ZUP)&-/>V]1U$EKD'\3`/53F1-8"CVC],VXNLOJ5I@_X!#K-*D=4WNWO0 MF'-YGZU$UAZDU3PBMY%6@TZWV]%*Z?//#._X^A/VR0^+SGW;8)#J&@B.S,'E MEJAB_9UPM%?PBLATT'9=W:AP_34W!)>MKYE],RM`=UM_?V=@LMF3`,VM45/:L`4'&+HN\X(R\0(HK'C`4DX MM@M0P1_Y%&>'^E>/_6""KM>K$STK7R_O+Y7?KJ[NE("!6X055@"HS5O:*Y$/ MO_W%TH-0;&^DV$!O$]&3,7JV(\4>C]D0G@:X`LIN"R#LB1_CN@"@36D>>MUU M[$?'Y1W$\/>1$PY=/P2=)G:"R7%WKR1;)Q@RV\,T/&0&1X._R^-2SC))3*SLO'(IE2.\`]@(@Y'Y'@\`,' M5@7Z!T*1_0")&P/&E`E>?8+?`\5EX"Z^/C-/F<;!\!D-=I0JC[`XG(C"4BJJ M/6L4(OZ<'7`U')*`^<*&#)['EDP-8!4)-4@V"7;+.5DR68(@!;Q1@@3^Y`(`F"F,$A5-4`BUR-?$Y::!_TAP#L&/=B(%]"WJ-QI6HX`)$4[!N!P[0\7! MS>)/B6F1KN;1:NR;$Y(>M!?1<*EDVOAP$X`_!"NYN)$0$87*UF&OL#+@UGEQ M1J!&W1GM<>B[+I@2#BG[V:4"0FK$4``Y'N-;2E"2P/X,\(`T&H(L>@5!Q"[\ M\9A4>$!5LRK!P6/<(.J2G8[MH;`)X,@\?P)_@O_EK@+@_U<;E#E[C*0Q@,AV M/-Z8%%$!%@H+8$DRB$8`']7A8KO2Q'Q0%0?0Y]$V.!!9>9N@[RE@<&X!FE*> M8FI@V,S@7%TI)Z#IU,DV>-(+#=AMA=* MXI!H1NS9`/$C`P'-OCW;@"6D56$H37TL_D8C$L\&2?N%!3/$A-P)/!RP"3Q6 MC&!?;0["=X;:,;K((\JC#\KD[S$0P+'96PG@Z=;D#)AY"41)R3R[1+,!I+$@9&M@>6`Z6 M_PL43!Q*MV7L!"%N1!4_^7$$H@`\DQ$)UX`]Q:X=`,1<)A,AC8B@*LZ+N41T!<'+\L0Y[-O^!0"Y#^"8P82//UH;;EZ$Y_.\_-= MX(..B69W((TC,`S1*)S2]8(&\+<$GBM`"7G+[%DR68$C(GBR8E)3#_D/%+2( M-'*SPID@4XC8`\5)P'X(\.80<>8+A0*)64#+-QC*9(*A=SL9PD>D,R$@"UA7GV/K,Z-T@FTUC&G>!/MH+F&#:6 MO'#1=@1K$:WE%[*ST#Q!2P6%I+2;1RBUHT'(F[+,]<- MI_80MH$Q8?I]:H]&\G?Z],]O\,XH!KI+@_KJC*+GMTH7&>(=&&I`[,$%FH[V M-&1O%?G3FQ0^!"V0"]$56;#*Y1;!T@,3'#YD#_]Z"H`J1O@Q/WBK_,?U]8_!O;TYS?\?Y-="-C,WO?O%+'GBP"/^ZW2N;2F4?I7EXWE M'Q-9B#C(XN,B!.[B2'FG"*`>78"3WN#W_.:D)+Z6B,=H5![T3GG(\W2QU:+] M`^#+5&;,#L*5:*(?@YVI!@RPB)6AF7WO^RZUZ*JBE<,1R+Z1TT$3N'<8RMA" MGNQ[^XEQJ,0X5DHJ=<5%>Z`EDB,02>W$!UTJQQ+%G.78TD:"'K#%`C3,7&Y# M8UH"#,G$;..FQG21KII)[E_3ER(1X\HX.#^XDGHX3I.'M0`Z:S[DZX+:Z MKH)>9>!1''[$7I@+9#A"WQ#C."+(%4:I2XERFD>(X44>&;*!UR-*VT^GKLP? M.#+R-79<=$I7>*CD'0YQ+(`S=O@_!2QDV$F+EPAPD!+WFX"Y5.X6%Z1_465T M'G;CLB=0L^+/<^ZT`I#0>(.1$T[]T)'!.)ZXD:F))?M2$]\;OQC&CR$8?/`, MK,<)4<:H)B M\5'X/P:$)Y]4>9!!8-WAVUM^5@'[)_GB/)K/CQSP,6)C@2C<,A)1)`A)+)'X M_VO"#X]`AQ-\!R@/MI@@J$"H03S+P5P;9JAM<'&-H%[($TPPG(.T?AN\)\*T MW=OQ)]][^@3\.N(7IIL@[-.-D-;VT0S`'8BH2JL$LF1S&P>+*.)RAC(-,OFX M,F"7<#NOEQKR"B:,\$F!DU`[WA-#-N8BUPF` M(3&W.Z0_CE!L,![7I+"=:%R023HG42HP,'4N M=.R,>%C,LP^YM5X8@.7RH?TW^#KJ>9-J@V$A45`))%@ M04-6]UU(JH[P/J9Z?"6#_`SBTYP<+48E`0&S1TYF+5XY\7$9HI%G4Y`X,/X< M'ZG*8\QYT&.O^2UL/APT7[#*2]8?R+(NM&3D*ZKX.#"P[_]%0-!FDA-8!;<( MT;/4'"T/8FTU^B[J.N>^O1>$<^O-=YX4G<:;H.OE)A2RP9-MH-B'M:9\(ZW& MGU<"+APH5Z.,>UML%,HZ,N8D)NXB1A]9](I%.RMQ36;`J^BBR"N1N*U/PN:! MY#\6+@OWAQ\>6@7R'0(#9.,REY-1P3<*<4=T*9WW.Y-X#)5J8QV5DW0V!8]3 MEB7A[DET*U1=G;I?.60(9S/=31Z&8=*I$RLPAMFJ\!QN$M0,;71',E*(I.^J MCW(_G#X,Z*"R"RXK\04AW/D_SU6F.^)>!IADL)S'Q@X5Y&?`'3.;=`>Y7C*; M')+AE%Q:24XGBXI56^,GNWZQY+2W.MQ$(:X]X(=GEO?:YG:8?%E6U_GKDK_A M7/;W^+R[QLDK*\[GW3^T3.C>SNWX@[S)D'8%%IJDECK@0\[>2F^@I(2QB\_7 M/SD%\+!HO"*EP`CP;#Y]F/&.ZQXS"1$&1D MRKL",_%7K*I-:>-2>0^?``&W*+/")-[F4W0-P4.E1C(,/JTOQ!$RS)C!29I/"WT:)YVU$@)TO@ MMN03+-(71@G6:4XQF$[7ZK+7`BAT\TJWUKA#R0U.8*"087VZEX0#@&$<'O(' M^RO$^VUV(H=F*`;(<1PQK".E1^QA4A4F#55I*-F8GW6F-C'\54@B3,UN`JT2 M\?0%ESP9,A!U=&'6@TS$DSU_+Y%_A=MOF77%IF,2/X0E'MI.]YMLCHIDX\C! M=`&`1;>;+D#V!DNEGB@*QD_Z>"7JWRP447^4EP2'K`#F>Z)P>/;\1&'::56< MB=JC`5:19<"^PLIHY:OG#/T14WZ_7U5'5JZ^8T4=0.1/DX*VWO>K4]!C>^*X ML[?K<2KRT:0,B^;G\[C0OR^>;R^PHX%1R9;^$?MH=V=]&F#&%]MQZ?21T;EC MP)_@V29^8VB86BD9_J'KNDF8*+U"B_;]9;D"CW*8*8S="DYAS5IK2U6JHNOJ MB-DH2,R5(6TWH.^$Y!;FJ#`-T3/_%R=D0<&+=)N]R"7X6,INRF+R'.[(`:6( M.5VDT>_Y4F8# M\=F2DD5#ASGR9#1G`(TY450!7A10\6O.?"I%OT[UVD?Z);"Y?*-1R)+#"!T\40WBA9&V]5 MT/I90W*$\//0&>KHY?9#AMY M1I<7W(0M_+/H\A$"OZ">R*$C"49D_UKXMFI%<:S$;\XSQ9Q?O"22L"DH,!]- M^,([HWQA0__)HYAT$Z((`FH*.@NPVPC"G``3N/DWD]UOJ`R$8/G!^1$Y((Q! M`.&-]A>T\H?)W33,PX@60=0.`*#YP8%71@QSML$,!!.PZ%`4]P%+A:(A5>:Z M.7P>.Q%A>AG>A9=E!%2V4A@[W_C+V3PYNHO\C>1DFY'%X%E'4FF2O&9!6C*`R?G>E4UOOA#6"7(A4,$X\Q MGGGR((Y(HJO"D?V-FHFYXC8?SUN*K@M8E11F$I"J(B]0$OV-1)D34`6N3'25 MI2"*PE!0"L/B$N#4/L>8L5SI4KDK1+<40YKX'G5M`'A?')MC)*`A_D[?N M4.6"*77#N_++(ZS(L95'5"M8*F,36A)$1\].,**@UXQ"_8[X-MA@J.9$."U4 M8KJ@*?:N)CDV/*=0)!>E3I2-+``(SB'TKCTEX*>A)V7<"\R((-1"MJ9VST5Q9 M:$HNMGKEC?ZOD'37L,4F&#GW2\4T'5D-C)UB%FK+PJQ6)F MSBZKT!G*#CLY-EYZ5^7XN$T980-)YXI(^4R+3&E`,L?Z:HAA0/C&;\CNMTEO MX&,QR`I>$/-`,O4@\B8<2&;*WK).`X*5D$O2BQM,3`>,%M!&;R%`>MGOCM7QI;:H(ELE"1^K9O'B.N=K] M^:+\?&>\N07\Y87\;'$502PB]DU76<#AF?CD9F($$-Q$'NY,RR0S=04$!`4` M8]&A--]VL#@$=.41_]T.7(??5TYK0B6FJ<*5QS]L?N>3;G5@HRSAA"YYB5<[ M)9T<*7*:_<@K^:#H,E\J8IZF.^,E8MDSIT--.Y79KW8P(@$IRVMA][QD0EP] M1=`FZ)YB<_$:",ACENOEZ8#9H@.<0!U')H4'DKL,@NQE33!=]A3%MK;R*]YN MO[@?/OOHC/N4?+F0!2FX#.>'B3]B[MEAWC06NQ(D/SWP*SE)O<]JMDWOJT@K M("%TRCOLM^:F5'G-7/G,IFJ;?$F):--4,L^X)'>[M-!DJX1N4F\CP'IEO#?$ M([@<>0H06UZ9.$T[0]`S%]M5W0S,-64RL=4\H1\CZI+0NE"+= MP3)Y$/F`YT2Y(3PYFDN^R^]R^6G/W.H*!ZI%^!P%%TRC5_/AM84&U1'K<2AT M*W)\\3'=R8LOLY<7C,1P1T04C^(NK]R2L:;YM@OP M&H6GJ#YNR'L2B"8F%"%)"TZR*1#>&GW)B"Q15X9?#1@L@+V&OU+'1F#!4%R$ M57-0KYQ3%;"\>N.SH3B4\EK,"D"2]`]^'S^R;H@6CR8PS^8^!8).L[I2I2F1 MASVB%"<;A:$`R8WPI"A@V7E^R8HFNC."F#2$,6Z20(4;=`7:ZC['`Q M.#4ZD%!$MBA8YSI_,:SHP!"OYXL[S[+'C%B6`EU)/QG9&7LI@$N.)"EZ7(6V MK'>&)2N\NA*W87\3Y;C$V8*,>-^M#%)]:DXXF?H!-O-?@^!,'P]9)845O:+[ MEC@ZP*4DMH0R5^P.*213,YDAA#!3:R/GN*RY:IW?H/!J90=S.K*D0H701\>9 MUKVW0HTL5.1XX^ MY]GG$9E'ACM/JHBQ:(K`P!88=%F8,Q]O7W#/P8`59SRBKO+T(;][SYL:BK3^ M+/5I*.<(#.$2-\I"`"XXDBV&(MTH;`."060BSYA[C@_!'VE5/6]4`<'U?9EQ=WC^H?--_KJDPK'"!5A. M&J=^6$6Z+ZUP"1:KV&49SE#WWB3TB:Y)N M5TNK9*D1CUPV]OV(=WMPQ.5TT5H"\Z5I,2UWVOG'_@]F5RF<3^O7M.0U6^HX MA["%TD;VA`CY(J^X-*<)A("\=9SG=12Q0Z;Y`1I`/`7-Q+4JLMM]#PT:PB%O M"9RP26:.<1R`4=*`#GN%R'B>]F^#)]L3W:>N$X,4?OD5[]3=CN\RG/XKNH(L M#-^SO/,KWS$T3@GQ$0A'!@QSM1EF0&0&8RT3#9? MYH$U4Y@9F_$"VKG9ZK%GQR.'WW3$^7Z3U5I(.@%<$V4N/]'X=NXRX6+!2)3P M)"/9DZ3>%=WL@$=3>B0H[I)#57[``>X_\FX,"Q`YI/'HH'EOX+0!;.PR"2:. M`4Q*)2D7XSE)8"`$E`[ED&=\_N8;#S,0(-?^9.*$9!;_(/.(O7?W-]?RE_Z[ M'U'A?D#%JVL7_Z!/7&$*`0S>/B[X)5E?N;_X?WS2:8#Y<"QF)B],7+:539!M M?MV&-U=)]I=$S5+E+RY!4WPJG77/1\WR@JNEA\?]W(('/8X#SPF?J1Z`AIEQ M.+"'3N8>[@]B3"1=]<5.5`"TF[G^"V00Q+8;_I@V(E!E",:?.IYHCI@&T-1T M&".%JGAQ4CZ$F'0GX#/JDX(]L1V98!`2@WJU+^Q9OHS1*SP#N2I6CXD^T'C7 M:OE2W-6/`1<8)R.TAH41FT8#L&4N+UWW_AE[0Q'X$'2\/)#+P;GF?)P4B291 M4.Z=O8>]3![!-C1U53AFGN16NC;%;4816!&G(;^9:09\Y7F8D>$J"H,5DMC_ M2TP^R!4J`V^,84] M`XSK\(>^WK]_`W;HT`$A%F(UVB\7NC70NKJ1[K@D$/O9@U5N#YK9-\U^G?:P MS*[KJW?TFNW!*K6'CJ[UNF9E6[B2V2@0R^_%5/+%^=TYR*^`)8EJ=./" MU-=":W2,;N;61J&UJH.P"#YW@7#5L',[C-['[(Z'88KZ0W>F]G[U_/3L)U=. M3\?^NJZ/N8&ZN6./^,/GVX<;Q52$+NC`*Q\___?-YX?;+W^25G@\;^\J.48E MF9J>N0:2C.6M7?_#)O9=+`[JP2;]EAZZ*.?\#HXQ+;?^BZXNE]L=$$/_/J$% M6?-%%U84'2B*[->M(:7'\W0@X=J:TU;6J:U$DLS-S3'?D:"AUE(I)-L>FWX. M]).%](A'E@T?U(:(S.5$5*JBM[ZSE>>H\XO]BEWE&?KKH5*P_K=!PW+WPJ"[ M"^W"9S1X]YW\P=#[ZJ"OE:YJ;^QI[8HO2U-[G2+XJHBUCSL1>^Z4/C@BILYO MI9\ZK53$V?LWUTI0LM51]4+T6[ M!5A\&\WN7-N+KKP17GVF7LY'[*^7IB.M;#KR[LOMWO:4KHX"%I.V18^JTX$VS/(&[_G%*86>^JIM%O($\T$XL'UQ'UE54- M#SD?EKZ,OMKO%XEXGL@A;8LFL-6,(J;M.>BN%>E4>SB,)S&_.3["%N,X[0:- MNE-2:S_TNJHV:).G6V*O:ZE:W]A[[K158T=78_7-\G5P?&03PQ3U16G74'5K M2]=NKWG3U<0\ES;=G`K-W2R]L[$O;`@/?G*&V`7Q"%UVEJ1,.\J%3+"UX9_,V#A1L30X/.:))(7(`3N@B:!POLKTG MAR;8I(V!I_Q@10,B-K4=[%;+C_A2X<VQ^9ZI]2PRJ M[0VTY3T7J8T'0;&\T6)^,J;XF-H=R`&XJF'UDB\7;-Z8_V;;FK$61(K]>B1Y M\=;;V/"5`!&$A5UD7V@DML)`LO@39XACH\9QVDE?[_%VSKS]#UA"84ACNZD/ M5#*?'L@@:Z'GZ#;;]95:W:3,P6'A#"**#93Y.@/%CFIW];FM/SC>96"S>]Y7 MD(VV^J"M/MB!?MHKR&WU`0_I&8<)Z246B)<:!J@^I35\G&1L$P/J:7;?M%33 M*)+>KUN8H>[X.GB,\,#<^-5+3?^6`OM#EW9_LJ][F!0%CK9\#:(&9Q[,K'QF*ULE^0\N]EKHE?7UU^^ MWKQ7;O[?'24^#Y'SE-#,\<_>5EW=HIX?E2(&\X7*#\GP6&KD+SO6@[R;H4SY MD<"9ZVB[_ZS.`1(XM4_+6+URP>:B:*XL!-UK4Q@-3&$8^Z&JO28[K#;9<=[) MCM*[KMY3O?G&AC'-`\+I+J`\TPECV[M%>]A0)5Y)WN?NZ9HZ,/IU]OKJBLBD MUV&OJYK=?GVB.S7@J%N<0Y5,!]N1DS:IAYH22&[7NM97]<&@SGS64#1W-;7; MT^N4O]@W_^VYAKRFYYS(V[X^P'!ZTZ*6C<9YQ^RIFCDX8N"R3+`E'=:T.7:5 MBW9]1!.9A=$7.V*WXT^.!_]]';"1$]UZ#_X4Y]T!="L&6ID71B<3A+N#5;)1 MN(^?/[SY1;O43`%=L;7F0X7X7"@?O!:3P`O!LQ@4[&KP_]*HX+)/Y[$3AH#. MSW[$[G@$Z0NO&[ZS@VCV/@YXUG1I+%4WTECJYMED%@>L^*(KP`R7O"+1?L<" M](BV!WO5^2X"7@*,A6'HSW;`?K5#-KK.>"9708"#;/%^RJ^S]!%8!O]T]6H' MHUN:OQC>QE$8V1[*AL\Q.:&%AK'1-\.%W1F69FG90'+EX"WL'X?D<4P"BN`Q M/F>-P\?__L$/0%:\.$.V*E*^9HK?JHV:.]I"-I9MY0ERQAZ[5VWT/ M1,G%7OT01\`1U6^C;_2ER-P&D%4[@0?E,#_!GOPSE=%0/R/$"JQ;$9Q;(+BG M]\J#N;,$X/Q^.^:?3:9CPKJ_P;NK=%I!]M5ZO8&F5R"G-D"9.[0'/[+=KU[` MAOZ3A^5[V;6N?=#T7/X_^%^]%Q#];$3X%J)PZRF97;.CR0/<#83<;F["R,$9 M12.96WU!XX!G"!]HCNE6V;\3NY>SA5LHKQN42@$5L=S?*0*H1_0P>!BFVKYR M`O3.,:[W=/H'P)?);]+5+I2W[WTO:\'6&/]ZW\CIX+W(WF$HX]B#ZI9L/[D* M#UIHA`Z$/75`RR@N-C%KB>0(1%([\;&\GUU+&PEZP&H*L,"&>$8!FV:B^,'\ M/>X,[G:)LRT$VS9DB3<5_Q4W!'/VXQ\V6M?1`^SUH_`T0:N+3D=1;&6\Q'N5CA& M>AJ>6K=FE<`M.C!'!F[AG`H!=]G9%K:0/$7RJ,',FCAAZ`!4"]4S(H>CJ^P*YF*=^=)#74,,JD#L[0GSM>Z3K073FG^;BX7[FLBTLO M%S;6[P*H4M_/08;I$0SY)%&"7YG'P(-T;)=_-(0W/C`;XVL;`%PO`N:KDWM6 MWQ#0;P/#?%#J-]OQPD\^J*CPUKOY%H$:CYWP&37K[?@]>XRJ`'J@#[1^&F+: MN&8.TZ*._@-CX4=OB+F6T;(`4)%DB9[-EBSY;F[=3,#]BS^S74R*W;ZRT:V7 MOKDM(*:.^"B\S`I\(*K2@[X%F\SQ;!?_>D6M;+:%KJ,;2["T:;4YQIU,?"\3 M)/T(!SU\QA@B<'[^H\7`+!`Z+K/HTN"L"(PO`\C@`/W/7<#&#&F%EOF=JA4+ M"$)M,,AE&#*K;0M)9K=%P>A9EM49S`=[MX1#'-'_B.>WQ(S1UP?=^31911!M M@:&^,>AUK4XU\`C1N"N&S%Y?Z^T'HBTP--!-4]M$0_PJ5.`/&1N%J#2D=L=4 M?18)JQ,T^4M%59`:2'^]UY'WM`H#5WI/_VV[\5(;:LF6UNMZ3>N7`IA6WBN\ M18]@J>ZMYTZN1B,'+2/;O;,=4!G7/&A78$MP/CUSM_-9]23HJVO\N^N*FV>H MLP[)+*;>-3+5&25AW'Z/E3&/WNEUM&UVL.,A'8:;S*;L;'ON@@.T>CMO4VJI MG*><&VIZ/P,P/'X\'^5@7=7?1[W:RI5VCA?4);P5'LLJ6Y\Y-A`#PY MUW8F1<79>E+I6MHBKR\L53%(5=#X_@$O>_VY8X"Y>7"0*L!E2<`+%7O=Q0'X MCR&30?RRE+&%?6UH6O&"NGGX"FZ.).26>UM?8:-W.L9@(_!+US\`[(7.9T/>/`H9F['MH^6-)`^6LE\W)E3F1Y)5P5 M;&+IYL#0BV%\.10'VT<%]%77W9;5C#IXXV9!/CGR/JHP32K;[6J-O*X">C^T MV.E;:>A]+4S[@_Z],)FSN%HHJ0T+;.;B4+O9$X7U^]V>=5SHJSN+*G=S\RT" M8-"A]5:EX,JJG$%?T[KKH)M;4NGA`+@U)^VL4Z6Q`4'7[78JV%[QD&W%N]L^-&ULBDTW8ML[F#5P].A.'PX' M&-O*?*_P';@]9(VT9?',\M!NVO::#U280#(TO!BW+0P'VL,..:0&;6Z7-)(^ MZ*VAR:([E8H8+V!;<`XX%8J.+@:;[AT M2UE>M-F0K511&5'=AC??9L]R<"H$#ZCU+HS.TOOKI4`]RGZWR4]UEE_6K\=F MUY'SEH=K66DI3*/VN\7ATEX/<;BD6@_'N$OB=49G_38W07B,799,6W8VG&0= MM[B]SKDPZGJD9U>:TMBF/^`N+;,=CHQL[\&"10^]R+L"`;1:S MQ/;@[W`18AO[O6?J'*PR9Q>"NC%,%7U,&]KF"5YXAIN98=( MFS'H&;T==Y9&Z&2P6*3-#\`:L('^8#&S/`?(]N!6[*SU>[TEP?9RT.8:`!X` MYFR+P@W0Y"#_PH8,E)1X%)26U%GT#R\8K<76(7\$3L3\\;@**]P:I'&.DLL? M`/2=E'A56Z,_WH['_`+PK;<`3/J-*DXD`W6)E>Z+WC MQM'?KJ M699F'`W84B1Y,>AV^]:NL&(#7`R$\+?D-ZH@4JL_Z&>A6[[2CA"5(D7#ZFC[ MA6B+>/">P=E6RA4%YU92%W\,>_]4(N%TRP"QD;FEL&2A[6$I)\%T33,&66*N M#I;2$FK0U?M:9T^@E),_';VG9^_/E0'E1HYGK8!6](ZE:=UE.)&K;`M&*3+1 M-:MG]7I5@U'Z+A-V<RS=#QX2]\=&9B= M@7%4>$L1KC[0M:Y9);S8`;$*2NWUC%6$BDML"4(IXC,U4UMQEMN"4):>^CU# M[U8.0CG9UK\OH&[WL!::%5;:&HQ1)]/5^KU\]&&7) MPNQH_>Y>P"@G/4S=+`7&;P$8Z$A!3B7NOJX;>K:J._/Y\BN7U$M6;U#%PJ5- M[9YNF+V*5BYUV-V^E36NURR,\XYNQ[_Y_BB\Q]D$5=@MO4$_L^NY%;8#H%P< M9V!EFP[O#D#I=%57,ZR*`2BG![I&5AMN`.`+>V%>7)&SW0,(,\)??KODFJ7. MNV?VLP2WS9*E;<=NS^CJ.Z]93H)K5G=0`+5_,!S1P497(.'M)Y:?SI9I.DU9 MJ/)GOJK#L*GU!V8FW%,*C'WL80T-K>R2W.D:?;TN>UA/E*MJ0\"]'73Z-=K# M&B)?M0=L2V5V=MP#E0M@Q_E;[YY%D$K?('F.KT1MV;D0I5U6'H'+/%NV8L^Y M0Q](C7*\3=QTY2JF(?NO0LTT9*L5J)J==YI$#>WP&?.*\#\XWOC%=I&\N.+Z MZ`T#'-/ZGO'_K:;\(A.Q++%VU7"7KKDR]%Q1Z"ZP?V81OG<7^#A48?3K[&N( MP\P^.!X<*1#"U3!R7AR<%%<%QLU.KY?M_UU\]6KA+AU]M;J:J>\"-W%*=G#/ M/9Q2>A.FX#66;>-$I1:N%N32=Z$R/5^V`CN3BTY>_L*F0EG=CL4(RSL[B&;% MNLF6JE,MNFR5X)86(%9^\$/5,%>%5BJZU3?#605LY86PEILF6`2V!:+.>%_Y M3J-^0&.I]R4#-JU;*<'G(]M[0G[@(U+V M9RI?='0]D_$N#<->-E'Z"'JFI5>X"3B\*L-B\:C5PEE>(W;E2P))@KF")I%"_8CEBZI9E]#9RY)+EJP6\/)X[/2M; M3[X]X/,$_M&;]].]D>BH\PV^E8N0NCVT"RO_V43BT/NH9A[7\_ M=-?W&B?(`R,5'-Y51#?I@W6P+ZY:%:2EB1_;\U0-ZET`]KHSJK(BV3('O75@ MYI>L`L32%(LIARI!1-/%B_R@(@EA6-U>9QU\F?5V!JZTB]+I5PB<%`W5QGXN M]/[`*B225L=0MH6U/%L/.MD*_C*PDO^"=SMOO8/&U`HN6168I?F;=Z;8!E1Y M"FFJARIY065]]CTVF;K^C,G62>$#^(2A/:34$'[ZV7='+`C1W(MFE=SU,3J6 MF:'CW:$ZS#Y+EQ;U^SF3J/I]Y@?[),%J+-8.J3E,R'FLDII\/7?;MNC258)< M7JA;N2+V;6%^SZ8!?)?>0S,O\YEJ;`M+SRCN-:OM"%AY&[BW)6"REP.FUJNY M'KBDOPM^O.S"I6_D61L6%@T+D[`:K]!Y\/EH^3W4E%J9L=]%UZT2V"SZS(W# M:CN9SIM;P9IFG+,1X@<_WS2Z$@_6ZG?U9=D11R@,`0[/Z\RK#= M>_@+%7&'J#1]\ MKSPX$W!M/K-7Y8L_L3V5_T%5P%!PQN^4B1T\.=Y;18/_CR^]^<^GZ!U^\!%_ M^'S[<*/HRG_:D^F[_P#'\)UR^^6WJ\\?_[^KAX^WGY6KS^^5V[N;+_3;/;[U MTZ-\_Z%[IR`N+FS7>8)?_QF'D3.>B3\ZWHCA![7+CN/1 M#JB5@C-4?K>#OQC&NA1I&*D$#?@1E\JK'2J.-_2#J1]@.E,!=??WV)TI^D!5 M#$WK`66`T:1$STQQ[==0\>`GX-U=1CQ_JTW?@OU<_SR%YMKTGP($#-I-G3Y@2^/M^KA!8L!K.]F:K$\&^O3%7\0/'CX,=+Y0^F,._)?F*`;GIT MA+TMG$?Z$*++)]89$B`CAT6(Q3">3OD-!\7+03`-_%$\C$+YL:\8K1_Q4Z$S MNIK@1FU:%TQECG8.P"@#P=`':0?@AD,'%G'&@!LX&#>FTR!0;&^$!"C0!5_V M<"P0@##V@TGLVCQ$'CW;D3*T/>61P=;Y$A,V(EC':*&K^0W`[T,_G,!'AT`X ML(2/H:ET6R/VPEQ_RD8)#"%>QGR<*3<`IDVOP"_1LQ.,E*D=8(#P\F`LQP4$ M%PA=K0:L#K3^=]N+D62(;76#R)$C#\AG1"0$U`RTJ%P!MH8N)Y./7H;[X-!> M?/<%SQG)@SB`LX0R!M%;B!5@#7Y"OSH^$55>W/P@L&;UWM%C\M?^NQ^!=(:X M(AN/&0;EF?+J1,]G=F=D]L=$"Q'B/(*GB"( M./_5@Q?R0HN@4OG283Q\SOXS[.V1HV54"!=.>BIX)&=,GW!$SS:7I)L%Q%H`,]II@:,9.%HAPV,.)P('CT M`TOK"7$_W^D=U>I;E\K#,^.6ETP@!K8#?T!*BFRD+U<9^?%CI-B/?AP15#S+ M022&%H_CQ8)Y4:T^^80#'W@I`!5YA7\#6RIV(P(,/SETIL@5)(;Q>ZL`51YM MUR:>S+PV2O$;$S\9!E*00C0L03BB-J9Y!9&`\-A@QD`$\T$OT0 M-P]M,"'`.N'25#)NB"$_$<+C;/IQG(`&PE]$H!0!("Z2_A$EA><#=EYLQR6/ M'%",?X0G1@`+,0^HD!A-$902"0,0HB1M9S'%=TJ`S.T64>/&>`-:@7\(?<]C M+O\7^-BS`TH%O'2P9O[)?#!=1LZ_&:TYIJ[["G4\8T\@HK`$PZ'N9QRWCW'H M>"R$DP8>%CBUP>,GDU/*T6'B=0&88^EDP5>EE\4E\2-C'E`$`P!0:<+)3+C> M!P&2,603`@R5):+H?%D54;\*/<+/"R&(A#1VP>(A MM$]!`V*EC20&;@R%Z)7A/P>,#':I+4C`NW!X:+C;TI&P*;/+"9,[;O:$QX&7 M/^]FLOUT_B@6N'[A_(^?`'$"G!:2SQ"':.&#O`M"K6(I9]!G-&GP(SS7P-[^O,;_K\)H&(K M%P$VDGBK="ZM:?1.D7]UV3C](P$[MB>..WN[GH"6$4@T:J&J%BHX!Y8Q-M M7MHS_N-VVJ3)I-;<4S/;4VO@J9TUKW6;>FJK>:TBH^0_KJ\_?+B^+F26)):Q M<0B_M`""4M+X'$\P^HH[VI'.:^9I'\YORGCB+:"G#F@]H6H,^DX4T(,[NG76 M**(4(8.I/,Y.3<4LM8^,2Z,#)A)6*KCL(#92AD8+G-=W?,>#=S]T=$WM=P[S55?6.WI)_'0[#&FAJ5S=6'\:Q M(LKUU#PM5`UAT';Q_6ND9FRS08L?,U"V50IYKV[->^;Y$\<[=*BL,=1R2HN? MR38;M/CQ`BQ;2***"U?2^HME5T/X,*D+FT^3`KCQ#N4^SEGY\ZD*1/M4NNVJ:MCXE^WVJ3MX9"])C78$OO^\6]H;6JV MA:IU3\YK\3/99H,6;U0Z9,^)V6N1\:!^IJ]R@-7AS(3#!@PMM6-H�\C>!M M;?%LJM:@HPXTHX'9B=HBM27>^A%O&^E:%6C"!^$+5]B`2`Z'/'2P:RK;9G/] MMDNDJ[;4:JAFKZ]JO2(YL%8J[()G2]?5@74$/)\R4EOBK1OQMMY1BB0^YL&? M\E:ZI^H5&6JG9ZC:8-!RX5[QK*M61U/U7NL5M<3;.#R7(=[6*UKED5RGSI`R M8H_1H3VBM#NT(X9@G:13--`TU32.4!M[5B*AKW?5CMYMH#:K05.FEK";>PK% M";]1SM0!]>#--VI)+\K@G)>#AP;3X0^[*$!!P=3X=8%\&UFODIA[(&=ZFMH; MG$BVX71/J@]&N:5V"EV":(0>;@KB3Y1%FGD89;A@B5+^B49?X)\R<[ZWF[@Q M/[AC_N4[D#G#66531LNJPF6#3>#+COPAQA\^9ZO$LY=B"5=Q@L7DK?. M3&/*_''^DC(-ML+':'A4'^,CE>#"SX<^\%8H:8%SD7TN"C=7'P)AO[`4N& M9(E91>F<4!:Q@#I'B(E!?'AH'MOI908:7Q;A.`T%UL=V_PS;_=-(/8)!CM6C MY;'3K81#"9UOB^\H"\_ST5=CWW7]5SP\/C-GRB?\\.EX.*+*<9T$Y$MI' MJ71I`3UU0.L)56/0=Z*`'J\FIX8:I1TWU(`D=SMNJ$9'T(X;.FQE1SMNJ*:' MT8X;.@%]V'BH&M-UZ)06/Y-M-FCQ8P;*ZG=ONQTW=#Z+G\DV&[3X\0(L];[T MU(X;*EG2WXX;JLM9M..&CL8$[;BANIQ%.V[H;*,,]82J,1;A*2U^)MMLT.(- MBWT!N+YW;<4#MNJ#G4VDYLJ=_$EE:EM<1;,SRWXX;:<4/M MQ);CXKD=-]02;V/QW(X;:L<--8983VHJ2VVQW(X;:@G[+$^A'3>TJQYJQPW5 MM%XE,?=.&Y MN[-D(%"R(V6:VQ(AK!WA)`RSCY[RNSVC$3\JS0_X<'7_J\`A@>/!@AEYQV\%(>75<%YZ9@J!C MB@T_@TD8`#C*U\O[2^6WJZN[].L^3C]RYS.*RGWP3PQ&?_S49\R2&...;CK@#*B1,";$^^/^*WY'WP:5CPX@P93:P:`AK\"0M" M'!IEPW\F>%I\Z8"-73;$R58$GA?"A@.;\("CHO@(*_PW.`@GFBGLVY0_[BN/ MXH\NGT;%O@V?;>^)1DP1%-&S'S(.E9*!2!Q]<.$;^+(- M?P::15&E_-WV8CN8*3J-F^K1G9TA[`5>M*=3%\^&.3@N"W84!3X>.7[+G7%0 M?(79L)$I\((_DM.HX!U8R<;S'<:3&.@5WKC@<"CV"%D#)0(^(0=K(6W!S_:( M)Z$NE3_X:"[V8KNQ31R`SSEPFO"-Y$GO26!$T'R&81)JPUE8<:",@8"!/&P7 M_R7B(NERK]KI<8G,>J/)8H7'QJ;5P%D-C'H# MY04I")08*:Z$"HX].QXY$8EAT$K.9*D0(SY$8#Z;(.TI;F+<$13.^"" M'!<+I&R.GH7Z91[H!1?L)V!;-L5OI/S+"3\Y5.4'5-8_DAQ?A,CQX.\3.FB5 M#U?$15!J!C&^S,%\(G&,:7XA>K]ZM$/:3P@HE?$B>OY&Z!X"!&NHP4!!8OM! M'*35>W=_DA`!T#X%&^PNM+OP;D$$0VV[X M8SK'4I53)\'J\L3P1B!T^XD65D&U@7X/44T#>FUE;#M!"I=D=3II%L8N0BJ& M4LGM\*<*XY'W,PQ.X1$C%3\SWLA>:8FMS0X>,W M.>G0,%":'0JR%"S/9`:H_*8@[^Z[4+GRP%QR@8ZG?A"A:2&)_;\`.C38)+`$ M"/#&7DR,9@C8*_(5X-BE$2ZL,ZZ<4AF9>!>CA&ZG<3!%(U<<;E8R+Z."G"8L MA?&K`#\$,G`(#HCR^WU=D;S"%/C*<<3@F0G*[U;#SVMXKH!M.1)W0<$Z]J/CILIXY(1#UP_C@(F=H(KA?M3R=Z*<;[6:D0B&.8,F"Z.2 M@4_XS:&8(3QE7@B_C.)`NFC\)0K_D-)!)1_%I`&YPAB2K!\Y8_2SQ^"#*.30 M$A`)_DY?;*[@Z&L[?&ZY.-^],(F?D#GX[#P]B_"#ZP`KCE2T'X+H`@-'P+HO M3%IBQ+A^X,"J0']`5]*T)6[(S.H&K0,6F$_=7-CR$\4\,>3T")R0J*>LFB$`E#W(^\FGHX#LY MO&<.8.:1Z!]CMC+$Z^!F*<`D56FZ&@^PL6_"Z;$7T7"IW&8:BY+*XP_!2BYN MA'L=H%P<]DH&^,AY<48Q.<;X/XA\/XK M,#Z[\,=C4EF!P^!!E>"0,=QTIV-[*'0@'!FV3I%DCR.QW(397B9< MQ-&,V$OM\V_/-F`):548!E/PFS".[-+9(&F_L``S0(FD)A]Y`H\5(]A7FX/P MG:%VC"[RR*,/LEL.#J8T":V^X,>=K33^"(K.`_J>M3(XGU<3:%%%>$5$8SA] M30.0A1300%/6?D6C@*$+*!,O<9BZ_R`;1_%0BCL4<2.'11B%">/IU)6>)SV$ M/!UR%R(1\4#R/),T]('W@.YAZ;\8C]?$H;27QTX0XD94\9,?1\"38!*/2,KQ MB%T`$'/A2'`X".5FR])K$A5N,Y1;)YP"V7NB7W#)V1"RW\$CP## M8\E'#\U2AT[DE^&RN\`'?0%.(.D#,`*G%')K62[#F$\#C?V47&CJ))FY`A%).IN%RR:)/K*(Q!OZU7L$W'#EKE8*CR$3?S\ M1GM#OXM"+OJ=B/SG-Z)XJ3R@[XF)#XN MITIWRXR5+ER3=CL&P%0R:E(,(R%7KUZH97 M>*=WJ:U4%3W4\-)G871TT)SL'>;TMY`+U6_X1AZZ`I"!\A#*6'%1C[>$<"YB MX!,>]S/&*+)6W1F?_R?PM+@3Z'*+%F/48-8E1A0W9#/8*D,E%9=S'[.N>M'S MLJ-#5@W7SZOB^U?!Q1\R65PM*D"3%(5*SHP]P8S;O\DVEV&%O%G/`PJ)7>\$ M:6P37!%P-?"UK&$/3IK,WGL4A!VQ%^:"9T'5NTG\`#V>U(%"6&V\**%-#RH)4O.O.A1,%9\DH?"$'2KQ@%.@=5(FAL:UB8BD3M`Q M&XI7PZ1>>O%1^#\&A">?5+E++;#N\.TM/ZN`_9,\3UEJ'?),\(B-!:)PRTA$ MD2`DL43B[:YQMA^!#B?X#I8.S5($%7"LQ;.B^G&=4WV^,>()1CQD7,#U48DY M+W00Z*^W8:RLP+V-@T44<9[FD619D[@J%)3A0>#A(:^,P-"1Y+A>HDLP\6;$P#Q8Q)M2'^D@CS&(V84$+*#@.I8T^Q>$A^; MV#,JZ7MD,EM#6;GS/>P_>,PJ#(6<$3BA[*),AOG+"`+K2ZF>+2EX`7+@\A%= M'R$#[%0501PQ[S,1VS@ M4OF0_AO>6DFT7)+6%=8,`9'$&+.UF/S*#+)2'&%15`;Y&<0G>1>^&.5>L38%B0/CS_&1JCS&G`<]]IK?PN;#05,!RU=DHE?6JZ#5(%]1 MQ<K_14#09I(36`6W"/ZRU/0K#^)>ZRE7,FA]E.A[058*&9)I7R->/#RU M9VTAS#+IZKJ^T$^,NPQ,7*+C52'23EO$Z".+7K'L8"6N^>4&T<.=UU)P@Y6X M^"&I31)M54? ME3EQ0(P M)(M$9/_@>7DZ652LVAH_V?6+):>]U>$FFF;M`3\\L[SK,;?#Y,NR/LA?EZ\+ MYQ)V)R\S5@C9#SE+(7NI26*^]586:MOG[3=`';==<]==[:75X:H2QAA'"9<2QZ7RGE_F7I0*81*6\2D(@^"A MVB`I@4[1-+"'%&+']Z4-M,1^751""RJJY5^,-=IX1Z'EV65FD4!.EK)L2:!8 M02OT+=9NB3M-4G=EFPN\IM?EA"T%E!LR+![U$A<2*-7A(5G9U,!.!,!,="R@ M:@5P!^@1>YC4J$@;3-H`-N:@G*E-G'85DNQ0LYM`A2N>ON`LGR$#4=439KV. M1"[8\Y=D,E5RV77%IF/B>\(2#SVF^TTV1X5S<>1@.!?`HE+_"Q!ZP5)Q(PL% MX9,^W@_X-[\2*`25J-;C=3=\3Q2NS)Z?*)/93_W++J2]2P6,J(P88%7+&@=O M55U+N3SUBEQGY$^3`IO>]ZN3;L7[HG_B6JAH1C*/"_W[XAG&`CL:&)5LZ1^Q MCR9EUEP'9GRQ'9=.GRZ>D\W+G^#9`%[./TS-@PS_T-VQ)+20WN="T_6R7!*[ M'&8*8[>"4UBSUMIT?%5T71TQ&P6)N3*D[0;TG9#)%N ML[=&31+2WQZQ3PZWW%K:;@IMF\VB[:]>ALP$@;]B M=P'>8X""+$X4\?IBSYX+4/%KSGPJ1;][ M[0188P-<]!>AVTW4DX!G0LEMSJM`8ZUX!%_R6ORX%7UBX+:5B.Y*D MOCR4!>;4/T7<]>:.N2BHV%QB+BZV8Q5*%`7.8\QM3AG,XYW+X)NQ%S!17[&X MM,M#I?12FB-*_/;L[N&`\0XP/^/Q9MDV;\<_!;9H6NL MRC5T7&C=U[KQ&(H*J&S#P4Q3*19@;PK,"\*[\+*,_\G+QF/G&W\Y MF^`DJO_!>?EQ[C(M039)+@[CS1L?7R#9B(+F](-:*X_ZB^QVD=04X>T@62"0 MN?N7S!L)GYWI5!9%X=4\E\(%#!-;,9YY\B#(TYCN\$7V-Q;*0TGR8K*WI$II MDR3!):M(9/]+49\"5($K$UUE*8A"(109PJ"P!#@UDK-=+"^5NT)T2X&_1 MO68!P8MC\V`2O]+%+[>K7:A)8$T=&S@ZU";2RT MP4"W([Y-C3&3F%:HQ%,1LY+[5Y-S"D7R2BHC>=4;@.`<@N]BA)M-(]M+LVOI M1A*SS?('LJKUR8@\QE"2+O8&]M/2XI9V\\._B+86"]ZX0;\*E:&\99^CYJ6U MPR>/VQ5DB+>L*'>3Y#WEQ0"0#Y0LD9U?TZ@:FTQ=?X;V!_F40PPO4$/Q^?[1 M+1'/ES`-T](A[)2229*)$B)/!&T6<$FDN]CY.RU]DOTY11T--?%;/-Q5\ M,66^=!=V^'?[_%)/U=I?VU^!)/]2>MCBAB MD?T(=4HGB_E2N>:]\=T9KX_(GCD=:MI!Q'ZU@Q$)+5F]!;OG:4MQ/0=!FU#C M>W_XU^D+K;6U*GDZP*;QW'/AJ./().\@J4$59"]+SNA"C*CELOG4EHO[X;./ MMCAO&G\AD\*B9SQ\@,8*G#[FTW[6F63Z:G[D'IL\"U2Y"053(*]-:"])CBS- MY&Z5,4D2VJO'Y^R6AL#7J4/^!>$Q;99?.N,],"M)43\\L[1:7U97)C0GQ']2 M\1)FXK>D!>!SN2K9Q#`<1DF71C_M+U=='J_8=*.2&:FU*;CJJ*QVI%4U';WX MF#;@Q4S9"R0YHRG3`S#S//7DPCL\7)Q0>VHTG9/+)5QEIR7?V&P7JP3QXF>V M.EA09$MQITQQ@1/^=3'&=K%);3?%`>`;..9,G,P1P4V)56;*W+Z MC9@SA"(M,6K0&Y#I*O25TPY/+=&=*]$E8HXNG&/C,TY06:)#RTW.\II[S.9* M--*0@P;=I/4FJ`S&\S:'BIK4SJG+94&Q%P#O`&%_ MXU&^Y;4+,NXQ?W437J-0"=5+#/F]1G$1FKSU-/>9C6Y'*V>"B+L\\-6`P0+8 M">\K]26B26'\SH^:@WIE$_V`Y:4\;US/H91ETBL`20H8\/OXD74=_KEGRSR; M&[4(.@T22'5';JR)DXV(9&&:LXT)!DP#!"'#=H!+=DR1GE&<9.12]SEMVRM2 M:-2#,N\Q?#Y"+&'SU?7.^2]]3%LA1T2>ZDR[Z-2P%< M)O/JX!%1GD5,+,B(]\G((-6G9CV3J1]@P]ZSP$MTRQ-$!+B6Q)92Y8G=((9FZF0PA9,<>RJ;;:VZ5Y3SDL9K>"'M MUY![40YK#`%`/H,(.^E]LVDP#C[P.$M"OO`B!<%BH-)`7.;*B:B(#9\]\GDF M@(UT1I)U[CC[GV>>A@$>&.T\JR9+7J)!BJ() MDSF@HCC^1T<%X%8(Z'UR)L5\+[* M**?)LZ+:8)`V\D4AP(%BL2L;YK.Q>0CH>"^F"ET>DDK.(XF*TKW53&P3RXKE MG5,.3"!-)HI9J2(9$N:Z)%!^6&:EN'1/,U.#CTG86DAH0][WSK1Z$U#32+I6(J5!!"DUNZ&5&*QR//`#V'I25*GZBY%!XZA$-3!=[4L?3=G;*+O4#`C>(JDUMQ3*WJE MO#VU.IW:6?-:MZFGMIK7*C)*RLR^22QCXQ!^:0$$I:3Q.9Y@!3_N:$.)MX">.J#UA*HQZ#M10`_NZ-99H\A\58JI/,Y.3<4LM8^,2Z,#)A+. M&W?906RD#(T6.*_O^(X'[W[HZ)K:ZYH_'NYLJAKXX/HI3 MLU6@;*L4\E[=FO<,AY9ZAPZ5-89:3FGQ,]EF@Q8_7H!E"TE4<>%*6G^QK.Z= MU_1>R)K>7"5O#H9,*2^A<\M"I$;[&GVU8QKJP.P<(R35^GVYL^BI5J>K&GW] M\&=QWHCOJY8Q4`>=?LL$1S^+GFIJ?1!(6H&S:&,?+52U,LK:Q>NBCYJQS08M MWK#8QP$]CH4+BAEGXB``+-[0.SMW)DV9:)=:MTU='1/_NM4F;0^'[#6IP9;8 M]X]_0VM3LRU4K7MR7HN?R38;M'BCTB%[3LQ>9_N")%U'#F-M(UZI`$SX(7[C*MJ(Z=+!KKL76 M+I&NVE*KH9J]OJKUBN3`6JFP"YXM75<'UA'P?,I(;8FW;L3;>DIHJMYKO:*6>!N'YS+$VWI%JT?LIGUYL67O MH3VB=-Z][)M^DD[10--4TSA";>Q9B82^WE4[>K>!VJP&39E:PF[N*10G_$8Y M4P?4@S?S3=8/K0C3GNZ[*$!!P=3X=8%\&UFODIA[(&=ZFMH;G$BVX71/J@]& MN:5V"EV":(0>;@KB3Y1%FGD89;A@B5*N>,1ET:ZB^QU[F5_KY"9FC]0\_\.C2_E"'F>_;$9_:U ME)N?5T?D*6=1,3X?DR!Y98H_97S.-\YUQ/%-A$.:1)62;<"F/KA?WA/.UYKZ M(:O9K+G#2DS`#P[`%*/+AD-P/CEN`M_S<69F2X4+5/C14WZW9S2,3"6I]N'J M_E>!0P+'@P4SN'R*G1'-Y,W,IL0!OUZ<#"^50SZ=4,&7J>.$'8SXE%&@6##) M&`[W300HC:[_[>KJ+OTZS>JD(9E39TAPT%0SUZ'^._QUV`QL+IA=A%,V1,&? MO,ZGJ>'B2T!+`:)ID#@\V%9B#SX`NYGX(^;BGA*N5%Z?07W`&URA^.DWPH8# MTE`D2M(ISG`03C03LX5#,5J8_NCRN7GLFY@+/)8#KFE,,4&E9"`21Y\C+..=1J,UR,M/(2]P(LX0!G/ACDXV`]G M:@<^'CE^*YVLS&S8B-#K0A'SB<@TV7483V*@5WCC0@Q%MD?(&B13[61&[4@, MJK='/%U^J?S!AP@R,98:1_/!_,+.7D[#/(KCB\YO08EXIJA?VE8._! MWJ;9P:9>'R(REQ-110FL,J4[#5<2@ MNPOM$O'B'ZK=L9U@N+`]7H%&G4V1@%?\IW]9NDH8VNI>J-K#8X*`,:`TW5M`-R MX"%KQ$KIY$\L#-]F\)#\A*'&0`0UV;^*J^Z&LU6@V$YCXMT^UKDBKTLW3=!#(\F>+W>N#4!%_?*E+=OH3' MTQ*N3$JF8')%)F5NOOQV^_8NP`*":';G8B;'&]W\*W:FDS8A4T%"1B\59JXJ MI'R<50VM-B'U09N2:6!*IN3,^SW23\5S[-N43--2,@?V&&_'8V?(%"85[Z%, MJVH#\3VUH_4::!\>"5TXS<9JPR7OP/P(+1#]NR[(RP.#/P7<9O@E()^>ED MUG[H=55MT*:RML1>UU*U_IJA+*T:.[J$//D\5L=0>_TFABGJB]*NH>K6EJY= M-HM5)ANU^EH1ED1&[)/SPD8?OUZ:P=Z*>]8=2FL[B/:!S&1W0`$2'CU8WV!-M._)O4YQ2\P\..6VIZA"9- M%YF6:AI%\D5ULUOKCJ_CY=<.PXU?/<&";-0R8&F",JVN:IAMB'1CB+2CFMJ6 ME8PGIOZN,I%0J?VJB(2>$=?]8)AJWSC$',1I\<^]%QJR<17E:SAJ*YJZG=GEZGD..^^6_/=40U/>=$WO;U`4;`FA9H:#3..V9/U(DBB`V8V_N5>N;OZ\^K73S>T M]\<$*T?LUEW=JBO'`GRFX2=3>\:C-=@W/HR2-NECWW7]5Z#+M_M#11X#2Y9H MB_<:TJB[LHK!HZS:%NHU,F16GU;@6AL(.^]`V"Z7N<0.1VSH\ZDM;Q6`@@6N MX['B5E]B5KAB6%)>O5_(23R$G70T4FIV'//2_BE?S-FTS8.'F`YR\;!WV>]\ M#W1,XXO92%6^Z_5U910S90)//[NSH]/<-J[416,>CD9S"E>CJ8X'VU$U36N)OF;BNSF( M;M!*32T"-56ML[KBH,5R1=?(U%Z_5%U'FO,Z9(:CYDD4F0M8FQCA*="+L3UQ MW-G;(E6N]0]TB#UQ,AOL%J0;K(S17?L>;1P/R,O&Z^A2Q'%#=4OW?YS0W3PP MQUNY9J&]*BF\*!7WOU=3"YHL9DHND:6\I+W8#WB[QQ\K(R>D4=/9H?*/S&-C MAP9E#XD30II9SNP(OHTO?:?A5'+\-%T9^LX:@'EKB;^9/ZKB-`V%BP('1#[9RFE;\_I!E=O'O3/:;/ M>QQN5;*L>A4_Q>#M$D?MQID&6+%SW`ED:6K:.NZKL_(&9G5:JZ.:^KQ-J:F=CE'&IK0]Q88G["<&"@WG?Y"E>FEH&4.SP?QI M]-3NH.7/0J@R5,LZXNVA6G#G9QR$@`F3"OA3-]6.WLLSZ%J+32,!+$_N--G>-/JJU3_)#&?EJ-I[[J?V.O3OMA?;P0R) MOK,KDW;5P6"/3'H[C'QD4;W7?![5.VI':WFT%CQ:<6),HGP M'7IB5Y,KW*9+3F6[[^QO]R=J?NK:EMKMU0X"V^/74+_KJ5I_I1[+J3&NKSP_ M4F;P[51C-5DQ]=3!:=:OGI)BJ@=S70']NR69RQBHEJ:=*W?U-+7;)B'JP5WU M5U[;\)>I6I9QKNS553L-JG$]:>[:Z%0=SJ4FQEV1D)%-#G8L.9B_"=)5.SUS M>;1KU36M;NZ:UI*;9`_/3DCZ4WFU484Z(UAZC"7Q8BOZ,:L12AW&>326J@P[ MAJE::YI&USM05D[NG>92S:':6JS4M"A6?0WVVB]]R/8:9ZBM&HG>\NKN9"-; M-5\B']#\9QQ&SGBVLN'^=^+B/MK%N3@0P8)&K;CB*;MU^RE@;$+S;*-G MK)JF&1EI2SGXDZY]KP)<]#@@6U=FS`[H%)ZP4(`^[8!K!'Y0@`=OPW\Q64:` M[A!!,<(8;``*/G3D4O`]]HT%0R>DT.\87C?IXR%Y4WKJ2M%JN(+B3"9L!"3# MW-E>9CKLXHF(7FU= MP:MSX>SY"MU._[*3D?89*;U8MVQ>]M>J_$55?O<]'['! M?11_G7Y(5UYY).O6WQS=O_5$38S>41=8A[OXMDV,K>>/8+2"<$,_1!&VK8OV)$X9^ M,!/'1UZ.[:4&=@!\AL?2_Y[,7=OSXHE*8X`Q"H;7%>$OMNO.+@F.C^/41PK8 MQ';`XUH>S_#FP@<0W]_IOR@][4?E9$]"Y4QP$,?^!B&0`XC6%RE MWX6_]6R']*L_E<@0NZ&_@A;SAL[4=KD`04KD(_72[1`^R&:G`F(0D2`G)U/; MFV5O9F82,+QNF/T+]HC+=0`/@D@%A5@]T`(VJA[^K/QS_QVP"3\;%@X#YY'` M2+!#DNS9?LF)LPQ3H=##9]>GA<0'@>&($?$Z3T^U^@9W0AW7A?02$DD[(BD!=7
    DU$\WG&#\,8?ZK1NQ5D2"L5S=7,%G9#3 MP:F$/]*Y5%J?8(/=F3IK2P)0:>S65K"Z#4V)(?S=P<@IN`E/Y+QQHV+NW]&2 MZ%+L8+6]"6P_`8O.C4/%Q($B]*%`AM7)8`&#Z(5YZ)!P$V2$+#^W?N(5&)/_MIPTSIN='4=\/G]DH=MGM M&%_(CZTN-8^Z'4O63N6>(^W8]JQQ"=5<%BS MV255TFIA>FS'$C>=6+?!3SN6N!U+?+IDWM#N5X7WV8XE/A=*;L<2MV.)SX[H MV['$I[520P?FMF.)#X'E7<82I_F.=8D,F?2X^?+;[=M,YQ&*N]SQL,MG=JSL M1SM/N)TGW,X3;N<)M_.$]T4X!<3&@NIOYPFW\X0+SM/N-"0W)9-"J/J='56.T_X>$37SA-NYPF7X<)_^VG4M>>#&PO MM([JR\.?RL.7J\_W M5]&IBLE8R4BP[8\L2?GI_ M\^5>_-GJOE-N_O'UX\.?=%P_O+_Y\/'ZX\./K;RZ2_I!T.FWTJG(%)V98G1) M&H!,P*&#)-\)&`KX!&P8^4&HC%@(WZ2@C\GOD6>&%2XTX@@),OC'J_E_4S&< MHVDZ9C3X:$TNK1:?)QCX]YP0A:83N3SDA&-]@*5'%*@6+S"<;+,X=+"3;7GP M0OD5'+3N(8@B\`3?Y+/5:2(.OI\-0'%,P/.NBZ/<07+3D%$LSWIV0)0*$4/3 M=[)Q*UB29ASF`$<`:`@8[DBTOG=G&R)@8H(/#8>_&/M@L#*/0WS&@T??\ZFB M(0/O4!E3CX'HDW/6G+4O6ND2'=A.[NYF@8ITM:EJYV MC2RE9T^F7NB?^Z\#BMWK++L<7^8VB$K!&'1PG.QH!84ELU:3&;GM@-/JYA%J MESUY4',N]))'C>RC"U[[N#'S"/6.KNI&=Q7!\:EPA+-D[C4-+`0I&$]]+YOC MH7_BI@!]9D4A`ZA.'YA`SIO+3SWFO;_@ZV<\0/4LZ=`PYVS(!;EGY\>\8S,/ M73?IGT(6O#A#AF,.L4B!C5KJ.2_J66^8H1_`O@V?<=0G(8[;<@4MOS.?TGN6 M]-2?]VB7*,4Y<61UZ<*;M-!"%H&7AW%2?'UAKNJB9ZI;`]4R]$OE#Z9,_1"= M$UMYLN%!7#?]VI(W-9"=\.:.-'HVYO?8"<#2:*WO5LX<7H!Z^JK1-\M0#Q@]1D?+4P]OPS-E`?QU0KX8%W(Q%NRUQL\9DI7: MTWOE;!^UH^D%39_63%D?/;T7'@M>O7%>@#%=VVNCJ'-IJK31INCBIW$3#A-6 MOU)!`E#>^R1998_\*94G/],D"8WG`Y6/"9+O`,G*#S*AVGN'O\O?^N]^Y"DI M>F@:^"_."'8EJ?T)[^3C2LE/!!V;#F/;K MC\<@^^EODZGKSQBL@K#@\K$;R2X#N+]K?P+?G9%?\FS#NP`1J`[,G:C=A)-WIB9$?T#_S@B0Q8,`$KS/:>R+W`JI@QO@9'-';&$6,>@1GRO!V@ M^8EY++!==Z:\4-`3%!/(U#&>##Z(RMCQ1YSJQK8C$J,ID?&U0^45K#X%%-HP MYN7WL)DLA`EYADI,FX(_$`Q4O79Q/WSV743R5.1-'4+@!!2LFR8_$V<'CB", M)QR%-79\RM]J+`YJP?N/A[S3F#="K/XQ.IB5NO14V;4>O%U461^`/*XE$-51 MLR`Y7(7F&9DBP3$]W+K)E-#IO.&USTM=*X`Y9P)(9[?JQR`"8G/0;`/=.W.8.U)6.B%U*TJO@-5*(>Q\?[K8\."!*&8O M(K.EHKI3447B=]_3G;<3OMQ_XB[5BP^^BN,ZT:P5PGG$&;IVV=&_OS#T[N6@ M^WTK<`I@C#"E7"B&"4Y99S7.3M.Z^>*$?UV,`\;2`JH`??^6L?+M#"Z-/A*) M?MFW6K8J@J]!AYCJTNKMG:7JJ;$PI*?\X(C`W8\M1^4Q9@)U]$10L^6G3=CJ MH.S1-J#K-#74'PP_RD878M/H&]#%?- M)Y;W%6K;;\JT=EG9*R6,)Q/,O*5I*KR>^P*>'H&3)O]$.DVDG5Q^^PZS>R(R MGC:'XC6[H3+BE7OXLJS;@Y\]!0N?Z/+<%+.2)%@HE;<\/U7H2M1/N@[&3U$< MP?_/]6\X>FYJ4&%F:HL$E%EJF$UEJ8#SR7K5?T)1L[=:JEE@L[=:LDGD#DI: M6H&[&C2GP.Y;V/E[-.9/JTU:7>W8=O5V]5IZ3U?<*S]W/[,5U*V@;E>ON["2 M5N2Y2ZL"J/K")K;CP1?/'5>M9*^-9"]`MI]CZB+9UERUJ[?6:Y68NH:_!?8P MBFVWQ=9FNGIZ"MB3':VFK"TTR#%J'UK5DIRI/VX)?R.2;KZQ8.B$3+G#4LT6 M8841UA:,;X6^!Q9,6C1M1--'4-Z.%SK#*O71N:N=/8T0+GFT]W3/N=$\4`]$ M?J'F;BT>=\5C\S5_/?#XPY]4.-QBUFMFS)U:+LMG;.`HCV\/W525[ M2Y@Z61R*E(YE%!4:V)W@2E<-S5"UP:#1''88#DHAQ&I93;E0OM,O->U,RHM+ MHBDS6TN[['1/C^M*XZ-WV;-:-*P99-=&`T]ZI;I*_M-?O5VI\2N=DGTNHKUX MG:.USS?@JF]J:D<[F-U05RG96N?[M,Y7S[UM+,^5QD?_4C^8#UQC-+36^9FN M5%?)?_JKMRLU?J53LLY_XYTE3D\7[A8FUWD#[?.P)JLSQ,T^&N+:95]O#?&- MAKC5&N)HB&LM&D[`$"\>"&J531XMJX_^I"1EVR.WVW9+WE%G'HQ5:HR,%@<' MT):U<,UNODV=H$':D3>M1.WA\/=EJVX-1RCEHX^,AJ\51#;1YFX2J MYTIU=4A/?_5VI<:O=$J>SMHK'&:S5:AQ:71`BX[\^-%E!W*"#-7L-/^:QQ[1 MN7N.J_G%9I6B=Z>"-/T\.7R+*R6#@V6D&XXJ?3!0.UJG]2S._>KM2XU, MD\7!R;M-3;L@TFJ_5ONUVN_H`K_5?JWVJ[?O=S9!W),21.>\>KM2XU1;M2ZU4LNTS13*_B0!Z#9EEJWSS8&+2ZRLAS]09: M2_]0^.A=]MLY'F"A&QU57U/'MD0+_12A',_]:9I=BJ^B/#@3%BJ?V:ORQ9_8 MGLK_H"KW+'#&[Y2)'3PYP#A:43Z:IBM6L>P!ELCO[)]Q&#GCF?BCXXT8?A"X MT?$(EH=GI@0X55OQQPH3!6K*%.=#AP3.V`\4?QHYOAJ@7P',2AQV#T8#F6AZ&JK M8@LSO0S9U*.O9_@,\B)LM&55#T3>H3AO;CAL%]^FTSGDI91&.3$YZ]Q<'5QN M0$A@IS8"9DLBQ>:_K,;128N0P]YK:S!]K`ZKG;@(Z5@MB10CD09W.-M)A%@] MU;!.,`!6.8'LO;E&764(DDC_%&<=5TXBJP.H)RU#^I;5*IE"B8:]VZEUE2%Z MZ\GLVDC@I$5(:Z86I(^]FZEUE2"MKUN,0GIGZLC`,;4$4DB$G*\1TE)((0KI MKQXC<-(BQ-!:`BE&(&=KA9C]ED(V4PC6'=9.A(B$=^1/EV2[S_>.7!UHK&B] M=\65=K4K>:L3+%=S%7(J5=1=^Y.I[V"U\*V-!_ M\H!E1@3"$!YG7FAC$:`R],-("9AK1P!%Y,/3+RS$GT.J`!2E@BI*CN&SXH0* M^S9E0_'P(U/2;RL^R"'%5EX9TC3\;L/O]A-3IH!2?X0`]909LX/P\F`'=2P" M2227(W^(\8<_[`!;S8:*`*D#;U\#>F,WPAK,JZ>`L0F0%"^2BA..3KYRTDA; MR569Z^3*JT1AY!,DTS@8/MLA`T*>3(">.=F>:6'JH,*RU$K,!P&7B?6J]:B= M>P^"#D711Y2[.YH+LJ:U+B6MAED;-%=Y/4ONKBYHUGNU07-26;R^)+29>#;T M&N%YZ@1D,-7.0SLF>ZB*,1[&U@<>%[L/OMY3.GX[OC^OX5FGN%+M]7CK%!_,*39:I_@45EK" MTJ?1Z[<6RVXJE?Z#*7'(Z%8`,?7%_?#9=T7O7U[,?X'=@.$\E8D_8BZ6\8\8 M;&7B>/R]L>T$RHOMQE0GF]1;^Q[]ZTC4SS[A7R^5CU[R-GYR]?NJ\LH("#:9 MNOX,[P_@LU2@C6_^Q6:*'8;QA%\X.)N2[6I["5=:M&V6*02MJNBS=XQ%C4%M M*DU/N7"Z1FB6B5;%U`G5>Y\N5<8KA5=`\H!P,?9HL'YQPK\N/@2,*0YBCN$U M,)#MQW%.RY8)7!K][ZFL:Z!_?WR(:Y^EU"X''<27>6D:J_&U!:5O2\XKM%1I MT5\LFLKO*XZ<%P?,I9$RCFT:K"P,O7MI]0%CYN#2J)9]RO#(,52$ MZXQW-8"J`KNY$A>+H<1%_\;(HF.C[$+7-F"L,Y=^^$ M0]&97_[W_T(V^IM\\=J?3)R(NKA<>:-K@!@XA7E#AX5+W@;G MV$,`O[#QSV\^!/X$L7ZAZ?"?R.<_=R],[\0#?/D1?_A\^W`#'P7U?7W[ M^^\?'WZ_^?QPKUQ]?@^_?W[X^/FWF\_7'V_N"5N/"6.>:!#_Y-CZ?F!VR MMD=/3G+<>@I=VE4LDAS&8NG>A9 M^61[_U;N`G^*M@W"]^G3M8+3*T$8:7U="?\58Y>?,6,1BAM_/':&C$0+2![V M[&,:#/,W3`$^P^Y6!(0=P?N=;D>Y_T-YB&UTFKV+^V<6O/K^"!!BCP`1P.U, MZ6L@`^6_J,KM%V70TRWM4L$1FQY@SV6R[1!P-[:_\KCLY`%E@X/BN*["TV.4 M-_,(B+_'[DP&GCN7RFPS$?WX%W?N3*DY&/T#^EB4 MC,KC[`2?=@> M1C%B!Y\2+SGI`IP:0F7$QBQ`LN3/`1CP4/CLOWHRX_D(5`('#']$4@/4#..` M'G8=^Q%#+@XV;L.C"P@L>SC$Q=*SQ(_"'P/L\R;`#6DO'`8.6K)Q)'&;+H,M MU\0(WW<6GC#7HWI'[?2/IDE+=>5+M6LY)3FO8N_CQY#]*X:W;U[P$S76IGJV MU=O]UU_O;_[Q%=2J$`CJ6;`M-L*G")HQ*@E@T$GL\E6! M4>%C8!@"`<.7`$)PGF;$PW=V\)?CA2#R^;>L[KM0`>)&<5<#2[=6QRU,`P)' MF`A'%WUF&VM&D2H930-D(ATSA$)*\8_BNHO`[,%22=='6&+\LH!:/,[4`2] M7C>U*N"?8)?_9GG-FJA?W_;.F,H^"BKC%):A&X)%D(BP70(VL7GUTG>FB1<) ME#%H#C@UHBA)+/$3+,DU,1*"8735CJG)OJV`]6S_R3/&?,+?Z]E["BAVPM`/ M9AS-Q-_O@TOEWG_T757YP58>?1#@('ZQ3.-'SN^\J5:&WR=V%!/^O<16%G8U M-YA&/N,,S+DT*76X)%@^8OM;[Y^Q-R1A3C!$XM,$N`Q=)(`!Y&.PL"A6*R,< MR,Q)%U(.X0JR(..<6F"!4\.?X5P.D*(%/5.02$,EGL(;8!`R9TJ\#Q]PT&3\ M8Y58$98J@8N$+(1`$H+A$B5C.G_742VKDP@3[I\EEK03<@]`FMR$:ML-28-& M-EG]=E9BC1F=@_(*^H\;W_S8`%Q/"N0$L]P!7(H7+G@E;A8V#-!._7"=2`7( ME\M4W'-/[63VG`I0>DU*40*AAI(T$YE:9?U*,_GFRV^W;Z5^^@+(N1U?^R^> M4(IW">=A0"MG,5^%MV-N)1L7FOD&NU/S?[B#PWT#*GGH3(`,?G[S\?.'-[]H MEUK_;S^56:Q"`'L7NK4)P&/"9UWHO5HCL'NA[_N$KU-++/_4^YA1&][EWEH/ MR$]Z:[T+4W_S"]IHB%)-%]!L^G(.C#MJ/_X5`RJ9]_#ICV'F#X6AN0,C\+T` MI."WYQW8]V#<7B?"Z5J:(Q^],`IBM'>O2%+K16%*S_'K_?OL,8*K:YJ@D%+I M473ITB#?D\JCMLJC+0#GKR^0(-A98&:5`#\'QFIR!-L>SHX>7BEAM#G$WJV` M$137,KK,+)&#X[W07+?>;T)?)VWABT(R=\0=T.4"@M4?S\'`#_EVC)0:WO$X MU:V'`2=3(^-IE=`PM?7$IAL=36)CTR+S)"8AA>?O612Y#%_XZ%W;X?,'VPG^ M&\.+:71H!8CFA=%9"^+`ZF3HJ=R:>X$85,5ZB"W=K!O$1F\]&0P,;6>0E]$S M&RWEE53"6/.AOK5\8_3ZVG+&21=:)@A3%%:1K2ZV@I0M5!-C<>=4),*.`8;LU M8/DG'E@P^>C]CNF?\'T@AL MK'ZA?]K)?^KT5]L-JQ:L&-!B?DH-`"WFK^P,Z*])]""U,C_PZ,:5B!>`L;E@ M(FVI@'2KJYD"XN(KYP#^Y'@,D'0=L)$390;E7(LDY;9:2>\E5NV&)=;P+[AC M#_[5>.RX#O`_>F9WM@.[^(#IXB7X,R]T0^*/?A;>'T%LZDNY>=T:"XG#X3,; MQ6"%CLDL_]4.V>@Z,PV+BGYN^0W4*\RE.M'L`8V5[3*,C9W]L\UMT M8]'!V>Q4/Y]#U;7SV6I%%X(+%/;^(6KOZ MN:U>0#!?\>+]<[^;T@KJ5E"WJ]==6$DK\MRE50%4?9'%;.>.JU:RUT:R%R#; MSS%-O6J\58@JOU@3\)E2+KL< MK7V^`5=]4U,[VL'LAKI*R=8ZWZ=UWCL]GBN-C_ZE?C`?N,9H:*WS,UVIKI+_ M]%=O5VK\2J=DG8N&+:>G"W<+D^L=#7M1GH/%`4*ML\FA9??0G)2DK4C+-_NEBPX-G00G;Z\R#L4J-D='B MX`#:LA:NVFOWJ[4^)5.R=-9>X7#;+8*-2Z-#FC1D1\_NNQ`3I"AFIWF7_/8 M(SIWSW$UO]BL4O3N5)"FGR>';W&E9'"PC'3#4:4/!FI'Z[2>Q7FN=,ZV?>M9 MM"NUGD61RR?-\2P.XC7H:E_75--JKY^74)8%\8WV"LH6QGA7NX#_[G5:4WRC M*=YM3?'!N\ZE<;(74/:I.-H+)755',TN@3VTRFCV3Z=-D M<7#R;E/3+HBTVJ_5?JWV.[K`;[5?J_WJ[?N=31#WI`31.:_>KM3XE4[),\A= MJ/A[[#'%U*CDJ3DMZ6MTF:+3:R]3M*53AT/OF917'?LR1;I?]=HX'6.A&1]77U+$MT4(_12C'\4]_^RD.+YYL>_KV?OC,1K'+;L;+;[=O:;KT[5B\(*NU:%9RF']-&0+0\,L7-O[YS8?`GZ!2N=!T^$_D M\Y^[%Z;VYA=",+X*K.JZX=0>`NI^?J.]H=\%*NEWXNB?WPB.SB*1XT]Y<"8L M5#ZS5^6+/[$]E?]!5>Y9X(S?*:_.*'I^JW0O.XX'&ID[8*"-77L:PA'(G][D MD%KE^'@!@&5]?ZC(S.>8;D?ZXQTY2D"N:]5`O@/'21QV#X9#2>6K%=@6%F$9 MLJE'"\D0Y4?8:"5>#T2NGRQ?^\C++F9TIW/(^P^-LI=SAJ"Y.H[9`.]SIQOK M9DLBQ4:-K,;128N0PUZA:C!]K([@G+@(Z5@MB10CD08WT]I)A%@]U;!.,-92 M.8'LO8]#764(DDC_%,?J5DXBJV-U)RU#^I;5*IE",>V]VZEUE2%ZZ\GL>F?] MI$5(:Z86I(^]FZEUE2"MKUN,0GIGZLC`,;4$4DB$G*\1TE)((0KIK^Y8?](B MQ-!:`BE&(&=KA9C]ED(V4PB6N-5.A(B$=^1/EV2[S__"MVHMEG/V)_V`%V;0QO@R^XK[`!M5R#"BNY*N$X M`9>))5[U*#=Y;T=,\=E"L#JTL5F&'6!LU5%L_+W=4%S7JO-FA. MBO'65U$U$\^&7B,\3YV`*H1K9]0+<>S+Y<#YVR?U?30/';>5-&7FCFZIIGOS`I_("I]M1+I2U MX8@3IJ6R8L="L=,#A&DF_&2<3!2XK+5C>[$=S%H!5$(`=0W5Z+4E8LOESW>M M`"HF@'2R>U``Z0<10.LLH,-:/"%&I>0`QX5M/P;*3[G-;LYD%9_^V&0"VTY8 M6:II#=3NH#D-D@XFK\PNR2NM%5A%$*9K*+!,-#&UAEM,A??\X$>VVQC&J4U> M+Y4]>"7'U$Y0]IS92@V(PA2FSD\L#-\>+#17`VOA;*CT%%>JO3+=15&(J2=' MBI,?F$6JT*BG6AA^9BLU0)WNQM8''N:W#[[>4SI^.[X_K]$FI[A2[?5XZQ0? MS"DV6J?X%%9:PM(;.C&6J[[--6#,U?O>CN5+OSN>,XDG*PIUX3^&+-2U+DSM M?X9Q"&SP/U02.DJ^08'X-TKL.?P#7^_?WU'7R/"-,F)#9V*[X<]O/G[^\.87 MS/*(>N3U$.T.O)X!7K\P^HT"OIL!OEL)YB\[6G6PV]\.2C68$]P`/(=H=^"K MIYH#`G\,JED*NZP!Q1KR&SMP'19&RV`V,YV6FL;:C`N M-',/<)2E!$-?10F[P5$=%2R!0[[./\8E3K4Z9)4(UDWX?P+,95!L"^:6VF(% MF%W#Z/7V`.66:F$5,CM:HM`V0GGM3R:B63A_YNO4]ZY]#SS6$`CE=LQ_CAPP M>]&8#>_L&9K`FX@C?W^L`,RZ;D@ZW0VF2K;WW[8;L_*[`T6=W9KVYA?3`&]P MQWT1,'/;6OJ@^#,;/?B9M2K9AI;25*G%*SF-CUC(`,+J:C@,X*TJ-E3!L)+KT"S[\X`?PDA\#8XIO5;$E73-![8A-E04@!WT& M%XM/7DTP7G7[6LTYZ-;`2H`NN&X.UE_MT`D?GNT([X_"V01LS((`9!W_5N;L MBC#%XLU7_6UBUVRY5`[<]_X$2,89WH'V]:)/SIB!6U<8F#N]\Z<`9NF'-BUE M?RN^E*&M6,_^\B M.Q5@X+RIO)D7))V57KQZT)@'%$A['[,[X#R_ ML.#YY:[[^Z+26O'1O$4.]#X!ZAA]#=DX=I%$;L=C<*PQK#?%/10G.U-2W>:/ MYF``.$?Q$,WUY-^!'Y9\9`M.*_SMC1#9WW:"J+<.HJ7?SI^3?/:K-V+!M3UU M(MO]A#17&:K*+E$4OJH05W:)''R<_NAIS@5_,CM8:M8;&2@,Z?>GM+W\0[#6 MWW[Z]ABXSEO\;_CU_P=02P,$%`````@`P88/1$```E[T``!4`'`!E MZ6U)8^_?MY[FF/)*1NX'\^:9XV M3C3B.\'$]6>?3\:6WK+:W>Z)1B/;G]A>X)//)WYP\N]__?E/&OS[]!==UVY< MXDVNM$[@Z%U_&ORL]>TYN=)NB4]".PK"G[6OMK=DGP0WKD="K1W,%QZ)"'R1 M//A*NSQMWFNZCB#[E?B3(!P/NQNR#U&TN#H[>WIZ.O6#1_LI"+_34R?`D;." M9>B0#2UC>&O^[;S3;/SQ>^/=1:-Y:2]FI\]3D*%C1_#].7P$WS<^L$9O1^>- MJXOSJ\8[Y+,B.UK2S;,:SQ\:EY<-^)=T_^2Y_O_7;7LYP',K=UUV<`.>1DW8M1X?5K?OSX\2S^=MUTI^7S M?>BMGW%QMF9G0QF^=27M4YQ0]XK&[/4"QXYB^\I]C"9LP?[2U\UT]I'>/-]1/F+[1RP+&"769F9]H9P6Y:P<^#3QW`@8W MN;8]IDWK@9"(YK&6V[$BO@9V"`IY()'KV%YI)KE4#L*TH93FG@U]M2V MZ<.-%SR5-J<=`OOQV0\BTM3-<&;[[O]B,P5OA3=Z9/?]>3S7K>5\;HT\$WC-Z&86V3VT' M[33R>^_/X4>]=%!$=C^`[VWH,,>9N]%\9<7@]YD/@ID5TIOA*!R`TR:XS7M* M_EC"^ M]0#3V$)R'?!!QY.[C`'N2_N@$;$`1.)>57"T$7M,)^6XXU&H*GIS/RR@V_)4 MJY*H)`R%B566J7`^+0!(::*5R5/&U10D54$V5D#E>7T/G8\58$W:L2*^"BTR M%Z-2$<>%3!-'H2H@DK3K(7@;VOZ,L"VV6'CCF82.2PG3 M31%74X3.032ZC.(B"<#O5V:[?J'I"*9_I2.@S"`N0:[JM=52$]E2%"M9>RW% M/IZ,C&<(:\[2B^?O/?@[TX,\0_(S(9MIY]3[SXL;^OVFTU.ZN/8;;]S<8=_&!>Y-'VXI$8 MM<&`7V`DQ@538D&0W;<%3)E/*W2T(`0O]OFDV6BLGV2'3L9L=HN25BW.*%N( MB$.X"[:Q[C\-@[E,XROM!F6$22,#7)QH3\2=/43`?ZU(KE9?Z)`X!'B'C!2F M2?F6*.V%P^V\9MPPDBL'UV:I)[6]O@M/MA4.CHN:X>!)IISZ!R%9V.YZGIX[ M3`3-<8!DW`M.V%&]E>C]B4F/>>.TLJV/*'5$Z_ M^B?E^"&%4L$!D=O=QV`+\CG>+;U?S(&%42A"H/XI>3X^1652=(CM;A**AQ6O M;;T+=%,"FI[$?.5L0W`;UY\AB=6_NT(G$E8YFUK5K")0V6U9?[:#AD0DIG)X MM"83E\EM>P/;A?G>*J9(IAFB#O7G.6AT(3U<;YTD4>LG- M>'"]Z\][T/`548=R6`Y9B8=/)H8=^JX_HS"9713TZS0RI[=!,*$6^#&9J]YJ6/_D)%_]`NER/&D=]0&)T_%G MVT=V<,H#=IO6.IV*%WWH#WYD,ZG=MO4/8J'J=^90(DF5&]1L3!!*XPG?#9$9 MTV[+^HO$>4`30X,99RW M)G,7LO7LA%\GSZ).KZ3C`G[$P!R.WL!)FUP6I8F#$/>H/N!AT\B16$**$P83=E5?J M!WZP-K.<%PDPO>L/N#CH\)I0#L:XI#CA7.+UTHWJ#Z$H;[VZYN^ M1:+(6YU)NU5K)BA70/2K?Q5>JG6D%!@@CK_.6NA8Y,Q:Y5O46B5;JK1&9ON7 M+V:O8PRMOVO&?\;=T3?M3<>XZ;:[HZ,MOQ8^)#DC[;L#25OCXO/N\N+=M,S?ZUS[9F]6`@2P73OT06E7+^,*:NQWJ1ZJ[,97-D211$:KWY> M44MJ7A"B[1I*KM]5+8_HD$5(''=]`F!K'H31ZD!`62&!I),2>?M^T"&44GU2 M`L83LH+.#DE^EDU22M!1(G\O"6%)D14=GFG3,Z.(S?*XEQ(4%?#<;K`TZDL[R<;CA4/[PN5#F*>05P9H]' M*8+H=D\=[I&+C>Z,6-5P6P6$^O`&3,N^5E(K"< M'M(0E%[FVD^7RIF&0!_)-N]^*[-<&BJ>/K-^*TI>'Y?;5]DU7`F8V--J=E2D MG"%+#F\9D-`-)ML#5PQV"5+*+@+CL2^M0.5,0:"*S?+8'CZ-2^.0*R#P0(>0 M";T!?+N4+MF+->8T]=H0C,KU:=N"99!B))3U6A*XTFLA9116_4)6FBO!@0C6 M0Q!&(Q+.$3#FDU#6`96`$:NPX\)8=E6R(`UE]Z)*`/EZ5RC34@QA(O^RJLM( M'U_2(??R4PN1%)3=AT(@7EC85X9W.8R+X%K#WM'^N.*Q/$Z5'/;^]TP1U0=V M?X-+'2^@RY#`'WUS9&CL@@=S>-OJ=_\;O[*KM?J=]`N\AZ\!*W47?$:2CUQ) MXJL?QG=WK>&WN-:M>]OOWG3;K?Y(:[7;YK@_ZO9OM8'9Z[:[1E6"\>Z03_/> M;'!Y9Z^(=_M?C?[(''ZKB+6<^^0S7#:Y7+)7P`=#9ARC;[&=L`K"`2N]JXCE MO'OF,SR?,=#5M]J]6NTL5A[K'/\/Z.RSOS=4DY/XX6E31Y0E5RII(!F2C\8)M)":KFE)\;R)CF1UMQAE"U M!()4028"/_Y*$X:JI=C)'&3\\T,S+W^HFNUL(B'CF1^@=]*)JAF6!&<9]V5# M=-7B2.:"PIL&,X()`K=\;@CR)<2U#?7J(H9!(W?.,D&8TT^7'MNW@8EYLE^S M?0UG1C1^;&?NR[!&W;LX*1Q;QLVX!T/]JQ&_1#3Z8F@MRXH/Y%H1KSL6ZN#, M6!WD@(2KQ7Y6YRJ5_"#)@!Z[O9YIP=@TAG$:!X9@?6D-#65T@[+QB\-D#$O? M<>2K7G0?'T]8Y1:P-]RR;7SZL"KV1V"SU;[^?<1BX'#%51>=@]]:>91ADEYB M%."0!:ORC=DAH21\)#=!:#P[A+))CGE/0;:([*PW;^W'XKHJ-`XXVL?+H=8> MS6X,WZ0-8SKAQW/^Q)H?SU-9B/9F;'6TOQYW@8#[H31;X<^Y)DT-'>2,!5PR]ST\./0S?@=\C;=D_?$$HIQOIP3U#8"XOMXM`*5N*R!7'"B)_IT1*?:R[F(\H4OSFI(2_G$P$V;W^ ML(:\3YIS("16.=5G\F/?3MPE*SF*B/BM$U[#^B-(,0A$6:OP7/*?JH@^7\`U8O^!OI$OZ/<)*J4![Y:+CD[X*+9:E^!(AK?'$2\3?` MY36_1Q1/4FJD7WNV\UVW'/B24#-^60RF/2Y[5^4NF!`/O/1RODCK@J\"_IX! MHBY)UZY[K?8ONM6&-JSV9<#4HP^&\'7_5KLS.T:/5<*,[P99O56GK40-JU=U MI*4/E_S-!"9V(H?&T/Z:2%PUVT,(K(3=HA>C93R3T'$I86!*?>,E?Z+*9`!S MO362Z_02W1N_&<-VUS(T!D_UWA*@6$84$H8)F./ZE6*I+/RI:(S'>&2-(,PR MH_JU-031CE!:)1EY.,]2OMSO:-Y%7J6/$[-LU?XQQ=RMY,?)5J2R7RS/*M-E M_]W;E,`G_P=02P,$%`````@`P88/14%IMATF&@``M(0!`!4`'`!EJE@1"7OM.[RT"3C<[!%A,>F;V"^6`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`Q.H@?)7B_ M/"8-6:@N28E"QSM^L&`E66,?/S2>^M+&07Z87`(DC(G\"%.JBAX?^8&QZDD= MB?@A<@N1.B/HH,"T;+]O>N0'SUPA2`YQ(GI3W0^L)8DQ[GTT7]D]+!Y/H%J^ MCX+HNWR=:`9!Y8T"-=RR>Z[O#Y%'QG_7,1[Q-#:37@(_5)[>>1RPJ&RA(V(& MBN!:,A!MU;[W9_G0T23(&KVI/\Q@V_Q296F4DX;,PJ1%*I2?9B`DMU!I^N3I M:C**DA"-93!Y6EW1\5@&:,R*DG!E6F3.)D42XDRNR2=!YLI0'M39I4F-UVLW MMCG]7C.F^)6\TUD(Q;A35;,J<4`7(Q[W]6&WF+DTK M(^C]VB4@#K]46Z+E`_(RPDU6E8_5M.UL",,*\G$Y;M#*"BVJ4ZI/HKFYLH/< M3AE53V+&/[8_[;:[XY^CG8^1 M?K8[32AEDZV7KD?M<\*^8F[Z#V&'L?)K"]-\.B'QQ0FR`S_Z21AQU.J-S5[+ MOVU^/-G"QY9$7?S'+6^V^8#L\-N336%:V1,%H(_CNR<8L#?E=B&_>5/+B\!O M.ES.46W=RW^:XH@3^Y]NAU_#(P5:Q'?CS#UWF6K/C>U!HK3(.[/`I`Y)S6*\_.I$'1011!43Q: MM"\LRF"H)$1B\[`D#K$LY'DDY,!QQMUFK@9Q2"L]$/O:(2VI-P-NB@02X.2T9K-@LM9]I#TYIUG;;Y9`6FG48,L]J$UG$K M1E*Z`N"H=%C".INF3M3$`T$X\0NWH-R8/LD*O8:SPC3^LDB9T+IPQ>C,K`\X M7.5E=W^-F4Q])V$W0):9IYZUSJ>`U)#R4/')F<(V6+O)&'[M*\`@D4V(NHSD MU`4I',E"9[!/$-SXA>@ M-D,9]0`'_O+I834A[OK5)R>]Z5R(Y08"872*0:6#@XW2K1L9ZM&7)FY/#)8#XV7U@Y!X[JZK*8 M60OAB8F,[2L^L8BACL\QB#)@M!&%`I0!,&-339-4.0ZY%`*I$[S`\H8O M.OY$O,LV+>J^TJ1&>S6J0@4=.&CRO.LFHE+V#T'7\0,OW*0?Z\EOD!/N=3;M M-X^Z16:P\AA[:_-(4Y?6HDJ!E.==>12"J11QHXX'E^+10$D/"C: M('?$59)(/JU`)@4O]O!Z6R$BTZ15DDYC-]M>P301:E.661.0 M)<&[:/B`\6X33)'P'CA*7R,]E;9=)FKHMRNRA+3)::?V?=1::E/!`QXTO[1M M+U0LG/LJ&'4K307'CHI3:7M==G9W<)-0T3;`X_VY3RQG-79&OZ^TQ_/[NN@3 M>-10K^7,HA12]KG,7N6JD)&J`\B)M&TB=$A\#8-1M]J,<#22DM8`R%Z3$9HB MZSGWM)\FHH+TL#0!62II*;O\3.+;^?7X'"I?/I$N M2UV*BZD$DBUXYA\ZVE-TB9VQ>H@.O[]Y8`_Y_F^>%2!W/@?:9$8IZI*65QF0 M+FFK`+'M0U%@FF6O5%1';2K2H8.&ES;_CR'1R;61X5*1P\@*\52M(`TT#4`V M\D[^!=T0M'2]8/-8%3DVM=D"B7O?!;751!?LL*JIRQ@W>H@MVD4M);+51T'7 MF;I+1-ZH@ME)%%.>C7VTH/5CBP>_G.PH@C_S_<"7VG+<.7PAZ(;;PUU(O/\H M=T+!2_[[B-LMXZMVVQO\)N$^8M['NA/8K\AMVY9/KGI=>0C_I3\8ZQJYCGLP M^M+J=_\WO#U9:_4[4N]2SO5N=T*1:ZHBX47=]W=WK=$?H8-UO_2[V)M:V-]: M[?;@OC_N]K]H0\Q6NZM+THOVW'<<>J-.A4ZNZN[VOV'/&8S^D(,LY>7O!,@& M%22YBGLX(IZ!6RIQ$M)HA\3=Y2!.>Q`\`?F4"IEP-NDXB7=)_;5T3WN3/3?AR%6.3"!I\03&,^H&"\W?S"P9?]H MW?1T.0`Y7A5/@#VG@B5=WDCOA;WSL$4<=SQJ]8U66V+?QO/8>`+Z!14ZZ>12 MKH&7,ZSP/4*>T."2/K+4PP'R[JX[OMLV03Q@DGY8[\OKA%GOE"=@`P-B(QQ( M;@QL;Q*LZ*1?/O`XR!P/&R+&0QQQ;;XAR:]R/F`>5_24/GIF573]!4EJPD^? M)S2A#[&).$`R4*Z'T!.8Z6,L'!9(5H#OB?2$!O11EQDE2%8B[17U!'SZ@$P+ M&B2C9CZQGH!,'Y;W8@C)>/G?6T^`SSLPOVFCP#L:>^L3'P^U_,4?:@$6NL.W M28WP9=+$DZ3T=U=(%68-19]<2<4-@QTN5_3(*O_N[3,RBNR67=JAGF_@RU`744K-MF1,']%L M99/]Q]1=0N%49O.^>?0@>RK_D4T+RU;7&\2J",8B@G=AP<_5\S5J?@'J,I=# M#S`.4:7I[JTWD'6(:!/-P!M9B\?`S]9BLXE4EVXAFD$.$-NU7,8>BI1$?(>\ M76/[?:(*[FKHB;93('W"3LQK/VV$:UOITE;N=3^PEB09=^^C^@9%K*0K!OC[EV8E[LW]-O[GM;K?M/#?1/CK[K6,HSP6>J-\`.G)&I] M%)#=.T/D;39LDY&%J;B0E$PM7(#N#0Q#P[2'J33L!L;7UDA7Q31<#MX4D[C1#SU+*9229IF2"I@XH^9D\.VX(9))'VH36Q:A/);=J8,\JG\SZ<;TNCDP> M:8=:#B]()K=JX'JX?#(;>PB[>)3QD!\,G.QD\DB;7%223&[5(#(OY),Y=@/3 MSLI9K-*ASN,6I&97`XB!*\$,[#Z-M==SQPJ,W5CVP6=R5%0L#MO4IU&,DO#$ M7#+55QNXADBBLPF=-"H0XHA0$219=*P#/'6WZ64N&!Z:B>:L8B>-"H0_8I0$ MJ18="0%PR1&DU#&4J^ZD48$P)X,F(#.BPYI=3/&3Q"PW*M#O%OG$I%&!F$F\ MPJ`[B(ZQ*)U)WWT.D9#"5WD[Y<)R\2Q(%:0DOX\IK_#W768R1MXS[:J@. M=4J-43UB<>?Y>@%QWYJ<5BLH$ZTYZ"D28[5<.IR5Z"G4;TU.:2OH[\Q3&)J# MGB+Z&FYH"I(^X/VWZ:Q,[Y5X?*YY7(XO3$XK&.L7UA?T!=EA/S_R;=\GR1-V MY$].*SA]**@MZ`6RIQC[2[N"W2#_!R:G%9Q>%%47=`39"[@9@+>>/,N6Z0@[ M'Y@T*S#=$*TNO/=`04>XD>X)-Y%MJC7'$*,OZ`OEK@+G7AZDY*J:%8SU4K0! M69(8R8$SD[VE+3PSZ:!IM/S1%#P%S/.Y2;-:<9X$Y4&7$1WVQ3%'>A1M[(5D M3IH5".X$:`@RG#N>$W1E.>465,<'/F@(FY=-L612!%;TV$<6[<`N]ET>XZG`$ED1U2`R/TY^J$.FB@@FG(/"K"*P!_E4,'%8BDQ"@)4BT[LZC\UO8*!%_B M%0;=H8283)&M[54XNR)(2Y!MB4%;I1/6%3OO(D%YT&7*BO\4W;EK6K5)4]E-;_SP M2TJ%DEUJY);]S71C[-X@)WRKU+377D,2_;?(#+`?`71D$:$X-=E5`=N*8)H2 M_4&L/;_!"E^O:0RQ%.3A-A\^]M`@28Z+>"X-[ M*H%I:85V<45)V!$V16B/V6:<-A>,O:K\,A0F-ZB]\/6S8(F_=C$>MOM%JE_PPVG5M M_^6Z3ABICDC/Y:$SG-8HP'[5^_#GH=?63\/7SI M9TP>;M)ON^WN^&==>90I:4CGAF:^B&!K+>6=L!53IJ2L`PT:>95SBN?8'>O9FN&YZQ\6 MLF<9>*+6KQY#L!HE91)8H+ZYMAE8MA6\YNOYF'*JRQ6LCNCT07'.,O=_3#GO MAC../E!P%H*Y=B6?D-68M' M_/G6,_+,!=HB',S74S3_"YDD("AN5?XVD1[ZMTJ?^.[T+ M:R&97O0`:_<,J4 M6JI3Q8.^I/0FLO+`!YVL'.[4KR@=5BY+2::F8 M#6X#!I-*J/Y"`CJEIA-I(J<"3/ MA,72#^D1X,-N!+C)]PU60;3ZLZ/;"!&SX9^W72?PS&FP,FUR]U<*R8<#I+CK M'-HPD$->BW7(UF+AH04V2!=CL1S?FH8)9G8WS:ZD.+$\X%GYPA*LG])F4VI5 MT_Y\WM\XP,-=U[41:?/;/1?)482UL^$,W-DP:O6_Z-K@=K/%P=#TW_51NVOH M&CGFJ'_L=/C8Z5#9G0Z)]A$VG=0]#U`5Y7<_L'4M:1_$/@B.S#U\9IW;.#[V#)9]TX;K#WEF9=]G6P>^4FM`Y* M9>O&<8.=KC3K7G):]_+@6X;R63>.&TQ)2;/N-:=UKP^^B2B?=>.XP<22+.N> MV"IHW01N,.$CS;J9/`X54[60:^ M:O`9."HW:51LOI8$#D_8I!F8LW^(RI7_YF!1`R>`@P:6-&EK'->YNHBWM_57Y*.#^?I5AWL'?\5^M9S%!A=@[I1:!WM5CR\GR84>8N"P M5['EWE.\OT]A;05&MDSTIQ3V"KDJ]OK=&HU1]_W,[[DS-UV.?F)74MSD/.!+\FT("O.( M$[M218W/B!SSBJVFP8LU:345)BJ3!A!OH@^Y)D)CKI!?80M#8"%C M"CZB&GUZ,K2"\%JCES,BA8MS_(F>*HQ,^+2^I6C;(FYSM MP=U==WRGDT1.J]_!?^^/N_TO>K_=U4M\K[+1J!FK!Q_]N<):ZL_H+465HMH5 M737R.J=Q?V-@WK!JFOY-CV>J]M39^"OY#SGNC7_R_U!+`P04````"`#!A@]% M$AMF=5=L``#_)08`%0`<`&5R9V\M,C`Q-#`V,S!?;&%B+GAM;%54"0`#:G/N M4VIS[E-U>`L``00E#@``!#D!``#EO6ESY#B2)OS]-=O_@*WML:DV4U9)>6?M MS(Z%KFS-*!5:25DU_;:-E5$1"(G;##*:9"A3_>L7!V_BY`&X>L=LNJH4[DYW M\H$#<#C<_^7?OF\C](33+$SB?_WAZ*?#'Q".5\DZC!_^]8>OMZ\6MR<7%S^@ M+`_B=1`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`>,\6WP/,XG-&AZ7&#)2 MOPDF)0,85)EHV847)T4U+?H+I?XO&#@C:FV36.^6!'0N\215LXFA'A$8W,@T MZV*%TT'R0XOU.J0[B""Z#L+U17P2[$*R,%)B1/08J/R;9S?1T\4[^;*8%G)\(E#H<8 MUX2E#3\8E`Y0N@O:4@1JRH"!UQN:K7?[B.ZT40$3>$JS,?B!Z]728XS@NK@/L(G M>X+:./_PT\=WUYB8'N=?XPRO]@3*IWO\)8GSQ^A9B)AQHES@:0IC*=K&R/&. MQ0F4[R*524,[+@Z]0BLN\0!1F?^$]J6X`_2'#Q^/T'J/T9:+A>$03_%]?A%G M>;JG?EVQ3Q41NIV,98JVI]PNE7?0:57K3Y]-PHDVGN;N[^UT[L],E$_W9V.L MROV9R/&.Q`F4-W9_;[ON;T+/)\'R21(_X30/B28"(]]W+6R0RT$]7J8S=$]E M?@7SL0)AX'TB*[K`?]\"]ZKF0F&<)^0/+":4T9@0"G+TA]<_'1ZB'4Y11O=2 M?#A\(>_C$;TY.F#GY(Y&13G2KW"^W)R&V2K9B\V_2^IP/-59O%>:Z1G>1LU4 MKTMJ>8`Q3@G\TUSCF%CZM_W,:;#Z8U@4.ZJ,Z-Z M7+YKC4O'8U#\@HJX\\`Q9R[3^QBS-5\[IDP%PAY#EE98CYF/_W30�Q(6F- MG+?H1TJ7;-"Z&,WGPX.#]\6?WOS1Y.Y\O"GM^^`C'SOFWKJZ_9%%0/,V46BI1Z3!2,BG/,!J*GI)%*]%ZB#'"`>#]ZDM,EX,5*OO'7U:O8CO+`T6^X=]ED^Q@'_] M[N`-68"W5_&'!^_>O;99Q0=D01*N,'\D6N,L#GB)4B1.T`F3%P/-T2/^E?HO33$,%$8 M\$VQ@#AX_>%#\:?7HO6#M_#%19;M\?JW($T#6:JJ@L[9F%&I60T"$1$,5"LT MZ\*4DZ*2=J;/OMRS2]IA_%`^2)#\I*1T]NG5JE8?7TP&X_,K=>L"H":N0#!O M%A2[NG&[O\]6:;BCP0B%&Y#3.L.#3MT*$3)"&)C0:-=%!2-'+7H8*90%1I6I MY!T:EXF30O6:.9,M`N_04&G5A41!@SC13,[A.`H(3!^)OMEU2I8\\<.79$V^ MEF2V4)([0D'K'0V&"G:!P3@09T$%#V),'M)ICZ9+IS41Y3>=UMQ8 M=3JM7@X,;(Y3WB*=]JASF^#UP?L/'^'=)UCNI`=V8A*74Z%(N>9,V/S=.[P4 M2O46S(QDWFFP7I3+?5:?QL,>2>)EN@3>OZ]*J_Z.*"_IYOJ\#$*+51X^A?FS M="LLH'+WB:4JUA^Y1P+D,\OTDHSDDG+>U?97Z7Y/1S#M&`^6-,P&1ZW':5[`[4FL**-]6 MK)9DM%*Z6==1V>%/;P\5Z^0^D>-5E$#!SB*J00'C&\O4$B^A,G:-X'#6KUSZ M?AI@PC=$!ZQ>-\OH'7][M=H=&(B)(2%"J:%LNF9!03SO\KH&[%L35_#6HRMX MJW4%;V&Z@K?&KF"N+,-:EWZO_,YDB?[. MXQ*]JV#_*[^#N41_9[Q$?S?O$IWH\M%D7O[H<5[N*MC_RA]ASLL?C>?ECS// MRT<_'>K'#L5P3N1_+707[8[FD M`/65>VHIQO*;C^Z29PX)IB9*GC$3Y3-YQL985?*,B1P8Z!NG_*CDF0\?)BW& M:7C;YV-AVNUD]XUM)7J[XS/,=.GU'CMQ,.`^B0U=U'_\)S3/->"/!\2D]BW@ MH]<';ZJ_"6\!0RM"8G;OUX+9]_U-@]O`QIPP1X7M'6'Y74X7]X6;E0`ND_CA M#J?;45@<*=`9/B(5,Y9.'@/6.Q,_RX%!L\KP3QY] M@G!C1[6CXJ9T"`,>!,H;#'Y15J[`^BDOQP\,-:WK!(Y:7B"B\R^M8]3P!T3@ M.Z4OJ/Y&A_VG@[?O.D/_4#SJ>?$D,J#1,Y%=ET\".GS?N1J^D@>]F.&K?%&3 M#5_A4Z!659WOW9W M3G+4&RH7,<$:SO)E;'E.8B;*YSF)C;&J5VJMH)N4/Y5?)4[N3>?NR:WYA0K/!N*]0G\H>]`-48L),(=C0, M,L-X7/1JK9:/FZ3:ZIN#]^_>R583XPNMWA*,%I,-FVI:9`%-A!::?_F,::;SXX.,NOEX`F::/O/::-=A44+*XAIIKUU%(M MKF=/-7MODC;ZWF/::%=!P5>&F3;ZWCAM]/U<::.R3`Q]#?=_#^)]D#[3@(%] MDLX@\=XS=D:\%&WZS@#9,-`\O4&"Q)Y.95[.J`]6Z1>=1^\//GWZ,-^B<[G* M$[KD//K@[-3)\BM4<<0Y1G%/^`L8PY(7,L$([DA^Z>-7;(YV]!H&F@TVC*\/ M7K^><>Q6`1[:9QN^XU^)=/P.%PUS`(^V1WUJ9#&$OY4U MJ^EH_7!P^%$Z6(&<^-J^OP51-9IM]/6DOX31)WDE4XR^CN@7/_K$]NA''^.S M''VO/QV\[2:Q_^,,O^-YQ]_QBQR`QS..P.-_M"%X[&`,OCEX^_8UQ"%8!:0^ MF(3Z/G@,]745[(?Z/H":'61J*4)]'V:OW/+QR*0.P)&_K]Q54%`'X`CD5^ZH MI:H#<#335SY-5OLM\7V+>'T6YV'^?!%ODG0;L+*[]UF>!JM<9(,9GS,LV)A1 MP<.$"09B+#3M@JAD1807<6;4X)ZR^#V9\'YZ2)Y^7N.0U[TG_](M=T_^]#O7 MX@8_A%3S.+\*MKACM9S,!:1T2E($R6B\`T:C6*^P'X=$38LHL3]8G!"LID%T M$:_Q]__`SU+C>G1N@2%1LXV,#A$@:(@UDV"C($:,&A%R'^@H_=@=$2LPJ_VS M*RR(E"HAT/P-Q)<7*"2=+"B-SZ],=F1A0N:Z]2G9&BELZ="Y_NY"-;L`:!&! M0H)(,RDD.#%90JP1)?>!C@519$V5.8^"!X%=G=]=H4&H5HF"UH\@OKY(H^Y7 MKV@0)?+QK8M4 MP:MSX(N5WW`4_4>#A$@ MT(@U4X&EXD",Q2-""F=X@W=)FH?QPVT>Y'LY4&3DCO>P2J4[6UDA+2#T*!64 M@NB?,U1Q(,Y25H+QB":&YA,RCSXDJ3P"TJ%RBQVABFW(M$@`(46DER3RP4A1 M2>L/$-?[^RA MZ3;&-'NHF_!YQ]X`9;M@K%AIDEO%C$IN])>2?W1[N6G`N<@RG&<:&':)7`). MK&`36FT*,"`2JM4[B6!$D*!0Q`>,$-&C=0\,B;I]?'0(@<%$K)WL4(+S_`(# M-B=!]KB(U_0?9W_;AT]!1%3,%OE)D*;/9)'_:Q#MN^=:EKPN865E3A-F1HQ@ M8&>C;0^&A`D&]A8KEF2>W>`5)C;0G'><%Z-$-MZ4+$X=F('R+3^FH`>#*P,E M>W-@P8+2BN<`Q7C26-1PB%W$3T3U)'TF=DAL;I.XA)!(N29DFK^#@8A`J=X) M1DD""@B\Z%V-;+6C4="[A8A&[39>),2`P*/6L(^DHE1A&*^2+6[X&!BHNDXQ MK&*+HH`@8UKK_36/F8W^;0&<3Y33F20)K#+,+@/HS`/ M<4:<)4LT>4RB-4XSZ@CS9\TQACF[2\38&M7$E"DO&!=DJ7`7D@UVYI":`OX9 M<1'HQU-6/"__(SC0FIVVJ1@\`=/@W$U.#1%\=B=P#48@QW!E%+THMD[&$OE+ MNL?KOHV:T+V1!!\')1:FB9^FI2EDKGWK'@`N9+)8UJ.MVLZ%7 MQWQK;B!]MT4F&3;>;K)ZA]\P?7LY4(])FK]BO=2:=;SB9NL&MF,0%0I[M:.2 M8?A4]9N0G:QKF)PF,Q@9T,IB4')X!ZB5FI/@$@@2@UU(=VXXR/#R/@H?6'DC MS82N8W*;5F-B0#N?1L4!!XDF:O8S:!@3BBA7"3T82#-W=-Z]FZ%+@^S'S)U7 MJ_$1#*@8[RQ\;R#,]@F>MP/:T)SQTK]]WM1@`P>;*_+M;",@(AY/8)*K+\%5 MGP&,)S+1LA=\HSV3:8]F@/$0R;Q,*-!"EA\J%$!#0O6YYM03C3M MSC!?P*FE]3FE^EP2R)KIFLC"Q%OR8UC5Q2TAI>-$9)FJG33D+AD8#,EU$Z0@ MK>T`_>&GP\,CLMY)T1-E.T#O#@X/#^G_HXQ7V0CV^6.2AG^GG9!O<4J/ MQQ=HUY7SYEV+:8VS\"&F4?@#]/K-AX./AQ_8L='KCT<'G]Y_*LE"6K%NS7Y) MZF(>!XC\AG=X%3[AZ/D`!0\/*28+.8RBD,!]S99T7%_>;/+@[>&G@X]OW_'F M'_5_$C%$2L[$P!@7C0HHRMN,/3*WL7ZQDNWH?IL&S%B0*-9;[S=Z%@I&P1&' MLVPO/FX/#3$4/`4\(:'`)9&9W;_7VV2L-[O#[>YU]C MKGKQ1]Y7H[X@HW_E`T1Z0O9@XR6CP%J>FQ'SB8^8F/G/M7+G/-X6X5(%90T> M<+>F%NLU*Z<11-=!N+Z(BSB`+)E"1NTTB46MLEHE34B-ZC M>A7&:,498&#IM%@3D9%$DV+8,J7<^3VKSS7,6%VBS,:8)N1,^,#@ST+97JVH M<@&\:O#"P.$-S@/:UNXL2&.R[L@6J]5^NVLJB`GKR0D>RU&"0-[_7"&<=S#=R#)+(`$*P`IU4\W"-'Y]*%;" M!NGBA2;*+>2!A3Q#;;7Q\!=SUZ(=9+L.TF7*2O2M69CA&J=LUV04H9,S^PM\ MZ@R2QT)EG&!F62MUM1'3*DH$$99%^^4J5&7T1OI,_F`H,T`.ORX'4-A)U-3" MK0X[SG3%HJWF:16X[UBEH75V?4*G;G590D;H'1\FVFE@41W$'#1.6N#Z(]:8 MR,87E0R^_5!;<9T/XM3>\66LHM;W\)@O1%RQF5O>U\&4R?,YLZ2O@QD'4)Q) MU-3/<_)#7A@`;)R/6"[^C3@]'8/9+/L-V,"`TEQ7R?:J6>0KR"&"S'!YWTX[F&YM/Q.ZE`LW*;575,F7;!)2N&A2+M;:2+H`M%*[ M8/51J_85FL12*;7;TK9*E=N%;86D8%"DUJ]?U);5LJU[C4#K*G*#GW"\EV:L MUS^[/9=L*]4^?>2_@0%$1Z$N`F[.?CV[^GIV"^-SGR19OMQ\3I)U=IM$\IFG M0^5VQA&JV)YI6B1@H"#6JS>S+&_OT/(HNN;Y?G%'0P$+':>%JG=JM^M4R8C#(T6G8JV9]?7:SN+NX^HS._O/Z[.H6RERS6+/"+5EM MB<1@$:';A$^9HNUMG>%:$+"]@1]Y#`B>QCKI+G&4L!?4<2Q>E M?3+'Q:R%2G8*6+=HP"!%HIB@4'5%AC88RJW*IEJT)582,[]XB].G<(4SM9?B!3A;?#`PUUL9FJX@/:_'C=;AL-(O9>J) M\RTK:G0&J_=0J1>/0UZ2+:G.WB:E%]#T517"IB8#"IR>@KV:3'3[?WZS_(** M'=SR"LC.C?5'NDKBI&U+@6U=4,"0V7EK*V.#>NVNM)Q@YCTK=7N!A+L_G=V@ MBZN3Y95+UC35A]-`PU,4;4.U3%!PAUQLI*$5@4T8:BN34J M)UY2.)\FVZKUYD+^,QAX]'42-WLLFLK^6$!A]*0F2?;_'(3Q,K[%>1ZQ\_[E MIM,?HF.&*9.S]']C`ZI[`%H.[UBQ4K,7$R!\B"8"59RT)E+0Z=D!P[405ZC= MZ'5HG%8!%ZG7JO_=)("UK1.IUBO\?7:'Z*8.!AC*.^]E.NYQD(6K1;P^#:-] MCM>:79PQMTL`69K4A)8AJW=?-4Q?&1+1-=G0D>WG*#%U2DZO;C\>G=V"J16YF\X?'BD8^:)[!@>\-5^ M>X_3Y8;G`#=NTF@\HKT8EW@<:F03H+8RP"!VH.)=")=B:,DAEOO-JPV"*S%H M:BX;N"-?62$#(I1;Y@W!,1/PXD#HD*$ M5%3P4-)538$42HH8+12XZ._,^;LHI[L=Y^U*W`ZG8;(FWS7-50$.@RMQQ_@A MC.G6`!T'Y(<5/D"<2P6/64?EP!)SKT%^`+F>!A]BL9VB!::R2S#-WEMNFGWP M[A)1#0Q1]-56@N-NP;:F=3H&F[)[GPZ&ZRS(R2R$T'`X;PH'`!7U!!@B`!P\>WT$[+E?%CC5O0&B3I&@59(\S>T<3&Z2>T8(9 M%/[$'M&8\^6@3^4)S<`WJ_N3J7V>I"?T[U'$*E$M-Z?X/I?[P4%BG`%RA)$5 M-`?(@`'2X8K;P[461VG61.#,OM/*.*D3'2(%)GC%;M5>Q`N$[CA'*T*N+\=; M7KL;Y&Z[S!!P*C;(!)YM3O"H%*IK"\:L$.+/=99F#'&8'5Y(\+-VCBW&%P.^ M,8ZPQMXTSF^JLD@Q*XQP'^'*ZM/P*5SC>)U=X7RYN0N^2^*VAKQN2RA9F-,N MK&3`Z!VG0[3MMY?"6]K;IR!'*>;-?O($W>.8-<8((K2J(TD;'.3[E.%Z53_7 M<9Q3-CB;4;/&6VD&T.SG>@NAWIVP]0O0>F=CB=Z'PZ1F6"]L6['6YLB@<=@IC+?`FCPF[)8BKPQ8^)47L]TR'A+>[6L+]S"698`$XOS_M0L#'; M**RA$P9["%A8,`[^W8M2[B<"A9TVOE\OQB?&38U405LG`RRB#16?&LB.W/=O M09H&Y,%TR$9!V,N1U)-[`*94:0$`>[30@"934`6H;P4/HDVTDSC&*Q;Z_1;F MC_(E`8Q@"(UU7\19GNYI'FAC@71<;8SK$7?.M\62'?HP46[;<`\WMMV6VUZ. M=YQ/H'P_-5$5/'EY@X&MEGA6[.D^#>.':Y[-R18QU^0C/`89<1&++,.Y/'O= M2H;S+LVVYO6R:TT%@`'\$*U5WG[5:!;"U@Y1N*)E)E#PD&*63C_5NG=65//V M3:-`+1$!`--*XPP@+>2'CFB5TF,!/>OZ5SE"FPO^>E\K#5T,E^5LY3S6W&I9 M/520=R!/H;T5HMO;.[?G.*K1.@VX]:)\8]O46!VT=7)`(]M0^2F!#<-M-S89 M=/CFZ]*-_@-C76VF^_ M)&@;*C\ILAW%FQMM,L>?%5H+\Q"K'FBP())M*0D&PL>J/P+CW@X'C2WE8VZB MUU8*@XSQML%C,,XEO5B,M]2?%./.KNH3B](]/1[=TIJW[.[!76)Q45_/[^4> MM*E9PFO0.F88>!V@\3B(TB=0LNH1#B_LRPTTNJZO90<&4OU5?0WO2X*H:?[% M((0Z6A"7D\7YGIYA%I<@U+.,A,7#Q*]47C"]"^EA(,Y,22N4;9@`]Q>BA`:8 MW(92,D*!E_8>E(+K14#-^`:4'G".?9B5]X+@M\P]%G!?-<)+>7-/`QP3')=D MZXQ>A!L:[8"<>Y[&AGL1K\M42LO8H8#3;Q!%:HHZ8M)C@X8S`UV-X4:+$%=I ML(Y*'>DL,?!D2D8PJ--Y-077R\#<(`\G@9R7DQ-ZG>P&KW#X-.RP1,SO/7:L M,DL;+A8Q`X:C6F.K>9=5(4PK09Y..MK6V#E#&3LP1%HX1C'O2\+CX&5@#XZ0 MJG&HSMS+CC3M:&/G#8X1!"5366VH:;ZR6(IWB(]6O5^VGB+;87B8C<%=7NS, M;O?WJY3\)WEN/3@O<9;]EH8Y3C8;T1"W%N',TPXTKO*VEOS>X3A"Z2X0"RG4 MZ7)OF]6"6@XW(K+0-RKL%9%&Z?_PZ>#P\-#E?=(RFJ">@(0,?N^4=A57WRHM MJ6'@S$1%HYNES7".2]2YN'?JZJ<10$`LE1XZ+DQ0QZ7"SXC]9MK.R6#=_39:-E% M7I.'5T0MKBDT%W&>&LM8-BIVVTY&]2'$>O6ZP^(<183`5]L>FTY)/EKUG,7K M2]6F1:1?]QV?L5Y]=7^>[$4V2GH#\.W+M=1]@P!4C*/HLU;L-UH6:3K1&O)Z M:9!G8HZP9YZ*$8Q_M=%6WEF/S'9-[G]&G!_]I90PNM^>9#G/]J[+S89'1I9Q MN=/-^EM=T3K3BMW9XGZ`4=4:WX+7.P8'*MQK9N4L#BR3M*E9O&5Y?Q$NR0"';DOAALS[G%[9_0^>7RMUMT?K/\@I;79S>+NXNKSVAQ)=/@?YY'.8W8S/BR6H&>&9X#9I3-:%POK%0_ MBM;R3\N'H;@(>M"_TG^GF4%H3YY"B](EY7-04#T(R&@]Q3MB1,C"88MXW0R; M2=ZVDL-M;46MZNT2BE)R,$C6Z]AO-%%S_!PTZ.\+I?9)A40QLE/9=8%(^MOFK M.$77E6$XP?8!PWD8!\2IQP\G299G9!B>AAG7VNA\0L7N[S!(;Y3\7$C."\9Q M6BJL/2TJZ"F`>Q5D86"VSE_ZG"1K:N15$N/M+DJ><761["X-XBQ@Y7#E07K1 M^<-(P4ZC'Y.]B-XIT2BI8,;&9*8(L^)>W5/)QL>J(Y8>=!U/9J(@PG42E6%H MV9C5V3+#TIAJ<6'(YQU\`Y3MPHMRLQ4$X6\EO,$-(W<73V2+F3_BM-YGL@*Y M9`1>AL%]&+&-(-FG:L(W([5+][EQJA!W><#C%RILKVE=;GC@^^K+\A"/R9/ M"Z6Y?AH>O[@3J*\&7(,!,-+Z6O:R3`N*9ZC`ND[Q+@C79]_I$MG*'$N2WV[<"N($.940.(!DL7%R3Y-R>!0]MHP8P6PB!0:8[!2;/'! M1Z%4YRX2&2%:<<3D\3H&<)WD0J6!LK7?O,L39'6+) M.U]OST[1Q94P_GMW" M3$LCQI)!FS]?$P-R,OG0DXT=/99>K-"PPZC57M M;JGE_\4O0FX5E:L(NR%GV(<5U^>]D`Q#I8KK=V'2Q:*H"&;I54-'8=K!0$`,H&AAI`6B$%C(L> MK+IN'7Q^<;6X.IEX'2Q)BR':KS!>9^?DV^JJ7HJ2-.SXG27(##&KRI*Q8?:. MQJ$:]\\EN`A$WR(*)?7Y#KHM.UM531U@M-'*CE8;K)M^)6E^A].M[NWH^;U@ MU-0L(49US/`P:JBQ&J.]U-HJP)M1.:]R(@C&FJ!I^@TF6K(K0+083:]"E1F+ MXXB!5OE.K$!*[QV)%DKVP,>):$YA"VVP(7:#([+-6U\':?X\`&Y]=@C0DQEE M`L,N+WA(2A16P+/K&"N_^`JE7!CY"Y'F8+H>E&]M*<#+A&V?>VW%[1V5@U56 MS]DO*!O;?'LW>G\(=>,^;L/^(F)0$-B)<`GA(<8U06S##PO&`S07`OE/BZO/9S222B'MJ?*? MV)8%&:=I^DR&9*];@A6CE^J,MSE96-E_/YGJO4@AK0L1Y.@>/X1Q3`]MZ)D. M>_(_YC<$6./13G'9%\3QVNS;.;P3O-_M^%W[("J+9EW$FR3=\HH2FH)FIMQ. M;_?:F=2ZPFO&ZGVA/DS?WF7-T MXN+J?'GS97%WL;P"DI=S$>>8O,G\.@C7DA?3)G&;U=M7KIVK6_\.!D<"I?HW M9C@)HA<98.#@BGP-`OKZ1#E>5RO[BQQOM8>MYOQ.MVJV9K5V:J;,8+!GJ[&% M%[M:7C6/6>MMV]7I/'F'DN!8XTR.%^FFM<4(#B*#PD?FO,Y"8K;F5-$P4T;O MV!RBK;@!5,@X60.+J0L92<%&`\&LS\:F>HS1LR83G;YTGC\)]2-!,#9D(P/?#@ M(^X\22_#E>`&K(+.&3)5:E8H%!'!0)Q"LW[%P/N\ZMQ?T6Z+"<&6015?!8/3 M@GE:Q5LE\J34WCV"L8J2>Y8T*EER@"N>ODP?@K@HU4ZR4U!\#4SP`S;&8RK'>( ML[P[0T?H%5K>?%Y<7?S_+"C'=K/%%='E%9"#R-OP(0XWX8I>Q^JY%-U`,F5V M&E2V,J@54S;B!`-E*W6%`'U-`'K[]7EQ`N;@O*H'5`]&;84]!8?;@+-6]7;\64H.!H-Z':7UG%#-`FX= M(C!+YPK5+)YAIG1[*GK(0#-R<6^(BZ,!Y*N[Y MW]"]Q]V?V3;D[']_O;BF1W$S18999/PN$6RB)%[.F,M9U-C8(J5E3SSG5A@1="8*63631;NBW5D[N[C*!7NKYZ(*>%`1>]@D*G M\XXZG<4=<3*WS.>0;>39U>W9[0&Z.IO+[_3+SNF7\#:,S@!D94@%)2,N&*"R M454(K_<$7HN3DYNO9V0Z^\]K!BT8JRIZ"F<W]>'%^>PB3)4MM.KN"D]=$J_;@O^V)Q6=/BF,R M/;G;"]QJI=LWML6T8#"G4;!W:ZPB1YP>G'OL&J1=E,KI?8)*O>B4$8.%E9G7 M.F*IF<>W9"U)O!8ZHQE,0#R5-(7Z.,C";+EIIE$?[[,PQEEVBJM*8KPWE&6B M\4,:DL7*+L(9+]'7F+,O#;9!+2^1UB5P.$[&"35RW*<``4:A6%SE?>2,;7)+!`(6D>AD= M#<_:;909+X`R=&)S#.K/M1FA7$$=HK2H[-5\"3F=7N)J/)DRN4S$,3.@F82C MYH`"'2MM7U#O]^*J@)GCDI-[N;1AX)YDM%!@9:@G\$[OTH1K,UB9LX-(DS>` MG2DOF)68I<*RFQS3=AE4)SD;S(TR2M>IS;I94$SF'1QZW?JE^_,ILMLGFMRV MNR!,*1"7Z6F8[9(LB):;RR1^8,T(BQ:$9A/?(%%.)\41QK8FS`%RO`-U`N5[ M,VPEBFX^(R+B541EH(`)F:M(5)BQE>(REO05,G!Z]C+<%9<::%Y=>,I2@'=D MCM&ZEX-=B!$U1@'6P^>W^!5\A"SAM=FT#3@W96,L&!HCFNO9G9,[)D+BN>6<*\O#K$XV-556P>K$B/Z5D3'Q.DG6V3,NJ MR`91GPF$.@L#3?8"JKC0:(G>43RI&9*;88V]>%D]FU;"#U):40(E^2-.44Y6 M``AO=U'RC,D?>8N'XMGH@3X8LO(W9YBJY5NGV*+ M:;VCUE#!_O$U)4=Y\!T*A,Z"E#8AI.TG;Q^#5!-G-^9R>KG5S(36;5G9RP['.8J2+*.M":L.'Y0=!N1N\"H*LHR5)68WPJ7KFAZ=VY6C1,WV.K%# M!`8Z,LWZ:\`.'0R0W.('.E_?X%V25NG6AI%J0UZG$1D;NO&=[L(YKOD2TW/./CCO4<4^Z>+;C=;9.M3:KW MP\:LWG$X3-_>#K<4@+@$Q$30HVBRJT6+27)V)IK15X]XO8_HQ9?.JI9>D5K1 MZ%48[8DE2M2.EN9TUA]G'4QE;Y MZB?[-*6%N.VPK6/W`V8SH\3H5?-"NYU@J?=LMQ5D">'2>N_:B=^8U5W*N)TQ M=0ZY&9]W3SA`6>5M@[.I;AM,[?/.PSC,,4L\OHASHC]-UC18D(Z2Y,<36ILJ M=HK&8KR#>+SNDIL3#-)EY7@?==^U'M.&&T8%>+7?-&?UCKIA^@HNH[)NV,7) M.+AM$2TF;>D@12Q^/*%<>;'+Z]-[1YF%DN*6)]?3W$20>"_)%0JR%=+[+G-> M9Y[+UIS*;YDR>L?3$&W[.8I)FJ,[G&Y10Q)JX>T`$6G.0=*'?%^#*FA_?PTE5&&L::\PE9P'_87^[^@*A1*?PAZ(0E_>J@#!B$E%# M)+15?AGSQNN39$LW(BSK@E49YZ9DBU4>/H6:675*P7YV#&-?A'A?,52J]X$R MN2G=8<-Y4,DSDW._(8\DNA<*GGW'Z2K,,!V=V,"?VW`[<^'V)E5>VYS5._Z& MZ=O+AJ`"Z.ES(0*5,A`3`LX9"YL[_!:D:1#GV3*]"1\>#6HB#Y?GR?4.,UOB M<>V$>0?Z5!;T_.L^S_(@7M-52,GK>(=3FB8N\[C(3XA:ST0_=H%<]%6-&']_ M"V7O,TQM46%+=ORPHO^":P&N,K8V!(,;XAVK$SVC3"$!E[\,+:D)\LRL'HMW MSV"GISP3:\\SL2+"2J?"A+'/7QTN3=9[UF*MTO1+&`O,D9Q+FS*[3`BP,ZB9 M$F#&"0-RMNIVD4>(P^U^6U6*[B%P5SW`"PJ#[R-0*&'VBD*E04H4"CGAHE"E M;@^%P7Y,*EK0],_OJVB_)E!@LL,GC&[Q M:I^RQ"@88;8KG//[[E3[Q5,01BR"F/!\_6;0A1DI>:764MQ>H!MD8OO^G)4( M[WYMG-Z]Q*G]%J<4@+^@ZM9ZL-M%X8I*HU4ZFO?7"X&>'-IOF,8!R2@FCB!X MP$3U>YP6QS19(_HG_=16`N`YMV'J]XKYXCC9AC'_YJ7(5P&7V?K:&4IJH3`G ML0&3%[SO:JJPJ+/9BI>.XI0LPZ-:FY_&1F:Q47Y2% M+&2``1%#+579Q6O"A\*2D?P;YYPK/E=LM\O==KW9%L9]%-3N8FY:E>OHFI04 M!ERT^O4.8\OHR+J,CF3`HB.+*$J^!>0+GB?I:;*_SS?[J-]F4;)D-V5V6NK9 MRJ!6Q6TMBP['V=M5R2+=%-F'VV9S`P2M652[CIHF"-Y21H>,$UR1'A4,H"!H8F6IBUQ$.9L,TV4C0;.FVX9 M+1[+*EJ@?`LCUIHT$-\2&2;'V40[QLQJ(AXBQ#LFQVJN;M,=5L)XFVX87K$J M?WF%\VZZ7V>HBDG=MJ61*]MN2=.G@Y;1H=!QMA*E$T/F)OCVA:Q1TS"(9$L\ M":T7T(C4%:*F2>C=*9EHU[_A_0UM2QI@H*&U*+-'O&:]PG2V=HB]P$:HL!`W M+4IXP!&IU]M[%C1\]0X,.I_3)--"IB#R`I66@D*(,`JGT,@3>IW!!!]-W:13 M$'J@5',5)L&T=Q\]LR,K+9QE9%.PO"<[2)SC2@'1FLV,SUTQ$@LSZC(D!DS> M?8JMIET871+R7U#*!;#35>DX5=A\-#=UDX_F M>+:JE`5*%NO_L\]RN@<:.JJ-);@>WY:F=4>Z(3NH,6^GLRAN0\=]4$EIN@#? MHUY:]E^UT]0RP;M*8*ZRF]8&$O]A4&[%7VT572$5D%53S$JD++U50A'I+"3S M65>B]ZD%-#`^MUPQP;B>O.C#-%L_=@V;WBB\V.[2Y(DWZ5-M`U4,+K>$>L6; MLXBU58_Q;L4KW@%`?+O9/%,_H58NMC2GKQ_9W^7O@7)6YM.O-., M](E?2BMG?2+9;D;')SXZ8OQ`%5:-CXGM$@=I@OHA:-UX"K3=F21&HZ*'%K,Q MTM70WTW09F0:;]=$IL3N-HE+KR-2KHF>YN]@EF`"I?J%&VJ2J;)AIH&#H@6= M/O/`E-DEA.P,:H++C!,,[*S4[?J.07 M+`>_DI(=%BK;1MFADO.^(%2V%)X$E5SB7!D0MS?GQ3K@'(M;;70HW.4]"%6K M4QY:/\-`B%"GWJ1(B*KI<(/GNBAXG:6;0I?KX)D=?)_NQ5]80NGN2RM5K;^X MD`S(EU?IID3`+GAF9R;K/9`@N=7=0\EJT5*&TWL20\QK)5[;"("6=SE$^>EN ME,[X65F%4%Y#]'2?$B-X>2S6T.^:O,C'(,/+C7P;9L,/+YUVD/:2D#0*5G_; MA[2P+LV+9L5U#]"&?''T1,7-57@NCO=!9+7_M^!S5X+.PHRZ#IT!$XQISD+3 MWMJ7L:+@X2%E44EA1.#%'!>K#N1@G<4-.89[,2=P`P_?RKC4EM9(+'L@L<.8 MQFDR[4HS+D,@_LP"BTA:"7!>;:,G6F]G!DS=C"XM->Y=T., M2J#YP>D>3'F14?"$B,SAH'QA>!P%Q3MZ5L^A2%:0Q0[&5^\YWB0CR],]NTW[ M/10N\/M4\&(:"AW[&*T+:5`N5;/ MR<;OT/`AT*W7-)*2T`@[I9EI-_QYQ&9=)$$N^N2&/L]V: MJ?K5[DS'X-VGVVC9ZY_,V5B7A"1&,>&<&3ZG8<8Z-=Q@ECIWEQSC&&_"51A$ MO(=11K9_YSC(]ZD02G;\[@KI#S"KKJ]OP0P#;@,T[LUAA0B4U]):5H M?4?%H`V7,Q<@6]-NHX]6;ZV]HTONR'>$/FCMN<3B#7F+SF.`\>9-L.&P%N[\7:&B;?VJJXO6-XL,K] M4GJ1EN%B[[O$5K:ERCU/RXQN^TE9L>]3T[IRF@=JUP>0J8:] MM2;9WI0\B#*YVNSL\9?@F?[=!"MB4I3@V) M.2:]\V"%%^P0W\BS-LG]36A]I>735TWK'4Z&"@HJA&S#+&-E7BF:>,[%`0IY MTXKY"OL53Z6@O\/I]B)FL9WL=)^*KJT:<[DL^V=H0K,*H(;%.XKL]-2!B:QZ MMK3=TY8Q'Z!UP3Y7[YW&RFRY:5NA:K5CPN:NLXZY$74C'3T/#&29*RI=0JO)2.E,DCDK& MYAU3]KIJW574QAQ9O.?)COLQ(F4FP+7&Q'*?4P=)+Y"('9(9BS.(&2I?84M# M#P-49DKJ'!;/BT[V)?=<1^?L'*L1>57D2I@PN#LT-U&\/C%74<.`C8F*O;-R MQE,<3/+`>=S,MZ`+\^JVQTP(NMK3$!;!NUCSQ@`066W#[0Q;]B950#-GA8$Z M:WU[^3U,`/-<4A0FM92Y[G,P=[G'-+@J,EW/X^Z^AJ'Z]?T, M#0,,4'IS.]M?DE,$"S^FIPP,"5J9KRU?PYOD_W0?J,CCXR M1+T^Z.P3URSW@7HQ1^NR_L;D\)T=R)H\`+:+;?4-MHN<`3+">EJ.!!CS:>]F MA5?;!9=:'7TDE(>:G"MC5D_3I=88R8PIY8,!/3MEM?-F%XB'+F(7M/940+XE M/;5J7A*H$['Y4I,O!UCH.,R?FX.-U:H2OIZI1+M#[;0OHT;U-'*!H'Y28X0W M@HN@,+]+=8O3D'CC1?]&2GNAN2V>Y'&@G.(56]5,/TY,)(,:)N:OPFJ4Z,6^ MG$%B;,N8,4(>P@-(Q>)X]G$BNMI3W><9=O50RN[UNI;&*.4M+0DO#.S:*]Q/ M]VQ=NZ*K[+4Q9N$M=(HB(^6";8X%C_@1H#SZ@) M)BRW"R]X<<1F(L&<-^4`LWX,J$$V\"79KJ%LGO%R!MLPPZ8:<,Y76AV;K)=: M=ORNRY!:F=4M06K$#`/8`S0V6&X%@T`\<^"\D7/QIKG7.=UCTV098Q'.P^J6 MQO6B[(;\0$`[2&EY#+Y(K#EZPSVG*`+?)G$3A.^:IP\"]SD\A=QEJDLB[5UR M&#`STE$;5^^`:\Z#Z$9"[%W"O6S;@Y\G:=.,2WHTGE[C])8Z;N;'1>]A$K'. M@#CA2ZC0.H%,&)">SA!-(9QJCK]NS_&L.4AW2$3L*0>--02KG#/3*/F-7:S+ M,][WY"[IVRMZ@&VQ@A4%K"3`@.51M08\&)J>H"]9?>!8`1=]* M*,]>[JXH'ME>W7"C!']Y2#&[CGP2!5D6;D*\7F0W>+U?T>()%S&-W`LC^C,\ MQ7E%TNE?4:]NZ72/@#%N9K-+6@-5L-PNAI3DST'Y4+2JGHJ"#*7E0/TM#TG;\[J(2`\RJ0Q(6S#"`/D#C7C!" MC$^6@I5Q0>C^F5878:(.9FVJQZ_H-G+(6#WL4[P-XK7(?C6]X^O5:K4[MZO% MQ#!09:"AY&YU,W&OK$F^9GPS9EW\%N:/9;Y^>?AQ&N1XD;$:37<)^X?LQ-^4 MVVG.A9U)K90+,U880+/6UP1VWXC`^O9%>1:%UC0J1B;8[#%)`H,V)DI"168"8&!Y!&:Z\() M9!VX:DJCVS=R8(L^7#!+E*DQU?H?LP>^1MN:D7_QR$\66295>8_.$N^-XQVH[59:DW&V.:I=], M^+QC;8"R70Q2,L3Z'#=%E/6Z'?<,8V/G^O;FO.C\?8[[D[WJ%P.>HF* MS?'=(0$SE,5Z=0'T=4<,YA?>^7"-T1^.WAT>'!X>5K"AX"IPY6,83U?4'M80 M-U)55,=\0U0AVY&_[8,TYS6B7A>%[H6?KMSN^/V$HPK.@_MP2BU%WRS#Y!VM M.]_L[13?;,*JJN5T4QATEUQGZ4:;=B)G]%9356F(M*2JD,N[/[=6U:"@JFN@ M:2J6618&*'D`%`9HJV]:1PY8CJ)&2WE2HBB(V[Q5,5<.8K>KT"K%088[><** MLO5V_)[NT)F9);E$IV:&`;\!&LNAV$OG[O1X0?ECD*-O0587JS`!J9M4U"F+ M)<%:*EFIK)VXW-=-*N)NG^G_T%2OMV2AQBI7_"F)UC@E\RYY8X\$MBRI)A-V M[!DCR'54?IBAW;"\G108WFB,ZI+`/'K@PNCBBOFB1R:*_B?';M%^8];."9W, ML`$9?G#R^6RS]UY$KIYA9EZ)*=S.T`/6N;,TA@R<6YSG$>95%T^"[/$\"%-V M3D%3H:(DZW?]'BK$94!PF('->*&=!.^0':5V%\24DJ<%-0^K)'YR_ALH_`*A MPA/*:7W<%1&J*[H`TB+TCB`3[517-9BC.S#S='.GV-[P#O9WR7'5O[Z^CWK. MN]?WMV86S,#6[X-4E^:^THLU^2-&]Y60XM8ME8(V7`SU#)1HU8(`[5B6I$7' MLKEZ_B19MF0>[3:(,(^+B%Z*F,Y==Q^%FG5+'P$1#$^@T*QWNDE(Z49^18A1 M%D38TVER.0=*NGDH^KZI.>`,=DM]U>[:1UM4M>*JUJBFG#YF?`-31/._@@V& M#[#2=0C89FZ7VEK-#.G':RG`SVK3NDNO%3%+66-U^9"'N_!7[,5N(`!A@LPU-(.2"Y7UESG%;LB M\25(_XKSNS2@MZQ,"E3IV7WB2V>4"FHR7K"HTRAL!L!5<_'!L[B65C=6J9=8P.R@I5Y:2IZ5WC0*EV%Q%"8E#!+0-%72?F:NMB%OY.571%0>RA2J5$ M84&QR0XE##>B4T]5^I'-+30Z,%6A%@DZ%*NUQ38ARZJ_TRM6LJN7-MS.\&-O M4@4H1N,V(X0 M4+@5&FB%WI:$EX-AD=JV2&8+0R!%VI8;,E,0:T^2[0['F2A>IR9U"4N5LDWP MB>C`0$RA7+\>_XZ7ZDA25MMQ'['5X_TS"HB0*)ROE&/5P(I?K&_J>I>2_&+;E7?0&2G+?H&R0J?T^959BO*-RO.[ZJ@RKAKRJ3MW)V5+N(V<[Q:^4 M+[NW$.O.D[1V^>PET&+F"H'P$S@KAM@T;PZ,Y.[HUWT^J:1ZPST4[Z&:@!,(13&8)C0 MDN[`N*T;H_&43+MQTILJ9@^=-M?RAJ9?)UE.V[[PE(QB?:8.$T[W%`_!VJE? MD2#*.]4C8(ROV>Q2Q97YAG+0(#M`._90VO)@Q_.,,'_N7"G]3,E&XXR9[YS9S..C(!G(P>FO]0#TUP(-*!::SZ%LYP7PKWKU7?) MHM2F-*U8?HO>C16[NXL2]D;5ER7,>6'`TU[A$:@L]D4>P-@(K(MZW:L2`2<1 M"P*\EB_!"-2&,N&#W.Y]1]0IH#[SK(%Q?Q.?[ MR/H%=KE!0%YLDA&RVZSP`2S4UQZG.R*")JQMB)`Y>QBV3:FLT'7=-&+S!#VE M$1+,"7D@@DVEJ`YER0;]X2WOOD-?'@K0?1*D:[1E79D.>,],?FKM'G&_DI5) M&#]8`J[%Y1MO`A-T<&NP@$9;7\^Q8'OB$K5(F^L;^FP!`*O$R3@;#+H!E#CH M=`78%6*+XYR9.P.4]^&6&[[J6[07EMPV6>3`@-%I(,?8D%;D1LL%PP79J-I+ MQBH=5HTNXH@$Z_S;*5-3Y3/="N-U=DX^GL8HB2LV9W MX;&`S),\B&:MIJ*Q0WLCTXX?BEM4W]BT88:!S`$:CX6FFYN>57N-!;%PNZ.[ MD>PFS/YZGF+<+*;W)8S#[7XK>C?6(IR!=*!Q%4XM^6%`=9C27;12CE>4I8YC MIRQ2LN5LON$8?!\-QU($/#BVC;.'(^=_87!L*6T.1\[F$(XT;VY%MEJGX5.X MQO'ZSR&.A.=\%LQ>(:@T2`D^(2=_)E&0DY5# M_CQ@'M8(`8$[I8%&^!-*@(]#E=I2//*$=[XX?*H$^)B7)6;8SPOPHX?W6JQ]KS;*K^MCX.<+D! MBU5.]D/Y\^)[V#_TZI,`.WI5*-C]%'U2]!?ZO_\UY_7JXR!KW]A;T,/=!TPK MPQP_UR37P3,K>/0M2-=G?]N'//>?5Y#)%#GS,SS$[<7K.5Y0^Q;VE$^`X9/F M,JL[8J[V--.$G6D4"0;S9N%/9]>\;^U%CI$9!\<_VJ@P'@XSW^!CQX9\VFI5 MF%7L?+4L[I!KIGP-1S4]$(P9*=G?<12E?ADMNJ&`K'SIW-M;JX)%ZK-Y!)3%&"ZX.'VR0B94U`ULYW?ER M697N]JZKQPH';9:NK,/W0M`VP+4UT.8R+M?27['S-F+S%8U3&2$+Q(EX8*#+ M7%%9^`T5K*@-M;DWM"K%5:5CS/A`@$M:&,:$"3Z\-&5?M/B:>X=(-Z+W^CWO M?7?/6P2OE_N!JM\'T2T$XX*MCZU<1N1\?K* MVQ$<+ZK`&+C>[=>Z@TH.:@A"](RR=?`XLY=8/#RD^($7PDC)C!>NV!&68G&C MXW!7:]M(];JFMI((W3 MZ)E,6\5$*;)0R^)LE!LJ7\%(0P]CE)LIJ3NB0ON*$26<$T87F<&'=?VE&[>Y M\PYG?([+_C6SO:9F\YO)'^)]!,UM67?8W;$[QW$U^/A0*ZML)[44+U/LOMKD M%$TDQ9.KD`S:M*I6LC>A"LGGG4K+)_%ZF?*J&&(ZYTV^16KV&GHWB;P/;IUF MTD;=O-K]S"4K6JNWY:9\N.*`5,?A#!)FJE?@4)/#@(F1CM+CJ!V/X587]N<^ M]Y1I*S_NU'%XQX[D<%--#AL[9D>9`NS,>HJI1KHBU&?(Z!U)0D,,G1&H^)^- MJO:N:>YXH'I4#,!9A]$[SH2&&#JN%X$SD:KV;FQ^G.U"'I:D)1//@C0*<28! MEIC2(9)4JC:@(R*#@A6%;H(+=&&CRND!P@6]$RAT"/91B!'$BK2L[F,^YD:T0SCZ7B\P\Q2 M4>D^WC">-ED,1Q]_\!:WT41LO']RN4Z:*,W,'Y9Y,/67K4BN<;GHP:+\L`=Y1@]M=^T61FA=2:2MCJNJOAVR MN6`MK$D<\-HCPK>B9G`'41/%:R"JJ('`S4#%'J@D8$&[P*#>RPC87(9_VX=K MWAJ)SR M720S:2@GXJ1]!Q$A6-52:6GIA/R!2G8_7?-XQWF2G@39H_'4TN'R.W$+35#/ MWBT6&#`TUM-X'N=!*K1)4K0B[`[;WXQJ?N-[_V)MD++Q#>`]BJVZ7>!13!+0 M<2&\_5M8B&FU&'&S&3G%]SGWU1E9191]9;OKCZKQ;%U)B7]R)FPR[03M5H&QCT6NF;.!X[?C=W9(98%9]9<:" M&08Z!V@L1&+5G,0G)-G]`M$:FH^Q>BE3#.:^I=0PBD!'B7,&^`F,K@`_0A8,P(\WH`OX4B)O.@L,\`/#"8L5G;FRZ6.T7<'0 M`U#B%S$V^-26"F-@3&G*M/':8,6?,7/,=K%JF3))Q&F\3'=[B(G,K_<.(P7" M&!8362'8*[0P#2\*I?('_'P]VT=Y&#\0PJ=P)5X@#1`"8D90&FCD_8428$!Z MJ-J#[F]4PE!62)L)K^S&:)GK(;R-TI[%J&)YI,'O!$*=X7FR%U#A>[1$&'B? MRHPN_IE<93:08GWC:%0HC#9R#4UR")?E]#ZXIH6!/KV"EG[5F_\<-K9`><`! M+@X&BHSUM')2\Z.J;+1R039TY'$INZ]\G.P?'H6WEA77>8=*^=ZP)-NXF-`7#REFS4\L$I7[K+YSQV7& MZ++%NWPP8&FGK$5&>+F("TH1?B&G2/ZPE0`-@+*4#COV%P5'=:*IG;\3= M*D%*(V'D\1%F<05:4(?^LW\+@VJ^_!:;5(`=(-)3R=C!QDMJS%K+@P'Q:8S0 M5+%E>`^JJV149EU*7[GD3>A#JEN1>8*(U/#5.HSV+,UU@^F1'A/1NE-1:3IK MS<7>NUL0Y4K=SKEJXG=G]"4LI/D;0]8FRX>/L2B@(\=6?Z-!(X.['ZC3WM^* M=\%_=@W&IE)==-'?0,&EH9#D^Z.2(#+S!Z$\JZPEP=UB053X)UE%A=X/YBURFW#8%7A=R&9#Y!*2[X+ M:$#5>Y?K)P',)$NQB3J,U^/A=)^2S1W9U85)D4JP)+LF:7=>UJH:>*FYKB$4Q1>7F\:0D$ZC*FIWEPBT*M=W!*2DWC%BIE\7&.=! MF*)MD/X5YWPBHCO'E3.T]";DK[LD;I9[:10^IOG=9>J>18$?2XG^EF:#3)B]?7V/F#7`V<5E#M,ESA.,-V654: M"?Z&@9%I#L>I0,%N4Z>'HG905)@0'>, MZM*L:T%8Q!N417EG9]M=E#QC2P'5R6L.4SD[*#0.) M0U0V=7Y/3(XP.9I.QP16;R#@\R*FFIB':8UEP42MP-QA`&X(>H%8[FL_(:SG MC<:6%[X*>]FAQPW.5F&\)C836%0S25RD=^]HRFGVF:8D\JYE.!`&O::2[/SZ MWS2OHG<=<)Q8&*-B4EODUP6;%P(RE)8/X(T>ZX5)7-T&X$]!#_PQ[+(,>8Z3 M@(+\'10=HNX2NW$SJ7A/P8=)7HHD)#%*-HQA-+U!VO"%>B@U+M+X&%&JW?)Q M$N^-FSIUF$#$,UH&&,4R&`<,I)JJ:1W#N*?,/N(74CR9<,&(6X@1I6>!`2EC M/0?$*IRCRC!$8<[K%V$F@0E31L!H,P]'R#%G6SQ@_CQ69B.O8L@*4NF2687T MO[\&E6%OJFVO`E/W2E0XT`F'; M+-&K&";'7;'!$6;650@'"/'N;<9J/ABU_MR/X#(GK^7<*?.LWW!+&($M@*S5 MUDXBW6+LSGP0OV';5%I^H<>(S8>'T1DA M?I.4R35EA8&QOC%F.*OY7@#6>LH.P!LKPK]&R;?9LIT_!V%,.W[G><3V_&1] MV)YI)1-1\S78RW`&PZ'F57BT%0`#F`.U[B*4BJ&-W+-*$(L=M4J)BX`[JX,D M'SS.PR=\3515U8-043MV@RJ5.YY/1`H#4UK])/ZMY$`[\JN[RCAE"#Y;9&0' M05"Z#586IV]J`3YKW^@-4VT2Y-PP4#9$9<-R-N6Q2H:"C-9E+"2Y.&4I]8X5 M$)22NCY#D2G;/3+ITL$`D%HYZ8'(KJ:?%1!J?)-?=SC.6"LS^]'1Y@;BHT0F M&3JH)BL,<%GK.\0UK1IB9DZ3K)3_[3&YP2M,INEULPJ4%I`#!3E/@AQD:"_G MT4H*#,2.45V>T5CC]=MC@M)"7OMRF1LDT]H_7UCI']EU.2L'.TJ<,U1/8'2% M[1&R8"!\O`%#ZTGY\-R=)$N!U$1OBR>7JJO\7K& MK.YZ&ML94[/UK0IN31V'^?!/D^$L8A]M]OY2_M01@1_O#]>]"H/@=X8(;/57L M9)55"F>3XW$4K/[ZZG;U2#3,BFL>:)>&JS!^``Z#X/M8&'`)+Q<&'?U[,."_ M_Z/`X";,_GJ>XJIC_4;Z]A0-0\+_4 M;V\X^%_^MR^=WV6X&33W-_A>P+=6::V=YR/"9/.)T3998V6W%6\?>L#LWN![ M:1_:=B:?_D./V6'N\\6KCU&2K* MW0YTG+'UCG28'"`[U%'*]W:LE;1R@[JG8J)G"MSRYGE0/H)AG=U#IS\S2C\A MOK;EYTEZ3=[O(]ERLRO[WW&Z"C/Z2W%/7QAHLI;A+MPWT+PZZ&1$+T42P'N M&CL.,:QN_6C##0.=0U3N0I-X9_2MD$,`R@2A#3VQJX[JA#4_W("S&&'XFJQ; MQ&8MXG5C&!J\)7N1O@`\U'@9I&WE@03Y0"-Z75.[D"_\+V9+9#GL65FIAJ^> M:PW]\)#B![)#;XSIPLI?R8Y?[)<-F-RMBTT-J%?`.@X8<#15L[>J+?DZSK7$ MUQ-CG@E.7V,NOE145H!23.<,-"HU*YR(B&!`0Z%9%PTEZ?$:[^\A`X&`-3* M27/B$T>`:*Z)RN62/+&H3^@VATBF:#M=J$L%`P@JU>39OB4.RB6G&QSLPM0$ M!069)PRTE)0@@-%`_/Y-Q4R^/J.?>P-Q$>=I&&?AJG1:^SS+R28FC!^:VBN7 MNL8RW&\O+,WK[S8,!<#`VT"MY7N1L)33V)#4HMI;8-=(;6SB!R-5*L,_4C7F MZ9$J$0`_['.2T)./-+:Q4/G.E9WD>@(P/[08WB'D^1;)!U M3[WJT]D9#V+ODCR(OL8I7B4/,3U%;MI^DF1Y53:]#,+H9I>Q$IW--=.87LT\ MX\1Y'P73V=`[,Z-""9IKJ:VK:N0_LKQ9-']?1OMPY,*-QK"ZY1+T39A6N09!A8G]H5*\@%:*EN@U*LF= MH=]`Z0K+"EH8R-0K*+LM5`"IDP`W%U#XS15CH*C(W0%%KW0-%#DM$*!H%93= M-G(*E&*O>8?3[7)3.=;XSW0?)SQO4-*[.^TQ4+L^V5$0PP"+@8:]$YMB]YX3 M'CJ)5?/4[-OP3F9PJ:[(+BFI,Z!HE*TP(J&#`0^UJ5D?>6S_#^-A"G7J1<>>C_G:'5V$0D2TL<3Q9F,0,C&136T0; M%_&ZU<75>-W8NVW0(WL(V^N%?,.&J^>@^V?T[_OH&;TY.J`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`!^G/J&O;'I`H:=W>`\CQBJZ?XTX++;%VQIKE+Y`^TU$6L'X)B@E@ MJ"S(X)>Y_&&"7BSTC9W\A,B?W?G+.RX3W=GQ+LXR\GN0IO0BV&)+7]-R>'%9-)_3X3BG9<:C%G<+GNML&FEIKN@0?(@XQTH]VOM;`7BW>K?:\MY'VN M>S1V3[\HFN*!$%9,T[TXD^74^*?!&'HN3!RR$#,9J&!6:E_C,&]5C;P-(GQ! M[UH]!3EM_;>2GDH8LSIL2F)E3*-/B1$?#-C;*2LH_)EWN]ME1``%Y(Z+0+M2 MQJS]%V^3:&T&-#6]X[Z*:K4[/13%Q#!P9*"AI#=B1GA!+F(Z4T2$[2H MJ)W>_%&KW+KC(R:%@1.M?L)[.P0>[,:.*XRP_,1KG%+_)K*B_;O#>XE]M1H7 M#^L?87QK@4;]JX/T=@D]==L3HEEG",7G[!`XG@-D'[3U*XPO*E))XM9G_J:+ M,DM3\5G[-.[*`4G4JTL`=0A@?%^)5MU/_,/BASJO=>8/W6W[2=%5E>XN]179 M8LCHJ_"/VA!9&2`Q%PSPV*BJ+Q'$HJW-(L\-T,T$M6,#G]*G<08@F7H55KH$ M,&`AT:KG4XZ!^)3CH3[E&)A/Z1IBYE..7XY/.1[O4X[G]BG]9+:[Y.XQ3-?7 M09H_7\2T`G.XQBG+/CA/TD66A0\QRVR+U^0_]EM6/L@RH7?L,SPF0$[S>A09 MD>,>`&-8S&254`V,XSFN<]-1H]2*'YRU-NL;G&.>7F+8?6VXVM/$`J[^' M'Y-]AF]W@?A>N3&KNPB.G3%U;,>,#P:\[93MQ8,8-]H0=@K:B(D@_[9A'2!X M440N!654S%P%#Y(X?XR>;PBP@XA?6N=V2-&FXW!7FL!(];K>@)(PIWN`TQ6L*\Q/RSUY(247HLOFJ7-%FV]0^E7>\:%7KPJ4D9$Z$ M9_J/;XXR#5J6.[9&BQ\8\C-JRAF_@5!4%N+>LNMV[-E=(LO6J";>3'G!H-!2 MX2XVS_?Y/BT<&,WSFJ3%W-S8O,(RIZ;A@8'"AOIFT",,+P!OM99=D%&B\F:3 M"EOSY3#4Y89IAB5-;[PE[>D#178+R9RM M@Q5*5H@2T'@?VQK%NM`H*.GV&H4%Z5R;H'V>Y63#3OS-3?(<1#D!W?(;7B_C M6EWAKMDP`0#.A::=K'48$5IR8N2;S1<$Z.H1IJK.U"MNL:U M^K2WHN94Q(#?WQTG`[/D=YH4S#``.$!CDSM+W0K4#3BRYI>SSW54W\9U]31\ M".,@8GT^V1T+M1_7ZM5QN!([4@L_E!L[8C.8F3LOD':2VFG;A2?GHW(Q;+$5Q MB]9]L5FKMN0A>4*[6OSI'I\&N:(ZBXK'<146O?J=:BMR!E`;3T-E>R'2/?%C MQ=G*JA;1+?`_$Z).PXPA=QFS,_1&=VV1B2IJ9RC2JUSA1TX*"CE:-7N8*1BH M,WHH6(RZ?#H8V:PD^;MK3-Y1G'\E,S79)=.*0A7!75+'85CA*<4B?3I3^FNFT;(](^8RB1]H,?LBTY2E[S!3#KNF$%_YA3S@D?BQ=W=) ML?4QQ-!T3P&(JAF,4^!LNJG=#P72Q)_G**-\$^RA&;R/_+TVLMJUR$6`7@/A6@UZU0KA]P MKTA]X_DDV(5Y$+'#O^5]%#ZP#,_L*N'G`.+OH&4"]%G,=>V?F#%.Q%A1@_<` MU=S^QXOZ4PD)`7T>M7[*@0/I(VA>/2Z M]=(12DI4DOI^YQ?Q*MEB>DZC?.LU&<3W+M!._N8Y,?J1DO_1USS!PC,\ET`X M0S1^__T-F!;3N7+7DC3 M6@*`43%2\>YGM);D:2AU]:2U^O`N"->%AQ4-+QT/@*]IK:KL^Z$?2]8_TC2/ M@KN%^-3K?L7QIR#E!Q75\P9\/ZSDD4KI[O\/?\ M..K<1;1BA/]E)?K:?%(F`OVE^">5A9@PUPD)O(1ML>RKCS<4W]*,`\!'M%2T MER^BX_2V*7HB&$K29X/Q)J,%\'6,5>QO70H&0*.HBE^N'O%Z'^'EIM*RV$C? M40`IOY4I+Z!O9ZUR+Y1;"*!I\XWO6@8?_L+$`/BNE6YD+;:XS_(T6`FS3T1T M@+Z74CW%.*,KT+^4#-Z_P>=4K M+-*%RXY&Y*4O7LT!Z$,8*MKON,'9R(Q#&:L3[1UO<^_S8Y%5RGZ[9QG8%<:,UXMMDN;AW]G?I2]`]%FGD@T(`).;)%@UE@]`S2<,H!Z@#LH(TP3]`Z#^,PQY?A$PU8Y,1(>FN`GPZ",.7GL%W3S[ZOHCVM>/$Y2=;?PB@2 M3L8V`@!]\F%Z]Z;R2@I?VG8^-_JQ$H5*6;Z".>S.CR!/0?0[H.\D5*L7.J5$ MU6&6WZL?+!Q17`EMM6BXQBE+:>D%653$`+Z$N8[=SZ)B\E-?K5E23+3!4Y!! M^1(:[?IK6A&YGTND59*W]-4+:*"\=Y5JXM1S`&]\ZA(.8+Z%H9Z*>[%"1A]? M:9H2"4"^C(&&LOH(?1;!UVC^Z9+\&_ES^2?R/_=!ALE?_B]02P,$%`````@` MP88/12,D%1!(20``^],$`!4`'`!EV-.'79 M]5Z],[E@Y8@F=L4Z>:+RYY??P!?)%(BP`1($,EJ=\1, M5=D`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`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`61*&Y)F;3<1#:.[;'N`W()G*N://T M`#4(`A)FWX5-HA(-M;<*]*EF7WE!,",^6_\]=W%/C[%2/]F+?!FNUWI6UH&OU+OVA!+;JK>J22)$&Z<:T[51*?BI!B'*C MVN11F6HDF]*P&Y.`O*INT_LQB:X)*VKJEY216:X533V6&IJP%G1:AE1Z+=^: MUOUZ_\*Q5K_W%ROZ2[H+?&`]H1,P_96[O?;6Q*';PFCWD.]@S;3`9%OPKZ8U;W+/GOO-?O9;7R?Z6*T$N:Z.7;2'N<]=GQ5H5N M.LS1Q/.K4&,=_DW4U\%=$/IT//+O]`?_9;T84ZV-ONT&S)GHY*>TZ+E)8\[FA\) M`W_5\WRJWI2QK$W+7Q7X/_7524N\>H@W3?W5O>WLA\[&]W:R4*:P>16"Y-&E M76B=@B$5Q+><"=64I[^19Q$')T6!))SC8X$CM0D:,CF6M-ER](LE@*"_Q@1Z MF8PFL9X1W_:H!&OF("D&_:@H$/TW&-$OE=H$#0/:FS7KT:5C;B"/K/L?M_(*+EI"B0C@_XZ.!( M;7![FNCOG#QX/CO?)N$(PETJIP:0E(_X2!%C8(Z;>(P,Z62ZS;F'EE%R5!#( MQ"=\3)1*;(Z`673GV*M+Q[/*3OW[7A>*@<]L^-`O$=?@Q)0X(#!;8NR%$.1L MH<+I25@/R@[&(S4`$)-GOF0+F)R!+NG/.(N(H#B4')1';Z[XYCEAVW(P([G" M4#Y0'L8YHI>P\9=7)])=T1\T;@BOCL0K6,%?]_J]?3@0_?MP>K.87DU&@^5X MU+L87`UNAN/>XI?Q>+E0,H'GQ]7&"NYBCJ*@O[6LAV1P$2<,LI\5H?5KJTVZN(EGG_5@AR7,V4^E\*UJ#L<29J?Q.JR MD6[7H:2<%#=F51P`JQLSQX.(\%1$PD1BZAD;S,F*T`[?.>2&A*FT`LT2UC)FPU>@#"(_#J;V M'KBYJ,=39HJEC)GU%9@HDP\+\B&AP(6',5*I(((JQJS\2IQ42(Z#H)E/'BP[ MZ(66$YXIHNEY6YMND@F,@I)JJIG[AI!AB>8]#B82KI5-?F9 MO"*0MP]\+Q/=E6W=V8X=VH2Y6I\ZD%?;>N`MF+MEJ&^@VVW8GJ MF+N74*6!RR)J`U]F&TG#R*BH:0SAJ0#5IB)0(U!FM1DL`-24VX\D,*I++B=V M8>BYCW3/Q%;@?/#?WKGE$%E70A9K0:8!*%':K!APHF1%PZ2!XGX+;.L5]:#T M:;-U2.L9#`DDK%D/-MM6$2L@TSO'WB8)4*I9JZ@'94V;242>-1`2.%B34K!: M6J7-8"+-#WI5DMEIU-E0:#-W2%,"VC=T_9!WX[DKA9-`637P_3#^PP`?%1S* MR)G-#]V67MKR5:%$:K.[P)@`+7"GD"@K+]WUW'D!0:J^DFH+9UF;]46%9:'H MW]&T#&(3SF$'["_?"XDJ)M,&C*2OVS#$J%#<%=/H+!ML<89&(#,.4G*1%E4^C"%5J$<:[/#U.%8&47Y)?)3LD2Z9,O,J^87R<%Z'5^R6<[, MLM<3-]V\"^XN>!6@(T";I4=Z!%3(CD/91^FP8F_!$3=(HVV2C=:;3P;SS8M#QG<2'R]`T\ M\K3W8Z&]?W^)1&W'4G!-=G>EN8Q*S]A9Z>Y&I8JDQ[%B%GM(M6+JQ_*NXT/U MC/CQP0O*&+^^Z>A5(1,BTJH@P4ACDFAC$(7WGF__\S#I5M%W6L]T&*LR;3P( M-'FQ%3\^(H&]==F0*4&>E><7-QV$"@%<+`%VM8@SR4FJ1%;'=&!J374HBHZ1 MHGB*%:=,XIOC55(F:;M?4*:*!P$.NG(FV:K-7$E1T[&J-;9R7,'1\2*_B0-5 M-AW8RB>`2U0W]FXG&=(@&S=A)=,1L`I4Z=JO::*H:A/!K6`ZCE69FLJ]@PD3 MT7X^#]C;.-F3G>7FH;UQM"^)6,'JE\DC<2.2B=2AAV,Q3@??)S4A1,"SS5$"W-I\];QTL/$3`+Y$/!_#I"N!NL\5GXE(A67<' MZYWMQ@^[L;<+*TFLK&C:""/+'A`)'+2="">Q;S!O=)&EABMMUQV']H(E.Z@K MNEL%$)DO;-I(H[CU.Y6W\U2R!(4WGNL514Q'+&![#ZQO/&V9).-2L."87%F> MW"!^ECCI;):C563/XM4PGNM,DH#3C,$B)+#PE?2J(%E>Y(I\SI#:QG.:U>01 MCA`.3F-QD^Y6S)E9(>,YRVHQ5"*O)O^?SY;M3MT%"4,GO5\^RK!5@C>K"*AG M/+F8&@5`Z3"I!]57R);QJ)CQG&)R>X=2(;N^3\SB4[(+_@LKL%?TT#FRG2@D MZ^J-(K@!XRG(Y-B6!`:''E9T6IE%!*G(9/F08A,7BU^)O;UG,CW296-+;B+F M;3#=G#P"6*V<\BT93VE6CV=5Z+I%?(Q)?=;39HRG3%,F38W[`GK8W'%H?T_B MTHX#1@O..>]`SCG,-V>QG`[_]LOT:C2>+_ZM-_[[[63Y:^_'T?AR,IPLD01R MJ:6U`54W&ER;]G`ISE)Q7*Y*,T^&L!;UE*+G),BV*%'>'(B!$*J[9$+_*CBT ME)5%1DQA6/$8R'4_GR(1`PO)4&+I#CR7N20.GFP((>75NLA-N20YSS&39XIB MWT;>SK)=P4FBO#@R5D0C[OCH4"Y0[KX830R0UB!AC9D;Y$G!'Q[<2KB/_BP+ M$IP@C_/A)$2J(J>BFFE?1Q6B0$C@(*TL%5)F%F`/.#S'(0Q5',JU8MI34H52 M%9PT7>@DD2_YU')<>EAY?G'37I)2/(A%P:12QYFIJI2'5]ZT.Z2*FHAEQ\$/ M+$Q.*39._Q;NY#Q]?.(11\3)7:$]$-_VF.G,#\U?I+640$W_CJ^2PN;S9C5$ MI/"=+.8'/=WDWS]9>F69'CC+E&PC:/:%7#I5I-*Z<8!VAI>B648@N>3-^K=Z MC;#4:#9G;KH>;T7(.KBDHK!IG.69FVXD%$FF`30[0"$]\I`8Y$:D/!+UT6S^ M:C/3AM+POGWI^4/V<\>)@9MN1N0N%&J/4DNF0U]@9-4`"0-M(L52:+2L6?EC`^Y:.?7]/$@U\.C"!#EIH$N22EK=DO'( M&F4"H2AIY^VKY?L6_3@;3(YEEWH(%F4HJ6$\YD66!Z[4.+:?[!0Y<8/0CYA, MN2G[@KBQD[3E'`;0);'"2)2\5:TUXY$PX,UI';1P\!U/Y\EMX2CR;7<[2VZ* MXBE\%OFK>_8,\V80!"04>HQ*-6,\!D;N+DX6']34)MF&ZS++:<5XI$M=8H7H MZ/3GX8VQ_')]V(2)=J;JS8%OR,TNIG7Q:I?&>$0UQF)U:U`2#9IV:LF'0Q5S M:SW;!-15Q9/FH"P:MNO4Q7+L'E' M!1>C%$$]_"I;@!)DV/5%`17MDV&FU)<1,PNE5]*54QZG%I0'--XL0NG-8`]T MCQ#6A?*`QF<%@$1K;,CJ@.SHU_EZO1KJIL:]VHA7&^LZ7Z2OA7K+HSRWE1NX MZ^P>2/[,4E(9R@0:+Q`(%H8(@:F$L"Z4#C1.&P`D6CX;,@^1.5D1^U'Y8%_> M!)0;I&=Y$2Y&*9)6&UX+4(*0'M$%J."_%CP$M.=/1VJ7@[RVH/P:/-+7D$ZK M)L;CZB'+$K:([K(P^,.`NR)!\-6W0^)M-AQME&X%RICA,[XB.FWZ.64;S\IY MLK0.E`XD,BP:M"L+^:^(2:S+I60SI/0GME>7LI2]DEG[?4&;IWH^% MC[UDFI;9,L;G@>EFDUR@3]V3'&.'XP-GYRC5`E"+M>NP3*II:2&Y2Z9190VF MFZ$5W%\ZWK>@7"$_@!1RP31R.%C\TKN\FGY=X-"VO6122E92R^S&DG5HYGLL MOG=]\7P;D/7$W3\B.5B%]J,=VI#7TU7:PJ.;7#9/MZJ*B.'8S^I]UDH74350 M[\Q)8[#^[RAY"3)8>G1N]]R5[9!"AY=>8]JJYVMH,O[!%5HG[#@&UHA0&E9V M0H*[SML]^.-#6,ET)D"MG!T''%:"I\NRZJY\8@5D1)(_55^55&C'=`[!-OA5 MA*;FF?J1^'=>0,Q;1XK6STO;M2C&[G;H!6$0/TT6)()##<&B%DSG/&QQNI"% M%<<*<;A;_>QY:];1&\\ENP?'>R9[#\6E;[D!E=Q.K]ZAIK4&VC:=FK'%`=0< M%9J6)28LG2,MAQSN?>&6&W!MTPD>VUJ").'$,5\V\A%,*%XJRVJ:36S9%6-4PX".' ME>N)^TCA\WQ;Y'A04 MT+:W"Q!XNS^\X#=)3=QT8LH[JN..L_:X"+W0VA2>Y:>U1 M`L`,QW:5=IP.Z/!YYEAT%777S'KVP"#(WA(5S`"0NL83I=8@Z/AE8BA2.)B] MM%T[)%?V(Q,WM-PM2Z"4+)=)0-'Q(L@G6J$IX\E4&^-=&4<]\J=]?U36PU`O;PI.PM?8H`6#6ZK-PY4'UG)LHN2:,)VJM04'EZW%B MW%J@D/L0B>>'2^+O`!16-V$\36OS%$)QP[$>YWL^)P_I`^[).VK"K;:@EO&L MK?5)!_S/+9R$Y*IR>MF`\H:MV?GFHM3#MJCIQ2+9A/)EK\Q-O MQ_PUX``TL=?%E/15QQ[W>SD),7'I?H_]P2PZCW1,N_(6$KE6\*27A8\,%9R^ MS[$QH"KB^\]4&WC)IX20G53'D\NV[FC@(%,S]IIVSP__'(-!(MZ^A92Z#0^' M[RRQ0O3PD,1'6$X&T\3=>/XN8:HZ'!;:`)['>]WX7&24``AFEX$WAR"DOLU641 MTI;Z?V\X33+H,-]N=T4<6&0>O+KQ=,/RB'LJ+9>>?V6O.![$K&QY4>-YAVNQ(!+_NW^L05^JX5J< MJ+[AT(2K9%MY?)C&G_>G_M9RTS!6"E'J^9=W]"ED\?G8Z_=8:*OC!10.^H^; MZ7+<.Z=_FH.;46\Z&\_C?YG,XI.N.RS!L.?8*UC"#$$= M@YO%/%.''$P);;/<>-@'(UO.(3W3@;,E'1X73OGBEWZJ^2\9SOY3/0J.MIVZ ML#:8MHNI^^O^(MKM+/^9SFOVUK4W]HKY^9V@4Z[[GTIU_S7+ZW5[?3V8_QIG MTYM\OIE<3H:#FV5O,!Q.;V^6DYO/O=GT:C*]C,/];QS>KGZG)>JSUOZE]F<[4V7O\;;5);P M=<923QK4);[;?:5&`:IBC+P`:!>DKF$=`_,&#;/`IF_O^C.ZJW73X,/8-,$B M#\L5[G6IPKUC"C=8QKE=F;[1?>#X9C%>_)_>S5A-YSA&C=B"M?1*-N0"+6(U M(14;=C\3>F(9ZG' MZ=%G?CNFJ\L_9O%H_[.?>SBJ:-;7?)<`.RMN!<.Z(N;B)%VK4&K# MRO&QG_?VSF7QXZPD[TH5A5G;Y^.K.$7^;,!.+,OYX&8Q&)HVJ_.$J]:?ZIH& M-8G7.2GMDFK$L,9!>3S2/06<#.OCIS[W,9ERA7Q?JI#,!"Y^+\:@4D(?@FGD MQ1==+SXW(ND\P_E ME\AG\:LPU]>3Y?7>6C" MCQW%E:`SK$6\*H5?%>1->%;T?LV^8W'^B M,#1J]K6ZL`([F&[R/D`746"[)`A&9!\=G&16E/?+T/S9SIA"VX&#.XD8&'"W M`9ENQD%H[^C!6A";?5S.]'-MTIR6"XJ#!$[X+Q/L&;+5A54W_7*:-&52L)C, M&\N_9#K*DE]-:7H94U7/^/-HLK=+,""ZG_QW[\L$UEY^#>-OI,DJ;)7PW:>7 MZT`#IAO>@O$WS63IEP5'5_ZAQ,L#-M?R"AM_#TQJ@A6+C&.3,]D]6+8?1^'Z M]-SYX`66,]U<>>XV3O^:)GT%SYI*K1E_\DMZ1JT!FJZHR?2!P:G+R0T(4SSY M9HP_O"6EDJHPX5#62SKJXEC#7*#1Q*721KO#1,/73F!UT\]E2:NC%"S(F+PF M%C/T'=9C\%PKT83Q)[+4*87B@X/6.:%;[8BP]_^V;IPA'TPGH*KQM["D:03C M@8.^Q;W]\)`$A_]BN6LG?<`7S"&TOO'WJN1#Z:20P<'F8!TO\$'V##.8QLJ* MQI^(DN8/B`4.XN843=H'9F4+C:NI[7[7)`54V_CB3PDP*QD33"2-Q M/\KMJ_992@8K^BN?RA*_7#WUL[08L"-'`^T:?T5)[A#2&)(XU#5YX7AI/4D8 M5WDUC+^=I&!=%4N/@Z.QY;M4)I:\-GYH'DQ5947CKQY),P;$`@=Q=.OL6$$0 M>Y-4O$U64M3XRT0*ZQQ'7AQT+,B6S=AS\N#Y>ZG@9W9@=>-/!J(4]Z2V7[+7?)>ER=>D77)2[[P MIW?(XQTN4A>@]6U`-I'#KE&"Z2:Y2(F1JSQ%2#30&<K,E1K7!SCG%U80.3R(KT:Q:GH^GD,X*PZ3Y7>6U M.@RL?0^'D<^&L+P25K70N7Q7LN!T.,]K>=XLD;:6)_/A9\_"H+H(TVCQWV;C M)("";'W`M;N6'DM*.!1K'R=!EDBSRI,&"=-DU5.NSN3+:GK-$[QJ+K_\2336 MK8Q<=21%H8,GR;I$VE>>D:@L91>&%0WS"5Z8JPJRC,DTT*D3O#PRJ%)YB=2G M/$_124(O#+KS'63V.LS)K'/R:U99K2[E^(+(K_4)H1-OX6QO5S6WP:N;-E;! M")&3R1`SA;14]5@2-64ZZ*\)QJJAPINP2[0^J:;MPK!@=3)_5WJZ6'(>O\LF M\J-R52IT,@2U*!(P(5>QZWG7>0S(4R4C\7M6`/1S97$P4#Y^>`SDNI^_+V]R M<;EPK-7O"SKKT,G2M]E;8=?>FCB#)[L,7U9%6*,+*%<*D=N!M`#UR-M9MBL' M=E;',-R52(*!SP0Z;,9-)L.)LZEMNFDP)5 M#X4&A=6JVW/+W=+>I5T8/Q%_90>$34,$ILXR#9@V!<`T6!X2=$I;FA4Y73*" MJ3^WM_>PY)CJ39I.`Z2BHFJPF4Y%RW^4>$1"RW:"&R8!G5O*7QUYSR_>&V[)=WB^_5!ZQNU MKRB^^B>+3HLL64_U6.+4-VJ$:8XE(3H:DP_$7[^EBY`_M![LT'*N"#UN2JF4 M?#/&CG0U)CY%K-JG3D;/Y)LQ=D+30IVLUF&,LNS?D/#*"U@X$WL5Q7-CHY%P M1]C(>PC]V&OZ:KI8].@!+WY5B![X%K\,YN,_RYY13QJ)HW@T@+,"M(%N[3=E MI=-RQC,20Q\F^4^85@\>J1[%]D,OU>ZDPM+;D)F)7=.D%0#"-PB"TW#7%IH)RR69,7XG4(UP)L^[/#Q6@ M*:\3YJ]:Z@T'("X(7\_(S5#9Q0%G*U-:TO2MB2)M7'FTGIP6Q&>A)3FWW5DV M"N)N<("OKF;Z#8,:+$`QT45)[CX[R=K'(Z&DH.G7"^K`SI5;OUL_H(CS`,FDKDU MF+GCN;RHL>-TDS`W-YJ;?8LE>VZ$[LV7ON4&+,%P^@1T4&I[RMQ>@?6-'>10@<'H\(G+/A$5E0S=IZOQ1\("TWS7>[UPLUQ1J?D;)L^0/'-=N)WU"RN MYZ!:4\;._NKS91W,\.1C%7E:O`$E9'UQEE!('7M#`"DGRTMW\F`N$KS[=YI[ MZ>;6MVN*B$^A$>Q#.,5-^R\(.>+0628PCJW%OHLL66%P3];Q^TD`4H[*FW8R M4&&E5&1DM'SVO0!"1UK.].6^"@T%$95GN=!C#I_-7]NS_:;_R"RE=+="`I:? M=GH7T"^&9"\!9Y6%535]L0^A#"X-2B6BDL&V#^8O^%44*"=>H^IC=J^]O^^Z M#0XF\,*^NSRU>OF^.W=]UOOQ=C'J_>^7G?C+3KQ[.W'Q*C58_W<4A$R^&NL5 MN)$N[,15Y$)A?"A_::+TAT+C1'F6?,'[$_R'*5Y,&%B?T.C$E`I_Q0+?_`H+ M!U>-_=8V0RH]'&(\UIN#;FE)TW8'U:=9>#+C.#G%@9,LCF:R>_"]QT2]*TP1 MHCJFS1+2+`%DPL075[X*SJKJF;9-J/(&P\.E4J"PUG&>KRSYJ=!85_XJF/A)R_+?O5CK9+1'\%(CZ.(#6K^3LZ@< M.#@.Q-/PGOB"CE>&(O:,4S)6?^*"MHVO2G MACY/&DS:(Y`L=Q[.GWN5ID9N6Z;-A;7T2AV\[ML&Q,"IKI_F[9"Z!L3W8";@ M;'UA(?+ESPQ6O.'^$A&O9"W.S3BGH1@"&W!%O4[N:6%@Z`J;Y$X(A_RDU[3, M+MIQAII4"QV,B%=`R"17UE-=KK(6.AA)KX"0+E>"Q?PR78$N"3?K^%&A#D9Z ME\NI"]3`WZ0?FUG/<>=&I>^0Q#WC%.Y@G+=8;ASG-*G82OX*+]E,-^.^E;#J M_KU`G'XNR3LWBGR6PBK.*1._F#.+_-6]%9#L@1G^")%KI9N!Y2I((?14'+AN M9#G2F_TX#Q&H*I#=3TC8A0N&:697-UTW9[7&N-_S/Y4%WK\;'$)J&05IX[,/Y4ZC'PVZ@;N^L9S M5\D_>%.<=#/=,F^HR8AIYDM[/_>>+8=E!@62>W#7`]3NF$5$2C9,7,97C&FW MKVSKSG9L>4JE&NF8_41%1$P$U^6V85JQI#V4E`[%ON5#/Y9S9CU;<99LP::E M_*W1#^E?%KW9X-?!Q=7+`U&2!_6T.TMQ8N+C MM0S88PG,-DFN/3>\=YZO"7L*2[3:J;1FVJ>Q:L3E3[HU(=-T8U;2J[<_G3=( M)*PUTTYT-8F4@:P](L]^.CMKCDA8:Z9#)VL2*0-9>T2>G_0I>PMHZLH3"6O- M]`-*-8F4@:P](I?,_5&6KT(E8Q=:S=!2`H#^E\7B?IS,S[D"^Q=9XW]@;EEJ*?ID5_J@Z!3?0+O3V%,4^JC$<]2O\E>=NE\3?Y4=EW/W2@S'M MR3UM[IV:YC?Y+>AXP+;M:AYOA(Z>=>5]V^+XXGP+.KZTQ76V.;Z$>+=\F*M> M"O_+G.)XAC2/+*(A\"%]C%P(3L( ML)T]FL+6B/U7V3Q8XU[M#K'][,^V5=<@_4(B[^"0;=]'[L=#J2QS&2QQ&J7Z]Q&&8C@!X MB` MC"X&9'0])`"%&>HE(D!?1`"*_=%+1(#.B``4>Z:.101\-][G*#99+][G+7J? MXP@I^1Z\S[^G>V1T82A=ND?^3MV$4>_]7MR$6W`31KDU?'$3;M%-&.7^\,5- MN$4W89RQ`B]NPJVZ"7<^7*!E-^'T,H!N3:=NW%7VN)]GN0(7,U:ONIKI:\UJ MGS.8'%K19TY>7N2&Z=EAZ5T0EVQLYM.3#)"`HG5)K)`.&0X3C^J4ARML]*,]MX.`L^/;TK8[+@M:&)A&(5-6]N@S7RE8MD`(J'+MAP;Z#@.=''F`-#&5[+NGF\+7W?^*7/+F MC!D-./Q45X.R@N6I3)A4!K@81-LH",_?L/)2;!0KFO-V;IJ/,D`T,\*&`!L` M.>O.Q,W[8U80`Z@/Y:=Y7-\0R>6"E!:76[B4?'F7'JU*=0SYVK?]&)3`D?K.[&S M=])LY*M!R"T]#4Q%4)C2Z"@B"B MO8Y-I'F?CH/30++H)9-J?!2VT_B(M(-?+"?B$MA4ZV"_)TP$-PNMP0$P(JMX MYM;"/Z1QNF'`]NB;]7>4TC9)8[;`I1'3+8,!8CPS=6#UM_06Q+?I:"BH[Z7GY[MTQ:R%_HSX<1A7K.X`UTSGD6'2KDFH*QBLB&I M@*35J2]WP1#'3H_(SG+7''[$5Q#$ M00-++_Y#8'"%-@#E!I-E11Z@5C:3$Y=N?P.;XA6C-]TD_;/=;;Z#H.TEM"ES M[[(UM>&4`TT3C_&L.MUD/>-0=%(*BCXF0PA'5!P!+I1[2GQD!_=,#F8>O0L_ M6[9[Y07!#:$_6%I/)>2DU6&US3UF5RL"1@8:72%]B_GE%3UTN`&Y)+QY[+B0 MN4?D:L3JE0K:\"ME!M2+[F1BV2\]G\HE>/OGI"`XOP42%GERZ-VW&4I]\!;5 MZ50N$4+KFH0BB<);3"=/>$H%+&0=AR!F,W7:\Z4W"_P-Y!:%7Q=*)*8CJQ0L M9F*CKHT/2@O/TW. M>"+;%I1W+(?>&J*V>5>I=C.I?`_Y%M,A&0@%#L-2UCLJZH*$H4.2L+RA%=Q? M6K8?&\4.2;CX!V/9=L!9<9`0JRBF5IW+^90D+G9B9>,7AY*!Z3A=)?R?+&OQ M.U0'YWHYC+%L3Y@%>1KK]L*BYY.-8)M97A3*'::SLDAH'$N6^!4Z_A)550_* M%I:#-%`LM.HE[GA%,D1H92BIF$[>WQG)0@%:'D8#HHPP%I)57BT'MT2[L#LL@+:D.YP>00+PF-68(JYCGI5J"$ M83)K*$*%^^PK8?I]C\44425/%S9\A4[+[")*JT$9[(+]PIS^K&+WJ6O+_YV$ M2]]BGH;`4*[J%J`,8;)B*$"DR[\LWJO>O[1 M4P=IG@KQC3.@.I0O3(8-67#TA`NWUA6G M*7$5*.J8K!$0$!">J`X1KZF:5@3J",I#6<-DDJ@47Y/*"):NPG3`/@=VD0$2,/$(ZK1>;S>.AQ>GY@712W>8;DQ_[Z=EB9OGA\Y(N!($5YW((8.]- MGI>^-_F1_F4^OAHLQZ/>;#!?_MI;S@+%X>GU33Q^F&+@]T=`V] MW0.A/'&.R&GQ\M)`W<*E62+!=2?#2USW\U]>>D/B[=6;_JOR%7#5QL"/5^%@ MJXZHFNWV^R]E>:EH5^CI/)\\D_:8)4>I4*[$QJW:'#BK.!Y"ZV*GB=)#AC=V MK0KKXO&`Y-#;3-/@9&!XJ&X24^WIP?*;*6#?9EX0LGQ5R?7'^(G]HNIFH\0P)?7AKS$R=!'&E#H#Y[6V51PJL+C@*`P^-4JAH9R8HZ43F*)/>%X.9 MDFH+[+2"D3D%U$SH6,7CWZ"J8.L=1IZJ,<&@8%":9)H"TH;I"J,.9KK\5HZ= M;I?>@)Y_'=MB[\@G'4H76Y[OBDP+0-(PW6`H(&2`J]Q)MRQU=<5M82,M@^T' M'2%7$E(#I+/L@C/+7D_4+G;1M=RO/2:$BE!),9A> M6\I&4OFZ6K++&12W.`M0 MFC`=J14@,J-'$*=-N2:@=&$Z3*N`9-AGY5,_[MI]O,P&XS\BMG&-7>?"_H5C MK7[O+U;TER28/K!/]9D,+`.\MR;.@(J[>\@[N)3[M;PN]6OY1/^R6$Z'?_ME M>C4:SQ?_UAO__7:R_+7WXVA\.1E.EO]."UQ<#89_ZR^&M,QXT9O.F,]+?S:G MO[[YW+N>CL97O<%B<7L]*SK#O+C``%Q@]MU9'%GR M5AL,5%!5)A/Z5T$&\+*RABGA@"MF(-?]_`/PC;I)LPEL$4]?A7GKR>9M^80U MNH!RI1`Y/Z<6H!YY.\OFW3Q6U$$PSP`&$`#X3*"#/Z!)Q\=XP;Z.T\#S)YEB M*:.^SD6"(D#C_P]/A;A?]1,:,.4"H$E(JIZ6BRSWN9VX_.[>#W2Y^0 M?,Z0:]NU=]&.,QE)MV),*00+Z>F4I`B.::JLIR:HREHQYBJJAZHB."U2Q=S. M5B%9C^Q'>TU/F+_:Q.%=G$O4-S:[U:9'"(@!8KYX#D7-H6=XM0FOHAUC3I>- M$24$R#QATM->13O&W"MU$69\ZKNR-S7TJE#;F`=E8^24@&&*$F7-*=0VYBS9 M+"6M:,E78F_OF4_Z(_&M+=EW:KI)3E]9X@[>Y3:XNC%72"E29.$P;O=/NC58 MA73OPFS^`@/^&ZX!/['(]U@PZI?$=O]B@'\QP+\8X#&:A@T8X(MSC,#N7E:P M"YCR^J[)RGXT9XN,Z^5%$4P=_#'!![4A"[K868OQR[7+YCR9\N6,6L9%HZ'$ M`^M4/DT[PVG$8COBA^)%<)X6,VKFAJ+)DTX3F.FV48CD41FC0950&$OETH1A MYH(H1O&DE-$01TGE;@W)!]NOQ+%0QF@`(AS%$KETIENXL()B@/>`79AMXYW& MQ?.A2/I.^N";Y:\3[ZQ##J1`''BHX3O=N//2!C#Z`:%])'3E+JUY2'5QS[PO MDUFJX"@OMC%7UNK&E1I0^+:A%]J2*VMUXY(,*'S+T&=)%]1&_TGM;EQ_28)A MBA(EK3BIW8U++TDPVKEA*?1$O/4#U>S&99<$"`9HJ,BM`ZO:R0LN(0PZ-\IW MU;NZN^-=77H%-XW"S'9S),VE"8>.(YJ=()@5>E"SA72Z'5,>'THP`7!7XE!),-9!1! MP-?KP)"NLF<_O?DHOG$_+8?`@:%JU)SB6R*I+E>&['MOSV#('LH9S4]?`]EC M2;4C^Q:([%M$;B)JR+YM&=EW0&3?22*K)W-8'63?M8SL!R"R'Q#YY*@A^Z%E M9#\!D?V$R$M'#=E/[2+[#KB"O9-=P71Z[B@A>RRI;F3?OX8A>RAG-+MW#62/ M)=6.+'`%>R^[@NG)&E8'V997L`]`9#_((JLI`78-:(]%U3YH@1/M>]F)5E-B MZCJCMN69]N,Y#-I#.;-YI6M`>RRJ=FB!$\)'Z0D!W3GL6%2]T)[_=`::$/+E MS*9P5H;V5%1-T-Y$["/339*G]M:E:#C/MKM-^\&[DZFJ!83=[`T@4'8'_\CA^J?KM<+`^'.86 M1S"=B,>)&&2]5\')(WS9MX3GCO*B9B^$*\;(Z7.#Y9+J\@1//Y9\6OAV2'G1 M3APP1%)J#M`^>B-&'`9450G_[ATBA1'!?[D`/K=B," M5`H((TJ@1L91W6[$A$H!H3/!1(P+>ZQO;/F.30(^^N6%NQ'W*1:U%7ROZ/^` MZ&9%NQ'`*1(3AV5TZ%A!L%>RJ3]GP4TY:Q?_/%]=$W]D)UB4%O?SH)U\9Z(U M2T73C&.:1:<"R'VI;D0P/$)#3=%#L^(H&]=2T6H!W(/.*JW)I12V4%:<<1\.IHZ4JE4/I`J97D+.BZ=7D/[SB%+;^CM=IXKFN*46S,:CP.GKB9:;4YQR7GH MTO.'5G`O,\\=530:SU-SLBO%0!,)92^8UWWBO=Y^0$\@$)P2:40T,3,B=V&B MF0$%:.F5S[.I[I+U(27F8.=%;GC.(:Q^LT;#CN`\-H6?+A=9+]R_&KCO1$DO M!;HGUX31F"8X;2JX:*)HZ87TC%BR9"9#YS!-[T?9=$.[/W#7<^)8\9A*Y.#P MUV#[1L.JX.0VCJC6K0EOJH!L*:5:,!NZ);M;D8)%$T&Y+Y4.FM*>9YVZ^V:"[ M-CEOQY4G]\'DR)/VYZB7LB<2]2:A!)LVVC0!'$).Q8K<2,M0ADW;@!J$45>6 MW;A;TTUV()JZN3[GC!J*BMQ<\U#*39N+F@94$^]9]]AKZX4U8^AE/0R]PI:^ MZOA3JT4HNZ:M2@W`IHG0:RN,?.;*TABAM5J$$FK:DM0`;+AVU(,5FW\"+4>G MX[;!G@#=W$F70ZEK(5X5OM;43KI^LU"23=NGF@+0@#HGEK0@;#^A4XUA0VT"Z74M-VJ,0C;]QV1 M=QJ!TX+.M'0JMC&=4E8:./RF#3]P$#3GU9K0XVA`*\5.71=>M+TO=>T2NU&I M-@9E2X\11\V'NQYP[5YBIHOE8.N36#"Y:\O3VE"^]%A@U/B2A,8L06+#J6PC M4+KTF%2TTM72>Y"%T#IV;*!]<$B\*V7^RNS/TVOO^$71;RXPS%"A52BO>BPK M:KPV!&5;1`_DP=M;#/B]C6*K;T!IN-[=CQ*X6Y4]Q@M:*$L_R35'('NIQ!6X.2I,>:T="Z M)@<=`D+]:-\K4>A8O2:AU.JQ:NBGE@>B?GXK@FQ+2T+9T&/,J,T&I@#;II*! M[@?9*/+I#HING6PO-9-.PWMAUF1`72CA>LPG(NJ.,X5"<=!U>9Z&\TPWN4Z+ MID51!2CJ>LP@`-2K!&AWC;I]\-R\VW$NZ#">,M+K'SE/;OHNZR,$2P2%/VZG]M]=P3O485U0YA4PR0M%HXM7CS M.MX].-XSD=>L\KI0;HQ9321D:4./U,B`5H:R8=2:(H=$BZKQA;CKNKXC@C:@ MY."RFT!PP<#1Q*4-O)':\H&;@S*'RS@BB99F9[NT>[%Y;4Z"ER@L%68=HQ_'"MGH4+9'%/,&\"3BTH!49-$D#9OW.W MG8-'-#]F$.+V4M(.=!08,X4HRM6R1EY&S'U932]+ZT)Y,6H%D<)!64=#XNMY MN0(TI(H2<4A5:PK*L5%[21V4VKOG3$+XCZ+[X7>:G.I0@@Q[CLBA@?$-F<(. MZZC?0B<]4$UP+G@D>E:%@:XP=U$/XDP9Z^DW?L@[M#:4#:,6"DDL-#'RV;)= MEH\U#)WXH$'7V>*T"YOPY)N!5'C_T"@+1X@U`-CUX#4_915TP* MMS04?CVV"SGX*T0VHA/TMP_$#6*\E!2BV`"4#CU&A":UH0P8S3>^^Z]_O??F M9$6H#.O\"@@A2[$M*&]ZC`QRO-6"2Q.%EY;M7UO^[R3DN;7):EVM%J%TZK$G MR-'9`'1Z9\[L_ICXCXEI,1Y=WRQ_7;&%$%:$4J3'HJ`T4P*`:&U'3?_A$RL@ MDZ-N@7?8_`;`#XTA8$8>&%WY2%TWHL>#Y-B5=B'[=+7"@&M#N=%C,I#C1A(2 MC2M3/+$.Z%RZ2UQ/Y:YU[/"9):B^MEU[%_$RGRBT`R5+C^U` M?A52@@FA$55"%NNI&^7/B'Y)/3R.BYL!4HW M!N.'(D1=)EM:NX6M0,G&8&I1A*@C9&>SU)6]J;%J%VI#R<5@N)&$I(ND*J_+ MA=I04C%8=20A04CJ(`KO/=_^9Y:)?O!HV0Z[;KIU*T*KG)V"PCL2J;8& M)1V#[:3U"&M&-O!(4RR#2!;'S'8(I3@:8>J=*B0F6^O MROLS<->Y\00C3[Y5*)T8K!4-0:C+%KC=^F1+=]>Y899VYPO==W/U#U`/2A(& M^P(8!DTTW,:/#I!U]DV!*W)Y42C8&$[W(F$UX9M^BJY\&V+S1_5I,2BN&`[2 M/"'U>H4`H>66AB*,X31;(;+.&[5I=LQ*E@_AY=EI62C(&$Z70G%;@?C!]H$` MIR6A\&(XQPE$U;W'F+BA;[N!O#X4 MF5G/[$?Q-7CFU'5J5HA/,"5#(0L'U/9%Z*@Q?;[7#H3626'IA99SZ_IDY6U= M9@G,]W[H!>$^24>VQ0=,$74;A5*/P1;0#(#MV'J2B,$E<]=,.LOIZU<[O)>@ MN_&O0/G'8&;0!+'FQ[-*DB>JA`%`T`5_XOL@ M`[^H!A1^/98E9?BK0=!EMTAV5NS-Q.EFKYCNK\3RN38*814H`7IL2*H$0� MQ,#1!6?V<0[XW-)`W,_/]!B"5(&OD%[7P;S`,^^@?50(C+`>HXDJPN6RZKH7 M>"#L:'!X^B7FE>[YTA/8P%WOM6OSB^=0Q-@>P69K?CH4J&"\JX2&&@<3J<<$ MHDIDL]AJ/@/O+Z(&8=IOT9)>60M,F1ZKA2IE0#0T<3'SO14AZX`YK:GQ(M4" MF",]Y@E5CA10TA63:P7W6;!WSM$PMRR"2)-O!LP<+K.#*EYFIK["VR^+>\^/ M'RJ/C6K,7IE%;JC-D.#&P53C,B@TBZW6726=3W9V$'C^<_Q]X>;RI"R8'ESF M`Z'D>NTV^8@G=L^7YWYO<3PZ6(.FT0;;![.*S"K1-,)Z34CZ1D)S[8-'`B[S M2.,(MQXID4FN&B5Q4A_*Y#DN>XLT0OHS=Z4?_'MD^2&[(5AZ0^+-2/I00^S* M`7\H0:HQ,(>X+#KUL$-%Z'[\-)DQ.7J,],+_( M[$YU$<3#K%A]59L#\XK+R%07/[UQ8V4O((RGL>6+!`']/96:>=?$>=O#Z>;* MMN[B+$\<>NLW"Z89E[&J*3P-O_N1>PBH8GY6;@],,"Z[56T$\3`KL<52:!+, M+RYK5!,XMC]75_10RT3>Q#>A@^0U+D-7*TQHRVY@AX5@I87ED`GS]WBT0A8T ML1(=J,&UPVO9Y8?/D]<)I--T8NQ9"\I M!H&]=>-+&7=]2-4K?X%9]S-0SM_@.G+KPKLU6XW.4:+M:^#!@NL4KQG]DC'S MEU^1G] MVW!Z?3U97H]OEHO>X&9$_WVSG-Q\'M\,)^-%[\>T_=[^`__^0Y-1].`\$,>A M\8"*C9ZG_HCH\+TD)+QB[Q.MIYL-2S80ATF1>R\*R.+!XGI]@FL#%1!13@Y) M8'2Y[5*5N'>>YPPK)W$I33HB8J6J$MC!%@\;,!QT)7J-OQ0/@R2[CBCRFU<8 M"+H>PZ4:Z&*Y<22<&Z5O/["1,:1_EA[?TL)E98&T8'E=6R`))E:F#_%NQ-W& M@R=@W61O>;A!]C9+HLAE.I0V`6\!R""6?$_2\G6#UQLB4+R*:D`&]9AG-3"8 MP\+T%ON\OXCN`O)'Q'KWR*2"[:L_EN^KS^G?%K<7B_'?;^F^NC?^$N^NF]I+ M-Y2"]$A@P88[RYS)K='H3ILNH208S++7BG+W[2S?EQ7<\S;9@(JF]M>5")9L MK,$XM!#RS[[+7!U*.\6]L@/7-[;35N!%&A:$3W!E.=4F<6)+SP^6]U9XX47; M^S`1I2B)6.]4&S.VTU<@O1Y@NNYXC[X<7X0FCL>Q[2MG#Q-.F<`6C!T!E"=/ M*6C:UI].R#3EK&=OP)QM>!JE\)C$[4<::>UC6WOFZ.)!XE9 M8B8N>\2A)C_[1H`T->_(H8^F(X`TY[39]V1!^^"06(5GQ(__/%7P..7V-Y3G#EUN!) M71&P4Q,S!$RRX,ZT5Y)!5Q)-PA/'=(Q3'GJ:B+VR5\P@?4E8Q`X=4/PGZ$I+ MPL.:$-`@D%77O?#A%;6Y]VS1O2<)IM_(>NH>^L*[)095A?NX(=!>+(H[/HH2WVONG@)6&7QQ:)I-&:$T;_CVG2@F5F;FCXD; M>XT&<'8@;4!)0G(T5<"G;:Y&$1E9W/6INAJ4$12G5"@*".?`8F;CH??HE@K" MX1%<&THGBD.O)"::5`O8BXJ)4+H5*%,H3K^*&+4Q&2;)$^)++L@D6"@.Y0#% MX;9*:H23'J_+,IN*TFI0XHP?:6'BM*TMJ_@H?6WYOY-PZ5O,ZBA\[T>F!2@U M**[.%;#1Y5<;QPC=NJ'M'!T.)D'N!QR&P+6A[*`P34ABHHD9YLG/3(:'Y`+$ M)1N[^%)>>A_/H4>N"2A'QNT2\J+57*GH)D3+.B4C1,7:I=84V(NV:Y2WM,8= M/2URZ?G%C6GFDB_V5P%4AQ*%PH`ABXI^?R'QN\]E!:&`H[!/\"75"VTA%T[% M:4A0.KP>M0-EU[B1 M0U$^+L?\(._T-^S_[JR`T)_\?U!+`P04````"`#!A@]%V!I/1-XA``#)K`$` M$0`<`&5R9V\M,C`Q-#`V,S`N>'-D550)``-J<^Y3:G/N4W5X"P`!!"4.```$ M.0$``.T]:W/;.)*?[ZKN/^A<=W5S5:=8LIWG)KLE2W*B&=O22G(RF2]3-`E) MW%"DA@_'WE]_:/!-`B!(T0-HE:F:F83HAOH!-!J-1N/]WQZW5N+[F`QG$Q..G_[ZW_\>P?_\_X_N]W.E8DLXUUGY.C= MB;UR_M*YU;;H7>Z78%N/R/;<-R[^23I=N/[NW>GI]^_?W]A.P_:=\?]YKW0';'N%D[@ZBCI M:SS_./WOLU&_]\?OO5?GO?Z%MEN_>%QA'D::C]O/\"?J\$?\O7_,!+?JOW^*9W<='#_XBAWYB>GB"?_M+_S7O].#=_W03VFV#PV_G$ M^Z*A\9?[F?_X\]LW7[Y:E]Z77>_^WOKE'T_?7._F8;8:OGI]-OKYR\7JXI?P M)]][^@9MM0[6NNU].,E(\OOY"\==GY[U>OW37V^N%P3N)`1\]VB9]C<:>/_M MV[>GI#4&+4$^WKM6W/7Y*33?:QY*>L:M)@?>M#U?L_4QD$?%(2T4)-NQ[6!+EX[ANZ?^TPZ=8J`NAD*NJ2=XU4AY!$P#?*931UHH MU,'421#@+P0&9A&V(1;:(MN_W`'["UR/<)'T_Q M_`J`JH%MC&W?])]@LKE;TO-)QS0^G'`AX+?P+Y-?,]#*M$U"4B_\I]_I=F+T M[!\UV^B$?74RG;T_+7:3Z3SPD#&U_TK^O'.1A[LA2-?X0X08@3"0=,W2`ZL> M3DH*%27Z$$NYEMR'CNTYEFE@@VI<:A9,Y\4&(=\+A=2X'UX/;X;BS^#0>+Q<_Q`WRG&DNYFV#?!-37"'[/"Q?$>?B MBNC\E.OX?X]6,8F\O.EJN@._"?\B94(PX/@*N>`I9+'$_[L9WV)E3*\ZT]EX M/EA.,,`/54Q7"]_1OVTGT?AJ,IPL?TPBG@XJC%[]+O@Z?=623G\82HH! M'&K>YLIROE?8R12,KZO7XF9R.%A\ZEQ=3[\Z`-SV=?QS<3GXCJU-G<#LZUK4*Y'O6 M703;K>8^83-EKFV\C=(UO$W1=2?`>PM[/=S]N3V,[9(T_G7HQ/I17?F.MBF^$^P-\>K\PZ,=BI=1CM?T'VJ MH,%[GLW!V.`%&>P.K,TS6`J.3NHONS.\/.)%%0OUVM21[2'O%F7$S@+@R_V, M*G=PAV=XT84E%\2.C_%_G=GQ\HG_5Q;;:#9`Q?MP1L:9"+S?QQ7U. M%3=XJMA8S^^PLS/^=49$?712?MV%_WHS[4F[MU`JXL)WOGPOJ/)]'?UA@0?U MU\'E]?CHA/NF.T<6..=X*^,_+5W-]C2]X#AR8/A"?TD5.GB3\_$U\>!G`S#@ MR_G@=C$8'J?;^+9;$=&H`N+KX!55!^`R_@A8Y/=0O>[0V6Y-?QNME7CK"DXX MLO-.>P4<7QNOZ3NI'MG9WMQ,EC?)THIWNN"ACV^/TCWO]_'>Z-Y#?P28FS'X MY%D54!KYQROQ#D;ZZ+XJT'YNFBZ$S]>Y7!.+$?(UTS+ MN]5<^/"`A(XY2TA\A3$VZ_QC3ZRW\%+<87]U=XW7^\YAD#"P_C3N# MQ8+DO$6_UXW@RY$/]R[,5&#KCAY6J8CM_O`#RU'=,=T("W0KC) M7M\X!K(&GA=L=UEU"9U_->F7KWUZ5$/@L*S;N;P>#'_I+H88!L+\,Q@9W=D< M-]]^[-Q,1^-K"/K?WGP]$F26-TP'XJJ/'-$!UH2XZ,%D_ MAUH[7M'/-7N-H%X`F13C1^3JIH=@SI2]02%HOE+HD0I0"C:?'\=AF8%P0HQ_ M'<^'D\6X`W/FF-U%//P#'TH;0:6M+["@V)3#2RX47RGTL`.9*7?+Q1+O6\%D M?1G,L8Z.^HR2L_2P/9$Z2'P]-<_<^.&.5-R7X.1QU,/C:[#IO8L?&J1?M^"H M30"8KZLZ=S7^M?4#_X%"?'.TZI`"?N^@SMN'$\^$6HTGT;>-BU8?3I"[=KIQ M6;;?,6LO'K=6#`)=2D_;8-G2[NNRC%&0]8R\7D/_K3*)1U]=)@L#]IE8'::_TBK# M>.K493@_VYZ)WU'R(UEVH\*'IVGEP^COQ>J([S'CCNMW[%)Y15YYS;`PZ+6C MDZXX*/"W;HS7A4_=_EGWO/_B$4Y!3QL0D8JA'A$Q7@,BZ'5#!7\^1H#??5GK M%UEE11D_3,6!/W139-'?Y]8HY?T^%?$46;X7?]F3FG)]T>;DD+X:T"-06E5D M<&0Q;T-$&"1O87#V7^U)3#-"JJB(*K42'PM]AX,*IP>L7;U[.D*OC M/][9>#QBU\D8!>@&.\T;Z^D&;>^1>T(8"?VT9NBF90'2AQ/?#<`D0F7@=]A4 MFHZQ)!;=",)KF?;$1UL`P_+!+B*VI`&`?G2=8/?A).S+ MQ"`U.;_8CW-!=.F\ MD-7(PJG`2Y;$:^1YD56;X44<]U9B21!L?(L=IWYO&>?TF5$6--E53H`>2CI?+!G&H4=46#EN.*/L%J6MUE7TB4R\;P`&?&!49Y%1IMTFLF! M"H1W==<,CR+S='/:I=-.=?W[^^TF6ZJ$CM2Q:U+U6D]C6+VMU;!:E]R9IE+U6<96]8X_:->N.V_Z)' MEVVN015J>R_.WS!DFVF03BW%4>QA<>[A9PJB2^>\N#%[$Q&]V"LN4;L7Y>10 M&92H@R"=NVR5S2HW5N72I)2["JS.&[Y!ID$XMQ>[U M2V*?V#[",O:GMH#O((BN(N>WSD-LRB[>%+E@'F^WT9&*TJ`E:)R_/M\SQ8/> M@W3^T\G)VON]4G%_\HJU]WNET-Z/Y5]7G_7]K-F!YCZ!N1=SV9MU><`22I;# MMN13[E`YZ917F'W%LU>/ARR?PO): M(7VF`)O7+<+?G-`>[3U70_9D`,5HO^%/-4 MG\<0`O=BVNMG#S]EMW5B\:<"1B5[X;T#/VZZ#Y^L_W"BXWD(;UIEF<;S$/G8 M`6B![331`Y(01L@SUS;0'3/):1=G*:@FMAR%:N"+$YQ=9!:*Y4`]T_HTY9=%\Y M[A"^6^&UO^EJA.[]O'*;HE\@]\'4D2>L[1*"PCJ.:175 M;!'^T/2977P8GJ"8GNMTI*K^!7@0&A='MF41W,=WMU,>H#3&%Q=WY*Q6:09_7315O3IJX"(VL-SH1@9(6?52"1\_ M^M@]`X_-SF[B!&&5Y94,MNEJ%6XDIG:I'$$Z-F.6ZZ$HR_G$QC^@>7#]@_Q? M.*6@":*J$QF>$\:T:Q9*K1)']>+@RJJ=?KQ,]S+X1]),'%65G66#>=CDN#Y< M9:&Q+H!S"*P+C_:Z2*HRGQFH8;AQZ81'ZPP#5P->V6DNFAY4-YU(99[!UP@5 MAGV0Z'7()#&3WJ8L+T0'2^?*M/'/F9JU\#4?A<\:%%).12"52S@MO^*Y1(_^ MI949D7R0IEG!?MQ'"TQ$DZ+@) MS,]'QS&\:;*39O#?1D=*"`2C;2'I_,Y#J\"Z-A^0AW=8GH=\;TE6Z!+G=3!4 M8#%^6'V&EU8_^[HZG3]Q"W%H8*+);6]15$H3&YR0+(]`!HD+59 MBM]A>10. MM9WI:]8UG!7PU=H`[S"XYBJY`9Y"7&>"I<5C`WJ3[&-[O-W#+O4@XYG1(Z(" M<-)9`3JB!2S13XG::YX\"%*9@<\)[!3"%#!%VS/'8,/4PF@>&\B9U MYEF-:M.O/7+H)XT*T7_EN,AHGVYUFNF'R!;:2>&<# MQC,,^86&*`IW?L=$3^+*%%$Z1S/L=XX\Y#X@DH2$-W)P?#2]]_"> MUD<3&YZ6=MRDAHD@K-J<#HQ_!!YY\+P.S^)8RIZ0,O:^#3:Z)H9P5F)43""Z<8++UKF-DA2@^JA-'3Y MXJ]_%HO:8VT6$Q3Y+,X6\ZLH6^`*I5&4XE=%Q^#,Z##OVE2#J3JK;LABS$C< M2=R8"B!5F;L-P&HSZXME%)6DE]?!:%85UT"ZN=6L-ASQ\$I>[@;#U/XYL-%Y M#Y:JQ/&NAE-5@W32!\$Z\/S^.2Q??"8+D*JS"3H!C616Y(F=?9VER*T(PD$R MG;Q;(,1Q%EI5=G,K7F;VD>O#!C*`(>KJR(:5NS;29QQ1Q7F_>FKF`575&MMV M]EY6\YB#4Y7%_&"[0O36M(ZI M6'>JQO5$.!PAG4S9=N0EU)NJXJ)%/)(PAWADB(U2/PNWW>#('B,^"O7&IJ*M MB<3H5M41(C@%B*]&F0?["K%^UZH*LD"NT%RKB2-[LL7^0V;#//N+!I&9&12TD+WZ$IR?#U. MA(X+2Y0)CMD5@I3\#%'NUDQ^SH4DQDS$6DBS8^LCRCX922Y4EZFE?%F[B'0P MM#3/,U'$5I/9-<#:UGZ5G5K(`2/V"F%N&3>Y=/\=W>W-)>$T=5>Q[& MC#,;0G((/D);S4XRKBM@5&4-QMP7T]_$T9C8M1KA16G@D9.FI4/^EW7\A3%4 M93MOHB=0:<$S\?",,EA"WN`&988YNGD7QI5L\,D<2VO]Q-+B8;0X'`6P*GZH3*AP/B0H.%C4OA)+@FCJJL1W/G M(_P'W+V+'OX'5/C)L;!9P(,P6C#950R+\%VF+&3'"T,K>?\@-*M%$H+I(\G." MF!27;BL*07;D#II MY<6!V1!7V74P=@X.:Y39?_QOBR;6EZ")A[N8#+1E'I ML1A:ZDL=4Q>&A6K1/W,\'TZ>0K=I_+C+55M_CIZ5-3(A=YE#FVQMS]*&1Q#X M`+CU*!S$^[EH8\#FOAZRY$T?5VG%FTEBL*K&H6MIB,EZ+5S)V\1BK&CI#%8K MTS(UN$D6DAQ9*?IUNBH4537-XR+CV=`R;8H^?3M=28Z%\YB`T]>99F*/]RJP M+!&V2QA-=V74N$A-'-F;ARO-=$G:1Z8R^-STOEVY M"&6#^L6B2;71)+M^P@07*B?51E.03]A[Z3[4,'TP#60;7TUD&3P.60@*\_;9 MP1XJO+/Q)#A:JQ`/A]?J$5N%J#"OM()MPN`*E?:L)%I*&AKE/"0O,X01=J3(P1Q>-G+9$C00/>Q1?2?LH^GT%H4?C,E3V[^J11Z MFWHOI!"E7FI>/MXX@..;-0&]?$I!9MH3?!I\UURC_)A8/O#Q'!U+SLUKCZ7V MA:3`UB938#]WDEE80"HI%5-4&5PV M8X5%/$=MP;R*@(Y@28=Z M8(Y-G(1`LR"9I2@HJ10HY"$/UFL7K6[,)Q.'N>RGK#P(M,2,U8- M)MF3GP:)"8PRU7+#CM&J\H`KD5P8:LQV]099_AIH_IB'T29[Z\.XCE7PL"NA M9#LW+`+S_G0EE*ILA'(N.`BBP))=:;[0!7DJ`DOG:6>&`P'.G,<:QLD\><=L MW<,'Q1VU][9ECKYK_"^+]J1-$I!O36/]GS$=R&>\7"9B/DF6M;(ZFRW)2*YNBR0]#4/`C-S16' MJ0*2?<':_",PC3"OF9"([#"-HTAVSO.KC269RTO-,[WE1O-I&7ZYZW/4>Q;- MT:5/3=KH"Q<52'37O`UWG!8AY1O,RT<9:<[W6S'9=K&C_H&PM9DS<;D6%94L(U2%[Z5GF0/A?V9 M*.;*M-BAY`U*AJ9P#8](+C!2N4KNT8>RTV@?O@HCIIVN5+V&%5\RCQ?UW.MS M&6]1=$"UV)^R@RM?-2C'7\R>G[]M5EJ:]^M"R%^J!GJ.H\8+40C_*V@V>KD/7W`LLN!>(`1],/9TM31!E#X@H M)9X3>,H/;^#!MRC,M]'1X0R)E"N!T-U!J%EZUMZT9,00(GN3O`90$7*@@,L>N(*4%C8#M;$4.=E-B%U@ M,JVP$'-\G;<<"")9W-]MUH%UDVYD'Y64.!C8OFF8%NDIJBQ&YX`I@SH]R![M MF8I]!7ZB3PIE&U-J6F7JFV26^JC4%W8572SZF^&KF$E!;5(NC2(ML)"AE_&&'`7B$!03#KB[G6-G3QD8MO\^+XRBH^#G%%O!%1SY&GF_"^'B3H)&5YSA`_"B!:,"-$%0[IK@(($)9.]IKARA[.>7T5SFSS.WLQ4*49(H?0QO1[ MYDQ.&%S94?M1,VW(C_3]L"6^0L[B*F:]`9ZJJ?=1BA9DQ9@/:(9_LQA:Y$$H M%V&DA'[C=<,C[QFL''>KZ16+9P62[(D:+1@Q8;9.73TIS:H.0KX"!)]!86/( MUE?LR"<4?MDXRFE3Y(9,[X+6:A.'#]*Q0C25*MZO"V77G,*6 M!?LSX6$R42+432J:)3ZD[`NBI<4A?OYY4J"%!\1":@C M9[E)T""\0`\MA0I##?!D)[TP"_12(B%).D1-)-F55WA%_*@T#VPCHRP&VPVZ MD7SY.RG+5J[##*]LI`H6`53UEL8=R1M$<5W!7#"9T:8J*Q&9V(RLD)E1#^6[ M[)4B/TA*%+.;5=UK9*=S4C$EYYQ0&F5K(4]7KD`-O4DVP8Q"D7BDI.5`LY27 M#)0XGJJ3G,E*9NFH)0(VGJHB(-?L[VP7Z<[:!GO]KM5*#$VSD"FG(]XQR'>H"9.J'4\##:_I0VUG8J/21$`BGW+YE`LB>V,7E8[D,L`%DU\^)-?(KB5X6DO=@AW=2L-)N5R!4;YFA!'MA)AL-]SOCH*A,WS9@,.O<-\%05087R\G?[-XY+KJ:1!'9PSXMES%KK355Q MA68Z_X!PP8:7&Q4RY4E9[VRED[PF$K>[X,G0IT*;'4JOH/+8LFQ:[%"R;-@' M,?&4%SZY*2-(/JS('.-'-/T]T%P?-EM+9XB<&8I2/4EA3DZ:?#ULV:M^,\(3 M1>['?[8;U3,C&*RM]AH8'&RU!P:+\)H#0Z0;A0=&YE[?>%I,-;6-Z#8?!#:C M3/_BS=KF'<@?'K5I+XR+QOC*#@AV0ACFD'B]R/-P.U[Z((`7U^.[-K5[\H1V MU?7!&OVHZCG3>"(5Q`H#(*PA1G+J*VZCU^A`_IRI33O/GC;IXQ#G3@5[[4RL M5GY$U5D',%?Q@'EY7]91_Z7ZLB_O(5<.LN-Z1HS MO)%\FD!]%<\T4$@#W'+SX`$KLI_$VPB\P&_)D9+`UGSO?B5G5Y?]FU8%]GS= MJYH*M?@CP*JY0LB_AEL3QG2U@L039H<.W>>-,LWD0=WKZ=VRD:B%S%813D5JO2$.8`$+>9.GH\C M>6G)TY.)WKGFVK0UBZ2>D2UQ>:@*8*BZ`&3JM>5/=$+R,L MS6T;CM3(]$A\8VJ3=3N30QBSP860KZ/WIYZ^05L-__'_`5!+`0(>`Q0````( M`,&&#T6AM9K\-ZD``'5M"0`1`!@```````$```"D@0````!E`Q0````(`,&& M#T7-`.-Z7A```)>]```5`!@```````$```"D@8*I``!E`L``00E#@``!#D!``!02P$"'@,4````"`#! MA@]%06FV'28:``"TA`$`%0`8```````!````I($ON@``97)G;RTR,#$T,#8S M,%]D968N>&UL550%``-J<^Y3=7@+``$$)0X```0Y`0``4$L!`AX#%`````@` MP88/11(;9G57;```_R4&`!4`&````````0```*2!I-0``&5R9V\M,C`Q-#`V M,S!?;&%B+GAM;%54!0`#:G/N4W5X"P`!!"4.```$.0$``%!+`0(>`Q0````( M`,&&#T4C)!402$D``/O3!``5`!@```````$```"D@4I!`0!E`L``00E#@``!#D!``!02P$"'@,4```` M"`#!A@]%V!I/1-XA``#)K`$`$0`8```````!````I('AB@$`97)G;RTR,#$T M,#8S,"YX`L``00E#@``!#D!``!02P4&``````8`!@`: )`@``"JT!```` ` end XML 36 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 6 - ACCRUED EXPENSES (Details) (USD $)
    Jun. 30, 2014
    Dec. 31, 2013
    Notes to Financial Statements    
    Executive compensation $ 710,928 $ 476,368
    Other accruals 108,199 60,671
    Total accrued expenses $ 819,127 $ 537,039
    XML 37 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 4 - PROPERTY AND EQUIPMENT (Tables)
    6 Months Ended
    Jun. 30, 2014
    Property, Plant and Equipment [Abstract]  
    Property and Equipment
         

    June 30,

    2014

     

    December 31,

    2013

     Office equipment $ 27,507    $ 26,284 
     Production equipment 85,046    83,615 
     Leasehold improvements 16,328    16,328 
          128,881    126,227 
     Less:  accumulated depreciation (76,094)   (64,082)
          $ 52,787    $ 62,145 
    XML 38 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 7 - NOTES PAYABLE (Details) (USD $)
    Jun. 30, 2014
    Dec. 31, 2013
    Notes payable - current, 7.85% unsecured, $781 due monthly
       
    Notes payable $ 0 $ 1,964
    Notes payable - current, 4.15% unsecured, $2,678 due monthly
       
    Notes payable 2,545 0
    Notes payable - current, 4.15% unsecured, $2,771 due monthly
       
    Notes payable 5,513 21,824
    Notes payable - current, 10.00% unsecured, interest only, due December 30, 2014
       
    Notes payable 25,000 0
    Notes Payable Current Total
       
    Notes payable 33,058 23,788
    Convertible Notes payable, net - 8%, unsecured note due June 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share
       
    Notes payable 312,500 263,496
    8% secured due August 2014 (net of discount related to beneficial conversion feature of $8,200 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share
       
    Notes payable 47,950 37,700
    6% unsecured, convertible into common stock at $2.00 per share, due March 31, 2014
       
    Notes payable 50,000 50,000
    Convertible Notes payable related party, net - 8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $25,345 in 2014 and $40,552 in 2013), convertible into common stock at a price to be determined after June 5, 2014
       
    Notes payable 27,690 22,448
    Notes payable - current, 8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $23,655 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014.
       
    Notes payable 28,483 0
    8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014.
       
    Notes payable 15,503 0
    8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014.
       
    Notes payable 10,273 0
    10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined
       
    Notes payable 17,913 0
    10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined
       
    Notes payable 70,600 0
    10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined
       
    Notes payable 6,558 0
    Convertible Notes Payable Current Total
       
    Notes payable 587,470 373,644
    0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share. This note was paid off on March 31, 2014.
       
    Notes payable 0 23,427
    Related Party Long Term Convertible Notes Payable Current Total
       
    Notes payable $ 0 $ 23,427
    XML 39 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 6 - ACCRUED EXPENSES (Tables)
    6 Months Ended
    Jun. 30, 2014
    Accounting Policies [Abstract]  
    Accrued Expenses
     

    June 30,

    2014

     

    December 31,

    2013

    Executive compensation $ 710,928   $ 476,368
    Other accruals 108,199   60,671
      $ 819,127   $ 537,039
    XML 40 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 41 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
    6 Months Ended
    Jun. 30, 2014
    Jun. 30, 2013
    CASH FLOWS FROM OPERATING ACTIVITIES:    
    Net loss $ (1,046,151) $ (1,490,612)
    Adjustments to reconcile net loss to net cash used in operating activities:    
    Depreciation/amortization 19,710 14,410
    Gain on settlement of accounts payable (103,021) 0
    Amortization of discount on convertible notes 254,202 51,591
    Stock-based compensation 388,541 725,434
    Loss on sale of stock subscription receivable 12,965 0
    Changes in operating assets and liabilities:    
    Accounts receivable (19,573) (18,944)
    Inventory 25,875 24,675
    Prepaid expenses 15,090 14,397
    Other current assets (1,300) (919)
    Accounts payable and accrued expenses 196,224 365,541
    NET CASH USED IN OPERATING ACTIVITIES (257,438) (314,427)
    CASH FLOWS FROM INVESTING ACTIVITIES:    
    Purchase of property and equipment (2,654) (38,105)
    Acquisition of patents and patents pending (net) (7,341) (5,117)
    NET CASH USED IN INVESTING ACTIVITIES (9,995) (43,222)
    CASH FLOWS FROM FINANCING ACTIVITIES:    
    Proceeds from issuance of common stock, preferred stock and warrants 0 372,000
    Proceeds from convertible notes payable short-term 267,000 0
    Payment on notes payable (20,969) (14,271)
    Payment on convertible note payable - related party (40,000) 0
    Proceeds from sale of stock subscription receivable 40,000 0
    NET CASH PROVIDED BY FINANCING ACTIVITIES 246,031 357,729
    NET CHANGE IN CASH (21,402) 80
    Cash at beginning of period 36,886 13,081
    Cash at end of period 15,484 13,161
    SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION:    
    Interest paid 840 770
    SUPPLEMENTAL DISCLOSURE OF NONCASH FLOWS FINANCING AND INVESTING ACTIVITIES:    
    Conversion of accounts payable, accrued compensation, notes payable and accrued interest to preferred and common stock 32,520 348,614
    Debt issued for license $ 0 $ 140,000
    XML 42 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
    Jun. 30, 2014
    Dec. 31, 2013
    Preferred Stock    
    Preferred stock, par value $ 0.001 $ 0.001
    Preferred stock, authorized 5,000,000 5,000,000
    Preferred stock Series A, designated 350,000 350,000
    Preferred stock, issued 237,807 281,969
    Preferred stock, aggregate liquidation value $ 1,189,035 $ 1,409,845
    Common Stock    
    Common Stock, par value $ 0.001 $ 0.001
    Common stock, authorized 150,000,000 150,000,000
    Common stock, Issued 9,133,091 8,297,645
    XML 43 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 10 - COMMITMENTS AND CONTINGENCIES
    6 Months Ended
    Jun. 30, 2014
    Commitments and Contingencies Disclosure [Abstract]  
    NOTE 10 - COMMITMENTS AND CONTINGENCIES

    NOTE 10 - COMMITMENTS AND CONTINGENCIES

     

    Leases

     

    On April 4, 2012, the Company entered into a Commercial Lease agreement with Lanz Properties, LLC for 13,081 square feet of office and warehouse space located at 13565 SW Tualatin-Sherwood Road, Suite 800, Sherwood, OR 97140. The new lease commenced on June 1, 2012 and will terminate on July 31, 2015. No rent was payable until October 2012. The base monthly rental rate started at $3,160, increasing to $3,260 in October 2013, and then $3,343 in June 2014. The Company has straight-lined the full value of the lease agreement over the life of the lease and has recorded this amount monthly. The amount of rent expense that is above the actual rent amount is recorded as deferred rent and is shown on the balance sheet in current liabilities as part of accounts payable and accrued expenses. The amount recorded for as of June 30, 2014 and 2013 is $4,160 and $15,585, respectively.

     

    XML 44 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
    Document and Entity Information
    6 Months Ended
    Jun. 30, 2014
    Aug. 14, 2014
    Document And Entity Information    
    Entity Registrant Name Entia Biosciences, Inc.  
    Entity Central Index Key 0001408299  
    Document Type 10-Q  
    Document Period End Date Jun. 30, 2014  
    Amendment Flag false  
    Current Fiscal Year End Date --12-31  
    Is Entity a Well-known Seasoned Issuer? No  
    Is Entity a Voluntary Filer? No  
    Is Entity's Reporting Status Current? Yes  
    Entity Filer Category Smaller Reporting Company  
    Entity Common Stock, Shares Outstanding   8,437,345
    Document Fiscal Period Focus Q2  
    Document Fiscal Year Focus 2014  
    XML 45 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 11 - SUBSEQUENT EVENTS
    6 Months Ended
    Jun. 30, 2014
    Subsequent Events [Abstract]  
    NOTE 11 - SUBSEQUENT EVENTS

    NOTE 11 – SUBSEQUENT EVENTS

     

    On July 14, 2014, we were notified by the Michael J Fox Foundation that we had been awarded a grant to conduct a pre-clinical study of our ErgoD2® medical food formulation as a potential therapy for Parkinson’s Disease.

     

    On July 14, 2014, we entered into a debt agreement with an investor for $42,500. The note is convertible after 180 days and is due in April 2015. The conversion price is not set for 180 days. Interest accrues at 8%. We have calculated a discount related to the beneficial conversion in the amount of $30,776 and will amortize over the life of the loan.

     

    In July 2014, an investor converted the remaining $33,000 from a note due in August 2014 for 226,530 shares of common stock.

     

    On July 1, 2014, we entered into a promissory note with Dr. Sobol, (a board member) for $15,000. The note matures on October 31, 2014 and does not accrue interest. In conjunction with the note, we granted Dr. Sobol a five year warrant to purchase 15,000 shares of common stock at $0.50 per share and fully vests upon receipt of monies. We calculated a discount on the granting of the warrants in the amount of $5,445 and will expense this in July. The note also contained a conversion feature where the member can convert the note into common stock at $0.50 per share. We calculated and posted a discount related to this beneficial conversion of $7,545 and will amortize this over the life of the loan.

     

    XML 46 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
    3 Months Ended 6 Months Ended
    Jun. 30, 2014
    Jun. 30, 2013
    Jun. 30, 2014
    Jun. 30, 2013
    Income Statement [Abstract]        
    REVENUES $ 104,693 $ 73,887 $ 267,261 $ 170,143
    COST OF GOODS SOLD 36,202 29,408 96,024 57,987
    GROSS PROFIT 68,491 44,479 171,237 112,156
    OPERATING EXPENSES        
    Advertising and promotion 13,136 81,878 35,086 128,273
    Professional fees 38,454 30,302 87,216 77,239
    Consulting fees 191,063 441,401 293,592 528,739
    General and administrative 342,938 493,896 717,148 805,814
    Total Operating Expenses 585,591 1,047,477 1,133,042 1,540,065
    LOSS FROM OPERATIONS (517,100) (1,002,998) (961,805) (1,427,909)
    OTHER INCOME (EXPENSES)        
    Interest income 0 2,450 0 4,898
    Interest expense (96,684) (37,790) (174,402) (67,601)
    Other income (expense) 0 0 (12,965) 0
    Gain on settlement of accounts payable 103,021 0 103,021 0
    NET LOSS $ (510,763) $ (1,038,338) $ (1,046,151) $ (1,490,612)
    NET LOSS PER COMMON SHARE        
    - BASIC AND DILUTED: $ (0.06) $ (0.14) $ (0.12) $ (0.20)
    Weighted common shares outstanding        
    - basic and diluted 8,532,935 7,456,281 8,429,958 7,308,930
    XML 47 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 5 - PATENTS AND LICENSES, NET
    6 Months Ended
    Jun. 30, 2014
    Notes to Financial Statements  
    NOTE 5 - PATENTS AND LICENSES, NET

    NOTE 5 - PATENTS AND LICENSES, NET

     

    Our identifiable long-lived intangible assets are patents and prepaid licenses. Patent and license amortization is $3,849 and $790 for the three months ended June 30, 2014 and 2013, respectively and $7,699 and $3,247 for the six months ended June 30, 2014 and 2013, respectively.

     

    The licenses are being amortized over an economic useful life of 17 years. The gross carrying amounts and accumulated amortization related to these intangible assets consist of the following at:

     

         

    June 30,

    2014

     

    December 31,

    2013

     Licenses and amortizable patents   $ 234,324    $ 234,324 
     Unamortized patents   346,231    125,301 
     Accumulated amortization   (23,826)   (16,127)
     Patents and Licenses, net   $ 343,141    $ 343,498 

     

    XML 48 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 4 - PROPERTY AND EQUIPMENT
    6 Months Ended
    Jun. 30, 2014
    Property, Plant and Equipment [Abstract]  
    NOTE 4 - PROPERTY AND EQUIPMENT

    NOTE 4 – PROPERTY AND EQUIPMENT

     

    Property and equipment, stated at cost, consists of the following:

     

         

    June 30,

    2014

     

    December 31,

    2013

     Office equipment $ 27,507    $ 26,284 
     Production equipment 85,046    83,615 
     Leasehold improvements 16,328    16,328 
          128,881    126,227 
     Less:  accumulated depreciation (76,094)   (64,082)
          $ 52,787    $ 62,145 

     

    XML 49 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 5 - PATENTS AND LICENSES, NET (Tables)
    6 Months Ended
    Jun. 30, 2014
    Notes to Financial Statements  
    Patents and Licenses
         

    June 30,

    2014

     

    December 31,

    2013

     Licenses and amortizable patents   $ 234,324    $ 234,324 
     Unamortized patents   346,231    125,301 
     Accumulated amortization   (23,826)   (16,127)
     Patents and Licenses, net   $ 343,141    $ 343,498 
    XML 50 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
    6 Months Ended
    Jun. 30, 2014
    Accounting Policies [Abstract]  
    Basis of presentation and principles of consolidation

    Basis of presentation and principles of consolidation

     

    The accompanying consolidated unaudited interim financial statements and related notes have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP) for interim financial information, and with the rules and regulations of the United states Securities and Exchange Commission (“SEC”) to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The unaudited interim financial statements furnished reflect all adjustments (consisting of normal recurring accruals) which are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. Unaudited interim results are not necessarily indicative of the results for the full year. These unaudited interim financial statements should be read in conjunction with the financial statements of the Company for the year ended December 31, 2013 and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the SEC.

     

    All intercompany accounts have been eliminated for the purpose of the consolidated financial statement presentation.

     

    Use of estimates

    Use of estimates

     

    The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

     

    Cash

    Cash

     

    We consider all highly liquid, short-term investments with original maturities of three months or less when purchased to be cash equivalents.

     

    Accounts receivable

    Accounts receivable

     

    Accounts receivable are recorded at the invoiced amount, net of allowance for doubtful accounts. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses based on specific identification of accounts in our existing accounts receivable. Outstanding account balances are reviewed individually for collectibility. We determine the allowance based on historical write-off experience, customer specific facts and economic conditions. Bad debt expense is included in general and administrative expenses, if any. We consider all accounts greater than 30 days old to be past due. Account balances are charged off against allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $2,526 at both June 30, 2014 and 2013.

     

    Inventory

    Inventory

     

    Inventory, which consists primarily of raw materials to be used in the production of our dietary supplement products, is stated at the lower of cost or market using the first-in, first-out method. We regularly review our inventory on hand and, when necessary, record a provision for excess or obsolete inventory.

     

    Property and equipment

    Property and equipment

     

    Property and equipment are recorded at cost. Additions and improvements that increase the value or extend the life of an asset are capitalized. Maintenance and repairs are expensed as incurred. Upon sale or retirement of property and equipment, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statement of operations. Depreciation is computed on a straight-line basis over the following estimated useful lives of the assets:

     

    Office equipment   3 years
    Production equipment   5 to 7 years
    Equipment under capital lease   5 to 7 years
    Leasehold improvements   Lesser of lease term or useful life of improvement

     

    Patents

    Patents

     

    Patents, once issued or purchased, are amortized using the straight-line method over their economic remaining useful lives. All internally developed process costs incurred to the point when a patent application is to be filed are expensed as incurred and classified as research and development costs. Patent application costs, generally legal costs, are capitalized pending disposition of the individual patent application, and are subsequently either amortized based on the initial patent life granted, generally 15 to 20 years for domestic patents and 5 to 20 years for foreign patents, or expensed if the patent application is rejected. The costs of defending and maintaining patents are expensed as incurred. Upon becoming fully amortized, the related cost and accumulated amortization are removed from the accounts.

     

    Impairment of long-lived assets

    Impairment of long-lived assets

     

    Our long-lived assets, which include property and equipment, patents, and licenses of patents are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

     

    We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of long-lived assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.

     

    Discount on convertible notes payable

    Discount on convertible notes payable

     

    We allocate the proceeds received from convertible notes between convertible notes payable and warrants, if applicable. The resulting discount for warrants is amortized using the effective interest method over the life of the debt instrument. After allocating a portion of the proceeds to the warrants, the effective conversion price of the convertible note payable can be determined. If the effective conversion price is lower than the market price at the date of issuance, a beneficial conversion feature is recorded as an additional discount to the convertible note payable. The beneficial conversion feature discount is amortized using the effective interest method over the life of the debt instrument. The amortization is recorded as interest expense on the consolidated statements of operations.

     

    Fair value of financial instruments

    Fair value of financial instruments

     

    The carrying amounts of our financial assets and liabilities, such as cash, accounts receivable and accounts payable, approximate their fair values (determined based on level 1 inputs in the fair value hierarchy) because of the short maturity of these instruments. Due to conversion features and other terms, it is not practical to estimate the fair value of notes payable and convertible notes.

     

    Fair value measurements

    Fair value measurements

     

    We measure fair value as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. We utilize a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

     

    Level 1   Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
         
    Level 2   Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
         
    Level 3   Unobservable inputs where there is little or no market data, which require the reporting entity to develop its own assumptions.

     

    We do not have any assets or liabilities measured at fair value on a recurring or a non-recurring basis. Consequently, we did not have any fair value adjustments for assets and liabilities measured at fair value at June 30, 2014 or 2013, nor any gains or losses reported in the consolidated statement of operations that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date for the periods ended June 30, 2014 and June 30, 2013.

     

    Revenue recognition

    Revenue recognition

     

    We recognize revenue when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred or services have been performed, (iii) amounts are fixed or determinable and (iv) collectibility of amounts is reasonably assured.

     

    Revenues from the sale of products, including shipping and handling fees but excluding statutory taxes collected from customers, as applicable, are recognized when shipment has occurred. We sell our products directly to customers. Persuasive evidence of an arrangement is demonstrated via order and invoice, product delivery is evidenced by a bill of lading from the third party carrier and title transfers upon shipment, the sales price to the customer is fixed upon acceptance of the order and there is no separate sales rebate, discount, or volume incentive.

     

    Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred. In 2012 and 2011, we incurred $26,059 and $32,784, respectively, in shipping costs included in cost of goods sold.

     

    Shipping and handling costs

    Shipping and handling costs

     

    Amounts charged to customers for shipping products are included in revenues and the related costs are classified in cost of goods sold as incurred. In 2013 and 2012, we incurred $31,996 and $26,059, respectively, in shipping costs included in cost of goods sold.

     

    Advertising and promotion costs

    Advertising and promotion costs

     

    Costs associated with the advertising and promotions of our products are expensed as incurred.

     

    Equity instruments issued to parties other than employees for acquiring goods or services

    Equity instruments issued to parties other than employees for acquiring goods or services

     

    We account for all transactions in which goods or services are the consideration received for the issuance of equity instruments based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the performance is complete or the date on which it is probable that performance will occur. Currently such transactions are primarily awards of warrants to purchase common stock.

     

    The fair value of each warrant award is estimated on the date of grant using a Black-Scholes option-pricing valuation model.

     

      The assumptions used to determine the fair value of our warrants are as follows:

     

    - The expected life of warrants issued represents the period of time the warrants are expected to be outstanding.
       
    - The expected volatility is generally based on the historical volatility of comparable companies’ stock over the contractual life of the warrant.
       
    - The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the warrant.
       
    - The expected dividend yield is based on our current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the warrant.

     

    Income taxes

    Income taxes

     

    We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in our consolidated statements of income in the period that includes the enactment date.

     

    We recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in our consolidated financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Should they occur, our policy is to classify interest and penalties related to tax positions as income tax expense.

     

    We did not record an income tax provision for the three months and six months ended June 30, 2014 and 2013 as we had a net taxable loss in the periods.

     

    Net loss per common share

    Net loss per common share

     

    Basic and diluted net loss per share has been computed by dividing our net loss by the weighted average number of common shares issued and outstanding. Convertible preferred stock, options and warrants to purchase our common stock as well as debt which are convertible into common stock are anti-dilutive and therefore are not included in the determination of the diluted net loss per share for three months ended June 30, 2014 and 2013 and the six months ended June 30, 2014 and 2013. The following table presents a reconciliation of basic loss per share and excluded dilutive securities:

     

     

         

    For the Three

    Months Ended

    June 30,

     

    For the Six

    Months Ended

    June 30,

          2014   2013   2014   2013
     Numerator:                
     Net loss     $ (510,763)   $ (1,038,338)   $ (1,046,151)   $ (1,490,612)
                       
     Denominator:              

    Weighted-average common shares outstanding

    8,532,935    7,456,281    8,429,958    7,308,930 
                       

    Basic and diluted

    net loss per share

    $ (0.06)   $ (0.14)   $ (0.12)   $ (0.20)
                       
     Common stock warrants 4,520,308    3,495,902    4,520,308    3,495,902 

    Series A convertible

    preferred stock

    2,378,070    2,411,940    2,378,070    2,411,940 
     Stock options 2,572,099    1,450,172    2,572,099    1,450,172 

    Convertible debt

    including interest

    900,321    816,516    900,321    816,516 

    Excluded dilutive

    securities

    10,370,798    8,174,530    10,370,798    8,174,530 

     

     

     

    Reclassifications

    Reclassifications

     

    Certain reclassifications have been made to prior period financial statements and footnotes in order to conform to the current period's presentation.

     

    Segments

    Segments

     

    We have determined that we operate in one segment for financial reporting purposes.

     

    Recently issued accounting pronouncements

    Recently issued accounting pronouncements

     

    In May 2014, the FASB issued new accounting guidance related to revenue recognition. This new standard will replace all current U.S. GAAP guidance on this topic and eliminate all industry-specific guidance. The new revenue recognition standard provides a unified model to determine when and how revenue is recognized. The core principle is that a company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration for which the entity expects to be entitled in exchange for those goods or services. This guidance will be effective for Entia beginning January 1, 2017 and can be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. We are evaluating the impact of adopting this new accounting standard on our financial statements.

     

    XML 51 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 8 - RELATED PARTY TRANSACTIONS
    6 Months Ended
    Jun. 30, 2014
    Related Party Transactions [Abstract]  
    NOTE 8 - RELATED PARTY TRANSACTIONS

    NOTE 8 – RELATED PARTY TRANSACTIONS

     

    Debt agreements from board member

     

    In December 2013, we entered into a promissory note due on March 31, 2014 at 0% in the principal amount of $40,000. The note was paid off on March 31, 2014.

     

    XML 52 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 6 - ACCRUED EXPENSES
    6 Months Ended
    Jun. 30, 2014
    Accounting Policies [Abstract]  
    NOTE 6 - ACCRUED EXPENSES

    NOTE 6 – ACCRUED EXPENSES

     

    Accrued expenses (included with accounts payable) consists of the following at:

     

     

    June 30,

    2014

     

    December 31,

    2013

    Executive compensation $ 710,928   $ 476,368
    Other accruals 108,199   60,671
      $ 819,127   $ 537,039

     

    XML 53 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 7 - NOTES PAYABLE
    6 Months Ended
    Jun. 30, 2014
    Debt Disclosure [Abstract]  
    NOTE 7 - NOTES PAYABLE

    NOTE 7 – NOTES PAYABLE

     

    Notes payable consists of the following:

     

         

    June 30,

    2014

     

    December 31,

    2013

    Notes payable - current      
    7.85% unsecured, $781 due monthly $ -   $ 1,964
    7.85% unsecured, $373 due monthly 2,545   -
    4.15% unsecured, $2,678 due monthly 5,513   21,824
    10.00% unsecured, interest only, due December 30, 2014 25,000   -
          $ 33,058   $ 23,788

     

     

    Convertible notes payable, net      
    8%, unsecured due June 2014  (net of discount related to beneficial conversion feature of $0 in 2014 and $49,004 in 2013), convertible into common stock at $0.45 per share. $ 312,500   $ 263,496
    8% secured due August 2014 (net of discount related to beneficial conversion feature of $2,050 in 2014 and $12,300 in 2013), convertible into preferred stock at $5.00 per share. 47,950   37,700
    6% unsecured, convertible into common stock at $2.00 per share, due on demand 50,000   50,000
    8% unsecured due August 2014 (net of discount related to beneficial conversion feature of $5,310 in 2014 and $40,552 in 2013), convertible into common stock at an average price of $0.205 per share 27,690   22,448
    8% unsecured due November 2014 (net of discount related to beneficial conversion feature of $13,517 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after September 2, 2014. 28,483   -
    8% unsecured due January 2015 (net of discount related to beneficial conversion feature of $16,997 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after October 17, 2014. 15,503   -
    8% unsecured due March 2015 (net of discount related to beneficial conversion feature of $22,227 in 2014 and $0 in 2013), convertible into common stock at a price to be determined after December 13, 2014. 10,273   -
               
    10% unsecured due March 2015 (net of discount related to warrants of $7,087 in 2014 and $0 in 2013) convertible price not yet determined 17,913   -
    10% unsecured due April 2015 (net of discount related to warrants of $29,400 in 2014 and $0 in 2013) convertible price not yet determined 70,600   -
    10% unsecured due April 2015 (net of discount related to warrants of $3,442 in 2014 and $0 in 2013) convertible price not yet determined 6,558   -
               
          $ 587,470   $ 373,644

     

     

    Convertible notes payable, net related party      
             
    0% unsecured due March 30, 2014 (net of discount related to beneficial conversion feature of $0 in 2014 and $16,573 in 2013) convertible into common stock at $0.65 per share.  This note was paid off on March 31, 2014. $ -   $ 23,427
               
          $ -   $ 23,427

     

     

     

    $312,500 in notes payable was due on June 30, 2014. We are currently in negotiations with the note holder to extend this note and we are not in default.

     

    During 2014, we entered into the following debenture agreements that accrue interest at 10%, mature in 1 year and grant the investor on a one warrant per dollar basis that are exercisable for 3 years at $1 per share and vest immediately:

     

    oOn April 15, 2014, we entered into an agreement for $10,000. We calculated the fair value of the warrants at $4,130,
    oOn April 27, 2014, we entered into an agreement for $100,000. We calculated the fair value of the warrants at $39,200, and
    oOn March 28, 2014, we entered into an agreement for $25,000. We calculated the fair value of the warrants at $9,450.

     

    We posted the fair value of the warrants as a discount on the notes and amortize them over the life of the debenture. Total value of the discounts is $52,780.

     

    In addition to the debentures, during 2014, we entered into the following convertible promissory notes with an interest rate of 8% per annum, compounded annually. If the note remains unpaid after one hundred eighty (180) days from the Issue date, the holder has the option to convert the principal and accrued interest into shares of our Company stock at a conversion price equal to 58% of the “trading price” as described in the note. We have calculated a discount for the beneficial conversion feature in the amount of $77,482 and will be amortized over the life of the loan. The amount amortized for 2014 is $14,603:

     

    oOn February 3, 2014, $42,000 due on November 3, 2014,
    oOn April 17, 2014, $32,500 due on January 17, 205, and
    oOn June 13, 2014, $32,500 due on March 13, 2015.

     

    On March 25, 2014, we entered into a line of credit arrangement. The line of credit is $60,000 with an interest rate of prime plus 3.00%. There are no loan covenants applicable to this line of credit and the amount outstanding as of June 30, 2014 is $11,750. The line of credit is reported on the balance sheet with accounts payable and accrued expenses.

     

    XML 54 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT)
    6 Months Ended
    Jun. 30, 2014
    Equity [Abstract]  
    NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT)

    NOTE 9 – STOCKHOLDERS’ EQUITY (DEFICIT)

     

    Preferred Stock

     

    On May 26, 2011, our board of directors designated 350,000 shares of preferred stock as Series A preferred stock, $0.001 par value. The Series A preferred stock is entitled to a liquidation preference in the amount of $5 per share, votes on an as converted basis with the common stock on all matters as to which holders of common stock shall be entitled to vote, and is currently convertible into common stock on a one-for-ten basis.

     

    During second quarter 2014, two investors converted 44,162 shares of Series A Preferred stock for 441,620 shares of common stock.

     

    Common stock

     

    During second quarter 2014, we issued shares of common stock for the following:

     

    o151,126 shares of common stock with a value of $32,520 upon conversion of $30,000 of convertible notes payable along with accrued interest of $2,520,
    o23,000 shares of common stock for a value of $13,113 for services rendered,
    o441,620 shares of common stock in exchange for 44,162 shares of Series A Preferred stock, and
    o80,000 shares of common stock with a value of $46,400 for the settlement of accounts payable in the amount of $149,421. We posted a gain on settlement in the amount of $103,021.

     

    During first quarter 2014, we issued shares of common stock for the following:

     

    o64,700 shares of common stock for a value of $39,556 for services rendered,
    o68,283 shares of common stock for a value of $44,250 for services to be performed in the future, and
    o6,717 shares of common stock with a value of $4,501 for the settlement of accounts payable.

     

    Stock incentive plan

     

    On September 17, 2010, our Board of Directors adopted the 2010 Stock Incentive Plan (“Plan”). The Plan provides for the grant of options to purchase shares of our common stock, and stock awards consisting of shares of our common stock, to eligible participants, including directors, executive officers, employees and consultants of the Company. We have reserved 4,650,000 shares of common stock for issuance under the Plan with an annual increase in shares of 50,000 as of January 1 of each year; commencing January 1, 2012. Stock options are granted at or below the closing price of our stock on the date of grant for terms ranging from four to fifteen years and generally vest over a five year period. The fair value of option grants were calculated at the date of the grants using the Black-Scholes option pricing model with the following assumptions:

     

       

    June 30,

    2014

     

    December 31,

    2013

     Expected dividend yield                             -                                -   
     Expected stock price volatility   210.51%-216.96%   216.96% - 236.55%
     Risk-free interest rate   0.28% - 1.84%   0.95% - 2.47%
     Expected term (in years)   3 - 7 years   5 - 10 years
     Weighted-average granted date fair value   $0.62   $0.45

     

     

    A summary of option activity under the stock option plan as of June 30, 2014 and changes during the quarter then ended is presented below:

                    Weighted    
                    Average    
                Weighted   Remaining    
        Number        Average   Contractual   Aggregate
        of   Exercise Price   Exercise     Term   Intrinsic
        Shares   Range   Price   (Years)   Value
    Outstanding, December 31, 2012   1,202,099    $0.40 - $1.00   $ 0.56   7.74   -
                         
    Exercisable, December 31, 2012   830,504    $0.40 - $1.00   $ 0.57   8.19   -
                         
    Granted   1,150,000    $0.38 - $0.81   $ 0.47   8.07   -
    Exercised   -                       -      $ -   -   -
    Expired   -                       -      $ -   -   -
                         
    Outstanding, December 31, 2013   2,352,099    $0.38 - $1.00   $ 0.51   7.90   199,505
                         
    Exercisable, December 31, 2013   1,810,344    $0.38 - $1.00   $ 0.52   7.88   138,707
                         
    Granted   220,000    $0.60-$0.75   $ 0.62   5.27    
    Exercised   -                       -      $ -   -    
    Expired   -                       -      $ -   -    
                         
    Outstanding, June 30, 2014   2,572,099    $0.38 - $1.00   $ 0.52   7.68   143,063
                         
    Exercisable, June 30, 2014   2,044,836    $0.38 - $1.00   $ 0.52   7.89   125,127

     

     

    The range of exercise prices for options outstanding under the 2010 Stock Incentive Plan at June 30, 2014 are as follows:

     

    Number of   Exercise
    shares   Price
    55,000   $ 0.38
    135,000   $ 0.40
    20,000   $ 0.44
    540,000   $ 0.45
    247,242   $ 0.47
    247,857   $ 0.49
    844,000   $ 0.50
    15,000   $ 0.62
    40,000   $ 0.65
    20,000   $ 0.75
    160,000   $ 0.60
    10,000   $ 0.81
    200,000   $ 0.85
    38,000   $ 1.00
    2,572,099    

     

     

    At June 30, 2014, the Company had 2,077,901 unissued shares available under the Plan. Also, at June 30, 2014, the Company had $263,507 of total unrecognized compensation cost related to unvested stock options, which is expected to be recognized over a weighted average period of 7 years.

     

    Warrants – Consulting Agreements

     

    Outstanding warrants to purchase common stock are as follows:

     

    Date of Issue   June 30, 2014   Exercise Price   Expiration
    June-14   15,000   $0.50   06/2019
    April-14   113,333   $0.65 - 1.00   04/2017 - 03/2021
    January-14   62,277   $0.65 - $1.00   01/2019 - 01/2021
    As of December
    2013
      4,349,698   $0.36 - $10.00   10/2013 - 10/2021
    Total   4,540,308        
    Less:            
    Expired   20,000        
    Exercised   -        
    Total   4,520,308        

     

     

    We use the Black-Scholes option-pricing model to determine the fair value of warrants on the date of grant. In determining the fair value of warrants, we employed the following key assumptions:

     

        June 30, 2014   December 31, 2013
    Risk-Free interest rate 0.28% - 1.91%   0.95% - 3.32%
    Expected dividend yield 0%   0%
    Volatility   210.51%-222.30%   216.48%-239.20%
    Expected life   3 - 7 years   3-10 years
        $0.75   $0.45

     

     

    At June 30, 2014 and 2013, the weighted-average Black-Scholes value of warrants granted was $0.75 and $0.45, respectively.

     

    XML 55 R34.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 5 - PATENTS AND LICENSES, NET (Details Narrative) (USD $)
    6 Months Ended 12 Months Ended
    Jun. 30, 2014
    Jun. 30, 2013
    Dec. 31, 2013
    Notes to Financial Statements      
    Patent and license amortization $ 7,699 $ 3,247  
    Amortization of licenses over economic useful life, maximum 17 years    
    License acquired for stock, fair value     $ 215,529
    XML 56 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 3 - INVENTORY (Tables)
    6 Months Ended
    Jun. 30, 2014
    Inventory Disclosure [Abstract]  
    Inventory
         

    June 30,

    2014

     

    December 31,

    2013

     Raw materials     $ 218,980    $ 240,750 
     Finished goods     45,150    49,255 
          264,130    290,005 
     Less:  reserve for excess and obsolete inventory (151,064)   (151,064)
          $ 113,066    $ 138,941 
    XML 57 R26.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables)
    6 Months Ended
    Jun. 30, 2014
    Option Activity
                    Weighted    
                    Average    
                Weighted   Remaining    
        Number        Average   Contractual   Aggregate
        of   Exercise Price   Exercise     Term   Intrinsic
        Shares   Range   Price   (Years)   Value
    Outstanding, December 31, 2012   1,202,099    $0.40 - $1.00   $ 0.56   7.74   -
                         
    Exercisable, December 31, 2012   830,504    $0.40 - $1.00   $ 0.57   8.19   -
                         
    Granted   1,150,000    $0.38 - $0.81   $ 0.47   8.07   -
    Exercised   -                       -      $ -   -   -
    Expired   -                       -      $ -   -   -
                         
    Outstanding, December 31, 2013   2,352,099    $0.38 - $1.00   $ 0.51   7.90   199,505
                         
    Exercisable, December 31, 2013   1,810,344    $0.38 - $1.00   $ 0.52   7.88   138,707
                         
    Granted   220,000    $0.60-$0.75   $ 0.62   5.27    
    Exercised   -                       -      $ -   -    
    Expired   -                       -      $ -   -    
                         
    Outstanding, June 30, 2014   2,572,099    $0.38 - $1.00   $ 0.52   7.68   143,063
                         
    Exercisable, June 30, 2014   2,044,836    $0.38 - $1.00   $ 0.52   7.89   125,127
    Range of Options Exercise Price
    Number of   Exercise
    shares   Price
    55,000   $ 0.38
    135,000   $ 0.40
    20,000   $ 0.44
    540,000   $ 0.45
    247,242   $ 0.47
    247,857   $ 0.49
    844,000   $ 0.50
    15,000   $ 0.62
    40,000   $ 0.65
    20,000   $ 0.75
    160,000   $ 0.60
    10,000   $ 0.81
    200,000   $ 0.85
    38,000   $ 1.00
    2,572,099    
    Outstanding Warrants
    Date of Issue   June 30, 2014   Exercise Price   Expiration
    June-14   15,000   $0.50   06/2019
    April-14   113,333   $0.65 - 1.00   04/2017 - 03/2021
    January-14   62,277   $0.65 - $1.00   01/2019 - 01/2021
    As of December
    2013
      4,349,698   $0.36 - $10.00   10/2013 - 10/2021
    Total   4,540,308        
    Less:            
    Expired   20,000        
    Exercised   -        
    Total   4,520,308        
    Option Member
     
    Black-Scholes Option-Pricing Model Assumptions
       

    June 30,

    2014

     

    December 31,

    2013

     Expected dividend yield                             -                                -   
     Expected stock price volatility   210.51%-216.96%   216.96% - 236.55%
     Risk-free interest rate   0.28% - 1.84%   0.95% - 2.47%
     Expected term (in years)   3 - 7 years   5 - 10 years
     Weighted-average granted date fair value   $0.62   $0.45
    Warrant Member
     
    Black-Scholes Option-Pricing Model Assumptions
        June 30, 2014   December 31, 2013
    Risk-Free interest rate 0.28% - 1.91%   0.95% - 3.32%
    Expected dividend yield 0%   0%
    Volatility   210.51%-222.30%   216.48%-239.20%
    Expected life   3 - 7 years   3-10 years
        $0.75   $0.45
    XML 58 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 9 - OPTION ACTIVITY (Details) (USD $)
    6 Months Ended 12 Months Ended
    Jun. 30, 2014
    Dec. 31, 2013
    Dec. 31, 2012
    Exercisable
         
    Number of Shares, instant 2,044,836 1,810,344 830,504
    Exercise Price Range, instant, minimum $ 0.38 $ 0.38 $ 0.40
    Exercise Price Range, instant, maximum $ 1.00 $ 1.00 $ 1.00
    Weighted Average Exercise Price, instant $ 0.52 $ 0.52 $ 0.57
    Weighted Average Remaining Contractual Life (in years), duration 7 years 10 months 7 years 10 months  
    Aggregate Intrinsic Value, instant $ 125,127 $ 138,707 $ 0
    Outstanding
         
    Number of Shares, instant 2,572,099 2,352,099 1,202,099
    Exercise Price Range, instant, minimum $ 0.38 $ 0.38 $ 0.40
    Exercise Price Range, instant, maximum $ 1.00 $ 1.00 $ 1.00
    Weighted Average Exercise Price, instant $ 0.52 $ 0.51 $ 0.56
    Weighted Average Remaining Contractual Life (in years), duration 7 years 8 months 7 years 10 months  
    Aggregate Intrinsic Value, instant 143,063 199,505 0
    Granted
         
    Number of Shares, duration 220,000 1,150,000  
    Exercise Price Range, duration, minimum $ 0.60 $ 0.38  
    Exercise Price Range, duration, maximum $ 0.75 $ 0.81  
    Weighted Average Exercise Price, duration $ 0.62 $ 0.47  
    Weighted Average Remaining Contractual Life (in years), duration 5 years 4 months 8 years 1 month  
    Aggregate Intrinsic Value, duration 0 0  
    Exercised
         
    Number of Shares, duration 0 0  
    Exercise Price Range, duration, minimum $ 0 $ 0  
    Exercise Price Range, duration, maximum $ 0 $ 0  
    Weighted Average Exercise Price, duration $ 0 $ 0  
    Weighted Average Remaining Contractual Life (in years), duration 0 years 0 years  
    Aggregate Intrinsic Value, duration 0 0  
    Expired
         
    Number of Shares, duration 0 0  
    Exercise Price Range, duration, minimum $ 0 $ 0  
    Exercise Price Range, duration, maximum $ 0 $ 0  
    Weighted Average Exercise Price, duration $ 0 $ 0  
    Weighted Average Remaining Contractual Life (in years), duration 0 years 0 years  
    Aggregate Intrinsic Value, duration $ 0 $ 0  
    XML 59 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
    CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
    Preferred Stock
    Common Stock
    Additional Paid In Capital
    Deferred Compensation
    Stock Subscriptions
    Accumulated Deficit
    Total
    Beginning Balance, Amount at Dec. 31, 2012 $ 110 $ 7,444 $ 5,115,587 $ (394,510) $ (49,000) $ (5,327,924) $ (648,293)
    Beginning Balance, Shares at Dec. 31, 2012 109,900 7,444,591          
    Issuance of preferred stock for cash, Shares 140,175            
    Issuance of preferred stock for cash, Amount 140   700,735       700,875
    Issuance of preferred stock for cancellation of debt, Shares 3,162            
    Issuance of preferred stock for cancellation of debt, Amount 3   15,747       15,750
    Deemed dividend related to beneficial conversion feature of convertible preferred stock, Shares     87,600       (87,600)
    Issuance of preferred stock for conversion of convertible notes payable, Shares 23,332            
    Issuance of preferred stock for conversion of convertible notes payable, Amount 23   116,629       116,652
    Issuance of preferred stock for conversion of accounts payable, Shares 30,400            
    Issuance of preferred stock for conversion of accounts payable, Amount 31   151,970       152,001
    Issuance of warrants in connection with convertible notes payable     16,400       16,400
    Beneficial conversion feature in connection with convertible notes payable     64,956       64,956
    Issuance of common stock for license agreement, Shares   200,000          
    Issuance of common stock for license agreement, Amount   200 215,329       215,529
    Issuance of common stock for conversion of preferred stock, Shares (25,000) 250,000          
    Issuance of common stock for conversion of preferred stock, Amount (25) 250 (225)        
    Issuance of common stock for conversion of accrued compensation, Shares   273,158          
    Issuance of common stock for conversion of accrued compensation, Amount   274 129,727       130,001
    Issuance of common stock for services, Shares   129,896          
    Issuance of common stock for services, Amount   130 83,270        
    Issuance of common stock and warrants for cash, Shares             4,607,050
    Stock compensation, Amount     413,921       413,921
    Issuance of warrants for services     584,108 (584,108)      
    Issuance of warrants for extension on debt     98,006       98,006
    Amortization of deferred compensation       796,042     796,042
    Net loss           (3,104,827) (3,104,827)
    Ending Balance, amount at Dec. 31, 2013 282 8,298 7,793,760 (182,576) (49,000) (8,520,351) (949,587)
    Ending Balance, shares at Dec. 31, 2013 281,969 8,297,645          
    Issuance of warrants in connection with convertible notes payable     52,780       52,780
    Beneficial conversion feature in connection with convertible notes payable     77,482       77,482
    Issuance of common stock for conversion of preferred stock, Shares (44,162) 441,620          
    Issuance of common stock for conversion of preferred stock, Amount (44) 442 (398) 0 0 0 0
    Issuance of common stock for conversion of convertible debt, Shares   151,126          
    Issuance of common stock for conversion of convertible debt, Amount   151 32,369 0 0 0 32,520
    Issuance of common stock for conversion of accounts payable, Shares   86,717          
    Issuance of common stock for conversion of accounts payable, Amount   87 50,814 0 0 0 50,901
    Issuance of common stock for future services, Shares   68,283          
    Issuance of common stock for future services, Amount   68 44,182 (44,250)      
    Issuance of common stock for services, Shares   87,700          
    Issuance of common stock for services, Amount   88 52,581        
    Stock compensation, Amount     108,739       108,739
    Receipt of stock subcription receivable, less write-off of $9,000         49,000   49,000
    Issuance of warrants for services     188,674 (188,674)      
    Amortization of deferred compensation       227,133     227,133
    Net loss           (1,046,151) (1,046,151)
    Ending Balance, amount at Jun. 30, 2014 $ 238 $ 9,134 $ 8,400,983 $ (188,367) $ 0 $ (9,566,502) $ (1,344,514)
    Ending Balance, shares at Jun. 30, 2014 237,807 9,133,091          
    XML 60 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 3 - INVENTORY
    6 Months Ended
    Jun. 30, 2014
    Inventory Disclosure [Abstract]  
    NOTE 3 - INVENTORY

    NOTE 3 – INVENTORY

     

    Inventory consists of the following:

     

     

         

    June 30,

    2014

     

    December 31,

    2013

     Raw materials     $ 218,980    $ 240,750 
     Finished goods     45,150    49,255 
          264,130    290,005 
     Less:  reserve for excess and obsolete inventory (151,064)   (151,064)
          $ 113,066    $ 138,941 

     

    XML 61 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 1 - ORGANIZATION AND OPERATIONS (Details Narrative) (USD $)
    Jun. 30, 2014
    Dec. 31, 2013
    Jun. 30, 2013
    Mar. 31, 2013
    Dec. 31, 2012
    Notes to Financial Statements          
    Cash and cash equivalents $ 15,484 $ 36,886 $ 13,161 $ 33,409 $ 13,081
    XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 133 289 1 false 47 0 false 9 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://ERGO/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://ERGO/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://ERGO/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://ERGO/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://ERGO/role/ConsolidatedStatementOfStockholdersEquityDeficit CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://ERGO/role/ConsolidatedStatementOfStockholdersEquityDeficitParenthetical CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://ERGO/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 00000008 - Disclosure - NOTE 1 - ORGANIZATION AND OPERATIONS Sheet http://ERGO/role/Note1-OrganizationAndOperations NOTE 1 - ORGANIZATION AND OPERATIONS false false R9.htm 00000009 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://ERGO/role/Note2-SummaryOfSignificantAccountingPolicies NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R10.htm 00000010 - Disclosure - NOTE 3 - INVENTORY Sheet http://ERGO/role/Note3-Inventory NOTE 3 - INVENTORY false false R11.htm 00000011 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT Sheet http://ERGO/role/Note4-PropertyAndEquipment NOTE 4 - PROPERTY AND EQUIPMENT false false R12.htm 00000012 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET Sheet http://ERGO/role/Note5-PatentsAndLicensesNet NOTE 5 - PATENTS AND LICENSES, NET false false R13.htm 00000013 - Disclosure - NOTE 6 - ACCRUED EXPENSES Sheet http://ERGO/role/Note6-AccruedExpenses NOTE 6 - ACCRUED EXPENSES false false R14.htm 00000014 - Disclosure - NOTE 7 - NOTES PAYABLE Notes http://ERGO/role/Note7-NotesPayable NOTE 7 - NOTES PAYABLE false false R15.htm 00000015 - Disclosure - NOTE 8 - RELATED PARTY TRANSACTIONS Sheet http://ERGO/role/Note8-RelatedPartyTransactions NOTE 8 - RELATED PARTY TRANSACTIONS false false R16.htm 00000016 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://ERGO/role/Note9-StockholdersEquityDeficit NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) false false R17.htm 00000017 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES Sheet http://ERGO/role/Note10-CommitmentsAndContingencies NOTE 10 - COMMITMENTS AND CONTINGENCIES false false R18.htm 00000018 - Disclosure - NOTE 11 - SUBSEQUENT EVENTS Sheet http://ERGO/role/Note11-SubsequentEvents NOTE 11 - SUBSEQUENT EVENTS false false R19.htm 00000019 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://ERGO/role/Note2-SummaryOfSignificantAccountingPoliciesPolicies NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R20.htm 00000020 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://ERGO/role/Note2-SummaryOfSignificantAccountingPoliciesTables NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R21.htm 00000021 - Disclosure - NOTE 3 - INVENTORY (Tables) Sheet http://ERGO/role/Note3-InventoryTables NOTE 3 - INVENTORY (Tables) false false R22.htm 00000022 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT (Tables) Sheet http://ERGO/role/Note4-PropertyAndEquipmentTables NOTE 4 - PROPERTY AND EQUIPMENT (Tables) false false R23.htm 00000023 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET (Tables) Sheet http://ERGO/role/Note5-PatentsAndLicensesNetTables NOTE 5 - PATENTS AND LICENSES, NET (Tables) false false R24.htm 00000024 - Disclosure - NOTE 6 - ACCRUED EXPENSES (Tables) Sheet http://ERGO/role/Note6-AccruedExpensesTables NOTE 6 - ACCRUED EXPENSES (Tables) false false R25.htm 00000025 - Disclosure - NOTE 7 - NOTES PAYABLE (Tables) Notes http://ERGO/role/Note7-NotesPayableTables NOTE 7 - NOTES PAYABLE (Tables) false false R26.htm 00000026 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) Sheet http://ERGO/role/Note9-StockholdersEquityDeficitTables NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Tables) false false R27.htm 00000027 - Disclosure - NOTE 1 - ORGANIZATION AND OPERATIONS (Details Narrative) Sheet http://ERGO/role/Note1-OrganizationAndOperationsDetailsNarrative NOTE 1 - ORGANIZATION AND OPERATIONS (Details Narrative) false false R28.htm 00000028 - Disclosure - NOTE 2 - ESTIMATED USEFUL LIVES OF THE ASSETS (Details) Sheet http://ERGO/role/Note2-EstimatedUsefulLivesOfAssetsDetails NOTE 2 - ESTIMATED USEFUL LIVES OF THE ASSETS (Details) false false R29.htm 00000029 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER COMMON SHARE (Details) Sheet http://ERGO/role/Note2-SummaryOfSignificantAccountingPolicies-NetLossPerCommonShareDetails NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - NET LOSS PER COMMON SHARE (Details) false false R30.htm 00000030 - Disclosure - NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://ERGO/role/Note2-SummaryOfSignificantAccountingPoliciesDetailsNarrative NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) false false R31.htm 00000031 - Disclosure - NOTE 3 - INVENTORY (Details) Sheet http://ERGO/role/Note3-InventoryDetails NOTE 3 - INVENTORY (Details) false false R32.htm 00000033 - Disclosure - NOTE 4 - PROPERTY AND EQUIPMENT - PROPERTY AND EQUIPMENT (Details) Sheet http://ERGO/role/Note4-PropertyAndEquipment-PropertyAndEquipmentDetails NOTE 4 - PROPERTY AND EQUIPMENT - PROPERTY AND EQUIPMENT (Details) false false R33.htm 00000035 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET - PATENTS AND LICENSES (Details) Sheet http://ERGO/role/Note5-PatentsAndLicensesNet-PatentsAndLicensesDetails NOTE 5 - PATENTS AND LICENSES, NET - PATENTS AND LICENSES (Details) false false R34.htm 00000036 - Disclosure - NOTE 5 - PATENTS AND LICENSES, NET (Details Narrative) Sheet http://ERGO/role/Note5-PatentsAndLicensesNetDetailsNarrative NOTE 5 - PATENTS AND LICENSES, NET (Details Narrative) false false R35.htm 00000037 - Disclosure - NOTE 6 - ACCRUED EXPENSES (Details) Sheet http://ERGO/role/Note6-AccruedExpensesDetails NOTE 6 - ACCRUED EXPENSES (Details) false false R36.htm 00000038 - Disclosure - NOTE 7 - NOTES PAYABLE (Details) Notes http://ERGO/role/Note7-NotesPayableDetails NOTE 7 - NOTES PAYABLE (Details) false false R37.htm 00000039 - Disclosure - NOTE 7 - NOTES PAYABLE (Details) (Parenthetical) Notes http://ERGO/role/Note7-NotesPayableDetailsParenthetical NOTE 7 - NOTES PAYABLE (Details) (Parenthetical) false false R38.htm 00000040 - Disclosure - NOTE 7 - NOTES PAYABLE (Details Narrative) Notes http://ERGO/role/Note7-NotesPayableDetailsNarrative NOTE 7 - NOTES PAYABLE (Details Narrative) false false R39.htm 00000041 - Disclosure - NOTE 8 - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://ERGO/role/Note8-RelatedPartyTransactionsDetailsNarrative NOTE 8 - RELATED PARTY TRANSACTIONS (Details Narrative) false false R40.htm 00000042 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) - BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) Sheet http://ERGO/role/Note9-StockholdersEquityDeficit-Black-ScholesOption-PricingModelAssumptionsDetails NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) - BLACK-SCHOLES OPTION-PRICING MODEL ASSUMPTIONS (Details) false false R41.htm 00000043 - Disclosure - NOTE 9 - OPTION ACTIVITY (Details) Sheet http://ERGO/role/Note9-OptionActivityDetails NOTE 9 - OPTION ACTIVITY (Details) false false R42.htm 00000044 - Disclosure - NOTE 9 - RANGE OF OPTIONS EXERCISE PRICE (Details) Sheet http://ERGO/role/Note9-RangeOfOptionsExercisePriceDetails NOTE 9 - RANGE OF OPTIONS EXERCISE PRICE (Details) false false R43.htm 00000045 - Disclosure - NOTE 9 - OUTSTANDING WARRANTS (Details) Sheet http://ERGO/role/Note9-OutstandingWarrantsDetails NOTE 9 - OUTSTANDING WARRANTS (Details) false false R44.htm 00000046 - Disclosure - NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) Sheet http://ERGO/role/Note9-StockholdersEquityDeficitDetailsNarrative NOTE 9 - STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) false false R45.htm 00000047 - Disclosure - NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://ERGO/role/Note10-CommitmentsAndContingenciesDetailsNarrative NOTE 10 - COMMITMENTS AND CONTINGENCIES (Details Narrative) false false R46.htm 00000048 - Disclosure - NOTE 11 - SUBSEQUENT EVENTS (Details Narrative) Sheet http://ERGO/role/Note11-SubsequentEventsDetailsNarrative NOTE 11 - SUBSEQUENT EVENTS (Details Narrative) false false All Reports Book All Reports Process Flow-Through: 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jul. 14, 2014' Process Flow-Through: Removing column 'Jul. 01, 2014' Process Flow-Through: Removing column 'Jun. 13, 2014' Process Flow-Through: Removing column 'Apr. 17, 2014' Process Flow-Through: Removing column 'Feb. 03, 2014' Process Flow-Through: Removing column 'Jun. 30, 2013' Process Flow-Through: Removing column 'Mar. 31, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' Process Flow-Through: 00000006 - Statement - CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Process Flow-Through: 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2013' ergo-20140630.xml ergo-20140630.xsd ergo-20140630_cal.xml ergo-20140630_def.xml ergo-20140630_lab.xml ergo-20140630_pre.xml true true XML 63 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 7 - NOTES PAYABLE (Details Narrative) (USD $)
    1 Months Ended 3 Months Ended
    Jul. 31, 2014
    Apr. 30, 2014
    Jun. 30, 2014
    Jul. 14, 2014
    Jul. 01, 2014
    Jun. 13, 2014
    Apr. 27, 2014
    Apr. 17, 2014
    Apr. 15, 2014
    Mar. 25, 2014
    Feb. 03, 2014
    Dec. 31, 2013
    Notes to Financial Statements                        
    Promissory note amount, instant             $ 25,000   $ 100,000 $ 10,000    
    Promissory note term in months, duration     12 months                  
    Interest rate of promissory note, instant             10.00%   10.00% 10.00%    
    Line of credit arrangement amount                   60,000    
    Interest rate of line of credit on top of prime                   3.00%    
    Line of credit amount oustanding                   11,750    
    Amount of note payable due on June 30, 2014     312,500                  
    Fair value of warrants granted to note holder             39,200   4,130 9,450    
    Convertible price, per share         $ 0.50              
    Discount for the beneficial conversion feature of the convertible promisorry note       30,776 7,545              
    Convertible promissory note amount, instant     587,470 42,500 15,000 32,500   32,500     42,000 373,644
    Convertible promissory note term in months, duration 4 months                      
    Due date of convertible promissory note     6 months                  
    Interest rate of convertible promissory note, instant       8.00%   8.00%   8.00%     8.00%  
    Convertible price, per share, instant         $ 0.50              
    Convertible price, percent of market trading price           58.00%   58.00%     58.00%  
    Period until Convertible note is convertible 180 days                      
    Discount for the beneficial conversion feature of the convertible promisorry note, instant       30,776 7,545              
    Discount for the beneficial conversion feature of the convertible promisorry note, duration     77,482                  
    Warrants granted for promissory note issuance 15,000 110,000 110,000                  
    Warrant term, in years 5 years 3 years 3 years                  
    Warrant exercise price per share $ 0.50 $ 1.00 $ 1.00                  
    Discount on granting warrants     52,780                  
    Beneficial conversion feature amortized in 2014     14,603                  
    Debt converted to common stock, value $ 33,000                      
    Debt converted to common stock, shares 226,530                      
    XML 64 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
    NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
    6 Months Ended
    Jun. 30, 2014
    Accounting Policies [Abstract]  
    Estimated Useful Lives of the Assets
    Office equipment   3 years
    Production equipment   5 to 7 years
    Equipment under capital lease   5 to 7 years
    Leasehold improvements   Lesser of lease term or useful life of improvement

     

    Net Loss Per Common Share
         

    For the Three

    Months Ended

    June 30,

     

    For the Six

    Months Ended

    June 30,

          2014   2013   2014   2013
     Numerator:                
     Net loss     $ (510,763)   $ (1,038,338)   $ (1,046,151)   $ (1,490,612)
                       
     Denominator:              

    Weighted-average common shares outstanding

    8,532,935    7,456,281    8,429,958    7,308,930 
                       

    Basic and diluted

    net loss per share

    $ (0.06)   $ (0.14)   $ (0.12)   $ (0.20)
                       
     Common stock warrants 4,520,308    3,495,902    4,520,308    3,495,902 

    Series A convertible

    preferred stock

    2,378,070    2,411,940    2,378,070    2,411,940 
     Stock options 2,572,099    1,450,172    2,572,099    1,450,172 

    Convertible debt

    including interest

    900,321    816,516    900,321    816,516 

    Excluded dilutive

    securities

    10,370,798    8,174,530    10,370,798    8,174,530 


Exhibit 31.1


CERTIFICATION


I, Marvin S. Hausman, M.D., Chief Executive Officer of Entia Biosciences, Inc., certify that:


1.

I have reviewed this Quarterly Report on Form 10-Q of Entia Biosciences, Inc;


2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Dated:  August 15, 2014

By:  /s/ Marvin S. Hausman, M.D.

 

       Marvin S. Hausman, M.D.

 

       President and Chief Executive Officer

     Acting Chief Financial Officer